Form 8-K
8-K — StableX Technologies, Inc.
Accession: 0001493152-26-019257
Filed: 2026-04-28
Period: 2026-04-27
CIK: 0001086745
SIC: 4899 (COMMUNICATION SERVICES, NEC)
Item: Entry into a Material Definitive Agreement
Item: Unregistered Sales of Equity Securities
Item: Material Modifications to Rights of Security Holders
Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — form8-k.htm (Primary)
EX-3.1 (ex3-1.htm)
EX-3.2 (ex3-2.htm)
EX-3.3 (ex3-3.htm)
EX-3.4 (ex3-4.htm)
EX-3.5 (ex3-5.htm)
EX-4.1 (ex4-1.htm)
EX-4.2 (ex4-2.htm)
EX-4.3 (ex4-3.htm)
EX-4.4 (ex4-4.htm)
EX-10.1 (ex10-1.htm)
EX-10.2 (ex10-2.htm)
EX-10.3 (ex10-3.htm)
EX-10.4 (ex10-4.htm)
EX-10.5 (ex10-5.htm)
EX-10.6 (ex10-6.htm)
EX-10.7 (ex10-7.htm)
EX-99.1 (ex99-1.htm)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K
8-K (Primary)
Filename: form8-k.htm · Sequence: 1
--12-31
false
0001086745
0001086745
2026-04-27
2026-04-27
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report
(Date
of earliest event reported):
April
27, 2026
Fabric.AI,
Inc.
StableX
Technologies, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
001-34643
98-0204758
(State
or other jurisdiction of
(Commission
(IRS
Employer
incorporation)
File
No.)
Identification
No.)
1185
Avenue of the Americas
New
York, NY 10036
(Address
of principal executive offices and zip code)
512-994-4917
(Registrant’s
telephone number, including area code)
StableX
Technologies, Inc.
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
Trading
Symbol(s)
Name
of each exchange on which registered
Common
stock, par value $0.0001 per share
SBLX
The
Nasdaq Stock Market LLC
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
1.01 Entry into a Material Definitive Agreement.
Joint
Development and License Agreement
On
April 27, 2026, Fabric.AI, Inc. (the “Company”), entered into a Joint Development and License Agreement (the “JDA”)
with Kopin Corporation, a Delaware corporation (“Kopin”), pursuant to which the Company and Kopin agreed to collaborate on
the development and commercialization of Kopin’s interface for GPU-to-GPU connectivity and will work together to develop a prototype
and demonstration version of the Project Technology (as defined below) in accordance with one or more statements of work or purchase
orders (each, a “Development Plan”) agreed in writing between the parties from time to time, which shall set out the scope,
deliverables, timelines and other relevant terms of the applicable development activities. Any data communications chip technology that
is to be developed by either party in performance of any Development Plan is herein referred to as the “Project Technology.”
Pursuant
to the JDA, the Company has agreed to pay Kopin up to $15,000,000 for the development of the Project Technology through achievement of
at least one successful prototype demonstrations (a “Successful Demo”) in accordance with the Development Plan(s) and the
funding schedule agreed by the parties (the “Development Funds”). The Company has agreed to issue an initial purchase order
of $5,000,000 within 10 business days after the date on which the JDA was entered into, and payable within ten business days of Kopin’s
receipt of such purchase order. Further, the Company agreed that it will ensure that at least $5,000,000 of funds are available in a
segregated account to cover Development Plan needs. Following this initial purchase order, the Company will pay Kopin the remaining Development
Funds in installments in accordance with a time-based funding schedule agreed by the parties as part of the applicable Development Plan.
Following achievement of a Successful Demo, the parties agreed to negotiate in good faith for a period of one year to agree upon a funding,
development, manufacturing and commercialization plan for production deployment of the Project Technology, as agreed in writing by the
parties (the “Production Plan”), which is expected to include an additional payment by the Company of approximately $15,000,000
to $25,000,000.
Pursuant
to the JDA, Kopin must (i) provide the Company with periodic written reports not less than once per month concerning all material activities
undertaken in respect of the applicable Development Plan, (ii) keep the Company informed on a timely basis concerning all material progress
in the applicable Development Plan, and (iii) at the Company’s reasonable written request, from time to time, provide the Company
with information relating to the progress of the applicable Development Plan.
In
further consideration of Kopin’s contributions to the development of the Project Technology, the Company has agreed to issue to
Kopin shares of the Company’s Series J Convertible Preferred Stock, par value $0.0001 per share (“Series J Preferred Stock”),
constituting 19.9% of the pro forma fully-diluted outstanding shares of the Company’s common stock, par value $0.0001 per share
(the “Common Stock”), excluding shares of common stock underlying unexercised options, warrants, and other common stock equivalents,
subject to certain anti-dilution adjustments upon the sale or issuance of Common Stock or common stock equivalents, or the conversion
or exercise of outstanding common stock equivalents as further described below. Pursuant to the JDA, the Company agreed to take all actions
necessary to give full force and effect to the adjustment provisions set forth in the Certificate of Designations Series J Convertible
Preferred Stock (the “Series J Certificate of Designations”), including through the issuance of additional shares of Series
J Preferred Stock to Kopin in such amounts as may be required to ensure that the number of shares of Series J Preferred Stock issued
to Kopin are convertible into the Maximum Issuance (as defined below) upon each Dilutive Issuance or Dilutive Conversion (as each term
is defined below), as applicable, in accordance with the terms of the Series J Certificate of Designations.
Pursuant
to the JDA, the Company and Kopin have agreed to jointly and equally own all right, title, and interest in the Project Technology developed
under the JDA, while Kopin retains sole ownership of pre-existing technology in its possession on the date of the JDA, and any improvements
and modifications to such technology, excluding Project Technology (the “Background Technology”). Kopin has granted the Company
a non-exclusive, royalty-free, worldwide license under Kopin’s Background Technology for developing and commercializing the Project
Technology within the scope of the Company’s rights under the JDA. The Company has the exclusive worldwide rights to commercialize
the Project Technology in all commercial markets, subject to Kopin’s exclusive worldwide rights to commercialize the Project Technology
for or with respect to: (a) government agencies, departments, instrumentalities or other public sector bodies, including defense, intelligence,
national security and public research bodies; (b) military, defense or government intelligence end users; and (c) defense contractors,
subcontractors, integrators and other entities primarily engaged in supplying products or services to government, military, defense or
government intelligence markets, in each case on a worldwide basis. All products incorporating the Project Technology are required to
be manufactured exclusively by or on behalf of Kopin.
The
JDA provides for the establishment of a joint steering committee (the “JSC”) to oversee and coordinate the performance of
the JDA, consisting of two representatives from each of the Company and Kopin. Michael Murray, Kopin’s Chief Executive Officer,
will serve as one of Kopin’s representatives and as chairperson of the JSC. Members of the JSC may be compensated by the Company
and/or Kopin in a manner to be determined by the parties.
Either
the Company or Kopin may terminate the JDA upon sixty days’ written notice for material breach (subject to a cure period) or immediately
upon a bankruptcy event of the other party. In the event of termination arising from the Company’s breach, failure to fund, or
a bankruptcy event, Kopin has the right to continue to develop, use, and commercialize the Project Technology without restriction, and
the Company has agreed to assign to Kopin all of its right, title, and interest in the Project Technology.
Pursuant
to the JDA, the Company has agreed that, during the term of the JDA and for three years thereafter, neither the Company nor its affiliates
will (a) acquire beneficial ownership of more than 9.9% of the outstanding voting securities of Kopin; (b) make or participate in any
tender offer, exchange offer, merger or other business combination involving Kopin; (c) solicit proxies or consents with respect to securities
of Kopin; or (d) otherwise seek to obtain control of Kopin other than through a transaction approved by Kopin’s board of directors.
The
JDA contains certain representations and warranties, covenants and indemnities customary for similar transactions. The representations,
warranties and covenants contained in the JDA were made solely for the benefit of the parties to the JDA and may be subject to limitations
agreed upon by the parties.
The
foregoing description of the JDA does not purport to be complete and is qualified in its entirety by reference to the full text of the
JDA, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Supply
Agreement
Concurrently
with the JDA, on April 27, 2026, the Company and Kopin also entered into that certain Commercial Supply Agreement (the “Supply
Agreement”). Under the Supply Agreement, Kopin has appointed the Company as the exclusive seller of any products incorporating
the Project Technology and developed under the JDA (the “Products”) to end users located worldwide, excluding countries subject
to comprehensive U.S. trade or economic sanctions (the “Territory”). Kopin has retained exclusive supply and distribution
rights with respect to the sale of Products to the automotive, military, and defense markets, and has the right to prioritize supply
to such markets.
The
Company is required to purchase its entire requirements for Products from Kopin, except following the occurrence of any of the following:
(a) Kopin’s failure to deliver at least 90% of the quantity of Products ordered by the Company in an accepted purchase order within
the applicable lead times agreed by the parties (plus a grace period of 30 days), in each case other than where such failure is due to
(x) supply constraints, component shortages or manufacturing limitations, or (y) compliance with Kopin’s other contractual, legal
or regulatory obligations; (b) Kopin’s written notice to the Company that Kopin will be unable to fulfill a material portion of
any purchase order; (c) Kopin’s failure, over two (2) consecutive quarters, to use commercially reasonable efforts to maintain
manufacturing capacity sufficient to support the Company’s forecasted requirements, as agreed between the parties; or (d) Kopin’s
discontinuation of manufacturing operations for the Products for a period of sixty (60) or more consecutive days (other than for scheduled
maintenance disclosed to the Company in advance), except, with regard to each of the foregoing, to the extent directly caused by (i)
acts beyond Kopin’s reasonable control; (ii) the Company’s failure to perform any of its obligations under the Supply Agreement;
(iii) Kopin’s compliance with any contractual, legal or regulatory obligation to prioritize supply to governmental, military or
defense customers; (iv) any increase in purchase orders or forecasted requirements by the Company that is not consistent with the most
recent forecast provided to Kopin or that exceeds agreed ramp-up parameters between the parties; or (v) any purchase order or requested
delivery date that does not comply with the applicable lead times agreed by the parties (each, an “Inability to Supply Event”).
In the event of an Inability to Supply Event, the Company may, solely to the extent necessary and subject to written agreement with Kopin,
manufacture Products in the Territory. Any such right terminates immediately upon Kopin’s ability to resume supply.
The
Company and Kopin have agreed to cooperate in good faith to develop a mutually acceptable manufacturing ramp-up plan (the “Ramp-Up
Plan”) which will include: (a) identification and procurement of tooling, equipment, and other capital assets required for factory
production of the Products; (b) qualification and sourcing of components and raw materials necessary for manufacture of the Products;
(c) establishment of a timeline for the commencement and scaling of commercial manufacturing operations; (d) a detailed budget setting
forth the estimated costs associated with each element of the Ramp-Up Plan. The parties intend to finalize the Ramp-Up Plan within one
year following successful completion of the product development phase under the JDA.
The
Supply Agreement has an initial term of four years commencing on the effective date, with automatic one-year renewal periods unless either
party provides written notice of non-renewal at least 90 days prior to the end of the then-current term. Upon expiration or termination,
all indebtedness of the Company to Kopin will become immediately due and payable, and the Company will be required to cease representing
itself as Kopin’s authorized representative and return or destroy all confidential information.
The
Supply Agreement also contains customary representations and warranties, indemnification provisions, product warranty provisions, confidentiality
obligations, insurance requirements, non-compete restrictions, and other miscellaneous terms.
The
foregoing description of the Supply Agreement does not purport to be complete and is qualified in its entirety by reference to the full
text of the Supply Agreement, which is filed as Exhibit 10.2 to this Current Report on Form 8-K and is incorporated herein by reference.
Series
J Convertible Preferred Stock
The
terms of the Series J Preferred Stock are as set forth in the Series J Certificate of Designations, attached hereto as Exhibit 3.1 to
this Current Report on Form 8-K, which was filed with the Secretary of State for the State of Delaware on April 27, 2026.
The
Series J Preferred Stock will be convertible into shares of Common Stock (the “Series J Conversion Shares”) at the election
of the holder at any time at an initial conversion price of $2.51 (the “Series J Conversion Price”), which such Series J
Conversion Price is subject to customary adjustments for stock dividends, stock splits, reclassifications and the like.
The
shares of Series J Preferred Stock will rank (i) pari passu to shares of the Company’s Series H-7 Convertible Preferred Stock,
par value $0.0001 per share (“Series H-7 Preferred Stock”), and any other class or series of capital stock expressly designated
as pari passu with the Series J Preferred Stock (“Parity Stock”) and (ii) senior to the Company’s Series A Junior Participating
Preferred Stock, par value $0.0001 per share, the Series H Preferred Stock, par value $0.0001 per share, the Series H Convertible Preferred
Stock, par value $0.0001 per share, the Series H-3 Convertible Preferred Stock, par value $0.0001 per share, the Series H-6 Convertible
Preferred Stock, par value $0.0001 per share, the Series I Convertible Preferred Stock, par value $0.0001 per share (“Series I
Preferred Stock”), and any other class or series of capital stock of the Company that is not expressly designated as Parity Stock
or senior in rank to the Series J Preferred Stock (“Senior Preferred Stock”) (such non-designated stock, “Junior Stock”),
with respect to the preferences as to dividends, distributions and payments upon the liquidation, dissolution and winding up of the Company.
The
number of Series J Conversion Shares initially may not exceed 291,049 (the “Maximum Issuance”); provided, however, that (1)
the sale and issuance, in one or more offerings, of any Common Stock or any securities entitling any person to acquire shares of Common
Stock (such issuance, a “Dilutive Issuance”) or (2) the issuance of Common Stock (a “Dilutive Conversion”) in
connection with any conversions or exercises of any common stock equivalents that are (x) outstanding as of April 27, 2026 or (y) approved
for grant by the Board on April 27, 2026, and not yet issued or outstanding as of such date (the “Existing Common Stock Equivalents”),
the Maximum Issuance (b) shall be increased to equal the sum of (i) the Maximum Issuance immediately prior to the date of such Dilutive
Issuance or Dilutive Conversion, plus (ii) 0.1999 shares of Common Stock for each share of Common Stock issued in connection with such
Dilutive Issuance or Dilutive Conversion, as the case may be. Notwithstanding anything to the contrary contained in the Series J Certificate
of Designations, once an adjustment to the Maximum Issuance has been made in respect of (A) Dilutive Issuances, and (B) any exercises
for cash of Existing Common Stock Equivalents, in an aggregate amount equal to $50 million, no further adjustments shall be made for
any subsequent Dilutive Conversions or Dilutive Issuances. For the avoidance of doubt, no adjustment to the Maximum Issuance may be made
with respect to a Dilutive Issuance or Dilutive Conversion to the extent that the shares of Common Stock issued in connection therewith
previously resulted in an adjustment to the Maximum Issuance.
Without
the prior express consent of the Required Holders (as defined in the Series J Certificate of Designations), voting together as a single
class, the Company may not (a) amend or repeal any provision of, or add any provision to, its Amended and Restated Certificate of Incorporation
(as amended, the “Charter”) or its Amended and Restated Bylaws, as amended, or file any certificate of designations or articles
of amendment of any series of shares of preferred stock, if such action would adversely alter or change in any respect the preferences,
rights, privileges or powers, or restrictions provided for the benefit of the Series J Preferred Stock; (b) increase or decrease (other
than by conversion) the authorized number of Series J Preferred Stock; (c) create or authorize (by reclassification or otherwise) any
new Senior Preferred Stock or Parity Stock; (d) purchase, repurchase or redeem any shares of Junior Stock (other than pursuant to the
terms of the Company’s equity incentive plans and options and other equity awards granted under such plans (that have in good faith
been approved by the Board)); (e) pay dividends or make any other distribution on any shares of any Junior Stock; (f) issue any shares
of Series J Preferred Stock other than as contemplated by the Series J Certificate of Designations; or (g) circumvent a right of the
Series J Preferred Stock under the Series J Certificate of Designations.
The
holders of the Series J Preferred Stock are entitled to dividends of 6% per annum accruing daily, which are payable semi-annually on
each June 30 and December 31 (each, a “Dividend Payment Date”) during the period in which any shares of Series J Preferred
Stock remain outstanding. Dividends are payable in cash; provided, however, that the Company may, at its sole option, elect to pay any
dividend in kind by issuing to the applicable holders of Series J Preferred Stock additional shares of Series J Preferred Stock having
an aggregate stated value equal to the amount of the dividend then due (each such payment, a “PIK Dividend”). If the Company
elects to pay a PIK Dividend, the stated value of the holder of Series J Preferred Stock’s Series J Preferred Stock shall be increased
by the amount of such PIK Dividend, or the Company will issue additional shares of Series J Preferred Stock to the holder of Series J
Preferred Stock reflecting such PIK Dividend. If, on a Dividend Payment Date, dividends on the Series J Preferred Stock have not been
declared and paid in full, such unpaid dividends shall continue to accrue daily from and after the initial Dividend Payment Date and
will compound on a semi-annual basis at the applicable rate for the Series J Preferred Stock on each subsequent Dividend Payment Date
until paid in full.
Pursuant
to the Series J Certificate of Designations, the Company is required to hold a meeting of its stockholders not later than July 26, 2026,
to seek approval under Nasdaq Stock Market Rule 5635(d) for the issuance of shares of Common Stock in excess of 19.99% of the Company’s
issued and outstanding shares of Common Stock at prices below the “Minimum Price” (as defined in Rule 5635 of the Rules of
the Nasdaq Stock Market) on the date of the JDA pursuant to the terms of the Series J Preferred Stock.
Except
as expressly set forth in the Series J Certificate of Designations or as otherwise required by law, the provisions of the Company’s
Amended and Restated Certificate of Incorporation, as amended, the Series J Preferred Stock do not have any voting rights prior to the
conversion thereof into shares of Common Stock; provided, however, that upon any such conversion of the Series J Preferred Stock into
shares of Common Stock, the holders of such converted shares shall be entitled to full voting rights as holders of Common Stock.
The
issuance of the Series J Preferred Stock is exempt from the registration requirements of the Securities Act of 1933, as amended (the
“Securities Act”), pursuant to the exemption for transactions by an issuer not involving any public offering under Section
4(a)(2) of the Securities Act and Rule 506 of Regulation D of the Securities Act and in reliance on similar exemptions under applicable
state laws. Kopin has represented to the Company that it is an accredited investor within the meaning of Rule 501(a) of Regulation D
and that it is acquiring the applicable securities for investment only and not with a view towards, or for resale in connection with,
the public sale or distribution thereof.
There
is no established public trading market for the Series J Preferred Stock and the Company does not intend to list the Series J Preferred
Stock on any national securities exchange or nationally recognized trading system.
Private
Placement
On
April 27, 2026, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited
investors (the “Investors”), pursuant to which it agreed to sell to the Investors (i) an aggregate of 21,500 shares of the
Company’s newly-designated Series K Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000
per share (“Stated Value”), initially convertible into up to 8,565,737 shares of the Company’s Common Stock at an initial
conversion price of $2.51 per share (the “Series K Preferred Stock”) and (ii) warrants to acquire up to an aggregate of 8,565,737
shares of Common Stock (the “Series K Warrants”) at an exercise price of $2.51 per share (collectively, the “Private
Placement”).
The
Private Placement is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”),
pursuant to the exemption for transactions by an issuer not involving any public offering under Section 4(a)(2) of the Securities Act
and Rule 506 of Regulation D of the Securities Act and in reliance on similar exemptions under applicable state laws. Each of the Investors
has represented to the Company that it is an accredited investor within the meaning of Rule 501(a) of Regulation D and that it is acquiring
the applicable securities for investment only and not with a view towards, or for resale in connection with, the public sale or distribution
thereof. The Series K Preferred Stock and Series K Warrants were offered and sold without any general solicitation by the Company or
its representatives.
The
closing of the Private Placement is expected to occur on April 29, 2026 (the “Closing Date”). The aggregate gross proceeds
from the Private Placement are expected to be $21,500,000. The Company expects to use the net proceeds from the Private Placement for
general corporate purposes.
The
Purchase Agreement contains certain representations and warranties, covenants and indemnification provisions customary for similar transactions.
The representations, warranties and covenants contained in the Purchase Agreement were made solely for the benefit of the applicable
parties to the Purchase Agreement and may be subject to limitations agreed upon by the applicable contracting parties. Among other covenants,
the Purchase Agreement requires the Company to hold a meeting of its stockholders not later than June 26, 2026, to seek approval for
the issuance of shares of Common Stock in excess of 19.99% of the Company’s issued and outstanding shares of Common Stock at prices
below the “Minimum Price” (as defined in Rule 5635 of the Rules of the Nasdaq Stock Market) on the date of the Purchase Agreement
pursuant to the terms of the Series K Preferred Stock and the applicable Series K Warrants (the “Stockholder Approval” and
the date on which such Stockholder Approval is received, the “Stockholder Approval Date”).
In
connection with the Private Placement, pursuant to an engagement letter, dated as of April 23, 2026 (the “GPN Agreement”)
with GP Nurmenkari Inc. (“GPN”), the Company engaged GPN to act as placement agent in connection with the Private Placement,
pursuant to which, the Company agreed to (i) pay GPN a cash fee equal to 8% of the gross proceeds of the Private Placement (including
any cash proceeds realized by the Company from the exercise of any outstanding warrants of the Company), (ii) reimbursement and payment
of certain expenses up to $10,000, and (iii) issue GPN on the Closing Date, warrants to purchase up to an aggregate number of shares
of Common Stock equal to 8% of the aggregate number of shares of Common Stock initially underlying the Series K Preferred Stock issued
in the Private Placement, including upon exercise of any outstanding warrants of the Company, with terms identical to the Series K Warrants.
Series
K Preferred Stock
The
terms of the Series K Preferred Stock are as set forth in the Certificate of Designations of the Series K Convertible Preferred Stock,
attached hereto as Exhibit 3.2 to this Current Report on Form 8-K (the “Series K Certificate of Designations”), which was
filed with the Secretary of State for the State of Delaware on April 27, 2026. All shares of capital stock of the Company rank junior
to shares of the Series K Preferred Stock, with respect to the preferences as to dividends, distributions and payments upon the liquidation,
dissolution and winding up of the Company.
The
shares of Series K Preferred Stock are convertible into shares of Common Stock (the “Series K Conversion Shares”) at the
election of the holder at any time at an initial conversion price of $2.51 per share (the “Series K Conversion Price”). The
Conversion Price is subject to customary adjustments for stock dividends, stock splits, reclassifications, stock combinations and the
like and dilutive issuances (in each case, subject to certain exceptions).
The
holders of the Series K Preferred Stock are entitled to dividends of 7% per annum (“Dividends”), compounded each calendar
quarter, which are payable in arrears (i) on the first trading day of each calendar quarter (each, a “Dividend Date”), with
the first Dividend Date being July 1, 2026, in cash out of funds legally available therefor; provided that a holder of the Series K Preferred
Stock and the Company may mutually agree to convert any Dividends into shares of Common Stock at a price to be mutually determined by
the Company and such holder, which shall not be less than the lower of (x) $0.502, which was 20% of the “Minimum Price” (as
defined in Rule 5635 of the Nasdaq Stock Market) on the date of the Purchase Agreement and (y) 20% of the “Minimum Price”
(as defined in Rule 5635 of the Nasdaq Stock Market) on the Stockholder Approval Date, in each case, subject to adjustment for stock
splits, stock dividends, stock combinations, recapitalizations or other similar events, or, in any case, such lower amount as permitted,
from time to time, by the Nasdaq Capital Market (the “Floor Price”).
The
holders of the Series K Preferred Stock are entitled to vote with holders of the Common Stock on an as-converted basis, with the number
of votes to which each holder of Series K Preferred Stock is entitled to be calculated assuming a conversion price of $2.51 per share,
which was the Minimum Price (as defined in Rule 5635 of the Rules of the Nasdaq Stock Market) applicable immediately before the execution
and delivery of the Purchase Agreement, subject to certain beneficial ownership limitations as set forth in the Series K Certificate
of Designations.
The
Series K Certificate of Designations includes certain Triggering Events (as defined in the Series K Certificate of Designations), including,
among other things, the suspension from trading or the failure of the Company’s Common Stock to be trading or listed (as applicable)
on an eligible market for a period of five (5) consecutive trading days and the Company’s failure to pay any amounts due to the
holders of the Series K Preferred Stock when due. Upon the occurrence and during the continuance of a Triggering Event, the Series K
Preferred Stock accrue dividends at the rate of 15% per annum. In addition, in connection with a Triggering Event, each holder of Series
K Preferred Stock will be able to require the Company to redeem in cash any or all of the holder’s Series K Preferred Stock at
a premium set forth in the Series K Certificate of Designations. Further, upon a Triggering Event, a holder of the Series K Preferred
Stock, at such holder’s option, by delivery of a notice of conversion (“Triggering Event Conversion Notice”) to the
Company, convert all, or any number of shares of Series K Preferred Stock held by such holder into shares of Common Stock at a price
equal to the lowest of (i) the applicable Series K Conversion Price as in effect on the applicable date of conversion, and (ii) the greater
of (x) the Floor Price and (y) 80% of the lowest volume weighted average price of the Common Stock of any trading day during the twenty
(20) consecutive trading day period ending and including the trading day immediately preceding the delivery or deemed delivery of the
applicable Triggering Event Conversion Notice.
Notwithstanding
the foregoing, the Company’s ability to settle conversions using shares of Common Stock is subject to certain limitations set forth
in the Series K Certificate of Designations, including a limit on the number of shares that may be issued until the time, if any, that
the Company has obtained the Stockholder Approval. Further, a holder of shares of Series K Preferred Stock may not convert any portion
of such holder’s shares of Series K Preferred Stock to the extent that the holder, together with its affiliates, would beneficially
own more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding shares of Common Stock immediately
after conversion, except that upon at least 61 days’ prior notice from the holder to the Company, the holder may increase the beneficial
ownership limitation to up to 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion.
The
Company is subject to certain affirmative and negative covenants regarding the incurrence of indebtedness, the existence of liens, the
repayment of indebtedness, the payment of cash in respect of dividends (other than dividends pursuant to the Series K Certificate of
Designations), distributions or redemptions, and the transfer of assets, among other matters. In addition, the Company is required to,
from the Closing Date until the date on which less than 1,050 shares of the Company’s Series I Preferred Stock are outstanding,
at all times, maintain unencumbered, unrestricted cash and cash equivalents on hand in amount equal to at least 20% of the aggregate
stated value of the Series I Preferred Stock then outstanding.
There
is no established public trading market for the Series K Preferred Stock and the Company does not intend to list the Series K Preferred
Stock on any national securities exchange or nationally recognized trading system.
Series
K Warrants
The
Series K Warrants will be exercisable for shares of Common Stock (the “Series K Warrant Shares”) immediately, at an exercise
price of $2.51 per share and expire five years from the date of issuance. The exercise price of each Series K Warrant is subject to customary
adjustments for stock dividends, stock splits, reclassifications, stock combinations and the like and dilutive issuances (in each case,
subject to certain exceptions). There is no established public trading market for the Series K Warrants and the Company does not intend
to list the Series K Warrants on any national securities exchange or nationally recognized trading system.
A
holder of the Series K Warrants may not exercise any portion of such holder’s Series K Warrants to the extent that the holder,
together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s
outstanding shares of Common Stock immediately after exercise, except that upon at least 61 days’ prior notice from the holder
to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of shares of Common Stock outstanding
immediately after giving effect to the exercise.
Registration
Rights
The
Series K Preferred Stock, the Series K Conversion Shares, the Series K Warrants and the Series K Warrant Shares have not been registered
under the Securities Act.
In
connection with the Purchase Agreement, on April 27, 2026, the Company and the Investors entered into a Registration Rights Agreement
(the “Registration Rights Agreement”), pursuant to which the Company is obligated, among other things, to (A) file a resale
registration statement (the “Registration Statement”) with the SEC to register for resale promptly following the Closing
Date, but in no event later than 30 calendar days after the Closing Date, the sum of (i) 200% of the maximum number of Series K Conversion
Shares issuable upon conversion of the Series K Preferred Stock ((x) assuming for purposes hereof that the shares of Series K Preferred
Stock are convertible at the Floor Price and (y) any such conversion shall not take into account any limitations on the conversion of
the Series K Preferred Stock set forth in the Series K Certificate of Designations) and (ii) 200% of the maximum number of Series K Warrant
Shares issuable upon exercise of the Series K Warrants ((x) assuming for purposes hereof that such Series K Warrants will be exercised
at the initial exercise price as set forth in such Series K Warrants and (y) any such exercise shall not take into account any limitations
on the exercise of such Series K Warrants as set forth therein), in each case subject to the adjustments set forth in the Series K Certificate
of Designations and Series K Warrants, (B) have such Registration Statement declared effective by the Effectiveness Deadline (as defined
in the Registration Rights Agreement and as may be amended from time to time), and (C) maintain the registration until the earlier of
(x) the date on which the holders of the Series K Preferred Stock or Series K Warrants may sell their Series K Conversion Shares or Series
K Warrant Shares without restriction pursuant to Rule 144 under the Securities Act, and (y) the date on which such holders no longer
hold any Series K Conversion Shares or Series K Warrant Shares. The Company will be obligated to pay certain liquidated damages to the
Investors if the Company fails to file the Registration Statement when required, fails to cause the Registration Statement to be declared
effective by the SEC when required, or fails to maintain the effectiveness of the Registration Statement pursuant to the terms of the
Registration Rights Agreement.
The
foregoing descriptions of the Purchase Agreement, the Series K Certificate of Designations, the Series K Warrant, and the Registration
Rights Agreement, do not purport to be complete and are qualified in their entirety by reference to the full text of such documents,
forms of which are filed as Exhibits 10.3, 3.2, 4.1 and 10.4, respectively, to this Current Report on Form 8-K and incorporated herein
by reference.
Omnibus
Amendments and Warrants
On
April 27, 2026, the Company entered into an Omnibus Waiver, Consent, Notice and Amendment Agreement (the “Series H-7 Omnibus Amendment”)
with the Required Holders (as defined in the Certificate of Designations of the Series H-7 Convertible Preferred Stock (the “Series
H-7 Certificate of Designations”), pursuant to which, the Required Holders agreed to amend and restate the Series H-7 Certificate
of Designations by filing an Amended and Restated Certificate of Designations of the Series H-7 Preferred Stock (the “Amended and
Restated Series H-7 Certificate of Designations”) with the Secretary of State of the State of Delaware. The Amended and Restated
Series H-7 Certificate of Designations (i) extends the maturity date of the Series H-7 Convertible Preferred Stock to October 27, 2027,
and (ii) removes the amortization payments and related terms and covenants.
On
April 27, 2026, the Company entered into an Omnibus Waiver, Consent, Notice and Amendment Agreement (the “Series I Omnibus Amendment”
and together with the Series H-7 Omnibus Amendment, the “Omnibus Amendments”) with the Required Holders (as defined in the
Certificate of Designations of the Series I Convertible Preferred Stock (the “Series I Certificate of Designations”), pursuant
to which, the Required Holders agreed to amend and restate the Series I Certificate of Designations by filing an Amended and Restated
Certificate of Designations of the Series I Preferred Stock (the “Amended and Restated Series I Certificate of Designations”)
with the Secretary of State of the State of Delaware. The Amended and Restated Series I Certificate of Designations (i) extends the maturity
date of the Series I Convertible Preferred Stock to October 27, 2027, and (ii) removes the amortization payments and related terms and
covenants.
Pursuant
to the Omnibus Amendments, the Company agreed to issue to the Required Holders, warrants to purchase up to an aggregate of 1,000,000
shares of the Company’s Common Stock (the “Waiver Warrants”), pro rata based on the number of shares of Series H-7
Preferred Stock and Series I Preferred Stock held as of the date of the Omnibus Amendments.
The
Waiver Warrants will be exercisable for shares of Common Stock immediately, at an exercise price of $5.00 per share and expire five years
from the date of issuance. The exercise price of each Waiver Warrant is subject to customary adjustments for stock dividends, stock splits,
reclassifications, stock combinations and the like (in each case, subject to certain exceptions). There is no established public trading
market for the Waiver Warrants and the Company does not intend to list the Waiver Warrants on any national securities exchange or nationally
recognized trading system.
The
foregoing descriptions of the Series H-7 Omnibus Amendment, the Series I Omnibus Amendment, the Amended and Restated Series H-7 Certificate
of Designations, the Amended and Restated Series I Certificate of Designations and the Waiver Warrant do not purport to be complete and
are qualified in their entirety by reference to the full text of such documents, forms of which are filed as Exhibits 10.5, 10.6, 3.3,
3.4, and 4.2 respectively, to this Current Report on Form 8-K and incorporated herein by reference.
Altucher
Consulting Agreement
As
previously disclosed, on August 4, 2025, the Company entered into a consulting services agreement (the “Prior Altucher Consulting
Agreement”) with James Altucher and Z-List Media, Inc. (the “Prior Consultants”), pursuant to which, the Prior Consultants
agreed to provide certain consulting services to the Company.
On
April 27, 2026, the Company and the Prior Consultants agreed to amend and restate the Prior Altucher Consulting Agreement by entering
into an amended and restated consulting services agreement (the “Altucher Consulting Agreement”) by and between the Company
and JD Advisors, LLC, an affiliate of the Prior Consultants (the “Consultant”). Pursuant to the Altucher Consulting Agreement,
the Consultant agreed to provide certain consulting services to the Company, including but not limited to: contributing to product development
and roadmap decisions, leading and advising on marketing strategy, branding and go-to-market execution, assisting with recruiting, hiring
and team-building efforts, managing and guiding social media presence and communications and supporting general management initiatives
across the business and any other consulting or advisory services which the Company reasonably requests that the Consultant provide to
the Company. The Altucher Consulting Agreement has a term of two years unless earlier terminated pursuant to the terms of the Altucher
Consulting Agreement or upon the mutual written consent of the Company and the Consultant in accordance with the terms of the Altucher
Consulting Agreement.
Pursuant
to the Altucher Consulting Agreement, and subject to the Consultant entering into a warrant cancellation agreement for the purpose of
cancelling previously issued warrants to purchase up to 900,000 shares of Common Stock under the Prior Altucher Consulting Agreement,
the Company will issue to the Consultant warrants to purchase up to an aggregate of 900,000 shares of Common Stock, consisting of: (i)
a warrant to purchase up to 300,000 shares of Common Stock at an exercise price of $3.00 per share, which are immediately exercisable
upon issuance (the “First Tranche Warrant”), (ii) a warrant to purchase up to 200,000 shares of Common Stock at an exercise
price of $6.00 per share, which will be exercisable six months from the date of issuance (the “Second Tranche Warrant”),
(iii) a warrant to purchase up to 200,000 shares of Common Stock at an exercise price of $9.00 per share (the “Third Tranche Warrant”),
which will be exercisable twelve months from the date of issuance, and (iv) a warrant to purchase up to 200,000 shares of Common Stock
at an exercise price of $12.00 per share (the “Fourth Tranche Warrant” and together with the First Tranche Warrant, the Second
Tranche Warrant and the Third Tranche Warrant, the “Consultant Warrants”), which will be exercisable eighteen months from
the date of issuance, in each case, with each Consultant Warrant subject to exercisability, forfeiture and such other terms as set forth
therein and will have a term of five years from the date of the applicable issuance.
The
Consultant Warrants and shares issuable upon exercise of such Consultant Warrants were issued pursuant to an exemption from registration
requirements of the Securities Act. There is no established public trading market for the Consultant Warrants and the Company does not
intend to list the Consultant Warrants on any national securities exchange or nationally recognized trading system.
The
foregoing descriptions of the Altucher Consulting Agreement and the Consultant Warrants do not purport to be complete and are qualified
in their entirety by reference to the full texts of the Altucher Consulting Agreement and Form of Consultant Warrant, copies of which
are filed as Exhibits 10.7 and 4.3 to this Current Report on Form 8-K and incorporated herein by reference.
Amendments
to Rights Agreement
As
previously reported in a Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 1, 2025, on July 31,
2025, the Board declared a dividend of one preferred share purchase right for each outstanding share of Company Stock (as defined in
the Rights Agreement (as defined below)) pursuant to the terms of that certain Rights Agreement, dated as of July 31, 2025, as the same
may be amended from time to time (the “Rights Agreement”), between the Company and Equiniti Trust Company LLC, as rights
agent (the “Rights Agent”).
On
April 27, 2026, the Company entered into that certain Amendment to Rights Agreement, by and between the Company and the Rights Agent
(the “Rights Amendment”), to amend the definition of “Exempt Person” under the Rights Agreement to include any
person that the Board has determined in good faith to be deemed an “Exempt Person” by adopting resolutions waiving the applicability
of the Rights Agreement to such person. On April 27, 2026, the Board adopted such resolutions in connection with the transactions contemplated
by the JDA, including the issuance of the Series J Preferred Stock, accordingly, the Rights Agreement does not apply to Kopin or any
of its affiliates or any future acquiror of Kopin in connection with the transactions contemplated by the JDA or the other transaction
agreements entered into in connection therewith.
The
foregoing descriptions of the Rights Amendment, do not purport to be complete and are qualified in their entirety by reference to the
full text of such documents, the form of which is filed as Exhibit 4.4 to this Current Report on Form 8-K and incorporated herein by
reference.
Item
3.02 Unregistered Sales of Equity Securities
The
matters described in Item 1.01 of this Current Report on Form 8-K related to the Private Placement, the transactions contemplated by
the JDA, including the issuance of the Series J Preferred Stock, the issuance of the Waiver Warrants and the issuance of the Consultant
Warrants are incorporated herein by reference.
In
connection with the issuance of the Series K Preferred Stock and Series K Warrants in the Private Placement, the securities of the Company
issued or issuable pursuant to the JDA, the Waiver Warrants and the Consultant Warrants described in Item 1.01, the Company relied upon
the exemption from registration provided by Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder for transactions
not involving a public offering.
This
report shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in
any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under
the securities laws of any such state or jurisdiction.
Item
3.03 Material Modification to Rights of Security Holders.
To
the extent required by Item 3.03 of Form 8-K, the information contained in Item 1.01 and 5.03 of this Current Report on Form 8-K is incorporated
herein by reference.
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers
On
April 27, 2026 (the “Board Approval Date”), the Board of the Company approved grants to Joshua Silverman, the Company’s
Chief Executive Officer, subject to the stockholder approval of an amendment to the Company’s Long-Term Incentive Plan (as amended,
the “Plan”) increasing the authorized share limit under the Plan (the “Incentive Plan Authorized Share Stockholder
Approval”), consisting of (i) restricted shares of Common Stock equal to an aggregate value of $900,000, calculated as of the Board
Approval Date (the “RSA Award”), vesting (i) 25% as of the date of the Incentive Plan Authorized Share Stockholder Approval
(the “Incentive Plan Approval Date”), (ii) 25% on June 30, 2026, (iii) 25% on September 30, 2026, and (iv) 25% on December
31, 2026, provided Mr. Silverman continues to provide services to the Company through the applicable vesting date and subject to the
terms and conditions of the Plan.
On
the Board Approval Date, the Board of the Company also approved grants to each of Sebastian Giordano, Zvi Joseph, Greg Schiffman, and
Wayne Walker, each a director of the Company (the “Directors”), of stock options to acquire the number of shares of Common
Stock equal to an aggregate value of $338,000 or, $84,500 each, as of the Board Approval Date, utilizing the black-scholes valuation
method to calculate the applicable number of shares on such date with an exercise price equal to the fair market value of the Company’s
Common Stock on the Incentive Plan Approval Date (the “Director Stock Options”). The Director Stock Options will be issued
on the Incentive Plan Approval Date and will be issued pursuant to, and be subject to the terms and conditions of, the Plan. The Director
Stock Options will vest (a) 25% as of the Incentive Plan Approval Date; (b) 25% on June 30, 2026; (c) 25% on September 30, 2026; and
(d) 25% on December 31, 2026, provided the Director continues to provide services to the Company through the applicable vesting date.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On
April 27, 2026, the Company filed a Certificate of Amendment to the Company’s Charter (the “Certificate of Amendment”)
to change the name of the Company from “StableX Technologies, Inc.” to “Fabric.AI, Inc.,” effective as of 12:01
Eastern Time on April 28, 2026 (the “Name Change”). In addition, effective before the open of market trading on April 29,
2026, the Company’s Common Stock will cease trading under the ticker symbol “SBLX” and will begin trading on the Nasdaq
Stock Market under the ticker symbol “FABC”.
The
Name Change does not affect the rights of the Company’s security holders. There will be no change to the Company’s CUSIP
in connection with the Name Change.
Pursuant
to Section 242 of the Delaware General Corporation Law, stockholder approval was not required to complete the Name Change or to approve
or effect the Certificate of Amendment. The information set forth herein is qualified in its entirety by reference to the complete text
of the Certificate of Amendment, a copy of which is filed with this report as Exhibit 3.5 and is incorporated by reference herein.
To
the extent required by Item 5.03 of Form 8-K, the information contained in Item 1.01 of this Current Report on Form 8-K is incorporated
herein by reference.
Item
5.08. Shareholder Director Nominations.
On
April 27, 2026, the Board determined that the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”)
will be held on Friday, June 12, 2026. The time and location of the 2026 Annual Meeting will be as set forth in the Company’s definitive
proxy statement for the 2026 Annual Meeting to be filed with the Securities and Exchange Commission.
Due
to the fact that the date of the 2026 Annual Meeting has been changed by more than 30 days from the anniversary date of the Company’s
2025 Annual Meeting of Stockholders, the Company is providing the due date for submission of any qualified stockholder proposal or qualified
stockholder nominations.
Stockholders
of the Company who wish to have a proposal considered for inclusion in the Company’s proxy materials for the 2026 Annual Meeting
pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), must ensure that such
proposal is received by the Company’s Secretary at 1185 Avenue of the Americas, New York, NY 10036, Attention: Secretary, on or
before the close of business on May 8, 2026, which the Company has determined to be a reasonable time before it expects to begin to print
and send its proxy materials in accordance with Rule 14a-5(f) and Rule 14a-8(e) under the Exchange Act. Any such proposal must also meet
the requirements set forth in the rules and regulations of the Securities and Exchange Commission in order to be eligible for inclusion
in the proxy materials for the 2026 Annual Meeting.
In
addition, in accordance with the requirements contained in the Company’s amended and restated Bylaws (“Bylaws”), stockholders
of the Company who wish to bring business before the 2026 Annual Meeting outside of Rule 14a-8 of the Exchange Act or to nominate a person
for election as a director must ensure that written notice of such proposal (including all information specified in the Company’s
Bylaws) is received by the Company’s Secretary at the address specified above no later than the close of business on May 8, 2026.
Any such proposal must meet the requirements set forth in the Company’s Bylaws in order to be brought before the 2026 Annual Meeting.
In
addition, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other
than the Company’s nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act
by May 8, 2026, which is the 10th calendar date following the date hereof.
Item 7.01
Regulation FD Disclosure.
On
April 28, 2026, the Company issued a press release announcing, among other things, its strategic pivot from its prior digital asset treasury
strategy to AI infrastructure, including the development of a suite of fabless semiconductor technologies, the JDA, Private Placement
and Name Change. A copy of the press release is furnished hereto as Exhibit 99.1 and incorporated by reference herein.
In
accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including
Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference
in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in
such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute
a determination by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination
of such information is required by Regulation FD.
Item
9.01 Financial Statements and Exhibits.
Exhibit
Number
Description
3.1
Certificate of Designation of Series J Preferred Stock of Fabric.AI, Inc.
3.2
Certificate of Designation of Series K Preferred Stock of Fabric.AI, Inc.
3.3
Amended and Restated Certificate of Designation of Series H-7 Preferred Stock of Fabric.AI, Inc.
3.4
Amended and Restated Certificate of Designation of Series I Preferred Stock of Fabric.AI, Inc.
3.5
Certificate of Amendment to Amended and Restated Certificate of Incorporation of Fabric.AI, Inc.
4.1
Form of Series K Warrant.
4.2
Form of Waiver Warrant.
4.3
Form of Consultant Warrant.
4.4
Amendment to Rights Agreement, dated as of April 27, 2026, by and between the Company and Equiniti Trust Company, LLC.
10.1
Joint Development and License Agreement, dated April 27, 2026, by and between the Company and Kopin Corporation
10.2
Commercial Supply Agreement, dated April 27, 2026, by and between the Company and Kopin Corporation
10.3
Form of Securities Purchase Agreement, dated April 27, 2026, by and among the Company and the investors signatory thereto.
10.4
Form of Registration Rights Agreement dated April 27, 2026, by and among the Company and the investors signatory thereto.
10.5
Form of Series H-7 Omnibus Waiver, Consent, Notice and Amendment Agreement, dated April 27, 2026, by and among the Company and the investors signatory thereto.
10.6
Form of Series I Omnibus Waiver, Consent, Notice and Amendment Agreement, dated April 27, 2026, by and among the Company and the investors signatory thereto.
10.7
Amended and Restated Consulting Services Agreement, dated April 27, 2026, by and between the Company and JD Advisors, LLC.
99.1
Press Release, Dated April 28, 2026.
104
Cover
Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
April 28, 2026
Fabric.AI,
Inc.
By:
/s/
Joshua Silverman
Name:
Joshua
Silverman
Title:
Chief
Executive Officer
EX-3.1
EX-3.1
Filename: ex3-1.htm · Sequence: 2
Exhibit
3.1
STABLEX
TECHNOLOGIES, INC.
CERTIFICATE
OF DESIGNATION OF PREFERENCES,
RIGHTS
AND LIMITATIONS
OF
SERIES
J CONVERTIBLE PREFERRED STOCK
I,
Joshua Silverman, hereby certify that I am the Chief Executive Officer of StableX Technologies, Inc. (the “Company”),
a corporation organized and existing under the Delaware General Corporation Law (the “DGCL”), and further do hereby
certify:
That
pursuant to the authority expressly conferred upon the Board of Directors of the Company (the “Board”) by the Company’s
Amended and Restated Certificate of Incorporation (as amended, the “Certificate of Incorporation”), and Section 151(g)
of the Delaware General Corporation Law, the Board on April 27, 2026, adopted the following resolution determining it desirable and in
the best interests of the Company and its stockholders for the Company to create a series of 51,575 shares of preferred stock designated
as “Series J Convertible Preferred Stock”, none of which shares have been issued:
RESOLVED,
that pursuant to the authority vested in the Board, in accordance with the provisions of the Certificate of Incorporation, a series of
preferred stock, par value $0.0001 per share, of the Company be and hereby is created pursuant to this certificate of designations (this
“Certificate of Designations”), and that the designation and number of shares thereof and the voting and other powers,
preferences and relative, participating, optional or other rights of the shares of such series and the qualifications, limitations and
restrictions thereof are as follows:
TERMS
OF SERIES J PREFERRED STOCK
Section
1. Definitions. For the purposes hereof, the following terms shall have the following meanings:
“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.
“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.
“Buy-In”
shall have the meaning set forth in Section 7(c)(iv).
“Commercial
Supply Agreement” means that certain Commercial Supply Agreement, dated as of April 27, 2026, by and between the Company and
the Holder.
“Commission”
means the United States Securities and Exchange Commission.
“Common
Stock” means the Company’s common stock, par value $0.0001 per share, and stock of any other class of securities into
which such securities may hereafter be reclassified or changed.
“Common
Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.
“Conversion
Amount” means the sum of the Stated Value at issue.
“Conversion
Date” shall have the meaning set forth in Section 7(a).
“Conversion
Price” shall have the meaning set forth in Section 7(b).
“Conversion
Shares” means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance
with the terms hereof.
“Dividend
Payment Date” means each June 30 and December 31 during the period in which any shares of Preferred Stock remain outstanding.
“Dividend
Rate” means six percent (6%) per annum.
“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
“Fundamental
Transaction” shall have the meaning set forth in Section 8(e).
“GAAP”
means United States generally accepted accounting principles.
“Holder”
shall have the meaning given such term in Section 2.
“Joint
Development Agreement” means the Joint Development & License Agreement, dated as
of
April 27, 2026, by and between the Company and the Holder.
“Liens”
means a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.
“Liquidation”
shall have the meaning set forth in Section 6.
“New
York Courts” shall have the meaning set forth in Section 12(d).
“Notice
of Conversion” shall have the meaning set forth in Section 7(a).
“Original
Issue Date” means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers
of any particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such Preferred
Stock.
“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.
“PIK
Dividend” shall have the meaning set forth in Section 4(b).
“Preferred
Stock” shall have the meaning set forth in Section 2.
“Securities”
means the Preferred Stock and the Conversion Shares.
“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
“Share
Delivery Date” shall have the meaning set forth in Section 7(c).
“Stated
Value” shall have the meaning set forth in Section 2, as the same may be increased pursuant to Section 4.
“Stockholder
Approval” means such approval as may be required by the applicable rules and regulations of the Trading Market (or any successor
entity) from the shareholders of the Company with respect to the transactions contemplated by the Transaction Documents, including the
issuance of all of the Conversion Shares in excess of 19.99% of the issued and outstanding Common Stock on the Closing Date.
“Subsidiary”
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the Original Issue Date.
“Successor
Entity” shall have the meaning set forth in Section 8(d).
“Trading
Day” means a day on which the principal Trading Market is open for business.
“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).
“Transaction
Documents” means this Certificate of Designations, the Joint Development Agreement, the Commercial Supply Agreement and any
other documents or agreements executed in connection with the transactions contemplated pursuant to the Joint Development Agreement.
“Transfer
Agent” means Issuer Direct Corporation, One Glenwood Avenue, Suite 1001, Raleigh, NC 27603, and any successor transfer agent
of the Company.
Section
2. Designation, Amount and Par Value. The series of preferred stock shall be designated as its Series J Convertible Preferred
Stock (the “Preferred Stock”) and the number of shares so designated shall be 51,575 (which shall not be subject to
increase without the written consent of a majority of the holders of the Preferred Stock then outstanding (each, a “Holder”
and collectively, the “Holders”)). Each share of Preferred Stock shall have a par value of $0.0001 per share and shall
have a stated value equal to $1,000, subject to increase set forth in Section 4 below (the “Stated Value”).
Section
3. Ranking. Except to the extent that the holders of at least a majority of the outstanding Preferred Stock (the “Required
Holders”) expressly consent to the creation of Parity Stock (as defined below) or Senior Preferred Stock (as defined below) in
accordance with Section 10, the Preferred Stock shall rank (i) senior in respect of the preferences as to dividends, distributions and
payments upon the liquidation, dissolution and winding up of the Company to the Common Stock, all Common Stock Equivalents, the Series
A Junior Participating Preferred Stock, the Series H Preferred Stock, the Series H Convertible Preferred Stock, the Series H-3 Convertible
Preferred Stock, the Series H-6 Convertible Preferred Stock, the Series I Convertible Preferred Stock and any other class or series of
capital stock of the Company hereafter issued that is not expressly designated as Parity Stock or Senior Preferred Stock (collectively,
the “Junior Stock”) and (ii) pari passu in respect of the preferences as to dividends, distributions and payments upon the
liquidation, dissolution and winding up of the Company’s Series H-7 Convertible Preferred Stock and any other class or series of
capital stock expressly designated as pari passu with the Preferred Stock (together, the “Existing Parity Stock”). The rights
of all such shares of Junior Stock of the Company shall be subject to the rights, powers, preferences and privileges of the Preferred
Stock. Without limiting any other provision of this Certificate of Designations, without the prior express consent of the Required Holders,
voting separately as a single class, the Company shall not hereafter authorize or issue any additional or other shares of capital stock
that are (i) of senior rank to the Preferred Stock in respect of the preferences as to dividends, distributions and payments upon the
liquidation, dissolution and winding up of the Company (collectively, the “Senior Preferred Stock”), or (ii) of pari passu
rank to the Preferred Stock in respect of the preferences as to dividends, distributions and payments upon the liquidation, dissolution
and winding up of the Company (collectively with the Existing Parity Stock, the “Parity Stock”). In the event of the merger
or consolidation of the Company with or into another corporation, the Preferred Stock shall maintain their relative rights, powers, designations,
privileges and preferences provided for herein and no such merger or consolidation shall be consummated if it would result in the Preferred
Stock being treated in any manner inconsistently with the foregoing.
Section
4. Dividends.
a)
Accrual
of Dividends. Holders shall be entitled to receive, and the Company shall pay, dividends at the Dividend Rate on the Stated Value
of each share of Preferred Stock, which dividends shall accrue daily from and after the Original Issue Date and shall be payable
semi-annually on each Dividend Payment Date.
b)
Payment of Dividends.
Dividends shall be payable in cash; provided, however, that the Company may, at its sole option, elect to pay any dividend
in kind by issuing to the Holder additional shares of Preferred Stock having an aggregate Stated Value equal to the amount of the
dividend then due (each such payment, a “PIK Dividend”). The Company shall provide the Holder with written notice
of its election to pay a PIK Dividend at least ten (10) Business Days prior to the applicable Dividend Payment Date. If the Company
elects to pay a PIK Dividend, the Stated Value of the Holder’s Preferred Stock shall be increased by the amount of such PIK
Dividend, or the Company shall issue additional shares of Preferred Stock to the Holder reflecting such PIK Dividend. Notwithstanding
the foregoing, the Company may not elect to issue a PIK Dividend if such PIK Dividend would result in Conversion Shares issuable
upon conversion of the Preferred Stock to exceed the Issuable Maximum and the requisite Stockholder Approval has not been obtained.
c)
Dividend Priority.
So long as any shares of Preferred Stock are outstanding, no dividends or other distribution of assets (or rights to acquire assets)
shall be declared or paid or set apart for payment, and no other distribution shall be made, upon the Common Stock or any class or
series of capital stock, unless and until all accrued and unpaid dividends on the Preferred Stock have been paid in full. Notwithstanding
the foregoing, dividends may be declared and paid on any class or series of capital stock ranking senior to the Preferred Stock prior
to the payment of dividends on the Preferred Stock. Dividends shall be cumulative and if, on the Dividend Payment Date, dividends
on the Preferred Stock have not been declared and paid in full, such unpaid dividends shall continue to accrue daily from and after
the initial dividend payment date and shall compound on a semi-annual basis at the applicable rate for the Preferred Stock on each
subsequent Dividend Payment Date until paid in full.
Section
5. Voting Rights. Except as expressly set forth in this Certificate of Designations or as otherwise required by law, the provisions
of the Certificate of Incorporation or Section 10 of this Certificate of Designations, the Preferred Stock shall not be entitled to any
voting rights prior to the conversion thereof into shares of Common Stock in accordance with Section 7 hereof; provided, however, that
upon any such conversion of the Preferred Stock into shares of Common Stock, the holders of such converted shares shall be entitled to
full voting rights as holders of Common Stock.
Section
6. Liquidation. Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary (a “Liquidation”),
the Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Company (the “Liquidation Funds”),
before any amount shall be paid to the holders of any of shares of Junior Stock, but pari passu with any Parity Stock then outstanding,
an amount per share of Preferred Stock equal to the amount per share such Holder would receive if such Holder converted such Preferred
Share into Common Stock immediately prior to the date of such payment (disregarding for such purposes any conversion limitations hereunder),
provided that if the Liquidation Funds are insufficient to pay the full amount due to the Holders and holders of shares of Parity Stock,
then each Holder and each holder of Parity Stock shall receive a percentage of the Liquidation Funds equal to the full amount of Liquidation
Funds payable to such Holder and such holder of Parity Stock as a liquidation preference, in accordance with their respective certificate
of designations (or equivalent), as a percentage of the full amount of Liquidation Funds payable to all holders of Preferred Stock and
all holders of shares of Parity Stock. To the extent necessary, the Company shall cause such actions to be taken by each of its subsidiaries
so as to enable, to the maximum extent permitted by law, the proceeds of a Liquidation to be distributed to the Holders in accordance
with this Section 6. All the preferential amounts to be paid to the Holders under this Section 6 shall be paid or set apart for payment
before the payment or setting apart for payment of any amount for, or the distribution of any Liquidation Funds of the Company to the
holders of shares of Junior Stock in connection with a Liquidation as to which this Section 6 applies. The Company shall mail written
notice of any such Liquidation, not less than forty-five (45) days prior to the payment date stated therein, to each Holder.
Section
7. Conversion.
a)
Conversions
at Option of Holder. Each share of Preferred Stock shall be convertible, at any time and from time to time from and after the
Original Issue Date at the option of the Holder thereof, into that number of shares of Common Stock (subject to the limitations set
forth in Section 7(e)) determined by dividing the Stated Value of such share of Preferred Stock by the Conversion Price. Holders
shall effect conversions by providing the Company with the form of conversion notice attached hereto as Annex A (a “Notice
of Conversion”). Each Notice of Conversion shall specify the number of shares of Preferred Stock to be converted, the number
of shares of Preferred Stock owned prior to the conversion at issue, the number of shares of Preferred Stock owned subsequent to
the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the date the applicable
Holder delivers by .pdf via email such Notice of Conversion to the Company (such date, the “Conversion Date”).
If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion
to the Company is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee
(or other type of guarantee or notarization) of any Notice of Conversion form be required. The calculations and entries set forth
in the Notice of Conversion shall control in the absence of manifest or mathematical error. To effect conversions of shares of Preferred
Stock, a Holder shall not be required to surrender the certificate(s) representing the shares of Preferred Stock to the Company unless
all of the shares of Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate
representing such shares of Preferred Stock promptly following the Conversion Date at issue. Shares of Preferred Stock converted
into Common Stock or redeemed in accordance with the terms hereof shall be canceled and shall not be reissued.
b)
Conversion Price.
The conversion price for the Preferred Stock shall equal $2.51, subject to adjustment herein (the “Conversion Price”).
c)
Mechanics of Conversion.
i.
Delivery of Conversion Shares Upon Conversion. Not later than one (1) Trading Day after each Conversion Date (the “Share
Delivery Date”), the Company shall deliver, or cause to be delivered, to the converting Holder the number of Conversion Shares
being acquired upon the conversion of the Preferred Stock. The Conversion Shares shall bear appropriate restrictive legends reflecting
that such shares are unregistered securities under the Securities Act.
ii.
Failure to Deliver Conversion Shares. If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to
or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Company
at any time on or before its receipt of such Conversion Shares, to rescind such Conversion, in which event the Company shall promptly
return to the Holder any original Preferred Stock certificate delivered to the Company and the Holder shall promptly return to the Company
the Conversion Shares issued to such Holder pursuant to the rescinded Notice of Conversion.
iii.
Obligation Absolute. The Company’s obligation to issue and deliver the Conversion Shares upon conversion of Preferred Stock
in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by a Holder to enforce the
same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce
the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by such Holder or any other
Person of any obligation to the Company or any violation or alleged violation of law by such Holder or any other Person, and irrespective
of any other circumstance which might otherwise limit such obligation of the Company to such Holder in connection with the issuance of
such Conversion Shares; provided, however, that such delivery shall not operate as a waiver by the Company of any such
action that the Company may have against such Holder.
iv.
Compensation for Buy-In on Failure to Timely Deliver Conversion Shares Upon Conversion. In addition to any other rights available
to the Holder, if the Company fails for any reason to deliver to a Holder the applicable Conversion Shares by the Share Delivery Date
pursuant to Section 7(c)(i), and if after such Share Delivery Date such Holder is required by its brokerage firm to purchase (in an open
market transaction or otherwise), or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive upon the conversion relating to such Share
Delivery Date (a “Buy-In”), then the Company shall (A) pay in cash to such Holder (in addition to any other remedies
available to or elected by such Holder) the amount, if any, by which (x) such Holder’s total purchase price (including any brokerage
commissions) for the Common Stock so purchased exceeds (y) the product of (1) the aggregate number of shares of Common Stock that such
Holder was entitled to receive from the conversion at issue multiplied by (2) the actual sale price at which the sell order giving rise
to such purchase obligation was executed (including any brokerage commissions) and (B) at the option of such Holder, either reissue (if
surrendered) the shares of Preferred Stock equal to the number of shares of Preferred Stock submitted for conversion (in which case,
such conversion shall be deemed rescinded) or deliver to such Holder the number of shares of Common Stock that would have been issued
if the Company had timely complied with its delivery requirements under Section 7(c)(i). For example, if a Holder purchases shares of
Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted conversion of shares of Preferred
Stock with respect to which the actual sale price of the Conversion Shares (including any brokerage commissions) giving rise to such
purchase obligation was a total of $10,000 under clause (A) of the immediately preceding sentence, the Company shall be required to pay
such Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to such Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company’s failure to timely deliver the Conversion Shares upon conversion of the shares of
Preferred Stock as required pursuant to the terms hereof.
v.
Reservation of Shares Issuable Upon Conversion. The Company covenants that it will at all times reserve and keep available out
of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Preferred Stock, free from
preemptive rights or any other actual contingent purchase rights of Persons other than the Holder (and the other holders of the Preferred
Stock), not less than such aggregate number of shares of the Common Stock as shall be issuable (taking into account the adjustments and
restrictions of Section 8) upon the conversion of the then outstanding shares of Preferred Stock. The Company covenants that all shares
of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable.
vi.
Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Preferred
Stock. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Company shall
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Conversion Price or round up to the next whole share.
vii.
Transfer Taxes and Expenses. The issuance of Conversion Shares on conversion of this Preferred Stock shall be made without charge
to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares,
provided that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance
and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares of Preferred Stock
and the Company shall not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting the
issuance thereof shall have paid to the Company the amount of such tax or shall have established to the satisfaction of the Company that
such tax has been paid. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Conversion and
all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Conversion Shares.
d)
[Reserved].
e) Exchange
Cap. Notwithstanding anything herein to the contrary, if the Company has not obtained Stockholder Approval or obtained a written
opinion from outside counsel to the Company that such approval is not required, which opinion shall be reasonably satisfactory to
the Required Holders, then the Company may not issue, upon conversion of the Preferred Stock, a number of shares of Common Stock
which, when aggregated with any shares of Common Stock issued on or after the Original Issue Date and prior to such Conversion Date
in connection with any conversion of Preferred Stock issued pursuant to the Joint Development Agreement, would exceed 291,049 shares
of Common Stock (subject to adjustment for forward and reverse stock splits, recapitalizations and the like) (such number of shares,
the “Issuable Maximum”). Holder shall be entitled to a portion of the Issuable Maximum equal to the quotient
obtained by dividing (x) the original Stated Value of Holder’s Preferred Stock by (y) the aggregate Stated Value of all
Preferred Stock issued on the Original Issue Date to Holder. In addition, Holder may allocate its pro-rata portion of the Issuable
Maximum among Preferred Stock held by it in its sole discretion. Such portion shall be adjusted upward ratably in the event Holder
no longer holds any Preferred Stock and the amount of shares issued to Holder pursuant to Holder’s Preferred Stock was less
than Holder’s pro-rata share of the Issuable Maximum. For any reason at any time, upon the written or oral request of a
Holder, the Company shall within one (1) Business Day confirm orally and in writing to such Holder the number of shares of Common
Stock then outstanding, including by virtue of any prior conversion or exercise of convertible or exercisable securities into Common
Stock, including, without limitation, pursuant to this Certificate of Designations or securities issued pursuant to the other
Transaction Documents.
Section
8. Certain Adjustments.
a) Stock
Dividends and Stock Splits. If the Company, at any time while this Preferred Stock is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any other Common
Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon conversion
of, or payment of a dividend on, this Preferred Stock), (ii) subdivides outstanding shares of Common Stock into a larger number of
shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of
shares, or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the
Company, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common
Stock (excluding any treasury shares of the Company) outstanding immediately before such event, and of which the denominator shall
be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section 8(a)
shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or
distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or
re-classification.
b) Adjustment
Upon Conversion of Existing Preferred Stock. Notwithstanding anything herein to the contrary and subject to Section 7(e), the
number of shares of Common Stock issuable upon conversion of the Preferred Stock may not exceed 291,049 (the “Maximum
Issuance”); provided, however, that upon (1) the sale and issuance, in one or more offerings, of any Common Stock or any
securities entitling any Person to acquire shares of Common Stock (each such issuance, a “Dilutive Issuance”) or
(2) the issuance of Common Stock (a “Dilutive Conversion”) in connection with any conversions or exercises of any
Common Stock Equivalents that are (x) outstanding as of April 27, 2026 or (y) approved for grant by the Board of Directors on April
27, 2026, and not yet issued or outstanding as of such date (the “Existing Common Stock Equivalents”), the
Maximum Issuance shall be increased to equal the sum of (i) the Maximum Issuance immediately prior to the date of such Dilutive
Issuance or Dilutive Conversion, plus (ii) 0.1999 shares of Common Stock for each share of Common Stock issued in connection with
such Dilutive Issuance or Dilutive Conversion, as the case may be. Notwithstanding anything to the contrary contained herein, once
an adjustment to the Maximum Issuance has been made in respect of (A) Dilutive Issuances, and (B) any exercises for cash of Existing
Common Stock Equivalents, in an aggregate amount equal to $50 million, no further adjustments shall be made for any subsequent
Dilutive Conversions or Dilutive Issuances and this Section shall have no further force and effect. The Company shall provide prompt
written notice within one Trading Day following an adjustment to the Maximum Issuance via electronic mail to each Holder. For the
avoidance of doubt, no adjustment to the Maximum Issuance shall be made with respect to a Dilutive Issuance or Dilutive Conversion
to the extent that the shares of Common Stock issued in connection therewith previously resulted in an adjustment to the Maximum
Issuance. In addition, from and after the date on which all the Existing Common Stock Equivalents have been fully exercised or
converted, as applicable, no further adjustments to the Maximum Issuance shall be made pursuant to this Section 8(b).
c) Pro
Rata Distributions. During such time as this Preferred Stock is outstanding, if the Company declares or makes any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a
dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a
“Distribution”), at any time after the issuance of this Preferred Stock, then, in each such case, the Holder
shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the
Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Preferred Stock (without regard to
any limitations on conversion hereof) immediately before the date of which a record is taken for such Distribution, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in
such Distribution.
d) Fundamental
Transaction. If, at any time while this Preferred Stock is outstanding, (i) the Company, directly or indirectly, in one or more
related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of
its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or
other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or
indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which
holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been
accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more
related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or
(v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or
other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement)
with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (each a
“Fundamental Transaction”), then, upon any subsequent conversion of this Preferred Stock, the Holder shall have
the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the
occurrence of such Fundamental Transaction (without regard to any limitation in Section 7(e) on the conversion of this Preferred
Stock), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving
corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such
Fundamental Transaction by a holder of the number of shares of Common Stock for which this Preferred Stock is convertible
immediately prior to such Fundamental Transaction (without regard to any limitation in Section 7(e) on the conversion of this
Preferred Stock). For purposes of any such conversion, the determination of the Conversion Price shall be appropriately adjusted to
apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common
Stock in such Fundamental Transaction, and the Company shall apportion the Conversion Price among the Alternate Consideration in a
reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
be given the same choice as to the Alternate Consideration it receives upon any conversion of this Preferred Stock following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the
survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this
Certificate of Designations and the other Transaction Documents in accordance with the provisions of this Section 8(d) pursuant to
written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the holder of this Preferred Stock, deliver to the Holder
in exchange for this Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in
form and substance to this Preferred Stock which is convertible for a corresponding number of shares of capital stock of such
Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of this
Preferred Stock (without regard to any limitations on the conversion of this Preferred Stock) prior to such Fundamental Transaction,
and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account
the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital
stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of
this Preferred Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to,
and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Certificate of
Designations and the other Transaction Documents referring to the “Company” shall refer instead to the Successor
Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this
Certificate of Designations and the other Transaction Documents with the same effect as if such Successor Entity had been named as
the Company herein.
e) Calculations.
All calculations under this Section 8 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For
purposes of this Section 8, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the
sum of the number of shares of Common Stock (excluding any treasury shares of the Company) issued and outstanding.
f) Notice
to the Holders.
i. Adjustment
to Conversion Price. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 8, the Company shall
promptly deliver to each Holder by .pdf via email a notice setting forth the Conversion Price after such adjustment and setting
forth a brief statement of the facts requiring such adjustment.
ii. Notice
to Allow Conversion by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any
shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in
connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or
transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is
converted into other securities, cash or property or (E) the Company shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be filed at each office or
agency maintained for the purpose of conversion of this Preferred Stock, and shall cause to be delivered by .pdf via email to each
Holder at its last .pdf via email number or email address as it shall appear upon the stock books of the Company, at least twenty
(20) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a
record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be
taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or
share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such
reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any
defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current
Report on Form 8-K. The Holder shall remain entitled to convert the Conversion Amount of this Preferred Stock (or any part hereof)
during the 20-day period commencing on the date of such notice through the effective date of the event triggering such notice except
as may otherwise be expressly set forth herein.
Section
9. Noncircumvention. The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation,
bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of
securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Certificate
of Designations, and will at all times in good faith carry out all the provisions of this Certificate of Designations and take all action
as may be required to protect the rights of the Holders hereunder. Without limiting the generality of the foregoing or any other provision
of this Certificate of Designations or the other Transaction Documents, the Company (a) shall not increase the par value of any shares
of Common Stock receivable upon the conversion of any Preferred Stock above the Conversion Price then in effect, (b) shall take all such
actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable shares
of Common Stock upon the conversion of Preferred Stock and (c) shall, so long as any Preferred Stock are outstanding, take all action
necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting
the conversion of the Preferred Stock, the maximum number of shares of Common Stock as shall from time to time be necessary to effect
the conversion of the Preferred Stock then outstanding (without regard to any limitations on conversion contained herein). Notwithstanding
anything herein to the contrary, if after the sixty (60) calendar day anniversary of the Original Issue Date of any Preferred Stock,
each Holder is not permitted to convert such Holder’s Preferred Stock in full for any reason (other than pursuant to restrictions
set forth in Section 7(e) hereof), the Company shall use its best efforts to promptly remedy such failure, including, without limitation,
obtaining such consents or approvals as necessary to effect such conversion into shares of Common Stock.
Section
10. Vote to Change the Terms of or Issue Preferred Shares. In addition to any other rights provided by law, except where the
vote or written consent of the holders of a greater number of shares is required by law or by another provision of the Certificate of
Incorporation, without first obtaining the affirmative vote at a meeting duly called for such purpose or the written consent without
a meeting of the Required Holders, voting together as a single class, the Company shall not (in any case, whether by amendment, modification,
recapitalization, merger, consolidation or otherwise): (a) amend or repeal any provision of, or add any provision to, its Certificate
of Incorporation or Bylaws, or file any certificate of designations or articles of amendment of any series of shares of preferred stock,
if such action would adversely alter or change in any respect the preferences, rights, privileges or powers, or restrictions provided
for the benefit of the Preferred Stock hereunder, regardless of whether any such action shall be by means of amendment to the Certificate
of Incorporation or by merger, consolidation or otherwise; (b) increase or decrease (other than by conversion) the authorized number
of Preferred Stock; (c) without limiting any provision of Section 3, create or authorize (by reclassification or otherwise) any new class
or series of Senior Preferred Stock or Parity Stock; (d) purchase, repurchase or redeem any shares of Junior Stock (other than pursuant
to the terms of the Company’s equity incentive plans and options and other equity awards granted under such plans (that have in
good faith been approved by the Board)); (e) without limiting any provision of Section 3, pay dividends or make any other distribution
on any shares of any Junior Stock; (f) issue any Preferred Stock other than as contemplated hereby; or (g) without limiting any provision
of Section 9, whether or not prohibited by the terms of the Preferred Stock, circumvent a right of the Preferred Stock hereunder.
Section
11. Miscellaneous.
a) Notices.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any
Notice of Conversion, shall be in writing and delivered personally, by .pdf via email, or sent by a nationally recognized overnight
courier service, addressed to the Company, at the address set forth above Attention: Chief Executive Officer, at such .pdf via email
number or address as the Company may specify for such purposes by notice to the Holders delivered in accordance with this Section 11
from time to time. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in
writing and delivered personally, by .pdf via email, or sent by a nationally recognized overnight courier service addressed to each
Holder at the .pdf via email number or address of such Holder appearing on the books of the Company, or if no such .pdf via email
number or address appears on the books of the Company, at the principal place of business of such Holder, as set forth in the Joint
Development Agreement. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest
of (i) the date of transmission, if such notice or communication is delivered via .pdf via email at the .pdf via email number set
forth in this Section 11 prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of
transmission, if such notice or communication is delivered via .pdf via email at the .pdf via email number set forth in this Section
11 on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day
following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the
party to whom such notice is required to be given.
b) Stockholder
Approval. The Company shall provide each stockholder entitled to vote at a special or annual meeting of stockholders of the
Company (the “Stockholder Meeting”), which shall be held no later than July 26, 2026 (the “Stockholder
Meeting Deadline”), to seek approval of resolutions (“Stockholder Resolutions”) providing for the
Stockholder Approval and the Company shall use its reasonable best efforts to solicit its stockholders’ approval of such
Stockholder Resolutions and to cause the board of directors of the Company to recommend to the stockholders that they approve such
Stockholder Resolutions. The Company shall be obligated to seek to obtain the Stockholder Approval by the Stockholder Meeting
Deadline. If, despite the Company’s reasonable best efforts the Stockholder Approval is not obtained on or prior to the
Stockholder Meeting Deadline, the Company shall cause an additional Stockholder Meeting to be held within 90 days later. If, despite
the Company’s reasonable best efforts the Stockholder Approval is not obtained after such subsequent stockholder meetings, the
Company shall cause an additional Stockholder Meeting to be held semi-annually thereafter until such Stockholder Approval is
obtained. Notwithstanding the above, the Company shall not be required to hold a Stockholder Meeting or seek Stockholder Approval
any time following the time when the shares of Preferred Stock are no longer outstanding if upon full conversion of the shares of
Preferred Stock, the shares of Common Stock issued pursuant to the shares of Preferred Stock would not exceed the Issuable
Maximum.
c) Absolute
Obligation. Except as expressly provided herein, no provision of this Certificate of Designations shall alter or impair the
obligation of the Company, which is absolute and unconditional, to pay liquidated damages, accrued dividends and accrued interest,
as applicable, on the shares of Preferred Stock at the time, place, and rate, and in the coin or currency, herein
prescribed.
d) Lost
or Mutilated Preferred Stock Certificate. If a Holder’s Preferred Stock certificate shall be mutilated, lost, stolen or
destroyed, the Company shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate,
or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Preferred Stock so
mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and
of the ownership hereof reasonably satisfactory to the Company.
e) Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designations
shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the
principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and
defense of the transactions contemplated by any of the Transaction Documents (whether brought against a party hereto or its
respective Affiliates, directors, officers, shareholders, employees or agents) shall be commenced in the state and federal courts
sitting in the City of New York, Borough of Manhattan (the “New York Courts”). Each party hereto hereby
irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in
connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any
claim that it is not personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper or
inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices to it under this Certificate of Designations and
agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall
be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each party hereto hereby
irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding
arising out of or relating to this Certificate of Designations or the transactions contemplated hereby. If any party shall commence
an action or proceeding to enforce any provisions of this Certificate of Designations, then the prevailing party in such action or
proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses incurred in the
investigation, preparation and prosecution of such action or proceeding.
f) Waiver.
Any waiver by the Company or a Holder of a breach of any provision of this Certificate of Designations shall not operate as or be
construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of
Designations or a waiver by any other Holders. The failure of the Company or a Holder to insist upon strict adherence to any term of
this Certificate of Designations on one or more occasions shall not be considered a waiver or deprive that party (or any other
Holder) of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designations
on any other occasion. Any waiver by the Company or a Holder must be in writing.
g) Severability.
If any provision of this Certificate of Designations is invalid, illegal or unenforceable, the balance of this Certificate of
Designations shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless
remain applicable to all other Persons and circumstances.
h) Next
Business Day. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment
shall be made on the next succeeding Business Day.
i) Headings.
The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designations and shall not
be deemed to limit or affect any of the provisions hereof.
j) Status
of Converted or Redeemed Preferred Stock. Shares of Preferred Stock may only be issued pursuant to the Joint Development
Agreement. If any shares of Preferred Stock shall be converted, redeemed or reacquired by the Company, such shares shall resume the
status of authorized but unissued shares of preferred stock and shall no longer be designated as Series J Convertible Preferred
Stock.
RESOLVED,
FURTHER, that the Executive Chairman, Chief Executive Officer, the President or any Vice-President, of the Company be and they hereby
are authorized and directed to prepare and file this Certificate of Designation of Preferences, Rights and Limitations in accordance
with the foregoing resolution and the provisions of Delaware law.
IN
WITNESS WHEREOF, the undersigned have executed this Certificate this 27th day of April, 2026.
/s/ Joshua Silverman
Name:
Joshua Silverman
Title:
Chief Executive Officer
ANNEX
A
NOTICE
OF CONVERSION
(TO
BE EXECUTED BY THE REGISTERED HOLDER IN ORDER TO CONVERT SHARES
OF
PREFERRED STOCK)
The
undersigned hereby elects to convert the number of shares of Series J Convertible Preferred Stock indicated below into shares of common
stock, par value $0.0001 per share (the “Common Stock”), of StableX Technologies, Inc., a Delaware corporation (the
“Company”), according to the conditions hereof, as of the date written below. If shares of Common Stock are to be
issued in the name of a Person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and
is delivering herewith such certificates and opinions as may be required by the Company. No fee will be charged to the Holders for any
conversion, except for any such transfer taxes.
Conversion
calculations:
Date
to Effect Conversion: _____________________________________________
Number
of shares of Preferred Stock owned prior to Conversion: ________________
Number
of shares of Preferred Stock to be Converted: ________________________
Stated
Value of shares of Preferred Stock to be Converted: ____________________
Number
of shares of Common Stock to be Issued: ___________________________
Applicable
Conversion Price:___________________________________________
Number
of shares of Preferred Stock subsequent to Conversion: ________________
Address
for Delivery: ______________________
[HOLDER]
By:
Name:
Title:
EX-3.2
EX-3.2
Filename: ex3-2.htm · Sequence: 3
Exhibit 3.2
CERTIFICATE
OF DESIGNATIONS OF
SERIES
K CONVERTIBLE PREFERRED STOCK OF
STABLEX
TECHNOLOGIES, INC.
I,
Joshua Silverman, hereby certify that I am the Chief Executive Officer of StableX Technologies, Inc. (the “Company”),
a corporation organized and existing under the Delaware General Corporation Law (the “DGCL”), and further do hereby
certify:
That
pursuant to the authority expressly conferred upon the Board of Directors of the Company (the “Board”) by the Company’s
Amended and Restated Certificate of Incorporation (as amended, the “Certificate of Incorporation”), and Section 151(g)
of the DGCL, on April 27, 2026, the Board adopted the following resolution determining it desirable and in the best interests of the
Company and its stockholders for the Company to create a series of 21,500 shares of preferred stock designated as “Series K
Convertible Preferred Stock”, none of which shares have been issued:
RESOLVED,
that pursuant to the authority vested in the Board, in accordance with the provisions of the Certificate of Incorporation, a series of
preferred stock, par value $0.0001 per share, of the Company be and hereby is created pursuant to this certificate of designations (this
“Certificate of Designations”), and that the designation and number of shares thereof and the voting and other powers,
preferences and relative, participating, optional or other rights of the shares of such series and the qualifications, limitations and
restrictions thereof are as follows:
TERMS
OF SERIES K CONVERTIBLE PREFERRED STOCK
1. Designation
and Number of Shares. There shall hereby be created and established a series of preferred stock of the Company designated as “Series
K Convertible Preferred Stock” (the “Preferred Shares”). The authorized number of Preferred Shares shall be
21,500. Each Preferred Share shall have a par value of $0.0001. Capitalized terms not defined herein shall have the meaning as set forth
in Section 33 below.
2. Ranking.
Except to the extent that the holders of at least a majority of the outstanding Preferred Shares (provided that such holders shall include
each of Iroquois Master Fund Ltd. and Iroquois Capital Investment Group, LLC (collectively, the “Iroquois Funds”),
provided that the Iroquois Funds collectively hold an aggregate of at least 20% of the Preferred Shares issued to the Iroquois Funds
on the Issuance Date (as defined herein) ) (the “Required Holders”) expressly consent to the creation of Parity Stock
(as defined below) or Senior Preferred Stock (as defined below) in accordance with Section 18, all shares of capital stock
of the Company shall be junior in rank to all Preferred Shares with respect to the preferences as to dividends, distributions and payments
upon the liquidation, dissolution and winding up of the Company (such junior stock is referred to herein collectively as “Junior
Stock”). The rights of all such shares of capital stock of the Company shall be subject to the rights, powers, preferences
and privileges of the Preferred Shares. Without limiting any other provision of this Certificate of Designations, without the prior express
consent of the Required Holders, voting separately as a single class, the Company shall not hereafter authorize or issue any additional
or other shares of capital stock that are (i) of senior rank to the Preferred Shares in respect of the preferences as to dividends,
distributions and payments upon the liquidation, dissolution and winding up of the Company (collectively, the “Senior Preferred
Stock”), (ii) of pari passu rank to the Preferred Shares in respect of the preferences as to dividends, distributions
and payments upon the liquidation, dissolution and winding up of the Company (collectively, the “Parity Stock”) or
(iii) any Junior Stock having a maturity date or any other date requiring redemption or repayment of such shares of Junior Stock.
In the event of the merger or consolidation of the Company with or into another corporation, the Preferred Shares shall maintain their
relative rights, powers, designations, privileges and preferences provided for herein and no such merger or consolidation shall be consummated
if it would result in the Preferred Shares being treated in any manner inconsistently with the foregoing.
3. Dividends
and Payments.
(a) From
and after the first date of issuance of any Preferred Shares (the “Initial Issuance Date”), each holder of a Preferred
Share (each, a “Holder” and collectively, the “Holders”) shall be entitled to receive dividends
on the Stated Value of the Preferred Shares (“Dividends”) payable, subject to the conditions and other terms hereof,
in cash out of funds legally available therefor at the Dividend Rate computed on the basis of a 360-day year and twelve 30-day months
and shall compound each calendar quarter; provided that a Holder and the Company may mutually agree to convert any Dividends into shares
of Common Stock at a price to be mutually determined by the Company and such Holder, which shall not be less than the Floor Price.
(b) Dividends
shall be payable in arrears on (i) each Dividend Date, and (ii) upon any redemption in accordance with Section 12 or any required
payment upon any Triggering Event. From and after the occurrence and during the continuance of any Triggering Event and ending on the
date on which such Triggering Event is subsequently cured (and no other Triggering Event then exists), Dividends shall accrue on the
Stated Value of each Preferred Share at fifteen percent (15.0%) per annum (the “Default Rate”) and shall be computed
on the basis of a 360-day year and twelve 30-day months.
4. Conversion.
At any time after the Initial Issuance Date, each Preferred Share shall be convertible into validly issued, fully paid and non-assessable
shares of Common Stock (as defined below), on the terms and conditions set forth in this Section 4.
(a) Holder’s
Conversion Right. Subject to the provisions of Section 4(d), at any time or times on or after the Initial Issuance Date, each Holder
shall be entitled to convert any portion of the outstanding Preferred Shares held by such Holder into validly issued, fully paid and
non-assessable shares of Common Stock in accordance with Section 4(c) at the Conversion Rate (as defined below). The Company shall not
issue any fraction of a share of Common Stock upon any conversion. If the issuance would result in the issuance of a fraction of a share
of Common Stock, the Company shall round such fraction of a share of Common Stock up to the nearest whole share. The Company shall pay
any and all transfer, stamp, issuance and similar taxes, costs and expenses (including, without limitation, fees and expenses of the
Transfer Agent (as defined below)) that may be payable with respect to the issuance and delivery of Common Stock upon conversion of any
Preferred Shares.
2
(b) Conversion
Rate. The number of shares of Common Stock issuable upon conversion of any Preferred Share pursuant to Section 4(a) shall be determined
by dividing (x) the Conversion Amount of such Preferred Share by (y) the Conversion Price (the “Conversion Rate”):
(i) “Conversion
Amount” means, with respect to each Preferred Share, as of the applicable date of determination, the sum of (1) the Stated
Value thereof, plus (2) the Additional Amount thereon, plus (3) the Make-Whole Amount, plus (4) and any accrued and unpaid Late Charges
(as defined below in Section 26(c)) with respect to such Stated Value and Additional Amount as of such date of determination.
(ii) “Conversion
Price” means, with respect to each Preferred Share, as of any Conversion Date or other date of determination, $2.51, subject
to adjustment as provided herein.
(c) Mechanics
of Conversion. The conversion of each Preferred Share shall be conducted in the following manner:
(i) Optional
Conversion. To convert a Preferred Share into shares of Common Stock on any date (a “Conversion Date”), a Holder
shall deliver (whether via electronic mail or otherwise), for receipt on or prior to 11:59 p.m., New York time, on such date, a copy
of an executed notice of conversion of the share(s) of Preferred Shares subject to such conversion in the form attached hereto as Exhibit
I (the “Conversion Notice”) to the Company. If required by Section 4(c)(iii), within two (2) Trading Days
following a conversion of any such Preferred Shares as aforesaid, such Holder shall surrender to a nationally recognized overnight delivery
service for delivery to the Company the original certificates, if any, representing the Preferred Shares (the “Preferred Share
Certificates”) so converted as aforesaid (or an indemnification undertaking with respect to the Preferred Shares in the case
of its loss, theft or destruction as contemplated by Section 20(b)). On or before the first (1st) Trading Day following the date of receipt
of a Conversion Notice, the Company shall transmit by electronic mail an acknowledgment of confirmation and representation as to whether
such shares of Common Stock may then be resold pursuant to Rule 144 or an effective and available registration statement, in the form
attached hereto as Exhibit II, of receipt of such Conversion Notice to such Holder and the Company’s transfer agent
(the “Transfer Agent”), which confirmation shall constitute an instruction to the Transfer Agent to process such Conversion
Notice in accordance with the terms herein. On or before the first (1st) Trading Day following each date on which the Company has received
a Conversion Notice (or such earlier date as required pursuant to the 1934 Act or other applicable law, rule or regulation for the settlement
of a trade initiated on the applicable Conversion Date of such shares of Common Stock issuable pursuant to such Conversion Notice) (the
“Share Delivery Deadline”), the Company shall (1) provided that the Transfer Agent is participating in the Depository
Trust Company’s (“DTC”) Fast Automated Securities Transfer Program (“FAST”), credit such
aggregate number of shares of Common Stock to which such Holder shall be entitled pursuant to such conversion to such Holder’s
or its designee’s balance account with DTC through its Deposit/Withdrawal at Custodian system, or (2) if the Transfer Agent is
not participating in FAST, upon the request of such Holder, issue and deliver (via reputable overnight courier) to the address as specified
in such Conversion Notice, a certificate, registered in the name of such Holder or its designee, for the number of shares of Common Stock
to which such Holder shall be entitled. If the number of Preferred Shares represented by the Preferred Share Certificate(s) submitted
for conversion pursuant to Section 4(c)(iii) is greater than the number of Preferred Shares being converted, then the Company shall,
as soon as practicable and in no event later than two (2) Trading Days after receipt of the Preferred Share Certificate(s) and at its
own expense, issue and deliver to such Holder (or its designee) a new Preferred Share Certificate or a new Book-Entry (in either case,
in accordance with Section 20(d)) representing the number of Preferred Shares not converted. The Person or Persons entitled to receive
the shares of Common Stock issuable upon a conversion of Preferred Shares shall be treated for all purposes as the record holder or holders
of such shares of Common Stock on the Conversion Date. Notwithstanding the foregoing, with respect to any Conversion Notice delivered
by a Buyer (as defined in the Securities Purchase Agreement) to the Company on or prior to 4:00 p.m. (New York City time) on the Trading
Day immediately prior to the date of initial issuance of such applicable Preferred Shares to be converted pursuant to such Conversion
Notice (each, an “Issuance Date”), which may be delivered at any time after the time of execution of the Securities
Purchase Agreement, the Company agrees to deliver the shares of Common Stock issuable upon conversion of such Preferred Shares to be
issued on such date subject to such notice(s) by 4:00 p.m. (New York City time) on such applicable Issuance Date and such Issuance Date
shall be the Share Delivery Deadline for purposes hereunder with respect to such Conversion Notice.
3
(ii) Company’s
Failure to Timely Convert. If the Company shall fail, for any reason or for no reason, on or prior to the applicable Share Delivery
Deadline, if the Transfer Agent is not participating in FAST, to issue and deliver to such Holder (or its designee) a certificate for
the number of shares of Common Stock to which such Holder is entitled and register such shares of Common Stock on the Company’s
share register or, if the Transfer Agent is participating in FAST, to credit such Holder’s or its designee’s balance account
with DTC for such number of shares of Common Stock to which such Holder is entitled upon such Holder’s conversion of any Conversion
Amount (as the case may be) (a “Conversion Failure”), then, in addition to all other remedies available to such Holder,
(X) the Company shall pay in cash from funds legally available therefor to such Holder on each day after the Share Delivery Deadline
that the issuance of such shares of Common Stock is not timely effected an amount equal to 1% of the product of (A) the sum of the number
of shares of Common Stock not issued to such Holder on or prior to the Share Delivery Deadline and to which such Holder is entitled,
multiplied by (B) any trading price of the Common Stock selected by such Holder in writing as in effect at any time during the period
beginning on the applicable Conversion Date and ending on the applicable Share Delivery Deadline, and (Y) such Holder, upon written notice
to the Company, may void its Conversion Notice with respect to, and retain or have returned, as the case may be, all, or any portion,
of such Preferred Shares that has not been converted pursuant to such Conversion Notice; provided that the voiding of a Conversion Notice
shall not affect the Company’s obligations to make any payments which have accrued prior to the date of such notice pursuant to
this Section 4(c)(ii) or otherwise. In addition to the foregoing, if on or prior to the Share Delivery Deadline the Transfer Agent is
not participating in FAST, the Company shall fail to issue and deliver to such Holder (or its designee) a certificate and register such
shares of Common Stock on the Company’s share register or, if the Transfer Agent is participating in FAST, the Transfer Agent shall
fail to credit the balance account of such Holder or such Holder’s designee, as applicable, with DTC for the number of shares of
Common Stock to which such Holder is entitled upon such Holder’s conversion hereunder or pursuant to the Company’s obligation
pursuant to clause (ii) below, and if on or after such Share Delivery Deadline such Holder acquires (in an open market transaction, stock
loan or otherwise) shares of Common Stock corresponding to all or any portion of the number of shares of Common Stock issuable upon such
conversion that such Holder is entitled to receive from the Company and has not received from the Company in connection with such Conversion
Failure (a “Buy-In”), then, in addition to all other remedies available to such Holder, the Company shall, within
two (2) Business Days after receipt of such Holder’s request and in such Holder’s discretion, either: (I) pay cash from funds
legally available therefor to such Holder in an amount equal to such Holder’s total purchase price (including brokerage commissions,
stock loan costs and other out-of-pocket expenses, if any) for the shares of Common Stock so acquired (including, without limitation,
by any other Person in respect, or on behalf, of such Holder) (the “Buy-In Price”), at which point the Company’s
obligation to so issue and deliver such certificate (and to issue such shares of Common Stock) or credit to the balance account of such
Holder or such Holder’s designee, as applicable, with DTC for the number of shares of Common Stock to which such Holder is entitled
upon such Holder’s conversion hereunder (as the case may be) (and to issue such shares of Common Stock) shall terminate, or (II)
promptly honor its obligation to so issue and deliver to such Holder a certificate or certificates representing such shares of Common
Stock or credit the balance account of such Holder or such Holder’s designee, as applicable, with DTC for the number of shares
of Common Stock to which such Holder is entitled upon such Holder’s conversion hereunder (as the case may be) and pay cash from
funds legally available therefor to such Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (x)
such number of shares of Common Stock multiplied by (y) the lowest Closing Sale Price of the Common Stock on any Trading Day during the
period commencing on the date of the applicable Conversion Notice and ending on the date of such issuance and payment under this clause
(II). Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity,
including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure
to timely deliver certificates representing shares of Common Stock (or to electronically deliver such shares of Common Stock) upon the
conversion of the Preferred Shares as required pursuant to the terms hereof. Notwithstanding anything herein to the contrary, with respect
to any given Conversion Failure, this Section 4(c)(ii) shall not apply to a Holder to the extent the Company has already paid such amounts
in full to such Holder with respect to such Conversion Failure, as applicable, pursuant to the analogous sections of the Securities Purchase
Agreement.
4
(iii) Registration;
Book-Entry. At the time of issuance of any Preferred Shares hereunder, the applicable Holder may, by written request (including by
electronic-mail) to the Company, elect to receive such Preferred Shares in the form of one or more Preferred Share Certificates or in
Book-Entry form. The Company (or the Transfer Agent, as custodian for the Preferred Shares) shall maintain a register (the “Register”)
for the recordation of the names and addresses of the Holders of each Preferred Share and the Stated Value of the Preferred Shares and
whether the Preferred Shares are held by such Holder in Preferred Share Certificates or in Book-Entry form (the “Registered
Preferred Shares”). The entries in the Register shall be conclusive and binding for all purposes absent manifest error. The
Company and each Holder of the Preferred Shares shall treat each Person whose name is recorded in the Register as the owner of a Preferred
Share for all purposes (including, without limitation, the right to receive payments and Dividends hereunder) notwithstanding notice
to the contrary. A Registered Preferred Share may be assigned, transferred or sold only by registration of such assignment or sale on
the Register. Upon its receipt of a written request to assign, transfer or sell one or more Registered Preferred Shares by such Holder
thereof, the Company shall record the information contained therein in the Register and issue one or more new Registered Preferred Shares
in the same aggregate Stated Value as the Stated Value of the surrendered Registered Preferred Shares to the designated assignee or transferee
pursuant to Section 19, provided that if the Company does not so record an assignment, transfer or sale (as the case may be) of such
Registered Preferred Shares within two (2) Business Days of such a request, then the Register shall be automatically deemed updated to
reflect such assignment, transfer or sale (as the case may be). Notwithstanding anything to the contrary set forth in this Section 4,
following conversion of any Preferred Shares in accordance with the terms hereof, the applicable Holder shall not be required to physically
surrender such Preferred Shares held in the form of a Preferred Share Certificate to the Company unless (A) the full or remaining number
of Preferred Shares represented by the applicable Preferred Share Certificate are being converted (in which event such certificate(s)
shall be delivered to the Company as contemplated by this Section 4(c)(iii)) or (B) such Holder has provided the Company with prior written
notice (which notice may be included in a Conversion Notice) requesting reissuance of Preferred Shares upon physical surrender of the
applicable Preferred Share Certificate. Each Holder and the Company shall maintain records showing the Stated Value, Dividends and Late
Charges converted and/or paid (as the case may be) and the dates of such conversions and/or payments (as the case may be) or shall use
such other method, reasonably satisfactory to such Holder and the Company, so as not to require physical surrender of a Preferred Share
Certificate upon conversion. If the Company does not update the Register to record such Stated Value, Dividends and Late Charges converted
and/or paid (as the case may be) and the dates of such conversions and/or payments (as the case may be) within two (2) Business Days
of such occurrence, then the Register shall be automatically deemed updated to reflect such occurrence. In the event of any dispute or
discrepancy, such records of such Holder establishing the number of Preferred Shares to which the record holder is entitled shall be
controlling and determinative in the absence of manifest error. A Holder and any transferee or assignee, by acceptance of a certificate,
acknowledge and agree that, by reason of the provisions of this paragraph, following conversion of any Preferred Shares, the number of
Preferred Shares represented by such certificate may be less than the number of Preferred Shares stated on the face thereof. Each Preferred
Share Certificate shall bear the following legend:
ANY
TRANSFEREE OR ASSIGNEE OF THIS CERTIFICATE SHOULD CAREFULLY REVIEW THE TERMS OF THE COMPANY’S CERTIFICATE OF DESIGNATIONS RELATING
TO THE SHARES OF SERIES K PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE, INCLUDING SECTION 4(c)(iii) THEREOF. THE NUMBER OF SHARES
OF SERIES K PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE MAY BE LESS THAN THE NUMBER OF SHARES OF SERIES K PREFERRED STOCK STATED
ON THE FACE HEREOF PURSUANT TO SECTION 4(c)(iii) OF THE CERTIFICATE OF DESIGNATIONS RELATING TO THE SHARES OF SERIES K PREFERRED STOCK
REPRESENTED BY THIS CERTIFICATE.
(iv) Pro
Rata Conversion; Disputes. In the event that the Company receives a Conversion Notice from more than one Holder for the same Conversion
Date and the Company can convert some, but not all, of such Preferred Shares submitted for conversion, the Company shall convert from
each Holder electing to have Preferred Shares converted on such date a pro rata amount of such Holder’s Preferred Shares submitted
for conversion on such date based on the number of Preferred Shares submitted for conversion on such date by such Holder relative to
the aggregate number of Preferred Shares submitted for conversion on such date. In the event of a dispute as to the number of shares
of Common Stock issuable to a Holder in connection with a conversion of Preferred Shares, the Company shall issue to such Holder the
number of shares of Common Stock not in dispute and resolve such dispute in accordance with Section 25.
5
(d) Limitation
on Beneficial Ownership.
(i) Beneficial
Ownership. The Company shall not effect the conversion of any of the Preferred Shares held by a Holder, and such Holder shall not
have the right to convert any of the Preferred Shares held by such Holder pursuant to the terms and conditions of this Certificate of
Designations and any such conversion shall be null and void and treated as if never made, to the extent that after giving effect to such
conversion, such Holder together with the other Attribution Parties collectively would beneficially own in excess of 4.99% (the “Maximum
Percentage”) of the shares of Common Stock outstanding immediately after giving effect to such conversion. For purposes of
the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such Holder and the other Attribution Parties
shall include the number of shares of Common Stock held by such Holder and all other Attribution Parties plus the number of shares of
Common Stock issuable upon conversion of the Preferred Shares with respect to which the determination of such sentence is being made,
but shall exclude shares of Common Stock which would be issuable upon (A) conversion of the remaining, nonconverted Preferred Shares
beneficially owned by such Holder or any of the other Attribution Parties and (B) exercise or conversion of the unexercised or nonconverted
portion of any other securities of the Company (including, without limitation, any convertible notes, convertible preferred stock or
warrants, including the Preferred Shares and the Warrants) beneficially owned by such Holder or any other Attribution Party subject to
a limitation on conversion or exercise analogous to the limitation contained in this Section 4(d)(i). For purposes of this Section 4(d)(i),
beneficial ownership shall be calculated in accordance with Section 13(d) of the 1934 Act. In addition, a determination as to any group
status as contemplated above shall be determined in accordance with Section 13(d) of the 1934 Act and the rules and regulations promulgated
thereunder. For purposes of determining the number of outstanding shares of Common Stock a Holder may acquire upon the conversion of
such Preferred Shares without exceeding the Maximum Percentage, such Holder may rely on the number of outstanding shares of Common Stock
as reflected in (x) the Company’s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form
8-K or other public filing with the SEC, as the case may be, (y) a more recent public announcement by the Company or (z) any other written
notice by the Company or the Transfer Agent, if any, setting forth the number of shares of Common Stock outstanding (the “Reported
Outstanding Share Number”). If the Company receives a Conversion Notice from a Holder at a time when the actual number of outstanding
shares of Common Stock is less than the Reported Outstanding Share Number, the Company shall notify such Holder in writing of the number
of shares of Common Stock then outstanding and, to the extent that such Conversion Notice would otherwise cause such Holder’s beneficial
ownership, as determined pursuant to this Section 4(d)(i), to exceed the Maximum Percentage, such Holder must notify the Company of a
reduced number of shares of Common Stock to be purchased pursuant to such Conversion Notice. For any reason at any time, upon the written
or oral request of any Holder, the Company shall within one (1) Business Day confirm orally and in writing or by electronic mail to such
Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be
determined after giving effect to the conversion or exercise of securities of the Company, including such Preferred Shares, by such Holder
and any other Attribution Party since the date as of which the Reported Outstanding Share Number was reported. In the event that the
issuance of shares of Common Stock to a Holder upon conversion of such Preferred Shares results in such Holder and the other Attribution
Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common
Stock (as determined under Section 13(d) of the 1934 Act), the number of shares so issued by which such Holder’s and the other
Attribution Parties’ aggregate beneficial ownership exceeds the Maximum Percentage (the “Excess Shares”) shall
be deemed null and void and shall be cancelled ab initio, and such Holder shall not have the power to vote or to transfer the Excess
Shares. Upon delivery of a written notice to the Company, any Holder may from time to time increase (with such increase not effective
until the sixty-first (61st) day after delivery of such notice) or decrease the Maximum Percentage of such Holder to any other
percentage not in excess of 9.99% as specified in such notice; provided that (i) any such increase in the Maximum Percentage will not
be effective until the sixty-first (61st) day after such notice is delivered to the Company and (ii) any such increase or
decrease will apply only to such Holder and the other Attribution Parties and not to any other Holder that is not an Attribution Party
of such Holder. For purposes of clarity, the shares of Common Stock issuable to a Holder pursuant to the terms of this Certificate of
Designations in excess of the Maximum Percentage shall not be deemed to be beneficially owned by such Holder for any purpose including
for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act. No prior inability to convert such Preferred Shares pursuant to this
paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent determination
of convertibility. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity
with the terms of this Section 4(d)(i) to the extent necessary to correct this paragraph (or any portion of this paragraph) which may
be defective or inconsistent with the intended beneficial ownership limitation contained in this Section 4(d)(i) or to make changes or
supplements necessary or desirable to properly give effect to such limitation. The limitation contained in this paragraph may not be
waived and shall apply to a successor holder of such Preferred Shares.
(ii) Principal
Market Regulation. The Company shall not issue any shares of Common Stock upon conversion of any Preferred Shares or otherwise pursuant
to the terms of this Certificate of Designations if the issuance of such shares of Common Stock (taken together with the issuance of
all other shares of Common Stock upon exercise of the Warrants and Placement Agent Warrants) would exceed the aggregate number of shares
of Common Stock which the Company may issue upon exercise or conversion (as the case may be) of the Preferred Shares, the Warrants and
Placement Agent Warrants without breaching the Company’s obligations under the rules and regulations of the Principal Market (the
number of shares which may be issued without violating such rules and regulations, including, but not limited to, rules related to the
aggregate offerings under Nasdaq Listing Rule 5635(d), the “Exchange Cap”), except that such limitation shall not
apply in the event that the Company (A) obtains the approval of its stockholders as required by the applicable rules and regulations
of the Principal Market for issuances of shares of Common Stock in excess of such amount (“Stockholder Approval”)
or (B) obtains a written opinion from outside counsel to the Company that such approval is not required, which opinion shall be reasonably
satisfactory to the Required Holders. Until such approval or such written opinion is obtained, no Holder shall be issued in the aggregate,
upon conversion or exercise (as the case may be) of any Preferred Shares or any Warrant, shares of Common Stock in an amount greater
than the product of (i) the Exchange Cap as of the Initial Issuance Date multiplied by (ii) the quotient of (1) the aggregate number
of Preferred Shares issued to such Holder on the Initial Issuance Date divided by (2) the aggregate number of Preferred Shares issued
to the Holders on the Initial Issuance Date (with respect to each Holder, the “Exchange Cap Allocation”). In the event
that any Holder shall sell or otherwise transfer any of such Holder’s Preferred Shares, the transferee shall be allocated a pro
rata portion of such Holder’s Exchange Cap Allocation with respect to such portion of such Preferred Shares so transferred, and
the restrictions of the prior sentence shall apply to such transferee with respect to the portion of the Exchange Cap Allocation so allocated
to such transferee. Upon conversion in full of a holder’s Preferred Shares, the difference (if any) between such holder’s
Exchange Cap Allocation and the number of shares of Common Stock actually issued to such holder upon such holder’s conversion in
full of such Preferred Shares shall be allocated, to the respective Exchange Cap Allocations of the remaining holders of Preferred Shares
and/or related Warrants on a pro rata basis in proportion to the shares of Common Stock underlying the Preferred Shares and/or related
Warrants then held by each such holder of Preferred Shares and/or related Warrants.
6
(e) Right
of Alternate Conversion.
(i) Alternate
Conversion Upon a Triggering Event. Subject to Section 4(d), at any time during a Triggering Event Redemption Right Period (as
defined herein), such Holder may, at such Holder’s option, by delivery of a Conversion Notice to the Company (the date of any such
Conversion Notice, each an “Alternate Conversion Date”), convert all, or any number of Preferred Shares (such Conversion
Amount of the Preferred Shares to be converted pursuant to this Section 4(e)(ii), each, an “Alternate Conversion Amount”)
held by such Holder into shares of Common Stock at the Alternate Conversion Price (each an “Alternate Conversion”).
(ii) Mechanics
of Alternate Conversion. On any Alternate Conversion Date, a Holder may voluntarily convert any Alternate Conversion Amount of Preferred
Shares pursuant to Section 4(c) (with “Alternate Conversion Price” replacing “Conversion Price”
for all purposes hereunder with respect to such Alternate Conversion and with “Alternate Conversion Amount” replacing
“Conversion Amount” in clause (x) of the definition of Conversion Rate above with respect to such Alternate Conversion)
by designating in the Conversion Notice delivered pursuant to this Section 4(e) of this Certificate of Designations that such
Holder is electing to use the Alternate Conversion Price for such conversion; provided that in the event of the Conversion Floor
Price Condition, on the applicable Alternate Conversion Date the Company shall also deliver to the Holder the applicable Alternate Conversion
Floor Amount. Notwithstanding anything to the contrary in this Section 4(e), but subject to Section 4(d), until the Company
delivers shares of Common Stock representing the applicable Alternate Conversion Amount of Preferred Shares to such Holder, such Preferred
Shares may be converted by such Holder into shares of Common Stock pursuant to Section 4(c) without regard to this Section
4(e).
5. Triggering
Event Redemptions.
(a) Triggering
Event. Each of the following events shall constitute a “Triggering Event” and each of the events in clauses (viii),
(ix), and (x) shall constitute a “Bankruptcy Triggering Event”:
7
(i) the
suspension from trading or the failure of the Common Stock to be trading or listed (as applicable) on an Eligible Market for a period
of five (5) consecutive Trading Days;
(ii) the
Company’s (A) failure to cure a Conversion Failure or a Delivery Failure (as defined in the Warrants) by delivery of the required
number of shares of Common Stock within five (5) Trading Days after the applicable Conversion Date or exercise date (as the case may
be) or (B) written notice to any holder of Preferred Shares or Warrants, including, without limitation, by way of public announcement
or through any of its agents, at any time, of its intention not to comply, as required, with a request for exercise of any Warrants for
Warrant Shares in accordance with the provisions of the Warrants or a request for conversion of any Preferred Shares into shares of Common
Stock that is requested in accordance with the provisions of this Certificate of Designations, other than pursuant to Section 4(d) hereof;
(iii) except
to the extent the Company is in compliance with Section 11(b) below, at any time following the tenth (10th) consecutive
day that a Holder’s Authorized Share Allocation (as defined in Section 11(a) below) is less than the sum of (A) 200% of the number
of shares of Common Stock that such Holder would be entitled to receive upon a conversion, in full, of all of the Preferred Shares then
held by such Holder (assuming a conversion at the Floor Price then in effect and without regard to any limitations on conversion set
forth in this Certificate of Designations) and (B) 200% of the number of shares of Common Stock that such Holder would then be entitled
to receive upon exercise in full of such Holder’s Warrants (without regard to any limitations on exercise set forth in the Warrants);
(iv) subject
to the provisions of Section 170 of the DGCL, the Board fails to declare any Dividend to be paid on the applicable Dividend Date in accordance
with Section 3 hereof;
(v) the
Company’s failure to pay to any Holder any Dividend on any Dividend Date (whether or not declared by the Board) or any other amount
when and as due under this Certificate of Designations (including, without limitation, the Company’s failure to pay any redemption
payments or other amounts hereunder), the Securities Purchase Agreement or any other Transaction Document or any other agreement, document,
certificate or other instrument delivered in connection with the transactions contemplated hereby and thereby (in each case, whether
or not permitted pursuant to the DGCL), except, solely with respect to the failure to pay Dividends and Late Charges when and as due
hereunder, only if such failure remains uncured for a period of at least five (5) Trading Days;
(vi) the
Company fails to remove any restrictive legend on any certificate or any shares of Common Stock issued to the applicable Holder upon
conversion or exercise (as the case may be) of any Securities (as defined in the Securities Purchase Agreement) acquired by such Holder
under the Transaction Documents as and when required by such Securities or the Securities Purchase Agreement, as applicable, unless otherwise
then prohibited by applicable federal securities laws, and any such failure remains uncured for at least five (5) Trading Days;
8
(vii) the
occurrence of any default under, redemption of or acceleration prior to maturity of at least an aggregate of $250,000 of Indebtedness
(as defined in the Securities Purchase Agreement) of the Company or any of its Subsidiaries;
(viii) bankruptcy,
insolvency, reorganization or liquidation proceedings or other proceedings for the relief of debtors shall be instituted by or against
the Company or any Subsidiary and, if instituted against the Company or any Subsidiary by a third party, shall not be dismissed within
thirty (30) days of their initiation;
(ix) the
commencement by the Company or any Subsidiary of a voluntary case or proceeding under any applicable federal, state or foreign bankruptcy,
insolvency, reorganization or other similar law or of any other case or proceeding to be adjudicated a bankrupt or insolvent, or the
consent by it to the entry of a decree, order, judgment or other similar document in respect of the Company or any Subsidiary in an involuntary
case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or to the
commencement of any bankruptcy or insolvency case or proceeding against it, or the filing by it of a petition or answer or consent seeking
reorganization or relief under any applicable federal, state or foreign law, or the consent by it to the filing of such petition or to
the appointment of or taking possession by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official
of the Company or any Subsidiary or of any substantial part of its property, or the making by it of an assignment for the benefit of
creditors, or the execution of a composition of debts, or the occurrence of any other similar federal, state or foreign proceeding, or
the admission by it in writing of its inability to pay its debts generally as they become due, the taking of corporate action by the
Company or any Subsidiary in furtherance of any such action or the taking of any action by any Person to commence a Uniform Commercial
Code foreclosure sale or any other similar action under federal, state or foreign law;
(x) the
entry by a court of (i) a decree, order, judgment or other similar document in respect of the Company or any Subsidiary of a voluntary
or involuntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar
law or (ii) a decree, order, judgment or other similar document adjudging the Company or any Subsidiary as bankrupt or insolvent, or
approving as properly filed a petition seeking liquidation, reorganization, arrangement, adjustment or composition of or in respect of
the Company or any Subsidiary under any applicable federal, state or foreign law or (iii) a decree, order, judgment or other similar
document appointing a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or any
Subsidiary or of any substantial part of its property, or ordering the winding up or liquidation of its affairs, and the continuance
of any such decree, order, judgment or other similar document or any such other decree, order, judgment or other similar document unstayed
and in effect for a period of thirty (30) consecutive days;
(xi) a
final judgment or judgments for the payment of money aggregating in excess of $250,000 are rendered against the Company and/or any of
its Subsidiaries and which judgments are not, within thirty (30) days after the entry thereof, bonded, discharged, settled or stayed
pending appeal, or are not discharged within thirty (30) days after the expiration of such stay; provided, however, any judgment which
is covered by insurance or an indemnity from a credit worthy party shall not be included in calculating the $250,000 amount set forth
above so long as the Company provides each Holder a written statement from such insurer or indemnity provider (which written statement
shall be reasonably satisfactory to each Holder) to the effect that such judgment is covered by insurance or an indemnity and the Company
or such Subsidiary (as the case may be) will receive the proceeds of such insurance or indemnity within thirty (30) days of the issuance
of such judgment;
9
(xii) the
Company and/or any Subsidiary, individually or in the aggregate, either (i) fails to pay, when due, or within any applicable grace period,
any payment with respect to any Indebtedness in excess of $250,000 due to any third party (other than, with respect to unsecured Indebtedness
only, payments contested by the Company and/or such Subsidiary (as the case may be) in good faith by proper proceedings and with respect
to which adequate reserves have been set aside for the payment thereof in accordance with GAAP) or is otherwise in breach or violation
of any agreement for monies owed or owing in an amount in excess of $250,000, which breach or violation permits the other party thereto
to declare a default or otherwise accelerate amounts due thereunder, or (ii) suffer to exist any other circumstance or event that would,
with or without the passage of time or the giving of notice, result in a default or event of default under any agreement binding the
Company or any Subsidiary, which default or event of default would or is likely to have a material adverse effect on the business, assets,
operations (including results thereof), liabilities, properties, condition (including financial condition) or prospects of the Company
or any of its Subsidiaries, individually or in the aggregate, but only if such failure or occurrence remains uncured for a period of
at least five (5) days;
(xiii) other
than as specifically set forth in another clause of this Section 5(a), the Company or any Subsidiary breaches any representation
or warranty in any material respect (other than representations or warranties subject to material adverse effect or materiality, which
may not be breached in any respect) or any covenant or other term or condition of any Transaction Document, except, in the case of a
breach of a covenant or other term or condition that is curable, only if such breach remains uncured for a period of five (5) consecutive
Trading Days;
(xiv) a
false or inaccurate certification (including a false or inaccurate deemed certification) by the Company as to whether any Triggering
Event has occurred;
(xv) any
breach or failure in any respect by the Company or any Subsidiary to comply with any provision of Section 15(l) of this Certificate of
Designations;
(xvi) any
Material Adverse Effect (as defined in the Securities Purchase Agreement) occurs that has not been cured, if capable of curing, within
five (5) Trading Days of the occurrence; or
(xvii) any
provision of any Transaction Document shall at any time for any reason (other than pursuant to the express terms thereof) cease to be
valid and binding on or enforceable against the Company, or the validity or enforceability thereof shall be contested, directly or indirectly,
by the Company or any Subsidiary, or a proceeding shall be commenced by the Company or any Subsidiary or any governmental authority having
jurisdiction over any of them, seeking to establish the invalidity or unenforceability thereof or the Company or any of its Subsidiaries
shall deny in writing that it has any liability or obligation purported to be created under one or more Transaction Documents.
10
(b) Notice
of a Triggering Event; Redemption Right. Upon the occurrence of a Triggering Event with respect to the Preferred Shares, the Company
shall within one (1) Business Day deliver written notice thereof via electronic mail and overnight courier (with next day delivery
specified) (a “Triggering Event Notice”) to each Holder. At any time after the earlier of a Holder’s receipt
of a Triggering Event Notice and such Holder becoming aware of a Triggering Event (such earlier date, the “Triggering Event
Right Commencement Date”) and ending (such ending date, the “Triggering Event Right Expiration Date”, and
each such period, a “Triggering Event Redemption Right Period”) on the fifteenth (15th) Trading Day after the later
of (x) the later of (1) the date such Triggering Event is cured and (2) the date the Company delivers written notice to
the Holders that such Triggering Event has been cured and (y) such Holder’s receipt of a Triggering Event Notice that includes
(I) a reasonable description of the applicable Triggering Event, (II) a certification as to whether, in the opinion of the Company, such
Triggering Event is capable of being cured and, if applicable, a reasonable description of any existing plans of the Company to cure
such Triggering Event and (III) a certification as to the date the Triggering Event occurred and, if cured on or prior to the date of
such Triggering Event Notice, the applicable Triggering Event Right Expiration Date, such Holder may require the Company to redeem (regardless
of whether such Triggering Event has been cured on or prior to the Triggering Event Right Expiration Date) all or any of the Preferred
Shares by delivering written notice thereof (the “Triggering Event Redemption Notice”) to the Company, which Triggering
Event Redemption Notice shall indicate the number of the Preferred Shares such Holder is electing to redeem. Each of the Preferred Shares
subject to redemption by the Company pursuant to this Section 5(b) shall be redeemed by the Company at a price equal to the greater of
(i) the product of (A) the Conversion Amount to be redeemed multiplied by (B) the Redemption Premium and (ii) the product of (X) the
Conversion Rate with respect to the Conversion Amount in effect at such time as such Holder delivers a Triggering Event Redemption Notice
multiplied by (Y) the product of (1) the Redemption Premium multiplied by (2) the greatest Closing Sale Price of the Common Stock on
any Trading Day during the period commencing on the date immediately preceding such Triggering Event and ending on the date the Company
makes the entire payment required to be made under this Section 5(b) (the “Triggering Event Redemption Price”). Redemptions
required by this Section 5(b) shall be made in accordance with the provisions of Section 12. To the extent redemptions required by this
Section 5(b) are deemed or determined by a court of competent jurisdiction to be prepayments of the Preferred Shares by the Company,
such redemptions shall be deemed to be voluntary prepayments. Notwithstanding anything to the contrary in this Section 5(b), but
subject to Section 4(d), until the Triggering Event Redemption Price (together with any Late Charges thereon) is paid in full, the Conversion
Amount submitted for redemption under this Section 5(b) (together with any Late Charges thereon) may be converted, in whole or in part,
by such Holder into Common Stock pursuant to the terms of this Certificate of Designations. In the event of the Company’s redemption
of any of the Preferred Shares under this Section 5(b), a Holder’s damages would be uncertain and difficult to estimate because
of the parties’ inability to predict future interest rates and the uncertainty of the availability of a suitable substitute investment
opportunity for such Holder. Accordingly, any redemption premium due under this Section 5(b) is intended by the parties to be, and shall
be deemed, a reasonable estimate of such Holder’s actual loss of its investment opportunity and not as a penalty. Any redemption
upon a Triggering Event shall not constitute an election of remedies by the applicable Holder or any other Holder, and all other rights
and remedies of each Holder shall be preserved.
(c) Mandatory
Redemption upon Bankruptcy Triggering Event. Notwithstanding anything to the contrary herein, and notwithstanding any conversion
that is then required or in process, upon any Bankruptcy Triggering Event, the Company shall immediately redeem, out of funds legally
available therefor, each of the Preferred Shares then outstanding at a redemption price equal to the applicable Triggering Event Redemption
Price (calculated as if such Holder shall have delivered the Triggering Event Redemption Notice immediately prior to the occurrence of
such Bankruptcy Triggering Event), without the requirement for any notice or demand or other action by any Holder or any other person
or entity, provided that a Holder may, in its sole discretion, waive such right to receive payment upon a Bankruptcy Triggering Event,
in whole or in part, and any such waiver shall not affect any other rights of such Holder or any other Holder hereunder, including any
other rights in respect of such Bankruptcy Triggering Event, any right to conversion, and any right to payment of such Triggering Event
Redemption Price or any other Redemption Price, as applicable.
6. Rights
Upon Fundamental Transactions.
(a) Assumption.
The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity (if the Successor Entity is
not the Company) assumes in writing all of the obligations of the Company under this Certificate of Designations and the other Transaction
Documents in accordance with the provisions of this Section 6(a) pursuant to written agreements in form and substance satisfactory to
the Required Holders and approved by the Required Holders prior to such Fundamental Transaction, including agreements to deliver to each
holder of Preferred Shares in exchange for such Preferred Shares a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Certificate of Designations, including, without limitation, having a stated value
and dividend rate equal to the stated value and dividend rate of the Preferred Shares held by the Holders and having similar ranking
to the Preferred Shares, and satisfactory to the Required Holders and (ii) the Successor Entity (including its Parent Entity) is a publicly
traded corporation whose shares of common stock are quoted on or listed for trading on an Eligible Market. Upon the occurrence of any
Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental
Transaction, the provisions of this Certificate of Designations and the other Transaction Documents referring to the “Company”
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Certificate of Designations and the other Transaction Documents with the same effect as if such Successor Entity
had been named as the Company herein and therein. In addition to the foregoing, upon consummation of a Fundamental Transaction, the Successor
Entity (if the Successor Entity is not the Company) shall deliver to each Holder confirmation that there shall be issued upon conversion
or redemption of the Preferred Shares at any time after the consummation of such Fundamental Transaction, in lieu of the shares of Common
Stock (or other securities, cash, assets or other property (except such items still issuable under Sections 7 and 17, which shall continue
to be receivable thereafter)) issuable upon the conversion or redemption of the Preferred Shares prior to such Fundamental Transaction,
such shares of the publicly traded common stock (or their equivalent) of the Successor Entity (including its Parent Entity) which each
Holder would have been entitled to receive upon the happening of such Fundamental Transaction had all the Preferred Shares held by each
Holder been converted immediately prior to such Fundamental Transaction (without regard to any limitations on the conversion of the Preferred
Shares contained in this Certificate of Designations), as adjusted in accordance with the provisions of this Certificate of Designations.
Notwithstanding the foregoing, such Holder may elect, at its sole option, by delivery of written notice to the Company to waive this
Section 6(a) to permit the Fundamental Transaction without the assumption of the Preferred Shares. The provisions of this Section 6 shall
apply similarly and equally to successive Fundamental Transactions and shall be applied without regard to any limitations on the conversion
or redemption of the Preferred Shares.
11
(b) Notice
of a Change of Control Redemption Right. No sooner than twenty (20) Trading Days nor later than ten (10) Trading Days prior to the
consummation of a Change of Control (the “Change of Control Date”), but not prior to the public announcement of such
Change of Control, the Company shall deliver written notice thereof via electronic mail and overnight courier to each Holder (a “Change
of Control Notice”). At any time during the period beginning after a Holder’s receipt of a Change of Control Notice or
such Holder becoming aware of a Change of Control if a Change of Control Notice is not delivered to such Holder in accordance with the
immediately preceding sentence (as applicable) and ending on the later of (A) the date of consummation of such Change of Control or (B)
twenty (20) Trading Days after the date of receipt of such Change of Control Notice or (C) twenty (20) Trading Days after the date of
the announcement of such Change of Control, such Holder may require the Company to redeem all or any portion of such Holder’s Preferred
Shares by delivering written notice thereof (“Change of Control Redemption Notice”) to the Company, which Change of
Control Redemption Notice shall indicate the number of Preferred Shares such Holder is electing to have the Company redeem. Each Preferred
Share subject to redemption pursuant to this Section 6(b) shall be redeemed by the Company in funds legally available therefor at a price
equal to the greatest of (i) the product of (x) the Change of Control Redemption Premium multiplied by (y) the Conversion Amount of the
Preferred Shares being redeemed, (ii) the product of (x) the Change of Control Redemption Premium multiplied by (y) the product of (A)
the Conversion Amount of the Preferred Shares being redeemed multiplied by (B) the quotient determined by dividing (I) the greatest Closing
Sale Price of the shares of Common Stock during the period beginning on the date immediately preceding the earlier to occur of (1) the
consummation of the applicable Change of Control and (2) the public announcement of such Change of Control and ending on the date such
Holder delivers the Change of Control Redemption Notice by (II) the Conversion Price then in effect and (iii) the product of (y) the
Change of Control Redemption Premium multiplied by (z) the product of (A) the Conversion Amount of the Preferred Shares being redeemed
multiplied by (B) the quotient of (I) the aggregate cash consideration and the aggregate cash value of any non-cash consideration per
share of Common Stock to be paid to such holders of the shares of Common Stock upon consummation of such Change of Control (any such
non-cash consideration constituting publicly-traded securities shall be valued at the highest of the Closing Sale Price of such securities
as of the Trading Day immediately prior to the consummation of such Change of Control, the Closing Sale Price of such securities on the
Trading Day immediately following the public announcement of such proposed Change of Control and the Closing Sale Price of such securities
on the Trading Day immediately prior to the public announcement of such proposed Change of Control) divided by (II) the Conversion Price
then in effect (the “Change of Control Redemption Price”). Redemptions required by this Section 6(b) shall have priority
to payments to all other stockholders of the Company in connection with such Change of Control. To the extent redemptions required by
this Section 6(b) are deemed or determined by a court of competent jurisdiction to be prepayments of the Preferred Shares by the Company,
such redemptions shall be deemed to be voluntary prepayments. Notwithstanding anything to the contrary in this Section 6(b), but
subject to Section 4(d), until the applicable Change of Control Redemption Price (together with any Late Charges thereon) is paid in
full to the applicable Holder, the Preferred Shares submitted by such Holder for redemption under this Section 6(b) may be converted,
in whole or in part, by such Holder into Common Stock pursuant to Section 4 or in the event the Conversion Date is after the consummation
of such Change of Control, stock or equity interests of the Successor Entity substantially equivalent to the Company’s shares of
Common Stock pursuant to Section 4. In the event of the Company’s redemption of any of the Preferred Shares under this Section
6(b), such Holder’s damages would be uncertain and difficult to estimate because of the parties’ inability to predict future
interest rates and the uncertainty of the availability of a suitable substitute investment opportunity for a Holder. Accordingly, any
redemption premium due under this Section 6(b) is intended by the parties to be, and shall be deemed, a reasonable estimate of such Holder’s
actual loss of its investment opportunity and not as a penalty. The Company shall make payment of the applicable Change of Control Redemption
Price concurrently with the consummation of such Change of Control if a Change of Control Redemption Notice is received prior to the
consummation of such Change of Control and within two (2) Trading Days after the Company’s receipt of such notice otherwise (the
“Change of Control Redemption Date”). Redemptions required by this Section 6 shall be made in accordance with the
provisions of Section 12.
7. Rights
Upon Issuance of Purchase Rights and Other Corporate Events.
(a) Purchase
Rights. In addition to any adjustments pursuant to Section 8 below, if at any time the Company grants, issues or sells any Options,
Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to all or substantially all of the
record holders of any class of Common Stock (the “Purchase Rights”), then each Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which such Holder could have acquired if such Holder
had held the number of shares of Common Stock acquirable upon complete conversion of all the Preferred Shares (without taking into account
any limitations or restrictions on the convertibility of the Preferred Shares and assuming for such purpose that all the Preferred Shares
were converted at the Floor Price as of the applicable record date) held by such Holder immediately prior to the date on which a record
is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent
that such Holder’s right to participate in any such Purchase Right would result in such Holder and the other Attribution Parties
exceeding the Maximum Percentage, then such Holder shall not be entitled to participate in such Purchase Right to such extent of the
Maximum Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Purchase Right
(and beneficial ownership) to such extent of any such excess) and such Purchase Right to such extent shall be held in abeyance (and,
if such Purchase Right has an expiration date, maturity date or other similar provision, such term shall be extended by such number of
days held in abeyance, if applicable) for the benefit of such Holder until such time or times, if ever, as its right thereto would not
result in such Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or times such Holder shall be
granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on any subsequent Purchase Right
held similarly in abeyance (and, if such Purchase Right has an expiration date, maturity date or other similar provision, such term shall
be extended by such number of days held in abeyance, if applicable)) to the same extent as if there had been no such limitation).
12
(b) Other
Corporate Events. In addition to and not in substitution for any other rights hereunder, prior to the consummation of any Fundamental
Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets with respect to or
in exchange for shares of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to ensure
that each Holder will thereafter have the right, at such Holder’s option, to receive upon a conversion of all the Preferred Shares
held by such Holder (i) in addition to the shares of Common Stock receivable upon such conversion, such securities or other assets to
which such Holder would have been entitled with respect to such shares of Common Stock had such shares of Common Stock been held by such
Holder upon the consummation of such Corporate Event (without taking into account any limitations or restrictions on the convertibility
of the Preferred Shares set forth in this Certificate of Designations) or (ii) in lieu of the shares of Common Stock otherwise receivable
upon such conversion, such securities or other assets received by the holders of shares of Common Stock in connection with the consummation
of such Corporate Event in such amounts as such Holder would have been entitled to receive had the Preferred Shares held by such Holder
initially been issued with conversion rights for the form of such consideration (as opposed to shares of Common Stock) at a conversion
rate for such consideration commensurate with the Conversion Rate. Provision made pursuant the preceding sentence shall be in a form
and substance satisfactory to the Required Holders. The provisions of this Section 7 shall apply similarly and equally to successive
Corporate Events and shall be applied without regard to any limitations on the conversion or redemption of the Preferred Shares set forth
in this Certificate of Designations.
8. Rights
Upon Issuance of Other Securities.
(a) Adjustment
of Conversion Price upon Issuance of Common Stock. If and whenever on or after the Subscription Date the Company grants, issues or
sells (or enters into any agreement or publicly announces its intention to grant, issue or sell), or in accordance with this Section
8(a) is deemed to have granted, issued or sold, any shares of Common Stock (including the granting, issuance or sale of shares of Common
Stock owned or held by or for the account of the Company, but excluding any Excluded Securities granted, issued or sold or deemed to
have been granted, issued or sold) for a consideration per share (the “New Issuance Price”) less than a price equal
to the Conversion Price in effect immediately prior to such granting, issuance or sale or deemed granting, issuance or sale (such Conversion
Price then in effect is referred to herein as the “Applicable Price”) (the foregoing a “Dilutive Issuance”),
then, immediately after such Dilutive Issuance, the Conversion Price then in effect shall be reduced to an amount equal to the New Issuance
Price. For all purposes of the foregoing (including, without limitation, determining the adjusted Conversion Price and the New Issuance
Price under this Section 8(a)), the following shall be applicable:
(i) Issuance
of Options. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell) any Options
and the lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Option or upon
conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the
terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued
and sold by the Company at the time of the granting, issuance or sale of such Option for such price per share. For purposes of this Section
8(a)(i), the “lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such
Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise
pursuant to the terms thereof” shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received
or receivable by the Company with respect to any one share of Common Stock upon the granting, issuance or sale of such Option, upon exercise
of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option or otherwise
pursuant to the terms thereof and (y) the lowest exercise price set forth in such Option for which one share of Common Stock is issuable
(or may become issuable assuming all possible market conditions) upon the exercise of any such Options or upon conversion, exercise or
exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof, minus (2)
the sum of all amounts paid or payable to the holder of such Option (or any other Person) with respect to any one share of Common Stock
upon the granting, issuance or sale of such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible
Security issuable upon exercise of such Option or otherwise pursuant to the terms thereof plus the value of any other consideration received
or receivable by, or benefit conferred on, the holder of such Option (or any other Person). Except as contemplated below, no further
adjustment of the Conversion Price shall be made upon the actual issuance of such share of Common Stock or of such Convertible Securities
upon the exercise of such Options or otherwise pursuant to the terms thereof or upon the actual issuance of such shares of Common Stock
upon conversion, exercise or exchange of such Convertible Securities.
(ii) Issuance
of Convertible Securities. If the Company in any manner issues or sells (or enters into any agreement to issue or sell) any Convertible
Securities and the lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise or
exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall
be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale (or the time of execution
of such agreement to issue or sell, as applicable) of such Convertible Securities for such price per share. For the purposes of this
Section 8(a)(ii), the “lowest price per share for which one share of Common Stock is at any time issuable upon the conversion,
exercise or exchange thereof or otherwise pursuant to the terms thereof” shall be equal to (1) the lower of (x) the sum of the
lowest amounts of consideration (if any) received or receivable by the Company with respect to one share of Common Stock upon the issuance
or sale (or pursuant to the agreement to issue or sell, as applicable) of the Convertible Security and upon conversion, exercise or exchange
of such Convertible Security or otherwise pursuant to the terms thereof and (y) the lowest conversion price set forth in such Convertible
Security for which one share of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon conversion,
exercise or exchange thereof or otherwise pursuant to the terms thereof minus (2) the sum of all amounts paid or payable to the holder
of such Convertible Security (or any other Person) with respect to any one share of Common Stock upon the issuance or sale (or the agreement
to issue or sell, as applicable) of such Convertible Security plus the value of any other consideration received or receivable by, or
benefit conferred on, the holder of such Convertible Security (or any other Person). Except as contemplated below, no further adjustment
of the Conversion Price shall be made upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of
such Convertible Securities or otherwise pursuant to the terms thereof, and if any such issuance or sale of such Convertible Securities
is made upon exercise of any Options for which adjustment of the Conversion Price has been or is to be made pursuant to other provisions
of this Section 8(a), except as contemplated below, no further adjustment of the Conversion Price shall be made by reason of such issuance
or sale.
13
(iii) Change
in Option Price or Rate of Conversion. If the purchase or exercise price provided for in any Options, the additional consideration,
if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible
Securities are convertible into or exercisable or exchangeable for shares of Common Stock increases or decreases at any time (other than
proportional changes in conversion or exercise prices, as applicable, in connection with an event referred to in Section 8(b) below),
the Conversion Price in effect at the time of such increase or decrease shall be adjusted to the Conversion Price which would have been
in effect at such time had such Options or Convertible Securities provided for such increased or decreased purchase price, additional
consideration or increased or decreased conversion rate (as the case may be) at the time initially granted, issued or sold. For purposes
of this Section 8(a)(iii), if the terms of any Option or Convertible Security (including, without limitation, any Option or Convertible
Security that was outstanding as of the Subscription Date) are increased or decreased in the manner described in the immediately preceding
sentence, then such Option or Convertible Security and the shares of Common Stock deemed issuable upon exercise, conversion or exchange
thereof shall be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 8(a)
shall be made if such adjustment would result in an increase of the Conversion Price then in effect.
(iv) Calculation
of Consideration Received. If any Option and/or Convertible Security and/or Adjustment Right is issued in connection with the issuance
or sale or deemed issuance or sale of any other securities of the Company (as determined by the Required Holders, the “Primary
Security”, and such Option and/or Convertible Security and/or Adjustment Right, the “Secondary Securities”
and together with the Primary Security, each a “Unit”), together comprising one integrated transaction, the aggregate
consideration per share of Common Stock with respect to such Primary Security shall be deemed to be the lower of (x) the purchase price
of such Unit, (y) if such Primary Security is an Option and/or Convertible Security, the lowest price per share for which one share of
Common Stock is at any time issuable upon the exercise or conversion of the Primary Security in accordance with Section 8(a)(i) or 8(a)(ii)
above and (z) the lowest VWAP of the shares of Common Stock on any Trading Day during the five (5) Trading Day period (the “Adjustment
Period”) immediately following the public announcement of such Dilutive Issuance (for the avoidance of doubt, if such public
announcement is released prior to the opening of the Principal Market on a Trading Day, such Trading Day shall be the first Trading Day
in such five (5) Trading Day period and if any Preferred Shares are converted, on any given Conversion Date during any such Adjustment
Period, solely with respect to such Preferred Shares converted on such applicable Conversion Date, such applicable Adjustment Period
shall be deemed to have ended on, and included, the Trading Day immediately prior to such Conversion Date). If any shares of Common Stock,
Options or Convertible Securities are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor
will be deemed to be the net amount of consideration received by the Company therefor. If any shares of Common Stock, Options or Convertible
Securities are issued or sold for a consideration other than cash, the amount of such consideration received by the Company will be the
fair value of such consideration, except where such consideration consists of publicly traded securities, in which case the amount of
consideration received by the Company for such securities will be the arithmetic average of the VWAPs of such security for each of the
five (5) Trading Days immediately preceding the date of receipt. If any shares of Common Stock, Options or Convertible Securities are
issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving entity, the amount
of consideration therefor will be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity
as is attributable to such shares of Common Stock, Options or Convertible Securities (as the case may be). The fair value of any consideration
other than cash or publicly traded securities will be determined jointly by the Company and the Required Holders. If such parties are
unable to reach agreement within ten (10) days after the occurrence of an event requiring valuation (the “Valuation Event”),
the fair value of such consideration will be determined within five (5) Trading Days after the tenth (10th) day following
such Valuation Event by an independent, reputable appraiser jointly selected by the Company and the Required Holders. The determination
of such appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall
be borne by the Company.
(v) Record
Date. If the Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A) to receive a dividend
or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe for or purchase shares
of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the issuance or sale of the
shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution
or the date of the granting of such right of subscription or purchase (as the case may be).
(b) Adjustment
of Conversion Price upon Subdivision or Combination of Common Stock. Without limiting any provision of Sections 7, 17 or 8(a), if
the Company at any time on or after the Subscription Date subdivides (by any stock split, stock dividend, stock combination, recapitalization
or other similar transaction) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Conversion
Price in effect immediately prior to such subdivision will be proportionately reduced. Without limiting any provision of Sections 7,
17 or 8(a), if the Company at any time on or after the Subscription Date combines (by any stock split, stock dividend, stock combination,
recapitalization or other similar transaction) one or more classes of its outstanding shares of Common Stock into a smaller number of
shares, the Conversion Price in effect immediately prior to such combination will be proportionately increased. Any adjustment pursuant
to this Section 8(b) shall become effective immediately after the effective date of such subdivision or combination. If any event requiring
an adjustment under this Section 8(b) occurs during the period that a Conversion Price is calculated hereunder, then the calculation
of such Conversion Price shall be adjusted appropriately to reflect such event.
14
(c) Holder’s
Right of Adjusted Conversion Price. In addition to and not in limitation of the other provisions of this Section 8(b), if the Company
in any manner issues or sells or enters into any agreement to issue or sell, any Common Stock, Options or Convertible Securities (any
such securities, “Variable Price Securities”) after the Subscription Date that are issuable pursuant to such agreement
or convertible into or exchangeable or exercisable for shares of Common Stock at a price which varies or may vary with the market price
of the shares of Common Stock, including by way of one or more reset(s) to a fixed price, but exclusive of such formulations reflecting
customary anti-dilution provisions (such as share splits, share combinations, share dividends and similar transactions) (each of the
formulations for such variable price being herein referred to as, the “Variable Price”), the Company shall provide
written notice thereof via electronic mail and overnight courier to each Holder on the date of such agreement and/or the issuance of
such shares of Common Stock, Convertible Securities or Options, as applicable. From and after the date the Company enters into such agreement
or issues any such Variable Price Securities, each Holder shall have the right, but not the obligation, in its sole discretion to substitute
the Variable Price for the Conversion Price upon conversion of the Preferred Shares by designating in the Conversion Notice delivered
upon any conversion of Preferred Shares that solely for purposes of such conversion such Holder is relying on the Variable Price rather
than the Conversion Price then in effect. A Holder’s election to rely on a Variable Price for a particular conversion of Preferred
Shares shall not obligate such Holder to rely on a Variable Price for any future conversions of Preferred Shares.
(d) Stock
Combination Event Adjustments. If at any time and from time to time on or after the Subscription Date there occurs any stock split,
stock dividend, stock combination, reverse stock split, recapitalization or other similar transaction involving the Common Stock (each,
a “Stock Combination Event”, and such date thereof, the “Stock Combination Event Date”) and the
Event Market Price is less than the Conversion Price then in effect (after giving effect to the adjustment in Section 8(b) above), then
on the fifth (5th) Trading Day immediately following such Stock Combination Event Date, the Conversion Price then in effect on such fifth
(5th) Trading Day following the Stock Combination Event (after giving effect to the adjustment in Section 8(b) above) shall be reduced
(but in no event increased) to the Event Market Price. For the avoidance of doubt, if the adjustment in the immediately preceding sentence
would otherwise result in an increase in the Conversion Price hereunder, no adjustment shall be made.
(e) Other
Events. In the event that the Company (or any Subsidiary) shall take any action to which the provisions hereof are not strictly applicable,
or, if applicable, would not operate to protect any Holder from dilution (other than with respect to Excluded Securities) or if any event
occurs of the type contemplated by the provisions of this Section 8 but not expressly provided for by such provisions (including, without
limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features), then the Board shall
in good faith determine and implement an appropriate adjustment in the Conversion Price so as to protect the rights of such Holder, provided
that no such adjustment pursuant to this Section 8(e) will increase the Conversion Price as otherwise determined pursuant to this Section
8, provided further that if such Holder does not accept such adjustments as appropriately protecting its interests hereunder against
such dilution, then the Board and such Holder shall agree, in good faith, upon an independent investment bank of nationally recognized
standing to make such appropriate adjustments, whose determination shall be final and binding absent manifest error and whose fees and
expenses shall be borne by the Company.
15
(f) Calculations.
All calculations under this Section 8 shall be made by rounding to the nearest cent or the nearest 1/100th of a share, as
applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account
of the Company, and the disposition of any such shares shall be considered an issue or sale of Common Stock.
(g) Voluntary
Adjustment by Company. Subject to the rules and regulations of the Principal Market, the Company may at any time any Preferred Shares
remain outstanding, with the prior written consent of the Required Holders, reduce the then current Conversion Price to any amount and
for any period of time deemed appropriate by the Board; provided that such price shall not be less than the Floor Price.
9. Reserved.
10. Noncircumvention.
The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws (as defined
in the Securities Purchase Agreement) or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement,
dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any
of the terms of this Certificate of Designations, and will at all times in good faith carry out all the provisions of this Certificate
of Designations and take all action as may be required to protect the rights of the Holders hereunder. Without limiting the generality
of the foregoing or any other provision of this Certificate of Designations or the other Transaction Documents, the Company (a) shall
not increase the par value of any shares of Common Stock receivable upon the conversion of any Preferred Shares above the Conversion
Price then in effect, (b) shall take all such actions as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and non-assessable shares of Common Stock upon the conversion of Preferred Shares and (c) shall, so long
as any Preferred Shares are outstanding, take all action necessary to reserve and keep available out of its authorized and unissued shares
of Common Stock, solely for the purpose of effecting the conversion of the Preferred Shares, the maximum number of shares of Common Stock
as shall from time to time be necessary to effect the conversion of the Preferred Shares then outstanding (without regard to any limitations
on conversion contained herein). Notwithstanding anything herein to the contrary, if after the sixty (60) calendar day anniversary of
the Initial Issuance Date, each Holder is not permitted to convert such Holder’s Preferred Shares in full for any reason (other
than pursuant to restrictions set forth in Section 4(d)(i) hereof), the Company shall use its best efforts to promptly remedy
such failure, including, without limitation, obtaining such consents or approvals as necessary to effect such conversion into shares
of Common Stock.
16
11. Authorized
Shares.
(a) Reservation.
So long as any Preferred Shares remain outstanding, the Company shall at all times reserve out of its authorized and unissued shares
of Common Stock a number of shares of Common Stock equal to at least 200% of the aggregate number of shares of Common Stock as shall
from time to time be necessary to effect the conversion, including without limitation, of all of the Preferred Shares then outstanding
at the Floor Price then in effect (without regard to any limitations on conversions, and, for the avoidance of doubt, shall not include
Dividends with respect to such Preferred Shares or any accrued and unpaid Late Charges thereon, and assuming the Preferred Shares remain
outstanding until the expiration date of the Warrants) (the “Required Reserve Amount”). The Required Reserve Amount
(including, without limitation, each increase in the number of shares so reserved) shall be allocated pro rata among the Holders based
on the number of the Preferred Shares held by each Holder on the Initial Issuance Date or increase in the number of reserved shares,
as the case may be (the “Authorized Share Allocation”). In the event that a Holder shall sell or otherwise transfer
any of such Holder’s Preferred Shares, each transferee shall be allocated a pro rata portion of such Holder’s Authorized
Share Allocation. Any shares of Common Stock reserved and allocated to any Person which ceases to hold any Preferred Shares shall be
allocated to the remaining Holders of Preferred Shares, pro rata based on the number of the Preferred Shares then held by the Holders.
(b) Insufficient
Authorized Shares. If, notwithstanding Section 11(a) and not in limitation thereof, at any time while any of the Preferred Shares
remain outstanding the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation
to reserve for issuance upon conversion of the Preferred Shares at least a number of shares of Common Stock equal to the Required Reserve
Amount (an “Authorized Share Failure”), then the Company shall immediately take all action necessary to increase the
Company’s authorized shares of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve Amount
for the Preferred Shares then outstanding (or deemed outstanding pursuant to Section 11(a) above). Without limiting the generality of
the foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later
than sixty (60) days after the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its stockholders for
the approval of an increase in the number of authorized shares of Common Stock. In connection with such meeting, the Company shall provide
each stockholder with a proxy statement and shall use its best efforts to solicit its stockholders’ approval of such increase in
authorized shares of Common Stock and to cause its board of directors to recommend to the stockholders that they approve such proposal
(or, if a majority of the voting power then in effect of the capital stock of the Company consents to such increase, in lieu of such
proxy statement, deliver to the stockholders of the Company an information statement that has been filed with (and either approved by
or not subject to comments from) the SEC with respect thereto). In the event that the Company is prohibited from issuing shares of Common
Stock to a Holder upon any conversion due to the failure by the Company to have sufficient shares of Common Stock available out of the
authorized but unissued shares of Common Stock (such unavailable number of shares of Common Stock, the “Authorized Failure Shares”),
in lieu of delivering such Authorized Failure Shares to such Holder, the Company shall pay legally available funds in exchange for the
redemption of such portion of the Conversion Amount of the Preferred Shares convertible into such Authorized Failure Shares at a price
equal to the sum of (i) the product of (x) such number of Authorized Failure Shares and (y) the greatest Closing Sale Price of the Common
Stock on any Trading Day during the period commencing on the date such Holder delivers the applicable Conversion Notice with respect
to such Authorized Failure Shares to the Company and ending on the date of such issuance and payment under this Section 11(b); and (ii)
to the extent such Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of
a sale by such Holder of Authorized Failure Shares, any brokerage commissions and other out-of-pocket expenses, if any, of such Holder
incurred in connection therewith. Nothing contained in Section 11(a) or this Section 11(b) shall limit any obligations of the Company
under any provision of the Securities Purchase Agreement.
17
12. Redemptions.
(a) General.
If a Holder has submitted a Triggering Event Redemption Notice in accordance with Section 5(b), the Company shall deliver the applicable
Triggering Event Redemption Price to such Holder in legally available funds within five (5) Business Days after the Company’s receipt
of such Holder’s Triggering Event Redemption Notice. If a Holder has submitted a Change of Control Redemption Notice in accordance
with Section 6(b), the Company shall deliver the applicable Change of Control Redemption Price to such Holder in legally available funds
concurrently with the consummation of such Change of Control if such notice is received prior to the consummation of such Change of Control
and within five (5) Business Days after the Company’s receipt of such notice otherwise. Notwithstanding anything herein to the
contrary, in connection with any redemption hereunder at a time a Holder is entitled to receive a cash payment under any of the other
Transaction Documents, at the option of such Holder delivered in writing to the Company, the applicable Redemption Price hereunder shall
be increased by the amount of such cash payment owed to such Holder under such other Transaction Document and, upon payment in full or
conversion in accordance herewith, shall satisfy the Company’s payment obligation under such other Transaction Document. In the
event of a redemption of less than all of the Preferred Shares, the Company shall promptly cause to be issued and delivered to such Holder
a new Preferred Share Certificate (in accordance with Section 20) (or evidence of the creation of a new Book-Entry) representing the
number of Preferred Shares which have not been redeemed. In the event that the Company does not pay the applicable Redemption Price to
a Holder within the time period required for any reason (including, without limitation, to the extent such payment is prohibited pursuant
to the DGCL), at any time thereafter and until the Company pays such unpaid Redemption Price in full, such Holder shall have the option,
in lieu of redemption, to require the Company to promptly return to such Holder all or any of the Preferred Shares that were submitted
for redemption and for which the applicable Redemption Price (together with any Late Charges thereon) has not been paid. Upon the Company’s
receipt of such notice, (x) the applicable Redemption Notice shall be null and void with respect to such Preferred Shares, (y) the Company
shall immediately return the applicable Preferred Share Certificate, or issue a new Preferred Share Certificate (in accordance with Section 20(d)),
to such Holder (unless the Preferred Shares are held in Book-Entry form, in which case the Company shall deliver evidence to such Holder
that a Book-Entry for such Preferred Shares then exists), and in each case the Additional Amount of such Preferred Shares shall be increased
by an amount equal to the difference between (1) the applicable Redemption Price (as the case may be, and as adjusted pursuant to
this Section 12, if applicable) minus (2) the Stated Value portion of the Conversion Amount submitted for redemption
and (z) the Conversion Price of such Preferred Shares shall be automatically adjusted with respect to each conversion effected thereafter
by such Holder to the lowest of (A) the Conversion Price as in effect on the date on which the applicable Redemption Notice is voided,
(B) the greater of (x) the Floor Price and (y) 75% of the lowest Closing Bid Price of the Common Stock during the period
beginning on and including the date on which the applicable Redemption Notice is delivered to the Company and ending on and including
the date on which the applicable Redemption Notice is voided and (C) the greater of (x) the Floor Price and (y) 75% of
the quotient of (I) the sum of the five (5) lowest VWAPs of the Common Stock during the twenty (20) consecutive Trading Day
period ending and including the Trading Day immediately preceding the applicable Conversion Date divided by (II) five (5) (it being
understood and agreed that all such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination
or other similar transaction during such period). A Holder’s delivery of a notice voiding a Redemption Notice and exercise of its
rights following such notice shall not affect the Company’s obligations to make any payments of Late Charges which have accrued
prior to the date of such notice with respect to the Preferred Shares subject to such notice.
(b) Redemption
by Multiple Holders. Upon the Company’s receipt of a Redemption Notice from any Holder for redemption or repayment as a result
of an event or occurrence substantially similar to the events or occurrences described in Section 5(b) or Section 6(b), the Company
shall immediately, but no later than one (1) Business Day of its receipt thereof, forward to each other Holder by electronic mail a copy
of such notice. If the Company receives one or more Redemption Notices, during the seven (7) Business Day period beginning on and including
the date which is two (2) Business Days prior to the Company’s receipt of the initial Redemption Notice and ending on and including
the date which is two (2) Business Days after the Company’s receipt of the initial Redemption Notice and the Company is unable
to redeem all of the Conversion Amount of such Preferred Shares designated in such initial Redemption Notice and such other Redemption
Notices received during such seven (7) Business Day period, then the Company shall redeem a pro rata amount from each Holder based on
the Stated Value of the Preferred Shares submitted for redemption pursuant to such Redemption Notices received by the Company during
such seven (7) Business Day period.
13. [Reserved.]
14. Voting
Rights. Except as otherwise provided herein or as required by applicable law and subject to the provisions of Section 4(d) hereof,
Holders of Preferred Shares shall be entitled to vote with the holders of Common Stock on all matters that such holders of Common Stock
are entitled to vote upon, in the same manner and with the same effect as the holders of Common Stock, voting together with the holders
of Common Stock as a single class. Subject to the provisions of Section 4(d) hereof, each Preferred Share shall entitle the Holder thereof
to cast that number of votes per Preferred Share as is equal to the Stated Value of such Preferred Share divided by the then applicable
Conversion Price; provided, however that in no event shall the then applicable Conversion Price for purposes of this Section
14 be less than the “Minimum Price” (as defined in Nasdaq Listing Rule 5635(d)) on the date immediately preceding
the Subscription Date (or $2.51 per share, as of the date of this Certificate of Designations, and subject to adjustments for any stock
splits, stock dividends, stock combinations, recapitalizations or other similar transactions following the date hereof). For purposes
of clarity, this Nasdaq Minimum Price shall apply only for purposes of this Section 14 of the Certificate of Designations and not apply
to any other section of the Certificate of Designations or any Transaction Document. Notwithstanding the foregoing, to the extent that
under the DGCL the vote of the holders of the Preferred Shares, voting separately as a class or series, as applicable, is required to
authorize a given action of the Company, the affirmative vote or consent of the Required Holders of the shares of the Preferred Shares,
voting together in the aggregate and not in separate series unless required under the DGCL, represented at a duly held meeting at which
a quorum is present or by written consent of the Required Holders (except as otherwise may be required under the DGCL), voting together
in the aggregate and not in separate series unless required under the DGCL, shall constitute the approval of such action by both the
class or the series, as applicable. For the avoidance of doubt, for purposes of determining the presence of a quorum at any meeting of
the stockholders of the Company at which the Preferred Shares are entitled to vote, the number of Preferred Shares and votes represented
by such shares shall be counted on an as converted to Common Stock basis, subject to any limitations on conversion set forth herein.
Holders of the Preferred Shares shall be entitled to written notice of all stockholder meetings or written consents (and copies of proxy
materials and other information sent to stockholders) with respect to which they would be entitled to vote, which notice would be provided
pursuant to the Company’s bylaws and the DGCL.
18
15. Covenants.
For so long as any Preferred Shares are outstanding, without the prior written consent of the Required Holders:
(a) Incurrence
of Indebtedness. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, incur
or guarantee, assume or suffer to exist any Indebtedness (other than Permitted Indebtedness).
(b) Existence
of Liens. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, allow or suffer
to exist any mortgage, lien, pledge, charge, security interest or other encumbrance upon or in any property or assets (including accounts
and contract rights) owned by the Company or any of its Subsidiaries (collectively, “Liens”) other than Permitted
Liens.
(c) Restricted
Payments and Investments. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,
redeem, defease, repurchase, repay or make any payments in respect of, by the payment of cash or cash equivalents (in whole or in part,
whether by way of open market purchases, tender offers, private transactions or otherwise), all or any portion of any Indebtedness (other
pursuant to this Certificate of Designations) whether by way of payment in respect of principal of (or premium, if any) or interest on,
such Indebtedness or make any Investment, as applicable, if at the time such payment with respect to such Indebtedness and/or Investment,
as applicable, is due or is otherwise made or, after giving effect to such payment, (i) an event constituting a Triggering Event has
occurred and is continuing or (ii) an event that with the passage of time and without being cured would constitute a Triggering Event
has occurred and is continuing.
(d) Restriction
on Redemption and Cash Dividends. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or
indirectly, redeem, repurchase or declare or pay any cash dividend or distribution on any of its capital stock (other than pursuant to
this Certificate of Designations, the Series A Certificate of Designations, the Series H-7 Certificate of Designations, the Series I
Certificate of Designations and Series J Certificate of Designations).
(e) Restriction
on Transfer of Assets. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,
sell, lease, license, assign, transfer, spin-off, split-off, close, convey or otherwise dispose of any assets or rights of the Company
or any Subsidiary owned or hereafter acquired whether in a single transaction or a series of related transactions, other than (i) sales,
leases, licenses, assignments, transfers, conveyances and other dispositions of such assets or rights by the Company and its Subsidiaries
in the ordinary course of business consistent with its past practice, or (ii) sales of inventory and product in the ordinary course of
business.
19
(f) Maturity
of Indebtedness. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, permit
any Indebtedness of the Company or any of its Subsidiaries to mature or accelerate prior to the conversion of all the Preferred Shares
other than as set forth in the definitive documentation governing such Indebtedness as in effect on the Initial Issuance Date.
(g) Change
in Nature of Business. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, engage
in any material line of business substantially different from those lines of business conducted by or publicly contemplated to be conducted
by the Company and/or its Subsidiaries on the Subscription Date or any business reasonably related or incidental thereto. The Company
shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, modify its or their corporate structure
or purpose in any material respect.
(h) Preservation
of Existence, Etc. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve, its existence,
rights and privileges, and become or remain, and cause each of its Subsidiaries to become or remain, duly qualified and in good standing
in each jurisdiction in which the character of the properties owned or leased by it or in which the transaction of its business makes
such qualification necessary; provided, however, that the Company shall have the right to merge or combine wholly-owned Subsidiaries
hereunder, or eliminate or dissolve foreign Subsidiaries, in each case where such restructuring does not have a material impact on the
Company’s assets or ability to comply with the provisions hereof.
(i) Maintenance
of Properties, Etc. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve, all of
its properties which are necessary or useful in the proper conduct of its business in good working order and condition, ordinary wear
and tear excepted, and comply, and cause each of its Subsidiaries to comply, at all times with the provisions of all leases to which
it is a party as lessee or under which it occupies property, so as to prevent any loss or forfeiture thereof or thereunder.
(j) Maintenance
of Intellectual Property. The Company will, and will cause each of its Subsidiaries to, take all action necessary or advisable to
maintain all of the Intellectual Property Rights of the Company and/or any of its Subsidiaries that are necessary or material to the
conduct of its business in full force and effect.
(k) Maintenance
of Insurance. The Company shall use reasonable best efforts to maintain, and cause each of its Subsidiaries to maintain, insurance
with responsible and reputable insurance companies or associations (including, without limitation, comprehensive general liability, hazard,
rent and business interruption insurance) with respect to its properties (including all real properties leased or owned by it) and business,
in such amounts and covering such risks as are generally consistent with the coverage held by the Company on the Initial Issuance Date.
20
(l) Transactions
with Affiliates. The Company shall not, nor shall it permit any of its Subsidiaries to, enter into, renew, extend or be a party to,
any transaction or series of related transactions (including, without limitation, the purchase, sale, lease, transfer or exchange of
property or assets of any kind or the rendering of services of any kind) with any affiliate, except transactions in the ordinary course
of business in a manner and to an extent, if applicable, consistent with past practice and necessary or desirable for the prudent operation
of its business, for fair consideration and on terms no less favorable to it or its Subsidiaries than would be reasonably expected to
be obtained in a comparable arm’s length transaction with a Person that is not an affiliate thereof.
(m) Restricted
Issuances. The Company shall not, directly or indirectly, without the prior written consent of the Required Holders, (i) issue any
Preferred Shares (other than as contemplated by the Securities Purchase Agreement and this Certificate of Designations), or (ii) issue
any other securities that would cause a breach or default under this Certificate of Designations or the Warrants.
(n) Stay,
Extension and Usury Laws. To the extent that it may lawfully do so, the Company (A) agrees that it will not at any time insist upon,
plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law (wherever or whenever
enacted or in force) that may affect the covenants or the performance of this Certificate of Designations; and (B) expressly waives all
benefits or advantages of any such law and agrees that it will not, by resort to any such law, hinder, delay or impede the execution
of any power granted to the Holders by this Certificate of Designations, but will suffer and permit the execution of every such power
as though no such law has been enacted.
(o) Taxes.
The Company and its Subsidiaries shall pay when due all taxes, fees or other charges of any nature whatsoever (together with any related
interest or penalties) now or hereafter imposed or assessed against the Company and its Subsidiaries or their respective assets or upon
their ownership, possession, use, operation or disposition thereof or upon their rents, receipts or earnings arising therefrom (except
where the failure to pay would not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries).
The Company and its Subsidiaries shall file on or before the due date therefor all personal property tax returns (except where the failure
to file would not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries). Notwithstanding
the foregoing, the Company and its Subsidiaries may contest, in good faith and by appropriate proceedings, taxes for which they maintain
adequate reserves therefor in accordance with GAAP.
(p) Cash
Minimum. From the Closing Date until the date on which less than 1,050 shares of the Series I Preferred Stock are outstanding, the
Company shall, at all times, maintain unencumbered, unrestricted cash and cash equivalents on hand in amount equal to at least 20% of
the aggregate stated value of the Series I Preferred Stock then outstanding. Such cash shall be maintained in one or more domestic deposit
accounts, money market accounts or certificates of deposit (with a maturity of no more than three months) with one or more Eligible Banks.
For purposes hereof, an “Eligible Bank” is a U.S. chartered commercial bank with total assets in excess of $300 billion.
21
(q) Independent
Investigation. At the request of any Holder either (x) at any time when a Triggering Event has occurred and is continuing, (y) upon
the occurrence of an event that with the passage of time or giving of notice would constitute a Triggering Event or (z) at any time such
Holder reasonably believes a Triggering Event may have occurred or be continuing, the Company shall hire an independent, reputable investment
bank selected by the Company and approved by such Holder to investigate as to whether any breach of the Certificate of Designations has
occurred (the “Independent Investigator”). If the Independent Investigator determines that such breach of the Certificate
of Designations has occurred, the Independent Investigator shall notify the Company of such breach and the Company shall deliver written
notice to each Holder of such breach. In connection with such investigation, the Independent Investigator may, during normal business
hours, inspect all contracts, books, records, personnel, offices and other facilities and properties of the Company and its Subsidiaries
and, to the extent available to the Company after the Company uses reasonable efforts to obtain them, the records of its legal advisors
and accountants (including the accountants’ work papers) and any books of account, records, reports and other papers not contractually
required of the Company to be confidential or secret, or subject to attorney-client or other evidentiary privilege, and the Independent
Investigator may make such copies and inspections thereof as the Independent Investigator may reasonably request. The Company shall furnish
the Independent Investigator with such financial and operating data and other information with respect to the business and properties
of the Company as the Independent Investigator may reasonably request. The Company shall permit the Independent Investigator to discuss
the affairs, finances and accounts of the Company with, and to make proposals and furnish advice with respect thereto to, the Company’s
officers, directors, key employees and independent public accountants or any of them (and by this provision the Company authorizes said
accountants to discuss with such Independent Investigator the finances and affairs of the Company and any Subsidiaries), all at such
reasonable times, upon reasonable notice, and as often as may be reasonably requested.
16. Liquidation,
Dissolution, Winding-Up. In the event of a Liquidation Event, the Holders shall be entitled to receive in cash out of the assets
of the Company, whether from capital or from earnings available for distribution to its stockholders (the “Liquidation Funds”),
before any amount shall be paid to the holders of any of shares of Junior Stock, but pari passu with any Parity Stock then outstanding,
an amount per Preferred Share equal to the greater of (A) 125% of the Conversion Amount of such Preferred Share on the date of such payment
and (B) the amount per share such Holder would receive if such Holder converted such Preferred Share into Common Stock immediately prior
to the date of such payment, provided that if the Liquidation Funds are insufficient to pay the full amount due to the Holders and holders
of shares of Parity Stock, then each Holder and each holder of Parity Stock shall receive a percentage of the Liquidation Funds equal
to the full amount of Liquidation Funds payable to such Holder and such holder of Parity Stock as a liquidation preference, in accordance
with their respective certificate of designations (or equivalent), as a percentage of the full amount of Liquidation Funds payable to
all holders of Preferred Shares and all holders of shares of Parity Stock. To the extent necessary, the Company shall cause such actions
to be taken by each of its Subsidiaries so as to enable, to the maximum extent permitted by law, the proceeds of a Liquidation Event
to be distributed to the Holders in accordance with this Section 16. All the preferential amounts to be paid to the Holders under this
Section 16 shall be paid or set apart for payment before the payment or setting apart for payment of any amount for, or the distribution
of any Liquidation Funds of the Company to the holders of shares of Junior Stock in connection with a Liquidation Event as to which this
Section 16 applies.
17. Distribution
of Assets. In addition to any adjustments pursuant to Section 7(a) and Section 8, if the Company shall declare or make any dividend
or other distributions of its assets (or rights to acquire its assets) to any or all holders of shares of Common Stock, by way of return
of capital or otherwise (including without limitation, any distribution of cash, stock or other securities, property or options by way
of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (the “Distributions”),
then each Holder, as holders of Preferred Shares, will be entitled to such Distributions as if such Holder had held the number of shares
of Common Stock acquirable upon complete conversion of the Preferred Shares (without taking into account any limitations or restrictions
on the convertibility of the Preferred Shares and assuming for such purpose that the Preferred Share was converted at the Floor Price
as of the applicable record date) immediately prior to the date on which a record is taken for such Distribution or, if no such record
is taken, the date as of which the record holders of Common Stock are to be determined for such Distributions (provided, however, that
to the extent that such Holder’s right to participate in any such Distribution would result in such Holder and the other Attribution
Parties exceeding the Maximum Percentage, then such Holder shall not be entitled to participate in such Distribution to such extent of
the Maximum Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution
(and beneficial ownership) to such extent of any such excess) and the portion of such Distribution shall be held in abeyance for the
benefit of such Holder until such time or times as its right thereto would not result in such Holder and the other Attribution Parties
exceeding the Maximum Percentage, at which time or times, if any, such Holder shall be granted such Distribution (and any Distributions
declared or made on such initial Distribution or on any subsequent Distribution held similarly in abeyance) to the same extent as if
there had been no such limitation).
18. Vote
to Change the Terms of or Issue Preferred Shares. In addition to any other rights provided by law, except where the vote or written
consent of the holders of a greater number of shares is required by law or by another provision of the Certificate of Incorporation,
without first obtaining the affirmative vote at a meeting duly called for such purpose or the written consent without a meeting of the
Required Holders, voting together as a single class, the Company shall not (in any case, whether by amendment, modification, recapitalization,
merger, consolidation or otherwise): (a) amend or repeal any provision of, or add any provision to, its Certificate of Incorporation
or bylaws, or file any certificate of designations or articles of amendment of any series of shares of preferred stock, if such action
would adversely alter or change in any respect the preferences, rights, privileges or powers, or restrictions provided for the benefit
of the Preferred Shares hereunder, regardless of whether any such action shall be by means of amendment to the Certificate of Incorporation
or by merger, consolidation or otherwise; provided that the affirmative vote of the Required Holders shall not be required for changes
to the Series A Preferred Stock, Series H-7 Preferred Stock, Series I Preferred Stock or Series J Preferred Stock; (b) increase or decrease
(other than by conversion) the authorized number of Preferred Shares; (c) without limiting any provision of Section 2, create or authorize
(by reclassification or otherwise) any new class or series of Senior Preferred Stock or Parity Stock, other than the Series J Preferred
Stock; (d) purchase, repurchase or redeem any shares of Junior Stock (other than pursuant to the terms of the Company’s equity
incentive plans and options and other equity awards granted under such plans (that have in good faith been approved by the Board)); (e)
without limiting any provision of Section 2, pay dividends or make any other distribution on any shares of any Junior Stock, other than
the Series A Preferred Stock; (f) issue any Preferred Shares other than as contemplated hereby or pursuant to the Securities Purchase
Agreement; or (g) without limiting any provision of Section 10, whether or not prohibited by the terms of the Preferred Shares, circumvent
a right of the Preferred Shares hereunder.
22
19. Transfer
of Preferred Shares. A Holder may transfer some or all of its Preferred Shares without the consent of the Company, but any such transfer
shall be in compliance with all applicable securities laws.
20. Reissuance
of Preferred Share Certificates and Book Entries.
(a) Transfer.
If any Preferred Shares are to be transferred, the applicable Holder shall surrender the applicable Preferred Share Certificate to the
Company (or, if the Preferred Shares are held in Book-Entry form, a written instruction letter to the Company), whereupon the Company
will forthwith issue and deliver upon the order of such Holder a new Preferred Share Certificate (in accordance with Section 20(d)) (or
evidence of the transfer of such Book-Entry), registered as such Holder may request, representing the outstanding number of Preferred
Shares being transferred by such Holder and, if less than the entire outstanding number of Preferred Shares is being transferred, a new
Preferred Share Certificate (in accordance with Section 20(d)) to such Holder representing the outstanding number of Preferred Shares
not being transferred (or evidence of such remaining Preferred Shares in a Book-Entry for such Holder). Such Holder and any assignee,
by acceptance of the Preferred Share Certificate or evidence of Book-Entry issuance, as applicable, acknowledge and agree that, by reason
of the provisions of Section 4(c)(i) following conversion or redemption of any of the Preferred Shares, the outstanding number of Preferred
Shares represented by the Preferred Shares may be less than the number of Preferred Shares stated on the face of the Preferred Shares.
(b) Lost,
Stolen or Mutilated Preferred Share Certificate. Upon receipt by the Company of evidence reasonably satisfactory to the Company of
the loss, theft, destruction or mutilation of a Preferred Share Certificate (as to which a written certification and the indemnification
contemplated below shall suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking
by the applicable Holder to the Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation
of such Preferred Share Certificate, the Company shall execute and deliver to such Holder a new Preferred Share Certificate (in accordance
with Section 20(d)) representing the applicable outstanding number of Preferred Shares.
(c) Preferred
Share Certificate and Book-Entries Exchangeable for Different Denominations and Forms. Each Preferred Share Certificate is exchangeable,
upon the surrender hereof by the applicable Holder at the principal office of the Company, for a new Preferred Share Certificate or Preferred
Share Certificate(s) or new Book-Entry (in accordance with Section 20(d)) representing, in the aggregate, the outstanding number of the
Preferred Shares in the original Preferred Share Certificate, and each such new Preferred Share Certificate and/or new Book-Entry, as
applicable, will represent such portion of such outstanding number of Preferred Shares from the original Preferred Share Certificate
as is designated in writing by such Holder at the time of such surrender. Each Book-Entry may be exchanged into one or more new Preferred
Share Certificates or split by the applicable Holder by delivery of a written notice to the Company into two or more new Book-Entries
(in accordance with Section 20(d)) representing, in the aggregate, the outstanding number of the Preferred Shares in the original Book-Entry,
and each such new Book-Entry and/or new Preferred Share Certificate, as applicable, will represent such portion of such outstanding number
of Preferred Shares from the original Book-Entry as is designated in writing by such Holder at the time of such surrender.
23
(d) Issuance
of New Preferred Share Certificate or Book-Entry. Whenever the Company is required to issue a new Preferred Share Certificate or
a new Book-Entry pursuant to the terms of this Certificate of Designations, such new Preferred Share Certificate or new Book-Entry (i)
shall represent, as indicated on the face of such Preferred Share Certificate or in such Book-Entry, as applicable, the number of Preferred
Shares remaining outstanding (or in the case of a new Preferred Share Certificate or new Book-Entry being issued pursuant to Section
20(a) or Section 20(c), the number of Preferred Shares designated by such Holder) which, when added to the number of Preferred Shares
represented by the other new Preferred Share Certificates or other new Book-Entry, as applicable, issued in connection with such issuance,
does not exceed the number of Preferred Shares remaining outstanding under the original Preferred Share Certificate or original Book-Entry,
as applicable, immediately prior to such issuance of new Preferred Share Certificate or new Book-Entry, as applicable, and (ii) shall
have an issuance date, as indicated on the face of such new Preferred Share Certificate or in such new Book-Entry, as applicable, which
is the same as the issuance date of the original Preferred Share Certificate or in such original Book-Entry, as applicable.
21. Remedies,
Characterizations, Other Obligations, Breaches and Injunctive Relief. The remedies provided in this Certificate of Designations shall
be cumulative and in addition to all other remedies available under this Certificate of Designations and any of the other Transaction
Documents, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall
limit any Holder’s right to pursue actual and consequential damages for any failure by the Company to comply with the terms of
this Certificate of Designations. No failure on the part of a Holder to exercise, and no delay in exercising, any right, power or remedy
hereunder shall operate as a waiver thereof; nor shall any single or partial exercise by such Holder of any right, power or remedy preclude
any other or further exercise thereof or the exercise of any other right, power or remedy. In addition, the exercise of any right or
remedy of a Holder at law or equity or under this Certificate of Designations or any of the documents shall not be deemed to be an election
of such Holder’s rights or remedies under such documents or at law or equity. The Company covenants to each Holder that there shall
be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with
respect to payments, conversion and the like (and the computation thereof) shall be the amounts to be received by a Holder and shall
not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company
acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holders and that the remedy at law for
any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, each Holder
shall be entitled, in addition to all other available remedies, to specific performance and/or temporary, preliminary and permanent injunctive
or other equitable relief from any court of competent jurisdiction in any such case without the necessity of proving actual damages and
without posting a bond or other security. The Company shall provide all information and documentation to a Holder that is requested by
such Holder to enable such Holder to confirm the Company’s compliance with the terms and conditions of this Certificate of Designations.
24
22. Payment
of Collection, Enforcement and Other Costs. If (a) any Preferred Shares are placed in the hands of an attorney for collection or
enforcement or is collected or enforced through any legal proceeding or a Holder otherwise takes action to collect amounts due under
this Certificate of Designations with respect to the Preferred Shares or to enforce the provisions of this Certificate of Designations
or (b) there occurs any bankruptcy, reorganization, receivership of the Company or other proceedings affecting Company creditors’
rights and involving a claim under this Certificate of Designations, then the Company shall pay the costs incurred by such Holder for
such collection, enforcement or action or in connection with such bankruptcy, reorganization, receivership or other proceeding, including,
without limitation, attorneys’ fees and disbursements. The Company expressly acknowledges and agrees that no amounts due under
this Certificate of Designations with respect to any Preferred Shares shall be affected, or limited, by the fact that the purchase price
paid for each Preferred Share was less than the original Stated Value thereof.
23. Construction;
Headings. This Certificate of Designations shall be deemed to be jointly drafted by the Company and the Holders and shall not be
construed against any such Person as the drafter hereof. The headings of this Certificate of Designations are for convenience of reference
and shall not form part of, or affect the interpretation of, this Certificate of Designations. Unless the context clearly indicates otherwise,
each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof. The terms “including,”
“includes,” “include” and words of like import shall be construed broadly as if followed by the words “without
limitation.” The terms “herein,” “hereunder,” “hereof” and words of like import refer to this
entire Certificate of Designations instead of just the provision in which they are found. Unless expressly indicated otherwise, all section
references are to sections of this Certificate of Designations. Terms used in this Certificate of Designations and not otherwise defined
herein, but defined in the other Transaction Documents, shall have the meanings ascribed to such terms on the Initial Issuance Date in
such other Transaction Documents unless otherwise consented to in writing by the Required Holders.
24. Failure
or Indulgence Not Waiver. No failure or delay on the part of a Holder in the exercise of any power, right or privilege hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further
exercise thereof or of any other right, power or privilege. No waiver shall be effective unless it is in writing and signed by an authorized
representative of the waiving party. This Certificate of Designations shall be deemed to be jointly drafted by the Company and all Holders
and shall not be construed against any Person as the drafter hereof. Notwithstanding the foregoing, nothing contained in this Section
24 shall permit any waiver of any provision of Section 4(d).
25. Dispute
Resolution.
(a) Submission
to Dispute Resolution.
(i) In
the case of a dispute relating to a Closing Bid Price, a Closing Sale Price, a Conversion Price, an Alternate Conversion Price, a VWAP
or a fair market value or the arithmetic calculation of a Conversion Rate, or the applicable Redemption Price (as the case may be) (including,
without limitation, a dispute relating to the determination of any of the foregoing), the Company or the applicable Holder (as the case
may be) shall submit the dispute to the other party via electronic mail (A) if by the Company, within two (2) Business Days after the
occurrence of the circumstances giving rise to such dispute or (B) if by such Holder at any time after such Holder learned of the circumstances
giving rise to such dispute. If such Holder and the Company are unable to promptly resolve such dispute relating to such Closing Bid
Price, such Closing Sale Price, such Conversion Price, such Alternate Conversion Price, such VWAP or such fair market value, or the arithmetic
calculation of such Conversion Rate or such applicable Redemption Price (as the case may be), at any time after the second (2nd) Business
Day following such initial notice by the Company or such Holder (as the case may be) of such dispute to the Company or such Holder (as
the case may be), then such Holder may, at its sole option, select an independent, reputable investment bank to resolve such dispute.
25
(ii) Such
Holder and the Company shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered in accordance
with the first sentence of this Section 25 and (B) written documentation supporting its position with respect to such dispute, in each
case, no later than 5:00 p.m. (New York time) by the fifth (5th) Business Day immediately following the date on which such
Holder selected such investment bank (the “Dispute Submission Deadline”) (the documents referred to in the immediately
preceding clauses (A) and (B) are collectively referred to herein as the “Required Dispute Documentation”) (it being
understood and agreed that if either such Holder or the Company fails to so deliver all of the Required Dispute Documentation by the
Dispute Submission Deadline, then the party who fails to so submit all of the Required Dispute Documentation shall no longer be entitled
to (and hereby waives its right to) deliver or submit any written documentation or other support to such investment bank with respect
to such dispute and such investment bank shall resolve such dispute based solely on the Required Dispute Documentation that was delivered
to such investment bank prior to the Dispute Submission Deadline). Unless otherwise agreed to in writing by both the Company and such
Holder or otherwise requested by such investment bank, neither the Company nor such Holder shall be entitled to deliver or submit any
written documentation or other support to such investment bank in connection with such dispute (other than the Required Dispute Documentation).
(iii) The
Company and such Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company and such
Holder of such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The fees and expenses
of such investment bank shall be borne solely by the Company, and such investment bank’s resolution of such dispute shall be final
and binding upon all parties absent manifest error.
(b) Miscellaneous.
The Company expressly acknowledges and agrees that (i) this Section 25 constitutes an agreement to arbitrate between the Company and
each Holder (and constitutes an arbitration agreement) under § 7501, et seq. of the New York Civil Practice Law and Rules (“CPLR”)
and that any Holder is authorized to apply for an order to compel arbitration pursuant to CPLR § 7503(a) in order to compel compliance
with this Section 25, (ii) a dispute relating to a Conversion Price includes, without limitation, disputes as to (A) whether an issuance
or sale or deemed issuance or sale of Common Stock occurred under Section 8(a), (B) the consideration per share at which an issuance
or deemed issuance of Common Stock occurred, (C) whether any issuance or sale or deemed issuance or sale of Common Stock was an issuance
or sale or deemed issuance or sale of Excluded Securities, (D) whether an agreement, instrument, security or the like constitutes an
Option or Convertible Security and (E) whether a Dilutive Issuance occurred, (iii) the terms of this Certificate of Designations and
each other applicable Transaction Document shall serve as the basis for the selected investment bank’s resolution of the applicable
dispute, such investment bank shall be entitled (and is hereby expressly authorized) to make all findings, determinations and the like
that such investment bank determines are required to be made by such investment bank in connection with its resolution of such dispute
and in resolving such dispute such investment bank shall apply such findings, determinations and the like to the terms of this Certificate
of Designations and any other applicable Transaction Documents, (iv) the applicable Holder (and only such Holder with respect to disputes
solely relating to such Holder), in its sole discretion, shall have the right to submit any dispute described in this Section 25 to any
state or federal court sitting in The City of New York, Borough of Manhattan, New York, in lieu of utilizing the procedures set forth
in this Section 25 and (v) nothing in this Section 25 shall limit such Holder from obtaining any injunctive relief or other equitable
remedies (including, without limitation, with respect to any matters described in this Section 25).
26
26. Notices;
Currency; Payments.
(a) Notices.
The Company shall provide each Holder of Preferred Shares with prompt written notice of all actions taken pursuant to the terms of this
Certificate of Designations, including in reasonable detail a description of such action and the reason therefor. Whenever notice is
required to be given under this Certificate of Designations, unless otherwise provided herein, such notice must be in writing and shall
be given in accordance with Section 9(f) of the Securities Purchase Agreement. The Company shall provide each Holder with prompt written
notice of all actions taken pursuant to this Certificate of Designations, including in reasonable detail a description of such action
and the reason therefore. Without limiting the generality of the foregoing, the Company shall give written notice to each Holder (i)
immediately upon any adjustment of the Conversion Price, setting forth in reasonable detail, and certifying, the calculation of such
adjustment and (ii) at least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A) with respect
to any dividend or distribution upon the Common Stock, (B) with respect to any grant, issuances, or sales of any Options, Convertible
Securities or rights to purchase stock, warrants, securities or other property to holders of shares of Common Stock or (C) for determining
rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that such information shall
be made known to the public prior to or in conjunction with such notice being provided to such Holder.
(b) Currency.
All dollar amounts referred to in this Certificate of Designations are in United States Dollars (“U.S. Dollars”),
and all amounts owing under this Certificate of Designations shall be paid in U.S. Dollars. All amounts denominated in other currencies
(if any) shall be converted into the U.S. Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. “Exchange
Rate” means, in relation to any amount of currency to be converted into U.S. Dollars pursuant to this Certificate of Designations,
the U.S. Dollar exchange rate as published in the Wall Street Journal on the relevant date of calculation (it being understood and agreed
that where an amount is calculated with reference to, or over, a period of time, the date of calculation shall be the final date of such
period of time).
(c) Payments.
Whenever any payment of cash is to be made by the Company to any Person pursuant to this Certificate of Designations, unless otherwise
expressly set forth herein, such payment shall be made in lawful money of the United States of America by wire transfer of immediately
available funds pursuant to wire transfer instructions that Holder shall provide to the Company in writing from time to time. Whenever
any amount expressed to be due by the terms of this Certificate of Designations is due on any day which is not a Business Day, the same
shall instead be due on the next succeeding day which is a Business Day. Any amount due under the Transaction Documents which is not
paid when due (except to the extent such amount is simultaneously accruing Dividends at the Default Rate hereunder) shall result in a
late charge being incurred and payable by the Company in an amount equal to interest on such amount at the rate of fifteen percent (15%)
per annum from the date such amount was due until the same is paid in full (“Late Charge”).
27
27. Waiver
of Notice. To the extent permitted by law, the Company hereby irrevocably waives demand, notice, presentment, protest and all other
demands and notices in connection with the delivery, acceptance, performance, default or enforcement of this Certificate of Designations
and the Securities Purchase Agreement.
28. Governing
Law. This Certificate of Designations shall be construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Certificate of Designations shall be governed by, the internal laws of the State of
Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other
jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Delaware. Except as otherwise
required by Section 25 above, the Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in The City of New York, Borough of Manhattan, New York, for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action
or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding
is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Nothing contained herein shall
be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein (i) shall be deemed
or operate to preclude any Holder from bringing suit or taking other legal action against the Company in any other jurisdiction to collect
on the Company’s obligations to such Holder, to realize on any collateral or any other security for such obligations, or to enforce
a judgment or other court ruling in favor of such Holder or (ii) shall limit, or shall be deemed or construed to limit, any provision
of Section 25 above. THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS CERTIFICATE OF DESIGNATIONS OR ANY TRANSACTION CONTEMPLATED
HEREBY.
29. Judgment
Currency.
(a) If
for the purpose of obtaining or enforcing judgment against the Company in any court in any jurisdiction it becomes necessary to convert
into any other currency (such other currency being hereinafter in this Section 29 referred to as the “Judgment Currency”)
an amount due in U.S. dollars under this Certificate of Designations, the conversion shall be made at the Exchange Rate prevailing on
the Trading Day immediately preceding:
(i) the
date actual payment of the amount due, in the case of any proceeding in the courts of New York or in the courts of any other jurisdiction
that will give effect to such conversion being made on such date: or
28
(ii) the
date on which the foreign court determines, in the case of any proceeding in the courts of any other jurisdiction (the date as of which
such conversion is made pursuant to this Section 29(a)(ii) being hereinafter referred to as the “Judgment Conversion Date”).
(b) If
in the case of any proceeding in the court of any jurisdiction referred to in Section 29(a)(ii) above, there is a change in the Exchange
Rate prevailing between the Judgment Conversion Date and the date of actual payment of the amount due, the applicable party shall pay
such adjusted amount as may be necessary to ensure that the amount paid in the Judgment Currency, when converted at the Exchange Rate
prevailing on the date of payment, will produce the amount of US dollars which could have been purchased with the amount of Judgment
Currency stipulated in the judgment or judicial order at the Exchange Rate prevailing on the Judgment Conversion Date.
(c) Any
amount due from the Company under this provision shall be due as a separate debt and shall not be affected by judgment being obtained
for any other amounts due under or in respect of this Certificate of Designations.
30. Severability.
If any provision of this Certificate of Designations is prohibited by law or otherwise determined to be invalid or unenforceable by a
court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to
apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not
affect the validity of the remaining provisions of this Certificate of Designations so long as this Certificate of Designations as so
modified continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the
prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations
or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties.
The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s),
the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).
31. Maximum
Payments. Without limiting Section 9(c) of the Securities Purchase Agreement, nothing contained herein shall be deemed to establish
or require the payment of a rate of interest or other charges in excess of the maximum permitted by applicable law. In the event that
the rate of interest required to be paid or other charges hereunder exceed the maximum permitted by such law, any payments in excess
of such maximum shall be credited against amounts owed by the Company to the applicable Holder and thus refunded to the Company.
32. Stockholder
Matters; Amendment.
(a) Stockholder
Matters. Any stockholder action, approval or consent required, desired or otherwise sought by the Company pursuant to the DGCL, the
Certificate of Incorporation, this Certificate of Designations or otherwise with respect to the issuance of Preferred Shares may be effected
by written consent of the Company’s stockholders or at a duly called meeting of the Company’s stockholders, all in accordance
with the applicable rules and regulations of the DGCL. This provision is intended to comply with the applicable sections of the DGCL
permitting stockholder action, approval and consent affected by written consent in lieu of a meeting.
29
(b) Amendment.
Except for Section 4(d)(i), which may not be amended or waived hereunder, this Certificate of Designations or any provision hereof may
be amended by obtaining the affirmative vote at a meeting duly called for such purpose, or written consent without a meeting in accordance
with the DGCL, of the Required Holders, voting separately as a single class, and with such other stockholder approval, if any, as may
then be required pursuant to the DGCL and the Certificate of Incorporation.
33. Certain
Defined Terms. For purposes of this Certificate of Designations, the following terms shall have the following meanings:
(a) “1934
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.
(b) “Additional
Amount” means, as of the applicable date of determination, with respect to each Preferred Share, all accrued and unpaid Dividends
on such Preferred Share.
(c) “Adjustment
Right” means any right granted with respect to any securities issued in connection with, or with respect to, any issuance or
sale (or deemed issuance or sale in accordance with Section 8(a)) of shares of Common Stock (other than rights of the type described
in Section 7(a) hereof) that could result in a decrease in the net consideration received by the Company in connection with, or with
respect to, such securities (including, without limitation, any cash settlement rights, cash adjustment or other similar rights).
(d) “Affiliate”
or “Affiliated” means, with respect to any Person, any other Person that directly or indirectly controls, is controlled
by, or is under common control with, such Person, it being understood for purposes of this definition that “control” of a
Person means the power directly or indirectly either to vote 10% or more of the stock having ordinary voting power for the election of
directors of such Person or direct or cause the direction of the management and policies of such Person whether by contract or otherwise.
(e) “Alternate
Conversion Floor Amount” means an amount in cash, to be delivered by wire transfer of immediately available funds pursuant
to wire instructions delivered to the Company by the Holder in writing, equal to the product obtained by multiplying (A) the higher of
(I) the highest price that the Common Stock trades at on the Trading Day immediately preceding the relevant Alternate Conversion Date
and (II) the applicable Alternate Conversion Price and (B) the difference obtained by subtracting (I) the number of shares of Common
Stock delivered (or to be delivered) to the Holder on the applicable Share Delivery Deadline with respect to such Alternate Conversion
from (II) the quotient obtained by dividing (x) the applicable Conversion Amount that the Holder has elected to be the subject of the
applicable Alternate Conversion, by (y) the applicable Alternate Conversion Price without giving effect to clause (x) of such definition.
30
(f) “Alternate
Conversion Price” means, with respect to any Alternate Conversion that price which shall be the lowest of (i) the applicable
Conversion Price as in effect on the applicable Conversion Date of the applicable Alternate Conversion, and (ii) the greater of (x) the
Floor Price and (y) 80% of the lowest VWAP of the Common Stock of any Trading Day during the twenty (20) consecutive Trading Day period
ending and including the Trading Day immediately preceding the delivery or deemed delivery of the applicable Conversion Notice (such
period, the “Alternate Conversion Measuring Period”). All such determinations to be appropriately adjusted for any
stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the
Common Stock during such Alternate Conversion Measuring Period.
(g) “Approved
Stock Plan” means any employee benefit plan or agreement which has been approved by the Board prior to or subsequent to the
Subscription Date pursuant to which shares of Common Stock and standard options to purchase Common Stock or other awards convertible,
exercisable for or exchangeable for shares of Common Stock may be issued to any employee, officer, consultant or director for services
provided to the Company in their capacity as such.
(h) “Attribution
Parties” means, collectively, the following Persons and entities: (i) any investment vehicle, including, any funds, feeder
funds or managed accounts, currently, or from time to time after the Initial Issuance Date, directly or indirectly managed or advised
by a Holder’s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of such Holder
or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with such Holder or any of the
foregoing and (iv) any other Persons whose beneficial ownership of the Company’s Common Stock would or could be aggregated with
such Holder’s and the other Attribution Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of the
foregoing is to subject collectively such Holder and all other Attribution Parties to the Maximum Percentage.
(i) “Bloomberg”
means Bloomberg, L.P.
(j) “Book-Entry”
means each entry on the Register evidencing one or more Preferred Shares held by a Holder in lieu of a Preferred Share Certificate issuable
hereunder.
(k) “Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial
banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”,
“non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day.
31
(l) “Change
of Control” means (a) any Fundamental Transaction other than (i) any merger of the Company or any of its, direct or indirect,
wholly-owned Subsidiaries with or into any of the foregoing Persons, (ii) any reorganization, recapitalization or reclassification of
the Common Stock in which holders of the Company’s voting power immediately prior to such reorganization, recapitalization or reclassification
continue after such reorganization, recapitalization or reclassification to hold publicly traded securities and, directly or indirectly,
are, in all material respects, the holders of the voting power of the surviving entity (or entities with the authority or voting power
to elect the members of the board of directors (or their equivalent if other than a corporation) of such entity or entities) after such
reorganization, recapitalization or reclassification, (iii) pursuant to a migratory merger effected solely for the purpose of changing
the jurisdiction of incorporation of the Company or any of its Subsidiaries or (iv) bona fide arm’s length sales or acquisitions
by the Company with one or more third parties as long as holders of the Company’s voting power as of the Issuance Date continue
after such sale or acquisition to hold publicly traded securities and, directly or indirectly, are, in all material respects, the holders
of at least 51% of the voting power of the surviving entity (or entities with the authority or voting power to elect the members of the
board of directors (or their equivalent if other than a corporation) of such entity or entities) after such sale or acquisition (in each
of clauses (i) through (iv), a “Change of Control Exception”), or (b) individuals who constitute the Continuing Directors,
taken together, ceasing for any reason to constitute at least a majority of the Board, other than in connection with a Change of Control
Exception.
(m) “Change
of Control Redemption Premium” means the greater of (i) 125% or (ii) the Black-Scholes Value of the remaining unconverted shares
of Preferred Stock on the date of the consummation of such Change of Control. For purposes of this definition “Black Scholes
Value” means the value of the unconverted shares of Preferred Stock based on the Black-Scholes Option Pricing Model obtained
from the “OV” function on Bloomberg determined as of the date in question for pricing purposes and reflecting (A)
a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of such Option, Convertible
Security or Adjustment Right (as the case may be) as of the date of issuance of such Option, Convertible Security or Adjustment Right
(as the case may be), (B) an expected volatility equal to the 100 day volatility obtained from the HVT function on Bloomberg (determined
utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated
Change of Control, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share
being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Change of Control and (ii)
the highest VWAP during the period beginning on the Trading Day immediately preceding the public announcement of the applicable contemplated
Change of Control (or the consummation of the applicable Change of Control, if earlier) and ending on the Trading Day of the Holder’s
request pursuant to this section, (D) a remaining option time equal to the remaining term of such Option, Convertible Security or Adjustment
Right (as the case may be), and (E) a zero cost of borrow.
(n) “Closing
Bid Price” and “Closing Sale Price” means, for any security as of any date, the last closing bid price and
last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market
begins to operate on an extended hours basis and does not designate the closing bid price or the closing trade price (as the case may
be) then the last bid price or last trade price, respectively, of such security prior to 4:00:00 p.m., New York time, as reported by
Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security, the last closing
bid price or last trade price, respectively, of such security on the principal securities exchange or trading market where such security
is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last trade price, respectively,
of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, or, if no
closing bid price or last trade price, respectively, is reported for such security by Bloomberg, the average of the bid prices, or the
ask prices, respectively, of any market makers for such security as reported in The Pink Open Market (or a similar organization or agency
succeeding to its functions of reporting prices). If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security
on a particular date on any of the foregoing bases, the Closing Bid Price or the Closing Sale Price (as the case may be) of such security
on such date shall be the fair market value as mutually determined by the Company and the Required Holder. If the Company and the Required
Holders are unable to agree upon the fair market value of such security, then such dispute shall be resolved in accordance with the procedures
in Section 25. All such determinations shall be appropriately adjusted for any stock splits, stock dividends, stock combinations, recapitalizations
or other similar transactions during such period.
32
(o) “Closing
Date” shall have the meaning set forth in the Securities Purchase Agreement, which date is the date the Company initially issued
the Preferred Shares and the Warrants pursuant to the terms of the Securities Purchase Agreement.
(p) “Common
Stock” means (i) the Company’s shares of common stock, par value $0.0001 per share, and (ii) any capital stock into which
such common stock shall have been changed or any share capital resulting from a reclassification of such common stock.
(q) “Contingent
Obligation” means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect
to any Indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such
liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability will be paid or
discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability will be protected (in
whole or in part) against loss with respect thereto.
(r) “Continuing
Directors” means the directors of the Company on the date hereof and each other director, if, in each case, such other director
is nominated for election by the Board a majority of whom are directors on the date hereof or whose election or nomination for election
was approved by one or more of such directors.
(s) “Conversion
Floor Price Condition” means that the relevant Alternate Conversion Price is being determined based on clause (x) of such definition.
(t) “Convertible
Securities” means any stock or other security (other than Options) that is at any time and under any circumstances, directly
or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any shares
of Common Stock.
(u) “Dividend
Date” means the first Trading Day of each calendar quarter with the first Dividend Date being July 1, 2026.
(v) “Dividend
Rate” means seven percent (7.0%) per annum, as may be adjusted from time to time in accordance with Section 3.
(w) “Eligible
Market” means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, the
OTCQX, the OTCQB or the Principal Market.
33
(x) “Event
Market Price” means, with respect to any Stock Combination Event Date, the lower of (i) the Conversion Price in effect
immediately after such Stock Combination Event Date (and, for the avoidance of doubt, as adjusted following such Stock Combination Event
Date as set forth herein), and (ii) the lowest VWAP of the Common Stock for any Trading Day during the eleven (11) consecutive Trading
Day period commencing on the fifth (5th) Trading Day immediately preceding the Stock Combination Event Date and ending on the fifth (5th)
Trading Day immediately following the Stock Combination Event Date.
(y) [Reserved.]
(z) “Floor
Price” means the lower of (x) $0.502 and (y) 20% of the “Minimum Price” (as defined in Rule 5635 of the Nasdaq
Stock Market) on the Stockholder Approval Date (as defined in the Securities Purchase Agreement), in each case, subject to adjustment
for stock splits, stock dividends, stock combinations, recapitalizations or other similar events, or, in any case, such lower amount
as permitted, from time to time, by the Principal Market.
(aa) “Fundamental
Transaction” means (A) that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise,
in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the surviving corporation)
another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or
assets of the Company or any of its “significant subsidiaries” (as defined in Rule 1-02 of Regulation S-X) to one or more
Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow the Company to be subject to or have its voting
stock be subject to or party to one or more Subject Entities making, a purchase, tender or exchange offer that is accepted by the holders
of at least either (x) more than 50% of the outstanding voting power of the Company, (y) more than 50% of the outstanding voting power
of the Company calculated as if any shares of voting stock held by all Subject Entities making or party to, or Affiliated with any Subject
Entities making or party to, such purchase, tender or exchange offer were not outstanding; or (z) such number of shares of voting stock
such that all Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such purchase, tender or
exchange offer, become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of more than 50% of the outstanding
voting power of the Company, or (iv) consummate a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with one or more Subject Entities whereby all such
Subject Entities, individually or in the aggregate, acquire, either (x) more than 50% of the outstanding voting power of the Company
(y) more than 50% of the outstanding voting power of the Company calculated as if any shares of voting stock held by all the Subject
Entities making or party to, or Affiliated with any Subject Entity making or party to, such stock purchase agreement or other business
combination were not outstanding; or (z) such number of shares of voting stock of the Company such that the Subject Entities become collectively
the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of more than 50% of the outstanding voting power of the Company,
or (v) reorganize, recapitalize or reclassify its Common Stock, (B) that the Company shall, directly or indirectly, including through
subsidiaries, Affiliates or otherwise, in one or more related transactions, allow any Subject Entity individually or the Subject Entities
in the aggregate to be or become the “beneficial owner” (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly,
whether through acquisition, purchase, assignment, conveyance, tender, tender offer, exchange, reduction in outstanding shares of voting
stock, merger, consolidation, business combination, reorganization, recapitalization, spin-off, scheme of arrangement, reorganization,
recapitalization or reclassification or otherwise in any manner whatsoever, of either (x) more than 50% of the aggregate ordinary voting
power represented by issued and outstanding shares of voting stock of the Company, (y) more than 50% of the aggregate ordinary voting
power represented by issued and outstanding shares of voting stock of the Company not held by all such Subject Entities as of the date
of this Certificate of Designations calculated as if any shares of voting stock of the Company held by all such Subject Entities were
not outstanding, or (z) a percentage of the aggregate ordinary voting power represented by issued and outstanding shares of voting stock
of the Company or other equity securities of the Company sufficient to allow such Subject Entities to effect a statutory short form merger
or other transaction requiring other stockholders of the Company to surrender their shares of voting stock of the Company without approval
of the stockholders of the Company or (C) directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or
more related transactions, the issuance of or the entering into any other instrument or transaction structured in a manner to circumvent,
or that circumvents, the intent of this definition in which case this definition shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this definition to the extent necessary to correct this definition or any portion of this
definition which may be defective or inconsistent with the intended treatment of such instrument or transaction.
34
(bb) “GAAP”
means United States generally accepted accounting principles, consistently applied.
(cc) “Group”
means a “group” as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5 thereunder.
(dd) [Reserved.]
(ee) “Indebtedness”
of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all obligations issued, undertaken or assumed as
the deferred purchase price of property or services, including, without limitation, “capital leases” in accordance with United
States generally accepted accounting principles consistently applied for the periods covered thereby (other than trade payables entered
into in the ordinary course of business consistent with past practice), (C) all reimbursement or payment obligations with respect to
letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds, debentures or similar instruments,
including obligations so evidenced incurred in connection with the acquisition of property, assets or businesses, (E) all indebtedness
created or arising under any conditional sale or other title retention agreement, or incurred as financing, in either case with respect
to any property or assets acquired with the proceeds of such indebtedness (even though the rights and remedies of the seller or bank
under such agreement in the event of default are limited to repossession or sale of such property), (F) all monetary obligations under
any leasing or similar arrangement which, in connection with United States generally accepted accounting principles, consistently applied
for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F) above
secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any mortgage,
deed of trust, lien, pledge, charge, security interest or other encumbrance of any nature whatsoever in or upon any property or assets
(including accounts and contract rights) with respect to any asset or property owned by any Person, even though the Person which owns
such assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all Contingent Obligations in
respect of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G) above.
35
(ff) “Intellectual
Property Rights” means, with respect to the Company and its Subsidiaries, all of their rights or licenses to use all trademarks,
trade names, service marks, service mark registrations, service names, original works of authorship, patents, patent rights, copyrights,
inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property rights and all applications
and registrations therefor.
(gg) “Investment”
means any beneficial ownership (including stock, partnership or limited liability company interests) of or in any Person, or any loan,
advance or capital contribution to any Person or the acquisition of all, or substantially all, of the assets of another Person or the
purchase of any assets of another Person for greater than the fair market value of such assets.
(hh) “Liquidation
Event” means, whether in a single transaction or series of transactions, the voluntary or involuntary liquidation, dissolution
or winding up of the Company or such Subsidiaries the assets of which constitute all or substantially all of the assets of the business
of the Company and its Subsidiaries, taken as a whole.
(ii)
“Make-Whole Amount” means, as of any given date and as applicable, in connection with any conversion, redemption or
other repayment hereunder, an amount equal to the amount of additional Dividends that would accrue under this Certificate of Designations
at the Dividend Rate then in effect assuming for calculation purposes that the Stated Value of this Certificate of Designations as of
the Closing Date remained outstanding through and including the one year anniversary of the applicable date of conversion of the Preferred
Shares.
(jj) [Reserved.]
(kk) “Options”
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.
(ll) “Parent
Entity” of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or
equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the
Person or Parent Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.
(mm) “Permitted
Indebtedness” means (i) Indebtedness existing on December 31, 2025 and reflected on the Company’s balance sheet included
in the Company’s Annual Report on Form 10-K filed with the SEC on March 30, 2026, (ii) Indebtedness secured by Permitted Liens
or unsecured but as described in clauses (iv) and (v) of the definition of Permitted Liens, and (iii) if less than 9,200 Preferred Shares
remain outstanding, the Permitted Senior Indebtedness.
36
(nn) “Permitted
Liens” means (i) any Lien for taxes not yet due or delinquent or being contested in good faith by appropriate proceedings for
which adequate reserves have been established in accordance with GAAP, (ii) any statutory Lien arising in the ordinary course of business
by operation of law with respect to a liability that is not yet due or delinquent, (iii) any Lien created by operation of law, such as
materialmen’s liens, mechanics’ liens and other similar liens, arising in the ordinary course of business with respect to
a liability that is not yet due or delinquent or that are being contested in good faith by appropriate proceedings, (iv) Liens (A) upon
or in any equipment acquired or held by the Company or any of its Subsidiaries to secure the purchase price of such equipment or Indebtedness
incurred solely for the purpose of financing the acquisition or lease of such equipment, or (B) existing on such equipment at the time
of its acquisition, provided that the Lien is confined solely to the property so acquired and improvements thereon, and the proceeds
of such equipment, in either case, with respect to Indebtedness in an aggregate amount not to exceed $150,000, (v) Liens incurred in
connection with the extension, renewal or refinancing of the Indebtedness secured by Liens of the type described in clause (iv) above,
provided that any extension, renewal or replacement Lien shall be limited to the property encumbered by the existing Lien and the principal
amount of the Indebtedness being extended, renewed or refinanced does not increase, (vi) Liens in favor of customs and revenue authorities
arising as a matter of law to secure payments of custom duties in connection with the importation of goods, (vii) Liens arising from
judgments, decrees or attachments in circumstances not constituting a Triggering Event under Section 5(a)(xi) and (viii) Liens with respect
to the Permitted Senior Indebtedness.
(oo) “Permitted
Senior Indebtedness” means non-convertible Indebtedness issued pursuant to a credit facility with a bank or similar financial
institution with no principal payments required prior to the 91st calendar day after the Initial Issuance Date, provided, however,
that the aggregate outstanding principal amount of such Indebtedness permitted hereunder does not at any time exceed $10 million; provided,
further, however, no Permitted Senior Indebtedness shall permit the lender to accelerate such Permitted Senior Indebtedness
as a result of the occurrence of any Triggering Event hereunder or the Holder’s delivery of a Triggering Event Redemption Notice.
(pp) “Person”
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or a government or any department or agency thereof.
(qq) “Principal
Market” means the Nasdaq Capital Market.
(rr) “Redemption
Notices” means, collectively, the Triggering Event Redemption Notices and the Change of Control Redemption Notices, and each
of the foregoing, individually, a “Redemption Notice.”
(ss) “Redemption
Premium” means 130%.
(tt) “Redemption
Prices” means, collectively, any Triggering Event Redemption Price and Change of Control Redemption Price, and each of the
foregoing, individually, a “Redemption Price.”
37
(uu) “SEC”
means the United States Securities and Exchange Commission or the successor thereto.
(vv) “Securities
Purchase Agreement” means that certain securities purchase agreement by and among the Company and the initial holders of Preferred
Shares, dated as of the Subscription Date, as may be amended from time in accordance with the terms thereof.
(ww) “Stated
Value” shall mean $1,000 per share, subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations,
reclassifications, combinations, subdivisions or other similar events occurring after the Initial Issuance Date with respect to the Preferred
Shares.
(xx) “Subscription
Date” means April 27, 2026.
(yy) “Subject
Entity” means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.
(zz) “Subsidiaries”
shall have the meaning as set forth in the Securities Purchase Agreement.
(aaa) “Successor
Entity” means the Person (or, if so elected by the Required Holders, the Parent Entity) formed by, resulting from or surviving
any Fundamental Transaction or the Person (or, if so elected by the Required Holders, the Parent Entity) with which such Fundamental
Transaction shall have been entered into.
(bbb) “Trading
Day” means, as applicable, (x) with respect to all price or trading volume determinations relating to the Common Stock, any
day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market for
the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded, provided that
“Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less
than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market
(or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the
hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the applicable Holder
or (y) with respect to all determinations other than price determinations relating to the Common Stock, any day on which The New York
Stock Exchange (or any successor thereto) is open for trading of securities.
(ccc) “Transaction
Documents” means the Securities Purchase Agreement, this Certificate of Designations, the Warrants and each of the other agreements
and instruments entered into or delivered by the Company or any of the Holders in connection with the transactions contemplated by the
Securities Purchase Agreement, all as may be amended from time to time in accordance with the terms thereof.
38
(ddd) “VWAP”
means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal Market (or, if the
Principal Market is not the principal trading market for such security, then on the principal securities exchange or securities market
on which such security is then traded), during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time,
as reported by Bloomberg through its “VAP” function (set to 09:30 start time and 16:00 end time) or, if the foregoing does
not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board
for such security during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg,
or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest
closing bid price and the lowest closing ask price of any of the market makers for such security as reported in The Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices). If the VWAP cannot be calculated for such security
on such date on any of the foregoing bases, the VWAP of such security on such date shall be the fair market value as mutually determined
by the Company and the Required Holders. If the Company and the Required Holders are unable to agree upon the fair market value of such
security, then such dispute shall be resolved in accordance with the procedures in Section 25. All such determinations shall be appropriately
adjusted for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period.
(eee) “Warrants”
has the meaning ascribed to such term in the Securities Purchase Agreement, and shall include all warrants issued in exchange therefor
or replacement thereof.
(fff) “Warrant
Shares” means, collectively, the shares of Common Stock issuable upon exercise of the Warrants.
34. Disclosure.
Upon receipt or delivery by the Company of any notice in accordance with the terms of this Certificate of Designations, unless the Company
has in good faith determined that the matters relating to such notice do not constitute material, non-public information relating to
the Company or any of its Subsidiaries, the Company shall on or prior to 9:00 am, New York city time on the Business Day immediately
following such notice delivery date, publicly disclose such material, non-public information on a Current Report on Form 8-K or otherwise.
In the event that the Company believes that a notice contains material, non-public information relating to the Company or any of its
Subsidiaries, the Company so shall indicate to the Holder explicitly in writing in such notice (or immediately upon receipt of notice
from such Holder, as applicable), and in the absence of any such written indication in such notice (or notification from the Company
immediately upon receipt of notice from such Holder), such Holder shall be entitled to presume that information contained in the notice
does not constitute material, non-public information relating to the Company or any of its Subsidiaries. Nothing contained in this Section
34 shall limit any obligations of the Company, or any rights of any Holder, under Section 4(l) of the Securities Purchase Agreement.
35. Absence
of Trading and Disclosure Restrictions. The Company acknowledges and agrees that no Holder is a fiduciary or agent of the Company
and that each Holder shall have no obligation to (a) maintain the confidentiality of any information provided by the Company or (b) refrain
from trading any securities while in possession of such information in the absence of a written non-disclosure agreement signed by an
officer of such Holder that explicitly provides for such confidentiality and trading restrictions. In the absence of such an executed,
written non-disclosure agreement, the Company acknowledges that each Holder may freely trade in any securities issued by the Company,
may possess and use any information provided by the Company in connection with such trading activity, and may disclose any such information
to any third party.
*
* * * *
39
IN
WITNESS WHEREOF, the Company has caused this Certificate of Designations of Series K Convertible Preferred Stock of StableX Technologies,
Inc. to be signed by its Chief Executive Officer on this 27th day of April, 2026.
STABLEX
TECHNOLOGIES, INC.
By:
/s/
Joshua Silverman
Name:
Joshua
Silverman
Title:
Chief
Executive Officer
Signature
Page to Certificate of Designations
EXHIBIT
I
STABLEX
TECHNOLOGIES, INC.
CONVERSION
NOTICE
Reference
is made to the Certificate of Designations, Preferences and Rights of the Series K Convertible Preferred Stock of StableX Technologies,
Inc. (the “Certificate of Designations”). In accordance with and pursuant to the Certificate of Designations, the
undersigned hereby elects to convert the number of shares of Series K Convertible Preferred Stock, par value $0.0001 per share (the “Preferred
Shares”), of StableX Technologies, Inc., a Delaware corporation (the “Company”), indicated below into shares
of common stock, par value $0.0001 per share (the “Common Stock”), of the Company, as of the date specified below.
Date
of Conversion:
Aggregate
number of Preferred Shares to be converted:
Aggregate
Stated Value of such Preferred Shares to be converted:
Aggregate
accrued and unpaid Dividends and accrued and
unpaid Late
Charges with respect to such Preferred Shares
and such
Aggregate Dividends to be converted:
AGGREGATE
CONVERSION AMOUNT TO BE
CONVERTED:
Please confirm
the following information:
Conversion
Price:
Number of
shares of Common Stock to be issued:
Please
issue the Common Stock into which the applicable Preferred Shares are being converted to Holder, or for its benefit, as follows:
☐ Check
here if requesting delivery as a certificate to the following name and to the following address:
Issue
to:
☐ Check
here if requesting delivery by Deposit/Withdrawal at Custodian as follows:
DTC
Participant:
DTC
Number:
Exhibit I
Account
Number:
Date:
_____________ __, ____
Name
of Registered Holder
By:
Name:
Title:
Tax
ID: _______________________
Address: ________________
Exhibit I
EXHIBIT
II
ACKNOWLEDGMENT
The
Company hereby (a) acknowledges this Conversion Notice, (b) certifies that the above indicated number of shares of Common Stock are eligible
to be resold by the Holder without restriction or any legend and (c) hereby directs _________________ to issue the above indicated number
of shares of Common Stock in accordance with the Transfer Agent Instructions dated [____] from the Company and acknowledged and agreed
to by ________________________.
STABLEX
TECHNOLOGIES, INC.
By:
Name:
Title:
Exhibit II
EX-3.3
EX-3.3
Filename: ex3-3.htm · Sequence: 4
Exhibit 3.3
AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS OF PREFERENCES
AND RIGHTS OF
SERIES H-7 CONVERTIBLE PREFERRED STOCK
OF
STABLEX TECHNOLOGIES, INC.
a Delaware corporation
This Amended and Restated Certificate
of Designations of Series H-7 Convertible Preferred Stock (this “Certificate of Designations”) is dated as of April
27, 2026 (the “Effective Date”);
WHEREAS, the board of directors (the “Board”)
of StableX Technologies, Inc. (the “Company”) pursuant to the authority expressly conferred upon the Board by the Company’s
Certificate of Incorporation (the “Certificate of Incorporation”), and Section 151 of the Delaware General Corporation
Law (“DGCL”), has previously fixed the rights, preferences, restrictions and other matters relating to a series of
the Company’s preferred stock, consisting of 22,000 authorized shares of preferred stock, classified as Series H-7 Convertible Preferred
Stock (the “Preferred Stock”), and the Certificate of Designations of the Preferred Stock (the “Original Certificate
of Designations”) evidencing such terms was filed with the Secretary of State of the State of Delaware on August 7, 2023;
WHEREAS, pursuant to the authority conferred
upon the Board in accordance with the Certificate of Incorporation and the Bylaws of the Company, the Board has duly adopted a resolution
amending and restating the rights of the Preferred Stock, declaring said amendment and restatement to be advisable and desirable; and
WHEREAS, this Certificate of Designations
has been duly adopted in accordance with Section 151 of the DGCL.
NOW, THEREFORE, be it resolved, that the
Board does hereby provide that the rights set forth in the Original Certificate of Designations are hereby amended and restated as follows:
SERIES H-7 PREFERRED STOCK
1. Designation and Number of Shares.
There shall hereby be created and established a series of preferred stock of the Company designated as “Series H-7 Convertible Preferred
Stock” (the “Preferred Shares”). The authorized number of Preferred Shares shall be 22,000. Each Preferred Share
shall have a par value of $0.0001. Capitalized terms not defined herein shall have the meaning as set forth in Section 33 below.
2. Ranking. Except to the extent
that the holders of at least a majority of the outstanding Preferred Shares (the “Required Holders”) expressly consent
to the creation of Parity Stock (as defined below) or Senior Preferred Stock (as defined below) in accordance with Section 18, all shares
of capital stock of the Company shall be junior in rank to all Preferred Shares with respect to the preferences as to dividends, distributions
and payments upon the liquidation, dissolution and winding up of the Company (such junior stock is referred to herein collectively as
“Junior Stock”). The rights of all such shares of capital stock of the Company shall be subject to the rights, powers,
preferences and privileges of the Preferred Shares. Without limiting any other provision of this Certificate of Designations, without
the prior express consent of the Required Holders, voting separately as a single class, the Company shall not hereafter authorize or issue
any additional or other shares of capital stock that are (i) of senior rank to the Preferred Shares in respect of the preferences as to
dividends, distributions and payments upon the liquidation, dissolution and winding up of the Company (collectively, the “Senior
Preferred Stock”), (ii) of pari passu rank to the Preferred Shares in respect of the preferences as to dividends, distributions
and payments upon the liquidation, dissolution and winding up of the Company (collectively, the “Parity Stock”) or
(iii) any Junior Stock having a maturity date or any other date requiring redemption or repayment of such shares of Junior Stock that
is prior to the Maturity Date. In the event of the merger or consolidation of the Company with or into another corporation, the Preferred
Shares shall maintain their relative rights, powers, designations, privileges and preferences provided for herein and no such merger or
consolidation shall be consummated if it would result in the Preferred Shares being treated in any manner inconsistently with the foregoing.
3. Dividends and Payments.
(a) From and after the first date of
issuance of any Preferred Shares (the “Initial Issuance Date”), each holder of a Preferred Share (each, a “Holder”
and collectively, the “Holders”) shall be entitled to receive dividends on the Stated Value of the Preferred Shares
(“Dividends”) payable, subject to the conditions and other terms hereof, in cash out of funds legally available therefor
at the Dividend Rate computed on the basis of a 360-day year and twelve 30-day months and shall compound each calendar quarter; provided
that a Holder and the Company may mutually agree to convert any Dividends into shares of Common Stock at a price to be mutually determined
by the Company and such Holder, which shall not be less than the Floor Price.
(b) Dividends shall be payable in arrears
on (i) each Dividend Date, and (ii) upon any redemption in accordance with Section 12 or any required payment upon any Triggering Event.
From and after the occurrence and during the continuance of any Triggering Event and ending on the date on which such Triggering Event
is subsequently cured (and no other Triggering Event then exists), Dividends shall accrue on the Stated Value of each Preferred Share
at fifteen percent (15.0%) per annum (the “Default Rate”) and shall be computed on the basis of a 360-day year and
twelve 30-day months.
(c) On the Maturity Date, the Company
shall pay to the Holder an amount in funds legally available therefor equal to the sum of (i) 107% of the Stated Value of the Preferred
Shares held by such Holder, (ii) accrued and unpaid Dividends and (iii) unpaid Late Charges. Other than as specifically permitted hereunder,
the Company may not prepay any portion of the aggregate Stated Value underlying outstanding Preferred Shares, accrued and unpaid Dividends
or accrued and unpaid Late Charges.
4. Conversion. At any time after
the Initial Issuance Date, each Preferred Share shall be convertible into validly issued, fully paid and non-assessable shares of Common
Stock (as defined below), on the terms and conditions set forth in this Section 4.
(a) Holder’s Conversion
Right. Subject to the provisions of Section 4(d), at any time or times on or after the Initial Issuance Date, each Holder shall be
entitled to convert any portion of the outstanding Preferred Shares held by such Holder into validly issued, fully paid and non-assessable
shares of Common Stock in accordance with Section 4(c) at the Conversion Rate (as defined below). The Company shall not issue any fraction
of a share of Common Stock upon any conversion. If the issuance would result in the issuance of a fraction of a share of Common Stock,
the Company shall round such fraction of a share of Common Stock up to the nearest whole share. The Company shall pay any and all transfer,
stamp, issuance and similar taxes, costs and expenses (including, without limitation, fees and expenses of the Transfer Agent (as defined
below)) that may be payable with respect to the issuance and delivery of Common Stock upon conversion of any Preferred Shares.
(b) Conversion Rate.
The number of shares of Common Stock issuable upon conversion of any Preferred Share pursuant to Section 4(a) shall be determined by dividing
(x) the Conversion Amount of such Preferred Share by (y) the Conversion Price (the “Conversion Rate”):
(i) “Conversion Amount”
means, with respect to each Preferred Share, as of the applicable date of determination, the sum of (1) the Stated Value thereof plus
(2) the Make Whole Amount, (3) the Additional Amount thereon and any accrued and unpaid Late Charges (as defined below in Section 26(c))
with respect to such Stated Value and Additional Amount as of such date of determination.
(ii) “Conversion Price”
means, with respect to each Preferred Share, as of any Conversion Date or other date of determination, $6.1933, as of the Effective Date,
subject to adjustment as provided herein following the Effective Date.
(c) Mechanics of Conversion.
The conversion of each Preferred Share shall be conducted in the following manner:
(i) Optional Conversion.
To convert a Preferred Share into shares of Common Stock on any date (a “Conversion Date”), a Holder shall deliver
(whether via electronic mail or otherwise), for receipt on or prior to 11:59 p.m., New York time, on such date, a copy of an executed
notice of conversion of the share(s) of Preferred Shares subject to such conversion in the form attached hereto as Exhibit I
(the “Conversion Notice”) to the Company. If required by Section 4(c)(iii), within two (2) Trading Days following a
conversion of any such Preferred Shares as aforesaid, such Holder shall surrender to a nationally recognized overnight delivery service
for delivery to the Company the original certificates, if any, representing the Preferred Shares (the “Preferred Share Certificates”)
so converted as aforesaid (or an indemnification undertaking with respect to the Preferred Shares in the case of its loss, theft or destruction
as contemplated by Section 20(b)). On or before the first (1st) Trading Day following
the date of receipt of a Conversion Notice, the Company shall transmit by electronic mail an acknowledgment of confirmation and representation
as to whether such shares of Common Stock may then be resold pursuant to Rule 144 or an effective and available registration statement,
in the form attached hereto as Exhibit II, of receipt of such Conversion Notice to such Holder and the Company’s transfer
agent (the “Transfer Agent”), which confirmation shall constitute an instruction to the Transfer Agent to process such
Conversion Notice in accordance with the terms herein. On or before the second (2nd) Trading Day following each date on which the Company
has received a Conversion Notice (or such earlier date as required pursuant to the 1934 Act or other applicable law, rule or regulation
for the settlement of a trade initiated on the applicable Conversion Date of such shares of Common Stock issuable pursuant to such Conversion
Notice) (the “Share Delivery Deadline”), the Company shall (1) provided that the Transfer Agent is participating in
The Depository Trust Company’s (“DTC”) Fast Automated Securities Transfer Program (“FAST”),
credit such aggregate number of shares of Common Stock to which such Holder shall be entitled pursuant to such conversion to such Holder’s
or its designee’s balance account with DTC through its Deposit/Withdrawal at Custodian system, or (2) if the Transfer Agent is not
participating in FAST, upon the request of such Holder, issue and deliver (via reputable overnight courier) to the address as specified
in such Conversion Notice, a certificate, registered in the name of such Holder or its designee, for the number of shares of Common Stock
to which such Holder shall be entitled. If the number of Preferred Shares represented by the Preferred Share Certificate(s) submitted
for conversion pursuant to Section 4(c)(iii) is greater than the number of Preferred Shares being converted, then the Company shall, as
soon as practicable and in no event later than two (2) Trading Days after receipt of the Preferred Share Certificate(s) and at its own
expense, issue and deliver to such Holder (or its designee) a new Preferred Share Certificate or a new Book-Entry (in either case, in
accordance with Section 20(d)) representing the number of Preferred Shares not converted. The Person or Persons entitled to receive the
shares of Common Stock issuable upon a conversion of Preferred Shares shall be treated for all purposes as the record holder or holders
of such shares of Common Stock on the Conversion Date. Notwithstanding the foregoing, with respect to any Conversion Notice delivered
by a Buyer (as defined in the Securities Purchase Agreement) to the Company on or prior to 4:00 p.m. (New York City time) on the Trading
Day immediately prior to the date of initial issuance of such applicable Preferred Shares to be converted pursuant to such Conversion
Notice (each, an “Issuance Date”), which may be delivered at any time after the time of execution of the Securities
Purchase Agreement, the Company agrees to deliver the shares of Common Stock issuable upon conversion of such Preferred Shares to be issued
on such date subject to such notice(s) by 4:00 p.m. (New York City time) on such applicable Issuance Date and such Issuance Date shall
be the Share Delivery Deadline for purposes hereunder with respect to such Conversion Notice.
(ii) Company’s Failure
to Timely Convert. If the Company shall fail, for any reason or for no reason, on or prior to the applicable Share Delivery Deadline,
if the Transfer Agent is not participating in FAST, to issue and deliver to such Holder (or its designee) a certificate for the number
of shares of Common Stock to which such Holder is entitled and register such shares of Common Stock on the Company’s share register
or, if the Transfer Agent is participating in FAST, to credit such Holder’s or its designee’s balance account with DTC for
such number of shares of Common Stock to which such Holder is entitled upon such Holder’s conversion of any Conversion Amount (as
the case may be) (a “Conversion Failure”), then, in addition to all other remedies available to such Holder, (X) the
Company shall pay in cash from funds legally available therefor to such Holder on each day after the Share Delivery Deadline that the
issuance of such shares of Common Stock is not timely effected an amount equal to 1% of the product of (A) the sum of the number of shares
of Common Stock not issued to such Holder on or prior to the Share Delivery Deadline and to which such Holder is entitled, multiplied
by (B) any trading price of the Common Stock selected by such Holder in writing as in effect at any time during the period beginning on
the applicable Conversion Date and ending on the applicable Share Delivery Deadline, and (Y) such Holder, upon written notice to the Company,
may void its Conversion Notice with respect to, and retain or have returned, as the case may be, all, or any portion, of such Preferred
Shares that has not been converted pursuant to such Conversion Notice; provided that the voiding of a Conversion Notice shall not affect
the Company’s obligations to make any payments which have accrued prior to the date of such notice pursuant to this Section 4(c)(ii)
or otherwise. In addition to the foregoing, if on or prior to the Share Delivery Deadline the Transfer Agent is not participating in FAST,
the Company shall fail to issue and deliver to such Holder (or its designee) a certificate and register such shares of Common Stock on
the Company’s share register or, if the Transfer Agent is participating in FAST, the Transfer Agent shall fail to credit the balance
account of such Holder or such Holder’s designee, as applicable, with DTC for the number of shares of Common Stock to which such
Holder is entitled upon such Holder’s conversion hereunder or pursuant to the Company’s obligation pursuant to clause (ii)
below, and if on or after such Share Delivery Deadline such Holder acquires (in an open market transaction, stock loan or otherwise) shares
of Common Stock corresponding to all or any portion of the number of shares of Common Stock issuable upon such conversion that such Holder
is entitled to receive from the Company and has not received from the Company in connection with such Conversion Failure (a “Buy-In”),
then, in addition to all other remedies available to such Holder, the Company shall, within two (2) Business Days after receipt of such
Holder’s request and in such Holder’s discretion, either: (I) pay cash from funds legally available therefor to such Holder
in an amount equal to such Holder’s total purchase price (including brokerage commission, stock loan costs and other out-of-pocket
expenses, if any) for the shares of Common Stock so acquired (including, without limitation, by any other Person in respect, or on behalf,
of such Holder) (the “Buy-In Price”), at which point the Company’s obligation to so issue and deliver such certificate
(and to issue such shares of Common Stock) or credit to the balance account of such Holder or such Holder’s designee, as applicable,
with DTC for the number of shares of Common Stock to which such Holder is entitled upon such Holder’s conversion hereunder (as the
case may be) (and to issue such shares of Common Stock) shall terminate, or (II) promptly honor its obligation to so issue and deliver
to such Holder a certificate or certificates representing such shares of Common Stock or credit the balance account of such Holder or
such Holder’s designee, as applicable, with DTC for the number of shares of Common Stock to which such Holder is entitled upon such
Holder’s conversion hereunder (as the case may be) and pay cash from funds legally available therefor to such Holder in an amount
equal to the excess (if any) of the Buy-In Price over the product of (x) such number of shares of Common Stock multiplied by (y) the lowest
Closing Sale Price of the Common Stock on any Trading Day during the period commencing on the date of the applicable Conversion Notice
and ending on the date of such issuance and payment under this clause (II). Nothing herein shall limit a Holder’s right to pursue
any other remedies available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company’s failure to timely deliver certificates representing shares of Common Stock (or to
electronically deliver such shares of Common Stock) upon the conversion of the Preferred Shares as required pursuant to the terms hereof.
Notwithstanding anything herein to the contrary, with respect to any given Conversion Failure, this Section 4(c)(ii) shall not apply to
a Holder to the extent the Company has already paid such amounts in full to such Holder with respect to such Conversion Failure, as applicable,
pursuant to the analogous sections of the Securities Purchase Agreement.
(iii) Registration; Book-Entry.
At the time of issuance of any Preferred Shares hereunder, the applicable Holder may, by written request (including by electronic-mail)
to the Company, elect to receive such Preferred Shares in the form of one or more Preferred Share Certificates or in Book-Entry form.
The Company (or the Transfer Agent, as custodian for the Preferred Shares) shall maintain a register (the “Register”)
for the recordation of the names and addresses of the Holders of each Preferred Share and the Stated Value of the Preferred Shares and
whether the Preferred Shares are held by such Holder in Preferred Share Certificates or in Book-Entry form (the “Registered Preferred
Shares”). The entries in the Register shall be conclusive and binding for all purposes absent manifest error. The Company and
each Holder of the Preferred Shares shall treat each Person whose name is recorded in the Register as the owner of a Preferred Share for
all purposes (including, without limitation, the right to receive payments and Dividends hereunder) notwithstanding notice to the contrary.
A Registered Preferred Share may be assigned, transferred or sold only by registration of such assignment or sale on the Register. Upon
its receipt of a written request to assign, transfer or sell one or more Registered Preferred Shares by such Holder thereof, the Company
shall record the information contained therein in the Register and issue one or more new Registered Preferred Shares in the same aggregate
Stated Value as the Stated Value of the surrendered Registered Preferred Shares to the designated assignee or transferee pursuant to Section
20, provided that if the Company does not so record an assignment, transfer or sale (as the case may be) of such Registered Preferred
Shares within two (2) Business Days of such a request, then the Register shall be automatically deemed updated to reflect such assignment,
transfer or sale (as the case may be). Notwithstanding anything to the contrary set forth in this Section 4, following conversion of any
Preferred Shares in accordance with the terms hereof, the applicable Holder shall not be required to physically surrender such Preferred
Shares held in the form of a Preferred Share Certificate to the Company unless (A) the full or remaining number of Preferred Shares represented
by the applicable Preferred Share Certificate are being converted (in which event such certificate(s) shall be delivered to the Company
as contemplated by this Section 4(c)(iii)) or (B) such Holder has provided the Company with prior written notice (which notice may be
included in a Conversion Notice) requesting reissuance of Preferred Shares upon physical surrender of the applicable Preferred Share Certificate.
Each Holder and the Company shall maintain records showing the Stated Value, Dividends and Late Charges converted and/or paid (as the
case may be) and the dates of such conversions and/or payments (as the case may be) or shall use such other method, reasonably satisfactory
to such Holder and the Company, so as not to require physical surrender of a Preferred Share Certificate upon conversion. If the Company
does not update the Register to record such Stated Value, Dividends and Late Charges converted and/or paid (as the case may be) and the
dates of such conversions and/or payments (as the case may be) within two (2) Business Days of such occurrence, then the Register shall
be automatically deemed updated to reflect such occurrence. In the event of any dispute or discrepancy, such records of such Holder establishing
the number of Preferred Shares to which the record holder is entitled shall be controlling and determinative in the absence of manifest
error. A Holder and any transferee or assignee, by acceptance of a certificate, acknowledge and agree that, by reason of the provisions
of this paragraph, following conversion of any Preferred Shares, the number of Preferred Shares represented by such certificate may be
less than the number of Preferred Shares stated on the face thereof. Each Preferred Share Certificate shall bear the following legend:
ANY TRANSFEREE OR ASSIGNEE OF THIS CERTIFICATE SHOULD
CAREFULLY REVIEW THE TERMS OF THE COMPANY’S CERTIFICATE OF DESIGNATIONS RELATING TO THE SHARES OF SERIES H-7 PREFERRED STOCK REPRESENTED
BY THIS CERTIFICATE, INCLUDING SECTION 4(c)(iii) THEREOF. THE NUMBER OF SHARES OF SERIES H-7 PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE
MAY BE LESS THAN THE NUMBER OF SHARES OF SERIES H-7 PREFERRED STOCK STATED ON THE FACE HEREOF PURSUANT TO SECTION 4(c)(iii) OF THE CERTIFICATE
OF DESIGNATIONS RELATING TO THE SHARES OF SERIES H-7 PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE.
(iv) Pro Rata Conversion; Disputes.
In the event that the Company receives a Conversion Notice from more than one Holder for the same Conversion Date and the Company can
convert some, but not all, of such Preferred Shares submitted for conversion, the Company shall convert from each Holder electing to have
Preferred Shares converted on such date a Holder Pro Rata Amount of such Holder’s Preferred Shares submitted for conversion on such
date based on the number of Preferred Shares submitted for conversion on such date by such Holder relative to the aggregate number of
Preferred Shares submitted for conversion on such date. In the event of a dispute as to the number of shares of Common Stock issuable
to a Holder in connection with a conversion of Preferred Shares, the Company shall issue to such Holder the number of shares of Common
Stock not in dispute and resolve such dispute in accordance with Section 25.
(d) Limitation on Beneficial
Ownership.
(i) Beneficial Ownership.
The Company shall not effect the conversion of any of the Preferred Shares held by a Holder, and such Holder shall not have the right
to convert any of the Preferred Shares held by such Holder pursuant to the terms and conditions of this Certificate of Designations and
any such conversion shall be null and void and treated as if never made, to the extent that after giving effect to such conversion, such
Holder together with the other Attribution Parties collectively would beneficially own in excess of 9.99% (the “Maximum Percentage”)
of the shares of Common Stock outstanding immediately after giving effect to such conversion. For purposes of the foregoing sentence,
the aggregate number of shares of Common Stock beneficially owned by such Holder and the other Attribution Parties shall include the number
of shares of Common Stock held by such Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon
conversion of the Preferred Shares with respect to which the determination of such sentence is being made, but shall exclude shares of
Common Stock which would be issuable upon (A) conversion of the remaining, nonconverted Preferred Shares beneficially owned by such Holder
or any of the other Attribution Parties and (B) exercise or conversion of the unexercised or nonconverted portion of any other securities
of the Company (including, without limitation, any convertible notes, convertible preferred stock or warrants, including the Preferred
Shares and the Warrants) beneficially owned by such Holder or any other Attribution Party subject to a limitation on conversion or exercise
analogous to the limitation contained in this Section 4(d)(i). For purposes of this Section 4(d)(i), beneficial ownership shall be calculated
in accordance with Section 13(d) of the 1934 Act. In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section 13(d) of the 1934 Act and the rules and regulations promulgated thereunder. For purposes of determining the
number of outstanding shares of Common Stock a Holder may acquire upon the conversion of such Preferred Shares without exceeding the Maximum
Percentage, such Holder may rely on the number of outstanding shares of Common Stock as reflected in (x) the Company’s most recent
Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the SEC, as the case
may be, (y) a more recent public announcement by the Company or (z) any other written notice by the Company or the Transfer Agent, if
any, setting forth the number of shares of Common Stock outstanding (the “Reported Outstanding Share Number”). If the
Company receives a Conversion Notice from a Holder at a time when the actual number of outstanding shares of Common Stock is less than
the Reported Outstanding Share Number, the Company shall notify such Holder in writing of the number of shares of Common Stock then outstanding
and, to the extent that such Conversion Notice would otherwise cause such Holder’s beneficial ownership, as determined pursuant
to this Section 4(d)(i), to exceed the Maximum Percentage, such Holder must notify the Company of a reduced number of shares of Common
Stock to be purchased pursuant to such Conversion Notice. For any reason at any time, upon the written or oral request of any Holder,
the Company shall within one (1) Business Day confirm orally and in writing or by electronic mail to such Holder the number of shares
of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect
to the conversion or exercise of securities of the Company, including such Preferred Shares, by such Holder and any other Attribution
Party since the date as of which the Reported Outstanding Share Number was reported. In the event that the issuance of shares of Common
Stock to a Holder upon conversion of such Preferred Shares results in such Holder and the other Attribution Parties being deemed to beneficially
own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section
13(d) of the 1934 Act), the number of shares so issued by which such Holder’s and the other Attribution Parties’ aggregate
beneficial ownership exceeds the Maximum Percentage (the “Excess Shares”) shall be deemed null and void and shall be
cancelled ab initio, and such Holder shall not have the power to vote or to transfer the Excess Shares. Upon delivery of a written notice
to the Company, any Holder may from time to time increase (with such increase not effective until the sixty-first (61st)
day after delivery of such notice) or decrease the Maximum Percentage of such Holder to any other percentage not in excess of 9.99% as
specified in such notice; provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st)
day after such notice is delivered to the Company and (ii) any such increase or decrease will apply only to such Holder and the other
Attribution Parties and not to any other Holder that is not an Attribution Party of such Holder. For purposes of clarity, the shares of
Common Stock issuable to a Holder pursuant to the terms of this Certificate of Designations in excess of the Maximum Percentage shall
not be deemed to be beneficially owned by such Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the
1934 Act. No prior inability to convert such Preferred Shares pursuant to this paragraph shall have any effect on the applicability of
the provisions of this paragraph with respect to any subsequent determination of convertibility. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 4(d)(i) to the extent necessary
to correct this paragraph (or any portion of this paragraph) which may be defective or inconsistent with the intended beneficial ownership
limitation contained in this Section 4(d)(i) or to make changes or supplements necessary or desirable to properly give effect to such
limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor holder of such Preferred Shares.
(ii) Principal Market Regulation.
The Company shall not issue any shares of Common Stock upon conversion of any Preferred Shares or otherwise pursuant to the terms of
this Certificate of Designations if the issuance of such shares of Common Stock (taken together with the issuance of all other shares
of Common Stock upon exercise of the Warrants) would exceed the aggregate number of shares of Common Stock which the Company may issue
upon exercise or conversion (as the case may be) of the Preferred Shares and the Warrants without breaching the Company’s obligations
under the rules and regulations of the Principal Market (the number of shares which may be issued without violating such rules and regulations,
the “Exchange Cap”), except that such limitation shall not apply in the event that the Company (A) obtains the approval
of its stockholders as required by the applicable rules and regulations of the Principal Market for issuances of shares of Common Stock
in excess of such amount or (B) obtains a written opinion from outside counsel to the Company that such approval is not required, which
opinion shall be reasonably satisfactory to the Required Holders. Until such approval or such written opinion is obtained, no Holder
shall be issued in the aggregate, upon conversion or exercise (as the case may be) of any Preferred Shares or any Warrant, shares of
Common Stock in an amount greater than the product of (i) the Exchange Cap as of the Initial Issuance Date multiplied by (ii) the quotient
of (1) the aggregate number of Preferred Shares issued to such Holder on the Initial Issuance Date divided by (2) the aggregate number
of Preferred Shares issued to the Holders on the Initial Issuance Date (with respect to each Holder, the “Exchange Cap Allocation”).
In the event that any Holder shall sell or otherwise transfer any of such Holder’s Preferred Shares, the transferee shall be allocated
a pro rata portion of such Holder’s Exchange Cap Allocation with respect to such portion of such Preferred Shares so transferred,
and the restrictions of the prior sentence shall apply to such transferee with respect to the portion of the Exchange Cap Allocation
so allocated to such transferee. Upon conversion in full of a holder’s Preferred Shares, the difference (if any) between such holder’s
Exchange Cap Allocation and the number of shares of Common Stock actually issued to such holder upon such holder’s conversion in
full of such Preferred Shares shall be allocated, to the respective Exchange Cap Allocations of the remaining holders of Preferred Shares
and/or related Warrants on a pro rata basis in proportion to the shares of Common Stock underlying the Preferred Shares and/or related
Warrants then held by each such holder of Preferred Shares and/or related Warrants. In the event that after November 5, 2023, the Company
is prohibited from issuing any shares of Common Stock pursuant to this Section 4(d)(ii)(the “Exchange Cap Shares”)
to a Holder, the Company shall pay cash from funds legally available therefor to such Holder in exchange for the redemption of such number
of Preferred Shares held by such Holder that are not convertible into such Exchange Cap Shares at a price equal to the sum of (i) the
product of (x) such number of Exchange Cap Shares and (y) the greatest Closing Sale Price of the Common Stock on any Trading Day during
the period commencing on the date such Holder delivers the applicable Conversion Notice with respect to such Exchange Cap Shares to the
Company and ending on the date of such issuance and payment under this Section 4(d)(ii) and (ii) to the extent such Holder purchases
(in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Holder of Exchange Cap
Shares, any brokerage commissions and other out-of-pocket expenses, if any, of such Holder incurred in connection therewith.
(e) Right of Alternate Conversion.
(i) Alternate Conversion Upon
a Triggering Event. Subject to Section 4(d), at any time during a Triggering Event Redemption Right Period (as defined below), such
Holder may, at such Holder’s option, by delivery of a Conversion Notice to the Company (the date of any such Conversion Notice,
each an “Alternate Conversion Date”), convert all, or any number of Preferred Shares (such Conversion Amount of the
Preferred Shares to be converted pursuant to this Section 4(e)(ii), each, an “Alternate Conversion Amount”) into shares
of Common Stock at the Alternate Conversion Price (each an “Alternate Conversion”).
(ii) Mechanics of Alternate
Conversion. On any Alternate Conversion Date, a Holder may voluntarily convert any Alternate Conversion Amount of Preferred Shares
pursuant to Section 4(c) (with “Alternate Conversion Price” replacing “Conversion Price” for all purposes hereunder
with respect to such Alternate Conversion and with “Alternate Conversion Amount” replacing “Conversion Amount”
in clause (x) of the definition of Conversion Rate above with respect to such Alternate Conversion) by designating in the Conversion Notice
delivered pursuant to this Section 4(e) of this Certificate of Designations that such Holder is electing to use the Alternate Conversion
Price for such conversion; provided that in the event of the Conversion Floor Price Condition, on the applicable Alternate Conversion
Date the Company shall also deliver to the Holder the applicable Alternate Conversion Floor Amount. Notwithstanding anything to the contrary
in this Section 4(e), but subject to Section 4(d), until the Company delivers shares of Common Stock representing the applicable Alternate
Conversion Amount of Preferred Shares to such Holder, such Preferred Shares may be converted by such Holder into shares of Common Stock
pursuant to Section 4(c) without regard to this Section 4(e).
5. Triggering Event Redemptions.
(a) Triggering Event.
Each of the following events shall constitute a “Triggering Event” and each of the events in clauses (viii), (ix),
and (x) shall constitute a “Bankruptcy Triggering Event”:
(i) the suspension from trading
or the failure of the Common Stock to be trading or listed (as applicable) on an Eligible Market for a period of five (5) consecutive
Trading Days;
(ii) the Company’s (A) failure
to cure a Conversion Failure or a Delivery Failure (as defined in the Warrants) by delivery of the required number of shares of Common
Stock within five (5) Trading Days after the applicable Conversion Date or exercise date (as the case may be) or (B) written notice to
any holder of Preferred Shares or Warrants, including, without limitation, by way of public announcement or through any of its agents,
at any time, of its intention not to comply, as required, with a request for exercise of any Warrants for Warrant Shares in accordance
with the provisions of the Warrants or a request for conversion of any Preferred Shares into shares of Common Stock that is requested
in accordance with the provisions of this Certificate of Designations, other than pursuant to Section 4(d) hereof;
(iii) except to the extent the
Company is in compliance with Section 11(b) below, at any time following the tenth (10th)
consecutive day that a Holder’s Authorized Share Allocation (as defined in Section 11(a) below) is less than the sum of (A) 150%
of the number of shares of Common Stock that such Holder would be entitled to receive upon a conversion, in full, of all of the Preferred
Shares then held by such Holder (assuming a conversion at the Floor Price then in effect and without regard to any limitations on conversion
set forth in this Certificate of Designations) and (B) 150% of the number of shares of Common Stock that such Holder would then be entitled
to receive upon exercise in full of such Holder’s Warrants (without regard to any limitations on exercise set forth in the Warrants);
(iv) subject to the applicable
provisions of the DGCL, the Board fails to declare any Dividend to be paid on the applicable Dividend Date in accordance with Section
3;
(v) the Company’s failure
to pay to any Holder any Dividend on any Dividend Date (whether or not declared by the Board) or any other amount when and as due under
this Certificate of Designations (including, without limitation, the Company’s failure to pay any redemption payments or amounts
hereunder), the Securities Purchase Agreement or any other Transaction Document or any other agreement, document, certificate or other
instrument delivered in connection with the transactions contemplated hereby and thereby (in each case, whether or not permitted pursuant
to the DGCL), except, in the case of a failure to pay Dividends and Late Charges when and as due, in each such case only if such failure
remains uncured for a period of at least five (5) Trading Days;
(vi) the Company fails to remove
any restrictive legend on any certificate or any shares of Common Stock issued to the applicable Holder upon conversion or exercise (as
the case may be) of any Securities (as defined in the Securities Purchase Agreement) acquired by such Holder under the Transaction Documents
as and when required by such Securities or the Securities Purchase Agreement, as applicable, unless otherwise then prohibited by applicable
federal securities laws, and any such failure remains uncured for at least five (5) Trading Days;
(vii) the occurrence of any default
under, redemption of or acceleration prior to maturity of at least an aggregate of $500,000 of Indebtedness (as defined in the Securities
Purchase Agreement) of the Company or any of its Subsidiaries;
(viii) bankruptcy, insolvency,
reorganization or liquidation proceedings or other proceedings for the relief of debtors shall be instituted by or against the Company
or any Subsidiary and, if instituted against the Company or any Subsidiary by a third party, shall not be dismissed within thirty (30)
days of their initiation;
(ix) the commencement by the Company
or any Subsidiary of a voluntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization
or other similar law or of any other case or proceeding to be adjudicated a bankrupt or insolvent, or the consent by it to the entry of
a decree, order, judgment or other similar document in respect of the Company or any Subsidiary in an involuntary case or proceeding under
any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or to the commencement of any bankruptcy
or insolvency case or proceeding against it, or the filing by it of a petition or answer or consent seeking reorganization or relief under
any applicable federal, state or foreign law, or the consent by it to the filing of such petition or to the appointment of or taking possession
by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or any Subsidiary or of
any substantial part of its property, or the making by it of an assignment for the benefit of creditors, or the execution of a composition
of debts, or the occurrence of any other similar federal, state or foreign proceeding, or the admission by it in writing of its inability
to pay its debts generally as they become due, the taking of corporate action by the Company or any Subsidiary in furtherance of any such
action or the taking of any action by any Person to commence a Uniform Commercial Code foreclosure sale or any other similar action under
federal, state or foreign law;
(x) the entry by a court of (i)
a decree, order, judgment or other similar document in respect of the Company or any Subsidiary of a voluntary or involuntary case or
proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or (ii) a decree,
order, judgment or other similar document adjudging the Company or any Subsidiary as bankrupt or insolvent, or approving as properly filed
a petition seeking liquidation, reorganization, arrangement, adjustment or composition of or in respect of the Company or any Subsidiary
under any applicable federal, state or foreign law or (iii) a decree, order, judgment or other similar document appointing a custodian,
receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or any Subsidiary or of any substantial
part of its property, or ordering the winding up or liquidation of its affairs, and the continuance of any such decree, order, judgment
or other similar document or any such other decree, order, judgment or other similar document unstayed and in effect for a period of thirty
(30) consecutive days;
(xi) a final judgment or judgments
for the payment of money aggregating in excess of $500,000 are rendered against the Company and/or any of its Subsidiaries and which judgments
are not, within thirty (30) days after the entry thereof, bonded, discharged, settled or stayed pending appeal, or are not discharged
within thirty (30) days after the expiration of such stay; provided, however, any judgment which is covered by insurance or an indemnity
from a credit worthy party shall not be included in calculating the $500,000 amount set forth above so long as the Company provides each
Holder a written statement from such insurer or indemnity provider (which written statement shall be reasonably satisfactory to each Holder)
to the effect that such judgment is covered by insurance or an indemnity and the Company or such Subsidiary (as the case may be) will
receive the proceeds of such insurance or indemnity within thirty (30) days of the issuance of such judgment;
(xii) the Company and/or any Subsidiary,
individually or in the aggregate, either (i) fails to pay, when due, or within any applicable grace period, any payment with respect to
any Indebtedness in excess of $500,000 due to any third party (other than, with respect to unsecured Indebtedness only, payments contested
by the Company and/or such Subsidiary (as the case may be) in good faith by proper proceedings and with respect to which adequate reserves
have been set aside for the payment thereof in accordance with GAAP) or is otherwise in breach or violation of any agreement for monies
owed or owing in an amount in excess of $500,000, which breach or violation permits the other party thereto to declare a default or otherwise
accelerate amounts due thereunder, or (ii) suffer to exist any other circumstance or event that would, with or without the passage of
time or the giving of notice, result in a default or event of default under any agreement binding the Company or any Subsidiary, which
default or event of default would or is likely to have a material adverse effect on the business, assets, operations (including results
thereof), liabilities, properties, condition (including financial condition) or prospects of the Company or any of its Subsidiaries, individually
or in the aggregate, but only if such failure or occurrence remains uncured for a period of at least five (5) days;
(xiii) other than as specifically
set forth in another clause of this Section 5(a), the Company or any Subsidiary breaches any representation or warranty in any material
respect (other than representations or warranties subject to material adverse effect or materiality, which may not be breached in any
respect) or any covenant or other term or condition of any Transaction Document, except, in the case of a breach of a covenant or other
term or condition that is curable, only if such breach remains uncured for a period of five (5) consecutive Trading Days;
(xiv) a false or inaccurate certification
(including a false or inaccurate deemed certification) by the Company as to whether any Triggering Event has occurred;
(xv) any breach or failure in
any respect by the Company or any Subsidiary to comply with any provision of Section 15(m) of this Certificate of Designations;
(xvi) any Material Adverse Effect
(as defined in the Securities Purchase Agreement) occurs that has not been cured, if capable of curing, within five (5) Trading Days of
the occurrence thereof; or
(xvii) any provision of any Transaction
Document shall at any time for any reason (other than pursuant to the express terms thereof) cease to be valid and binding on or enforceable
against the Company, or the validity or enforceability thereof shall be contested, directly or indirectly, by the Company or any Subsidiary,
or a proceeding shall be commenced by the Company or any Subsidiary or any governmental authority having jurisdiction over any of them,
seeking to establish the invalidity or unenforceability thereof or the Company or any of its Subsidiaries shall deny in writing that it
has any liability or obligation purported to be created under one or more Transaction Documents.
(b) Notice of a Triggering
Event; Redemption Right. Upon the occurrence of a Triggering Event with respect to the Preferred Shares, the Company shall within
one (1) Business Day deliver written notice thereof via electronic mail and overnight courier (with next day delivery specified) (a “Triggering
Event Notice”) to each Holder. At any time after the earlier of a Holder’s receipt of a Triggering Event Notice and such
Holder becoming aware of a Triggering Event (such earlier date, the “Triggering Event Right Commencement Date”) and
ending (such ending date, the “Triggering Event Right Expiration Date”, and each such period, a “Triggering
Event Redemption Right Period”) on the fifteenth (15th) Trading Day after the later of (x) the later of (1) the date such Triggering
Event is cured and (2) the date the Company delivers written notice to the Holders of the cure of such Triggering Event and (y) such Holder’s
receipt of a Triggering Event Notice that includes (I) a reasonable description of the applicable Triggering Event, (II) a certification
as to whether, in the opinion of the Company, such Triggering Event is capable of being cured and, if applicable, a reasonable description
of any existing plans of the Company to cure such Triggering Event and (III) a certification as to the date the Triggering Event occurred
and, if cured on or prior to the date of such Triggering Event Notice, the applicable Triggering Event Right Expiration Date, such Holder
may require the Company to redeem (regardless of whether such Triggering Event has been cured on or prior to the Triggering Event Right
Expiration Date) all or any of the Preferred Shares by delivering written notice thereof (the “Triggering Event Redemption Notice”)
to the Company, which Triggering Event Redemption Notice shall indicate the number of the Preferred Shares such Holder is electing to
redeem. Each of the Preferred Shares subject to redemption by the Company pursuant to this Section 5(b) shall be redeemed by the Company
at a price equal to the greater of (i) the product of (A) the Conversion Amount to be redeemed multiplied by (B) the Redemption Premium
and (ii) the product of (X) the Conversion Rate with respect to the Conversion Amount in effect at such time as such Holder delivers a
Triggering Event Redemption Notice multiplied by (Y) the product of (1) the Redemption Premium multiplied by (2) the greatest Closing
Sale Price of the Common Stock on any Trading Day during the period commencing on the date immediately preceding such Triggering Event
and ending on the date the Company makes the entire payment required to be made under this Section 5(b) (the “Triggering Event
Redemption Price”). Redemptions required by this Section 5(b) shall be made in accordance with the provisions of Section 12.
To the extent redemptions required by this Section 5(b) are deemed or determined by a court of competent jurisdiction to be prepayments
of the Preferred Shares by the Company, such redemptions shall be deemed to be voluntary prepayments. Notwithstanding anything to the
contrary in this Section 5(b), but subject to Section 4(d), until the Triggering Event Redemption Price (together with any Late Charges
thereon) is paid in full, the Conversion Amount submitted for redemption under this Section 5(b) (together with any Late Charges thereon)
may be converted, in whole or in part, by such Holder into Common Stock pursuant to the terms of this Certificate of Designations. In
the event of the Company’s redemption of any of the Preferred Shares under this Section 5(b), a Holder’s damages would be
uncertain and difficult to estimate because of the parties’ inability to predict future interest rates and the uncertainty of the
availability of a suitable substitute investment opportunity for such Holder. Accordingly, any redemption premium due under this Section
5(b) is intended by the parties to be, and shall be deemed, a reasonable estimate of such Holder’s actual loss of its investment
opportunity and not as a penalty. Any redemption upon a Triggering Event shall not constitute an election of remedies by the applicable
Holder or any other Holder, and all other rights and remedies of each Holder shall be preserved.
(c) Mandatory Redemption
upon Bankruptcy Triggering Event. Notwithstanding anything to the contrary herein, and notwithstanding any conversion that is then
required or in process, upon any Bankruptcy Triggering Event, whether occurring prior to or following the Maturity Date, the Company shall
immediately redeem, out of funds legally available therefor, each of the Preferred Shares then outstanding at a redemption price equal
to the applicable Triggering Event Redemption Price (calculated as if such Holder shall have delivered the Triggering Event Redemption
Notice immediately prior to the occurrence of such Bankruptcy Triggering Event), without the requirement for any notice or demand or other
action by any Holder or any other person or entity, provided that a Holder may, in its sole discretion, waive such right to receive payment
upon a Bankruptcy Triggering Event, in whole or in part, and any such waiver shall not affect any other rights of such Holder or any other
Holder hereunder, including any other rights in respect of such Bankruptcy Triggering Event, any right to conversion, and any right to
payment of such Triggering Event Redemption Price or any other Redemption Price, as applicable.
6. Rights Upon Fundamental Transactions.
(a) Assumption. The Company
shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity (if the Successor Entity is not the Company)
assumes in writing all of the obligations of the Company under this Certificate of Designations and the other Transaction Documents in
accordance with the provisions of this Section 6(a) pursuant to written agreements in form and substance satisfactory to the Required
Holders and approved by the Required Holders prior to such Fundamental Transaction, including agreements to deliver to each holder of
Preferred Shares in exchange for such Preferred Shares a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Certificate of Designations, including, without limitation, having a stated value and dividend rate
equal to the stated value and dividend rate of the Preferred Shares held by the Holders and having similar ranking to the Preferred Shares,
and satisfactory to the Required Holders, and (ii) the Successor Entity (including its Parent Entity) is a publicly traded corporation
whose shares of common stock are quoted on or listed for trading on an Eligible Market. Upon the occurrence of any Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Certificate of Designations and the other Transaction Documents referring to the “Company” shall refer instead to
the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under
this Certificate of Designations and the other Transaction Documents with the same effect as if such Successor Entity had been named as
the Company herein and therein. In addition to the foregoing, upon consummation of a Fundamental Transaction, the Successor Entity (if
the Successor Entity is not the Company) shall deliver to each Holder confirmation that there shall be issued upon conversion or redemption
of the Preferred Shares at any time after the consummation of such Fundamental Transaction, in lieu of the shares of Common Stock (or
other securities, cash, assets or other property (except such items still issuable under Sections 7 and 17, which shall continue to be
receivable thereafter)) issuable upon the conversion or redemption of the Preferred Shares prior to such Fundamental Transaction, such
shares of the publicly traded common stock (or their equivalent) of the Successor Entity (including its Parent Entity) which each Holder
would have been entitled to receive upon the happening of such Fundamental Transaction had all the Preferred Shares held by each Holder
been converted immediately prior to such Fundamental Transaction (without regard to any limitations on the conversion of the Preferred
Shares contained in this Certificate of Designations), as adjusted in accordance with the provisions of this Certificate of Designations.
Notwithstanding the foregoing, such Holder may elect, at its sole option, by delivery of written notice to the Company to waive this Section
6(a) to permit the Fundamental Transaction without the assumption of the Preferred Shares. The provisions of this Section 6 shall apply
similarly and equally to successive Fundamental Transactions and shall be applied without regard to any limitations on the conversion
or redemption of the Preferred Shares.
(b) Notice of a Change of
Control Redemption Right. No sooner than twenty (20) Trading Days nor later than ten (10) Trading Days prior to the consummation of
a Change of Control (the “Change of Control Date”), but not prior to the public announcement of such Change of Control,
the Company shall deliver written notice thereof via electronic mail and overnight courier to each Holder (a “Change of Control
Notice”). At any time during the period beginning after a Holder’s receipt of a Change of Control Notice or such Holder
becoming aware of a Change of Control if a Change of Control Notice is not delivered to such Holder in accordance with the immediately
preceding sentence (as applicable) and ending on the later of (A) the date of consummation of such Change of Control or (B) twenty (20)
Trading Days after the date of receipt of such Change of Control Notice or (C) twenty (20) Trading Days after the date of the announcement
of such Change of Control, such Holder may require the Company to redeem all or any portion of such Holder’s Preferred Shares by
delivering written notice thereof (“Change of Control Redemption Notice”) to the Company, which Change of Control Redemption
Notice shall indicate the number of Preferred Shares such Holder is electing to have the Company redeem. Each Preferred Share subject
to redemption pursuant to this Section 6(b) shall be redeemed by the Company in funds legally available therefor at a price equal to the
greatest of (i) the product of (w) the Change of Control Redemption Premium multiplied by (y) the Conversion Amount of the Preferred Shares
being redeemed, (ii) the product of (x) the Change of Control Redemption Premium multiplied by (y) the product of (A) the Conversion Amount
of the Preferred Shares being redeemed multiplied by (B) the quotient determined by dividing (I) the greatest Closing Sale Price of the
shares of Common Stock during the period beginning on the date immediately preceding the earlier to occur of (1) the consummation of the
applicable Change of Control and (2) the public announcement of such Change of Control and ending on the date such Holder delivers the
Change of Control Redemption Notice by (II) the Conversion Price then in effect and (iii) the product of (y) the Change of Control Redemption
Premium multiplied by (z) the product of (A) the Conversion Amount of the Preferred Shares being redeemed multiplied by (B) the quotient
of (I) the aggregate cash consideration and the aggregate cash value of any non-cash consideration per share of Common Stock to be paid
to such holders of the shares of Common Stock upon consummation of such Change of Control (any such non-cash consideration constituting
publicly-traded securities shall be valued at the highest of the Closing Sale Price of such securities as of the Trading Day immediately
prior to the consummation of such Change of Control, the Closing Sale Price of such securities on the Trading Day immediately following
the public announcement of such proposed Change of Control and the Closing Sale Price of such securities on the Trading Day immediately
prior to the public announcement of such proposed Change of Control) divided by (II) the Conversion Price then in effect (the “Change
of Control Redemption Price”). Redemptions required by this Section 6(b) shall have priority to payments to all other stockholders
of the Company in connection with such Change of Control. To the extent redemptions required by this Section 6(b) are deemed or determined
by a court of competent jurisdiction to be prepayments of the Preferred Shares by the Company, such redemptions shall be deemed to be
voluntary prepayments. Notwithstanding anything to the contrary in this Section 6(b), but subject to Section 4(d), until the applicable
Change of Control Redemption Price (together with any Late Charges thereon) is paid in full to the applicable Holder, the Preferred Shares
submitted by such Holder for redemption under this Section 6(b) may be converted, in whole or in part, by such Holder into Common Stock
pursuant to Section 4 or in the event the Conversion Date is after the consummation of such Change of Control, stock or equity interests
of the Successor Entity substantially equivalent to the Company’s shares of Common Stock pursuant to Section 4. In the event of
the Company’s redemption of any of the Preferred Shares under this Section 6(b), such Holder’s damages would be uncertain
and difficult to estimate because of the parties’ inability to predict future interest rates and the uncertainty of the availability
of a suitable substitute investment opportunity for a Holder. Accordingly, any redemption premium due under this Section 6(b) is intended
by the parties to be, and shall be deemed, a reasonable estimate of such Holder’s actual loss of its investment opportunity and
not as a penalty. The Company shall make payment of the applicable Change of Control Redemption Price concurrently with the consummation
of such Change of Control if a Change of Control Redemption Notice is received prior to the consummation of such Change of Control and
within two (2) Trading Days after the Company’s receipt of such notice otherwise (the “Change of Control Redemption Date”).
Redemptions required by this Section 6 shall be made in accordance with the provisions of Section 12.
7. Rights Upon Issuance of Purchase
Rights and Other Corporate Events.
(a) Purchase Rights.
In addition to any adjustments pursuant to Section 8 below, if at any time the Company grants, issues or sells any Options, Convertible
Securities or rights to purchase stock, warrants, securities or other property pro rata to all or substantially all of the record holders
of any class of Common Stock (the “Purchase Rights”), then each Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which such Holder could have acquired if such Holder had held the number
of shares of Common Stock acquirable upon complete conversion of all the Preferred Shares (without taking into account any limitations
or restrictions on the convertibility of the Preferred Shares and assuming for such purpose that all the Preferred Shares were converted
at the Alternate Conversion Price as of the applicable record date) held by such Holder immediately prior to the date on which a record
is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent
that such Holder’s right to participate in any such Purchase Right would result in such Holder and the other Attribution Parties
exceeding the Maximum Percentage, then such Holder shall not be entitled to participate in such Purchase Right to such extent of the Maximum
Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Purchase Right (and beneficial
ownership) to such extent of any such excess) and such Purchase Right to such extent shall be held in abeyance (and, if such Purchase
Right has an expiration date, maturity date or other similar provision, such term shall be extended by such number of days held in abeyance,
if applicable) for the benefit of such Holder until such time or times, if ever, as its right thereto would not result in such Holder
and the other Attribution Parties exceeding the Maximum Percentage, at which time or times such Holder shall be granted such right (and
any Purchase Right granted, issued or sold on such initial Purchase Right or on any subsequent Purchase Right held similarly in abeyance
(and, if such Purchase Right has an expiration date, maturity date or other similar provision, such term shall be extended by such number
of days held in abeyance, if applicable)) to the same extent as if there had been no such limitation).
(b) Other Corporate Events.
In addition to and not in substitution for any other rights hereunder, prior to the consummation of any Fundamental Transaction pursuant
to which holders of shares of Common Stock are entitled to receive securities or other assets with respect to or in exchange for shares
of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to ensure that each Holder will
thereafter have the right, at such Holder’s option, to receive upon a conversion of all the Preferred Shares held by such Holder
(i) in addition to the shares of Common Stock receivable upon such conversion, such securities or other assets to which such Holder would
have been entitled with respect to such shares of Common Stock had such shares of Common Stock been held by such Holder upon the consummation
of such Corporate Event (without taking into account any limitations or restrictions on the convertibility of the Preferred Shares set
forth in this Certificate of Designations) or (ii) in lieu of the shares of Common Stock otherwise receivable upon such conversion, such
securities or other assets received by the holders of shares of Common Stock in connection with the consummation of such Corporate Event
in such amounts as such Holder would have been entitled to receive had the Preferred Shares held by such Holder initially been issued
with conversion rights for the form of such consideration (as opposed to shares of Common Stock) at a conversion rate for such consideration
commensurate with the Conversion Rate. Provision made pursuant the preceding sentence shall be in a form and substance satisfactory to
the Required Holders. The provisions of this Section 7 shall apply similarly and equally to successive Corporate Events and shall be applied
without regard to any limitations on the conversion or redemption of the Preferred Shares set forth in this Certificate of Designations.
8. Rights Upon Issuance of Other Securities.
(a) Adjustment of Conversion
Price upon Issuance of Common Stock. If and whenever on or after the Subscription Date the Company grants, issues or sells (or enters
into any agreement or publicly announces its intention to grant, issue or sell), or in accordance with this Section 8(a) is deemed to
have granted, issued or sold, any shares of Common Stock (including the granting, issuance or sale of shares of Common Stock owned or
held by or for the account of the Company, but excluding any Excluded Securities granted, issued or sold or deemed to have been granted,
issued or sold) for a consideration per share (the “New Issuance Price”) less than a price equal to the Conversion
Price in effect immediately prior to such granting, issuance or sale or deemed granting, issuance or sale (such Conversion Price then
in effect is referred to herein as the “Applicable Price”) (the foregoing a “Dilutive Issuance”),
then, immediately after such Dilutive Issuance, the Conversion Price then in effect shall be reduced to an amount equal to the New Issuance
Price. For all purposes of the foregoing (including, without limitation, determining the adjusted Conversion Price and the New Issuance
Price under this Section 8(a)), the following shall be applicable:
(i) Issuance of Options.
If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell) any Options and the lowest
price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Option or upon conversion, exercise
or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof is less
than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company
at the time of the granting, issuance or sale of such Option for such price per share. For purposes of this Section 8(a)(i), the “lowest
price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Option or upon conversion, exercise
or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof”
shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received or receivable by the Company with
respect to any one share of Common Stock upon the granting, issuance or sale of such Option, upon exercise of such Option and upon conversion,
exercise or exchange of any Convertible Security issuable upon exercise of such Option or otherwise pursuant to the terms thereof and
(y) the lowest exercise price set forth in such Option for which one share of Common Stock is issuable (or may become issuable assuming
all possible market conditions) upon the exercise of any such Options or upon conversion, exercise or exchange of any Convertible Securities
issuable upon exercise of any such Option or otherwise pursuant to the terms thereof, minus (2) the sum of all amounts paid or payable
to the holder of such Option (or any other Person) with respect to any one share of Common Stock upon the granting, issuance or sale of
such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise
of such Option or otherwise pursuant to the terms thereof plus the value of any other consideration received or receivable by, or benefit
conferred on, the holder of such Option (or any other Person). Except as contemplated below, no further adjustment of the Conversion Price
shall be made upon the actual issuance of such share of Common Stock or of such Convertible Securities upon the exercise of such Options
or otherwise pursuant to the terms thereof or upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange
of such Convertible Securities.
(ii) Issuance of Convertible
Securities. If the Company in any manner issues or sells (or enters into any agreement to issue or sell) any Convertible Securities
and the lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise or exchange thereof
or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding
and to have been issued and sold by the Company at the time of the issuance or sale (or the time of execution of such agreement to issue
or sell, as applicable) of such Convertible Securities for such price per share. For the purposes of this Section 8(a)(ii), the “lowest
price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise or exchange thereof or otherwise
pursuant to the terms thereof” shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received
or receivable by the Company with respect to one share of Common Stock upon the issuance or sale (or pursuant to the agreement to issue
or sell, as applicable) of the Convertible Security and upon conversion, exercise or exchange of such Convertible Security or otherwise
pursuant to the terms thereof and (y) the lowest conversion price set forth in such Convertible Security for which one share of Common
Stock is issuable (or may become issuable assuming all possible market conditions) upon conversion, exercise or exchange thereof or otherwise
pursuant to the terms thereof minus (2) the sum of all amounts paid or payable to the holder of such Convertible Security (or any other
Person) with respect to any one share of Common Stock upon the issuance or sale (or the agreement to issue or sell, as applicable) of
such Convertible Security plus the value of any other consideration received or receivable by, or benefit conferred on, the holder of
such Convertible Security (or any other Person). Except as contemplated below, no further adjustment of the Conversion Price shall be
made upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities or otherwise
pursuant to the terms thereof, and if any such issuance or sale of such Convertible Securities is made upon exercise of any Options for
which adjustment of the Conversion Price has been or is to be made pursuant to other provisions of this Section 8(a), except as contemplated
below, no further adjustment of the Conversion Price shall be made by reason of such issuance or sale.
(iii) Change in Option Price
or Rate of Conversion. If the purchase or exercise price provided for in any Options, the additional consideration, if any, payable
upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible Securities are convertible
into or exercisable or exchangeable for shares of Common Stock increases or decreases at any time (other than proportional changes in
conversion or exercise prices, as applicable, in connection with an event referred to in Section 8(b) below), the Conversion Price in
effect at the time of such increase or decrease shall be adjusted to the Conversion Price which would have been in effect at such time
had such Options or Convertible Securities provided for such increased or decreased purchase price, additional consideration or increased
or decreased conversion rate (as the case may be) at the time initially granted, issued or sold. For purposes of this Section 8(a)(iii),
if the terms of any Option or Convertible Security (including, without limitation, any Option or Convertible Security that was outstanding
as of the Subscription Date) are increased or decreased in the manner described in the immediately preceding sentence, then such Option
or Convertible Security and the shares of Common Stock deemed issuable upon exercise, conversion or exchange thereof shall be deemed to
have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 8(a) shall be made if such adjustment
would result in an increase of the Conversion Price then in effect.
(iv) Calculation of Consideration
Received. If any Option and/or Convertible Security and/or Adjustment Right is issued in connection with the issuance or sale or deemed
issuance or sale of any other securities of the Company (as determined by the Required Holders, the “Primary Security”,
and such Option and/or Convertible Security and/or Adjustment Right, the “Secondary Securities” and together with the
Primary Security, each a “Unit”), together comprising one integrated transaction, the aggregate consideration per share
of Common Stock with respect to such Primary Security shall be deemed to be the lower of (x) the purchase price of such Unit, (y) if such
Primary Security is an Option and/or Convertible Security, the lowest price per share for which one share of Common Stock is at any time
issuable upon the exercise or conversion of the Primary Security in accordance with Section 8(a)(i) or 8(a)(ii) above and (z) the lowest
VWAP of the shares of Common Stock on any Trading Day during the five (5) Trading Day period (the “Adjustment Period”)
immediately following the public announcement of such Dilutive Issuance (for the avoidance of doubt, if such public announcement is released
prior to the opening of the Principal Market on a Trading Day, such Trading Day shall be the first Trading Day in such five Trading Day
period and if any Preferred Shares are converted, on any given Conversion Date during any such Adjustment Period, solely with respect
to such Preferred Shares converted on such applicable Conversion Date, such applicable Adjustment Period shall be deemed to have ended
on, and included, the Trading Day immediately prior to such Conversion Date). If any shares of Common Stock, Options or Convertible Securities
are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor will be deemed to be the net amount
of consideration received by the Company therefor. If any shares of Common Stock, Options or Convertible Securities are issued or sold
for a consideration other than cash, the amount of such consideration received by the Company will be the fair value of such consideration,
except where such consideration consists of publicly traded securities, in which case the amount of consideration received by the Company
for such securities will be the arithmetic average of the VWAPs of such security for each of the five (5) Trading Days immediately preceding
the date of receipt. If any shares of Common Stock, Options or Convertible Securities are issued to the owners of the non-surviving entity
in connection with any merger in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be
the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such shares of Common
Stock, Options or Convertible Securities (as the case may be). The fair value of any consideration other than cash or publicly traded
securities will be determined jointly by the Company and the Required Holders. If such parties are unable to reach agreement within ten
(10) days after the occurrence of an event requiring valuation (the “Valuation Event”), the fair value of such consideration
will be determined within five (5) Trading Days after the tenth (10th) day following such
Valuation Event by an independent, reputable appraiser jointly selected by the Company and the Required Holders. The determination of
such appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall be
borne by the Company.
(v) Record Date. If the
Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A) to receive a dividend or other distribution
payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe for or purchase shares of Common Stock, Options
or Convertible Securities, then such record date will be deemed to be the date of the issuance or sale of the shares of Common Stock deemed
to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting
of such right of subscription or purchase (as the case may be).
(b) Adjustment of Conversion
Price upon Subdivision or Combination of Common Stock. Without limiting any provision of Sections 7, 17 or 8(a), if the Company at
any time on or after the Subscription Date subdivides (by any stock split, stock dividend, stock combination, recapitalization or other
similar transaction) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Conversion Price
in effect immediately prior to such subdivision will be proportionately reduced. Without limiting any provision of Sections 7, 17 or 8(a),
if the Company at any time on or after the Subscription Date combines (by any stock split, stock dividend, stock combination, recapitalization
or other similar transaction) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Conversion
Price in effect immediately prior to such combination will be proportionately increased. Any adjustment pursuant to this Section 8(b)
shall become effective immediately after the effective date of such subdivision or combination. If any event requiring an adjustment under
this Section 8(b) occurs during the period that a Conversion Price is calculated hereunder, then the calculation of such Conversion Price
shall be adjusted appropriately to reflect such event.
(c) Holder’s Right
of Adjusted Conversion Price. In addition to and not in limitation of the other provisions of this Section 8(b), if the Company in
any manner issues or sells or enters into any agreement to issue or sell, any Common Stock, Options or Convertible Securities (any such
securities, “Variable Price Securities”) after the Subscription Date that are issuable pursuant to such agreement or
convertible into or exchangeable or exercisable for shares of Common Stock at a price which varies or may vary with the market price of
the shares of Common Stock, including by way of one or more reset(s) to a fixed price, but exclusive of such formulations reflecting customary
anti-dilution provisions (such as share splits, share combinations, share dividends and similar transactions) (each of the formulations
for such variable price being herein referred to as, the “Variable Price”), the Company shall provide written notice
thereof via electronic mail and overnight courier to each Holder on the date of such agreement and/or the issuance of such shares of Common
Stock, Convertible Securities or Options, as applicable. From and after the date the Company enters into such agreement or issues any
such Variable Price Securities, each Holder shall have the right, but not the obligation, in its sole discretion to substitute the Variable
Price for the Conversion Price upon conversion of the Preferred Shares by designating in the Conversion Notice delivered upon any conversion
of Preferred Shares that solely for purposes of such conversion such Holder is relying on the Variable Price rather than the Conversion
Price then in effect. A Holder’s election to rely on a Variable Price for a particular conversion of Preferred Shares shall not
obligate such Holder to rely on a Variable Price for any future conversions of Preferred Shares.
(d) Stock Combination Event
Adjustments. If at any time and from time to time on or after the Subscription Date there occurs any stock split, stock dividend,
stock combination, reverse stock split, recapitalization or other similar transaction involving the Common Stock (each, a “Stock
Combination Event”, and such date thereof, the “Stock Combination Event Date”) and the Event Market Price
is less than the Conversion Price then in effect (after giving effect to the adjustment in Section 8(b) above), then on the fifth (5th)
Trading Day immediately following such Stock Combination Event Date, the Conversion Price then in effect on such fifth (5th) Trading Day
following the Stock Combination Event (after giving effect to the adjustment in Section 8(b) above) shall be reduced (but in no event
increased) to the Event Market Price. For the avoidance of doubt, if the adjustment in the immediately preceding sentence would otherwise
result in an increase in the Conversion Price hereunder, no adjustment shall be made.
(e) Other Events. In
the event that the Company (or any Subsidiary) shall take any action to which the provisions hereof are not strictly applicable, or, if
applicable, would not operate to protect any Holder from dilution or if any event occurs of the type contemplated by the provisions of
this Section 8 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights,
phantom stock rights or other rights with equity features), then the Board shall in good faith determine and implement an appropriate
adjustment in the Conversion Price so as to protect the rights of such Holder, provided that no such adjustment pursuant to this Section
8(e) will increase the Conversion Price as otherwise determined pursuant to this Section 8, provided further that if such Holder does
not accept such adjustments as appropriately protecting its interests hereunder against such dilution, then the Board and such Holder
shall agree, in good faith, upon an independent investment bank of nationally recognized standing to make such appropriate adjustments,
whose determination shall be final and binding absent manifest error and whose fees and expenses shall be borne by the Company.
(f) Calculations. All
calculations under this Section 8 shall be made by rounding to the nearest cent or the nearest 1/100th
of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned
or held by or for the account of the Company, and the disposition of any such shares shall be considered an issue or sale of Common Stock.
(g) Voluntary Adjustment
by Company. Subject to the rules and regulations of the Principal Market, the Company may at any time any Preferred Shares remain
outstanding, with the prior written consent of the Required Holders, reduce the then current Conversion Price to any amount and for any
period of time deemed appropriate by the Board.
9. Reserved.
10. Noncircumvention. The Company
hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws (as defined in the Securities
Purchase Agreement) or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue
or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Certificate of Designations, and will at all times in good faith carry out all the provisions of this Certificate of Designations and
take all action as may be required to protect the rights of the Holders hereunder. Without limiting the generality of the foregoing or
any other provision of this Certificate of Designations or the other Transaction Documents, the Company (a) shall not increase the par
value of any shares of Common Stock receivable upon the conversion of any Preferred Shares above the Conversion Price then in effect,
(b) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid
and non-assessable shares of Common Stock upon the conversion of Preferred Shares and (c) shall, so long as any Preferred Shares are outstanding,
take all action necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose
of effecting the conversion of the Preferred Shares, the maximum number of shares of Common Stock as shall from time to time be necessary
to effect the conversion of the Preferred Shares then outstanding (without regard to any limitations on conversion contained herein).
Notwithstanding anything herein to the contrary, if after the sixty (60) calendar day anniversary of the Initial Issuance Date, each Holder
is not permitted to convert such Holder’s Preferred Shares in full for any reason (other than pursuant to restrictions set forth
in Section 4(d)(i) hereof), the Company shall use its best efforts to promptly remedy such failure, including, without limitation, obtaining
such consents or approvals as necessary to effect such conversion into shares of Common Stock.
11. Authorized Shares.
(a) Reservation. So long
as any Preferred Shares remain outstanding, the Company shall at all times reserve at least 150% of the aggregate number of shares of
Common Stock as shall from time to time be necessary to effect the conversion of all of the Preferred Shares then outstanding at the Floor
Price then in effect (without regard to any limitations on conversions and assuming the Preferred Shares remain outstanding until the
Maturity Date) (the “Required Reserve Amount”). The Required Reserve Amount (including, without limitation, each increase
in the number of shares so reserved) shall be allocated pro rata among the Holders based on the number of the Preferred Shares held by
each Holder on the Initial Issuance Date or increase in the number of reserved shares, as the case may be (the “Authorized Share
Allocation”). In the event that a Holder shall sell or otherwise transfer any of such Holder’s Preferred Shares, each
transferee shall be allocated a pro rata portion of such Holder’s Authorized Share Allocation. Any shares of Common Stock reserved
and allocated to any Person which ceases to hold any Preferred Shares shall be allocated to the remaining Holders of Preferred Shares,
pro rata based on the number of the Preferred Shares then held by the Holders.
(b) Insufficient Authorized
Shares. If, notwithstanding Section 11(a) and not in limitation thereof, at any time while any of the Preferred Shares remain outstanding
the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation to reserve
for issuance upon conversion of the Preferred Shares at least a number of shares of Common Stock equal to the Required Reserve Amount
(an “Authorized Share Failure”), then the Company shall immediately take all action necessary to increase the Company’s
authorized shares of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve Amount for the Preferred
Shares then outstanding (or deemed outstanding pursuant to Section 11(a) above). Without limiting the generality of the foregoing sentence,
as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later than sixty (60) days after
the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its stockholders for the approval of an increase
in the number of authorized shares of Common Stock. In connection with such meeting, the Company shall provide each stockholder with a
proxy statement and shall use its best efforts to solicit its stockholders’ approval of such increase in authorized shares of Common
Stock and to cause its board of directors to recommend to the stockholders that they approve such proposal (or, if a majority of the voting
power then in effect of the capital stock of the Company consents to such increase, in lieu of such proxy statement, deliver to the stockholders
of the Company an information statement that has been filed with (and either approved by or not subject to comments from) the SEC with
respect thereto). In the event that the Company is prohibited from issuing shares of Common Stock to a Holder upon any conversion due
to the failure by the Company to have sufficient shares of Common Stock available out of the authorized but unissued shares of Common
Stock (such unavailable number of shares of Common Stock, the “Authorized Failure Shares”), in lieu of delivering such
Authorized Failure Shares to such Holder, the Company shall pay legally available funds in exchange for the redemption of such portion
of the Conversion Amount of the Preferred Shares convertible into such Authorized Failure Shares at a price equal to the sum of (i) the
product of (x) such number of Authorized Failure Shares and (y) the greatest Closing Sale Price of the Common Stock on any Trading Day
during the period commencing on the date such Holder delivers the applicable Conversion Notice with respect to such Authorized Failure
Shares to the Company and ending on the date of such issuance and payment under this Section 11(a); and (ii) to the extent such Holder
purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Holder of Authorized
Failure Shares, any brokerage commissions and other out-of-pocket expenses, if any, of such Holder incurred in connection therewith. Nothing
contained in Section 11(a) or this Section 11(b) shall limit any obligations of the Company under any provision of the Securities Purchase
Agreement.
12. Redemptions.
(a) General. If a Holder
has submitted a Triggering Event Redemption Notice in accordance with Section 5(b), the Company shall deliver the applicable Triggering
Event Redemption Price to such Holder in legally available funds within five (5) Business Days after the Company’s receipt of such
Holder’s Triggering Event Redemption Notice. If a Holder has submitted a Change of Control Redemption Notice in accordance with
Section 6(b), the Company shall deliver the applicable Change of Control Redemption Price to such Holder in legally available funds concurrently
with the consummation of such Change of Control if such notice is received prior to the consummation of such Change of Control and within
five (5) Business Days after the Company’s receipt of such notice otherwise. If a Holder has submitted a Maturity Redemption Notice
in accordance with Section 13 below, the Company shall deliver the applicable Maturity Redemption Price to such Holder in legally available
funds on the applicable Maturity Redemption Date. Notwithstanding anything herein to the contrary, in connection with any redemption hereunder
at a time a Holder is entitled to receive a cash payment under any of the other Transaction Documents, at the option of such Holder delivered
in writing to the Company, the applicable Redemption Price hereunder shall be increased by the amount of such cash payment owed to such
Holder under such other Transaction Document and, upon payment in full or conversion in accordance herewith, shall satisfy the Company’s
payment obligation under such other Transaction Document. In the event of a redemption of less than all of the Preferred Shares, the Company
shall promptly cause to be issued and delivered to such Holder a new Preferred Share Certificate (in accordance with Section 20) (or evidence
of the creation of a new Book-Entry) representing the number of Preferred Shares which have not been redeemed. In the event that the Company
does not pay the applicable Redemption Price to a Holder within the time period required for any reason (including, without limitation,
to the extent such payment is prohibited pursuant to the DGCL), at any time thereafter and until the Company pays such unpaid Redemption
Price in full, such Holder shall have the option, in lieu of redemption, to require the Company to promptly return to such Holder all
or any of the Preferred Shares that were submitted for redemption and for which the applicable Redemption Price (together with any Late
Charges thereon) has not been paid. Upon the Company’s receipt of such notice, (x) the applicable Redemption Notice shall be null
and void with respect to such Preferred Shares, (y) the Company shall immediately return the applicable Preferred Share Certificate, or
issue a new Preferred Share Certificate (in accordance with Section 20(d)), to such Holder (unless the Preferred Shares are held in Book-Entry
form, in which case the Company shall deliver evidence to such Holder that a Book-Entry for such Preferred Shares then exists), and in
each case the Additional Amount of such Preferred Shares shall be increased by an amount equal to the difference between (1) the applicable
Redemption Price (as the case may be, and as adjusted pursuant to this Section 12, if applicable) minus (2) the Stated Value portion of
the Conversion Amount submitted for redemption and (z) the Conversion Price of such Preferred Shares shall be automatically adjusted with
respect to each conversion effected thereafter by such Holder to the lowest of (A) the Conversion Price as in effect on the date on which
the applicable Redemption Notice is voided, (B) the greater of (x) the Floor Price and (y) 75% of the lowest Closing Bid Price of the
Common Stock during the period beginning on and including the date on which the applicable Redemption Notice is delivered to the Company
and ending on and including the date on which the applicable Redemption Notice is voided and (C) the greater of (x) the Floor Price and
(y) 75% of the quotient of (I) the sum of the five (5) lowest VWAPs of the Common Stock during the twenty (20) consecutive Trading Day
period ending and including the Trading Day immediately preceding the applicable Conversion Date divided by (II) five (5) (it being understood
and agreed that all such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other
similar transaction during such period). A Holder’s delivery of a notice voiding a Redemption Notice and exercise of its rights
following such notice shall not affect the Company’s obligations to make any payments of Late Charges which have accrued prior to
the date of such notice with respect to the Preferred Shares subject to such notice.
(b) Redemption by Multiple
Holders. Upon the Company’s receipt of a Redemption Notice from any Holder for redemption or repayment as a result of an event
or occurrence substantially similar to the events or occurrences described in Section 5(b) or Section 6(b), the Company shall immediately,
but no later than one (1) Business Day of its receipt thereof, forward to each other Holder by electronic mail a copy of such notice.
If the Company receives one or more Redemption Notices, during the seven (7) Business Day period beginning on and including the date which
is two (2) Business Days prior to the Company’s receipt of the initial Redemption Notice and ending on and including the date which
is two (2) Business Days after the Company’s receipt of the initial Redemption Notice and the Company is unable to redeem all of
the Conversion Amount of such Preferred Shares designated in such initial Redemption Notice and such other Redemption Notices received
during such seven (7) Business Day period, then the Company shall redeem a pro rata amount from each Holder based on the Stated Value
of the Preferred Shares submitted for redemption pursuant to such Redemption Notices received by the Company during such seven (7) Business
Day period.
13. Reserved.
14. Voting Rights. Except as otherwise
provided herein or as required by applicable law, Holders of Preferred Shares shall be entitled to vote with holders of the Common Stock
on all matters that such holders of Common Stock are entitled to vote upon, in the same manner and with the same effect as the holders
of Common Stock, voting together with the holders of Common Stock as a single class. Each Preferred Share shall entitle the Holder thereof
to cast that number of votes per Preferred Share equal to the number of Conversion Shares underlying the Preferred Shares determined by
dividing the Stated Value by the NASDAQ Minimum Price (as defined in Nasdaq Listing Rule 5635(d)) immediately preceding the execution
and delivery of the Securities Purchase Agreement (or $92.16 per share, as of the Effective Date, and subject to adjustments for any stock
splits, stock dividends, stock combinations, recapitalizations or other similar transactions following the Effective Date). For purposes
of clarity, NASDAQ Minimum Price shall apply only for purposes of this Section 14 of the Certificate of Designations and not apply to
any other section of the Certificate of Designations or any Transaction Document. Notwithstanding the foregoing, to the extent that under
the DGCL the vote of the holders of the Preferred Shares, voting separately as a class or series, as applicable, is required to authorize
a given action of the Company, the affirmative vote or consent of the Required Holders of the shares of the Preferred Shares, voting together
in the aggregate and not in separate series unless required under the DGCL, represented at a duly held meeting at which a quorum is present
or by written consent of the Required Holders (except as otherwise may be required under the DGCL), voting together in the aggregate and
not in separate series unless required under the DGCL, shall constitute the approval of such action by both the class or the series, as
applicable. Solely for purposes of determining the presence of a quorum at any meeting of the stockholders of the Company at which the
Preferred Shares are entitled to vote, the number of Preferred Shares and votes represented by such shares shall be counted on an as converted
to Common Stock basis, disregarding, for such purposes, any limitations on conversion set forth herein. Holders of the Preferred Shares
shall be entitled to written notice of all stockholder meetings or written consents (and copies of proxy materials and other information
sent to stockholders) with respect to which they would be entitled to vote, which notice would be provided pursuant to the Bylaws and
the DGCL.
15. Covenants. For so long as any
Preferred Shares are outstanding, without the prior written consent of the Required Holders:
(a) Incurrence of Indebtedness.
The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, incur or guarantee, assume
or suffer to exist any Indebtedness (other than Permitted Indebtedness).
(b) Existence of Liens.
The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, allow or suffer to exist any
mortgage, lien, pledge, charge, security interest or other encumbrance upon or in any property or assets (including accounts and contract
rights) owned by the Company or any of its Subsidiaries (collectively, “Liens”) other than Permitted Liens.
(c) Restricted Payments and
Investments. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, redeem, defease,
repurchase, repay or make any payments in respect of, by the payment of cash or cash equivalents (in whole or in part, whether by way
of open market purchases, tender offers, private transactions or otherwise), all or any portion of any Indebtedness (other pursuant to
this Certificate of Designations) whether by way of payment in respect of principal of (or premium, if any) or interest on, such Indebtedness
or make any Investment, as applicable, if at the time such payment with respect to such Indebtedness and/or Investment, as applicable,
is due or is otherwise made or, after giving effect to such payment, (i) an event constituting a Triggering Event has occurred and is
continuing or (ii) an event that with the passage of time and without being cured would constitute a Triggering Event has occurred and
is continuing.
(d) Restriction on Redemption
and Cash Dividends. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, redeem,
repurchase or declare or pay any cash dividend or distribution on any of its capital stock (other than as required by this Certificate
of Designations, the Series A Certificate of Designations, the Series I Certificate of Designations, the Series J Certificate of Designations
or the certificate of designations for the Series K Convertible Preferred Stock, par value $0.0001 per share (“Series K Preferred
Stock”), of the Company).
(e) Restriction on Transfer
of Assets. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, sell, lease,
license, assign, transfer, spin-off, split-off, close, convey or otherwise dispose of any assets or rights of the Company or any Subsidiary
owned or hereafter acquired whether in a single transaction or a series of related transactions, other than (i) sales, leases, licenses,
assignments, transfers, conveyances and other dispositions of such assets or rights by the Company and its Subsidiaries in the ordinary
course of business consistent with its past practice, or (ii) sales of inventory and product in the ordinary course of business.
(f) Maturity of Indebtedness.
The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, permit any Indebtedness of
the Company or any of its Subsidiaries to mature or accelerate prior to the Maturity Date.
(g) Change in Nature of Business.
The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, engage in any material line
of business substantially different from those lines of business conducted by or publicly contemplated to be conducted by the Company
and/or its Subsidiaries on the Subscription Date or any business reasonably related or incidental thereto. The Company shall not, and
the Company shall cause each of its Subsidiaries to not, directly or indirectly, modify its or their corporate structure or purpose in
any material respect.
(h) Preservation of Existence,
Etc. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve, its existence, rights and
privileges, and become or remain, and cause each of its Subsidiaries to become or remain, duly qualified and in good standing in each
jurisdiction in which the character of the properties owned or leased by it or in which the transaction of its business makes such qualification
necessary; provided, however, that the Company shall have the right to merge or combine wholly-owned Subsidiaries hereunder, or eliminate
or dissolve foreign Subsidiaries, in each case where such restructuring does not have a material impact on the Company’s assets
or ability to comply with the provisions hereof.
(i) Maintenance of Properties,
Etc. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve, all of its properties which
are necessary or useful in the proper conduct of its business in good working order and condition, ordinary wear and tear excepted, and
comply, and cause each of its Subsidiaries to comply, at all times with the provisions of all leases to which it is a party as lessee
or under which it occupies property, so as to prevent any loss or forfeiture thereof or thereunder.
(j) Maintenance of Intellectual
Property. The Company will, and will cause each of its Subsidiaries to, take all action necessary or advisable to maintain all of
the Intellectual Property Rights of the Company and/or any of its Subsidiaries that are necessary or material to the conduct of its business
in full force and effect.
(k) Maintenance of Insurance.
The Company shall use reasonable best efforts to maintain, and cause each of its Subsidiaries to maintain, insurance with responsible
and reputable insurance companies or associations (including, without limitation, comprehensive general liability, hazard, rent and business
interruption insurance) with respect to its properties (including all real properties leased or owned by it) and business, in such amounts
and covering such risks as are generally consistent with the coverage held by the Company on the Initial Issuance Date.
(l) Transactions with Affiliates.
The Company shall not, nor shall it permit any of its Subsidiaries to, enter into, renew, extend or be a party to, any transaction or
series of related transactions (including, without limitation, the purchase, sale, lease, transfer or exchange of property or assets of
any kind or the rendering of services of any kind) with any affiliate, except transactions in the ordinary course of business in a manner
and to an extent, if applicable, consistent with past practice and necessary or desirable for the prudent operation of its business, for
fair consideration and on terms no less favorable to it or its Subsidiaries than would be reasonably expected to be obtained in a comparable
arm’s length transaction with a Person that is not an affiliate thereof.
(m) Restricted Issuances.
The Company shall not, directly or indirectly, without the prior written consent of the Required Holders, (i) issue any Preferred Shares
(other than as contemplated by the Securities Purchase Agreement and this Certificate of Designations) or (ii) issue any other securities
that would cause a breach or default under this Certificate of Designations or the Warrants.
(n) Stay, Extension and Usury
Laws. To the extent that it may lawfully do so, the Company (A) agrees that it will not at any time insist upon, plead, or in any
manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law (wherever or whenever enacted or in force)
that may affect the covenants or the performance of this Certificate of Designations; and (B) expressly waives all benefits or advantages
of any such law and agrees that it will not, by resort to any such law, hinder, delay or impede the execution of any power granted to
the Holders by this Certificate of Designations, but will suffer and permit the execution of every such power as though no such law has
been enacted.
(o) Taxes. The Company
and its Subsidiaries shall pay when due all taxes, fees or other charges of any nature whatsoever (together with any related interest
or penalties) now or hereafter imposed or assessed against the Company and its Subsidiaries or their respective assets or upon their ownership,
possession, use, operation or disposition thereof or upon their rents, receipts or earnings arising therefrom (except where the failure
to pay would not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries). The Company and
its Subsidiaries shall file on or before the due date therefor all personal property tax returns (except where the failure to file would
not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries). Notwithstanding the foregoing,
the Company and its Subsidiaries may contest, in good faith and by appropriate proceedings, taxes for which they maintain adequate reserves
therefor in accordance with GAAP.
(p) Cash Minimum .
From January 1, 2025, and until no Preferred Shares are outstanding, the Company shall, at all times, maintain unencumbered, unrestricted
cash and cash equivalents on hand in amount equal to at least 120% of the aggregate Stated Value of the Preferred Shares then outstanding.
Such cash shall be maintained in one or more domestic deposit accounts, money market accounts or certificates of deposit (with a maturity
of no more than three months) with one or more Eligible Banks. For purposes hereof, an “Eligible Bank” is a U.S. chartered
commercial bank with total assets in excess of $300 billion.
(q) Reserved.
(r) Independent Investigation.
At the request of any Holder either (x) at any time when a Triggering Event has occurred and is continuing, (y) upon the occurrence of
an event that with the passage of time or giving of notice would constitute a Triggering Event or (z) at any time such Holder reasonably
believes a Triggering Event may have occurred or be continuing, the Company shall hire an independent, reputable investment bank selected
by the Company and approved by such Holder to investigate as to whether any breach of the Certificate of Designations has occurred (the
“Independent Investigator”). If the Independent Investigator determines that such breach of the Certificate of Designations
has occurred, the Independent Investigator shall notify the Company of such breach and the Company shall deliver written notice to each
Holder of such breach. In connection with such investigation, the Independent Investigator may, during normal business hours, inspect
all contracts, books, records, personnel, offices and other facilities and properties of the Company and its Subsidiaries and, to the
extent available to the Company after the Company uses reasonable efforts to obtain them, the records of its legal advisors and accountants
(including the accountants’ work papers) and any books of account, records, reports and other papers not contractually required
of the Company to be confidential or secret, or subject to attorney-client or other evidentiary privilege, and the Independent Investigator
may make such copies and inspections thereof as the Independent Investigator may reasonably request. The Company shall furnish the Independent
Investigator with such financial and operating data and other information with respect to the business and properties of the Company as
the Independent Investigator may reasonably request. The Company shall permit the Independent Investigator to discuss the affairs, finances
and accounts of the Company with, and to make proposals and furnish advice with respect thereto to, the Company’s officers, directors,
key employees and independent public accountants or any of them (and by this provision the Company authorizes said accountants to discuss
with such Independent Investigator the finances and affairs of the Company and any Subsidiaries), all at such reasonable times, upon reasonable
notice, and as often as may be reasonably requested.
16. Liquidation, Dissolution, Winding-Up.
In the event of a Liquidation Event, the Holders shall be entitled to receive in cash out of the assets of the Company, whether from capital
or from earnings available for distribution to its stockholders (the “Liquidation Funds”), before any amount shall
be paid to the holders of any of shares of Junior Stock, but pari passu with any Parity Stock then outstanding, an amount per Preferred
Share equal to the greater of (A) 125% of the Conversion Amount of such Preferred Share on the date of such payment and (B) the amount
per share such Holder would receive if such Holder converted such Preferred Share into Common Stock immediately prior to the date of such
payment, provided that if the Liquidation Funds are insufficient to pay the full amount due to the Holders and holders of shares of Parity
Stock, then each Holder and each holder of Parity Stock shall receive a percentage of the Liquidation Funds equal to the full amount of
Liquidation Funds payable to such Holder and such holder of Parity Stock as a liquidation preference, in accordance with their respective
certificate of designations (or equivalent), as a percentage of the full amount of Liquidation Funds payable to all holders of Preferred
Shares and all holders of shares of Parity Stock. To the extent necessary, the Company shall cause such actions to be taken by each of
its Subsidiaries so as to enable, to the maximum extent permitted by law, the proceeds of a Liquidation Event to be distributed to the
Holders in accordance with this Section 16. All the preferential amounts to be paid to the Holders under this Section 16 shall be paid
or set apart for payment before the payment or setting apart for payment of any amount for, or the distribution of any Liquidation Funds
of the Company to the holders of shares of Junior Stock in connection with a Liquidation Event as to which this Section 16 applies.
17. Distribution of Assets. In
addition to any adjustments pursuant to Section 7(a) and Section 8, if the Company shall declare or make any dividend or other distributions
of its assets (or rights to acquire its assets) to any or all holders of shares of Common Stock, by way of return of capital or otherwise
(including without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off,
reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (the “Distributions”),
then each Holder, as holders of Preferred Shares, will be entitled to such Distributions as if such Holder had held the number of shares
of Common Stock acquirable upon complete conversion of the Preferred Shares (without taking into account any limitations or restrictions
on the convertibility of the Preferred Shares and assuming for such purpose that the Preferred Share was converted at the Alternate Conversion
Price as of the applicable record date)immediately prior to the date on which a record is taken for such Distribution or, if no such record
is taken, the date as of which the record holders of Common Stock are to be determined for such Distributions (provided, however, that
to the extent that such Holder’s right to participate in any such Distribution would result in such Holder and the other Attribution
Parties exceeding the Maximum Percentage, then such Holder shall not be entitled to participate in such Distribution to such extent of
the Maximum Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution
(and beneficial ownership) to such extent of any such excess) and the portion of such Distribution shall be held in abeyance for the benefit
of such Holder until such time or times as its right thereto would not result in such Holder and the other Attribution Parties exceeding
the Maximum Percentage, at which time or times, if any, such Holder shall be granted such Distribution (and any Distributions declared
or made on such initial Distribution or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had
been no such limitation).
18. Vote to Change the Terms of or
Issue Preferred Shares. In addition to any other rights provided by law, except where the vote or written consent of the holders of
a greater number of shares is required by law or by another provision of the Certificate of Incorporation, without first obtaining the
affirmative vote at a meeting duly called for such purpose or the written consent without a meeting of the Required Holders, voting together
as a single class, the Company shall not (in any case, whether by amendment, modification, recapitalization, merger, consolidation or
otherwise): (a) amend or repeal any provision of, or add any provision to, its Certificate of Incorporation or Bylaws, or file any certificate
of designations or articles of amendment of any series of shares of preferred stock, if such action would adversely alter or change in
any respect the preferences, rights, privileges or powers, or restrictions provided for the benefit of the Preferred Shares hereunder,
regardless of whether any such action shall be by means of amendment to the Certificate of Incorporation or by merger, consolidation or
otherwise; provided that the affirmative vote of the Required Holders shall not be required for changes to the Series A Preferred Stock,
Series K Preferred Stock, Series I Preferred Stock or Series J Preferred Stock; (b) increase or decrease (other than by conversion) the
authorized number of Preferred Shares; (c) without limiting any provision of Section 2, create or authorize (by reclassification or otherwise)
any new class or series of Senior Preferred Stock or Parity Stock, other than the Series J Preferred Stock and Series K Preferred Stock;
(d) purchase, repurchase or redeem any shares of Junior Stock (other than pursuant to the terms of the Company’s equity incentive
plans and options and other equity awards granted under such plans (that have in good faith been approved by the Board)); (e) without
limiting any provision of Section 2, pay dividends or make any other distribution on any shares of any Junior Stock; (f) issue any Preferred
Shares other than as contemplated hereby or pursuant to the Securities Purchase Agreement; or (g) without limiting any provision of Section
10, whether or not prohibited by the terms of the Preferred Shares, circumvent a right of the Preferred Shares hereunder.
19. Transfer of Preferred Shares.
A Holder may transfer some or all of its Preferred Shares without the consent of the Company, but any such transfer shall be in compliance
with all applicable securities laws.
20. Reissuance of Preferred Share Certificates
and Book Entries.
(a) Transfer. If any
Preferred Shares are to be transferred, the applicable Holder shall surrender the applicable Preferred Share Certificate to the Company
(or, if the Preferred Shares are held in Book-Entry form, a written instruction letter to the Company), whereupon the Company will forthwith
issue and deliver upon the order of such Holder a new Preferred Share Certificate (in accordance with Section 20(d)) (or evidence of the
transfer of such Book-Entry), registered as such Holder may request, representing the outstanding number of Preferred Shares being transferred
by such Holder and, if less than the entire outstanding number of Preferred Shares is being transferred, a new Preferred Share Certificate
(in accordance with Section 20(d)) to such Holder representing the outstanding number of Preferred Shares not being transferred (or evidence
of such remaining Preferred Shares in a Book-Entry for such Holder). Such Holder and any assignee, by acceptance of the Preferred Share
Certificate or evidence of Book-Entry issuance, as applicable, acknowledge and agree that, by reason of the provisions of Section 4(c)(i)
following conversion or redemption of any of the Preferred Shares, the outstanding number of Preferred Shares represented by the Preferred
Shares may be less than the number of Preferred Shares stated on the face of the Preferred Shares.
(b) Lost, Stolen or Mutilated
Preferred Share Certificate. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of a Preferred Share Certificate (as to which a written certification and the indemnification contemplated below shall suffice
as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking by the applicable Holder to the
Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation of such Preferred Share Certificate,
the Company shall execute and deliver to such Holder a new Preferred Share Certificate (in accordance with Section 20(d)) representing
the applicable outstanding number of Preferred Shares.
(c) Preferred Share Certificate
and Book-Entries Exchangeable for Different Denominations and Forms. Each Preferred Share Certificate is exchangeable, upon the surrender
hereof by the applicable Holder at the principal office of the Company, for a new Preferred Share Certificate or Preferred Share Certificate(s)
or new Book-Entry (in accordance with Section 20(d)) representing, in the aggregate, the outstanding number of the Preferred Shares in
the original Preferred Share Certificate, and each such new Preferred Share Certificate and/or new Book-Entry, as applicable, will represent
such portion of such outstanding number of Preferred Shares from the original Preferred Share Certificate as is designated in writing
by such Holder at the time of such surrender. Each Book-Entry may be exchanged into one or more new Preferred Share Certificates or split
by the applicable Holder by delivery of a written notice to the Company into two or more new Book-Entries (in accordance with Section
20(d)) representing, in the aggregate, the outstanding number of the Preferred Shares in the original Book-Entry, and each such new Book-Entry
and/or new Preferred Share Certificate, as applicable, will represent such portion of such outstanding number of Preferred Shares from
the original Book-Entry as is designated in writing by such Holder at the time of such surrender.
(d) Issuance of New Preferred
Share Certificate or Book-Entry. Whenever the Company is required to issue a new Preferred Share Certificate or a new Book-Entry pursuant
to the terms of this Certificate of Designations, such new Preferred Share Certificate or new Book-Entry (i) shall represent, as indicated
on the face of such Preferred Share Certificate or in such Book-Entry, as applicable, the number of Preferred Shares remaining outstanding
(or in the case of a new Preferred Share Certificate or new Book-Entry being issued pursuant to Section 20(a) or Section 20(c), the number
of Preferred Shares designated by such Holder) which, when added to the number of Preferred Shares represented by the other new Preferred
Share Certificates or other new Book-Entry, as applicable, issued in connection with such issuance, does not exceed the number of Preferred
Shares remaining outstanding under the original Preferred Share Certificate or original Book-Entry, as applicable, immediately prior to
such issuance of new Preferred Share Certificate or new Book-Entry, as applicable, and (ii) shall have an issuance date, as indicated
on the face of such new Preferred Share Certificate or in such new Book-Entry, as applicable, which is the same as the issuance date of
the original Preferred Share Certificate or in such original Book-Entry, as applicable.
21. Remedies, Characterizations, Other
Obligations, Breaches and Injunctive Relief. The remedies provided in this Certificate of Designations shall be cumulative and in
addition to all other remedies available under this Certificate of Designations and any of the other Transaction Documents, at law or
in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit any Holder’s
right to pursue actual and consequential damages for any failure by the Company to comply with the terms of this Certificate of Designations.
No failure on the part of a Holder to exercise, and no delay in exercising, any right, power or remedy hereunder shall operate as a waiver
thereof; nor shall any single or partial exercise by such Holder of any right, power or remedy preclude any other or further exercise
thereof or the exercise of any other right, power or remedy. In addition, the exercise of any right or remedy of a Holder at law or equity
or under this Certificate of Designations or any of the documents shall not be deemed to be an election of such Holder’s rights
or remedies under such documents or at law or equity. The Company covenants to each Holder that there shall be no characterization concerning
this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments, conversion
and the like (and the computation thereof) shall be the amounts to be received by a Holder and shall not, except as expressly provided
herein, be subject to any other obligation of the Company (or the performance thereof). No failure on the part of a Holder to exercise,
and no delay in exercising, any right, power or remedy hereunder shall operate as a waiver thereof; nor shall any single or partial exercise
by such Holder of any right, power or remedy preclude any other or further exercise thereof or the exercise of any other right, power
or remedy. In addition, the exercise of any right or remedy of any Holder at law or equity or under Preferred Shares or any of the documents
shall not be deemed to be an election of such Holder’s rights or remedies under such documents or at law or equity. The Company
acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holders and that the remedy at law for
any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, each Holder
shall be entitled, in addition to all other available remedies, to specific performance and/or temporary, preliminary and permanent injunctive
or other equitable relief from any court of competent jurisdiction in any such case without the necessity of proving actual damages and
without posting a bond or other security. The Company shall provide all information and documentation to a Holder that is requested by
such Holder to enable such Holder to confirm the Company’s compliance with the terms and conditions of this Certificate of Designations.
22. Payment of Collection, Enforcement
and Other Costs. If (a) any Preferred Shares are placed in the hands of an attorney for collection or enforcement or is collected
or enforced through any legal proceeding or a Holder otherwise takes action to collect amounts due under this Certificate of Designations
with respect to the Preferred Shares or to enforce the provisions of this Certificate of Designations or (b) there occurs any bankruptcy,
reorganization, receivership of the Company or other proceedings affecting Company creditors’ rights and involving a claim under
this Certificate of Designations, then the Company shall pay the costs incurred by such Holder for such collection, enforcement or action
or in connection with such bankruptcy, reorganization, receivership or other proceeding, including, without limitation, attorneys’
fees and disbursements. The Company expressly acknowledges and agrees that no amounts due under this Certificate of Designations with
respect to any Preferred Shares shall be affected, or limited, by the fact that the purchase price paid for each Preferred Share was less
than the original Stated Value thereof.
23. Construction; Headings. This
Certificate of Designations shall be deemed to be jointly drafted by the Company and the Holders and shall not be construed against any
such Person as the drafter hereof. The headings of this Certificate of Designations are for convenience of reference and shall not form
part of, or affect the interpretation of, this Certificate of Designations. Unless the context clearly indicates otherwise, each pronoun
herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof. The terms “including,”
“includes,” “include” and words of like import shall be construed broadly as if followed by the words “without
limitation.” The terms “herein,” “hereunder,” “hereof” and words of like import refer to this
entire Certificate of Designations instead of just the provision in which they are found. Unless expressly indicated otherwise, all section
references are to sections of this Certificate of Designations. Terms used in this Certificate of Designations and not otherwise defined
herein, but defined in the other Transaction Documents, shall have the meanings ascribed to such terms on the Initial Issuance Date in
such other Transaction Documents unless otherwise consented to in writing by the Required Holders.
24. Failure or Indulgence Not Waiver.
No failure or delay on the part of a Holder in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof,
nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other
right, power or privilege. No waiver shall be effective unless it is in writing and signed by an authorized representative of the waiving
party. This Certificate of Designations shall be deemed to be jointly drafted by the Company and all Holders and shall not be construed
against any Person as the drafter hereof. Notwithstanding the foregoing, nothing contained in this Section 24 shall permit any waiver
of any provision of Section 4(d).
25. Dispute Resolution.
(a) Submission to Dispute
Resolution.
(i) In the case of a dispute relating
to a Closing Bid Price, a Closing Sale Price, a Conversion Price, an Alternate Conversion Price, a VWAP or a fair market value or the
arithmetic calculation of a Conversion Rate, or the applicable Redemption Price (as the case may be) (including, without limitation, a
dispute relating to the determination of any of the foregoing), the Company or the applicable Holder (as the case may be) shall submit
the dispute to the other party via electronic mail (A) if by the Company, within two (2) Business Days after the occurrence of the circumstances
giving rise to such dispute or (B) if by such Holder at any time after such Holder learned of the circumstances giving rise to such dispute.
If such Holder and the Company are unable to promptly resolve such dispute relating to such Closing Bid Price, such Closing Sale Price,
such Conversion Price, such Alternate Conversion Price, such VWAP or such fair market value, or the arithmetic calculation of such Conversion
Rate or such applicable Redemption Price (as the case may be), at any time after the second (2nd)
Business Day following such initial notice by the Company or such Holder (as the case may be) of such dispute to the Company or such Holder
(as the case may be), then such Holder may, at its sole option, select an independent, reputable investment bank to resolve such dispute.
(ii) Such Holder and the Company
shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered in accordance with the first sentence
of this Section 25 and (B) written documentation supporting its position with respect to such dispute, in each case, no later than 5:00
p.m. (New York time) by the fifth (5th) Business Day immediately following the date on
which such Holder selected such investment bank (the “Dispute Submission Deadline”) (the documents referred to in the
immediately preceding clauses (A) and (B) are collectively referred to herein as the “Required Dispute Documentation”)
(it being understood and agreed that if either such Holder or the Company fails to so deliver all of the Required Dispute Documentation
by the Dispute Submission Deadline, then the party who fails to so submit all of the Required Dispute Documentation shall no longer be
entitled to (and hereby waives its right to) deliver or submit any written documentation or other support to such investment bank with
respect to such dispute and such investment bank shall resolve such dispute based solely on the Required Dispute Documentation that was
delivered to such investment bank prior to the Dispute Submission Deadline). Unless otherwise agreed to in writing by both the Company
and such Holder or otherwise requested by such investment bank, neither the Company nor such Holder shall be entitled to deliver or submit
any written documentation or other support to such investment bank in connection with such dispute (other than the Required Dispute Documentation).
(iii) The Company and such Holder
shall cause such investment bank to determine the resolution of such dispute and notify the Company and such Holder of such resolution
no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The fees and expenses of such investment bank
shall be borne solely by the Company, and such investment bank’s resolution of such dispute shall be final and binding upon all
parties absent manifest error.
(b) Miscellaneous. The
Company expressly acknowledges and agrees that (i) this Section 25 constitutes an agreement to arbitrate between the Company and each
Holder (and constitutes an arbitration agreement) under § 7501, et seq. of the New York Civil Practice Law and Rules (“CPLR”)
and that any Holder is authorized to apply for an order to compel arbitration pursuant to CPLR § 7503(a) in order to compel compliance
with this Section 25, (ii) a dispute relating to a Conversion Price includes, without limitation, disputes as to (A) whether an issuance
or sale or deemed issuance or sale of Common Stock occurred under Section 8(a), (B) the consideration per share at which an issuance or
deemed issuance of Common Stock occurred, (C) whether any issuance or sale or deemed issuance or sale of Common Stock was an issuance
or sale or deemed issuance or sale of Excluded Securities, (D) whether an agreement, instrument, security or the like constitutes an Option
or Convertible Security and (E) whether a Dilutive Issuance occurred, (iii) the terms of this Certificate of Designations and each other
applicable Transaction Document shall serve as the basis for the selected investment bank’s resolution of the applicable dispute,
such investment bank shall be entitled (and is hereby expressly authorized) to make all findings, determinations and the like that such
investment bank determines are required to be made by such investment bank in connection with its resolution of such dispute and in resolving
such dispute such investment bank shall apply such findings, determinations and the like to the terms of this Certificate of Designations
and any other applicable Transaction Documents, (iv) the applicable Holder (and only such Holder with respect to disputes solely relating
to such Holder), in its sole discretion, shall have the right to submit any dispute described in this Section 25 to any state or federal
court sitting in The City of New York, Borough of Manhattan in lieu of utilizing the procedures set forth in this Section 25 and (v) nothing
in this Section 25 shall limit such Holder from obtaining any injunctive relief or other equitable remedies (including, without limitation,
with respect to any matters described in this Section 25).
26. Notices; Currency; Payments.
(a) Notices. The Company
shall provide each Holder of Preferred Shares with prompt written notice of all actions taken pursuant to the terms of this Certificate
of Designations, including in reasonable detail a description of such action and the reason therefor. Whenever notice is required to be
given under this Certificate of Designations, unless otherwise provided herein, such notice must be in writing and shall be given in accordance
with Section 9(f) of the Securities Purchase Agreement. The Company shall provide each Holder with prompt written notice of all actions
taken pursuant to this Certificate of Designations, including in reasonable detail a description of such action and the reason therefore.
Without limiting the generality of the foregoing, the Company shall give written notice to each Holder (i) immediately upon any adjustment
of the Conversion Price, setting forth in reasonable detail, and certifying, the calculation of such adjustment and (ii) at least fifteen
(15) days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon
the Common Stock, (B) with respect to any grant, issuances, or sales of any Options, Convertible Securities or rights to purchase stock,
warrants, securities or other property to holders of shares of Common Stock or (C) for determining rights to vote with respect to any
Fundamental Transaction, dissolution or liquidation, provided in each case that such information shall be made known to the public prior
to or in conjunction with such notice being provided to such Holder.
(b) Currency. All dollar
amounts referred to in this Certificate of Designations are in United States Dollars (“U.S. Dollars”), and all amounts
owing under this Certificate of Designations shall be paid in U.S. Dollars. All amounts denominated in other currencies (if any) shall
be converted into the U.S. Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. “Exchange
Rate” means, in relation to any amount of currency to be converted into U.S. Dollars pursuant to this Certificate of Designations,
the U.S. Dollar exchange rate as published in the Wall Street Journal on the relevant date of calculation (it being understood and agreed
that where an amount is calculated with reference to, or over, a period of time, the date of calculation shall be the final date of such
period of time).
(c) Payments. Whenever
any payment of cash is to be made by the Company to any Person pursuant to this Certificate of Designations, unless otherwise expressly
set forth herein, such payment shall be made in lawful money of the United States of America by wire transfer of immediately available
funds pursuant to wire transfer instructions that Holder shall provide to the Company in writing from time to time. Whenever any amount
expressed to be due by the terms of this Certificate of Designations is due on any day which is not a Business Day, the same shall instead
be due on the next succeeding day which is a Business Day. Any amount due under the Transaction Documents which is not paid when due (except
to the extent such amount is simultaneously accruing Dividends at the Default Rate hereunder) shall result in a late charge being incurred
and payable by the Company in an amount equal to interest on such amount at the rate of fifteen percent (15%) per annum from the date
such amount was due until the same is paid in full (“Late Charge”).
27. Waiver of Notice. To the extent
permitted by law, the Company hereby irrevocably waives demand, notice, presentment, protest and all other demands and notices in connection
with the delivery, acceptance, performance, default or enforcement of this Certificate of Designations and the Securities Purchase Agreement.
28. Governing Law. This Certificate
of Designations shall be construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation
and performance of this Certificate of Designations shall be governed by, the internal laws of the State of Delaware, without giving effect
to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdictions) that would cause
the application of the laws of any jurisdictions other than the State of Delaware. Except as otherwise required by Section 25 above, the
Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough
of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue
of such suit, action or proceeding is improper. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any manner permitted by law. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner
permitted by law. Nothing contained herein (i) shall be deemed or operate to preclude any Holder from bringing suit or taking other legal
action against the Company in any other jurisdiction to collect on the Company’s obligations to such Holder, to realize on any collateral
or any other security for such obligations, or to enforce a judgment or other court ruling in favor of such Holder or (ii) shall limit,
or shall be deemed or construed to limit, any provision of Section 25 above. THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY
HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF
THIS CERTIFICATE OF DESIGNATIONS OR ANY TRANSACTION CONTEMPLATED HEREBY.
29. Judgment Currency.
(a) If for the purpose of obtaining
or enforcing judgment against the Company in any court in any jurisdiction it becomes necessary to convert into any other currency (such
other currency being hereinafter in this Section 29 referred to as the “Judgment Currency”) an amount due in U.S. dollars
under this Certificate of Designations, the conversion shall be made at the Exchange Rate prevailing on the Trading Day immediately preceding:
(i) the date actual payment of
the amount due, in the case of any proceeding in the courts of New York or in the courts of any other jurisdiction that will give effect
to such conversion being made on such date: or
(ii) the date on which the foreign
court determines, in the case of any proceeding in the courts of any other jurisdiction (the date as of which such conversion is made
pursuant to this Section 29(a)(ii) being hereinafter referred to as the “Judgment Conversion Date”).
(b) If in the case of any proceeding
in the court of any jurisdiction referred to in Section 29(a)(ii) above, there is a change in the Exchange Rate prevailing between the
Judgment Conversion Date and the date of actual payment of the amount due, the applicable party shall pay such adjusted amount as may
be necessary to ensure that the amount paid in the Judgment Currency, when converted at the Exchange Rate prevailing on the date of payment,
will produce the amount of US dollars which could have been purchased with the amount of Judgment Currency stipulated in the judgment
or judicial order at the Exchange Rate prevailing on the Judgment Conversion Date.
(c) Any amount due from the
Company under this provision shall be due as a separate debt and shall not be affected by judgment being obtained for any other amounts
due under or in respect of this Certificate of Designations.
30. Severability. If any provision
of this Certificate of Designations is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent
jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest
extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity
of the remaining provisions of this Certificate of Designations so long as this Certificate of Designations as so modified continues to
express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity
or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations
of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor
in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which
comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).
31. Maximum Payments. Without limiting
Section 9(d) of the Securities Purchase Agreement, nothing contained herein shall be deemed to establish or require the payment of a rate
of interest or other charges in excess of the maximum permitted by applicable law. In the event that the rate of interest required to
be paid or other charges hereunder exceed the maximum permitted by such law, any payments in excess of such maximum shall be credited
against amounts owed by the Company to the applicable Holder and thus refunded to the Company.
32. Stockholder Matters; Amendment.
(a) Stockholder Matters.
Any stockholder action, approval or consent required, desired or otherwise sought by the Company pursuant to the DGCL, the Certificate
of Incorporation, this Certificate of Designations or otherwise with respect to the issuance of Preferred Shares may be effected by written
consent of the Company’s stockholders or at a duly called meeting of the Company’s stockholders, all in accordance with the
applicable rules and regulations of the DGCL. This provision is intended to comply with the applicable sections of the DGCL permitting
stockholder action, approval and consent affected by written consent in lieu of a meeting.
(b) Amendment. Except
for Section 4(d)(i), which may not be amended or waived hereunder, this Certificate of Designations or any provision hereof may be amended
by obtaining the affirmative vote at a meeting duly called for such purpose, or written consent without a meeting in accordance with the
DGCL, of the Required Holders, voting separate as a single class, and with such other stockholder approval, if any, as may then be required
pursuant to the DGCL and the Certificate of Incorporation.
33. Certain Defined Terms. For
purposes of this Certificate of Designations, the following terms shall have the following meanings:
(a) “1934 Act”
means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.
(b) [Reserved.]
(c) “Additional Amount”
means, as of the applicable date of determination, with respect to each Preferred Share, all accrued and unpaid Dividends on such Preferred
Share.
(d) “Adjustment Right”
means any right granted with respect to any securities issued in connection with, or with respect to, any issuance or sale (or deemed
issuance or sale in accordance with Section 8(a)) of shares of Common Stock (other than rights of the type described in Section 7(a) hereof)
that could result in a decrease in the net consideration received by the Company in connection with, or with respect to, such securities
(including, without limitation, any cash settlement rights, cash adjustment or other similar rights).
(e) “Affiliate”
or “Affiliated” means, with respect to any Person, any other Person that directly or indirectly controls, is controlled
by, or is under common control with, such Person, it being understood for purposes of this definition that “control” of a
Person means the power directly or indirectly either to vote 10% or more of the stock having ordinary voting power for the election of
directors of such Person or direct or cause the direction of the management and policies of such Person whether by contract or otherwise.
(f) “Alternate Conversion
Floor Amount” means an amount in cash, to be delivered by wire transfer of immediately available funds pursuant to wire instructions
delivered to the Company by the Holder in writing, equal to the product obtained by multiplying (A) the applicable Conversion Amount by
(B) 25%.
(g) “Alternate Conversion
Price” means, with respect to any Alternate Conversion that price which shall be the lowest of (i) the applicable Conversion
Price as in effect on the applicable Conversion Date of the applicable Alternate Conversion, and (ii) the greater of (x) the Floor Price
and (y) seventy-five percent (75%) of the lowest VWAP of the Common Stock of any Trading Day during the twenty (20) consecutive Trading
Day period ending and including the Trading Day immediately preceding the delivery or deemed delivery of the applicable Conversion Notice
(such period, the “Alternate Conversion Measuring Period”). All such determinations to be appropriately adjusted for
any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases
the Common Stock during such Alternate Conversion Measuring Period.
(h) “Approved Stock
Plan” means any employee benefit plan or agreement which has been approved by the Board prior to or subsequent to the Subscription
Date pursuant to which shares of Common Stock and standard options to purchase Common Stock may be issued to any employee, officer, consultant
or director for services provided to the Company in their capacity as such.
(i) “Attribution Parties”
means, collectively, the following Persons and entities: (i) any investment vehicle, including, any funds, feeder funds or managed accounts,
currently, or from time to time after the Initial Issuance Date, directly or indirectly managed or advised by a Holder’s investment
manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of such Holder or any of the foregoing, (iii) any
Person acting or who could be deemed to be acting as a Group together with such Holder or any of the foregoing and (iv) any other Persons
whose beneficial ownership of the Company’s Common Stock would or could be aggregated with such Holder’s and the other Attribution
Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of the foregoing is to subject collectively such Holder
and all other Attribution Parties to the Maximum Percentage.
(j) “Bloomberg”
means Bloomberg, L.P.
(k) “Book-Entry”
means each entry on the Register evidencing one or more Preferred Shares held by a Holder in lieu of a Preferred Share Certificate issuable
hereunder.
(l) “Business Day”
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are
open for use by customers on such day.
(m) Reserved.
(n) “Change of Control”
means (1) any Fundamental Transaction other than (i) any merger of the Company or any of its, direct or indirect, wholly-owned Subsidiaries
with or into any of the foregoing Persons, (ii) any reorganization, recapitalization or reclassification of the Common Stock in which
holders of the Company’s voting power immediately prior to such reorganization, recapitalization or reclassification continue after
such reorganization, recapitalization or reclassification to hold publicly traded securities and, directly or indirectly, are, in all
material respects, the holders of the voting power of the surviving entity (or entities with the authority or voting power to elect the
members of the board of directors (or their equivalent if other than a corporation) of such entity or entities) after such reorganization,
recapitalization or reclassification, (iii) pursuant to a migratory merger effected solely for the purpose of changing the jurisdiction
of incorporation of the Company or any of its Subsidiaries or (iv) bone fide arm’s length sales or acquisitions by the Company with
one or more third parties as long as holders of the Company’s voting power as of the Issuance Date continue after such sale or acquisition
to hold publicly traded securities and, directly or indirectly, are, in all material respects, the holders of at least 51% of the voting
power of the surviving entity (or entities with the authority or voting power to elect the members of the board of directors (or their
equivalent if other than a corporation) of such entity or entities) after such sale or acquisition; or (2) a reconstitution of the board
of directors of the Company whereby three or more members of such board of directors resign or are replaced.
(o) “Change of Control
Redemption Premium” means 150%.
(p) “Closing Bid Price”
and “Closing Sale Price” means, for any security as of any date, the last closing bid price and last closing trade
price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market begins to operate
on an extended hours basis and does not designate the closing bid price or the closing trade price (as the case may be) then the last
bid price or last trade price, respectively, of such security prior to 4:00:00 p.m., New York time, as reported by Bloomberg, or, if the
Principal Market is not the principal securities exchange or trading market for such security, the last closing bid price or last trade
price, respectively, of such security on the principal securities exchange or trading market where such security is listed or traded as
reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last trade price, respectively, of such security
in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, or, if no closing bid price
or last trade price, respectively, is reported for such security by Bloomberg, the average of the bid prices, or the ask prices, respectively,
of any market makers for such security as reported in The Pink Open Market (or a similar organization or agency succeeding to its functions
of reporting prices). If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security on a particular date on any
of the foregoing bases, the Closing Bid Price or the Closing Sale Price (as the case may be) of such security on such date shall be the
fair market value as mutually determined by the Company and the Required Holder. If the Company and the Required Holders are unable to
agree upon the fair market value of such security, then such dispute shall be resolved in accordance with the procedures in Section 25.
All such determinations shall be appropriately adjusted for any stock splits, stock dividends, stock combinations, recapitalizations or
other similar transactions during such period.
(q) “Closing Date”
shall have the meaning set forth in the Securities Purchase Agreement, which date is the date the Company initially issued the Preferred
Shares and the Warrants pursuant to the terms of the Securities Purchase Agreement.
(r) “Common Stock”
means (i) the Company’s shares of common stock, $0.0001 par value per share, and (ii) any capital stock into which such common stock
shall have been changed or any share capital resulting from a reclassification of such common stock.
(s) “Contingent Obligation”
means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect to any Indebtedness, lease,
dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such liability, or the primary
effect thereof, is to provide assurance to the obligee of such liability that such liability will be paid or discharged, or that any agreements
relating thereto will be complied with, or that the holders of such liability will be protected (in whole or in part) against loss with
respect thereto.
(t) “Conversion Floor
Price Condition” means that the relevant Alternate Conversion Price, is being determined based on clause (x) of such definitions.
(u) Reserved.
(v) “Convertible Securities”
means any stock or other security (other than Options) that is at any time and under any circumstances, directly or indirectly, convertible
into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any shares of Common Stock.
(w) “Dividend Date”
means the first Trading Day of each calendar quarter.
(x) “Dividend Rate”
means eight percent (8.0%) per annum, as may be adjusted from time to time in accordance with Section 2.
(y) “Eligible Market”
means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market or the Principal Market.
(z) Reserved.
(aa) Reserved.
(bb) “Event Market
Price” means, with respect to any Stock Combination Event Date, the lower of (i)
the Conversion Price in effect immediately after such Stock Combination Event Date (and, for the avoidance of doubt, as adjusted following
such Stock Combination Event Date as set forth herein), and (ii) the lowest VWAP of the Common Stock for any Trading Day during the eleven
(11) consecutive Trading Day period commencing on the fifth (5th) Trading Day immediately preceding the Stock Combination Event Date and
ending on the fifth (5th) Trading Day immediately following the Stock Combination Event Date.
(cc) “Excluded Securities”
means (i) shares of Common Stock or standard options to purchase Common Stock issued or issuable to directors, officers, employees or
other service providers of the Company for services rendered to the Company in their capacity as such pursuant to an Approved Stock Plan
(as defined above), provided that (A) all such issuances (taking into account the shares of Common Stock issuable upon exercise of such
options) after the Subscription Date pursuant to this clause (i) do not, in the aggregate, exceed more than 2% of the Common Stock issued
and outstanding immediately prior to the Subscription Date and (B) the exercise price of any such options is not lowered, none of such
options are amended to increase the number of shares issuable thereunder and none of the terms or conditions of any such options are
otherwise materially changed in any manner that adversely affects any of the Buyers (as defined in the Securities Purchase Agreement;
provided further that the foregoing clause (i)(A)(i) shall not apply from August 4, 2025, until November 4, 2025; (ii) shares of Common
Stock issued or issuable upon the conversion or exercise of Convertible Securities (other than standard options to purchase Common Stock
issued or issuable pursuant to an Approved Stock Plan that are covered by clause (i) above) issued prior to the Subscription Date, provided
that the conversion price of any such Convertible Securities (other than standard options to purchase shares of Common Stock issued pursuant
to an Approved Stock Plan that are covered by clause (i) above) is not lowered (other than in accordance with the terms thereof in effect
as of the Subscription Date) from the conversion price in effect as of the Subscription Date (whether pursuant to the terms of such Convertible
Securities or otherwise), none of such Convertible Securities (other than standard options to purchase Common Stock issued pursuant to
an Approved Stock Plan that are covered by clause (i) above) are amended to increase the number of shares issuable thereunder and none
of the terms or conditions of any such Convertible Securities (other than standard options to purchase Common Stock issued pursuant to
an Approved Stock Plan that are covered by clause (i) above) are otherwise materially changed in any manner that adversely affects any
of the Buyers; (iii) the Conversion Shares issuable upon conversion of the Preferred Shares or otherwise pursuant to the terms of this
Certificate of Designations; provided, that the terms of this Certificate of Designations are not amended, modified or changed on or
after the Subscription Date (other than in accordance with the terms thereof, including antidilution adjustments pursuant to the terms
thereof in effect as of the Subscription Date), (iv) the Warrant Shares; provided, that the terms of the Warrants are not amended, modified
or changed on or after the Subscription Date (other than antidilution adjustments pursuant to the terms thereof in effect as of the Subscription
Date), (v) securities issued as consideration for the acquisition of another entity by the Company by merger, purchase of substantially
all of the assets or other reorganization or bona fide joint venture agreement, provided that such issuance is approved by the majority
of the disinterested directors of the Company and provided that such securities are issued as “restricted securities” (as
defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith
during the Restricted Period and such issuance does not, in the aggregate, exceed more than 5% of the shares of Common Stock issued and
outstanding immediately prior to the date hereof and (vi) securities issued pursuant to those certain Restricted Stock and Cash-Settled
Restricted Stock Unit Award Agreements, dated as of December 2, 2024, by and between the Company and each director of the Company, which
includes the issuance of (i) fully vested restricted shares of the Company’s Common Stock issued under the StableX, Inc. Long-Term
Incentive Plan, as amended and (ii) fully vested cash-settled restricted stock units of the Company (the “RSUs”),
representing shares of Common Stock and shares of Common Stock underlying the RSUs in an aggregate amount equal to the quotient of (i)
$713,125 divided by (ii) the Closing Sale Price of the Company’s Common Stock on December 2, 2024.
(dd) “Floor Price”
means $11.904, as of the Effective Date (subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations
or other similar events following the Effective Date) which was 20% of the “Minimum Price” (as defined in Rule 5635 of the
Nasdaq Stock Market) on the Stockholder Approval Date (as defined in the Purchase Agreement) (as adjusted for stock splits, stock dividends,
stock combinations, recapitalizations or other similar events subsequent to the Stockholder Approval Date and prior to the Effective Date)
or, in any case, such lower amount as permitted, from time to time, by the Principal Market.
(ee) “Fundamental Transaction”
means (A) that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related
transactions, (i) consolidate or merge with or into (whether or not the Company is the surviving corporation) another Subject Entity,
or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or assets of the Company or
any of its “significant subsidiaries” (as defined in Rule 1-02 of Regulation S-X) to one or more Subject Entities, or (iii)
make, or allow one or more Subject Entities to make, or allow the Company to be subject to or have its voting stock be subject to or party
to one or more Subject Entities making, a purchase, tender or exchange offer that is accepted by the holders of at least either (x) more
than 50% of the outstanding voting power of the Company, (y) more than 50% of the outstanding voting power of the Company calculated as
if any shares of voting stock held by all Subject Entities making or party to, or Affiliated with any Subject Entities making or party
to, such purchase, tender or exchange offer were not outstanding; or (z) such number of shares of voting stock such that all Subject Entities
making or party to, or Affiliated with any Subject Entity making or party to, such purchase, tender or exchange offer, become collectively
the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of more than 50% of the outstanding voting power of the Company, or
(iv) consummate a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off or scheme of arrangement) with one or more Subject Entities whereby all such Subject Entities, individually or in the aggregate,
acquire, either (x) more than 50% of the outstanding voting power of the Company (y) more than 50% of the outstanding voting power of
the Company calculated as if any shares of voting stock held by all the Subject Entities making or party to, or Affiliated with any Subject
Entity making or party to, such stock purchase agreement or other business combination were not outstanding; or (z) such number of shares
of voting stock of the Company such that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under
the 1934 Act) of more than 50% of the outstanding voting power of the Company, or (v) reorganize, recapitalize or reclassify its Common
Stock, (B) that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related
transactions, allow any Subject Entity individually or the Subject Entities in the aggregate to be or become the “beneficial owner”
(as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, whether through acquisition, purchase, assignment, conveyance,
tender, tender offer, exchange, reduction in outstanding shares of voting stock, merger, consolidation, business combination, reorganization,
recapitalization, spin-off, scheme of arrangement, reorganization, recapitalization or reclassification or otherwise in any manner whatsoever,
of either (x) more than 50% of the aggregate ordinary voting power represented by issued and outstanding shares of voting stock of the
Company, (y) more than 50% of the aggregate ordinary voting power represented by issued and outstanding shares of voting stock of the
Company not held by all such Subject Entities as of the date of this Certificate of Designations calculated as if any shares of voting
stock of the Company held by all such Subject Entities were not outstanding, or (z) a percentage of the aggregate ordinary voting power
represented by issued and outstanding shares of voting stock of the Company or other equity securities of the Company sufficient to allow
such Subject Entities to effect a statutory short form merger or other transaction requiring other stockholders of the Company to surrender
their shares of voting stock of the Company without approval of the stockholders of the Company or (C) directly or indirectly, including
through subsidiaries, Affiliates or otherwise, in one or more related transactions, the issuance of or the entering into any other instrument
or transaction structured in a manner to circumvent, or that circumvents, the intent of this definition in which case this definition
shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this definition to the extent necessary
to correct this definition or any portion of this definition which may be defective or inconsistent with the intended treatment of such
instrument or transaction.
(ff) “GAAP”
means United States generally accepted accounting principles, consistently applied.
(gg) “Group”
means a “group” as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5 thereunder.
(hh) Reserved.
(ii) “Indebtedness”
means of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all obligations issued, undertaken or assumed
as the deferred purchase price of property or services, including, without limitation, “capital leases” in accordance with
United States generally accepted accounting principles consistently applied for the periods covered thereby (other than trade payables
entered into in the ordinary course of business consistent with past practice), (C) all reimbursement or payment obligations with respect
to letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds, debentures or similar
instruments, including obligations so evidenced incurred in connection with the acquisition of property, assets or businesses, (E) all
indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as financing, in either case
with respect to any property or assets acquired with the proceeds of such indebtedness (even though the rights and remedies of the seller
or bank under such agreement in the event of default are limited to repossession or sale of such property), (F) all monetary obligations
under any leasing or similar arrangement which, in connection with United States generally accepted accounting principles, consistently
applied for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F)
above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any mortgage,
deed of trust, lien, pledge, charge, security interest or other encumbrance of any nature whatsoever in or upon any property or assets
(including accounts and contract rights) with respect to any asset or property owned by any Person, even though the Person which owns
such assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all Contingent Obligations in respect
of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G) above.
(jj) Reserved.
(kk) Reserved.
(ll) Reserved.
(mm) Reserved.
(nn) “Intellectual
Property Rights” means, with respect to the Company and its Subsidiaries, all of their rights or licenses to use all trademarks,
trade names, service marks, service mark registrations, service names, original works of authorship, patents, patent rights, copyrights,
inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property rights and all applications
and registrations therefor.
(oo) “Investment”
means any beneficial ownership (including stock, partnership or limited liability company interests) of or in any Person, or any loan,
advance or capital contribution to any Person or the acquisition of all, or substantially all, of the assets of another Person or the
purchase of any assets of another Person for greater than the fair market value of such assets.
(pp) “Liquidation Event”
means, whether in a single transaction or series of transactions, the voluntary or involuntary liquidation, dissolution or winding up
of the Company or such Subsidiaries the assets of which constitute all or substantially all of the assets of the business of the Company
and its Subsidiaries, taken as a whole.
(qq) “Make-Whole Amount”
means, as of any given date and as applicable, in connection with any conversion, redemption or other repayment hereunder, an amount equal
to the amount of additional Dividends that would accrue under this Certificate of Designations at the Dividend Rate then in effect assuming
for calculation purposes that the Stated Value of this Certificate of Designations as of the Closing Date remained outstanding through
and including the twelve (12) month anniversary of the Subscription Date.
(rr) “Material Adverse
Effect” means any material adverse effect on the business, properties, assets, liabilities, operations, results of operations,
condition (financial or otherwise) or prospects of the Company and its Subsidiaries, if any, individually or taken as a whole, or on the
transactions contemplated hereby or on the other Transaction Documents (as defined below), or by the agreements and instruments to be
entered into in connection therewith or on the authority or ability of the Company to perform its obligations under the Transaction Documents.
(ss) “Maturity Date”
shall mean October 27, 2027; provided, however, the Maturity Date may be extended at the option of a Holder (i) in the event that, and
for so long as, a Triggering Event shall have occurred and be continuing or any event shall have occurred and be continuing that with
the passage of time and the failure to cure would result in a Triggering Event or (ii) through the date that is twenty (20) Business Days
after the consummation of a Fundamental Transaction in the event that a Fundamental Transaction is publicly announced or a Change of Control
Notice is delivered prior to the Maturity Date, provided further that if a Holder elects to convert some or all of its Preferred Shares
pursuant to Section 4 hereof, and the Conversion Amount would be limited pursuant to Section 4(d) hereunder, the Maturity Date shall automatically
be extended until such time as such provision shall not limit the conversion of such Preferred Shares.
(tt) “Options”
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.
(uu) “Parent Entity”
of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent equity security
is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent Entity with
the largest public market capitalization as of the date of consummation of the Fundamental Transaction.
(vv) “Permitted Indebtedness”
means (i) Indebtedness existing on January 31, 2023, and reflected on the Company’s balance sheet included in the Company’s
Quarterly Report on Form 10-Q filed with the SEC on May 9, 2023, (ii) Indebtedness secured by Permitted Liens or unsecured but as described
in clauses (iv) and (v) of the definition of Permitted Liens and (iii) if (x) the Stockholder Approval Date has occurred, and (y) less
than 4,400 Preferred Shares remain outstanding, the Permitted Senior Indebtedness.
(ww) “Permitted Liens”
means (i) any Lien for taxes not yet due or delinquent or being contested in good faith by appropriate proceedings for which adequate
reserves have been established in accordance with GAAP, (ii) any statutory Lien arising in the ordinary course of business by operation
of law with respect to a liability that is not yet due or delinquent, (iii) any Lien created by operation of law, such as materialmen’s
liens, mechanics’ liens and other similar liens, arising in the ordinary course of business with respect to a liability that is
not yet due or delinquent or that are being contested in good faith by appropriate proceedings, (iv) Liens (A) upon or in any equipment
acquired or held by the Company or any of its Subsidiaries to secure the purchase price of such equipment or Indebtedness incurred solely
for the purpose of financing the acquisition or lease of such equipment, or (B) existing on such equipment at the time of its acquisition,
provided that the Lien is confined solely to the property so acquired and improvements thereon, and the proceeds of such equipment, in
either case, with respect to Indebtedness in an aggregate amount not to exceed $150,000, (v) Liens incurred in connection with the extension,
renewal or refinancing of the Indebtedness secured by Liens of the type described in clause (iv) above, provided that any extension, renewal
or replacement Lien shall be limited to the property encumbered by the existing Lien and the principal amount of the Indebtedness being
extended, renewed or refinanced does not increase, (vi) Liens in favor of customs and revenue authorities arising as a matter of law to
secure payments of custom duties in connection with the importation of goods, (vii) Liens arising from judgments, decrees or attachments
in circumstances not constituting a Triggering Event under Section 5(a)(vii) and (viii) Liens with respect to the Permitted Senior Indebtedness.
(xx) “Permitted Senior
Indebtedness” means non-convertible Indebtedness issued pursuant to a credit facility with a bank or similar financial institution
with no principal payments required prior to the 91st calendar day after the Maturity
Date and otherwise on terms and conditions acceptable to the Eligible Buyers (as defined in the Securities Purchase Agreement) in their
sole and absolute discretion, provided, however, that the aggregate outstanding principal amount of such Indebtedness permitted
hereunder does not at any time exceed $10 million; provided, further, however, no Permitted Senior Indebtedness shall permit the lender
to accelerate such Permitted Senior Indebtedness as a result of the occurrence of any Triggering Event hereunder or the Holder’s
delivery of a Triggering Event Redemption Notice.
(yy) “Person”
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or a government or any department or agency thereof.
(zz) Reserved.
(aaa) “Principal Market”
means the Nasdaq Capital Market.
(bbb) “Redemption Notices”
means, collectively, the Triggering Event Redemption Notices, the Maturity Redemption Notice and the Change of Control Redemption Notices,
and each of the foregoing, individually, a “Redemption Notice.”
(ccc) “Redemption Premium”
means 130%.
(ddd) “Redemption Prices”
means, collectively, any Triggering Event Redemption Price, Change of Control Redemption Price and Maturity Redemption Price (including
in each case, any interest, damages and Make Whole Amount thereon), and each of the foregoing, individually, a “Redemption Price.”
(eee) “SEC”
means the United States Securities and Exchange Commission or the successor thereto.
(fff) “Securities Purchase
Agreement” means that certain securities purchase agreement by and among the Company and the initial holders of Preferred Shares,
dated as of the Subscription Date, as may be amended from time in accordance with the terms thereof.
(ggg) “Stated Value”
shall mean $1,000 per share, subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications,
combinations, subdivisions or other similar events occurring after the Initial Issuance Date with respect to the Preferred Shares.
(hhh) “Subscription
Date” means August 7, 2023.
(iii) “Subject Entity”
means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.
(jjj) “Subsidiaries”
shall have the meaning as set forth in the Securities Purchase Agreement.
(kkk) “Successor Entity”
means the Person (or, if so elected by the Required Holders, the Parent Entity) formed by, resulting from or surviving any Fundamental
Transaction or the Person (or, if so elected by the Required Holders, the Parent Entity) with which such Fundamental Transaction shall
have been entered into.
(lll) “Trading Day”
means, as applicable, (x) with respect to all price or trading volume determinations relating to the Common Stock, any day on which the
Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market for the Common Stock,
then on the principal securities exchange or securities market on which the Common Stock is then traded, provided that “Trading
Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours
or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange
or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00:00
p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the applicable Holder or (y) with respect
to all determinations other than price determinations relating to the Common Stock, any day on which The New York Stock Exchange (or any
successor thereto) is open for trading of securities.
(mmm) “Transaction
Documents” means the Securities Purchase Agreement, this Certificate of Designations, the Warrants and each of the other agreements
and instruments entered into or delivered by the Company or any of the Holders in connection with the transactions contemplated by the
Securities Purchase Agreement, all as may be amended from time to time in accordance with the terms thereof.
(nnn) Reserved.
(ooo) “VWAP”
means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal Market (or, if the
Principal Market is not the principal trading market for such security, then on the principal securities exchange or securities market
on which such security is then traded), during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time,
as reported by Bloomberg through its “VAP” function (set to 09:30 start time and 16:00 end time) or, if the foregoing does
not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for
such security during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg,
or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing
bid price and the lowest closing ask price of any of the market makers for such security as reported in The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices). If the VWAP cannot be calculated for such security on such date
on any of the foregoing bases, the VWAP of such security on such date shall be the fair market value as mutually determined by the Company
and the Required Holders. If the Company and the Required Holders are unable to agree upon the fair market value of such security, then
such dispute shall be resolved in accordance with the procedures in Section 25. All such determinations shall be appropriately adjusted
for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period.
(ppp) “Warrants”
has the meaning ascribed to such term in the Securities Purchase Agreement, and shall include all warrants issued in exchange therefor
or replacement thereof.
(qqq) “Warrant Shares”
means, collectively, the shares of Common Stock issuable upon exercise of the Warrants.
34. Disclosure. Upon receipt or
delivery by the Company of any notice in accordance with the terms of this Certificate of Designations, unless the Company has in good
faith determined that the matters relating to such notice do not constitute material, non-public information relating to the Company or
any of its Subsidiaries, the Company shall on or prior to 9:00 am, New York city time on the Business Day immediately following such notice
delivery date, publicly disclose such material, non-public information on a Current Report on Form 8-K or otherwise. In the event that
the Company believes that a notice contains material, non-public information relating to the Company or any of its Subsidiaries, the Company
so shall indicate to the Holder explicitly in writing in such notice (or immediately upon receipt of notice from such Holder, as applicable),
and in the absence of any such written indication in such notice (or notification from the Company immediately upon receipt of notice
from such Holder), such Holder shall be entitled to presume that information contained in the notice does not constitute material, non-public
information relating to the Company or any of its Subsidiaries. Nothing contained in this Section 34 shall limit any obligations of the
Company, or any rights of any Holder, under Section 4(l) of the Securities Purchase Agreement.
35. Absence of Trading and Disclosure
Restrictions. The Company acknowledges and agrees that no Holder is a fiduciary or agent of the Company and that each Holder shall
have no obligation to (a) maintain the confidentiality of any information provided by the Company or (b) refrain from trading any securities
while in possession of such information in the absence of a written non-disclosure agreement signed by an officer of such Holder that
explicitly provides for such confidentiality and trading restrictions. In the absence of such an executed, written non-disclosure agreement,
the Company acknowledges that each Holder may freely trade in any securities issued by the Company, may possess and use any information
provided by the Company in connection with such trading activity, and may disclose any such information to any third party.
* * * * *
IN WITNESS WHEREOF, the Company has caused
this Amended and Restated Certificate of Designations of Series H-7 Convertible Preferred Stock of StableX Technologies, Inc. to be signed
by its Chief Executive Officer on this 27th day of April, 2026.
STABLEX TECHNOLOGIES, INC.
By:
/s/ Joshua Silverman
Name:
Joshua Silverman
Title:
Chief Executive Officer
EXHIBIT I
STABLEX TECHNOLOGIES, INC.
CONVERSION NOTICE
Reference is made to the Amended and Restated
Certificate of Designations, Preferences and Rights of the Series H-7 Convertible Preferred Stock of StableX Technologies, Inc. (the “Certificate
of Designations”). In accordance with and pursuant to the Certificate of Designations, the undersigned hereby elects to convert
the number of shares of Series H-7 Convertible Preferred Stock, $0.0001 par value per share (the “Preferred Shares”),
of StableX Technologies, Inc., a Delaware corporation (the “Company”), indicated below into shares of common stock,
$0.0001 value per share (the “Common Stock”), of the Company, as of the date specified below.
Date of Conversion:
Aggregate number of Preferred Shares to be converted
Aggregate Stated Value of such Preferred Shares to be
converted:
Aggregate accrued and unpaid Dividends, Make-Whole Amount and accrued and unpaid Late Charges with respect to such Preferred Shares, such Aggregate Make-Whole
Amount and such Aggregate Dividends to be converted:
AGGREGATE CONVERSION AMOUNT TO BE CONVERTED:
Please confirm the following information:
Conversion Price:
Number of shares of Common Stock to be issued:
☐
If this Conversion Notice is being delivered with respect to an Alternate Conversion, check here if Holder is electing to use the following Alternate Conversion Price:____________
Please issue the Common Stock into which the applicable Preferred
Shares are being converted to Holder, or for its benefit, as follows:
☐
Check here if requesting delivery as a certificate to the following name and to the following address:
Issue to:
☐ Check here
if requesting delivery by Deposit/Withdrawal at Custodian as follows:
DTC Participant:
DTC Number:
Account Number:
Date: _____________ __, ____
Name of Registered Holder
By:
Name:
Title:
Tax
ID:
Address:
EXHIBIT II
ACKNOWLEDGMENT
The Company hereby (a) acknowledges this
Conversion Notice, (b) certifies that the above indicated number of shares of Common Stock are eligible to be resold by the Holder without
restriction or any legend and (c) hereby directs _________________ to issue the above indicated number of shares of Common Stock in accordance
with the Transfer Agent Instructions dated [ ]___, from the Company and acknowledged and agreed to by ________________________.
STABLEX TECHNOLOGIES, INC.
By:
Name:
Title:
EX-3.4
EX-3.4
Filename: ex3-4.htm · Sequence: 5
Exhibit 3.4
AMENDED
AND RESTATED CERTIFICATE OF DESIGNATIONS OF
SERIES
I CONVERTIBLE PREFERRED STOCK OF
STABLEX
TECHNOLOGIES, INC.
This
Amended and Restated Certificate of Designations of Series I Convertible Preferred Stock (this “Certificate of Designations”)
is dated as of April 27, 2026 (the “Effective Date”);
WHEREAS,
the board of directors (the “Board”) of StableX Technologies, Inc. (the “Company”) pursuant to
the authority expressly conferred upon the Board by the Company’s Certificate of Incorporation (the “Certificate of Incorporation”),
and Section 151 of the Delaware General Corporation Law (“DGCL”), has previously fixed the rights, preferences, restrictions
and other matters relating to a series of the Company’s preferred stock, consisting of 7,000 authorized shares of preferred stock,
classified as Series I Convertible Preferred Stock (the “Preferred Stock”), and the Certificate of Designations of
the Preferred Stock (the “Original Certificate of Designations”) evidencing such terms was filed with the Secretary
of State of the State of Delaware on August 6, 2025;
WHEREAS,
pursuant to the authority conferred upon the Board in accordance with the Certificate of Incorporation and the Bylaws of the Company,
the Board has duly adopted a resolution amending and restating the rights of the Preferred Stock, declaring said amendment and restatement
to be advisable and desirable; and
WHEREAS,
this Certificate of Designations has been duly adopted in accordance with Section 151 of the DGCL.
NOW,
THEREFORE, be it resolved, that the Board does hereby provide that the rights set forth in the Original Certificate of Designations are
hereby amended and restated as follows:
TERMS
OF SERIES I CONVERTIBLE PREFERRED STOCK
1.
Designation and Number of Shares. There shall hereby be created and established a series of preferred stock of the Company designated
as “Series I Convertible Preferred Stock” (the “Preferred Shares”). The authorized number of Preferred
Shares shall be seven thousand (7,000) shares. Each Preferred Share shall have a par value of $0.0001. Capitalized terms not defined
herein shall have the meaning as set forth in Section 33 below.
2.
Ranking. Except to the extent that the holders of at least a majority of the outstanding Preferred Shares (the “Required
Holders”) expressly consent to the creation of Parity Stock (as defined below) or Senior Preferred Stock (as defined below)
in accordance with Section 18, all shares of capital stock of the Company shall be junior in rank to all Preferred Shares with
respect to the preferences as to dividends, distributions and payments upon the liquidation, dissolution and winding up of the Company
(such junior stock is referred to herein collectively as “Junior Stock”). The rights of all such shares of capital
stock of the Company shall be subject to the rights, powers, preferences and privileges of the Preferred Shares. Without limiting any
other provision of this Certificate of Designations, without the prior express consent of the Required Holders, voting separately as
a single class, the Company shall not hereafter authorize or issue any additional or other shares of capital stock that are (i) of senior
rank to the Preferred Shares in respect of the preferences as to dividends, distributions and payments upon the liquidation, dissolution
and winding up of the Company (collectively, the “Senior Preferred Stock”), (ii) of pari passu rank to the Preferred
Shares in respect of the preferences as to dividends, distributions and payments upon the liquidation, dissolution and winding up of
the Company (collectively, the “Parity Stock”) or (iii) any Junior Stock having a maturity date or any other date
requiring redemption or repayment of such shares of Junior Stock that is prior to the Maturity Date. In the event of the merger or consolidation
of the Company with or into another corporation, the Preferred Shares shall maintain their relative rights, powers, designations, privileges
and preferences provided for herein and no such merger or consolidation shall be consummated if it would result in the Preferred Shares
being treated in any manner inconsistently with the foregoing. Further to the foregoing, the Preferred Shares shall rank junior to shares
of Series H-7 Convertible Preferred Stock, par value $0.0001 per share (“Series H-7 Preferred Stock”), of the Company
issued and outstanding pursuant to that certain Certificate of Designations establishing the rights, preferences, restrictions and other
matters relating to the Series H-7 Preferred Stock (as may be amended from time to time, the “Series H-7 Certificate of Designations”)
with respect to the preferences as to dividends, distributions and payments upon the liquidation, dissolution and winding up of the Company.
3.
Dividends and Payments.
(a)
From and after the first date of issuance of any Preferred Shares (the “Initial Issuance Date”), each holder of a
Preferred Share (each, a “Holder” and collectively, the “Holders”) shall be entitled to receive
dividends on the Stated Value of the Preferred Shares (“Dividends”) payable, subject to the conditions and other terms
hereof, in cash out of funds legally available therefor at the Dividend Rate computed on the basis of a 360-day year and twelve 30-day
months and shall compound each calendar quarter; provided that a Holder and the Company may mutually agree to convert any Dividends into
shares of Common Stock at a price to be mutually determined by the Company and such Holder, which shall not be less than the Floor Price.
(b)
Dividends shall be payable in arrears on (i) each Dividend Date, and (ii) upon any redemption in accordance with Section 12 or
any required payment upon any Triggering Event. From and after the occurrence and during the continuance of any Triggering Event and
ending on the date on which such Triggering Event is subsequently cured (and no other Triggering Event then exists), Dividends shall
accrue on the Stated Value of each Preferred Share at fifteen percent (15.0%) per annum (the “Default Rate”) and shall
be computed on the basis of a 360-day year and twelve 30-day months.
(c)
On the Maturity Date, the Company shall pay to the Holder an amount in funds legally available therefor equal to the sum of (i) 107%
of the Stated Value of the Preferred Shares held by such Holder, (ii) accrued and unpaid Dividends and (iii) unpaid Late Charges. Other
than as specifically permitted hereunder, the Company may not prepay any portion of the aggregate Stated Value underlying outstanding
Preferred Shares, accrued and unpaid Dividends or accrued and unpaid Late Charges.
4.
Conversion. At any time after the Initial Issuance Date, each Preferred Share shall be convertible into validly issued, fully
paid and non-assessable shares of Common Stock (as defined below), on the terms and conditions set forth in this Section 4.
(a)
Holder’s Conversion Right. Subject to the provisions of Section 4(d), at any time or times on or after the Initial Issuance
Date, each Holder shall be entitled to convert any portion of the outstanding Preferred Shares held by such Holder into validly issued,
fully paid and non-assessable shares of Common Stock in accordance with Section 4(c) at the Conversion Rate (as defined below).
The Company shall not issue any fraction of a share of Common Stock upon any conversion. If the issuance would result in the issuance
of a fraction of a share of Common Stock, the Company shall round such fraction of a share of Common Stock up to the nearest whole share.
The Company shall pay any and all transfer, stamp, issuance and similar taxes, costs and expenses (including, without limitation, fees
and expenses of the Transfer Agent (as defined below)) that may be payable with respect to the issuance and delivery of Common Stock
upon conversion of any Preferred Shares.
(b)
Conversion Rate. The number of shares of Common Stock issuable upon conversion of any Preferred Share pursuant to Section 4(a)
shall be determined by dividing (x) the Conversion Amount of such Preferred Share by (y) the Conversion Price (the “Conversion
Rate”):
(i)
“Conversion Amount” means, with respect to each Preferred Share, as of the applicable date of determination, the sum
of (1) the Stated Value thereof, plus (2) the Additional Amount thereon and any accrued and unpaid Late Charges (as defined below in
Section 26(c)) with respect to such Stated Value and Additional Amount as of such date of determination.
(ii)
“Conversion Price” means, with respect to each Preferred Share, as of any Conversion Date or other date of determination,
$8.00, as of the date of the Original Certificate of Designations and subject to adjustment as provided herein.
(c)
Mechanics of Conversion. The conversion of each Preferred Share shall be conducted in the following manner:
(i)
Optional Conversion. To convert a Preferred Share into shares of Common Stock on any date (a “Conversion Date”), a
Holder shall deliver (whether via electronic mail or otherwise), for receipt on or prior to 11:59 p.m., New York time, on such date,
a copy of an executed notice of conversion of the share(s) of Preferred Shares subject to such conversion in the form attached hereto
as Exhibit I (the “Conversion Notice”) to the Company. If required by Section 4(c)(iii), within
two (2) Trading Days following a conversion of any such Preferred Shares as aforesaid, such Holder shall surrender to a nationally recognized
overnight delivery service for delivery to the Company the original certificates, if any, representing the Preferred Shares (the “Preferred
Share Certificates”) so converted as aforesaid (or an indemnification undertaking with respect to the Preferred Shares in the
case of its loss, theft or destruction as contemplated by Section 20(b)). On or before the first (1st) Trading Day following the
date of receipt of a Conversion Notice, the Company shall transmit by electronic mail an acknowledgment of confirmation and representation
as to whether such shares of Common Stock may then be resold pursuant to Rule 144 or an effective and available registration statement,
in the form attached hereto as Exhibit II, of receipt of such Conversion Notice to such Holder and the Company’s
transfer agent (the “Transfer Agent”), which confirmation shall constitute an instruction to the Transfer Agent to
process such Conversion Notice in accordance with the terms herein. On or before the first (1st) Trading Day following each date on which
the Company has received a Conversion Notice (or such earlier date as required pursuant to the 1934 Act or other applicable law, rule
or regulation for the settlement of a trade initiated on the applicable Conversion Date of such shares of Common Stock issuable pursuant
to such Conversion Notice) (the “Share Delivery Deadline”), the Company shall (1) provided that the Transfer Agent
is participating in the Depository Trust Company’s (“DTC”) Fast Automated Securities Transfer Program (“FAST”),
credit such aggregate number of shares of Common Stock to which such Holder shall be entitled pursuant to such conversion to such Holder’s
or its designee’s balance account with DTC through its Deposit/Withdrawal at Custodian system, or (2) if the Transfer Agent is
not participating in FAST, upon the request of such Holder, issue and deliver (via reputable overnight courier) to the address as specified
in such Conversion Notice, a certificate, registered in the name of such Holder or its designee, for the number of shares of Common Stock
to which such Holder shall be entitled. If the number of Preferred Shares represented by the Preferred Share Certificate(s) submitted
for conversion pursuant to Section 4(c)(iii) is greater than the number of Preferred Shares being converted, then the Company
shall, as soon as practicable and in no event later than two (2) Trading Days after receipt of the Preferred Share Certificate(s) and
at its own expense, issue and deliver to such Holder (or its designee) a new Preferred Share Certificate or a new Book-Entry (in either
case, in accordance with Section 20(d)) representing the number of Preferred Shares not converted. The Person or Persons entitled
to receive the shares of Common Stock issuable upon a conversion of Preferred Shares shall be treated for all purposes as the record
holder or holders of such shares of Common Stock on the Conversion Date. Notwithstanding the foregoing, with respect to any Conversion
Notice delivered by a Buyer (as defined in the Securities Purchase Agreement) to the Company on or prior to 4:00 p.m. (New York City
time) on the Trading Day immediately prior to the date of initial issuance of such applicable Preferred Shares to be converted pursuant
to such Conversion Notice (each, an “Issuance Date”), which may be delivered at any time after the time of execution
of the Securities Purchase Agreement, the Company agrees to deliver the shares of Common Stock issuable upon conversion of such Preferred
Shares to be issued on such date subject to such notice(s) by 4:00 p.m. (New York City time) on such applicable Issuance Date and such
Issuance Date shall be the Share Delivery Deadline for purposes hereunder with respect to such Conversion Notice.
(ii)
Company’s Failure to Timely Convert. If the Company shall fail, for any reason or for no reason, on or prior to the applicable
Share Delivery Deadline, if the Transfer Agent is not participating in FAST, to issue and deliver to such Holder (or its designee) a
certificate for the number of shares of Common Stock to which such Holder is entitled and register such shares of Common Stock on the
Company’s share register or, if the Transfer Agent is participating in FAST, to credit such Holder’s or its designee’s
balance account with DTC for such number of shares of Common Stock to which such Holder is entitled upon such Holder’s conversion
of any Conversion Amount (as the case may be) (a “Conversion Failure”), then, in addition to all other remedies available
to such Holder, (X) the Company shall pay in cash from funds legally available therefor to such Holder on each day after the Share Delivery
Deadline that the issuance of such shares of Common Stock is not timely effected an amount equal to 1% of the product of (A) the sum
of the number of shares of Common Stock not issued to such Holder on or prior to the Share Delivery Deadline and to which such Holder
is entitled, multiplied by (B) any trading price of the Common Stock selected by such Holder in writing as in effect at any time during
the period beginning on the applicable Conversion Date and ending on the applicable Share Delivery Deadline, and (Y) such Holder, upon
written notice to the Company, may void its Conversion Notice with respect to, and retain or have returned, as the case may be, all,
or any portion, of such Preferred Shares that has not been converted pursuant to such Conversion Notice; provided that the voiding
of a Conversion Notice shall not affect the Company’s obligations to make any payments which have accrued prior to the date of
such notice pursuant to this Section 4(c)(ii) or otherwise. In addition to the foregoing, if on or prior to the Share Delivery
Deadline the Transfer Agent is not participating in FAST, the Company shall fail to issue and deliver to such Holder (or its designee)
a certificate and register such shares of Common Stock on the Company’s share register or, if the Transfer Agent is participating
in FAST, the Transfer Agent shall fail to credit the balance account of such Holder or such Holder’s designee, as applicable, with
DTC for the number of shares of Common Stock to which such Holder is entitled upon such Holder’s conversion hereunder or pursuant
to the Company’s obligation pursuant to clause (ii) below, and if on or after such Share Delivery Deadline such Holder acquires
(in an open market transaction, stock loan or otherwise) shares of Common Stock corresponding to all or any portion of the number of
shares of Common Stock issuable upon such conversion that such Holder is entitled to receive from the Company and has not received from
the Company in connection with such Conversion Failure (a “Buy-In”), then, in addition to all other remedies available
to such Holder, the Company shall, within two (2) Business Days after receipt of such Holder’s request and in such Holder’s
discretion, either: (I) pay cash from funds legally available therefor to such Holder in an amount equal to such Holder’s total
purchase price (including brokerage commissions, stock loan costs and other out-of-pocket expenses, if any) for the shares of Common
Stock so acquired (including, without limitation, by any other Person in respect, or on behalf, of such Holder) (the “Buy-In
Price”), at which point the Company’s obligation to so issue and deliver such certificate (and to issue such shares of
Common Stock) or credit to the balance account of such Holder or such Holder’s designee, as applicable, with DTC for the number
of shares of Common Stock to which such Holder is entitled upon such Holder’s conversion hereunder (as the case may be) (and to
issue such shares of Common Stock) shall terminate, or (II) promptly honor its obligation to so issue and deliver to such Holder a certificate
or certificates representing such shares of Common Stock or credit the balance account of such Holder or such Holder’s designee,
as applicable, with DTC for the number of shares of Common Stock to which such Holder is entitled upon such Holder’s conversion
hereunder (as the case may be) and pay cash from funds legally available therefor to such Holder in an amount equal to the excess (if
any) of the Buy-In Price over the product of (x) such number of shares of Common Stock multiplied by (y) the lowest Closing Sale Price
of the Common Stock on any Trading Day during the period commencing on the date of the applicable Conversion Notice and ending on the
date of such issuance and payment under this clause (II). Nothing herein shall limit a Holder’s right to pursue any other remedies
available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief
with respect to the Company’s failure to timely deliver certificates representing shares of Common Stock (or to electronically
deliver such shares of Common Stock) upon the conversion of the Preferred Shares as required pursuant to the terms hereof. Notwithstanding
anything herein to the contrary, with respect to any given Conversion Failure, this Section 4(c)(ii) shall not apply to a Holder
to the extent the Company has already paid such amounts in full to such Holder with respect to such Conversion Failure, as applicable,
pursuant to the analogous sections of the Securities Purchase Agreement.
(iii)
Registration; Book-Entry. At the time of issuance of any Preferred Shares hereunder, the applicable Holder may, by written request
(including by electronic-mail) to the Company, elect to receive such Preferred Shares in the form of one or more Preferred Share Certificates
or in Book-Entry form. The Company (or the Transfer Agent, as custodian for the Preferred Shares) shall maintain a register (the “Register”)
for the recordation of the names and addresses of the Holders of each Preferred Share and the Stated Value of the Preferred Shares and
whether the Preferred Shares are held by such Holder in Preferred Share Certificates or in Book-Entry form (the “Registered
Preferred Shares”). The entries in the Register shall be conclusive and binding for all purposes absent manifest error. The
Company and each Holder of the Preferred Shares shall treat each Person whose name is recorded in the Register as the owner of a Preferred
Share for all purposes (including, without limitation, the right to receive payments and Dividends hereunder) notwithstanding notice
to the contrary. A Registered Preferred Share may be assigned, transferred or sold only by registration of such assignment or sale on
the Register. Upon its receipt of a written request to assign, transfer or sell one or more Registered Preferred Shares by such Holder
thereof, the Company shall record the information contained therein in the Register and issue one or more new Registered Preferred Shares
in the same aggregate Stated Value as the Stated Value of the surrendered Registered Preferred Shares to the designated assignee or transferee
pursuant to Section 19, provided that if the Company does not so record an assignment, transfer or sale (as the case may
be) of such Registered Preferred Shares within two (2) Business Days of such a request, then the Register shall be automatically deemed
updated to reflect such assignment, transfer or sale (as the case may be). Notwithstanding anything to the contrary set forth in this
Section 4, following conversion of any Preferred Shares in accordance with the terms hereof, the applicable Holder shall not be
required to physically surrender such Preferred Shares held in the form of a Preferred Share Certificate to the Company unless (A) the
full or remaining number of Preferred Shares represented by the applicable Preferred Share Certificate are being converted (in which
event such certificate(s) shall be delivered to the Company as contemplated by this Section 4(c)(iii)) or (B) such Holder has
provided the Company with prior written notice (which notice may be included in a Conversion Notice) requesting reissuance of Preferred
Shares upon physical surrender of the applicable Preferred Share Certificate. Each Holder and the Company shall maintain records showing
the Stated Value, Dividends and Late Charges converted and/or paid (as the case may be) and the dates of such conversions and/or payments
(as the case may be) or shall use such other method, reasonably satisfactory to such Holder and the Company, so as not to require physical
surrender of a Preferred Share Certificate upon conversion. If the Company does not update the Register to record such Stated Value,
Dividends and Late Charges converted and/or paid (as the case may be) and the dates of such conversions and/or payments (as the case
may be) within two (2) Business Days of such occurrence, then the Register shall be automatically deemed updated to reflect such occurrence.
In the event of any dispute or discrepancy, such records of such Holder establishing the number of Preferred Shares to which the record
holder is entitled shall be controlling and determinative in the absence of manifest error. A Holder and any transferee or assignee,
by acceptance of a certificate, acknowledge and agree that, by reason of the provisions of this paragraph, following conversion of any
Preferred Shares, the number of Preferred Shares represented by such certificate may be less than the number of Preferred Shares stated
on the face thereof. Each Preferred Share Certificate shall bear the following legend:
ANY
TRANSFEREE OR ASSIGNEE OF THIS CERTIFICATE SHOULD CAREFULLY REVIEW THE TERMS OF THE COMPANY’S CERTIFICATE OF DESIGNATIONS RELATING
TO THE SHARES OF SERIES I PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE, INCLUDING SECTION 4(c)(iii) THEREOF. THE NUMBER OF
SHARES OF SERIES I PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE MAY BE LESS THAN THE NUMBER OF SHARES OF SERIES I PREFERRED STOCK
STATED ON THE FACE HEREOF PURSUANT TO SECTION 4(C)(III) OF THE CERTIFICATE OF DESIGNATIONS RELATING TO THE SHARES OF SERIES I
PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE.
(iv)
Pro Rata Conversion; Disputes. In the event that the Company receives a Conversion Notice from more than one Holder for the same
Conversion Date and the Company can convert some, but not all, of such Preferred Shares submitted for conversion, the Company shall convert
from each Holder electing to have Preferred Shares converted on such date a pro rata amount of such Holder’s Preferred Shares submitted
for conversion on such date based on the number of Preferred Shares submitted for conversion on such date by such Holder relative to
the aggregate number of Preferred Shares submitted for conversion on such date. In the event of a dispute as to the number of shares
of Common Stock issuable to a Holder in connection with a conversion of Preferred Shares, the Company shall issue to such Holder the
number of shares of Common Stock not in dispute and resolve such dispute in accordance with Section 25.
(d)
Limitation on Beneficial Ownership.
(i)
Beneficial Ownership. The Company shall not effect the conversion of any of the Preferred Shares held by a Holder, and such Holder
shall not have the right to convert any of the Preferred Shares held by such Holder pursuant to the terms and conditions of this Certificate
of Designations and any such conversion shall be null and void and treated as if never made, to the extent that after giving effect to
such conversion, such Holder together with the other Attribution Parties collectively would beneficially own in excess of 4.99% (the
“Maximum Percentage”) of the shares of Common Stock outstanding immediately after giving effect to such conversion.
For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such Holder and the other
Attribution Parties shall include the number of shares of Common Stock held by such Holder and all other Attribution Parties plus the
number of shares of Common Stock issuable upon conversion of the Preferred Shares with respect to which the determination of such sentence
is being made, but shall exclude shares of Common Stock which would be issuable upon (A) conversion of the remaining, nonconverted Preferred
Shares beneficially owned by such Holder or any of the other Attribution Parties and (B) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any convertible notes, convertible preferred
stock or warrants, including the Preferred Shares and the Warrants) beneficially owned by such Holder or any other Attribution Party
subject to a limitation on conversion or exercise analogous to the limitation contained in this Section 4(d)(i). For purposes
of this Section 4(d)(i), beneficial ownership shall be calculated in accordance with Section 13(d) of the 1934 Act. In addition,
a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the 1934 Act and
the rules and regulations promulgated thereunder. For purposes of determining the number of outstanding shares of Common Stock a Holder
may acquire upon the conversion of such Preferred Shares without exceeding the Maximum Percentage, such Holder may rely on the number
of outstanding shares of Common Stock as reflected in (x) the Company’s most recent Annual Report on Form 10-K, Quarterly Report
on Form 10-Q, Current Report on Form 8-K or other public filing with the SEC, as the case may be, (y) a more recent public announcement
by the Company or (z) any other written notice by the Company or the Transfer Agent, if any, setting forth the number of shares of Common
Stock outstanding (the “Reported Outstanding Share Number”). If the Company receives a Conversion Notice from a Holder
at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the Company
shall notify such Holder in writing of the number of shares of Common Stock then outstanding and, to the extent that such Conversion
Notice would otherwise cause such Holder’s beneficial ownership, as determined pursuant to this Section 4(d)(i), to exceed
the Maximum Percentage, such Holder must notify the Company of a reduced number of shares of Common Stock to be purchased pursuant to
such Conversion Notice. For any reason at any time, upon the written or oral request of any Holder, the Company shall within one (1)
Business Day confirm orally and in writing or by electronic mail to such Holder the number of shares of Common Stock then outstanding.
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including such Preferred Shares, by such Holder and any other Attribution Party since the date as of which
the Reported Outstanding Share Number was reported. In the event that the issuance of shares of Common Stock to a Holder upon conversion
of such Preferred Shares results in such Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate,
more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section 13(d) of the
1934 Act), the number of shares so issued by which such Holder’s and the other Attribution Parties’ aggregate beneficial
ownership exceeds the Maximum Percentage (the “Excess Shares”) shall be deemed null and void and shall be cancelled
ab initio, and such Holder shall not have the power to vote or to transfer the Excess Shares. Upon delivery of a written notice to the
Company, any Holder may from time to time increase (with such increase not effective until the sixty-first (61st) day after delivery
of such notice) or decrease the Maximum Percentage of such Holder to any other percentage not in excess of 9.99% as specified in such
notice; provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after
such notice is delivered to the Company and (ii) any such increase or decrease will apply only to such Holder and the other Attribution
Parties and not to any other Holder that is not an Attribution Party of such Holder. For purposes of clarity, the shares of Common Stock
issuable to a Holder pursuant to the terms of this Certificate of Designations in excess of the Maximum Percentage shall not be deemed
to be beneficially owned by such Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act.
No prior inability to convert such Preferred Shares pursuant to this paragraph shall have any effect on the applicability of the provisions
of this paragraph with respect to any subsequent determination of convertibility. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 4(d)(i) to the extent necessary
to correct this paragraph (or any portion of this paragraph) which may be defective or inconsistent with the intended beneficial ownership
limitation contained in this Section 4(d)(i) or to make changes or supplements necessary or desirable to properly give effect
to such limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor holder of such Preferred
Shares.
(ii)
Principal Market Regulation. The Company shall not issue any shares of Common Stock upon conversion of any Preferred Shares or
otherwise pursuant to the terms of this Certificate of Designations if the issuance of such shares of Common Stock (taken together with
the issuance of all other shares of Common Stock upon exercise of the Warrants) would exceed the aggregate number of shares of Common
Stock which the Company may issue upon exercise or conversion (as the case may be) of the Preferred Shares and the Warrants without breaching
the Company’s obligations under the rules and regulations of the Principal Market (the number of shares which may be issued without
violating such rules and regulations, including, but not limited to, rules related to the aggregate offerings under Nasdaq Listing Rule
5635(d), the “Exchange Cap”), except that such limitation shall not apply in the event that the Company (A) obtains
the approval of its stockholders as required by the applicable rules and regulations of the Principal Market for issuances of shares
of Common Stock in excess of such amount (“Stockholder Approval”) or (B) obtains a written opinion from outside counsel
to the Company that such approval is not required, which opinion shall be reasonably satisfactory to the Required Holders. Until such
approval or such written opinion is obtained, no Holder shall be issued in the aggregate, upon conversion or exercise (as the case may
be) of any Preferred Shares or any Warrant, shares of Common Stock in an amount greater than the product of (i) the Exchange Cap as of
the Initial Issuance Date multiplied by (ii) the quotient of (1) the aggregate number of Preferred Shares issued to such Holder on the
Initial Issuance Date divided by (2) the aggregate number of Preferred Shares issued to the Holders on the Initial Issuance Date (with
respect to each Holder, the “Exchange Cap Allocation”). In the event that any Holder shall sell or otherwise transfer
any of such Holder’s Preferred Shares, the transferee shall be allocated a pro rata portion of such Holder’s Exchange Cap
Allocation with respect to such portion of such Preferred Shares so transferred, and the restrictions of the prior sentence shall apply
to such transferee with respect to the portion of the Exchange Cap Allocation so allocated to such transferee. Upon conversion in full
of a holder’s Preferred Shares, the difference (if any) between such holder’s Exchange Cap Allocation and the number of shares
of Common Stock actually issued to such holder upon such holder’s conversion in full of such Preferred Shares shall be allocated,
to the respective Exchange Cap Allocations of the remaining holders of Preferred Shares and/or related Warrants on a pro rata basis in
proportion to the shares of Common Stock underlying the Preferred Shares and/or related Warrants then held by each such holder of Preferred
Shares and/or related Warrants.
(e)
Right of Alternate Conversion.
(i)
Alternate Conversion Upon a Triggering Event. Subject to Section 4(d), at any time during a Triggering Event Redemption Right
Period (as defined herein), such Holder may, at such Holder’s option, by delivery of a Conversion Notice to the Company (the date
of any such Conversion Notice, each an “Alternate Conversion Date”), convert all, or any number of Preferred Shares
(such Conversion Amount of the Preferred Shares to be converted pursuant to this Section 4(e)(ii), each, an “Alternate
Conversion Amount”) held by such Holder into shares of Common Stock at the Alternate Conversion Price (each an “Alternate
Conversion”).
(ii)
Mechanics of Alternate Conversion. On any Alternate Conversion Date, a Holder may voluntarily convert any Alternate Conversion
Amount of Preferred Shares pursuant to Section 4(c) (with “Alternate Conversion Price” replacing “Conversion
Price” for all purposes hereunder with respect to such Alternate Conversion and with “Alternate Conversion Amount”
replacing “Conversion Amount” in clause (x) of the definition of Conversion Rate above with respect to such Alternate
Conversion) by designating in the Conversion Notice delivered pursuant to this Section 4(e) of this Certificate of Designations
that such Holder is electing to use the Alternate Conversion Price for such conversion; provided that in the event of the Conversion
Floor Price Condition, on the applicable Alternate Conversion Date the Company shall also deliver to the Holder the applicable Alternate
Conversion Floor Amount. Notwithstanding anything to the contrary in this Section 4(e), but subject to Section 4(d), until
the Company delivers shares of Common Stock representing the applicable Alternate Conversion Amount of Preferred Shares to such Holder,
such Preferred Shares may be converted by such Holder into shares of Common Stock pursuant to Section 4(c) without regard to this
Section 4(e).
5.
Triggering Event Redemptions.
(a)
Triggering Event. Each of the following events shall constitute a “Triggering Event” and each of the events in clauses
(viii), (ix), and (x) shall constitute a “Bankruptcy Triggering Event”:
(i)
the suspension from trading or the failure of the Common Stock to be trading or listed (as applicable) on an Eligible Market for a period
of five (5) consecutive Trading Days;
(ii)
the Company’s (A) failure to cure a Conversion Failure or a Delivery Failure (as defined in the Warrants) by delivery of the required
number of shares of Common Stock within five (5) Trading Days after the applicable Conversion Date or exercise date (as the case may
be) or (B) written notice to any holder of Preferred Shares or Warrants, including, without limitation, by way of public announcement
or through any of its agents, at any time, of its intention not to comply, as required, with a request for exercise of any Warrants for
Warrant Shares in accordance with the provisions of the Warrants or a request for conversion of any Preferred Shares into shares of Common
Stock that is requested in accordance with the provisions of this Certificate of Designations, other than pursuant to Section 4(d)
hereof;
(iii)
except to the extent the Company is in compliance with Section 11(b) below, at any time following the tenth (10th) consecutive
day that a Holder’s Authorized Share Allocation (as defined in Section 11(a) below) is less than the sum of (A) 200% of
the number of shares of Common Stock that such Holder would be entitled to receive upon a conversion, in full, of all of the Preferred
Shares then held by such Holder (assuming a conversion at the Floor Price then in effect and without regard to any limitations on conversion
set forth in this Certificate of Designations) and (B) 200% of the number of shares of Common Stock that such Holder would then be entitled
to receive upon exercise in full of such Holder’s Warrants (without regard to any limitations on exercise set forth in the Warrants);
(iv)
subject to the provisions of Section 170 of the DGCL, the Board fails to declare any Dividend to be paid on the applicable Dividend Date
in accordance with Section 3 hereof;
(v)
the Company’s failure to pay to any Holder any Dividend on any Dividend Date (whether or not declared by the Board) or any other
amount when and as due under this Certificate of Designations (including, without limitation, the Company’s failure to pay any
redemption payments or other amounts hereunder), the Securities Purchase Agreement or any other Transaction Document or any other agreement,
document, certificate or other instrument delivered in connection with the transactions contemplated hereby and thereby (in each case,
whether or not permitted pursuant to the DGCL), except, solely with respect to the failure to pay Dividends and Late Charges when and
as due hereunder, only if such failure remains uncured for a period of at least five (5) Trading Days;
(vi)
the Company fails to remove any restrictive legend on any certificate or any shares of Common Stock issued to the applicable Holder upon
conversion or exercise (as the case may be) of any Securities (as defined in the Securities Purchase Agreement) acquired by such Holder
under the Transaction Documents as and when required by such Securities or the Securities Purchase Agreement, as applicable, unless otherwise
then prohibited by applicable federal securities laws, and any such failure remains uncured for at least five (5) Trading Days;
(vii)
the occurrence of any default under, redemption of or acceleration prior to maturity of at least an aggregate of $250,000 of Indebtedness
(as defined in the Securities Purchase Agreement) of the Company or any of its Subsidiaries;
(viii)
bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings for the relief of debtors shall be instituted
by or against the Company or any Subsidiary and, if instituted against the Company or any Subsidiary by a third party, shall not be dismissed
within thirty (30) days of their initiation;
(ix)
the commencement by the Company or any Subsidiary of a voluntary case or proceeding under any applicable federal, state or foreign bankruptcy,
insolvency, reorganization or other similar law or of any other case or proceeding to be adjudicated a bankrupt or insolvent, or the
consent by it to the entry of a decree, order, judgment or other similar document in respect of the Company or any Subsidiary in an involuntary
case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or to the
commencement of any bankruptcy or insolvency case or proceeding against it, or the filing by it of a petition or answer or consent seeking
reorganization or relief under any applicable federal, state or foreign law, or the consent by it to the filing of such petition or to
the appointment of or taking possession by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official
of the Company or any Subsidiary or of any substantial part of its property, or the making by it of an assignment for the benefit of
creditors, or the execution of a composition of debts, or the occurrence of any other similar federal, state or foreign proceeding, or
the admission by it in writing of its inability to pay its debts generally as they become due, the taking of corporate action by the
Company or any Subsidiary in furtherance of any such action or the taking of any action by any Person to commence a Uniform Commercial
Code foreclosure sale or any other similar action under federal, state or foreign law;
(x)
the entry by a court of (i) a decree, order, judgment or other similar document in respect of the Company or any Subsidiary of a voluntary
or involuntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar
law or (ii) a decree, order, judgment or other similar document adjudging the Company or any Subsidiary as bankrupt or insolvent, or
approving as properly filed a petition seeking liquidation, reorganization, arrangement, adjustment or composition of or in respect of
the Company or any Subsidiary under any applicable federal, state or foreign law or (iii) a decree, order, judgment or other similar
document appointing a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or any
Subsidiary or of any substantial part of its property, or ordering the winding up or liquidation of its affairs, and the continuance
of any such decree, order, judgment or other similar document or any such other decree, order, judgment or other similar document unstayed
and in effect for a period of thirty (30) consecutive days;
(xi)
a final judgment or judgments for the payment of money aggregating in excess of $250,000 are rendered against the Company and/or any
of its Subsidiaries and which judgments are not, within thirty (30) days after the entry thereof, bonded, discharged, settled or stayed
pending appeal, or are not discharged within thirty (30) days after the expiration of such stay; provided, however, any
judgment which is covered by insurance or an indemnity from a credit worthy party shall not be included in calculating the $250,000 amount
set forth above so long as the Company provides each Holder a written statement from such insurer or indemnity provider (which written
statement shall be reasonably satisfactory to each Holder) to the effect that such judgment is covered by insurance or an indemnity and
the Company or such Subsidiary (as the case may be) will receive the proceeds of such insurance or indemnity within thirty (30) days
of the issuance of such judgment;
(xii)
the Company and/or any Subsidiary, individually or in the aggregate, either (i) fails to pay, when due, or within any applicable grace
period, any payment with respect to any Indebtedness in excess of $250,000 due to any third party (other than, with respect to unsecured
Indebtedness only, payments contested by the Company and/or such Subsidiary (as the case may be) in good faith by proper proceedings
and with respect to which adequate reserves have been set aside for the payment thereof in accordance with GAAP) or is otherwise in breach
or violation of any agreement for monies owed or owing in an amount in excess of $250,000, which breach or violation permits the other
party thereto to declare a default or otherwise accelerate amounts due thereunder, or (ii) suffer to exist any other circumstance or
event that would, with or without the passage of time or the giving of notice, result in a default or event of default under any agreement
binding the Company or any Subsidiary, which default or event of default would or is likely to have a material adverse effect on the
business, assets, operations (including results thereof), liabilities, properties, condition (including financial condition) or prospects
of the Company or any of its Subsidiaries, individually or in the aggregate, but only if such failure or occurrence remains uncured for
a period of at least five (5) days;
(xiii)
other than as specifically set forth in another clause of this Section 5(a), the Company or any Subsidiary breaches any representation
or warranty in any material respect (other than representations or warranties subject to material adverse effect or materiality, which
may not be breached in any respect) or any covenant or other term or condition of any Transaction Document, except, in the case of a
breach of a covenant or other term or condition that is curable, only if such breach remains uncured for a period of five (5) consecutive
Trading Days;
(xiv)
a false or inaccurate certification (including a false or inaccurate deemed certification) by the Company as to whether any Triggering
Event has occurred;
(xv)
any breach or failure in any respect by the Company or any Subsidiary to comply with any provision of Section 15(m) of this Certificate
of Designations;
(xvi)
any Material Adverse Effect (as defined in the Securities Purchase Agreement) occurs that has not been cured, if capable of curing, within
five (5) Trading Days of the occurrence; or
(xvii)
any provision of any Transaction Document shall at any time for any reason (other than pursuant to the express terms thereof) cease to
be valid and binding on or enforceable against the Company, or the validity or enforceability thereof shall be contested, directly or
indirectly, by the Company or any Subsidiary, or a proceeding shall be commenced by the Company or any Subsidiary or any governmental
authority having jurisdiction over any of them, seeking to establish the invalidity or unenforceability thereof or the Company or any
of its Subsidiaries shall deny in writing that it has any liability or obligation purported to be created under one or more Transaction
Documents.
(b)
Notice of a Triggering Event; Redemption Right. Upon the occurrence of a Triggering Event with respect to the Preferred Shares,
the Company shall within one (1) Business Day deliver written notice thereof via electronic mail and overnight courier (with next day
delivery specified) (a “Triggering Event Notice”) to each Holder. At any time after the earlier of a Holder’s
receipt of a Triggering Event Notice and such Holder becoming aware of a Triggering Event (such earlier date, the “Triggering
Event Right Commencement Date”) and ending (such ending date, the “Triggering Event Right Expiration Date”,
and each such period, a “Triggering Event Redemption Right Period”) on the fifteenth (15th) Trading Day after the
later of (x) the later of (1) the date such Triggering Event is cured and (2) the date the Company delivers written notice to the Holders
that such Triggering Event has been cured and (y) such Holder’s receipt of a Triggering Event Notice that includes (I) a reasonable
description of the applicable Triggering Event, (II) a certification as to whether, in the opinion of the Company, such Triggering Event
is capable of being cured and, if applicable, a reasonable description of any existing plans of the Company to cure such Triggering Event
and (III) a certification as to the date the Triggering Event occurred and, if cured on or prior to the date of such Triggering Event
Notice, the applicable Triggering Event Right Expiration Date, such Holder may require the Company to redeem (regardless of whether such
Triggering Event has been cured on or prior to the Triggering Event Right Expiration Date) all or any of the Preferred Shares by delivering
written notice thereof (the “Triggering Event Redemption Notice”) to the Company, which Triggering Event Redemption
Notice shall indicate the number of the Preferred Shares such Holder is electing to redeem. Each of the Preferred Shares subject to redemption
by the Company pursuant to this Section 5(b) shall be redeemed by the Company at a price equal to the greater of (i) the product
of (A) the Conversion Amount to be redeemed multiplied by (B) the Redemption Premium and (ii) the product of (X) the Conversion Rate
with respect to the Conversion Amount in effect at such time as such Holder delivers a Triggering Event Redemption Notice multiplied
by (Y) the product of (1) the Redemption Premium multiplied by (2) the greatest Closing Sale Price of the Common Stock on any Trading
Day during the period commencing on the date immediately preceding such Triggering Event and ending on the date the Company makes the
entire payment required to be made under this Section 5(b) (the “Triggering Event Redemption Price”). Redemptions
required by this Section 5(b) shall be made in accordance with the provisions of Section 12. To the extent redemptions
required by this Section 5(b) are deemed or determined by a court of competent jurisdiction to be prepayments of the Preferred
Shares by the Company, such redemptions shall be deemed to be voluntary prepayments. Notwithstanding anything to the contrary in this
Section 5(b), but subject to Section 4(d), until the Triggering Event Redemption Price (together with any Late Charges
thereon) is paid in full, the Conversion Amount submitted for redemption under this Section 5(b) (together with any Late Charges
thereon) may be converted, in whole or in part, by such Holder into Common Stock pursuant to the terms of this Certificate of Designations.
In the event of the Company’s redemption of any of the Preferred Shares under this Section 5(b), a Holder’s damages
would be uncertain and difficult to estimate because of the parties’ inability to predict future interest rates and the uncertainty
of the availability of a suitable substitute investment opportunity for such Holder. Accordingly, any redemption premium due under this
Section 5(b) is intended by the parties to be, and shall be deemed, a reasonable estimate of such Holder’s actual loss of
its investment opportunity and not as a penalty. Any redemption upon a Triggering Event shall not constitute an election of remedies
by the applicable Holder or any other Holder, and all other rights and remedies of each Holder shall be preserved.
(c)
Mandatory Redemption upon Bankruptcy Triggering Event. Notwithstanding anything to the contrary herein, and notwithstanding any
conversion that is then required or in process, upon any Bankruptcy Triggering Event, whether occurring prior to or following the Maturity
Date, the Company shall immediately redeem, out of funds legally available therefor, each of the Preferred Shares then outstanding at
a redemption price equal to the applicable Triggering Event Redemption Price (calculated as if such Holder shall have delivered the Triggering
Event Redemption Notice immediately prior to the occurrence of such Bankruptcy Triggering Event), without the requirement for any notice
or demand or other action by any Holder or any other person or entity, provided that a Holder may, in its sole discretion, waive
such right to receive payment upon a Bankruptcy Triggering Event, in whole or in part, and any such waiver shall not affect any other
rights of such Holder or any other Holder hereunder, including any other rights in respect of such Bankruptcy Triggering Event, any right
to conversion, and any right to payment of such Triggering Event Redemption Price or any other Redemption Price, as applicable.
6.
Rights Upon Fundamental Transactions.
(a)
Assumption. The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity (if the
Successor Entity is not the Company) assumes in writing all of the obligations of the Company under this Certificate of Designations
and the other Transaction Documents in accordance with the provisions of this Section 6(a) pursuant to written agreements in form
and substance satisfactory to the Required Holders and approved by the Required Holders prior to such Fundamental Transaction, including
agreements to deliver to each holder of Preferred Shares in exchange for such Preferred Shares a security of the Successor Entity evidenced
by a written instrument substantially similar in form and substance to this Certificate of Designations, including, without limitation,
having a stated value and dividend rate equal to the stated value and dividend rate of the Preferred Shares held by the Holders and having
similar ranking to the Preferred Shares, and satisfactory to the Required Holders and (ii) the Successor Entity (including its Parent
Entity) is a publicly traded corporation whose shares of common stock are quoted on or listed for trading on an Eligible Market. Upon
the occurrence of any Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after
the date of such Fundamental Transaction, the provisions of this Certificate of Designations and the other Transaction Documents referring
to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company
and shall assume all of the obligations of the Company under this Certificate of Designations and the other Transaction Documents with
the same effect as if such Successor Entity had been named as the Company herein and therein. In addition to the foregoing, upon consummation
of a Fundamental Transaction, the Successor Entity (if the Successor Entity is not the Company) shall deliver to each Holder confirmation
that there shall be issued upon conversion or redemption of the Preferred Shares at any time after the consummation of such Fundamental
Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property (except such items still issuable
under Sections 7 and 17, which shall continue to be receivable thereafter)) issuable upon the conversion or redemption
of the Preferred Shares prior to such Fundamental Transaction, such shares of the publicly traded common stock (or their equivalent)
of the Successor Entity (including its Parent Entity) which each Holder would have been entitled to receive upon the happening of such
Fundamental Transaction had all the Preferred Shares held by each Holder been converted immediately prior to such Fundamental Transaction
(without regard to any limitations on the conversion of the Preferred Shares contained in this Certificate of Designations), as adjusted
in accordance with the provisions of this Certificate of Designations. Notwithstanding the foregoing, such Holder may elect, at its sole
option, by delivery of written notice to the Company to waive this Section 6(a) to permit the Fundamental Transaction without
the assumption of the Preferred Shares. The provisions of this Section 6 shall apply similarly and equally to successive Fundamental
Transactions and shall be applied without regard to any limitations on the conversion or redemption of the Preferred Shares.
(b)
Notice of a Change of Control Redemption Right. No sooner than twenty (20) Trading Days nor later than ten (10) Trading Days prior
to the consummation of a Change of Control (the “Change of Control Date”), but not prior to the public announcement
of such Change of Control, the Company shall deliver written notice thereof via electronic mail and overnight courier to each Holder
(a “Change of Control Notice”). At any time during the period beginning after a Holder’s receipt of a Change
of Control Notice or such Holder becoming aware of a Change of Control if a Change of Control Notice is not delivered to such Holder
in accordance with the immediately preceding sentence (as applicable) and ending on the later of (A) the date of consummation of such
Change of Control or (B) twenty (20) Trading Days after the date of receipt of such Change of Control Notice or (C) twenty (20) Trading
Days after the date of the announcement of such Change of Control, such Holder may require the Company to redeem all or any portion of
such Holder’s Preferred Shares by delivering written notice thereof (“Change of Control Redemption Notice”)
to the Company, which Change of Control Redemption Notice shall indicate the number of Preferred Shares such Holder is electing to have
the Company redeem. Each Preferred Share subject to redemption pursuant to this Section 6(b) shall be redeemed by the Company
in funds legally available therefor at a price equal to the greatest of (i) the product of (x) the Change of Control Redemption Premium
multiplied by (y) the Conversion Amount of the Preferred Shares being redeemed, (ii) the product of (x) the Change of Control Redemption
Premium multiplied by (y) the product of (A) the Conversion Amount of the Preferred Shares being redeemed multiplied by (B) the quotient
determined by dividing (I) the greatest Closing Sale Price of the shares of Common Stock during the period beginning on the date immediately
preceding the earlier to occur of (1) the consummation of the applicable Change of Control and (2) the public announcement of such Change
of Control and ending on the date such Holder delivers the Change of Control Redemption Notice by (II) the Conversion Price then in effect
and (iii) the product of (y) the Change of Control Redemption Premium multiplied by (z) the product of (A) the Conversion Amount of the
Preferred Shares being redeemed multiplied by (B) the quotient of (I) the aggregate cash consideration and the aggregate cash value of
any non-cash consideration per share of Common Stock to be paid to such holders of the shares of Common Stock upon consummation of such
Change of Control (any such non-cash consideration constituting publicly-traded securities shall be valued at the highest of the Closing
Sale Price of such securities as of the Trading Day immediately prior to the consummation of such Change of Control, the Closing Sale
Price of such securities on the Trading Day immediately following the public announcement of such proposed Change of Control and the
Closing Sale Price of such securities on the Trading Day immediately prior to the public announcement of such proposed Change of Control)
divided by (II) the Conversion Price then in effect (the “Change of Control Redemption Price”). Redemptions required
by this Section 6(b) shall have priority to payments to all other stockholders of the Company in connection with such Change of
Control. To the extent redemptions required by this Section 6(b) are deemed or determined by a court of competent jurisdiction
to be prepayments of the Preferred Shares by the Company, such redemptions shall be deemed to be voluntary prepayments. Notwithstanding
anything to the contrary in this Section 6(b), but subject to Section 4(d), until the applicable Change of Control Redemption
Price (together with any Late Charges thereon) is paid in full to the applicable Holder, the Preferred Shares submitted by such Holder
for redemption under this Section 6(b) may be converted, in whole or in part, by such Holder into Common Stock pursuant to Section
4 or in the event the Conversion Date is after the consummation of such Change of Control, stock or equity interests of the Successor
Entity substantially equivalent to the Company’s shares of Common Stock pursuant to Section 4. In the event of the Company’s
redemption of any of the Preferred Shares under this Section 6(b), such Holder’s damages would be uncertain and difficult
to estimate because of the parties’ inability to predict future interest rates and the uncertainty of the availability of a suitable
substitute investment opportunity for a Holder. Accordingly, any redemption premium due under this Section 6(b) is intended by
the parties to be, and shall be deemed, a reasonable estimate of such Holder’s actual loss of its investment opportunity and not
as a penalty. The Company shall make payment of the applicable Change of Control Redemption Price concurrently with the consummation
of such Change of Control if a Change of Control Redemption Notice is received prior to the consummation of such Change of Control and
within two (2) Trading Days after the Company’s receipt of such notice otherwise (the “Change of Control Redemption Date”).
Redemptions required by this Section 6 shall be made in accordance with the provisions of Section 12.
7.
Rights Upon Issuance of Purchase Rights and Other Corporate Events.
(a)
Purchase Rights. In addition to any adjustments pursuant to Section 8 below, if at any time the Company grants, issues
or sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to all or substantially
all of the record holders of any class of Common Stock (the “Purchase Rights”), then each Holder will be entitled
to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which such Holder could have acquired if
such Holder had held the number of shares of Common Stock acquirable upon complete conversion of all the Preferred Shares (without taking
into account any limitations or restrictions on the convertibility of the Preferred Shares and assuming for such purpose that all the
Preferred Shares were converted at the Floor Price as of the applicable record date) held by such Holder immediately prior to the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided,
however, to the extent that such Holder’s right to participate in any such Purchase Right would result in such Holder and
the other Attribution Parties exceeding the Maximum Percentage, then such Holder shall not be entitled to participate in such Purchase
Right to such extent of the Maximum Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a
result of such Purchase Right (and beneficial ownership) to such extent of any such excess) and such Purchase Right to such extent shall
be held in abeyance (and, if such Purchase Right has an expiration date, maturity date or other similar provision, such term shall be
extended by such number of days held in abeyance, if applicable) for the benefit of such Holder until such time or times, if ever, as
its right thereto would not result in such Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or
times such Holder shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on any
subsequent Purchase Right held similarly in abeyance (and, if such Purchase Right has an expiration date, maturity date or other similar
provision, such term shall be extended by such number of days held in abeyance, if applicable)) to the same extent as if there had been
no such limitation).
(b)
Other Corporate Events. In addition to and not in substitution for any other rights hereunder, prior to the consummation of any
Fundamental Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets with respect
to or in exchange for shares of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to
ensure that each Holder will thereafter have the right, at such Holder’s option, to receive upon a conversion of all the Preferred
Shares held by such Holder (i) in addition to the shares of Common Stock receivable upon such conversion, such securities or other assets
to which such Holder would have been entitled with respect to such shares of Common Stock had such shares of Common Stock been held by
such Holder upon the consummation of such Corporate Event (without taking into account any limitations or restrictions on the convertibility
of the Preferred Shares set forth in this Certificate of Designations) or (ii) in lieu of the shares of Common Stock otherwise receivable
upon such conversion, such securities or other assets received by the holders of shares of Common Stock in connection with the consummation
of such Corporate Event in such amounts as such Holder would have been entitled to receive had the Preferred Shares held by such Holder
initially been issued with conversion rights for the form of such consideration (as opposed to shares of Common Stock) at a conversion
rate for such consideration commensurate with the Conversion Rate. Provision made pursuant the preceding sentence shall be in a form
and substance satisfactory to the Required Holders. The provisions of this Section 7 shall apply similarly and equally to successive
Corporate Events and shall be applied without regard to any limitations on the conversion or redemption of the Preferred Shares set forth
in this Certificate of Designations.
8.
Rights Upon Issuance of Other Securities.
(a)
Adjustment of Conversion Price upon Issuance of Common Stock. If and whenever on or after the Subscription Date the Company grants,
issues or sells (or enters into any agreement or publicly announces its intention to grant, issue or sell), or in accordance with this
Section 8(a) is deemed to have granted, issued or sold, any shares of Common Stock (including the granting, issuance or sale of
shares of Common Stock owned or held by or for the account of the Company, but excluding any Excluded Securities granted, issued or sold
or deemed to have been granted, issued or sold) for a consideration per share (the “New Issuance Price”) less than
a price equal to the Conversion Price in effect immediately prior to such granting, issuance or sale or deemed granting, issuance or
sale (such Conversion Price then in effect is referred to herein as the “Applicable Price”) (the foregoing a “Dilutive
Issuance”), then, immediately after such Dilutive Issuance, the Conversion Price then in effect shall be reduced to an amount
equal to the New Issuance Price. For all purposes of the foregoing (including, without limitation, determining the adjusted Conversion
Price and the New Issuance Price under this Section 8(a)), the following shall be applicable:
(i)
Issuance of Options. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell)
any Options and the lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such
Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise
pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and
to have been issued and sold by the Company at the time of the granting, issuance or sale of such Option for such price per share. For
purposes of this Section 8(a)(i), the “lowest price per share for which one share of Common Stock is at any time issuable
upon the exercise of any such Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of
any such Option or otherwise pursuant to the terms thereof” shall be equal to (1) the lower of (x) the sum of the lowest amounts
of consideration (if any) received or receivable by the Company with respect to any one share of Common Stock upon the granting, issuance
or sale of such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon
exercise of such Option or otherwise pursuant to the terms thereof and (y) the lowest exercise price set forth in such Option for which
one share of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon the exercise of any such
Options or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise
pursuant to the terms thereof, minus (2) the sum of all amounts paid or payable to the holder of such Option (or any other Person) with
respect to any one share of Common Stock upon the granting, issuance or sale of such Option, upon exercise of such Option and upon conversion,
exercise or exchange of any Convertible Security issuable upon exercise of such Option or otherwise pursuant to the terms thereof plus
the value of any other consideration received or receivable by, or benefit conferred on, the holder of such Option (or any other Person).
Except as contemplated below, no further adjustment of the Conversion Price shall be made upon the actual issuance of such share of Common
Stock or of such Convertible Securities upon the exercise of such Options or otherwise pursuant to the terms thereof or upon the actual
issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities.
(ii)
Issuance of Convertible Securities. If the Company in any manner issues or sells (or enters into any agreement to issue or sell)
any Convertible Securities and the lowest price per share for which one share of Common Stock is at any time issuable upon the conversion,
exercise or exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share of Common
Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale (or the time
of execution of such agreement to issue or sell, as applicable) of such Convertible Securities for such price per share. For the purposes
of this Section 8(a)(ii), the “lowest price per share for which one share of Common Stock is at any time issuable upon the
conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof” shall be equal to (1) the lower of (x) the
sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to one share of Common Stock upon
the issuance or sale (or pursuant to the agreement to issue or sell, as applicable) of the Convertible Security and upon conversion,
exercise or exchange of such Convertible Security or otherwise pursuant to the terms thereof and (y) the lowest conversion price set
forth in such Convertible Security for which one share of Common Stock is issuable (or may become issuable assuming all possible market
conditions) upon conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof minus (2) the sum of all amounts
paid or payable to the holder of such Convertible Security (or any other Person) with respect to any one share of Common Stock upon the
issuance or sale (or the agreement to issue or sell, as applicable) of such Convertible Security plus the value of any other consideration
received or receivable by, or benefit conferred on, the holder of such Convertible Security (or any other Person). Except as contemplated
below, no further adjustment of the Conversion Price shall be made upon the actual issuance of such shares of Common Stock upon conversion,
exercise or exchange of such Convertible Securities or otherwise pursuant to the terms thereof, and if any such issuance or sale of such
Convertible Securities is made upon exercise of any Options for which adjustment of the Conversion Price has been or is to be made pursuant
to other provisions of this Section 8(a), except as contemplated below, no further adjustment of the Conversion Price shall be
made by reason of such issuance or sale.
(iii)
Change in Option Price or Rate of Conversion. If the purchase or exercise price provided for in any Options, the additional consideration,
if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible
Securities are convertible into or exercisable or exchangeable for shares of Common Stock increases or decreases at any time (other than
proportional changes in conversion or exercise prices, as applicable, in connection with an event referred to in Section 8(b)
below), the Conversion Price in effect at the time of such increase or decrease shall be adjusted to the Conversion Price which would
have been in effect at such time had such Options or Convertible Securities provided for such increased or decreased purchase price,
additional consideration or increased or decreased conversion rate (as the case may be) at the time initially granted, issued or sold.
For purposes of this Section 8(a)(iii), if the terms of any Option or Convertible Security (including, without limitation, any
Option or Convertible Security that was outstanding as of the Subscription Date) are increased or decreased in the manner described in
the immediately preceding sentence, then such Option or Convertible Security and the shares of Common Stock deemed issuable upon exercise,
conversion or exchange thereof shall be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant
to this Section 8(a) shall be made if such adjustment would result in an increase of the Conversion Price then in effect.
(iv)
Calculation of Consideration Received. If any Option and/or Convertible Security and/or Adjustment Right is issued in connection
with the issuance or sale or deemed issuance or sale of any other securities of the Company (as determined by the Required Holders, the
“Primary Security”, and such Option and/or Convertible Security and/or Adjustment Right, the “Secondary Securities”
and together with the Primary Security, each a “Unit”), together comprising one integrated transaction, the aggregate
consideration per share of Common Stock with respect to such Primary Security shall be deemed to be the lower of (x) the purchase price
of such Unit, (y) if such Primary Security is an Option and/or Convertible Security, the lowest price per share for which one share of
Common Stock is at any time issuable upon the exercise or conversion of the Primary Security in accordance with Section 8(a)(i)
or 8(a)(ii) above and (z) the lowest VWAP of the shares of Common Stock on any Trading Day during the five (5) Trading Day period
(the “Adjustment Period”) immediately following the public announcement of such Dilutive Issuance (for the avoidance
of doubt, if such public announcement is released prior to the opening of the Principal Market on a Trading Day, such Trading Day shall
be the first Trading Day in such five (5) Trading Day period and if any Preferred Shares are converted, on any given Conversion Date
during any such Adjustment Period, solely with respect to such Preferred Shares converted on such applicable Conversion Date, such applicable
Adjustment Period shall be deemed to have ended on, and included, the Trading Day immediately prior to such Conversion Date). If any
shares of Common Stock, Options or Convertible Securities are issued or sold or deemed to have been issued or sold for cash, the consideration
received therefor will be deemed to be the net amount of consideration received by the Company therefor. If any shares of Common Stock,
Options or Convertible Securities are issued or sold for a consideration other than cash, the amount of such consideration received by
the Company will be the fair value of such consideration, except where such consideration consists of publicly traded securities, in
which case the amount of consideration received by the Company for such securities will be the arithmetic average of the VWAPs of such
security for each of the five (5) Trading Days immediately preceding the date of receipt. If any shares of Common Stock, Options or Convertible
Securities are issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving entity,
the amount of consideration therefor will be deemed to be the fair value of such portion of the net assets and business of the non-surviving
entity as is attributable to such shares of Common Stock, Options or Convertible Securities (as the case may be). The fair value of any
consideration other than cash or publicly traded securities will be determined jointly by the Company and the Required Holders. If such
parties are unable to reach agreement within ten (10) days after the occurrence of an event requiring valuation (the “Valuation
Event”), the fair value of such consideration will be determined within five (5) Trading Days after the tenth (10th) day following
such Valuation Event by an independent, reputable appraiser jointly selected by the Company and the Required Holders. The determination
of such appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall
be borne by the Company.
(v)
Record Date. If the Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A) to receive
a dividend or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe for or purchase
shares of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the issuance or sale
of the shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution
or the date of the granting of such right of subscription or purchase (as the case may be).
(b)
Adjustment of Conversion Price upon Subdivision or Combination of Common Stock. Without limiting any provision of Sections
7, 17 or 8(a), if the Company at any time on or after the Subscription Date subdivides (by any stock split, stock dividend,
stock combination, recapitalization or other similar transaction) one or more classes of its outstanding shares of Common Stock into
a greater number of shares, the Conversion Price in effect immediately prior to such subdivision will be proportionately reduced. Without
limiting any provision of Sections 7, 17 or 8(a), if the Company at any time on or after the Subscription Date combines
(by any stock split, stock dividend, stock combination, recapitalization or other similar transaction) one or more classes of its outstanding
shares of Common Stock into a smaller number of shares, the Conversion Price in effect immediately prior to such combination will be
proportionately increased. Any adjustment pursuant to this Section 8(b) shall become effective immediately after the effective
date of such subdivision or combination. If any event requiring an adjustment under this Section 8(b) occurs during the period
that a Conversion Price is calculated hereunder, then the calculation of such Conversion Price shall be adjusted appropriately to reflect
such event.
(c)
Holder’s Right of Adjusted Conversion Price. In addition to and not in limitation of the other provisions of this Section
8(b), if the Company in any manner issues or sells or enters into any agreement to issue or sell, any Common Stock, Options or Convertible
Securities (any such securities, “Variable Price Securities”) after the Subscription Date that are issuable pursuant
to such agreement or convertible into or exchangeable or exercisable for shares of Common Stock at a price which varies or may vary with
the market price of the shares of Common Stock, including by way of one or more reset(s) to a fixed price, but exclusive of such formulations
reflecting customary anti-dilution provisions (such as share splits, share combinations, share dividends and similar transactions) (each
of the formulations for such variable price being herein referred to as, the “Variable Price”), the Company shall
provide written notice thereof via electronic mail and overnight courier to each Holder on the date of such agreement and/or the issuance
of such shares of Common Stock, Convertible Securities or Options, as applicable. From and after the date the Company enters into such
agreement or issues any such Variable Price Securities, each Holder shall have the right, but not the obligation, in its sole discretion
to substitute the Variable Price for the Conversion Price upon conversion of the Preferred Shares by designating in the Conversion Notice
delivered upon any conversion of Preferred Shares that solely for purposes of such conversion such Holder is relying on the Variable
Price rather than the Conversion Price then in effect. A Holder’s election to rely on a Variable Price for a particular conversion
of Preferred Shares shall not obligate such Holder to rely on a Variable Price for any future conversions of Preferred Shares.
(d)
Stock Combination Event Adjustments. If at any time and from time to time on or after the Subscription Date there occurs any stock
split, stock dividend, stock combination, recapitalization or other similar transaction involving the Common Stock (each, a “Stock
Combination Event”, and such date thereof, the “Stock Combination Event Date”) and the Event Market Price
is less than the Conversion Price then in effect (after giving effect to the adjustment in Section 8(b) above), then on the fifth
(5th) Trading Day immediately following such Stock Combination Event Date, the Conversion Price then in effect on such fifth (5th) Trading
Day following the Stock Combination Event (after giving effect to the adjustment in Section 8(b) above) shall be reduced (but
in no event increased) to the Event Market Price. For the avoidance of doubt, if the adjustment in the immediately preceding sentence
would otherwise result in an increase in the Conversion Price hereunder, no adjustment shall be made.
(e)
Other Events. In the event that the Company (or any Subsidiary) shall take any action to which the provisions hereof are not strictly
applicable, or, if applicable, would not operate to protect any Holder from dilution (other than with respect to Excluded Securities)
or if any event occurs of the type contemplated by the provisions of this Section 8 but not expressly provided for by such provisions
(including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features),
then the Board shall in good faith determine and implement an appropriate adjustment in the Conversion Price so as to protect the rights
of such Holder, provided that no such adjustment pursuant to this Section 8(e) will increase the Conversion Price as otherwise
determined pursuant to this Section 8, provided further that if such Holder does not accept such adjustments as appropriately
protecting its interests hereunder against such dilution, then the Board and such Holder shall agree, in good faith, upon an independent
investment bank of nationally recognized standing to make such appropriate adjustments, whose determination shall be final and binding
absent manifest error and whose fees and expenses shall be borne by the Company.
(f)
Calculations. All calculations under this Section 8 shall be made by rounding to the nearest cent or the nearest 1/100th
of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held
by or for the account of the Company, and the disposition of any such shares shall be considered an issue or sale of Common Stock.
(g)
Voluntary Adjustment by Company. Subject to the rules and regulations of the Principal Market, the Company may at any time any
Preferred Shares remain outstanding, with the prior written consent of the Required Holders, reduce the then current Conversion Price
to any amount and for any period of time deemed appropriate by the Board.
9.
Reserved.
10.
Noncircumvention. The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation,
Bylaws (as defined in the Securities Purchase Agreement) or through any reorganization, transfer of assets, consolidation, merger, scheme
of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms of this Certificate of Designations, and will at all times in good faith carry out all the provisions of this Certificate
of Designations and take all action as may be required to protect the rights of the Holders hereunder. Without limiting the generality
of the foregoing or any other provision of this Certificate of Designations or the other Transaction Documents, the Company (a) shall
not increase the par value of any shares of Common Stock receivable upon the conversion of any Preferred Shares above the Conversion
Price then in effect, (b) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally
issue fully paid and non-assessable shares of Common Stock upon the conversion of Preferred Shares and (c) shall, so long as any Preferred
Shares are outstanding, take all action necessary to reserve and keep available out of its authorized and unissued shares of Common Stock,
solely for the purpose of effecting the conversion of the Preferred Shares, the maximum number of shares of Common Stock as shall from
time to time be necessary to effect the conversion of the Preferred Shares then outstanding (without regard to any limitations on conversion
contained herein). Notwithstanding anything herein to the contrary, if after the sixty (60) calendar day anniversary of the Initial Issuance
Date, each Holder is not permitted to convert such Holder’s Preferred Shares in full for any reason (other than pursuant to restrictions
set forth in Section 4(d)(i) hereof), the Company shall use its best efforts to promptly remedy such failure, including, without
limitation, obtaining such consents or approvals as necessary to effect such conversion into shares of Common Stock.
11.
Authorized Shares.
(a)
Reservation. So long as any Preferred Shares remain outstanding, the Company shall at all times reserve out of its authorized
and unissued shares of Common Stock a number of shares of Common Stock equal to at least 200% of the aggregate number of shares of Common
Stock as shall from time to time be necessary to effect the conversion, including without limitation, of all of the Preferred Shares
then outstanding at the Floor Price then in effect (without regard to any limitations on conversions, and, for the avoidance of doubt,
shall not include Dividends with respect to such Preferred Shares or any accrued and unpaid Late Charges thereon, and assuming the Preferred
Shares remain outstanding until the Maturity Date) (the “Required Reserve Amount”). The Required Reserve Amount (including,
without limitation, each increase in the number of shares so reserved) shall be allocated pro rata among the Holders based on the number
of the Preferred Shares held by each Holder on the Initial Issuance Date or increase in the number of reserved shares, as the case may
be (the “Authorized Share Allocation”). In the event that a Holder shall sell or otherwise transfer any of such Holder’s
Preferred Shares, each transferee shall be allocated a pro rata portion of such Holder’s Authorized Share Allocation. Any shares
of Common Stock reserved and allocated to any Person which ceases to hold any Preferred Shares shall be allocated to the remaining Holders
of Preferred Shares, pro rata based on the number of the Preferred Shares then held by the Holders.
(b)
Insufficient Authorized Shares. If, notwithstanding Section 11(a) and not in limitation thereof, at any time while any
of the Preferred Shares remain outstanding the Company does not have a sufficient number of authorized and unreserved shares of Common
Stock to satisfy its obligation to reserve for issuance upon conversion of the Preferred Shares at least a number of shares of Common
Stock equal to the Required Reserve Amount (an “Authorized Share Failure”), then the Company shall immediately take
all action necessary to increase the Company’s authorized shares of Common Stock to an amount sufficient to allow the Company to
reserve the Required Reserve Amount for the Preferred Shares then outstanding (or deemed outstanding pursuant to Section 11(a)
above). Without limiting the generality of the foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized
Share Failure, but in no event later than sixty (60) days after the occurrence of such Authorized Share Failure, the Company shall hold
a meeting of its stockholders for the approval of an increase in the number of authorized shares of Common Stock. In connection with
such meeting, the Company shall provide each stockholder with a proxy statement and shall use its best efforts to solicit its stockholders’
approval of such increase in authorized shares of Common Stock and to cause its board of directors to recommend to the stockholders that
they approve such proposal (or, if a majority of the voting power then in effect of the capital stock of the Company consents to such
increase, in lieu of such proxy statement, deliver to the stockholders of the Company an information statement that has been filed with
(and either approved by or not subject to comments from) the SEC with respect thereto). In the event that the Company is prohibited from
issuing shares of Common Stock to a Holder upon any conversion due to the failure by the Company to have sufficient shares of Common
Stock available out of the authorized but unissued shares of Common Stock (such unavailable number of shares of Common Stock, the “Authorized
Failure Shares”), in lieu of delivering such Authorized Failure Shares to such Holder, the Company shall pay legally available
funds in exchange for the redemption of such portion of the Conversion Amount of the Preferred Shares convertible into such Authorized
Failure Shares at a price equal to the sum of (i) the product of (x) such number of Authorized Failure Shares and (y) the greatest Closing
Sale Price of the Common Stock on any Trading Day during the period commencing on the date such Holder delivers the applicable Conversion
Notice with respect to such Authorized Failure Shares to the Company and ending on the date of such issuance and payment under this Section
11(b); and (ii) to the extent such Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver
in satisfaction of a sale by such Holder of Authorized Failure Shares, any brokerage commissions and other out-of-pocket expenses, if
any, of such Holder incurred in connection therewith. Nothing contained in Section 11(a) or this Section 11(b) shall limit
any obligations of the Company under any provision of the Securities Purchase Agreement.
12.
Redemptions.
(a)
General. If a Holder has submitted a Triggering Event Redemption Notice in accordance with Section 5(b), the Company shall
deliver the applicable Triggering Event Redemption Price to such Holder in legally available funds within five (5) Business Days after
the Company’s receipt of such Holder’s Triggering Event Redemption Notice. If a Holder has submitted a Change of Control
Redemption Notice in accordance with Section 6(b), the Company shall deliver the applicable Change of Control Redemption Price
to such Holder in legally available funds concurrently with the consummation of such Change of Control if such notice is received prior
to the consummation of such Change of Control and within five (5) Business Days after the Company’s receipt of such notice otherwise.
Notwithstanding anything herein to the contrary, in connection with any redemption hereunder at a time a Holder is entitled to receive
a cash payment under any of the other Transaction Documents, at the option of such Holder delivered in writing to the Company, the applicable
Redemption Price hereunder shall be increased by the amount of such cash payment owed to such Holder under such other Transaction Document
and, upon payment in full or conversion in accordance herewith, shall satisfy the Company’s payment obligation under such other
Transaction Document. In the event of a redemption of less than all of the Preferred Shares, the Company shall promptly cause to be issued
and delivered to such Holder a new Preferred Share Certificate (in accordance with Section 20) (or evidence of the creation of
a new Book-Entry) representing the number of Preferred Shares which have not been redeemed. In the event that the Company does not pay
the applicable Redemption Price to a Holder within the time period required for any reason (including, without limitation, to the extent
such payment is prohibited pursuant to the DGCL), at any time thereafter and until the Company pays such unpaid Redemption Price in full,
such Holder shall have the option, in lieu of redemption, to require the Company to promptly return to such Holder all or any of the
Preferred Shares that were submitted for redemption and for which the applicable Redemption Price (together with any Late Charges thereon)
has not been paid. Upon the Company’s receipt of such notice, (x) the applicable Redemption Notice shall be null and void with
respect to such Preferred Shares, (y) the Company shall immediately return the applicable Preferred Share Certificate, or issue a new
Preferred Share Certificate (in accordance with Section 20(d)), to such Holder (unless the Preferred Shares are held in Book-Entry
form, in which case the Company shall deliver evidence to such Holder that a Book-Entry for such Preferred Shares then exists), and in
each case the Additional Amount of such Preferred Shares shall be increased by an amount equal to the difference between (1) the applicable
Redemption Price (as the case may be, and as adjusted pursuant to this Section 12, if applicable) minus (2) the Stated
Value portion of the Conversion Amount submitted for redemption and (z) the Conversion Price of such Preferred Shares shall be automatically
adjusted with respect to each conversion effected thereafter by such Holder to the lowest of (A) the Conversion Price as in effect on
the date on which the applicable Redemption Notice is voided, (B) the greater of (x) the Floor Price and (y) 75% of the lowest Closing
Bid Price of the Common Stock during the period beginning on and including the date on which the applicable Redemption Notice is delivered
to the Company and ending on and including the date on which the applicable Redemption Notice is voided and (C) the greater of (x) the
Floor Price and (y) 75% of the quotient of (I) the sum of the five (5) lowest VWAPs of the Common Stock during the twenty (20) consecutive
Trading Day period ending and including the Trading Day immediately preceding the applicable Conversion Date divided by (II) five (5)
(it being understood and agreed that all such determinations shall be appropriately adjusted for any stock dividend, stock split, stock
combination or other similar transaction during such period). A Holder’s delivery of a notice voiding a Redemption Notice and exercise
of its rights following such notice shall not affect the Company’s obligations to make any payments of Late Charges which have
accrued prior to the date of such notice with respect to the Preferred Shares subject to such notice.
(b)
Redemption by Multiple Holders. Upon the Company’s receipt of a Redemption Notice from any Holder for redemption or repayment
as a result of an event or occurrence substantially similar to the events or occurrences described in Section 5(b) or Section
6(b), the Company shall immediately, but no later than one (1) Business Day of its receipt thereof, forward to each other Holder
by electronic mail a copy of such notice. If the Company receives one or more Redemption Notices, during the seven (7) Business Day period
beginning on and including the date which is two (2) Business Days prior to the Company’s receipt of the initial Redemption Notice
and ending on and including the date which is two (2) Business Days after the Company’s receipt of the initial Redemption Notice
and the Company is unable to redeem all of the Conversion Amount of such Preferred Shares designated in such initial Redemption Notice
and such other Redemption Notices received during such seven (7) Business Day period, then the Company shall redeem a pro rata amount
from each Holder based on the Stated Value of the Preferred Shares submitted for redemption pursuant to such Redemption Notices received
by the Company during such seven (7) Business Day period.
13.
[Reserved].
14.
Voting Rights. Except as otherwise provided herein or as required by applicable law and subject to the provisions of Section
4(d) hereof, Holders of Preferred Shares shall be entitled to vote with the holders of Common Stock on all matters that such holders
of Common Stock are entitled to vote upon, in the same manner and with the same effect as the holders of Common Stock, voting together
with the holders of Common Stock as a single class. Subject to the provisions of Section 4(d) hereof, each Preferred Share shall
entitle the Holder thereof to cast that number of votes per Preferred Share as is equal to the Stated Value of such Preferred Share divided
by the then applicable Conversion Price; provided, however that in no event shall the then applicable Conversion Price
for purposes of this Section 14 be less than the “Minimum Price” (as defined in Nasdaq Listing Rule 5635(d))
on the date immediately preceding the Subscription Date (or $7.628 per share, as of the date of the Effective Date, and subject to adjustments
for any stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions following the Effective Date).
For purposes of clarity, this Nasdaq Minimum Price shall apply only for purposes of this Section 14 of the Certificate of Designations
and not apply to any other section of the Certificate of Designations or any Transaction Document. Notwithstanding the foregoing, to
the extent that under the DGCL the vote of the holders of the Preferred Shares, voting separately as a class or series, as applicable,
is required to authorize a given action of the Company, the affirmative vote or consent of the Required Holders of the shares of the
Preferred Shares, voting together in the aggregate and not in separate series unless required under the DGCL, represented at a duly held
meeting at which a quorum is present or by written consent of the Required Holders (except as otherwise may be required under the DGCL),
voting together in the aggregate and not in separate series unless required under the DGCL, shall constitute the approval of such action
by both the class or the series, as applicable. For the avoidance of doubt, for purposes of determining the presence of a quorum at any
meeting of the stockholders of the Company at which the Preferred Shares are entitled to vote, the number of Preferred Shares and votes
represented by such shares shall be counted on an as converted to Common Stock basis, subject to any limitations on conversion set forth
herein. Holders of the Preferred Shares shall be entitled to written notice of all stockholder meetings or written consents (and copies
of proxy materials and other information sent to stockholders) with respect to which they would be entitled to vote, which notice would
be provided pursuant to the Company’s bylaws and the DGCL.
15.
Covenants. For so long as any Preferred Shares are outstanding, without the prior written consent of the Required Holders:
(a)
Incurrence of Indebtedness. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,
incur or guarantee, assume or suffer to exist any Indebtedness (other than Permitted Indebtedness).
(b)
Existence of Liens. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,
allow or suffer to exist any mortgage, lien, pledge, charge, security interest or other encumbrance upon or in any property or assets
(including accounts and contract rights) owned by the Company or any of its Subsidiaries (collectively, “Liens”) other
than Permitted Liens.
(c)
Restricted Payments and Investments. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly
or indirectly, redeem, defease, repurchase, repay or make any payments in respect of, by the payment of cash or cash equivalents (in
whole or in part, whether by way of open market purchases, tender offers, private transactions or otherwise), all or any portion of any
Indebtedness (other pursuant to this Certificate of Designations) whether by way of payment in respect of principal of (or premium, if
any) or interest on, such Indebtedness or make any Investment, as applicable, if at the time such payment with respect to such Indebtedness
and/or Investment, as applicable, is due or is otherwise made or, after giving effect to such payment, (i) an event constituting a Triggering
Event has occurred and is continuing or (ii) an event that with the passage of time and without being cured would constitute a Triggering
Event has occurred and is continuing.
(d)
Restriction on Redemption and Cash Dividends. The Company shall not, and the Company shall cause each of its Subsidiaries to not,
directly or indirectly, redeem, repurchase or declare or pay any cash dividend or distribution on any of its capital stock (other than
as required by this Certificate of Designations, the Series A Certificate of Designations, the Series H-7 Certificate of Designations,
the Series J Certificate of Designations or the certificate of designations for the Series K Convertible Preferred Stock, par value $0.0001
per share (“Series K Preferred Stock”), of the Company).
(e)
Restriction on Transfer of Assets. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly
or indirectly, sell, lease, license, assign, transfer, spin-off, split-off, close, convey or otherwise dispose of any assets or rights
of the Company or any Subsidiary owned or hereafter acquired whether in a single transaction or a series of related transactions, other
than (i) sales, leases, licenses, assignments, transfers, conveyances and other dispositions of such assets or rights by the Company
and its Subsidiaries in the ordinary course of business consistent with its past practice, or (ii) sales of inventory and product in
the ordinary course of business.
(f)
Maturity of Indebtedness. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,
permit any Indebtedness of the Company or any of its Subsidiaries to mature or accelerate prior to the Maturity Date.
(g)
Change in Nature of Business. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or
indirectly, engage in any material line of business substantially different from those lines of business conducted by or publicly contemplated
to be conducted by the Company and/or its Subsidiaries on the Subscription Date or any business reasonably related or incidental thereto.
The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, modify its or their corporate
structure or purpose in any material respect.
(h)
Preservation of Existence, Etc. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve,
its existence, rights and privileges, and become or remain, and cause each of its Subsidiaries to become or remain, duly qualified and
in good standing in each jurisdiction in which the character of the properties owned or leased by it or in which the transaction of its
business makes such qualification necessary; provided, however, that the Company shall have the right to merge or combine
wholly-owned Subsidiaries hereunder, or eliminate or dissolve foreign Subsidiaries, in each case where such restructuring does not have
a material impact on the Company’s assets or ability to comply with the provisions hereof.
(i)
Maintenance of Properties, Etc. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve,
all of its properties which are necessary or useful in the proper conduct of its business in good working order and condition, ordinary
wear and tear excepted, and comply, and cause each of its Subsidiaries to comply, at all times with the provisions of all leases to which
it is a party as lessee or under which it occupies property, so as to prevent any loss or forfeiture thereof or thereunder.
(j)
Maintenance of Intellectual Property. The Company will, and will cause each of its Subsidiaries to, take all action necessary
or advisable to maintain all of the Intellectual Property Rights of the Company and/or any of its Subsidiaries that are necessary or
material to the conduct of its business in full force and effect.
(k)
Maintenance of Insurance. The Company shall use reasonable best efforts to maintain, and cause each of its Subsidiaries to maintain,
insurance with responsible and reputable insurance companies or associations (including, without limitation, comprehensive general liability,
hazard, rent and business interruption insurance) with respect to its properties (including all real properties leased or owned by it)
and business, in such amounts and covering such risks as are generally consistent with the coverage held by the Company on the Initial
Issuance Date.
(l)
Transactions with Affiliates. The Company shall not, nor shall it permit any of its Subsidiaries to, enter into, renew, extend
or be a party to, any transaction or series of related transactions (including, without limitation, the purchase, sale, lease, transfer
or exchange of property or assets of any kind or the rendering of services of any kind) with any affiliate, except transactions in the
ordinary course of business in a manner and to an extent, if applicable, consistent with past practice and necessary or desirable for
the prudent operation of its business, for fair consideration and on terms no less favorable to it or its Subsidiaries than would be
reasonably expected to be obtained in a comparable arm’s length transaction with a Person that is not an affiliate thereof.
(m)
Restricted Issuances. The Company shall not, directly or indirectly, without the prior written consent of the Required Holders,
(i) issue any Preferred Shares (other than as contemplated by the Securities Purchase Agreement and this Certificate of Designations)
or (ii) issue any other securities that would cause a breach or default under this Certificate of Designations or the Warrants.
(n)
Stay, Extension and Usury Laws. To the extent that it may lawfully do so, the Company (A) agrees that it will not at any time
insist upon, plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law (wherever
or whenever enacted or in force) that may affect the covenants or the performance of this Certificate of Designations; and (B) expressly
waives all benefits or advantages of any such law and agrees that it will not, by resort to any such law, hinder, delay or impede the
execution of any power granted to the Holders by this Certificate of Designations, but will suffer and permit the execution of every
such power as though no such law has been enacted.
(o)
Taxes. The Company and its Subsidiaries shall pay when due all taxes, fees or other charges of any nature whatsoever (together
with any related interest or penalties) now or hereafter imposed or assessed against the Company and its Subsidiaries or their respective
assets or upon their ownership, possession, use, operation or disposition thereof or upon their rents, receipts or earnings arising therefrom
(except where the failure to pay would not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries).
The Company and its Subsidiaries shall file on or before the due date therefor all personal property tax returns (except where the failure
to file would not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries). Notwithstanding
the foregoing, the Company and its Subsidiaries may contest, in good faith and by appropriate proceedings, taxes for which they maintain
adequate reserves therefor in accordance with GAAP.
(p)
Cash Minimum. From the Closing Date until no shares of Preferred Shares are outstanding, the Company shall, at all times, maintain
unencumbered, unrestricted cash and cash equivalents on hand in amount equal to at least 50% of the aggregate Stated Value of the Preferred
Shares then outstanding. Such cash shall be maintained in one or more domestic deposit accounts, money market accounts or certificates
of deposit (with a maturity of no more than three months) with one or more Eligible Banks. For purposes hereof, an “Eligible
Bank” is a U.S. chartered commercial bank with total assets in excess of $300 billion.
(q)
Independent Investigation. At the request of any Holder either (x) at any time when a Triggering Event has occurred and is continuing,
(y) upon the occurrence of an event that with the passage of time or giving of notice would constitute a Triggering Event or (z) at any
time such Holder reasonably believes a Triggering Event may have occurred or be continuing, the Company shall hire an independent, reputable
investment bank selected by the Company and approved by such Holder to investigate as to whether any breach of the Certificate of Designations
has occurred (the “Independent Investigator”). If the Independent Investigator determines that such breach of the
Certificate of Designations has occurred, the Independent Investigator shall notify the Company of such breach and the Company shall
deliver written notice to each Holder of such breach. In connection with such investigation, the Independent Investigator may, during
normal business hours, inspect all contracts, books, records, personnel, offices and other facilities and properties of the Company and
its Subsidiaries and, to the extent available to the Company after the Company uses reasonable efforts to obtain them, the records of
its legal advisors and accountants (including the accountants’ work papers) and any books of account, records, reports and other
papers not contractually required of the Company to be confidential or secret, or subject to attorney-client or other evidentiary privilege,
and the Independent Investigator may make such copies and inspections thereof as the Independent Investigator may reasonably request.
The Company shall furnish the Independent Investigator with such financial and operating data and other information with respect to the
business and properties of the Company as the Independent Investigator may reasonably request. The Company shall permit the Independent
Investigator to discuss the affairs, finances and accounts of the Company with, and to make proposals and furnish advice with respect
thereto to, the Company’s officers, directors, key employees and independent public accountants or any of them (and by this provision
the Company authorizes said accountants to discuss with such Independent Investigator the finances and affairs of the Company and any
Subsidiaries), all at such reasonable times, upon reasonable notice, and as often as may be reasonably requested.
16.
Liquidation, Dissolution, Winding-Up. In the event of a Liquidation Event, the Holders shall be entitled to receive in cash out
of the assets of the Company, whether from capital or from earnings available for distribution to its stockholders (the “Liquidation
Funds”), before any amount shall be paid to the holders of any of shares of Junior Stock, but pari passu with any Parity Stock
then outstanding, an amount per Preferred Share equal to the greater of (A) 125% of the Conversion Amount of such Preferred Share on
the date of such payment and (B) the amount per share such Holder would receive if such Holder converted such Preferred Share into Common
Stock immediately prior to the date of such payment, provided that if the Liquidation Funds are insufficient to pay the full amount
due to the Holders and holders of shares of Parity Stock, then each Holder and each holder of Parity Stock shall receive a percentage
of the Liquidation Funds equal to the full amount of Liquidation Funds payable to such Holder and such holder of Parity Stock as a liquidation
preference, in accordance with their respective certificate of designations (or equivalent), as a percentage of the full amount of Liquidation
Funds payable to all holders of Preferred Shares and all holders of shares of Parity Stock. To the extent necessary, the Company shall
cause such actions to be taken by each of its Subsidiaries so as to enable, to the maximum extent permitted by law, the proceeds of a
Liquidation Event to be distributed to the Holders in accordance with this Section 16. All the preferential amounts to be paid
to the Holders under this Section 16 shall be paid or set apart for payment before the payment or setting apart for payment of
any amount for, or the distribution of any Liquidation Funds of the Company to the holders of shares of Junior Stock in connection with
a Liquidation Event as to which this Section 16 applies.
17.
Distribution of Assets. In addition to any adjustments pursuant to Section 7(a) and Section 8, if the Company shall
declare or make any dividend or other distributions of its assets (or rights to acquire its assets) to any or all holders of shares of
Common Stock, by way of return of capital or otherwise (including without limitation, any distribution of cash, stock or other securities,
property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar
transaction) (the “Distributions”), then each Holder, as holders of Preferred Shares, will be entitled to such Distributions
as if such Holder had held the number of shares of Common Stock acquirable upon complete conversion of the Preferred Shares (without
taking into account any limitations or restrictions on the convertibility of the Preferred Shares and assuming for such purpose that
the Preferred Share was converted at the Floor Price as of the applicable record date)immediately prior to the date on which a record
is taken for such Distribution or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined
for such Distributions (provided, however, that to the extent that such Holder’s right to participate in any such
Distribution would result in such Holder and the other Attribution Parties exceeding the Maximum Percentage, then such Holder shall not
be entitled to participate in such Distribution to such extent of the Maximum Percentage (and shall not be entitled to beneficial ownership
of such shares of Common Stock as a result of such Distribution (and beneficial ownership) to such extent of any such excess) and the
portion of such Distribution shall be held in abeyance for the benefit of such Holder until such time or times as its right thereto would
not result in such Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or times, if any, such Holder
shall be granted such Distribution (and any Distributions declared or made on such initial Distribution or on any subsequent Distribution
held similarly in abeyance) to the same extent as if there had been no such limitation).
18.
Vote to Change the Terms of or Issue Preferred Shares. In addition to any other rights provided by law, except where the vote
or written consent of the holders of a greater number of shares is required by law or by another provision of the Certificate of Incorporation,
without first obtaining the affirmative vote at a meeting duly called for such purpose or the written consent without a meeting of the
Required Holders, voting together as a single class, the Company shall not (in any case, whether by amendment, modification, recapitalization,
merger, consolidation or otherwise): (a) amend or repeal any provision of, or add any provision to, its Certificate of Incorporation
or bylaws, or file any certificate of designations or articles of amendment of any series of shares of preferred stock, if such action
would adversely alter or change in any respect the preferences, rights, privileges or powers, or restrictions provided for the benefit
of the Preferred Shares hereunder, regardless of whether any such action shall be by means of amendment to the Certificate of Incorporation
or by merger, consolidation or otherwise; provided that the affirmative vote of the Required Holders shall not be required for
changes to the Series A Preferred Stock, Series H-7 Preferred Stock, Series J Preferred Stock or Series K Preferred Stock; (b) increase
or decrease (other than by conversion) the authorized number of Preferred Shares; (c) without limiting any provision of Section 2,
create or authorize (by reclassification or otherwise) any new class or series of Senior Preferred Stock or Parity Stock, other than
the Series J Preferred Stock and Series K Preferred Stock; (d) purchase, repurchase or redeem any shares of Junior Stock (other than
pursuant to the terms of the Company’s equity incentive plans and options and other equity awards granted under such plans (that
have in good faith been approved by the Board)); (e) without limiting any provision of Section 2, pay dividends or make any other
distribution on any shares of any Junior Stock, other than the Series A Junior Participating Preferred Stock, par value $0.0001 per share
(the “Series A Preferred Stock”), of the Company; (f) issue any Preferred Shares other than as contemplated hereby
or pursuant to the Securities Purchase Agreement; or (g) without limiting any provision of Section 10, whether or not prohibited
by the terms of the Preferred Shares, circumvent a right of the Preferred Shares hereunder.
19.
Transfer of Preferred Shares. A Holder may transfer some or all of its Preferred Shares without the consent of the Company, but
any such transfer shall be in compliance with all applicable securities laws.
20.
Reissuance of Preferred Share Certificates and Book Entries.
(a)
Transfer. If any Preferred Shares are to be transferred, the applicable Holder shall surrender the applicable Preferred Share
Certificate to the Company (or, if the Preferred Shares are held in Book-Entry form, a written instruction letter to the Company), whereupon
the Company will forthwith issue and deliver upon the order of such Holder a new Preferred Share Certificate (in accordance with Section
20(d)) (or evidence of the transfer of such Book-Entry), registered as such Holder may request, representing the outstanding number
of Preferred Shares being transferred by such Holder and, if less than the entire outstanding number of Preferred Shares is being transferred,
a new Preferred Share Certificate (in accordance with Section 20(d)) to such Holder representing the outstanding number of Preferred
Shares not being transferred (or evidence of such remaining Preferred Shares in a Book-Entry for such Holder). Such Holder and any assignee,
by acceptance of the Preferred Share Certificate or evidence of Book-Entry issuance, as applicable, acknowledge and agree that, by reason
of the provisions of Section 4(c)(i) following conversion or redemption of any of the Preferred Shares, the outstanding number
of Preferred Shares represented by the Preferred Shares may be less than the number of Preferred Shares stated on the face of the Preferred
Shares.
(b)
Lost, Stolen or Mutilated Preferred Share Certificate. Upon receipt by the Company of evidence reasonably satisfactory to the
Company of the loss, theft, destruction or mutilation of a Preferred Share Certificate (as to which a written certification and the indemnification
contemplated below shall suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking
by the applicable Holder to the Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation
of such Preferred Share Certificate, the Company shall execute and deliver to such Holder a new Preferred Share Certificate (in accordance
with Section 20(d)) representing the applicable outstanding number of Preferred Shares.
(c)
Preferred Share Certificate and Book-Entries Exchangeable for Different Denominations and Forms. Each Preferred Share Certificate
is exchangeable, upon the surrender hereof by the applicable Holder at the principal office of the Company, for a new Preferred Share
Certificate or Preferred Share Certificate(s) or new Book-Entry (in accordance with Section 20(d)) representing, in the aggregate,
the outstanding number of the Preferred Shares in the original Preferred Share Certificate, and each such new Preferred Share Certificate
and/or new Book-Entry, as applicable, will represent such portion of such outstanding number of Preferred Shares from the original Preferred
Share Certificate as is designated in writing by such Holder at the time of such surrender. Each Book-Entry may be exchanged into one
or more new Preferred Share Certificates or split by the applicable Holder by delivery of a written notice to the Company into two or
more new Book-Entries (in accordance with Section 20(d)) representing, in the aggregate, the outstanding number of the Preferred
Shares in the original Book-Entry, and each such new Book-Entry and/or new Preferred Share Certificate, as applicable, will represent
such portion of such outstanding number of Preferred Shares from the original Book-Entry as is designated in writing by such Holder at
the time of such surrender.
(d)
Issuance of New Preferred Share Certificate or Book-Entry. Whenever the Company is required to issue a new Preferred Share Certificate
or a new Book-Entry pursuant to the terms of this Certificate of Designations, such new Preferred Share Certificate or new Book-Entry
(i) shall represent, as indicated on the face of such Preferred Share Certificate or in such Book-Entry, as applicable, the number of
Preferred Shares remaining outstanding (or in the case of a new Preferred Share Certificate or new Book-Entry being issued pursuant to
Section 20(a) or Section 20(c), the number of Preferred Shares designated by such Holder) which, when added to the number
of Preferred Shares represented by the other new Preferred Share Certificates or other new Book-Entry, as applicable, issued in connection
with such issuance, does not exceed the number of Preferred Shares remaining outstanding under the original Preferred Share Certificate
or original Book-Entry, as applicable, immediately prior to such issuance of new Preferred Share Certificate or new Book-Entry, as applicable,
and (ii) shall have an issuance date, as indicated on the face of such new Preferred Share Certificate or in such new Book-Entry, as
applicable, which is the same as the issuance date of the original Preferred Share Certificate or in such original Book-Entry, as applicable.
21.
Remedies, Characterizations, Other Obligations, Breaches and Injunctive Relief. The remedies provided in this Certificate of Designations
shall be cumulative and in addition to all other remedies available under this Certificate of Designations and any of the other Transaction
Documents, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall
limit any Holder’s right to pursue actual and consequential damages for any failure by the Company to comply with the terms of
this Certificate of Designations. No failure on the part of a Holder to exercise, and no delay in exercising, any right, power or remedy
hereunder shall operate as a waiver thereof; nor shall any single or partial exercise by such Holder of any right, power or remedy preclude
any other or further exercise thereof or the exercise of any other right, power or remedy. In addition, the exercise of any right or
remedy of a Holder at law or equity or under this Certificate of Designations or any of the documents shall not be deemed to be an election
of such Holder’s rights or remedies under such documents or at law or equity. The Company covenants to each Holder that there shall
be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with
respect to payments, conversion and the like (and the computation thereof) shall be the amounts to be received by a Holder and shall
not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). No failure
on the part of a Holder to exercise, and no delay in exercising, any right, power or remedy hereunder shall operate as a waiver thereof;
nor shall any single or partial exercise by such Holder of any right, power or remedy preclude any other or further exercise thereof
or the exercise of any other right, power or remedy. In addition, the exercise of any right or remedy of any Holder at law or equity
or under Preferred Shares or any of the documents shall not be deemed to be an election of such Holder’s rights or remedies under
such documents or at law or equity. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable
harm to the Holders and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event
of any such breach or threatened breach, each Holder shall be entitled, in addition to all other available remedies, to specific performance
and/or temporary, preliminary and permanent injunctive or other equitable relief from any court of competent jurisdiction in any such
case without the necessity of proving actual damages and without posting a bond or other security. The Company shall provide all information
and documentation to a Holder that is requested by such Holder to enable such Holder to confirm the Company’s compliance with the
terms and conditions of this Certificate of Designations.
22.
Payment of Collection, Enforcement and Other Costs. If (a) any Preferred Shares are placed in the hands of an attorney for collection
or enforcement or is collected or enforced through any legal proceeding or a Holder otherwise takes action to collect amounts due under
this Certificate of Designations with respect to the Preferred Shares or to enforce the provisions of this Certificate of Designations
or (b) there occurs any bankruptcy, reorganization, receivership of the Company or other proceedings affecting Company creditors’
rights and involving a claim under this Certificate of Designations, then the Company shall pay the costs incurred by such Holder for
such collection, enforcement or action or in connection with such bankruptcy, reorganization, receivership or other proceeding, including,
without limitation, attorneys’ fees and disbursements. The Company expressly acknowledges and agrees that no amounts due under
this Certificate of Designations with respect to any Preferred Shares shall be affected, or limited, by the fact that the purchase price
paid for each Preferred Share was less than the original Stated Value thereof.
23.
Construction; Headings. This Certificate of Designations shall be deemed to be jointly drafted by the Company and the Holders
and shall not be construed against any such Person as the drafter hereof. The headings of this Certificate of Designations are for convenience
of reference and shall not form part of, or affect the interpretation of, this Certificate of Designations. Unless the context clearly
indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof.
The terms “including,” “includes,” “include” and words of like import shall
be construed broadly as if followed by the words “without limitation.” The terms “herein,” “hereunder,”
“hereof” and words of like import refer to this entire Certificate of Designations instead of just the provision in
which they are found. Unless expressly indicated otherwise, all section references are to sections of this Certificate of Designations.
Terms used in this Certificate of Designations and not otherwise defined herein, but defined in the other Transaction Documents, shall
have the meanings ascribed to such terms on the Initial Issuance Date in such other Transaction Documents unless otherwise consented
to in writing by the Required Holders.
24.
Failure or Indulgence Not Waiver. No failure or delay on the part of a Holder in the exercise of any power, right or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude
other or further exercise thereof or of any other right, power or privilege. No waiver shall be effective unless it is in writing and
signed by an authorized representative of the waiving party. This Certificate of Designations shall be deemed to be jointly drafted by
the Company and all Holders and shall not be construed against any Person as the drafter hereof. Notwithstanding the foregoing, nothing
contained in this Section 24 shall permit any waiver of any provision of Section 4(d).
25.
Dispute Resolution.
(a)
Submission to Dispute Resolution.
(i)
In the case of a dispute relating to a Closing Bid Price, a Closing Sale Price, a Conversion Price, an Alternate Conversion Price, a
VWAP or a fair market value or the arithmetic calculation of a Conversion Rate, or the applicable Redemption Price (as the case may be)
(including, without limitation, a dispute relating to the determination of any of the foregoing), the Company or the applicable Holder
(as the case may be) shall submit the dispute to the other party via electronic mail (A) if by the Company, within two (2) Business Days
after the occurrence of the circumstances giving rise to such dispute or (B) if by such Holder at any time after such Holder learned
of the circumstances giving rise to such dispute. If such Holder and the Company are unable to promptly resolve such dispute relating
to such Closing Bid Price, such Closing Sale Price, such Conversion Price, such Alternate Conversion Price, such VWAP or such fair market
value, or the arithmetic calculation of such Conversion Rate or such applicable Redemption Price (as the case may be), at any time after
the second (2nd) Business Day following such initial notice by the Company or such Holder (as the case may be) of such dispute to the
Company or such Holder (as the case may be), then such Holder may, at its sole option, select an independent, reputable investment bank
to resolve such dispute.
(ii)
Such Holder and the Company shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered in accordance
with the first sentence of this Section 25 and (B) written documentation supporting its position with respect to such dispute,
in each case, no later than 5:00 p.m. (New York time) by the fifth (5th) Business Day immediately following the date on which such Holder
selected such investment bank (the “Dispute Submission Deadline”) (the documents referred to in the immediately preceding
clauses (A) and (B) are collectively referred to herein as the “Required Dispute Documentation”) (it being understood
and agreed that if either such Holder or the Company fails to so deliver all of the Required Dispute Documentation by the Dispute Submission
Deadline, then the party who fails to so submit all of the Required Dispute Documentation shall no longer be entitled to (and hereby
waives its right to) deliver or submit any written documentation or other support to such investment bank with respect to such dispute
and such investment bank shall resolve such dispute based solely on the Required Dispute Documentation that was delivered to such investment
bank prior to the Dispute Submission Deadline). Unless otherwise agreed to in writing by both the Company and such Holder or otherwise
requested by such investment bank, neither the Company nor such Holder shall be entitled to deliver or submit any written documentation
or other support to such investment bank in connection with such dispute (other than the Required Dispute Documentation).
(iii)
The Company and such Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company and such
Holder of such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The fees and expenses
of such investment bank shall be borne solely by the Company, and such investment bank’s resolution of such dispute shall be final
and binding upon all parties absent manifest error.
(b)
Miscellaneous. The Company expressly acknowledges and agrees that (i) this Section 25 constitutes an agreement to arbitrate
between the Company and each Holder (and constitutes an arbitration agreement) under § 7501, et seq. of the New York Civil Practice
Law and Rules (“CPLR”) and that any Holder is authorized to apply for an order to compel arbitration pursuant to CPLR
§ 7503(a) in order to compel compliance with this Section 25, (ii) a dispute relating to a Conversion Price includes, without
limitation, disputes as to (A) whether an issuance or sale or deemed issuance or sale of Common Stock occurred under Section 8(a),
(B) the consideration per share at which an issuance or deemed issuance of Common Stock occurred, (C) whether any issuance or sale or
deemed issuance or sale of Common Stock was an issuance or sale or deemed issuance or sale of Excluded Securities, (D) whether an agreement,
instrument, security or the like constitutes an Option or Convertible Security and (E) whether a Dilutive Issuance occurred, (iii) the
terms of this Certificate of Designations and each other applicable Transaction Document shall serve as the basis for the selected investment
bank’s resolution of the applicable dispute, such investment bank shall be entitled (and is hereby expressly authorized) to make
all findings, determinations and the like that such investment bank determines are required to be made by such investment bank in connection
with its resolution of such dispute and in resolving such dispute such investment bank shall apply such findings, determinations and
the like to the terms of this Certificate of Designations and any other applicable Transaction Documents, (iv) the applicable Holder
(and only such Holder with respect to disputes solely relating to such Holder), in its sole discretion, shall have the right to submit
any dispute described in this Section 25 to any state or federal court sitting in The City of New York, Borough of Manhattan,
New York, in lieu of utilizing the procedures set forth in this Section 25 and (v) nothing in this Section 25 shall limit
such Holder from obtaining any injunctive relief or other equitable remedies (including, without limitation, with respect to any matters
described in this Section 25).
26.
Notices; Currency; Payments.
(a)
Notices. The Company shall provide each Holder of Preferred Shares with prompt written notice of all actions taken pursuant to
the terms of this Certificate of Designations, including in reasonable detail a description of such action and the reason therefor. Whenever
notice is required to be given under this Certificate of Designations, unless otherwise provided herein, such notice must be in writing
and shall be given in accordance with Section 9(f) of the Securities Purchase Agreement. The Company shall provide each Holder
with prompt written notice of all actions taken pursuant to this Certificate of Designations, including in reasonable detail a description
of such action and the reason therefore. Without limiting the generality of the foregoing, the Company shall give written notice to each
Holder (i) immediately upon any adjustment of the Conversion Price, setting forth in reasonable detail, and certifying, the calculation
of such adjustment and (ii) at least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A)
with respect to any dividend or distribution upon the Common Stock, (B) with respect to any grant, issuances, or sales of any Options,
Convertible Securities or rights to purchase stock, warrants, securities or other property to holders of shares of Common Stock or (C)
for determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that such
information shall be made known to the public prior to or in conjunction with such notice being provided to such Holder.
(b)
Currency. All dollar amounts referred to in this Certificate of Designations are in United States Dollars (“U.S. Dollars”),
and all amounts owing under this Certificate of Designations shall be paid in U.S. Dollars. All amounts denominated in other currencies
(if any) shall be converted into the U.S. Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. “Exchange
Rate” means, in relation to any amount of currency to be converted into U.S. Dollars pursuant to this Certificate of Designations,
the U.S. Dollar exchange rate as published in the Wall Street Journal on the relevant date of calculation (it being understood and agreed
that where an amount is calculated with reference to, or over, a period of time, the date of calculation shall be the final date of such
period of time).
(c)
Payments. Whenever any payment of cash is to be made by the Company to any Person pursuant to this Certificate of Designations,
unless otherwise expressly set forth herein, such payment shall be made in lawful money of the United States of America by wire transfer
of immediately available funds pursuant to wire transfer instructions that Holder shall provide to the Company in writing from time to
time. Whenever any amount expressed to be due by the terms of this Certificate of Designations is due on any day which is not a Business
Day, the same shall instead be due on the next succeeding day which is a Business Day. Any amount due under the Transaction Documents
which is not paid when due (except to the extent such amount is simultaneously accruing Dividends at the Default Rate hereunder) shall
result in a late charge being incurred and payable by the Company in an amount equal to interest on such amount at the rate of fifteen
percent (15%) per annum from the date such amount was due until the same is paid in full (“Late Charge”).
27.
Waiver of Notice. To the extent permitted by law, the Company hereby irrevocably waives demand, notice, presentment, protest and
all other demands and notices in connection with the delivery, acceptance, performance, default or enforcement of this Certificate of
Designations and the Securities Purchase Agreement.
28.
Governing Law. This Certificate of Designations shall be construed and enforced in accordance with, and all questions concerning
the construction, validity, interpretation and performance of this Certificate of Designations shall be governed by, the internal laws
of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware
or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Delaware. Except
as otherwise required by Section 25 above, the Company hereby irrevocably submits to the exclusive jurisdiction of the state and
federal courts sitting in The City of New York, Borough of Manhattan, New York, for the adjudication of any dispute hereunder or in connection
herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in
any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action
or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein shall
be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein (i) shall be deemed
or operate to preclude any Holder from bringing suit or taking other legal action against the Company in any other jurisdiction to collect
on the Company’s obligations to such Holder, to realize on any collateral or any other security for such obligations, or to enforce
a judgment or other court ruling in favor of such Holder or (ii) shall limit, or shall be deemed or construed to limit, any provision
of Section 25 above. THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR
THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS CERTIFICATE OF DESIGNATIONS OR ANY TRANSACTION
CONTEMPLATED HEREBY.
29.
Judgment Currency.
(a)
If for the purpose of obtaining or enforcing judgment against the Company in any court in any jurisdiction it becomes necessary to convert
into any other currency (such other currency being hereinafter in this Section 29 referred to as the “Judgment Currency”)
an amount due in U.S. dollars under this Certificate of Designations, the conversion shall be made at the Exchange Rate prevailing on
the Trading Day immediately preceding:
(i)
the date actual payment of the amount due, in the case of any proceeding in the courts of New York or in the courts of any other jurisdiction
that will give effect to such conversion being made on such date: or
(ii)
the date on which the foreign court determines, in the case of any proceeding in the courts of any other jurisdiction (the date as of
which such conversion is made pursuant to this Section 29(a)(ii) being hereinafter referred to as the “Judgment Conversion
Date”).
(b)
If in the case of any proceeding in the court of any jurisdiction referred to in Section 29(a)(ii) above, there is a change in
the Exchange Rate prevailing between the Judgment Conversion Date and the date of actual payment of the amount due, the applicable party
shall pay such adjusted amount as may be necessary to ensure that the amount paid in the Judgment Currency, when converted at the Exchange
Rate prevailing on the date of payment, will produce the amount of US dollars which could have been purchased with the amount of Judgment
Currency stipulated in the judgment or judicial order at the Exchange Rate prevailing on the Judgment Conversion Date.
(c)
Any amount due from the Company under this provision shall be due as a separate debt and shall not be affected by judgment being obtained
for any other amounts due under or in respect of this Certificate of Designations.
30.
Severability. If any provision of this Certificate of Designations is prohibited by law or otherwise determined to be invalid
or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall
be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such
provision shall not affect the validity of the remaining provisions of this Certificate of Designations so long as this Certificate of
Designations as so modified continues to express, without material change, the original intentions of the parties as to the subject matter
hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective
expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred
upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s)
with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).
31.
Maximum Payments. Without limiting Section 9(c) of the Securities Purchase Agreement, nothing contained herein shall be deemed
to establish or require the payment of a rate of interest or other charges in excess of the maximum permitted by applicable law. In the
event that the rate of interest required to be paid or other charges hereunder exceed the maximum permitted by such law, any payments
in excess of such maximum shall be credited against amounts owed by the Company to the applicable Holder and thus refunded to the Company.
32.
Stockholder Matters; Amendment.
(a)
Stockholder Matters. Any stockholder action, approval or consent required, desired or otherwise sought by the Company pursuant
to the DGCL, the Certificate of Incorporation, this Certificate of Designations or otherwise with respect to the issuance of Preferred
Shares may be effected by written consent of the Company’s stockholders or at a duly called meeting of the Company’s stockholders,
all in accordance with the applicable rules and regulations of the DGCL. This provision is intended to comply with the applicable sections
of the DGCL permitting stockholder action, approval and consent affected by written consent in lieu of a meeting.
(b)
Amendment. Except for Section 4(d)(i), which may not be amended or waived hereunder, this Certificate of Designations or
any provision hereof may be amended by obtaining the affirmative vote at a meeting duly called for such purpose, or written consent without
a meeting in accordance with the DGCL, of the Required Holders, voting separately as a single class, and with such other stockholder
approval, if any, as may then be required pursuant to the DGCL and the Certificate of Incorporation.
33.
Certain Defined Terms. For purposes of this Certificate of Designations, the following terms shall have the following meanings:
(a)
“1934 Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.
(b)
“Additional Amount” means, as of the applicable date of determination, with respect to each Preferred Share, all accrued
and unpaid Dividends on such Preferred Share.
(c)
”Adjustment Right” means any right granted with respect to any securities issued in connection with,
or with respect to, any issuance or sale (or deemed issuance or sale in accordance with Section 8(a)) of shares of Common Stock
(other than rights of the type described in Section 7(a) hereof) that could result in a decrease in the net consideration received
by the Company in connection with, or with respect to, such securities (including, without limitation, any cash settlement rights, cash
adjustment or other similar rights).
(d)
”Affiliate” or “Affiliated” means, with respect to any Person, any other Person that directly
or indirectly controls, is controlled by, or is under common control with, such Person, it being understood for purposes of this definition
that “control” of a Person means the power directly or indirectly either to vote 10% or more of the stock having ordinary
voting power for the election of directors of such Person or direct or cause the direction of the management and policies of such Person
whether by contract or otherwise.
(e)
”Alternate Conversion Floor Amount” means an amount in cash, to be delivered by wire transfer
of immediately available funds pursuant to wire instructions delivered to the Company by the Holder in writing, equal to the product
obtained by multiplying (A) the higher of (I) the highest price that the Common Stock trades at on the Trading Day immediately preceding
the relevant Alternate Conversion Date and (II) the applicable Alternate Conversion Price and (B) the difference obtained by subtracting
(I) the number of shares of Common Stock delivered (or to be delivered) to the Holder on the applicable Share Delivery Deadline with
respect to such Alternate Conversion from (II) the quotient obtained by dividing (x) the applicable Conversion Amount that the Holder
has elected to be the subject of the applicable Alternate Conversion, by (y) the applicable Alternate Conversion Price without giving
effect to clause (x) of such definition.
(f)
”Alternate Conversion Price” means, with respect to any Alternate Conversion that price which shall
be the lowest of (i) the applicable Conversion Price as in effect on the applicable Conversion Date of the applicable Alternate Conversion,
and (ii) the greater of (x) the Floor Price and (y) 80% of the lowest VWAP of the Common Stock of any Trading Day during the twenty (20)
consecutive Trading Day period ending and including the Trading Day immediately preceding the delivery or deemed delivery of the applicable
Conversion Notice (such period, the “Alternate Conversion Measuring Period”). All such determinations to be appropriately
adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases
or increases the Common Stock during such Alternate Conversion Measuring Period.
(g)
“Approved Stock Plan” means any employee benefit plan or agreement which has been approved by the Board prior to or
subsequent to the Subscription Date pursuant to which shares of Common Stock and standard options to purchase Common Stock or other awards
convertible, exercisable for or exchangeable for shares of Common Stock may be issued to any employee, officer, consultant or director
for services provided to the Company in their capacity as such.
(h)
“Attribution Parties” means, collectively, the following Persons and entities: (i) any investment vehicle, including,
any funds, feeder funds or managed accounts, currently, or from time to time after the Initial Issuance Date, directly or indirectly
managed or advised by a Holder’s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates
of such Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with such Holder
or any of the foregoing and (iv) any other Persons whose beneficial ownership of the Company’s Common Stock would or could be aggregated
with such Holder’s and the other Attribution Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of
the foregoing is to subject collectively such Holder and all other Attribution Parties to the Maximum Percentage.
(i)
“Bloomberg” means Bloomberg, L.P.
(j)
“Book-Entry” means each entry on the Register evidencing one or more Preferred Shares held by a Holder in lieu of
a Preferred Share Certificate issuable hereunder.
(k)
“Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New
York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not
be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential
employee” or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental
authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York
generally are open for use by customers on such day.
(l)
“Change of Control” means (a) any Fundamental Transaction other than (i) any merger of the Company or any of its,
direct or indirect, wholly-owned Subsidiaries with or into any of the foregoing Persons, (ii) any reorganization, recapitalization or
reclassification of the Common Stock in which holders of the Company’s voting power immediately prior to such reorganization, recapitalization
or reclassification continue after such reorganization, recapitalization or reclassification to hold publicly traded securities and,
directly or indirectly, are, in all material respects, the holders of the voting power of the surviving entity (or entities with the
authority or voting power to elect the members of the board of directors (or their equivalent if other than a corporation) of such entity
or entities) after such reorganization, recapitalization or reclassification, (iii) pursuant to a migratory merger effected solely for
the purpose of changing the jurisdiction of incorporation of the Company or any of its Subsidiaries or (iv) bona fide arm’s length
sales or acquisitions by the Company with one or more third parties as long as holders of the Company’s voting power as of the
Issuance Date continue after such sale or acquisition to hold publicly traded securities and, directly or indirectly, are, in all material
respects, the holders of at least 51% of the voting power of the surviving entity (or entities with the authority or voting power to
elect the members of the board of directors (or their equivalent if other than a corporation) of such entity or entities) after such
sale or acquisition (in each of clauses (i) through (iv), a “Change of Control Exception”), or (b) individuals who
constitute the Continuing Directors, taken together, ceasing for any reason to constitute at least a majority of the Board, other than
in connection with a Change of Control Exception.
(m)
“Change of Control Redemption Premium” means the greater of (i) 125% or (ii) the Black-Scholes Value of the remaining
unconverted shares of Preferred Stock on the date of the consummation of such Change of Control. For purposes of this definition “Black
Scholes Value” means the value of the unconverted shares of Preferred Stock based on the Black-Scholes Option Pricing Model
obtained from the “OV” function on Bloomberg determined as of the date in question for pricing purposes and reflecting
(A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement
of the applicable Change of Control and the Maturity Date, (B) an expected volatility equal to the 100 day volatility obtained from the
HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public
announcement of the applicable contemplated Change of Control, (C) the underlying price per share used in such calculation shall be the
greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being
offered in such Change of Control and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the
public announcement of the applicable contemplated Change of Control (or the consummation of the applicable Change of Control, if earlier)
and ending on the Trading Day of the Holder’s request pursuant to this section, (D) a remaining option time equal to the time between
the date of the public announcement of the applicable contemplated Change of Control and the Maturity Date, and (E) a zero cost of borrow.
(n)
“Closing Bid Price” and “Closing Sale Price” means, for any security as of any date, the last closing
bid price and last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the
Principal Market begins to operate on an extended hours basis and does not designate the closing bid price or the closing trade price
(as the case may be) then the last bid price or last trade price, respectively, of such security prior to 4:00:00 p.m., New York time,
as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security, the
last closing bid price or last trade price, respectively, of such security on the principal securities exchange or trading market where
such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last trade
price, respectively, of such security in the over-the-counter market on the electronic bulletin board for such security as reported by
Bloomberg, or, if no closing bid price or last trade price, respectively, is reported for such security by Bloomberg, the average of
the bid prices, or the ask prices, respectively, of any market makers for such security as reported in The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices). If the Closing Bid Price or the Closing Sale Price cannot be
calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price or the Closing Sale Price (as the
case may be) of such security on such date shall be the fair market value as mutually determined by the Company and the Required Holder.
If the Company and the Required Holders are unable to agree upon the fair market value of such security, then such dispute shall be resolved
in accordance with the procedures in Section 25. All such determinations shall be appropriately adjusted for any stock splits,
stock dividends, stock combinations, recapitalizations or other similar transactions during such period.
(o)
“Closing Date” shall have the meaning set forth in the Securities Purchase Agreement, which date is the date the Company
initially issued the Preferred Shares and the Warrants pursuant to the terms of the Securities Purchase Agreement.
(p)
“Common Stock” means (i) the Company’s shares of common stock, par value $0.0001 per share, and (ii) any capital
stock into which such common stock shall have been changed or any share capital resulting from a reclassification of such common stock.
(q)
“Contingent Obligation” means, as to any Person, any direct or indirect liability, contingent or otherwise, of that
Person with respect to any Indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the
Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability
will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability will
be protected (in whole or in part) against loss with respect thereto.
(r)
“Continuing Directors” means the directors of the Company on the date hereof and each other director, if, in each
case, such other director is nominated for election by the Board a majority of whom are directors on the date hereof or whose election
or nomination for election was approved by one or more of such directors.
(s)
“Conversion Floor Price Condition” means that the relevant Alternate Conversion Price is being determined based on
clause (x) of such definition.
(t)
“Convertible Securities” means any stock or other security (other than Options) that is at any time and under any
circumstances, directly or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof
to acquire, any shares of Common Stock.
(u)
“Dividend Date” means the first Trading Day of each calendar quarter.
(v)
“Dividend Rate” means seven percent (7.0%) per annum, as may be adjusted from time to time in accordance with Section
3.
(w)
“Eligible Market” means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq
Global Market, the OTCQX, the OTCQB or the Principal Market.
(x)
“Event Market Price” means, with respect to any Stock Combination Event Date, the lower of (i) the Conversion Price
in effect immediately after such Stock Combination Event Date (and, for the avoidance of doubt, as adjusted following such Stock Combination
Event Date as set forth herein), and (ii) the lowest VWAP of the Common Stock for any Trading Day during the eleven (11) consecutive
Trading Day period commencing on the fifth (5th) Trading Day immediately preceding the Stock Combination Event Date and ending on the
fifth (5th) Trading Day immediately following the Stock Combination Event Date.
(y)
”Excluded Securities” means (i) shares of Common Stock or standard options to purchase Common Stock issued
to directors, officers or employees of the Company for services rendered to the Company in their capacity as such pursuant to an Approved
Stock Plan (as defined above), provided that (A) following November 4, 2025 (the “Equity Award Restriction Date”),
all such issuances (taking into account the shares of Common Stock issuable upon exercise of such options) after the Equity Award Restriction
Date pursuant to this clause (i) do not, in the aggregate, exceed more than 10.0% of the Common Stock issued and outstanding immediately
prior to the Equity Award Restriction Date and (B) the exercise price of any such options is not lowered, none of such options are amended
to increase the number of shares issuable thereunder and none of the terms or conditions of any such options are otherwise materially
changed in any manner that adversely affects any of the Buyers (as defined in the Securities Purchase Agreement); (ii) shares of Common
Stock issued upon the conversion or exercise of Convertible Securities (other than standard options to purchase Common Stock issued pursuant
to an Approved Stock Plan that are covered by clause (i) above) issued prior to the Subscription Date, provided that the conversion
price of any such Convertible Securities (other than standard options to purchase Common Stock issued pursuant to an Approved Stock Plan
that are covered by clause (i) above) is not lowered (other than in accordance with the terms thereof in effect as of the Subscription
Date) from the conversion price in effect as of the Subscription Date (whether pursuant to the terms of such Convertible Securities or
otherwise), none of such Convertible Securities (other than standard options to purchase Common Stock issued pursuant to an Approved
Stock Plan that are covered by clause (i) above) are amended to increase the number of shares issuable thereunder and none of the terms
or conditions of any such Convertible Securities (other than standard options to purchase Common Stock issued pursuant to an Approved
Stock Plan that are covered by clause (i) above) are otherwise materially changed in any manner that adversely affects any of the Buyers;
(iii) the shares of Common Stock issuable upon conversion of the Preferred Shares or otherwise pursuant to the terms of this Certificate
of Designations; provided, that the terms of this Certificate of Designations are not amended, modified or changed on or after
the Subscription Date (other than in accordance with the terms thereof, including antidilution adjustments pursuant to the terms thereof
in effect as of the Subscription Date), (iv) the shares of Common Stock issuable upon exercise of the Warrants; provided, that
the terms of the Warrants are not amended, modified or changed on or after the Subscription Date (other than antidilution adjustments
pursuant to the terms thereof in effect as of the Subscription Date), (v) the issuance of the payment of dividends of preferred share
purchase rights (the “Rights”), with each such Right entitling the holder to purchase from the Company one one-thousandth
of a share of Series A Junior Participating Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”),
of the Company, declared by the board of directors of the Company on July 31, 2025, to stockholders of record at the close of business
on August 11, 2025, (vi) the Series A Preferred Stock, pursuant to that certain Certificate of Designations establishing the rights,
preferences, restrictions and other matters relating to the Series A Preferred Stock (the “Series A Certificate of Designations”),
and (vii) shares of Common Stock as payment of dividends on the Series A Preferred Stock in accordance with the Series A Certificate
of Designations.
(z)
“Floor Price” means $1.5256, as of the Effective Date (subject to adjustment for stock splits, stock dividends, stock
combinations, recapitalizations or other similar events following the Effective Date), which was 20% of the “Minimum Price”
(as defined in Rule 5635 of the Nasdaq Stock Market) on the Stockholder Approval Date (as defined in the Purchase Agreement) (as adjusted
for stock splits, stock dividends, stock combinations, recapitalizations or other similar events subsequent to the Stockholder Approval
Date and prior to the Effective Date) or, in any case, such lower amount as permitted, from time to time, by the Principal Market.
(aa)
“Fundamental Transaction” means (A) that the Company shall, directly or indirectly, including through subsidiaries,
Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the
surviving corporation) another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all
of the properties or assets of the Company or any of its “significant subsidiaries” (as defined in Rule 1-02 of Regulation
S-X) to one or more Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow the Company to be subject
to or have its voting stock be subject to or party to one or more Subject Entities making, a purchase, tender or exchange offer that
is accepted by the holders of at least either (x) more than 50% of the outstanding voting power of the Company, (y) more than 50% of
the outstanding voting power of the Company calculated as if any shares of voting stock held by all Subject Entities making or party
to, or Affiliated with any Subject Entities making or party to, such purchase, tender or exchange offer were not outstanding; or (z)
such number of shares of voting stock such that all Subject Entities making or party to, or Affiliated with any Subject Entity making
or party to, such purchase, tender or exchange offer, become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934
Act) of more than 50% of the outstanding voting power of the Company, or (iv) consummate a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with one
or more Subject Entities whereby all such Subject Entities, individually or in the aggregate, acquire, either (x) more than 50% of the
outstanding voting power of the Company (y) more than 50% of the outstanding voting power of the Company calculated as if any shares
of voting stock held by all the Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such stock
purchase agreement or other business combination were not outstanding; or (z) such number of shares of voting stock of the Company such
that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of more than 50% of
the outstanding voting power of the Company, or (v) reorganize, recapitalize or reclassify its Common Stock, (B) that the Company shall,
directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions, allow any Subject
Entity individually or the Subject Entities in the aggregate to be or become the “beneficial owner” (as defined in Rule 13d-3
under the 1934 Act), directly or indirectly, whether through acquisition, purchase, assignment, conveyance, tender, tender offer, exchange,
reduction in outstanding shares of voting stock, merger, consolidation, business combination, reorganization, recapitalization, spin-off,
scheme of arrangement, reorganization, recapitalization or reclassification or otherwise in any manner whatsoever, of either (x) more
than 50% of the aggregate ordinary voting power represented by issued and outstanding shares of voting stock of the Company, (y) more
than 50% of the aggregate ordinary voting power represented by issued and outstanding shares of voting stock of the Company not held
by all such Subject Entities as of the date of this Certificate of Designations calculated as if any shares of voting stock of the Company
held by all such Subject Entities were not outstanding, or (z) a percentage of the aggregate ordinary voting power represented by issued
and outstanding shares of voting stock of the Company or other equity securities of the Company sufficient to allow such Subject Entities
to effect a statutory short form merger or other transaction requiring other stockholders of the Company to surrender their shares of
voting stock of the Company without approval of the stockholders of the Company or (C) directly or indirectly, including through subsidiaries,
Affiliates or otherwise, in one or more related transactions, the issuance of or the entering into any other instrument or transaction
structured in a manner to circumvent, or that circumvents, the intent of this definition in which case this definition shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this definition to the extent necessary to correct
this definition or any portion of this definition which may be defective or inconsistent with the intended treatment of such instrument
or transaction.
(bb)
“GAAP” means United States generally accepted accounting principles, consistently applied.
(cc)
“Group” means a “group” as that term is used in Section 13(d) of the 1934 Act and as defined in
Rule 13d-5 thereunder.
(dd)
“Indebtedness” means of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all obligations
issued, undertaken or assumed as the deferred purchase price of property or services, including, without limitation, “capital leases”
in accordance with United States generally accepted accounting principles consistently applied for the periods covered thereby (other
than trade payables entered into in the ordinary course of business consistent with past practice), (C) all reimbursement or payment
obligations with respect to letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds,
debentures or similar instruments, including obligations so evidenced incurred in connection with the acquisition of property, assets
or businesses, (E) all indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as
financing, in either case with respect to any property or assets acquired with the proceeds of such indebtedness (even though the rights
and remedies of the seller or bank under such agreement in the event of default are limited to repossession or sale of such property),
(F) all monetary obligations under any leasing or similar arrangement which, in connection with United States generally accepted accounting
principles, consistently applied for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to
in clauses (A) through (F) above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise,
to be secured by) any mortgage, deed of trust, lien, pledge, charge, security interest or other encumbrance of any nature whatsoever
in or upon any property or assets (including accounts and contract rights) with respect to any asset or property owned by any Person,
even though the Person which owns such assets or property has not assumed or become liable for the payment of such indebtedness, and
(H) all Contingent Obligations in respect of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G)
above.
(ee)
Reserved.
(ff)
Reserved.
(gg)
Reserved.
(hh)
“Intellectual Property Rights” means, with respect to the Company and its Subsidiaries, all of their rights or licenses
to use all trademarks, trade names, service marks, service mark registrations, service names, original works of authorship, patents,
patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property
rights and all applications and registrations therefor.
(ii)
“Investment” means any beneficial ownership (including stock, partnership or limited liability company interests)
of or in any Person, or any loan, advance or capital contribution to any Person or the acquisition of all, or substantially all, of the
assets of another Person or the purchase of any assets of another Person for greater than the fair market value of such assets.
(jj)
“Liquidation Event” means, whether in a single transaction or series of transactions, the voluntary or involuntary
liquidation, dissolution or winding up of the Company or such Subsidiaries the assets of which constitute all or substantially all of
the assets of the business of the Company and its Subsidiaries, taken as a whole.
(kk)
“Maturity Date” shall mean October 27, 2027; provided, however, the Maturity Date may be extended upon
the mutual consent of a Holder and the Company with respect to such Holder; and provided further, however, the Maturity
Date may be extended at the option of a Holder with respect to such Holder (i) in the event that, and for so long as, a Triggering Event
shall have occurred and be continuing or any event shall have occurred and be continuing that with the passage of time and the failure
to cure would result in a Triggering Event or (ii) through the date that is twenty (20) Business Days after the consummation of a Fundamental
Transaction in the event that a Fundamental Transaction is publicly announced or a Change of Control Notice is delivered prior to the
Maturity Date, provided further that if a Holder elects to convert some or all of its Preferred Shares pursuant to Section
4 hereof, and the Conversion Amount would be limited pursuant to Section 4(d) hereunder, the Maturity Date shall automatically
be extended until such time as such provision shall not limit the conversion of such Preferred Shares.
(ll)
“Options” means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible
Securities.
(mm)
“Parent Entity” of a Person means an entity that, directly or indirectly, controls the applicable Person and whose
common stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent
Entity, the Person or Parent Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.
(nn)
“Permitted Indebtedness” means (i) Indebtedness existing on June 30, 2025, and reflected on the Company’s balance
sheet included in the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 14, 2025, (ii) Indebtedness secured by
Permitted Liens or unsecured but as described in clauses (iv) and (v) of the definition of Permitted Liens and (iii) if (x) the Stockholder
Approval Date has occurred, and (y) less than 3,000 Preferred Shares remain outstanding, the Permitted Senior Indebtedness.
(oo)
“Permitted Liens” means (i) any Lien for taxes not yet due or delinquent or being contested in good faith by appropriate
proceedings for which adequate reserves have been established in accordance with GAAP, (ii) any statutory Lien arising in the ordinary
course of business by operation of law with respect to a liability that is not yet due or delinquent, (iii) any Lien created by operation
of law, such as materialmen’s liens, mechanics’ liens and other similar liens, arising in the ordinary course of business
with respect to a liability that is not yet due or delinquent or that are being contested in good faith by appropriate proceedings, (iv)
Liens (A) upon or in any equipment acquired or held by the Company or any of its Subsidiaries to secure the purchase price of such equipment
or Indebtedness incurred solely for the purpose of financing the acquisition or lease of such equipment, or (B) existing on such equipment
at the time of its acquisition, provided that the Lien is confined solely to the property so acquired and improvements thereon,
and the proceeds of such equipment, in either case, with respect to Indebtedness in an aggregate amount not to exceed $150,000, (v) Liens
incurred in connection with the extension, renewal or refinancing of the Indebtedness secured by Liens of the type described in clause
(iv) above, provided that any extension, renewal or replacement Lien shall be limited to the property encumbered by the existing
Lien and the principal amount of the Indebtedness being extended, renewed or refinanced does not increase, (vi) Liens in favor of customs
and revenue authorities arising as a matter of law to secure payments of custom duties in connection with the importation of goods, (vii)
Liens arising from judgments, decrees or attachments in circumstances not constituting a Triggering Event under Section 5(a)(vii)
and (viii) Liens with respect to the Permitted Senior Indebtedness.
(pp)
“Permitted Senior Indebtedness” means non-convertible Indebtedness issued pursuant to a credit facility with a bank
or similar financial institution with no principal payments required prior to the 91st calendar day after the Maturity Date, provided,
however, that the aggregate outstanding principal amount of such Indebtedness permitted hereunder does not at any time exceed
$10 million; provided, further, however, no Permitted Senior Indebtedness shall permit the lender to accelerate
such Permitted Senior Indebtedness as a result of the occurrence of any Triggering Event hereunder or the Holder’s delivery of
a Triggering Event Redemption Notice.
(qq)
“Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust,
an unincorporated organization, any other entity or a government or any department or agency thereof.
(rr)
“Principal Market” means the Nasdaq Capital Market.
(ss)
“Redemption Notices” means, collectively, the Triggering Event Redemption Notices and the Change of Control Redemption
Notices, and each of the foregoing, individually, a “Redemption Notice.”
(tt)
“Redemption Premium” means 130%.
(uu)
“Redemption Prices” means, collectively, any Triggering Event Redemption Price and Change of Control Redemption Price,
and each of the foregoing, individually, a “Redemption Price.”
(vv)
“SEC” means the United States Securities and Exchange Commission or the successor thereto.
(ww)
“Securities Purchase Agreement” means that certain securities purchase agreement by and among the Company and the
initial holders of Preferred Shares, dated as of the Subscription Date, as may be amended from time in accordance with the terms thereof.
(xx)
“Stated Value” shall mean $1,000 per share, subject to adjustment for stock splits, stock dividends, recapitalizations,
reorganizations, reclassifications, combinations, subdivisions or other similar events occurring after the Initial Issuance Date with
respect to the Preferred Shares.
(yy)
“Subscription Date” means August 4, 2025.
(zz)
“Subject Entity” means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.
(aaa)
“Subsidiaries” shall have the meaning as set forth in the Securities Purchase Agreement.
(bbb) “Successor
Entity” means the Person (or, if so elected by the Required Holders, the Parent Entity) formed by, resulting from or surviving
any Fundamental Transaction or the Person (or, if so elected by the Required Holders, the Parent Entity) with which such Fundamental
Transaction shall have been entered into.
(ccc)
“Trading Day” means, as applicable, (x) with respect to all price or trading volume determinations relating to the
Common Stock, any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading
market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded,
provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such
exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading
on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange
or market, then during the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in writing
by the applicable Holder or (y) with respect to all determinations other than price determinations relating to the Common Stock, any
day on which The New York Stock Exchange (or any successor thereto) is open for trading of securities.
(ddd)
“Transaction Documents” means the Securities Purchase Agreement, this Certificate of Designations, the Warrants and
each of the other agreements and instruments entered into or delivered by the Company or any of the Holders in connection with the transactions
contemplated by the Securities Purchase Agreement, all as may be amended from time to time in accordance with the terms thereof.
(eee)
“VWAP” means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal
Market (or, if the Principal Market is not the principal trading market for such security, then on the principal securities exchange
or securities market on which such security is then traded), during the period beginning at 9:30 a.m., New York time, and ending at 4:00
p.m., New York time, as reported by Bloomberg through its “VAP” function (set to 09:30 start time and 16:00 end time)
or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the
electronic bulletin board for such security during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York
time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours,
the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported
in The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices). If the VWAP cannot be
calculated for such security on such date on any of the foregoing bases, the VWAP of such security on such date shall be the fair market
value as mutually determined by the Company and the Required Holders. If the Company and the Required Holders are unable to agree upon
the fair market value of such security, then such dispute shall be resolved in accordance with the procedures in Section 25. All
such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination, recapitalization or other
similar transaction during such period.
(fff)
“Warrants” has the meaning ascribed to such term in the Securities Purchase Agreement, and shall include all warrants
issued in exchange therefor or replacement thereof.
(ggg)
“Warrant Shares” means, collectively, the shares of Common Stock issuable upon exercise of the Warrants.
34.
Disclosure. Upon receipt or delivery by the Company of any notice in accordance with the terms of this Certificate of Designations,
unless the Company has in good faith determined that the matters relating to such notice do not constitute material, non-public information
relating to the Company or any of its Subsidiaries, the Company shall on or prior to 9:00 am, New York city time on the Business Day
immediately following such notice delivery date, publicly disclose such material, non-public information on a Current Report on Form
8-K or otherwise. In the event that the Company believes that a notice contains material, non-public information relating to the Company
or any of its Subsidiaries, the Company so shall indicate to the Holder explicitly in writing in such notice (or immediately upon receipt
of notice from such Holder, as applicable), and in the absence of any such written indication in such notice (or notification from the
Company immediately upon receipt of notice from such Holder), such Holder shall be entitled to presume that information contained in
the notice does not constitute material, non-public information relating to the Company or any of its Subsidiaries. Nothing contained
in this Section 34 shall limit any obligations of the Company, or any rights of any Holder, under Section 4(l) of the Securities
Purchase Agreement.
35.
Absence of Trading and Disclosure Restrictions. The Company acknowledges and agrees that no Holder is a fiduciary or agent of
the Company and that each Holder shall have no obligation to (a) maintain the confidentiality of any information provided by the Company
or (b) refrain from trading any securities while in possession of such information in the absence of a written non-disclosure agreement
signed by an officer of such Holder that explicitly provides for such confidentiality and trading restrictions. In the absence of such
an executed, written non-disclosure agreement, the Company acknowledges that each Holder may freely trade in any securities issued by
the Company, may possess and use any information provided by the Company in connection with such trading activity, and may disclose any
such information to any third party.
*
* * * *
IN
WITNESS WHEREOF, the Company has caused this Amended and Restated Certificate of Designations of Series I Convertible Preferred Stock
of StableX Technologies, Inc. to be signed by its Chief Executive Officer on this 27th day of April, 2026.
STABLEX
TECHNOLOGIES, INC.
By:
/s/
Josuha Silverman
Name:
Joshua
Silverman
Title:
Chief
Executive Officer
EXHIBIT
I
STABLEX
TECHNOLOGIES, INC.
CONVERSION
NOTICE
Reference
is made to the Amended and Restated Certificate of Designations, Preferences and Rights of the Series I Convertible Preferred Stock of
StableX Technologies, Inc. (the “Certificate of Designations”). In accordance with and pursuant to the Certificate
of Designations, the undersigned hereby elects to convert the number of shares of Series I Convertible Preferred Stock, $0.0001 par value
per share (the “Preferred Shares”), of StableX Technologies, Inc. a Delaware corporation (the “Company”),
indicated below into shares of common stock, $0.0001 value per share (the “Common Stock”), of the Company, as of the
date specified below.
● Date
of Conversion
●
Aggregate
number of Preferred Shares to be converted
●
Aggregate
Stated Value of such Preferred Shares to be converted:
●
Aggregate
accrued and unpaid Dividends and accrued and unpaid Late Charges with respect to such Preferred Shares and such aggregate Dividends
to be converted:
●
AGGREGATE
CONVERSION AMOUNT TO BE CONVERTED:
Please
confirm the following information:
●
Conversion
Price:
●
Number
of shares of Common Stock to be issued:
☐ If
this Conversion Notice is being delivered with respect to an Alternate Conversion, check here if Holder is electing to use the following
Alternate Conversion Price: ____________
Please
issue the Common Stock into which the applicable Preferred Shares are being converted to Holder, or for its benefit, as follows:
☐ Check
here if requesting delivery as a certificate to the following name and to the following address:
Issue
to:
☐
Check
here if requesting delivery by Deposit/Withdrawal at Custodian as follows:
DTC
Participant:
DTC
Number:
Account
Number:
Date:
______________________________
Name
of Registered Holder
By:
Name:
Title:
Tax
ID: _____________________________
Address:________________________
EXHIBIT
II
ACKNOWLEDGMENT
The
Company hereby (a) acknowledges this Conversion Notice, (b) certifies that the above indicated number of shares of Common Stock are eligible
to be resold by the Holder without restriction or any legend and (c) hereby directs _________________ to issue the above indicated number
of shares of Common Stock in accordance with the Transfer Agent Instructions dated __________, 2025 from the Company and acknowledged
and agreed to by ________________________.
STABLEX
TECHNOLOGIES, INC.
By:
Name:
Title:
EX-3.5
EX-3.5
Filename: ex3-5.htm · Sequence: 6
Exhibit 3.5
Certificate
of Amendment
of
Certificate
of Incorporation
of
StableX
Technologies, INC.
StableX
Technologies, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware
(the “Corporation”) hereby certifies:
1.
The Amended and Restated Certificate of Incorporation of the Corporation was filed with the Secretary of State of Delaware on May 28, 2020 (as amended, the “Certificate of Incorporation”).
2.
Resolutions were duly adopted by the Board of Directors of the Corporation setting forth this proposed amendment to the Certificate of Incorporation.
3.
Article I of the Certificate of Incorporation is hereby amended and restated in its entirety to read as follows:
“The
name of the corporation is Fabric.AI, Inc. (hereinafter referred to as the “Corporation”).
4.
The foregoing amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.
5.
The effective date of this Certificate of Amendment to the Certificate of Incorporation shall be 12:01 a.m. on April 28, 2026.
[Signature
page follows.]
IN
WITNESS WHEREOF, said corporation has caused this Certificate of Amendment to be executed this 27th day of April, 2026.
StableX
Technologies, Inc.
By:
/s/
Joshua Silverman
Name:
Joshua
Silverman
Title:
Executive
Chairman
EX-4.1
EX-4.1
Filename: ex4-1.htm · Sequence: 7
Exhibit 4.1
FORM
OF WARRANT
NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED
FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO
THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE
144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER
LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. THE NUMBER OF SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT
MAY BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF PURSUANT TO SECTION 1(a) OF THIS WARRANT.
STABLEX
TECHNOLOGIES, INC.
Warrant
to Purchase Common Stock
Warrant
No.:
Date
of Issuance: [●] (“Issuance Date”)
StableX
Technologies, Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, [BUYER], the registered holder hereof or its permitted assigns (the “Holder”),
is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect,
upon exercise of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer
or replacement hereof, the “Warrant”), at any time or times on or after the Issuance Date, but not after 11:59 p.m.,
New York time, on the Expiration Date (as defined below), _________________1 (subject to adjustment as provided herein)
fully paid and non-assessable shares of Common Stock (as defined below) (the “Warrant Shares”, and such
number of Warrant Shares, the “Warrant Number”). Except as otherwise defined herein, capitalized terms in this Warrant
shall have the meanings set forth in Section 19 or in the Securities Purchase Agreement (as defined below). This Warrant is one of the
Warrants to Purchase Common Stock (the “SPA Warrants”) issued pursuant to Section 1 of that certain Securities Purchase
Agreement, dated as of April 27, 2026 (the “Subscription Date”), by and among the Company and the investors (the “Buyers”)
referred to therein, as amended from time to time (the “Securities Purchase Agreement”).
1
100% warrant coverage (equal to number of shares of Common Stock issuable upon conversion of Preferred Shares)
1. EXERCISE
OF WARRANT.
(a) Mechanics
of Exercise. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section
1(f)), this Warrant may be exercised by the Holder on any day on or after the Issuance Date (an “Exercise Date”),
in whole or in part, by delivery (whether via electronic mail or otherwise) of a written notice, in the form attached hereto as Exhibit
A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant. Within one (1)
Trading Day (or any other settlement cycle as may be in effect pursuant to Rule 15c6-1 under the Exchange Act from time to time)
following an exercise of this Warrant as aforesaid, the Holder shall deliver payment to the Company of an amount equal to the
Exercise Price in effect on the date of such exercise multiplied by the number of Warrant Shares as to which this Warrant was so
exercised (the “Aggregate Exercise Price”) in cash or via wire transfer of immediately available funds if the
Holder did not notify the Company in such Exercise Notice that such exercise was made pursuant to a Cashless Exercise (as defined in
Section 1(d)). The Holder shall not be required to deliver the original of this Warrant in order to effect an exercise hereunder.
Execution and delivery of an Exercise Notice with respect to less than all of the Warrant Shares shall have the same effect as
cancellation of the original of this Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number of
Warrant Shares. Execution and delivery of an Exercise Notice for all of the then-remaining Warrant Shares shall have the same effect
as cancellation of the original of this Warrant after delivery of the Warrant Shares in accordance with the terms hereof. On or
before the first (1st) Trading Day following the date on which the Company has received an Exercise Notice, the Company shall
transmit by facsimile or electronic mail an acknowledgment of confirmation of receipt of such Exercise Notice, in the form attached
hereto as Exhibit B, to the Holder and the Company’s transfer agent (the “Transfer Agent”),
which confirmation shall constitute an instruction to the Transfer Agent to process such Exercise Notice in accordance with the
terms herein. On or before the first (1st) Trading Day following the date on which the Company has received such Exercise Notice (or
such earlier date as required pursuant to the 1934 Act or other applicable law, rule or regulation for the settlement of a trade of
such Warrant Shares initiated on the applicable Exercise Date), the Company shall (X) provided that the Transfer Agent is
participating in The Depository Trust Company (“DTC”) Fast Automated Securities Transfer Program
(“FAST”), upon the request of the Holder, credit such aggregate number of shares of Common Stock to which the
Holder is entitled pursuant to such exercise to the Holder’s or its designee’s balance account with DTC through its
Deposit/Withdrawal at Custodian system, or (Y) if the Transfer Agent is not participating in the DTC FAST, upon the request of the
Holder, issue and deliver (via reputable overnight courier) to the address as specified in the Exercise Notice, a certificate,
registered in the name of the Holder or its designee, for the number of shares of Common Stock to which the Holder shall be entitled
pursuant to such exercise. Upon delivery of an Exercise Notice, the Holder shall be deemed for all corporate purposes to have become
the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date such
Warrant Shares are credited to the Holder’s DTC account or the date of delivery of the certificates evidencing such Warrant
Shares (as the case may be). If this Warrant is submitted in connection with any exercise pursuant to this Section 1(a) and the
number of Warrant Shares represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being
acquired upon an exercise and upon surrender of this Warrant to the Company by the Holder, then, at the request of the Holder, the
Company shall as soon as practicable and in no event later than two (2) Business Days after any exercise and at its own expense,
issue and deliver to the Holder (or its designee) a new Warrant (in accordance with Section 7(d)) representing the right to purchase
the number of Warrant Shares purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares
with respect to which this Warrant is exercised. No fractional shares of Common Stock are to be issued upon the exercise of this
Warrant, but rather the number of shares of Common Stock to be issued shall be rounded up to the nearest whole number. The Company
shall pay any and all transfer, stamp, issuance and similar taxes, costs and expenses (including, without limitation, fees and
expenses of the Transfer Agent) that may be payable with respect to the issuance and delivery of Warrant Shares upon exercise of
this Warrant. Notwithstanding the foregoing, except in the case where an exercise of this Warrant is validly made pursuant to a
Cashless Exercise, the Company’s failure to deliver Warrant Shares to the Holder on or prior to the later of (i) two (2)
Trading Days after receipt of the applicable Exercise Notice (or such earlier date as required pursuant to the 1934 Act or other
applicable law, rule or regulation for the settlement of a trade of such Warrant Shares initiated on the applicable Exercise Date)
and (ii) one (1) Trading Day after the Company’s receipt of the Aggregate Exercise Price (or valid notice of a Cashless
Exercise if permissible) (such later date, the “Share Delivery Date”) shall not be deemed to be a breach of this
Warrant. Notwithstanding anything to the contrary contained in this Warrant or the Registration Rights Agreement, after the
effective date of the Registration Statement (as defined in the Registration Rights Agreement) and prior to the Holder’s
receipt of the notice of a Grace Period (as defined in the Registration Rights Agreement), the Company shall cause the Transfer
Agent to deliver unlegended shares of Common Stock to the Holder (or its designee) in connection with any sale of Registrable
Securities (as defined in the Registration Rights Agreement) with respect to which the Holder has entered into a contract for sale,
and delivered a copy of the prospectus included as part of the particular Registration Statement to the extent applicable, and for
which the Holder has not yet settled. From the Issuance Date through and including the Expiration Date, the Company shall maintain a
transfer agent that participates in FAST.
(b) Exercise
Price. For purposes of this Warrant, “Exercise Price” means $2.51, subject to adjustment as provided
herein.
(c) Company’s
Failure to Timely Deliver Securities. If the Company shall fail, for any reason or for no reason, on or prior to the Share
Delivery Date, either (I) if the Transfer Agent is not participating in FAST, to issue and deliver to the Holder (or its designee) a
certificate for the number of Warrant Shares to which the Holder is entitled and register such Warrant Shares on the Company’s
share register or, if the Transfer Agent is participating in FAST, to credit the balance account of the Holder or the Holder’s
designee with DTC for such number of Warrant Shares to which the Holder is entitled upon the Holder’s exercise of this Warrant
(as the case may be) or (II) if a Registration Statement covering the resale of the Warrant Shares that are the subject of the
Exercise Notice (the “Unavailable Warrant Shares”) is not available for the resale of such Unavailable Warrant
Shares and the Company fails to promptly, but in no event later than as required pursuant to the Registration Rights Agreement (x)
so notify the Holder and (y) deliver the Warrant Shares electronically without any restrictive legend by crediting such aggregate
number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the Holder’s or its designee’s
balance account with DTC through its Deposit/Withdrawal At Custodian system (the event described in the immediately foregoing clause
(II) is hereinafter referred as a “Notice Failure” and together with the event described in clause (I) above, a
“Delivery Failure”), then, in addition to all other remedies available to the Holder, (X) the Company shall pay
in cash to the Holder on each day after the Share Delivery Date and during such Delivery Failure an amount equal to 2% of the
product of (A) the sum of the number of shares of Common Stock not issued to the Holder on or prior to the Share Delivery Date and
to which the Holder is entitled, multiplied by (B) any trading price of the Common Stock selected by the Holder in writing as in
effect at any time during the period beginning on the applicable Exercise Date and ending on the applicable Share Delivery Date, and
(Y) the Holder, upon written notice to the Company, may void its Exercise Notice with respect to, and retain or have returned, as
the case may be, any portion of this Warrant that has not been exercised pursuant to such Exercise Notice; provided that the voiding
of an Exercise Notice shall not affect the Company’s obligations to make any payments which have accrued prior to the date of
such notice pursuant to this Section 1(c) or otherwise. In addition to the foregoing, if on or prior to the Share Delivery Date
either (I) the Transfer Agent is not participating in the DTC FAST, the Company shall fail to issue and deliver to the Holder (or
its designee) a certificate and register such shares of Common Stock on the Company’s share register or, if the Transfer Agent
is participating in the DTC FAST, the Transfer Agent shall fail to credit the balance account of the Holder or the Holder’s
designee with DTC for the number of shares of Common Stock to which the Holder is entitled upon the Holder’s exercise
hereunder or pursuant to the Company’s obligation pursuant to clause (ii) below or (II) a Notice Failure occurs, and if on or
after such Share Delivery Date the Holder acquires (in an open market transaction, stock loan or otherwise) shares of Common Stock
corresponding to all or any portion of the number of shares of Common Stock issuable upon such exercise that the Holder is entitled
to receive from the Company and has not received from the Company in connection with such Delivery Failure or Notice Failure, as
applicable (a “Buy-In”), then, in addition to all other remedies available to the Holder, the Company shall,
within two (2) Business Days after the Holder’s request and in the Holder’s discretion, either (i) pay cash to the
Holder in an amount equal to the Holder’s total purchase price (including brokerage commissions, stock loan costs and other
out-of-pocket expenses, if any) for the shares of Common Stock so acquired (including, without limitation, by any other Person in
respect, or on behalf, of the Holder) (the “Buy-In Price”), at which point the Company’s obligation to so
issue and deliver such certificate (and to issue such shares of Common Stock) or credit the balance account of such Holder or such
Holder’s designee, as applicable, with DTC for the number of Warrant Shares to which the Holder is entitled upon the
Holder’s exercise hereunder (as the case may be) (and to issue such Warrant Shares) shall terminate, or (ii) promptly honor
its obligation to so issue and deliver to the Holder a certificate or certificates representing such Warrant Shares or credit the
balance account of such Holder or such Holder’s designee, as applicable, with DTC for the number of Warrant Shares to which
the Holder is entitled upon the Holder’s exercise hereunder (as the case may be) and pay cash to the Holder in an amount equal
to the excess (if any) of the Buy-In Price over the product of (A) such number of Warrant Shares multiplied by (B) the lowest
Closing Sale Price of the Common Stock on any Trading Day during the period commencing on the date of the applicable Exercise Notice
and ending on the date of such issuance and payment under this clause (ii) (the “Buy-In Payment Amount”). Nothing
shall limit the Holder’s right to pursue any other remedies available to it hereunder, at law or in equity, including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver
certificates representing shares of Common Stock (or to electronically deliver such shares of Common Stock) upon the exercise of
this Warrant as required pursuant to the terms hereof. While this Warrant is outstanding, the Company shall cause its transfer agent
to participate in FAST. In addition to the foregoing rights, (i) if the Company fails to deliver the applicable number of Warrant
Shares upon an exercise pursuant to Section 1 by the applicable Share Delivery Date, then the Holder shall have the right to rescind
such exercise in whole or in part and retain and/or have the Company return, as the case may be, any portion of this Warrant that
has not been exercised pursuant to such Exercise Notice; provided that the rescission of an exercise shall not affect the
Company’s obligation to make any payments that have accrued prior to the date of such notice pursuant to this Section 1(c) or
otherwise, and (ii) if a registration statement (which may be the Registration Statement) covering the issuance or resale of the
Warrant Shares that are subject to an Exercise Notice is not available for the issuance or resale, as applicable, of such Warrant
Shares, as required by and in accordance with the terms of the Registration Rights Agreement, and the Holder has submitted an
Exercise Notice prior to receiving notice of the non-availability of such registration statement and the Company has not already
delivered the Warrant Shares underlying such Exercise Notice electronically without any restrictive legend by crediting such
aggregate number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the Holder’s or its
designee’s balance account with DTC through its Deposit / Withdrawal At Custodian system, the Holder shall have the option, by
delivery of notice to the Company, to (x) rescind such Exercise Notice in whole or in part and retain or have returned, as the case
may be, any portion of this Warrant that has not been exercised pursuant to such Exercise Notice; provided that the rescission of an
Exercise Notice shall not affect the Company’s obligation to make any payments that have accrued prior to the date of such
notice pursuant to this Section 1(c) or otherwise, and/or (y) switch some or all of such Exercise Notice from a cash exercise to a
Cashless Exercise.
(d) Cashless
Exercise. Notwithstanding anything contained herein to the contrary (other than Section 1(f) below), if at the time of exercise
hereof a Registration Statement (as defined in the Registration Rights Agreement) is not effective (or the prospectus contained
therein is not available for use) for the resale by the Holder of all of the Warrant Shares, then the Holder may, in its sole
discretion, exercise this Warrant in whole or in part and, in lieu of making the cash payment otherwise contemplated to be made to
the Company upon such exercise in payment of the Aggregate Exercise Price, elect instead to receive upon such exercise the
“Net Number” of Warrant Shares determined according to the following formula (a “Cashless
Exercise”):
Net Number = (A x B) - (A x C)
B
For
purposes of the foregoing formula:
A=
the total number of shares with respect to which this Warrant is then being exercised.
B
= as elected by the Holder: (i) the VWAP of the Common Stock on the Trading Day immediately preceding the date of the applicable Exercise
Notice if such Exercise Notice is (1) both executed and delivered pursuant to Section 1(a) hereof on a day that is not a Trading Day
or (2) both executed and delivered pursuant to Section 1(a) hereof on a Trading Day prior to the opening of “regular trading hours”
(as defined in Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option
of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Exercise Notice or (z) the Bid
Price of the Common Stock as of the time of the Holder’s execution of the applicable Exercise Notice if such Exercise Notice is
executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter pursuant to Section
1(a) hereof, or (iii) the Closing Sale Price of the Common Stock on the date of the applicable Exercise Notice if the date of such Exercise
Notice is a Trading Day and such Exercise Notice is both executed and delivered pursuant to Section 1(a) hereof after the close of “regular
trading hours” on such Trading Day.
C
= the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.
If
the Warrant Shares are issued in a Cashless Exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
1933 Act, the Warrant Shares take on the registered characteristics of the Warrants being exercised. For purposes of Rule 144(d) promulgated
under the 1933 Act, as in effect on the Subscription Date, it is intended that the Warrant Shares issued in a Cashless Exercise shall
be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the
date this Warrant was originally issued pursuant to the Securities Purchase Agreement.
(e) Disputes.
In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Warrant Shares
to be issued pursuant to the terms hereof, the Company shall promptly issue to the Holder the number of Warrant Shares that are not
disputed and resolve such dispute in accordance with Section 15.
(f) Limitations
on Exercises.
(i)
Beneficial Ownership. The Company shall not effect the exercise of any portion of this Warrant, and the Holder shall not have
the right to exercise any portion of this Warrant, pursuant to the terms and conditions of this Warrant and any such exercise shall
be null and void and treated as if never made, to the extent that after giving effect to such exercise, the Holder together with the
other Attribution Parties collectively would beneficially own in excess of [4.99][9.99]% (the “Maximum
Percentage”) of the Common Stock outstanding immediately after giving effect to such exercise. For purposes of the
foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by the Holder and the other Attribution
Parties shall include the number of shares of Common Stock held by the Holder and all other Attribution Parties plus the number of
shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being
made, but shall exclude shares of Common Stock which would be issuable upon (A) exercise of the remaining, unexercised portion of
this Warrant beneficially owned by the Holder or any of the other Attribution Parties and (B) exercise or conversion of the
unexercised or unconverted portion of any other securities of the Company (including, without limitation, any convertible notes or
convertible preferred stock or warrants, including other SPA Warrants) beneficially owned by the Holder or any other Attribution
Party subject to a limitation on conversion or exercise analogous to the limitation contained in this Section 1(f)(i). For purposes
of this Section 1(f)(i), beneficial ownership shall be calculated in accordance with Section 13(d) of the 1934 Act. In addition, a
determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the 1934 Act and
the rules and regulations promulgated thereunder. For purposes of determining the number of outstanding shares of Common Stock the
Holder may acquire upon the exercise of this Warrant without exceeding the Maximum Percentage, the Holder may rely on the number of
outstanding shares of Common Stock as reflected in (x) the Company’s most recent Annual Report on Form 10-K, Quarterly Report
on Form 10-Q, Current Report on Form 8-K or other public filing with the SEC, as the case may be, (y) a more recent public
announcement by the Company or (z) any other written notice by the Company or the Transfer Agent, if any, setting forth the number
of shares of Common Stock outstanding (the “Reported Outstanding Share Number”). If the Company receives an
Exercise Notice from the Holder at a time when the actual number of outstanding shares of Common Stock is less than the Reported
Outstanding Share Number, the Company shall (i) notify the Holder in writing of the number of shares of Common Stock then
outstanding and, to the extent that such Exercise Notice would otherwise cause the Holder’s beneficial ownership, as
determined pursuant to this Section 1(f)(i), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced
number of Warrant Shares to be acquired pursuant to such Exercise Notice (the number of shares by which such purchase is reduced,
the “Reduction Shares”) and (ii) as soon as reasonably practicable, the Company shall return to the Holder any
exercise price paid by the Holder for the Reduction Shares. For any reason at any time, upon the written or oral request of the
Holder, the Company shall within one (1) Business Day confirm orally and in writing or by electronic mail to the Holder the number
of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after
giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder and any other
Attribution Party since the date as of which the Reported Outstanding Share Number was reported. In the event that the issuance of
shares of Common Stock to the Holder upon exercise of this Warrant results in the Holder and the other Attribution Parties being
deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock
(as determined under Section 13(d) of the 1934 Act), the number of shares so issued by which the Holder’s and the other
Attribution Parties’ aggregate beneficial ownership exceeds the Maximum Percentage (the “Excess Shares”)
shall be deemed null and void and shall be cancelled ab initio, and the Holder shall not have the power to vote or to transfer the
Excess Shares. As soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company
shall return to the Holder the exercise price paid by the Holder for the Excess Shares. Upon delivery of a written notice to the
Company, the Holder may from time to time increase (with such increase not effective until the sixty-first (61st) day after delivery
of such notice) or decrease the Maximum Percentage to any other percentage not in excess of 9.99% as specified in such notice;
provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after such
notice is delivered to the Company and (ii) any such increase or decrease will apply only to the Holder and the other Attribution
Parties and not to any other holder of SPA Warrants that is not an Attribution Party of the Holder. For purposes of clarity, the
shares of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be
beneficially owned by the Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act. No
prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions of
this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 1(f)(i) to the extent necessary to
correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended beneficial
ownership limitation contained in this Section 1(f)(i) or to make changes or supplements necessary or desirable to properly give
effect to such limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor holder of
this Warrant.
(ii)
Principal Market Regulation. The Company shall not issue any shares of Common Stock upon the exercise of this Warrant
if the issuance of such shares of Common Stock (taken together with the issuance of such shares upon the conversion of the Preferred
Shares or otherwise pursuant to the terms of the Certificate of Designations) would exceed the aggregate number of shares of Common
Stock which the Company may issue upon exercise or conversion or otherwise pursuant to the terms of the Certificate of Designations,
the SPA Warrants and Placement Agent Warrants without breaching the Company’s obligations under the rules or regulations of
the Principal Market (the number of shares which may be issued without violating such rules and regulations, the “Exchange
Cap”), except that such limitation shall not apply in the event that the Company (A) obtains the approval of its
stockholders as required by the applicable rules of the Principal Market for issuances of shares of Common Stock in excess of such
amount or (B) obtains a written opinion from outside counsel to the Company that such approval is not required, which opinion shall
be reasonably satisfactory to the Holder. Until such approval or such written opinion is obtained, no Buyer shall be issued in the
aggregate, upon conversion or exercise (as the case may be) of any Preferred Shares or any of the SPA Warrants or otherwise pursuant
to the terms of the Certificate of Designations or the SPA Warrants, shares of Common Stock in an amount greater than the product of
(i) the Exchange Cap as of the Issuance Date multiplied by (ii) the quotient of (1) the aggregate number of Preferred Shares issued
to such Buyer pursuant to the Securities Purchase Agreement on the Closing Date (as defined in the Securities Purchase Agreement)
divided by (2) the aggregate stated value of all Preferred Shares issued to the Buyers pursuant to the Securities Purchase Agreement
on the Closing Date (with respect to each Buyer, the “Exchange Cap Allocation”). In the event that any Buyer
shall sell or otherwise transfer any of such Buyer’s SPA Warrants, the transferee shall be allocated a pro rata portion of
such Buyer’s Exchange Cap Allocation with respect to such portion of such SPA Warrants so transferred, and the restrictions of
the prior sentence shall apply to such transferee with respect to the portion of the Exchange Cap Allocation so allocated to such
transferee. Upon conversion and exercise in full of a holder’s Preferred Shares and SPA Warrants, the difference (if any)
between such holder’s Exchange Cap Allocation and the number of shares of Common Stock actually issued to such holder upon
such holder’s conversion in full of such Preferred Shares and such holder’s exercise in full of such SPA Warrants shall
be allocated, to the respective Exchange Cap Allocations of the remaining holders of Preferred Shares and related SPA Warrants on a
pro rata basis in proportion to the shares of Common Stock underlying the Preferred Shares and related SPA Warrants then held by
each such holder of Preferred Shares and related SPA Warrants.
(g) Reservation
of Shares.
(i) Required
Reserve Amount. So long as this Warrant remains outstanding, the Company shall at all times keep reserved for issuance under this
Warrant a number of shares of Common Stock at least equal to 200% of the maximum number of shares of Common Stock as shall be necessary
to satisfy the Company’s obligation to issue shares of Common Stock under the SPA Warrants then outstanding (without regard to
any limitations on exercise) (the “Required Reserve Amount”); provided that at no time shall the number of shares
of Common Stock reserved pursuant to this Section 1(g)(i) be reduced other than proportionally in connection with any exercise or redemption
of SPA Warrants or such other event covered by Section 2(a) below. The Required Reserve Amount (including, without limitation, each increase
in the number of shares so reserved) shall be allocated pro rata among the holders of the SPA Warrants based on the number of shares
of Common Stock issuable upon exercise of SPA Warrants held by each holder on the Closing Date (as defined in the Securities Purchase
Agreement) (without regard to any limitations on exercise) or increase in the number of reserved shares, as the case may be (the “Authorized
Share Allocation”). In the event that a holder shall sell or otherwise transfer any of such holder’s SPA Warrants, each
transferee shall be allocated a pro rata portion of such holder’s Authorized Share Allocation. Any shares of Common Stock reserved
and allocated to any Person which ceases to hold any SPA Warrants shall be allocated to the remaining holders of SPA Warrants, pro rata
based on the number of shares of Common Stock issuable upon exercise of the SPA Warrants then held by such holders (without regard to
any limitations on exercise).
(ii) Insufficient
Authorized Shares. If, notwithstanding Section 1(g)(i) above, and not in limitation thereof, at any time while any of the SPA Warrants
remain outstanding, the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its
obligation to reserve the Required Reserve Amount (an “Authorized Share Failure”), then the Company shall use its
best efforts to take all action necessary to increase the Company’s authorized shares of Common Stock to an amount sufficient to
allow the Company to reserve the Required Reserve Amount for all the SPA Warrants then outstanding. Without limiting the generality of
the foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later
than sixty (60) days after the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its stockholders for
the approval of an increase in the number of authorized shares of Common Stock. In connection with such meeting, the Company shall provide
each stockholder with a proxy statement and shall use its best efforts to solicit its stockholders’ approval of such increase in
authorized shares of Common Stock and to cause its board of directors to recommend to the stockholders that they approve such proposal.
Notwithstanding the foregoing, if at any such time of an Authorized Share Failure, the Company is able to obtain the written consent
of a majority of the shares of its issued and outstanding shares of Common Stock to approve the increase in the number of authorized
shares of Common Stock, the Company may satisfy this obligation by obtaining such consent and submitting for filing with the SEC an Information
Statement on Schedule 14C. In the event that the Company is prohibited from issuing shares of Common Stock upon an exercise of this Warrant
due to the failure by the Company to have sufficient shares of Common Stock available out of the authorized but unissued shares of Common
Stock (such unavailable number of shares of Common Stock, the “Authorization Failure Shares”), in lieu of delivering
such Authorization Failure Shares to the Holder, the Company shall pay cash in exchange for the cancellation of such portion of this
Warrant exercisable into such Authorization Failure Shares at a price equal to the sum of (i) the product of (x) such number of Authorization
Failure Shares and (y) the greatest Closing Sale Price of the Common Stock on any Trading Day during the period commencing on the date
the Holder delivers the applicable Exercise Notice with respect to such Authorization Failure Shares to the Company and ending on the
date of such issuance and payment under this Section 1(g); and (ii) to the extent the Holder purchases (in an open market transaction
or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of Authorization Failure Shares, any Buy-In Payment
Amount, brokerage commissions and other out-of-pocket expenses, if any, of the Holder incurred in connection therewith. Nothing contained
in this Section 1(g) shall limit any obligations of the Company under any provision of the Securities Purchase Agreement.
2. ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant
are subject to adjustment from time to time as set forth in this Section 2.
(a)
Stock Dividends and Splits. Without limiting any provision of Section 2(b), Section 3 or Section 4, if the Company, at any time
on or after the Subscription Date, (i) pays a stock dividend on one or more classes of its then outstanding shares of Common Stock or
otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, other than Excluded Securities
(as defined in the Securities Purchase Agreement), (ii) subdivides (by any stock split, stock dividend, recapitalization or otherwise)
one or more classes of its then outstanding shares of Common Stock into a larger number of shares or (iii) combines (by combination,
reverse stock split or otherwise) one or more classes of its then outstanding shares of Common Stock into a smaller number of shares
then in each such case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common
Stock outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding
immediately after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the
record date for the determination of stockholders entitled to receive such dividend or distribution, and any adjustment pursuant to clause
(ii) or (iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination. If any
event requiring an adjustment under this paragraph occurs during the period that an Exercise Price is calculated hereunder, then the
calculation of such Exercise Price shall be adjusted appropriately to reflect such event.
(b)
Adjustment Upon Issuance of Shares of Common Stock. If and whenever on or after the Subscription Date, the Company shall sell,
enter into an agreement to sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue
(or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents (but
excluding any Excluded Securities), at an effective price per share less than the Exercise Price then in effect (such lower price, the
“Base Share Price” and such issuances collectively, a “Dilutive Issuance”) (it being understood
and agreed that if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase
price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights
per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective price per
share that is less than the Exercise Price, such issuance shall be deemed to have occurred for less than the Exercise Price on such date
of the Dilutive Issuance at such effective price), then simultaneously with the consummation (or, if earlier, the announcement) of each
Dilutive Issuance the Exercise Price shall be reduced and only reduced to equal the Base Share Price. Notwithstanding the foregoing,
no adjustments shall be made, paid or issued under this Section 2(b) in respect of any issuances of Excluded Securities. The Company
shall notify the Holder, in writing, no later than the Trading Day following the issuance or deemed issuance of any Common Stock or Common
Stock Equivalents subject to this Section 2(b), indicating therein the applicable issuance price, or applicable reset price, exchange
price, conversion price and other pricing terms.
(i)
Issuance of Options. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell)
any Options and the lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such
Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise
pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and
to have been issued and sold by the Company at the time of the granting, issuance or sale (or the time of execution of such agreement
to grant, issue or sell, as applicable) of such Option for such price per share. For purposes of this Section 2(b)(i), the “lowest
price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Options or upon conversion,
exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof”
shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received or receivable by the Company
with respect to any one share of Common Stock upon the granting, issuance or sale (or pursuant to the agreement to grant, issue or sell,
as applicable) of such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible Security issuable
upon exercise of such Option or otherwise pursuant to the terms thereof and (y) the lowest exercise price set forth in such Option for
which one share of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon the exercise of any
such Options or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise
pursuant to the terms thereof minus (2) the sum of all amounts paid or payable to the holder of such Option (or any other Person) upon
the granting, issuance or sale (or the agreement to grant, issue or sell, as applicable) of such Option, upon exercise of such Option
and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option or otherwise pursuant to
the terms thereof plus the value of any other consideration received or receivable by, or benefit conferred on, the holder of such Option
(or any other Person). Except as contemplated below, no further adjustment of the Exercise Price shall be made upon the actual issuance
of such shares of Common Stock or of such Convertible Securities upon the exercise of such Options or otherwise pursuant to the terms
of or upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities.
(ii)
Issuance of Convertible Securities. If the Company in any manner issues or sells (or enters into any agreement to issue or sell)
any Convertible Securities and the lowest price per share for which one share of Common Stock is at any time issuable upon the conversion,
exercise or exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share of Common
Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale (or the time
of execution of such agreement to issue or sell, as applicable) of such Convertible Securities for such price per share. For the purposes
of this Section 2(b)(ii), the “lowest price per share for which one share of Common Stock is at any time issuable upon the conversion,
exercise or exchange thereof or otherwise pursuant to the terms thereof” shall be equal to (1) the lower of (x) the sum of the
lowest amounts of consideration (if any) received or receivable by the Company with respect to one share of Common Stock upon the issuance
or sale (or pursuant to the agreement to issue or sell, as applicable) of the Convertible Security and upon conversion, exercise or exchange
of such Convertible Security or otherwise pursuant to the terms thereof and (y) the lowest conversion price set forth in such Convertible
Security for which one share of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon conversion,
exercise or exchange thereof or otherwise pursuant to the terms thereof minus (2) the sum of all amounts paid or payable to the holder
of such Convertible Security (or any other Person) upon the issuance or sale (or the agreement to issue or sell, as applicable) of such
Convertible Security plus the value of any other consideration received or receivable by, or benefit conferred on, the holder of such
Convertible Security (or any other Person). Except as contemplated below, no further adjustment of the Exercise Price shall be made upon
the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities or otherwise
pursuant to the terms thereof, and if any such issuance or sale of such Convertible Securities is made upon exercise of any Options for
which adjustment of this Warrant has been or is to be made pursuant to other provisions of this Section 2(b), except as contemplated
below, no further adjustment of the Exercise Price shall be made by reason of such issuance or sale.
(iii)
Calculation of Consideration Received. If any Option and/or Convertible Security and/or Adjustment Right is issued in connection
with the issuance or sale or deemed issuance or sale of any other securities of the Company (as determined by the Holder, the “Primary
Security”, and such Option and/or Convertible Security and/or Adjustment Right, the “Secondary Securities”
and together with the Primary Security, each a “Unit”), together comprising one integrated transaction, the aggregate
consideration per share of Common Stock with respect to such Primary Security shall be deemed to be the lower of (x) the purchase price
of such Unit, (y) if such Primary Security is an Option and/or Convertible Security, the lowest price per share for which one share of
Common Stock is at any time issuable upon the exercise or conversion of the Primary Security in accordance with Sections 2(b)(i) or 2(b)(ii)
above and (z) the lowest VWAP of the shares of Common Stock on any Trading Day during the five (5) Trading Day period (the “Adjustment
Period”) immediately following the public announcement of such Dilutive Issuance (for the avoidance of doubt, if such public
announcement is released prior to the opening of the Principal Market on a Trading Day, such Trading Day shall be the first Trading Day
in such five Trading Day period and if this Warrant is exercised, on any given Exercise Date during any such Adjustment Period, solely
with respect to such portion of this Warrant exercised on such applicable Exercise Date, such applicable Adjustment Period shall be deemed
to have ended on, and included, the Trading Day immediately prior to such Exercise Date). If any shares of Common Stock, Options or Convertible
Securities are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor will be deemed to be
the net amount of consideration received by the Company therefor. If any shares of Common Stock, Options or Convertible Securities are
issued or sold for a consideration other than cash, the amount of such consideration received by the Company will be the fair value of
such consideration, except where such consideration consists of publicly traded securities, in which case the amount of consideration
received by the Company for such securities will be the arithmetic average of the VWAPs of such security for each of the five (5) Trading
Days immediately preceding the date of receipt. If any shares of Common Stock, Options or Convertible Securities are issued to the owners
of the non-surviving entity in connection with any merger in which the Company is the surviving entity, the amount of consideration therefor
will be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to
such shares of Common Stock, Options or Convertible Securities (as the case may be). The fair value of any consideration other than cash
or publicly traded securities will be determined jointly by the Company and the Holder. If such parties are unable to reach agreement
within ten (10) days after the occurrence of an event requiring valuation (the “Valuation Event”), the fair value
of such consideration will be determined within five (5) Trading Days after the tenth (10th) day following such Valuation
Event by an independent, reputable appraiser jointly selected by the Company and the Holder. The determination of such appraiser shall
be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall be borne by the Company.
(iv)
Record Date. If the Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A) to receive
a dividend or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe for or purchase
shares of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the issuance or sale
of the shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution
or the date of the granting of such right of subscription or purchase (as the case may be).
(c)
Number of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to Section 2, the number of Warrant
Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that after such
adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the
aggregate Exercise Price in effect immediately prior to such adjustment (without regard to any limitations on exercise contained
herein).
(d) Reserved.
(e)
Stock Combination Event Adjustment. If at any time and from time to time on or after the Issuance Date there occurs
any stock split, stock dividend, stock combination, reverse stock split, recapitalization or other similar transaction involving the
outstanding Common Stock (each, a “Stock Combination Event”, and such date thereof, the “Stock
Combination Event Date”) and the Event Market Price is less than the Exercise Price then in effect (after giving effect to
the adjustment in clause 2(a) above), then on the sixteenth (16th) Trading Day immediately following such Stock Combination Event
(“Stock Combination Event Adjustment Date”), the Exercise Price then in effect on the Stock Combination Event
Adjustment Date (after giving effect to the adjustment in clause 2(a) above) shall be reduced (but in no event increased) to the
Event Market Price. For the avoidance of doubt, if the adjustment in the immediately preceding sentence would otherwise result in an
increase in the Exercise Price hereunder, no adjustment shall be made.
(f) Other
Events. In the event that the Company (or any Subsidiary (as defined in the Securities Purchase Agreement)) shall take any
action to which the provisions hereof are not strictly applicable, or, if applicable, would not operate to protect the Holder from
dilution or if any event occurs of the type contemplated by the provisions of this Section 2 but not expressly provided for by such
provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with
equity features), then the Company’s board of directors shall in good faith determine and implement an appropriate adjustment
in the Exercise Price and the number of Warrant Shares (if applicable) so as to protect the rights of the Holder, provided that no
such adjustment pursuant to this Section 2(f) will increase the Exercise Price or decrease the number of Warrant Shares as otherwise
determined pursuant to this Section 2, provided further that if the Holder does not accept such adjustments as appropriately
protecting its interests hereunder against such dilution, then the Company’s board of directors and the Holder shall agree, in
good faith, upon an independent investment bank of nationally recognized standing to make such appropriate adjustments, whose
determination shall be final and binding absent manifest error and whose fees and expenses shall be borne by the Company.
(g)
Calculations. All calculations under this Section 2 shall be made by rounding to the nearest cent or the nearest 1/100th of a
share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by
or for the account of the Company, and the disposition of any such shares shall be considered an issuance or sale of shares of
Common Stock.
(h) Voluntary
Adjustment By Company. Subject to the rules and regulations of the Principal Market, the Company may at any time during the term
of this Warrant, with the prior written consent of the Required Holders (as defined in the Securities Purchase Agreement), reduce
the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors of the
Company.
3. RIGHTS
UPON DISTRIBUTION OF ASSETS. In addition to any adjustments pursuant to Section 2 above or Section 4(a) below, if the Company shall
declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock,
by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property,
options, evidence of indebtedness or any other assets by way of a dividend, spin off, reclassification, corporate rearrangement, scheme
of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then,
in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated
therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations or restrictions on exercise of this Warrant, including without limitation, the Maximum Percentage) immediately before
the date on which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of
shares of Common Stock are to be determined for the participation in such Distribution (provided, however, that to the extent that the
Holder’s right to participate in any such Distribution would result in the Holder and the other Attribution Parties exceeding the
Maximum Percentage, then the Holder shall not be entitled to participate in such Distribution to the extent of the Maximum Percentage
(and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution (and beneficial ownership)
to the extent of any such excess) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until
such time or times, if ever, as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum
Percentage, at which time or times the Holder shall be granted such Distribution (and any Distributions declared or made on such initial
Distribution or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had been no such limitation).
4. PURCHASE
RIGHTS; FUNDAMENTAL TRANSACTIONS.
(a)
Purchase Rights. In addition to any adjustments pursuant to Sections 2 or 3 above, if at any time the Company grants, issues or
sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon
the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations or
restrictions on exercise of this Warrant, including without limitation, the Maximum Percentage) immediately before the date on which
a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the grant, issuance or sale of such Purchase Rights
(provided, however, that to the extent that the Holder’s right to participate in any such Purchase Right would
result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to
participate in such Purchase Right to the extent of the Maximum Percentage (and shall not be entitled to beneficial ownership of
such shares of Common Stock as a result of such Purchase Right (and beneficial ownership) to the extent of any such excess) and such
Purchase Right to such extent shall be held in abeyance for the benefit of the Holder until such time or times, if ever, as its
right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or
times the Holder shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on
any subsequent Purchase Right held similarly in abeyance) to the same extent as if there had been no such limitation).
(b) Fundamental
Transactions. The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity assumes
in writing all of the obligations of the Company under this Warrant and the other Transaction Documents (as defined in the
Securities Purchase Agreement) in accordance with the provisions of this Section 4(b) pursuant to written agreements in form and
substance satisfactory to the Holder and approved by the Holder prior to such Fundamental Transaction, including agreements to
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Warrant, including, without limitation, which is exercisable for a corresponding
number of shares of capital stock equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant
(without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise
price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the
shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such adjustments to
the number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
immediately prior to the consummation of such Fundamental Transaction) and (ii) the Successor Entity (including its Parent Entity)
is a publicly traded corporation whose common stock is quoted on or listed for trading on an Eligible Market. Upon the consummation
of each Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of
the applicable Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the
“Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall
assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such
Successor Entity had been named as the Company herein. Upon consummation of each Fundamental Transaction, the Successor Entity shall
deliver to the Holder confirmation that there shall be issued upon exercise of this Warrant at any time after the consummation of
the applicable Fundamental Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property
(except such items still issuable under Sections 3 and 4(a) above, which shall continue to be receivable thereafter)) issuable upon
the exercise of this Warrant prior to the applicable Fundamental Transaction, such shares of publicly traded common stock (or its
equivalent) of the Successor Entity (including its Parent Entity) which the Holder would have been entitled to receive upon the
happening of the applicable Fundamental Transaction had this Warrant been exercised immediately prior to the applicable Fundamental
Transaction (without regard to any limitations on the exercise of this Warrant), as adjusted in accordance with the provisions of
this Warrant. Notwithstanding the foregoing, and without limiting Section 1(f) hereof, the Holder may elect, at its sole option, by
delivery of written notice to the Company to waive this Section 4(b) to permit the Fundamental Transaction without the assumption of
this Warrant. In addition to and not in substitution for any other rights hereunder, prior to the consummation of each Fundamental
Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets with respect to
or in exchange for shares of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to
insure that the Holder will thereafter have the right to receive upon an exercise of this Warrant at any time after the consummation
of the applicable Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the Common Stock (or other
securities, cash, assets or other property (except such items still issuable under Sections 3 and 4(a) above, which shall continue
to be receivable thereafter)) issuable upon the exercise of the Warrant prior to such Fundamental Transaction, such shares of stock,
securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription rights) which the
Holder would have been entitled to receive upon the happening of the applicable Fundamental Transaction had this Warrant been
exercised immediately prior to the applicable Fundamental Transaction (without regard to any limitations on the exercise of this
Warrant). Provision made pursuant to the preceding sentence shall be in a form and substance reasonably satisfactory to the
Holder.
(c) Black
Scholes Value. Notwithstanding the foregoing and the provisions of Section 4(b) above, at the request of the Holder delivered at
any time commencing on the earliest to occur of (x) the public disclosure of any Fundamental Transaction, (y) the consummation of
any Fundamental Transaction and (z) the Holder first becoming aware of any Fundamental Transaction through the date that is ninety
(90) days after the public disclosure of the consummation of such Fundamental Transaction by the Company pursuant to a Current
Report on Form 8-K filed with the SEC, the Company or the Successor Entity (as the case may be) shall purchase this Warrant from the
Holder on the date of such request by paying to the Holder cash in an amount equal to the greatest of (i) the Black Scholes Value of
the remaining unexercised portion of this Warrant, and (ii) the positive difference between (1) the product of the number of Warrant
Shares underlying the unexercised portion of the Warrant and the highest VWAP for the Common Stock during the period commencing
twenty (20) Trading Days prior to the public announcement of the Fundamental Transaction and ending on the consummation thereof and
(2) the remaining aggregate Exercise Price of this Warrant. Payment of such amounts shall be made by the Company (or at the
Company’s direction) to the Holder on or prior to the later of (x) the second (2nd) Trading Day after the date of such request
and (y) the date of consummation of such Fundamental Transaction; provided, however, that if the Fundamental Transaction is not
within the Company’s control, including in the event that such Fundamental Transaction is not approved by the board of
directors of the Company, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or
form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is
being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that
consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice
to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that if
holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of
Common Stock will be deemed to have received common stock of the Successor Entity (which such Successor Entity may be the Company
following such Fundamental Transaction) in such Fundamental Transaction.
(d) Application.
The provisions of this Section 4 shall apply similarly and equally to successive Fundamental Transactions and Corporate Events and
shall be applied as if this Warrant (and any such subsequent warrants) were fully exercisable and without regard to any limitations
on the exercise of this Warrant (provided that the Holder shall continue to be entitled to the benefit of the Maximum Percentage,
applied however with respect to shares of capital stock registered under the 1934 Act and thereafter receivable upon exercise of
this Warrant (or any such other warrant)).
5. NONCIRCUMVENTION.
The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation (as defined in the
Securities Purchase Agreement), Bylaws (as defined in the Securities Purchase Agreement) or through any reorganization, transfer of assets,
consolidation, merger, scheme of arrangement, dissolution, issuance or sale of securities, or any other voluntary action, avoid or seek
to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out all the provisions
of this Warrant and take all action as may be required to protect the rights of the Holder. Without limiting the generality of the foregoing,
the Company (a) shall not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant above the
Exercise Price then in effect, and (b) shall take all such actions as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and non-assessable shares of Common Stock upon the exercise of this Warrant. Notwithstanding anything herein
to the contrary, if after the sixty (60) calendar day anniversary of the Issuance Date, the Holder is not permitted to exercise this
Warrant in full for any reason (other than pursuant to restrictions set forth in Section 1(f) hereof), the Company shall use its best
efforts to promptly remedy such failure, including, without limitation, obtaining such consents or approvals as necessary to permit such
exercise into shares of Common Stock.
6. WARRANT
HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder
of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of capital stock of the Company for any purpose,
nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Warrant,
any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any
reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings,
receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled
to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities
on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such
liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 6, the Company shall provide the
Holder with copies of the same notices and other information given to the stockholders of the Company generally, contemporaneously with
the giving thereof to the stockholders; provided that the Company shall have no such obligation to the extent such information is filed
with the SEC through EDGAR and are available to the public through the EDGAR system.
7. REISSUANCE
OF WARRANTS.
(a) Transfer
of Warrant. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company will
forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)), registered as the Holder may
request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total
number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 7(d)) to the Holder
representing the right to purchase the number of Warrant Shares not being transferred.
(b) Lost,
Stolen or Mutilated Warrant. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant (as to which a written certification and the indemnification contemplated below shall
suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the
Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the
Company shall execute and deliver to the Holder a new Warrant (in accordance with Section 7(d)) representing the right to purchase
the Warrant Shares then underlying this Warrant.
(c) Exchangeable
for Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the
Company, for a new Warrant or Warrants (in accordance with Section 7(d)) representing in the aggregate the right to purchase the
number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion
of such Warrant Shares as is designated by the Holder at the time of such surrender; provided, however, no warrants for fractional
shares of Common Stock shall be given.
(d) Issuance
of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant
(i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to
purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a) or
Section 7(c), the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the
other new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this
Warrant), (iii) shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date,
and (iv) shall have the same rights and conditions as this Warrant.
(e) Representation
by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any
exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for
distributing or reselling such Warrant Shares or any part thereof in violation of the 1933 Act or any applicable state securities
law, except pursuant to sales registered or exempted under the 1933 Act.
8. NOTICES.
Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance
with Section 9(f) of the Securities Purchase Agreement. The Company shall provide the Holder with prompt written notice of all actions
taken pursuant to this Warrant (other than the issuance of shares of Common Stock upon exercise in accordance with the terms hereof),
including in reasonable detail a description of such action and the reason therefor. Without limiting the generality of the foregoing,
the Company will give written notice to the Holder (i) immediately upon each adjustment of the Exercise Price and the number of Warrant
Shares, setting forth in reasonable detail, and certifying, the calculation of such adjustment(s), (ii) at least fifteen (15) days prior
to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the Common
Stock, (B) with respect to any grants, issuances or sales of any Options, Convertible Securities or rights to purchase stock, warrants,
securities or other property to holders of Common Stock or (C) for determining rights to vote with respect to any Fundamental Transaction,
dissolution or liquidation, provided in each case that such information shall be made known to the public prior to or in conjunction
with such notice being provided to the Holder, and (iii) at least ten (10) Trading Days prior to the consummation of any Fundamental
Transaction. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the
Company or any of its Subsidiaries, the Company shall simultaneously file such notice with the SEC (as defined in the Securities Purchase
Agreement) pursuant to a Current Report on Form 8-K. If the Company or any of its Subsidiaries provides material non-public information
to the Holder that is not simultaneously filed in a Current Report on Form 8-K and the Holder has not agreed to receive such material
non-public information, the Company hereby covenants and agrees that the Holder shall not have any duty of confidentiality to the Company,
any of its Subsidiaries or any of their respective officers, directors, employees, affiliates or agents with respect to, or a duty to
any of the foregoing not to trade on the basis of, such material non-public information. It is expressly understood and agreed that the
time of execution specified by the Holder in each Exercise Notice shall be definitive and may not be disputed or challenged by the Company.
9. DISCLOSURE.
Upon delivery by the Company to the Holder (or receipt by the Company from the Holder) of any notice in accordance with the terms of
this Warrant, unless the Company has in good faith determined that the matters relating to such notice do not constitute material, non-public
information relating to the Company or any of its Subsidiaries, the Company shall on or prior to 9:00 am, New York City time on the Business
Day immediately following such notice delivery date, publicly disclose such material, non-public information on a Current Report on Form
8-K or otherwise. In the event that the Company believes that a notice contains material, non-public information relating to the Company
or any of its Subsidiaries, the Company so shall indicate to the Holder explicitly in writing in such notice (or immediately upon receipt
of notice from the Holder, as applicable), and in the absence of any such written indication in such notice (or notification from the
Company immediately upon receipt of notice from the Holder), the Holder shall be entitled to presume that information contained in the
notice does not constitute material, non-public information relating to the Company or any of its Subsidiaries. Nothing contained in
this Section 9 shall limit any obligations of the Company, or any rights of the Holder, under Section 4(i) of the Securities Purchase
Agreement.
10. ABSENCE
OF TRADING AND DISCLOSURE RESTRICTIONS. The Company acknowledges and agrees that the Holder is not a fiduciary or agent of the Company
and that the Holder shall have no obligation to (a) maintain the confidentiality of any information provided by the Company or (b) refrain
from trading any securities while in possession of such information in the absence of a written non-disclosure agreement signed by an
officer of the Holder that explicitly provides for such confidentiality and trading restrictions. In the absence of such an executed,
written non-disclosure agreement, the Company acknowledges that the Holder may freely trade in any securities issued by the Company,
may possess and use any information provided by the Company in connection with such trading activity, and may disclose any such information
to any third party.
11. AMENDMENT
AND WAIVER. Except as otherwise provided herein, the provisions of this Warrant (other than Section 1(f)) may be amended and the
Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company
has obtained the written consent of the Required Holders (as defined in the Securities Purchase Agreement). No waiver shall be effective
unless it is in writing and signed by an authorized representative of the waiving party.
12. SEVERABILITY.
If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent
jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest
extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity
of the remaining provisions of this Warrant so long as this Warrant as so modified continues to express, without material change, the
original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s)
in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization
of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the
prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of
the prohibited, invalid or unenforceable provision(s).
13. GOVERNING
LAW. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of New York, without giving
effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would
cause the application of the laws of any jurisdictions other than the State of New York. The Company hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to the Company
at the address set forth in Section 9(f) of the Securities Purchase Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. The Company hereby irrevocably submits to the exclusive jurisdiction of the state and
federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection
herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in
any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action
or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein shall
be deemed or operate to preclude the Holder from bringing suit or taking other legal action against the Company in any other jurisdiction
to collect on the Company’s obligations to the Holder, to realize on any collateral or any other security for such obligations,
or to enforce a judgment or other court ruling in favor of the Holder. THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE
TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS
WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.
14. CONSTRUCTION;
HEADINGS. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any
Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect the
interpretation of, this Warrant. Terms used in this Warrant but defined in the other Transaction Documents shall have the meanings ascribed
to such terms on the Closing Date (as defined in the Securities Purchase Agreement) in such other Transaction Documents unless otherwise
consented to in writing by the Holder.
15. DISPUTE
RESOLUTION.
(a) Submission
to Dispute Resolution.
(i)
In the case of a dispute relating to the Exercise Price, the Closing Sale Price, the Bid Price, Black Scholes Value or fair market
value or the arithmetic calculation of the number of Warrant Shares (as the case may be) (including, without limitation, a dispute
relating to the determination of any of the foregoing), the Company or the Holder (as the case may be) shall submit the dispute to
the other party via facsimile (A) if by the Company, within two (2) Business Days after the occurrence of the circumstances giving
rise to such dispute or (B) if by the Holder, at any time after the Holder learned of the circumstances giving rise to such dispute.
If the Holder and the Company are unable to promptly resolve such dispute relating to such Exercise Price, such Closing Sale Price,
such Bid Price, such Black Scholes Value or such fair market value or such arithmetic calculation of the number of Warrant Shares
(as the case may be), at any time after the second (2nd) Business Day following such initial notice by the Company or the Holder (as
the case may be) of such dispute to the Company or the Holder (as the case may be), then the Holder may, at its sole option, select
an independent, reputable investment bank to resolve such dispute.
(ii)
The Holder and the Company shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered in
accordance with the first sentence of this Section 15 and (B) written documentation supporting its position with respect to such
dispute, in each case, no later than 5:00 p.m. (New York time) by the fifth (5th) Business Day immediately following the date on
which the Holder selected such investment bank (the “Dispute Submission Deadline”) (the documents referred to in
the immediately preceding clauses (A) and (B) are collectively referred to herein as the “Required Dispute
Documentation”) (it being understood and agreed that if either the Holder or the Company fails to so deliver all of the
Required Dispute Documentation by the Dispute Submission Deadline, then the party who fails to so submit all of the Required Dispute
Documentation shall no longer be entitled to (and hereby waives its right to) deliver or submit any written documentation or other
support to such investment bank with respect to such dispute and such investment bank shall resolve such dispute based solely on the
Required Dispute Documentation that was delivered to such investment bank prior to the Dispute Submission Deadline). Unless
otherwise agreed to in writing by both the Company and the Holder or otherwise requested by such investment bank, neither the
Company nor the Holder shall be entitled to deliver or submit any written documentation or other support to such investment bank in
connection with such dispute (other than the Required Dispute Documentation).
(iii)
The Company and the Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company and
the Holder of such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The fees
and expenses of such investment bank shall be borne solely by the Company, and such investment bank’s resolution of such
dispute shall be final and binding upon all parties absent manifest error.
(b) Miscellaneous.
The Company expressly acknowledges and agrees that (i) this Section 15 constitutes an agreement to arbitrate between the Company and
the Holder (and constitutes an arbitration agreement) under the rules then in effect under § 7501, et seq. of the New York
Civil Practice Law and Rules (“CPLR”) and that the Holder is authorized to apply for an order to compel
arbitration pursuant to CPLR § 7503(a) in order to compel compliance with this Section 15, (ii) the terms of this Warrant and
each other applicable Transaction Document shall serve as the basis for the selected investment bank’s resolution of the
applicable dispute, such investment bank shall be entitled (and is hereby expressly authorized) to make all findings, determinations
and the like that such investment bank determines are required to be made by such investment bank in connection with its resolution
of such dispute, (iii) the Holder (and only the Holder), in its sole discretion, shall have the right to submit any dispute
described in this Section 15 to any state or federal court sitting in The City of New York, Borough of Manhattan in lieu of
utilizing the procedures set forth in this Section 15 and (iv) nothing in this Section 15 shall limit the Holder from obtaining any
injunctive relief or other equitable remedies (including, without limitation, with respect to any matters described in this Section
15).
16. REMEDIES,
CHARACTERIZATION, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies provided in this Warrant shall be cumulative
and in addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity
(including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder
to pursue actual and consequential damages for any failure by the Company to comply with the terms of this Warrant. The Company
covenants to the Holder that there shall be no characterization concerning this instrument other than as expressly provided herein.
Amounts set forth or provided for herein with respect to payments, exercises and the like (and the computation thereof) shall be the
amounts to be received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of the
Company (or the performance thereof). The Company acknowledges that a breach by it of its obligations hereunder will cause
irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that,
in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other
available remedies, to specific performance and/or temporary, preliminary and permanent injunctive or other equitable relief from
any court of competent jurisdiction in any such case without the necessity of proving actual damages and without posting a bond or
other security. The Company shall provide all information and documentation to the Holder that is requested by the Holder to enable
the Holder to confirm the Company’s compliance with the terms and conditions of this Warrant (including, without limitation,
compliance with Section 2 hereof). The issuance of shares and certificates for shares as contemplated hereby upon the exercise of
this Warrant shall be made without charge to the Holder or such shares for any issuance tax or other costs in respect thereof,
provided that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the
issuance and delivery of any certificate in a name other than the Holder or its agent on its behalf.
17.
PAYMENT OF COLLECTION, ENFORCEMENT AND OTHER COSTS. If (a) this Warrant is placed in the hands of an attorney for
collection or enforcement or is collected or enforced through any legal proceeding or the holder otherwise takes action to collect
amounts due under this Warrant or to enforce the provisions of this Warrant or (b) there occurs any bankruptcy, reorganization,
receivership of the company or other proceedings affecting company creditors’ rights and involving a claim under this Warrant,
then the Company shall pay the costs incurred by the Holder for such collection, enforcement or action or in connection with such
bankruptcy, reorganization, receivership or other proceeding, including, without limitation, attorneys’ fees and
disbursements.
18. TRANSFER.
This Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company, except as may otherwise be required
by Section 2(g) of the Securities Purchase Agreement and applicable securities laws.
19. CERTAIN
DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:
(a)
“1933 Act” means the Securities Act of 1933, as amended, and the rules and regulations thereunder.
(b)
“1934 Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.
(c)
“Adjustment Right” means any right granted with respect to any securities issued in connection with, or with respect
to, any issuance or sale (or deemed issuance or sale in accordance with Section 2) of Common Stock (other than rights of the type described
in Section 3 and 4 hereof) that could result in a decrease in the net consideration received by the Company in connection with, or with
respect to, such securities (including, without limitation, any cash settlement rights, cash adjustment or other similar rights).
(d)
“Affiliate” means, with respect to any Person, any other Person that directly or indirectly controls, is controlled
by, or is under common control with, such Person, it being understood for purposes of this definition that “control” of a
Person means the power directly or indirectly either to vote 10% or more of the stock having ordinary voting power for the election of
directors of such Person or direct or cause the direction of the management and policies of such Person whether by contract or otherwise.
(e)
“Attribution Parties” means, collectively, the following Persons and entities: (i) any investment vehicle, including,
any funds, feeder funds or managed accounts, currently, or from time to time after the Issuance Date, directly or indirectly managed
or advised by the Holder’s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of
the Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with the Holder or
any of the foregoing and (iv) any other Persons whose beneficial ownership of the Company’s Common Stock would or could be aggregated
with the Holder’s and the other Attribution Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of
the foregoing is to subject collectively the Holder and all other Attribution Parties to the Maximum Percentage.
(f)
“Bid Price” means, for any security as of the particular time of determination, the bid price for such security on
the Principal Market as reported by Bloomberg as of such time of determination, or, if the Principal Market is not the principal securities
exchange or trading market for such security, the bid price of such security on the principal securities exchange or trading market where
such security is listed or traded as reported by Bloomberg as of such time of determination, or if the foregoing does not apply, the
bid price of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg
as of such time of determination, or, if no bid price is reported for such security by Bloomberg as of such time of determination, the
average of the bid prices of any market makers for such security as reported in The Pink Open Market (or a similar organization or agency
succeeding to its functions of reporting prices) as of such time of determination. If the Bid Price cannot be calculated for a security
as of the particular time of determination on any of the foregoing bases, the Bid Price of such security as of such time of determination
shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree
upon the fair market value of such security, then such dispute shall be resolved in accordance with the procedures in Section 15. All
such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction
during such period.
(g)
[Reserved.]
(h)
“Black Scholes Value” means the value of the unexercised portion of this Warrant remaining on the date of the Holder’s
request pursuant to Section 4(c)(i), which value is calculated using the Black Scholes Option Pricing Model obtained from the “OV”
function on Bloomberg utilizing (i) an underlying price per share equal to the greater of (1) the highest Closing Sale Price of the Common
Stock during the period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction
(or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder’s request
pursuant to Section 4(c)(i) and (2) the sum of the price per share being offered in cash in the applicable Fundamental Transaction (if
any) plus the value of the non-cash consideration being offered in the applicable Fundamental Transaction (if any), (ii) a strike price
equal to the Exercise Price in effect on the date of the Holder’s request pursuant to Section 4(c)(i), (iii) a risk-free interest
rate corresponding to the U.S. Treasury rate for a period equal to the greater of (1) the remaining term of this Warrant as of the date
of the Holder’s request pursuant to Section 4(c)(i) and (2) the remaining term of this Warrant as of the date of consummation of
the applicable Fundamental Transaction or as of the date of the Holder’s request pursuant to Section 4(c)(i) if such request is
prior to the date of the consummation of the applicable Fundamental Transaction, (iv) a zero cost of borrow and (v) an expected volatility
equal to the 30 day volatility obtained from the “HVT” function on Bloomberg (determined utilizing a 365 day annualization
factor) as of the Trading Day immediately following the earliest to occur of (A) the public disclosure of the applicable Fundamental
Transaction and (B) the date of the Holder’s request pursuant to Section 4(c)(i).
(i)
“Bloomberg” means Bloomberg, L.P.
(j)
“Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New
York are authorized or required by law to remain closed; provided, however, for clarification,
commercial banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”,
“non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day.
(k)
“Closing Sale Price” means, for any security as of any date, the last closing trade price for such security on the
Principal Market, as reported by Bloomberg, or, if the Principal Market begins to operate on an extended hours basis and does not designate
the closing trade price, then the last trade price of such security prior to 4:00:00 p.m., New York time, as reported by Bloomberg, or,
if the Principal Market is not the principal securities exchange or trading market for such security, the last trade price of such security
on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing
does not apply, the last trade price of such security in the over-the-counter market on the electronic bulletin board for such security
as reported by Bloomberg, or, if no last trade price is reported for such security by Bloomberg, the average of the ask prices of any
market makers for such security as reported in The Pink Open Market (or a similar organization or agency succeeding to its functions
of reporting prices). If the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases,
the Closing Sale Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder.
If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved in
accordance with the procedures in Section 15. All such determinations shall be appropriately adjusted for any stock dividend, stock split,
stock combination or other similar transaction during such period.
(l)
“Common Stock” means (i) the Company’s shares of common stock, $0.0001 par value per share, and (ii) any capital
stock into which such common stock shall have been changed or any capital stock resulting from a reclassification of such common stock.
(m)
“Convertible Securities” means any stock or other security (other than Options) that is at any time and under any
circumstances, directly or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof
to acquire, any Common Stock.
(n)
“Eligible Market” means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq
Global Market, the Nasdaq Capital Market or the Principal Market.
(o)
[Reserved]
(p)
“Event Market Price” means, with respect to any Stock Combination Event Date, the lower of (i) the Exercise Price
in effect immediately after such Stock Combination Event Date (and, for the avoidance of doubt, as adjusted following such Stock Combination
Event Date as set forth herein), and (ii) the lowest VWAP of the Common Stock for any Trading Day during the eleven (11) consecutive
Trading Day period commencing on the fifth (5th) Trading Day immediately preceding the Stock Combination Event Date and ending on the
fifth (5th) Trading Day immediately following the Stock Combination Event Date.
(o)
“Expiration Date” means the date that is the fifth (5th) anniversary of the Issuance Date or, if such date falls on
a day other than a Trading Day or on which trading does not take place on the Principal Market (a “Holiday”), the
next date that is not a Holiday.
(q)
“Fundamental Transaction” means (A) that the Company shall, directly or indirectly, including through subsidiaries,
Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the
surviving corporation) another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all
of the properties or assets of the Company or any of its “significant subsidiaries” (as defined in Rule 1-02 of Regulation
S-X) to one or more Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow the Company to be subject
to or have its voting stock be subject to or party to one or more Subject Entities making, a purchase, tender or exchange offer that
is accepted by the holders of at least either (x) more than 50% of the outstanding voting power of the Company, (y) more than 50% of
the outstanding voting power of the Company calculated as if any shares of voting stock held by all Subject Entities making or party
to, or Affiliated with any Subject Entities making or party to, such purchase, tender or exchange offer were not outstanding; or (z)
such number of shares of voting stock such that all Subject Entities making or party to, or Affiliated with any Subject Entity making
or party to, such purchase, tender or exchange offer, become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934
Act) of more than 50% of the outstanding voting power of the Company, or (iv) consummate a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with one
or more Subject Entities whereby all such Subject Entities, individually or in the aggregate, acquire, either (x) more than 50% of the
outstanding voting power of the Company (y) more than 50% of the outstanding voting power of the Company calculated as if any shares
of voting stock held by all the Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such stock
purchase agreement or other business combination were not outstanding; or (z) such number of shares of voting stock of the Company such
that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of more than 50% of
the outstanding voting power of the Company, or (v) reorganize, recapitalize or reclassify its Common Stock, (B) that the Company shall,
directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions, allow any Subject
Entity individually or the Subject Entities in the aggregate to be or become the “beneficial owner” (as defined in Rule 13d-3
under the 1934 Act), directly or indirectly, whether through acquisition, purchase, assignment, conveyance, tender, tender offer, exchange,
reduction in outstanding shares of voting stock, merger, consolidation, business combination, reorganization, recapitalization, spin-off,
scheme of arrangement, reorganization, recapitalization or reclassification or otherwise in any manner whatsoever, of either (x) more
than 50% of the aggregate ordinary voting power represented by issued and outstanding shares of voting stock of the Company, (y) more
than 50% of the aggregate ordinary voting power represented by issued and outstanding shares of voting stock of the Company not held
by all such Subject Entities as of the date of this Warrant calculated as if any shares of voting stock of the Company held by all such
Subject Entities were not outstanding, or (z) a percentage of the aggregate ordinary voting power represented by issued and outstanding
shares of voting stock of the Company or other equity securities of the Company sufficient to allow such Subject Entities to effect a
statutory short form merger or other transaction requiring other stockholders of the Company to surrender their shares of voting stock
of the Company without approval of the stockholders of the Company or (C) directly or indirectly, including through subsidiaries, Affiliates
or otherwise, in one or more related transactions, the issuance of or the entering into any other instrument or transaction structured
in a manner to circumvent, or that circumvents, the intent of this definition in which case this definition shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this definition to the extent necessary to correct this definition
or any portion of this definition which may be defective or inconsistent with the intended treatment of such instrument or transaction.
(r)
“Group” means a “group” as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5
thereunder.
(s)
[Reserved]
(t)
[Reserved]
(u)
“Options” means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible
Securities.
(v)
“Parent Entity” of a Person means an entity that, directly or indirectly, controls the applicable Person and whose
common stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent
Entity, the Person or Parent Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.
(w)
“Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust,
an unincorporated organization, any other entity or a government or any department or agency thereof.
(x) “Principal
Market” means the Nasdaq Capital Market.
(y) “Registration
Rights Agreement” means that certain registration rights agreement, dated as of the Closing Date, by and among the Company
and the Buyers of the Preferred Shares and SPA Warrants relating to, among other things, the registration of the resale of the shares
of Common Stock issuable upon conversion of the Preferred Shares or otherwise pursuant to the terms of the Certificate of Designations
and exercise of the SPA Warrants, as may be amended from time to time.
(z) “SEC”
means the United States Securities and Exchange Commission or the successor thereto.
(aa)
“Subject Entity” means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.
(ab) “Successor
Entity” means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Fundamental
Transaction or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction shall have been
entered into.
(ac)
“Trading Day” means, as applicable, (x) with respect to all price or trading volume determinations relating to the
Common Stock, any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading
market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded,
provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange or
market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange
or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during
the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the Holder or
(y) with respect to all determinations other than price or trading volume determinations relating to the Common Stock, any day on which
The New York Stock Exchange (or any successor thereto) is open for trading of securities.
(ad)
[Reserved]
(ae)
“VWAP” means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal
Market (or, if the Principal Market is not the principal trading market for such security, then on the principal securities exchange
or securities market on which such security is then traded), during the period beginning at 9:30 a.m., New York time, and ending at 4:00
p.m., New York time, as reported by Bloomberg through its “VAP” function (set to 09:30 start time and 16:00 end time) or,
if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic
bulletin board for such security during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time, as
reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the
average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported in
The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices). If the VWAP cannot be calculated
for such security on such date on any of the foregoing bases, the VWAP of such security on such date shall be the fair market value as
mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such
security, then such dispute shall be resolved in accordance with the procedures in Section 15. All such determinations shall be appropriately
adjusted for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period.
[signature
page follows]
IN
WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common Stock to be duly executed as of the Issuance Date set out
above.
STABLEX
TECHNOLOGIES, INC.
By:
Name:
Joshua
Silverman
Title:
Chief Executive
Officer
EXHIBIT
A
EXERCISE
NOTICE
TO
BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS
WARRANT
TO PURCHASE COMMON STOCK
STABLEX
TECHNOLOGIES, INC.
The
undersigned holder hereby elects to exercise the Warrant to Purchase Common Stock No. _______ (the “Warrant”) of STABLEX
TECHNOLOGIES, INC., a Delaware corporation (the “Company”), as specified below. Capitalized terms used herein and
not otherwise defined shall have the respective meanings set forth in the Warrant.
1. Form
of Exercise Price. The Holder intends that payment of the Aggregate Exercise Price shall be made as:
☐ a
“Cash Exercise” with respect to _________________ Warrant Shares; and/or
☐ a
“Cashless Exercise” with respect to _______________ Warrant Shares.
In
the event that the Holder has elected a Cashless Exercise with respect to some or all of the Warrant Shares to be issued pursuant hereto,
the Holder hereby represents and warrants that (i) this Exercise Notice was executed by the Holder at __________ [a.m.][p.m.] on the
date set forth below and (ii) if applicable, the Bid Price as of such time of execution of this Exercise Notice was $________.
2. Payment
of Exercise Price. In the event that the Holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to
be issued pursuant hereto, the Holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in accordance
with the terms of the Warrant.
3. Delivery
of Warrant Shares. The Company shall deliver to Holder, or its designee or agent as specified below, __________ shares of Common
Stock in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit, as follows:
☐ Check
here if requesting delivery as a certificate to the following name and to the following address:
Issue
to:
☐ Check
here if requesting delivery by Deposit/Withdrawal at Custodian as follows:
DTC
Participant:
DTC
Number:
Account
Number:
Date: ___________________________ __, __
Name
of Registered Holder
By:
Name:
Title:
Tax ID:
Facsimile:
Address:
EXHIBIT
B
ACKNOWLEDGMENT
The
Company hereby acknowledges this Exercise Notice and hereby directs ______________ to issue the above indicated number of shares of Common
Stock in accordance with the Transfer Agent Instructions dated _________, 202_, from the Company and acknowledged and agreed to by _______________.
STABLEX
TECHNOLOGIES, INC.
By:
Name:
Title:
EX-4.2
EX-4.2
Filename: ex4-2.htm · Sequence: 8
Exhibit 4.2
NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.
COMMON
STOCK PURCHASE WARRANT
StableX
Technologies, Inc.
Warrant
Shares: _______
Initial
Exercise Date: [_______], 2026
THIS
COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the
“Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m.
(New York City time) on [______________]1 (the “Termination Date”) but not thereafter, to subscribe for
and purchase from StableX Technologies, Inc., a Delaware corporation (the “Company”), up to [ ] shares (as subject
to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock, par value $0.0001 per share (“Common
Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined
in Section 2(b).
Section
1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Omnibus Waiver, Consent, Notice and Amendment Agreement (the “Agreement”), dated April 27, 2026, among the Company
and the investor listed on the signature page attached thereto and as set forth below.
a) “Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.
1
Insert the date that is five (5) years following the Initial Exercise Date, provided that, if such date is not a Trading Day, insert the
immediately following Trading Day.
b) “Bid
Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB Venture Market (“OTCQB”) or the OTCQX
Best Market (“OTCQX”) is not a Trading Market, the volume weighted average price of the Common Stock for such date
(or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on
OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (“Pink Market”) operated
by the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.
c) “Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.
d) “Commission”
means the United States Securities and Exchange Commission.
e) “Common
Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.
f) “Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
g) “Subsidiaries”
means any Person in which the Company, directly or indirectly, (i) owns any of the outstanding capital stock or holds any equity or similar
interest of such Person or (ii) controls or operates all or any part of the business, operations or administration of such Person.
h) “Trading
Day” means a day on which the principal Trading Market is open for trading.
i) Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).
2
j) “Transfer
Agent” means Equiniti Trust Company LLC, and any successor transfer agent of the Company.
k) “VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market operated
by the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.
Section
2. Exercise.
a) Exercise
of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein), in each case following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United
States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably
practicable following the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting
in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver
any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. The Holder and any assignee, by acceptance
of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the
Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount
stated on the face hereof.
3
b) Exercise
Price. The exercise price per share of Common Stock under this Warrant shall be $5.00, subject to adjustment hereunder (the “Exercise
Price”).
c) Cashless
Exercise. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, and subject to the prior written consent of the Company,
then this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the
Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:
(A)
=
as
applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined
in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of
the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (“Bloomberg”) as of the time of
the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading
hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of
“regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable
Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;
(B)
=
the
Exercise Price of this Warrant, as adjusted hereunder; and
(X)
=
the
number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.
4
If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The
Company agrees not to take any position contrary to this Section 2(c). For the avoidance of doubt, the
Holder cannot cashless exercise pursuant to this Section 2(c) if at the time of exercise hereof there is an effective registration statement
registering, or the prospectus contained therein is available for the resale of the Warrant Shares by the Holder.
d) Mechanics
of Exercise.
i. Delivery
of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares acquired hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the
Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate or a book-entry
certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares
to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date
that is the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each
case after the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). Upon
delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the
Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided
that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one
(1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each case after the delivery to the
Company of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice
of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty,
for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice
of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third (3rd) Trading Day after the Warrant Share
Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds
such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains
outstanding and exercisable. As used herein, “Standard Settlement Period” means the standard settlement period, expressed
in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date
of delivery of the Notice of Exercise.
5
ii. Delivery
of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.
iii. Rescission
Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.
iv. Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.
6
v. No
Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.
vi. Charges,
Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided,
however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.
vii. Closing
of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.
e) Holder’s
Exercise Limitations. The Company shall not effect any exercise of this Warrant, and
a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section
2 or otherwise, to the extent that after giving effect to such issuance after exercise as
set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s
Affiliates, and any other Persons acting as a group together with the Holder or any of the
Holder’s Affiliates (such Persons, “Attribution Parties”)), would
beneficially own in excess of the Beneficial Ownership Limitation (as defined below).
For purposes of the foregoing sentence, the number of shares of Common Stock beneficially
owned by the Holder and its Affiliates and Attribution Parties shall include the number of
shares of Common Stock issuable upon exercise of this Warrant with respect to which such
determination is being made, but shall exclude the number of shares of Common Stock which
would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)
exercise or conversion of the unexercised or nonconverted portion of any other securities
of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially
owned by the Holder or any of its Affiliates or Attribution Parties. Except as set
forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and
regulations promulgated thereunder, it being acknowledged by the Holder that the Company
is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be
filed in accordance therewith. To the extent that the limitation contained in this Section
2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and
of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder,
and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder
together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition,
a determination as to any group status as contemplated above shall be determined in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.
For purposes of this Section 2(e), in determining the number of outstanding shares of Common
Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected
in (A) the Company’s most recent periodic or annual report filed with the Commission,
as the case may be, (B) a more recent public announcement by the Company or (C) a more recent
written notice by the Company or the Transfer Agent setting forth the number of shares of
Common Stock outstanding. Upon the written or oral request of a Holder, the Company
shall within one (1) Trading Day confirm orally and in writing to the Holder the number of
shares of Common Stock then outstanding. In any case, the number of outstanding shares
of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution
Parties since the date as of which such number of outstanding shares of Common Stock was
reported. The “Beneficial Ownership Limitation” shall be [9.99/4.99%]
of the number of shares of the Common Stock outstanding immediately after giving effect to
the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder,
upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no
event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after
giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held
by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase
in the Beneficial Ownership Limitation will not be effective until the 61st day
after such notice is delivered to the Company. The provisions of this paragraph shall be
construed and implemented in a manner otherwise than in strict conformity with the terms
of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective
or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
make changes or supplements necessary or desirable to properly give effect to such limitation.
The limitations contained in this paragraph shall apply to a successor holder of this Warrant.
7
Section
3. Certain Adjustments.
a) Stock
Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.
b) Subsequent
Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that to the extent that the Holder’s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).
c) Pro
Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided,
however, that to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).
d) Calculations.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.
e) Notice
to Holder.
i. Adjustment
to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.
8
ii. Notice
to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.
Section
4. Transfer of Warrant.
a) Transferability.
Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any
registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or
its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the
Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees,
as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a
new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned
this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date
on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance
herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.
9
b) New
Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.
c) Warrant
Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant
Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.
d) Representation
by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.
Section
5. Miscellaneous.
a) No
Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a “cashless exercise” pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.
b) Loss,
Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.
10
c) Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.
d) Authorized
Shares.
The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).
Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.
Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.
11
e) Jurisdiction.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Agreement.
f) Restrictions.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.
g) Nonwaiver
and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies, notwithstanding the fact that the right
to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Agreement, if
the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the
Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited
to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due
pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.
h) Notices.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice provisions of the Agreement.
i) Limitation
of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.
j) Remedies.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.
k) Successors
and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.
l) Amendment.
Other than Section 2(e) and this Section 5(l), which may not be modified, amended or waived, this Warrant may be modified or amended
or the provisions hereof waived with the written consent of the Company, on the one hand, and the Holder of this Warrant, on the other
hand.
m) Severability.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.
n) Headings.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.
********************
(Signature
Page Follows)
12
IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.
STABLEX TECHNOLOGIES, Inc.
By:
Name:
Title:
NOTICE
OF EXERCISE
To: StableX
Technologies, Inc.
(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.
(2) Payment
shall take the form of (check applicable box):
☐ in
lawful money of the United States; or
☐ if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).
(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:
_______________________________
The
Warrant Shares shall be delivered to the following DWAC Account Number:
_______________________________
_______________________________
_______________________________
(4) Accredited
Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act
of 1933, as amended.
[SIGNATURE
OF HOLDER]
Name
of Investing Entity: ________________________________________________________________________
Signature
of Authorized Signatory of Investing Entity: _________________________________________________
Name
of Authorized Signatory: ___________________________________________________________________
Title
of Authorized Signatory: ____________________________________________________________________
Date:
_______________________________________________________________________________________
EXHIBIT
B
ASSIGNMENT
FORM
(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)
FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to
Name:
(Please
Print)
Address:
(Please
Print)
Phone
Number:
Address:
Dated:
_______________ __, ______
Holder’s
Signature: _______________________
Holder’s
Address: _______________________
EX-4.3
EX-4.3
Filename: ex4-3.htm · Sequence: 9
Exhibit
4.3
NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.
STABLEX
TECHNOLOGIES, INC.
Warrant
To Purchase Shares Of Common Stock
Warrant
Shares: _______
Issue
Date: April __, 2026
This
WARRANT TO PURCHASE SHARES OF COMMON STOCK (this “Warrant”) certifies that, for value received, JD Advisors,
LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the Exercisability Date (as defined herein) and on or prior to 5:00 p.m. (New York City
time) on _________ (the “Termination Date”) but not thereafter, to subscribe for and purchase from StableX Technologies,
Inc., a Delaware corporation (the “Company”), up to _________ shares (as subject to adjustment hereunder, the “Warrant
Shares”) of common stock, par value $0.0001 per share (“Common Stock”). The purchase price of one share
of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(c). This Warrant is one of the Warrants
to purchase shares of Common Stock (the “Consulting Warrants”) issued pursuant to that certain Amended and Restated
Consulting Agreement (the “Consulting Agreement”), dated April 27, 2026, by and among the Company and JD Advisors,
LLC.
Section
1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in the Consulting Agreement
and as set forth below.
“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.
“Bid
Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock is not then listed or quoted on a Trading Market and
if the Common Stock is listed or quoted for trading on the OTC Market Group’s OTCQB exchange (“OTCQB”) or OTCQX
exchange (“OTCQX”) (or any successors to either of the foregoing) , the VWAP of the Common Stock for such date (or
the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB
or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent bid price per share of Common Stock so reported, or (d) in all other cases, the
fair market value of a share of the Common Stock as determined by an independent appraiser selected in good faith by the Holder reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.
1
“Business
Day” means any day other than a Saturday, a Sunday or any day on which commercial banks in the City of New York are authorized
or required by law or executive order to close or be closed; provided, however, for clarification, commercial banks in the City of New
York shall not be deemed to be authorized or required by law or executive order to close or be closed due to “stay at home”,
“shelter-in-place”, “non-essential employee” or any other similar orders or restrictions or the closure of any
physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including
for wire transfers) of commercial banks in the City of New York are open for use by customers on such day.
“Common
Stock Equivalents” means any securities of the Company or its subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares of Common
Stock.
“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.
“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
“Trading
Day” means a day on which the principal Trading Market is open for trading.
“Trading
Market” means any of the following markets or exchanges on which the shares of Common Stock are listed or quoted for trading
on the date in question: the NYSE American, the Nasdaq Stock Market LLC, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq
Global Select Market, or the New York Stock Exchange (or any successors to any of the foregoing).
“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the shares of Common Stock are then
listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on the Trading Market on which the Common Stock are then listed or quoted as reported by Bloomberg (based on a trading day from
9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the shares of Common Stock are listed or quoted on the OTCQB
or OTCQX (each as operated by OTC Markets Group, Inc., or any successor market), the volume weighted average price of the Common Stock
for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the shares of Common Stock are not then listed
or quoted for trading on the OTCQB or OTCQX Markets and if prices for the Common Stock are then reported in the OTC Pink Market published
by OTC Markets Group Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid
price per share of the shares of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock
as determined by an independent appraiser selected in good faith by the Board of Directors of the Company and reasonably acceptable to
the Holder, the fees and expenses of which shall be paid by the Company.
2
Section
2. Exercise.
a)
Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times
on or after the Exercisability Date (as defined below) and on or before the Termination Date by delivery to the Company of a duly executed
facsimile copy or PDF copy submitted by email (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice
of Exercise”). Within one (1) Trading Day following the date of exercise as aforesaid, the Holder shall deliver the aggregate
Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United
States bank unless the cashless exercise procedure specified in Section 2(d) below is specified in the applicable Notice of Exercise.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading
Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.
b)
Exercisability Date. The Warrant Shares shall become exercisable [________], provided there has been no breach or alleged breach
by the Holder of the terms of the Consulting Agreement. If there has been any breach or alleged breach by the Holder of the terms of
the Consulting Agreement prior to the Termination Date, this Warrant shall be forfeited and terminated immediately upon notice of such
breach by the Company to the Holder.
c)
Exercise Price. The exercise price per share of Common Stock under this Warrant shall be $[____], subject to adjustment hereunder
(the “Exercise Price”).
d)
Cashless Exercise. Notwithstanding anything contained herein to the contrary, if, and only if, at the time of exercise hereof,
there is no effective registration statement, or the prospectus contained therein is not available for use, registering for resale by
the Holder of all of the Warrant Shares, then the Holder may, in its sole discretion, exercise this Warrant in whole or in part, in lieu
of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the Exercise Price, elect
instead to receive upon such exercise the “Net Number” of Warrant Shares determined according to the following formula (a
“Cashless Exercise”):
Net
Number = (A x B) - (A x C)
B
3
For
purposes of the foregoing formula:
A
=
the
number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a Cashless Exercise.
B
=
as
applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined
in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the
Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid
Price of the Common Stock on the Company’s principal Trading Market as reported by Bloomberg L.P. (“Bloomberg”)
as of the time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during
“regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours
after the close of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the
date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is
both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading
Day.
C =
the
Exercise Price of this Warrant, as adjusted hereunder.
If
Warrant Shares are issued in such a Cashless Exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised, and the holding period
of the Warrants being exercised may be tacked onto the holding period of the Warrant Shares. The Company agrees not to take any position
contrary to this Section 2(d).
Notwithstanding
anything to the contrary contained herein, the Warrant may not be exercised pursuant to a Cashless Exercise at any time during which
there is an effective registration statement registering the resale by the Holder of the Warrant Shares.
4
e)
Mechanics of Exercise.
i. Delivery
of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased
hereunder to be transmitted by the Company’s transfer agent (the “Transfer Agent”)
to the Holder by crediting the account of the Holder’s or its designee’s balance
account with The Depository Trust Company through its Deposit or Withdrawal at Custodian
system (“DWAC”) if the Company is then a participant in such system and
either (A) there is an effective registration statement permitting the issuance of the Warrant
Shares to or resale of the Warrant Shares by Holder or (B) the Warrant Shares are eligible
for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144,
and otherwise by physical delivery of a certificate, registered in the Company’s share
register in the name of the Holder or its designee, for the number of Warrant Shares to which
the Holder is entitled pursuant to such exercise to the address specified by the Holder in
the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after
the delivery to the Company by the Holder of the Notice of Exercise, (ii) one (1) Trading
Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of
Trading Days comprising the Standard Settlement Period after the delivery to the Company
of the Notice of Exercise (such date, the “Warrant Share Delivery Date”).
Notwithstanding the foregoing, the Company shall not be required to cause the applicable
Warrant Shares to be transmitted or a certificate or book-entry statement to be physically
delivered unless and until the aggregate Exercise Price is received by the Company (other
than in the case of a Cashless Exercise). Upon delivery of the Notice of Exercise, the Holder
shall be deemed for all corporate purposes to have become the holder of record of the Warrant
Shares with respect to which this Warrant has been exercised, irrespective of the date of
delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other
than in the case of a Cashless Exercise) is received within one (1) Trading Day following
delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the
Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date,
other than the Company’s failure to receive the aggregate Exercise Price, other than
in the case of a Cashless Exercise or any delays caused by the Transfer Agent, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000
of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the
date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading
Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading
Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder
rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant
in the FAST program so long as this Warrant remains outstanding and exercisable. As used
herein, “Standard Settlement Period” means the standard settlement period,
expressed in a number of Trading Days, on the Company’s primary Trading Market with
respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.
ii. Delivery
of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the
Company shall, at the request of a Holder and upon surrender of this Warrant certificate,
at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant,
which new Warrant shall in all other respects be identical with this Warrant.
iii. Rescission
Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the
Warrant Shares pursuant to Section 2(e)(i) by the Warrant Share Delivery Date, then the Holder
will have the right to rescind such exercise; provided, however, that the Holder shall
be required to return any Warrant Shares or Common Stock subject to any such rescinded exercise
notice concurrently with the return to the Holder of the aggregate Exercise Price paid to
the Company for such Warrant Shares and the restoration of the Holder’s right to acquire
such Warrant Shares pursuant to this Warrant (including, issuance of a replacement warrant
certificate evidencing such restored right).
iv. No
Fractional Shares or Scrip. No fractional shares or scrip
representing fractional shares shall be issued upon the exercise of this Warrant. As to any
fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise,
the Company shall, at its election, either pay a cash adjustment in respect of such final
fraction in an amount equal to such fraction multiplied by the Exercise Price or round up
to the next whole share.
5
v. Charges,
Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder
for any issue or transfer tax or other incidental expense in respect of the issuance of such
Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; provided, however, that in the event that Warrant Shares are to be
issued in a name other than the name of the Holder, this Warrant when surrendered for exercise
shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and
the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse
it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees
required for same-day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions)
required for same-day electronic delivery of the Warrant Shares.
vi. Closing
of Books. The Company will not close its stockholder books or records in any manner which
prevents the timely exercise of this Warrant, pursuant to the terms hereof.
f)
Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right
to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(f), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(f) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(f), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed
with the Securities and Exchange Commission (the “Commission”), as the case may be, (B) a more recent public announcement
by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common
Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing
to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or
its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The
“Beneficial Ownership Limitation” shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants,
9.99%) of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock
issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section 2(f), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares
of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held
by the Holder and the provisions of this Section 2(f) shall continue to apply. Any increase in the Beneficial Ownership Limitation will
not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(f) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant
6
g)
Trading Market Regulation. The Company shall not issue any shares of Common Stock upon the exercise of this Warrant if the issuance of
such shares of Common Stock would exceed the aggregate number of shares of Common Stock which the Company may issue upon exercise or
conversion or otherwise pursuant to the terms of the Consulting Warrants without breaching the Company’s obligations under the
rules or regulations of the Trading Market (the number of shares which may be issued without violating such rules and regulations, the
“Exchange Cap”), except that such limitation shall not apply in the event that the Company (A) obtains the approval
of its stockholders as required by the applicable rules of the Trading Market for issuances of shares of Common Stock in excess of the
Exchange Cap or (B) obtains a written opinion from outside counsel to the Company that such approval is not required, which opinion shall
be reasonably satisfactory to the Holder.
Section
3. Certain Adjustments.
a)
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification. For the purposes of clarification, the Exercise Price
of this Warrant will not be adjusted in the event that the Company or any subsidiary thereof, as applicable, sells or grants any option
to purchase, or sell or any grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option
to purchase or other disposition) any Common Stock or Common Stock Equivalents, at an effective price per share less than the Exercise
Price then in effect.
7
b)
Fundamental Transaction. In case of any reclassification of the Common Stock (other than in a transaction to which Section 3(a) applies),
any consolidation of the Company with, or merger of the Company into, any other entity, any merger of another entity into the Company
(other than a merger that does not result in any reclassification, conversion, exchange or cancellation of outstanding Common Stock of
the Company), then lawful provision shall be made as part of the terms of such transaction whereby the Holder of this Warrant then outstanding
shall have the right thereafter, during the period this Warrant shall be exercisable, to exercise this Warrant only for the kind and
amount of securities, cash and other property receivable upon the reclassification, consolidation, merger, sale, transfer or share exchange
by a holder of the number of Common Stock of the Company into which this Warrant might have been able to exercise for immediately prior
to the reclassification, consolidation, merger, sale, transfer or share exchange assuming that such holder of Common Stock failed to
exercise rights of election, if any, as to the kind or amount of securities, cash or other property receivable upon consummation of such
transaction subject to adjustment as provided in Section 3(a) above following the date of consummation of such transaction. The provisions
of this Section 3(b) shall similarly apply to successive reclassifications, consolidations, mergers, sales, transfers or share exchanges.
c)
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case
may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall
be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.
d)
Notice to Holder.
i. Adjustment
to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision
of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email
a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring
such adjustment.
ii. Notice
to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other
distribution in whatever form) on the Common Stock, (B) the Company shall declare a special
nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe
for or purchase any shares of capital stock of any class or of any rights, (D) the approval
of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (and all of its subsidiaries,
taken as a whole) is a party, any sale or transfer of all or substantially all of the assets
of the Company, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case,
the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile
number or email address as it shall appear upon the Warrant Register of the Company, at least
20 calendar days prior to the applicable record or effective date hereinafter specified,
a notice stating (x) the date on which a record is to be taken for the purpose of such dividend,
distribution, redemption, rights or warrants, or if a record is not to be taken, the date
as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or
close, and the date as of which it is expected that holders of the Common Stock of record
shall be entitled to exchange their shares of Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or
share exchange; provided that the failure to deliver such notice or any defect therein or
in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes,
or contains, as reasonably determined by the Company, material, non-public information regarding
the Company or any of the subsidiaries, the Company shall simultaneously file such notice
with the Commission pursuant to a Current Report on Form 8-K, The Holder shall remain entitled
to exercise this Warrant during the period commencing on the date of such notice to the effective
date of the event triggering such notice except as may otherwise be expressly set forth herein.
Notwithstanding the foregoing, no notice need be given to the Holder if the Company makes
a public announcement of the applicable event via nationally distributed press release or
via a publicly available and legally compliant filing with the Commission.
8
Section
4. Transfer of Warrant.
a)
Transferability. Prior to the vesting in full of the Warrant Shares pursuant to the terms and conditions of this Warrant, this
Warrant and all rights hereunder are non-transferable without the written consent of the Company. Upon the vesting in full of the Warrant
Shares pursuant to the terms and conditions of this Warrant and subject to compliance with any applicable securities laws and the conditions
set forth in Section 4(d), this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant
at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. This Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.
b)
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.
c)
Warrant Register. The Company shall register this Warrant, upon records to be maintained by or on behalf of the Company for that purpose
(the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat
the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the
Holder, and for all other purposes, absent actual notice to the contrary.
d)
Representation by Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any
exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing
or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except
pursuant to sales registered or exempted under the Securities Act.
9
Section
5. Miscellaneous.
a)
No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(e)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a “Cashless Exercise” pursuant to
Section 2(d), in no event shall the Company be required to net cash settle an exercise of this Warrant.
b)
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.
c)
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business
Day.
d)
Authorized Shares.
i.
The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock
a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).
ii.
Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such reasonable action as may be necessary or appropriate in order that
the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use
commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction
thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.
10
iii.
Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or
in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents therein, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.
e)
Governing Law; Venue. This Warrant shall be deemed to have been executed and delivered in New York and both this Warrant and the transactions
contemplated hereby shall be governed as to validity, interpretation, construction, effect, and in all other respects by the laws of
the State of New York applicable to agreements wholly performed within the borders of such state and without regard to the conflicts
of laws principles thereof (other than Section 5-1401 of The New York General Obligations Law). Each of the Holder and the Company: (a)
agrees that any legal suit, action or proceeding arising out of or relating to this Warrant and/or the transactions contemplated hereby
shall be instituted exclusively in the Supreme Court of the State of New York, New York County, or in the United States District Court
for the Southern District of New York, (b) waives any objection which it may have or hereafter to the venue of any such suit, action
or proceeding, and (c) irrevocably consents to the jurisdiction of Supreme Court of the State of New York, New York County, or in the
United States District Court for the Southern District of New York in any such suit, action or proceeding. Each of the Holder and the
Company further agrees to accept and acknowledge service of any and all process which may be served in any such suit, action or proceeding
in the Supreme Court of the State of New York, New York County, or in the United States District Court for the Southern District of New
York and agrees that service of process upon the Company mailed by certified mail to the Company’s address or delivered by Federal
Express via overnight delivery shall be deemed in every respect effective service of process upon the Company, in any such suit, action
or proceeding, and service of process upon the Holder mailed by certified mail to the Holder’s address or delivered by Federal
Express via overnight delivery shall be deemed in every respect effective service process upon the Holder, in any such suit, action or
proceeding. THE HOLDER (ON BEHALF OF ITSELF, ITS SUBSIDIARIES AND, TO THE FULLEST EXTENT PERMITTED BY LAW, ON BEHALF OF ITS RESPECTIVE
EQUITY HOLDERS AND CREDITORS) HEREBY WAIVES ANY RIGHT HOLDER MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY CLAIM BASED UPON, ARISING
OUT OF OR IN CONNECTION WITH THIS WARRANT AND THE TRANSACTIONS CONTEMPLATED BY THIS WARRANT.
f)
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.
g)
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate
as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision
of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.
h)
Notices. Any and all notices or other communications or deliveries to be provided hereunder shall be made in accordance with the Consulting
Agreement.
i)
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for
the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors
of the Company.
j)
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including to seek recovery of damages,
will be entitled to seek specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be
adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive
and not to assert the defense in any action for specific performance that a remedy at law would be adequate.
k) Successors
and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit
of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions
of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder
or holder of Warrant Shares.
l)
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one
hand, and the Holder of this Warrant, on the other hand.
m)
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be
ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions
of this Warrant.
n)
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.
********************
(Signature
Page Follows)
11
IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.
STABLEX
TECHNOLOGIES, INC.
By:
Name:
Joshua
Silverman
Title:
Chief
Executive Officer
12
NOTICE
OF EXERCISE
TO:
STABLEX
TECHNOLOGIES, INC.
(1)
The undersigned hereby elects to purchase _________Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.
(2)
Payment shall take the form of (check applicable box):
☐
in lawful money of the United States; or
☐
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the
formula set forth in subsection 2(d), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant
to the cashless exercise procedure set forth in subsection 2(d).
(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:
The
Warrant Shares shall be delivered to the following DWAC Account Number:
[SIGNATURE
OF HOLDER]
Name
of Investing Entity:____________________________________________
_________________________________________________________________
Signature
of Authorized Signatory of Investing Entity:
______________________________________________________
Name
of Authorized Signatory:
____________________________________________________________
Title
of Authorized Signatory:
Date:___________________________________________________________
13
ASSIGNMENT
FORM
(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)
FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to
Name:
(Please
Print)
Address:
(Please
Print)
Phone Number:
Email Address:
Dated: ____________
Holder’s Signature: _______________________________
Holder’s Address: ________________________________
14
EX-4.4
EX-4.4
Filename: ex4-4.htm · Sequence: 10
Exhibit 4.4
Amendment
to Rights Agreement
This
Amendment (this “Amendment”) to the Rights Agreement, is made as of April 27, 2026, by and between StableX Technologies,
Inc., a Delaware corporation (the “Company”), and Equiniti Trust Company, LLC (“Rights Agent”),
as rights agent, is amending that certain Rights Agreement, dated as of July 31, 2025, by and between the Company and the Rights Agent
(the “Rights Agreement”). Except as set forth herein, any defined terms contained herein have the respective meaning(s)
set forth in the Rights Agreement.
WITNESSETH
WHEREAS,
the Company and the Rights Agent desire, pursuant to and in accordance with Section 27 of the Rights Agreement, to amend the Rights Agreement
to make certain amendments to the definition of “Exempt Person” under the Rights Agreement.
NOW,
THEREFORE, in consideration of the premises and the mutual agreements herein set forth, the Company and the Rights Agent agree as follows:
1. Amendment
to Rights Plan. The parties hereby agree that Section 1(q) of the Rights Agreement is
hereby amended and restated as follows (emphasis added):
(q) “Exempt
Person” shall mean (A) the Company or any Subsidiary of the Company, in each case
including, without limitation, in its fiduciary capacity, or any employee benefit plan of
the Company or of any Subsidiary of the Company, or any entity or trustee holding (or acting
in a fiduciary capacity in respect of) Company Stock for or pursuant to the terms of any
such plan or for the purpose of funding any such plan or funding other employee benefits
for employees of the Company or of any Subsidiary of the Company, or (B) any other Person
if the Board of Directors has determined in good faith that such Person shall be an “Exempt
Person.”
2. Counterparts;
Facsimile Execution. This Amendment may be executed in one or more counterparts (including
by electronic mail, in PDF or by DocuSign or similar electronic signature), all of which
shall be considered one and the same agreement and shall become effective when one or more
counterparts have been signed by each of the parties and delivered to the other parties.
Counterparts may be delivered via facsimile, electronic mail (including any electronic signature
covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic
Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission
method and any counterpart so delivered shall be deemed to have been duly and validly delivered
and be valid and effective for all purposes.
3. Governing
Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement
and interpretation of this Amendment shall be governed by the internal laws of the State
of New York, without giving effect to any choice of law or conflict of law provision or rule
(whether of the State of New York or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in The City
of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection
herewith or with any transaction contemplated hereby, and hereby irrevocably waives, and
agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is brought
in an inconvenient forum or that the venue of such suit, action or proceeding is improper.
Each party hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by mailing a copy thereof to such party
at the address for such notices to it under the Rights Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any manner permitted
by law.
4. Terms
and Conditions of the Rights Agreement. Except as modified and amended herein, all of
the terms and conditions of the Rights Agreement shall remain in full force and effect.
[Signature
pages follow immediately.]
In
witness whereof, the undersigned has executed and delivered
this Amendment as of the date first above written.
Company:
STABLEX
TECHNOLOGIES, Inc.
By:
/s/
Joshua Silverman
Name:
Joshua
Silverman
Title:
Chief
Executive Officer
In
witness whereof, the undersigned has executed and delivered
this Amendment as of the date first above written.
Rights
Agent:
EQUINITI
TRUST COMPANY, LLC
By:
/s/
Krista Riley
Name
of signatory:
Krista
Riley
Title:
Manager,
Corporate Stock Transfer
EX-10.1
EX-10.1
Filename: ex10-1.htm · Sequence: 11
Exhibit 10.1
JOINT
DEVELOPMENT & LICENSE AGREEMENT
This
Joint Development & License Agreement (the “Agreement”) is entered into as of April 27, 2026 (“Effective
Date”) by and between Kopin Corporation, a Delaware corporation having a place of business at 125 North Drive, Westborough,
MA 01581 (“Kopin”), and StableX Technologies, Inc., a Delaware corporation having a place of business at 1185
Avenue of the Americas, New York, New York 10036 (“StableX”), each referred to herein as a “Party”
and together the “Parties.”
RECITALS
WHEREAS,
Kopin is in the business of developing and manufacturing advanced display and optical technologies;
WHEREAS,
StableX is in the business of acquiring and developing stablecoin assets, infrastructure, and related technologies to capitalize on the
growth of the stablecoin industry;
WHEREAS,
Kopin and StableX desire to work together to further develop and commercialize Kopin’s proprietary interface for GPU-to-GPU connectivity
on the terms set forth herein; and
WHEREAS,
Kopin and StableX have concurrently entered into various transaction agreements, including an Exclusive Supply and Distribution Agreement
(the “Supply Agreement” and together with this Agreement, the “Transaction Agreements”)
to facilitate the Project.
NOW,
THEREFORE, in consideration of the foregoing, the mutual covenants and agreements of the Parties contained herein, and other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties to this Agreement agree as follows:
ARTICLE
I -DEFINITIONS
1.1
“Affiliate” means a corporation or other legal entity directly or indirectly (a) controlled by a Party, (b)
controlling the Party, or (c) controlled by the corporation, legal entity or persons which control the Party. For the purposes of this
paragraph, to “control” a corporation or an entity means to own or control, either directly or indirectly such as through
intermediary entities, (1) more than fifty percent (50%) of the shares or other securities entitled to vote for election of directors
(or other managing authority) of the corporation or entity; or (2) more than fifty percent (50%) of the equity or other ownership interest
of the corporation or entity.
1.2
“Bankruptcy Event” means, with respect to any Person, the occurrence of any of the following: (a) such Person
shall commence a voluntary case or other proceeding seeking liquidation, reorganization, or other relief with respect to itself or its
debts under any bankruptcy, insolvency, or other similar law now or hereafter in effect, or seeking the appointment of a trustee, receiver,
liquidator, custodian, or other similar official of it or any substantial part of its property; (b) such Person shall consent to any
such relief or to the appointment of or taking possession by any such official in an involuntary case or other proceeding commenced against
it; (c) an involuntary case or other proceeding shall be commenced against such Person seeking liquidation, reorganization, or other
relief with respect to it or its debts under any bankruptcy, insolvency, or other similar law now or hereafter in effect, or seeking
the appointment of a trustee, receiver, liquidator, custodian, or other similar official of it or any substantial part of its property,
and such involuntary case or other proceeding shall remain undismissed and unstayed for a period of sixty (60) consecutive days; (d)
such Person shall make a general assignment for the benefit of creditors; (e) such Person shall fail generally to pay, or shall admit
in writing its inability to pay, its debts as they become due; (f) such Person shall take any corporate or other organizational action
to authorize any of the foregoing; or (g) such Person shall cease to conduct substantially all of its business operations for a period
of ninety (90) or more consecutive days, other than as a result of a permitted transfer or assignment of this Agreement.
Page 1 of 22
1.3
“Control”, “Controls,” or “Controlled by” means the possession
by a Party (whether by ownership, license, or otherwise other than pursuant to this Agreement) of (a) with respect to any materials and
information, the legal authority or right to possession of such materials or information, with the right to provide such materials or
information to the other Party on the terms set forth herein, or (b) with respect to intellectual property and other intangible rights,
the legal authority or right to grant a license, sublicense, access, or right to use (as applicable) to the other Party under such intellectual
property and other intangible rights on the terms set forth herein, in each case (a) and (b), without breaching or otherwise violating
the terms of any arrangement or agreement with a third party or requiring consent from a third party; provided that neither Party
shall be deemed to Control any item or right of a third party if access by the other Party to such item or right requires or triggers
a payment obligation to such third party, unless the other Party agrees to bear such payment obligation.
1.4
“Development Plan” is defined in Section 2.1.
1.5
“Development Work” means all engineering, design, research, development, customization, and testing activities
performed by or on behalf of Kopin to develop the Project Technology in accordance with the applicable Development Plan.
1.6
“Field” means data communications chips expressly identified in an agreed Development Plan, including GPU-to-GPU,
Board-to-Board and Rack-to-Rack communications, and excluding any applications, use cases, architectures or technologies not expressly
set out in such Development Plan.
1.7
“HyperScaler Products” shall mean Products and Services using the Project Technology for end users in commercial
hyperscaler deployments only.
1.8
“Intellectual Property Rights” means any and all rights, title, and interest in and to intellectual property,
whether protected, created, or arising under the laws of the United States or any other jurisdiction, including: (a) patents, patent
applications, patent disclosures, and all related continuations, continuations-in-part, divisionals, reissues, re-examinations, substitutions,
and extensions thereof; (b) trademarks, service marks, trade names, trade dress, logos, corporate names, domain names, and other source
identifiers, together with all goodwill associated therewith; (c) copyrights, works of authorship, and moral rights; (d) trade secrets,
know-how, inventions, processes, techniques, methodologies, and other confidential or proprietary information; (e) mask works and semiconductor
topography rights; (f) database rights; (g) rights of publicity and privacy; (h) all registrations, applications, renewals, extensions,
and reversions of the foregoing; and (i) all other intellectual property rights and proprietary rights, however denominated, throughout
the world.
Page 2 of 22
1.9
“JSC” is identified in Section 2.1.
1.10
“Kopin Background Technology” means all Technology Controlled by Kopin on the Effective Date (including, for
clarity, the existing production version of the Monochrome MicroLED and the color MicroLED Design and production line configuration),
and any improvements and modifications to such Technology that is Controlled by Kopin at any time, excluding Project Technology.
1.11
“Military, Government and Defense Products” shall mean Products and Services using the Project Technology for
or with respect to: (a) government agencies, departments, instrumentalities or other public sector bodies, including defense, intelligence,
national security and public research bodies; (b) military, defense or government intelligence end users; and (c) defense contractors,
subcontractors, integrators and other entities primarily engaged in supplying products or services to government, military, defense or
government intelligence markets, in each case on a worldwide basis.
1.12
“Ordinary Course of Business” means, with respect to StableX, the conduct of its business in good faith and
in a manner consistent with (a) its stated business objectives and business plan as communicated to Kopin as of the Effective Date (including
as reflected in its organizational and governing documents provided to Kopin prior to the Effective Date), (b) maintaining organizational,
operational and financial resources reasonably sufficient to perform its obligations under this Agreement, and (c) using commercially
reasonable efforts to pursue active sales, marketing and commercial engagement activities in the hyperscale market, in each case subject
to temporary deviations caused by events outside StableX’s reasonable control.
1.13
“Production Plan” means the funding, development, manufacturing and commercialization plan for production deployment
of the Project Technology, as agreed in writing by the Parties pursuant to Section 2.3(e).
1.14
“Products” and “Services” used separately or together, means any equipment or services,
respectively, designed, developed or commercialized pursuant to any Development Plan and, if applicable, any agreed Production Plan under
this Agreement.
1.15
“Project Technology” means all Technology in the Field that is developed by either party in performance of
an agreed Development Plan, irrespective of inventorship, but excluding Kopin Background Technology and any next generation, follow-on
or derivative chipsets or technologies not expressly identified in such Development Plan. For the avoidance of doubt, Project Technology
shall not include any current generation IP with respect to the Monochrome and Color MicroLED developments under IBAS and SBIR developments,
next generation, follow-on or derivative chipsets, architectures or technologies, or any broader platform or system-level developments,
except to the extent expressly and specifically identified in an agreed Development Plan.
Page 3 of 22
1.16
“Successful Demo” means achievement of the prototype demonstration criteria expressly identified as such in
each applicable Development Plan.
1.17
“Technology” means any information, data, materials, discovery, invention, idea, discovery, process, protocol,
techniques, formulation, know-how, trade secret, method, development, enhancement, modification, improvement, work of authorship, computer
software (including, but not limited to, source code and object or executable code), material, or sample; and documentation of any of
the foregoing (including any records, data, concepts, information, designs, programs, formulae, or writings); in each case whether patentable
or not, or susceptible to copyright, trade secret, or any other form of legal protection under applicable law (including regulations).
ARTICLE
II -TECHNOLOGY DEVELOPMENT
2.1
General. The Parties will work together to develop a prototype and demonstration version of the Project Technology in accordance
with one or more statements of work or purchase orders (each, a “Development Plan”) agreed in writing between
the Parties from time to time, which shall set out the scope, deliverables, timelines and other relevant terms of the applicable development
activities. Following achievement of a Successful Demo, the Parties may proceed to production deployment and commercialization only pursuant
to an agreed Production Plan. The Parties acknowledge that StableX is funding the development of the prototype and demonstration version
of the Project Technology and, subject to agreement on a Production Plan, may take commercial risk associated with bringing the Project
Technology to production, while Kopin is performing the Development Work and retaining ownership of the Kopin Background Technology.
The project that is the subject of a Development Plan is a “Project”. Kopin will provide and make available
all equipment, materials, supplies and personnel reasonably required to fulfill its agreed upon development obligations as set forth
in the applicable Development Plan. In addition, Kopin will keep StableX informed on a regular basis as to the progress and results of
its work under each Development Plan. All Development Plans and Projects shall be subject to approval in accordance with Article III
and also oversight by the Joint Steering Committee (the “JSC”) as set forth in Article III; provided that Kopin
shall retain day-to-day responsibility for the conduct and execution of the Development Work and, within five (5) business days of the
Effective Date Kopin will provide a detailed staff listing of which personnel will conduct the Development Work. The Parties acknowledge
that the objective of each Development Plan is to enable production deployment of the Project Technology, subject to the funding and
commercialization framework set out in this Agreement. No Development Plan shall expand the scope of the Field without the prior written
agreement of both Parties.
2.2
Development Plan. Kopin agrees to work diligently towards completion of the goals and objectives set forth in each Development
Plan and to use commercially reasonable efforts to carry out the obligations and activities specified in each Development Plan. Any material
modification to a Development Plan shall require JSC approval.
Page 4 of 22
2.3
Budget and Costs.
(a)
StableX agrees that it will pay Kopin up to $15,000,000 in the aggregate for the development of the Project Technology through achievement
of at least one Successful Demo meeting the criteria expressly agreed in the applicable Development Plan and the funding schedule agreed
by the Parties (the “Development Funds”). As of the Effective Date, StableX shall ensure that at least $5,000,000
of funds are available in a segregated account to cover Development Plan needs and StableX shall not use such funds for any purpose inconsistent
with its payment obligations under this Agreement. StableX shall, at Kopin’s reasonable request, provide an account statement within
three (3) business days. StableX agrees not to take any action that would materially impair the availability of funds in the segregated
account or the Development Funds generally.
(b)
Each Development Plan includes a budget (“Budget”) setting forth Kopin’s budget with respect to its performance
of such Development Plan. StableX shall issue a Purchase Order (as defined below) in an initial funding amount of $5,000,000 within ten
(10) business days after the Effective Date (“Kickoff Payment”), which StableX shall pay to Kopin within ten
(10) business days of Kopin’s receipt of such Purchase Order. Following the Kickoff Payment, the remaining Development Funds shall
be paid by StableX to Kopin in installments in accordance with a time-based funding schedule agreed by the Parties as part of the applicable
Development Plan, which shall provide for the full funding of the Development Work through to Successful Demo. StableX shall issue Purchase
Orders in accordance with such funding schedule, and Kopin shall issue invoices accordingly. Each invoice shall be payable within ten
(10) business days of receipt. Each Purchase Order shall be subject to review and approval by the JSC, which approval shall not be unreasonably
withheld, conditioned or delayed and shall be based on consistency with the Budget and the applicable Development Plan. For the avoidance
of doubt, StableX’s obligation to fund any Purchase Order shall not be contingent on the achievement or verification of any technological
or development milestones. A Development Plan may include indicative milestones or workstreams for tracking and reporting purposes, but
such milestones shall not operate as a condition to payment. Except as set forth in this Section 2.3, each Party shall be solely responsible
for any costs or expenses it incurs in the performance of its obligations hereunder. For the avoidance of doubt, in no event shall StableX’s
aggregate monetary obligations hereunder exceed $15,000,000 without its express prior written consent.
(c)
Kopin shall (i) provide StableX with periodic written reports (“Development Reports”) not less than once per
month concerning all material activities undertaken in respect of the applicable Development Plan, (ii) keep StableX informed on a timely
basis concerning all material progress in the applicable Development Plan, and (iii) at StableX’s reasonable written request, from
time to time, provide StableX with information relating to the progress of the applicable Development Plan. If progress in respect of
the applicable Development Plan differs materially from that anticipated in the applicable Development Plan or a preceding Development
Report, Kopin shall endeavor to explain, in its Development Report, the reason therefor and may propose a modified Development Plan.
Kopin shall also make reasonable efforts to provide StableX with any reasonable additional data that StableX reasonably requires to evaluate
the performance of Kopin hereunder.
Page 5 of 22
(d)
StableX shall ensure that sufficient funds are available to meet its payment obligations as they fall due under this Agreement and shall
not withhold, defer, set off or otherwise delay any payments except as expressly permitted under this Agreement. Failure by StableX to
make any payment when due, or to maintain such committed funding, shall constitute a material breach of this Agreement.
(e)
Following achievement of a Successful Demo, the Parties shall engage in good faith negotiations for a period of 1 year to agree a Production
Plan (“Negotiation Period”), which is expected to include an additional payment by StableX of approximately
$15,000,000 to $25,000,000, subject to the agreed scope, specifications and deployment requirements. In negotiating the Production Plan,
the Parties shall take into account the results of the Successful Demo, the technical requirements for production deployment, and the
commercial objectives of the Parties. If the Parties do not reach agreement on the Production Plan within such Negotiation Period, or
if StableX does not commit to funding production deployment on terms agreed in the Production Plan, StableX shall be deemed to have elected
not to proceed with the Project for purposes of Section 9.5.
2.4
Additional Consideration; Preferred Equity. In further consideration of Kopin’s contributions to the development of the
Project Technology, StableX shall issue to Kopin shares of Convertible Preferred Stock (the “Convertible Preferred Stock”)
on the terms and conditions set forth in the applicable certificate of designations. The Parties acknowledge that such issuance is intended
to provide Kopin with a meaningful equity participation in StableX, and StableX shall take all actions reasonably necessary to give effect
to the agreed economic position of the Parties in connection with such issuance. The Parties acknowledge and agree that, following the
next or series of equity financing or capital raising by StableX of up to $50,000,000, Kopin is intended to hold equity securities representing
19.99% of StableX’s equity capitalization (including shares of common stock underlying unexercised options, warrants and other
common stock equivalents issued in connection with such financing transaction), and StableX shall work together in good faith to implement
such structure, including through the issuance of additional equity securities to Kopin. The Parties acknowledge that such issuance constitutes
material consideration for Kopin’s entry into this Agreement.
2.5
Marketing and Commercialization Support Plan. The Parties shall discuss in good faith and agree a marketing and commercialization
support plan for the Project Technology, including allocation of responsibilities and costs, following the Effective Date. Without limiting
the foregoing, the Parties intend that (a) Kopin shall be primarily responsible for developing and executing a robust marketing and sales
strategy for Military, Government and Defense Products on a worldwide basis, and (b) StableX shall be primarily responsible for developing
and executing a robust marketing and sales strategy for Products and Services in the Commercial Market (as defined in Section 4.4) on
a worldwide basis, in each case subject to further agreement between the Parties in the applicable plan. The Parties shall ensure that
any such plan is consistent with the allocation of rights set out in this Agreement.
Page 6 of 22
ARTICLE
III -– governance
3.1
Establishment of Joint Steering Committee. Within ten (10) business days after the Effective Date, the Parties shall establish
a joint steering committee to oversee and coordinate the performance of this Agreement. Each Party shall appoint two (2) representatives
to the JSC, each of whom is an officer or employee of the applicable Party having sufficient seniority within such Party to make decisions
arising within the scope of the JSC’s responsibilities. Kopin’s representatives shall include its CEO (presently Michael
Murray) as the titular Chairperson of the JSC. The Parties acknowledge that appropriate compensation arrangements for the Chairperson
of the JSC have not been finalized as of the Effective Date, and the Parties shall work together in good faith following the Effective
Date to determine and agree upon reasonable compensation for such role, which may include the entry into a consulting agreement or other
arrangement on mutually acceptable terms. Each Party may replace its JSC representatives upon written notice to the other Party provided
that such replacement meets the requirements set forth above. In addition, the JSC may, upon approval of the JSC, invite subject matter
experts to act as non-voting observers on the JSC.
3.2
Powers; Decision Making. Notwithstanding anything to the contrary in this Agreement, the JSC shall have oversight authority with
respect to the adoption and performance of any Development Plan, including review of the direction, scope, prioritization, and progress
of the Development Work. In the event of any dispute or disagreement between the Parties concerning the implementation and performance
of any Development Plan or any material matter relating to a Development Plan, such dispute shall be submitted to the JSC for resolution.
All decisions of the JSC shall be made by a majority vote, with each representative having one (1) vote; provided, however, that in the
event of a deadlock over a material aspect regarding the implementation and performance of a Development Plan and any matter relating
to changes in a Development Plan, such matter shall be escalated to the Chief Executive Officer (or equivalent senior executive) of each
Party. Such executives shall meet (in person or by videoconference) and use good faith efforts to resolve the deadlock within 10 business
days of such escalation. If the Parties are unable to resolve the deadlock within such period, then, notwithstanding Section 10.1, such
matter shall be finally resolved by arbitration before a panel of three (3) arbitrators. Each Party shall appoint one (1) arbitrator,
and the two party-appointed arbitrators shall appoint the third arbitrator, who shall act as chair. The arbitration shall be conducted
in New York, New York, in the English language, in accordance with the rules of the American Arbitration Association then in effect.
The decision of the arbitrators shall be final and binding on the Parties. All costs associated with such arbitration shall be borne
equally by the Parties.
3.3
Meetings. The JSC shall hold meetings at such times as it elects to do so, but in no event shall such meetings be held less frequently
than once per calendar quarter. Meetings of the JSC may be held in person or by video teleconference.
Page 7 of 22
ARTICLE
IV -INTELLECTUAL PROPERTY RIGHTS
4.1
Ownership of Intellectual Property Rights.
(a)
As between the Parties, Kopin owns all right, title and interest in all Kopin Background Technology, including all Intellectual Property
Rights relating thereto.
(b)
The Parties hereby agree to jointly and equally own all right, title and interest in any Project Technology, including all Intellectual
Property Rights arising therefrom and relating thereto, and to the extent one Party might solely own any Project Technology based on
inventorship each Party hereby agrees to assign, and does hereby assign, an undivided one-half ownership of such right, title, and interest,
to the other Party. Each Party agrees to execute, at no expense, any necessary documents to demonstrate such undivided ownership as reasonably
requested by the other Party.
(c)
Each employee, agent, or independent contractor of a Party or its Affiliates performing any work under a Development Plan will, prior
to commencing such work, be bound by invention assignment obligations, including: (i) promptly reporting any invention, discovery, process,
or other Technology; (ii) presently assigning to the applicable Party all of his or her rights, title, and interests in and to any invention,
discovery, process or other Technology; (iii) cooperating in the preparation, filing, prosecution, maintenance, and enforcement of any
patent or patent application; and (iv) performing all acts and signing, executing, acknowledging, and delivering any and all documents
required for effecting the obligations and purposes of this Agreement. It is understood and agreed that any such invention assignment
agreement need not reference or be specific to this Agreement.
4.2
Licenses to Background Technology. Subject to the terms of this Agreement, Kopin grants a non-exclusive, non-transferable (except
to Affiliates and permitted subcontractors, solely to the extent such Affiliates or subcontractors are required to execute the defined
responsibilities of StableX under this Agreement), non-sublicensable except as expressly permitted herein, royalty-free, worldwide, and
fully paid-up license under Kopin Background Technology to StableX for: (i) conducting the applicable Development Plan in accordance
with its terms and (ii) developing, commercializing and otherwise using the Project Technology solely within StableX’s rights expressly
granted under this Agreement, which includes (x) incorporation into Products and Services for the Commercial Market; and (y) marketing,
distributing and selling such Products and Services in the Commercial Market. For the avoidance of doubt, StableX shall not manufacture,
or have manufactured by any third party, any Products or Services incorporating any Kopin Background Technology or any Project Technology,
and all such Products and Services shall be manufactured exclusively by or on behalf of Kopin, irrespective of field of use, product
category, customer channel or route to market, in each case subject to and in accordance with the terms of the Supply Agreement. For
the purpose of clarity, Products and Services may be used and sold under this Section 4.2; provided that no license is granted under
this Section 4.2 with respect to Kopin Background Technology other than to the extent necessary for the exercise of StableX’s rights
in Project Technology under this Agreement. The license granted under this Section 4.2 shall terminate automatically upon termination
of this Agreement, except to the extent expressly preserved under Section 9.5. For the avoidance of doubt: (a) StableX shall not use
Kopin Background Technology to develop any products or technologies outside the scope of the Project Technology or following termination
of this Agreement, except as expressly permitted under Section 9.5 and (b) under no circumstances shall any right, title or interest
in Kopin Background Technology transfer to StableX, whether by termination, expiration, breach, operation of law or otherwise.
Page 8 of 22
4.3
Disclosure of Technology. Each Party shall use customary and reasonable measures to document and keep contemporaneous written
records of Development Work under the applicable Development Plan, including activities related to conception and reduction to practice
of Project Technology. Each Party shall promptly and fully disclose to the other Party in writing all Project Technology developed, created,
invented, authored, conceived or reduced to practice by or on behalf of such Party. Except as set forth in Section 4.5, each Party is
prohibited from making public disclosures or patent filings about such Project Technology without the prior written consent of the other
Party, which consent will not be unreasonably withheld, conditioned, or delayed.
4.4
Use of Project Technology. Notwithstanding any other provision of this Agreement and irrespective of the co-ownership of Project
Technology, neither Party shall have the right to commercialize or grant a license to any third party for any Project Technology or any
related Intellectual Property Right without the prior written consent of the other Party, which shall not be unreasonably withheld, conditioned,
or delayed; provided that: (a) Kopin shall have the exclusive worldwide rights to commercialize Military, Government and Defense Products
using Project Technology, including for all government, military, defense and government intelligence customers and through contractors,
integrators, resellers and other intermediaries serving such markets; and (b) StableX shall have the exclusive worldwide rights to commercialize
Products and Services using Project Technology in all markets and for all end users other than government, military, defense and government
intelligence customers (the “Commercial Market”). For the avoidance of doubt, each Party may commercialize
Project Technology within its respective exclusive field as set out above without further consent from the other Party.
4.5
Protection of Project Technology.
(a)
The Parties shall cooperate in developing a strategy for identifying and protecting any Project Technology, including, but not limited
to, registering or applying for patent and other intellectual property protection thereon (“Filings”). Kopin
will have the right, in its reasonable discretion, to make any Filings after good faith discussion with StableX in respect of Project
Technology, and Kopin will instruct its counsel to comply with the requirements of this Agreement regarding the protection, maintenance,
and enforcement of such Filings. If Kopin determines to file one or more patent applications, it shall instruct an appropriately qualified
patent attorney to draft, file and prosecute patent application(s), with the input of StableX. All reasonable costs and legal fees incurred
in connection with making, prosecuting, and maintaining Filings will be borne equally by the Parties, unless otherwise agreed in writing
by the Parties with respect to a particular Filing or jurisdiction. For the avoidance of doubt, each Party’s share of such costs
shall be borne separately and shall not be deducted from, credited against, or otherwise included within the Development Funds or any
amounts payable by StableX to Kopin for Development Work under this Agreement. Each Party will cooperate and supply any information that
is reasonably necessary to assist the other in the sharing, preparation, and filing of documentation necessary to protect, maintain,
and enforce the Project Technology. Such cooperation will include, but not be limited to, the execution of any and all documentation
necessary to properly complete any Filing. Such patent counsel shall represent Kopin only, unless the Parties expressly agree otherwise
in writing, and StableX may retain separate counsel at its own expense.
Page 9 of 22
(b)
In the event that Kopin has an opportunity to protect any specific Project Technology or a specific Intellectual Property Right related
thereto in any given jurisdiction and Kopin declines in writing to do so in that jurisdiction, it will provide at least 30 days’
notice to StableX, which will then, in its sole discretion, take whatever action it deems appropriate at its sole cost and expense, including
without limitation, by making such Filings as it deems appropriate, or pursuing or maintaining such Filings, to protect any aspect of
the Project Technology in such jurisdiction.
(c)
Each Party will cooperate and supply any information that is reasonably necessary to assist the other in the sharing, preparation, and
filing of documentation necessary to protect the Project Technology. Such cooperation will include, but not be limited to, the execution
of any and all documentation necessary to properly complete any Filing.
4.6
Enforcement of Rights in Project Technology.
(a)
Primary Right to Enforce/Protect. If either Party believes that any right in the Project Technology is being infringed, misappropriated,
or misused by a third party, such party shall promptly notify the other Party of such infringement or misuse, along with all the relevant
non-privileged facts then in its possession, and Kopin will have the primary right, within sixty (60) days from the date it becomes aware
of the infringement, misappropriation, or misuse, to proceed to protect or enforce the Project Technology, including as to the filing
and maintenance of a claim, demand, investigation, suit or other proceeding against such third party (an “Action”),
as appropriate, regarding such infringement, misappropriation, or misuse. Such Action shall be conducted at the joint cost and expense
of the Parties, with each Party bearing fifty percent (50%) of all out-of-pocket costs and expenses incurred in connection with such
Action. StableX agrees to cooperate as reasonably necessary in support of any such Action. All damages, profits, awards and royalties
obtained in connection with such Action shall be applied first to reimburse the Parties for their respective out-of-pocket costs and
expenses incurred in connection with such Action, and any remaining amounts shall be shared equally between the Parties. If required
by law, Kopin is authorized to pursue the Action in the name of StableX; provided however, that if Kopin takes action in the name
of StableX, it shall indemnify and hold StableX harmless from and against any and all monetary damages, fines, fees, penalties, obligations,
deficiencies, losses and out-of-pocket expenses that StableX incurs or is subject to directly as a result of such Action. StableX agrees
that, if required for standing, it may be joined to such Action involving litigation, arbitration, or such other dispute proceeding.
Kopin shall keep StableX reasonably informed regarding the conduct of any such Action and shall not settle any such Action in a manner
that materially adversely affects StableX’s rights in the Project Technology without StableX’s prior written consent (not
to be unreasonably withheld, conditioned or delayed).
Page 10 of 22
(b)
Secondary Right to Enforce/Protect. If Kopin declines to proceed with an Action within such (60) day period, then StableX may
proceed in its sole discretion, at the joint cost and expense of the Parties, with each Party bearing fifty percent (50%) of all out-of-pocket
costs and expenses incurred in connection with such Action, to file and prosecute such Action in its own name, or if required by law,
jointly with Kopin (and in such event, StableX is hereby authorized to take action in the name of Kopin); provided however, that
if StableX takes action in the name of Kopin, it shall indemnify and hold Kopin harmless from and against any and all monetary damages,
fines, fees, penalties, obligations, deficiencies, losses and out-of-pocket expenses that Kopin incurs or is subject to directly as a
result of such Action. Any damages, profits, awards and royalties recovered in connection with such Action shall be applied first to
reimburse the Parties for their respective out-of-pocket costs and expenses incurred in connection with such Action, and any remaining
amounts shall be shared equally between the Parties. If required for standing, Kopin hereby agrees to be joined to such Action involving
litigation, arbitration, or such other dispute proceeding.
4.7
Third-Party Challenge to Intellectual Property Rights in Project Technology. In the event a third party challenges the (i) validity,
(ii) enforceability, (iii) scope, or (iv) ownership of any of the co-owned Intellectual Property Rights in Project Technology before
any governmental authority with authority to determine the validity, enforceability, scope or ownership of such rights (an “IP
Challenge”), Kopin will have the primary right to manage such IP Challenge; provided that all reasonable out-of-pocket
costs and expenses incurred in connection with such IP Challenge shall be borne equally by the Parties. Kopin shall keep StableX reasonably
informed regarding the conduct of any such IP Challenge and shall not settle or compromise any such IP Challenge in a manner that materially
adversely affects StableX’s rights in the Project Technology without StableX’s prior written consent (not to be unreasonably
withheld, conditioned or delayed). Kopin will instruct its counsel to copy StableX on all relevant correspondence, to provide StableX
copies of draft responses at least 20 days before any deadline to permit StableX to provide input on such proposed responses, and to
review and consider any such input in good faith when finalizing and filing any such responses. If Kopin elects not to manage, or fails
to act sufficiently promptly with respect to, such IP Challenge, StableX shall have the secondary right to manage such IP Challenge on
substantially the same terms, mutatis mutandis.
ARTICLE
V -CONFIDENTIALITY
5.1
Confidentiality. Each Party agrees to use at least the same degree of care to keep confidential all proprietary ideas, plans and
information, including information of a technological or business nature received from the other Party at any time in connection with
this Agreement (“Confidential Information”) as such Party would use to keep confidential its own confidential
information, which degree of care will require at least commercially reasonable efforts. Each Party will only use the other Party’s
Confidential Information in furtherance of the joint development under this Agreement, and is only permitted to disclose the other Party’s
Confidential Information to its employees and agents who are performing work under this Agreement and have a need to know such Confidential
Information. These obligations of confidentiality shall not apply to: (a) information that, at the time of disclosure or thereafter becomes
publicly known through no fault of the receiving Party; (b) information that, at the time of disclosure, is already known to the receiving
Party (other than through the disclosing Party) as evidenced by written documents in its possession at the time; or (c) information that
is developed independently by the receiving Party without reference to or use of the disclosing Party’s Confidential Information.
Page 11 of 22
5.2
Required Disclosure. If Confidential Information is required to be disclosed by the receiving Party pursuant to law, rule or regulation
or a governmental authority, including pursuant to a valid and effective subpoena or court order, such Confidential Information may be
disclosed, provided that the receiving Party being required to disclose the Confidential Information: (i) promptly notifies the disclosing
Party of the disclosure requirement (to the extent legally permitted), (ii) reasonably cooperates with the disclosing Party’s efforts
to resist or narrow the disclosure (including to obtain an order or other reliable assurance that confidential treatment will be accorded
to the disclosing Party’s Confidential Information) at the disclosing Party’s request and expense, and (iii) furnishes only
that portion of the Confidential Information that is legally required to be disclosed.
5.3
Ownership of Confidential Information. The Parties acknowledge that each has a valuable proprietary interest in its Confidential
Information. The Parties acknowledge that neither has any right, title, or interest in the other’s Confidential Information except
as expressly set out in this Agreement.
5.4
Employees, Agents and Consultants. The Parties agree that their respective employees, financial or legal consultants or representatives,
or any Affiliates, having access to any of the other Party’s Confidential Information must be subject to a valid, binding and enforceable
arrangement to maintain the obligations of confidentiality and non-use of this Article V before receiving any such Confidential Information
of a disclosing Party, and the Parties shall be liable for any breach of any such obligation by their employees, consultants, or representatives
or those of their Affiliates. Each Party may disclose the terms of this Agreement in confidence to its professional advisors, attorneys,
insurers, financing sources and investors, and in confidence in connection with bona fide strategic transactional discussions with third
parties.
5.5
Injunctive Relief. The Parties acknowledge that the breach or threatened breach of this Article V may result in irreparable injury
to the disclosing Party and that, in addition to its other remedies, the disclosing Party will be entitled to seek injunctive relief
to restrain any threatened or continued breach of this Article V. The Parties hereby waive any requirement for the posting of a bond
or other security in connection with the granting to the disclosing Party of such injunctive relief.
5.6
Survivability. The provisions of this Article V shall survive the termination of this Agreement.
Page 12 of 22
ARTICLE
VI -SUBCONTRACTORS AND AFFILIATES
6.1
Subcontractors. Each Party agrees that it will perform its activities under a Development Plan through its own employees and may engage
independent contractors or subcontractors without prior consent, provided that such Party remains responsible for such entities’
compliance with the terms of this Agreement and ensures that such contractors are bound by written obligations of confidentiality and,
where applicable, invention assignment, no less protective than those set out in this Agreement.
6.2
Performance by Affiliates. Each Party may exercise its rights and perform its obligations under this Agreement directly or through
one or more of its Affiliates. Each Party’s Affiliates will have the benefit of all rights (including all licenses) of such Party
under this Agreement; provided that any exercise of rights by an Affiliate shall remain subject to the same field, purpose and other
restrictions applicable to such Party. Each Party will remain responsible for the acts and omissions of its respective Affiliates.
ARTICLE
VII -REPRESENTATIONS AND WARRANTIES
7.1
Project Technology. Neither Party makes any representations or warranties of any kind, either express or implied, and assumes
no responsibilities whatsoever with respect to the use, sale, or other disposition by the other Party of that other Party’s products
or services whether or not such products or services relate to Project Technology.
7.2
Kopin Representations and Warranties. Kopin hereby represents and warrants that: (a) Kopin has all necessary consents, approvals,
authorizations, licenses and permits to carry on and conduct the Development Work under each Development Plan and to grant the rights
to StableX as expressly set out herein; (b) Kopin has the right to grant the license under Section 4.2 without conflict with the rights
of any third party, and has secured all necessary and appropriate consents to grant such license; (c) the Kopin Background Technology
is not, to Kopin’s knowledge, the subject of any pending litigation or administrative proceeding that would reasonably be expected
to materially impair Kopin’s ability to grant the rights expressly granted under this Agreement; and (d) Kopin shall perform this
Agreement and exercise its rights hereunder in accordance with applicable law, including without limitation applicable export control
laws.
7.3
StableX Representations and Warranties. StableX hereby represents and warrants that:
7.4
(a) StableX has all necessary consents, approvals, authorizations, licenses and permits to perform its obligations under this Agreement
and to grant the rights to Kopin as expressly set out herein;
Page 13 of 22
7.5
(b) the Convertible Preferred Stock issued to Kopin are in amount equal to 19.99% of the pro forma fully-diluted outstanding shares of
common stock of StableX (excluding shares of common stock underlying unexercised options, warrants and other common stock equivalents),
and the common stock issuable upon conversion thereof, are, or when issued will be, duly authorized, validly issued, fully paid and non-assessable.
The authorized, issued and outstanding capitalization of StableX is as set forth in StableX’s most recently filed periodic reports
with the U.S. Securities and Exchange Commission (the “SEC”), and since the date of such filing, there has
been no change in the capitalization of StableX other than as disclosed in subsequent filings with the SEC or as contemplated by this
Agreement and no Person has any right to acquire any equity securities of StableX other than as disclosed in the SEC Reports or as contemplated
by this Agreement;
7.6
(c) StableX shall perform this Agreement and exercise its rights hereunder in accordance with applicable law;
7.7
StableX is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite
corporate power and authority to own, lease and operate its properties and assets and to carry on its business as now being conducted
and as contemplated by this Agreement;
7.8
the Convertible Preferred Stock to be issued to Kopin pursuant to Section 2.4 has been duly authorized by all necessary corporate action
on the part of StableX, and when issued and delivered in accordance with the terms of this Agreement and the applicable certificate of
designations, such Convertible Preferred Stock will be validly issued, fully paid and non-assessable, free and clear of all liens, encumbrances
and restrictions, other than restrictions on transfer under applicable securities laws and the organizational documents of StableX;
7.9
the shares of common stock to be issued to Kopin upon conversion of the Convertible Preferred Stock have been duly authorized by all
necessary corporate action on part of StableX, and when issued and delivered in accordance with the terms of this Agreement and the applicable
certificate of designations, such shares of common stock will be validly issued, fully paid and non-assessable, free and clear of all
liens, encumbrances and restrictions, other than restrictions on transfer under applicable securities laws and the organizational documents
of StableX;
7.10
StableX has timely filed all required reports, schedules, forms, statements and other documents with the SEC (collectively, the “SEC
Reports”), and each SEC Report, as of the date of its filing (or, if amended or superseded by a subsequent filing, as of
the date of the last such amendment or superseding filing prior to the Effective Date), complied in all material respects with the applicable
requirements of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder, and none of the SEC Reports, as of their respective dates, contained any untrue statement of a material fact
or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading, and the financial statements included in the SEC Reports were prepared in accordance
with United States generally accepted accounting principles applied on a consistent basis throughout the periods involved (except as
may be indicated in the notes thereto or, in the case of unaudited statements, as permitted by applicable SEC rules) and fairly present
in all material respects the financial condition, results of operations and cash flows of StableX as of the dates and for the periods
indicated;
Page 14 of 22
7.11
since the date of the most recent balance sheet included in StableX’s most recently filed periodic report with the SEC prior to
the Effective Date, there has been no event, occurrence, development or circumstance that, individually or in the aggregate, has had
or would reasonably be expected to have a material adverse effect on (i) the business, assets, liabilities, financial condition or results
of operations of StableX and its subsidiaries, taken as a whole, or (ii) StableX’s ability to consummate the transactions contemplated
by this Agreement and to perform its obligations hereunder; and
7.12
the execution, delivery and performance of this Agreement by StableX and the consummation of the transactions contemplated hereby do
not and will not (i) conflict with or violate any provision of the certificate of incorporation, bylaws or other organizational documents
of StableX, (ii) conflict with, or constitute a default (or an event that, with notice or lapse of time or both, would become a default)
under, result in the creation of any lien upon any of the properties or assets of StableX, or give to others any rights of termination,
amendment, acceleration or cancellation of, any material agreement, contract, lease, license or instrument to which StableX is a party
or by which any property or asset of StableX is bound or affected, in each case as disclosed or filed as an exhibit in the SEC Reports,
or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws)
applicable to StableX or by which any property or asset of StableX is bound or affected.
7.13
EXCEPT AS EXPRESSLY WARRANTED HEREIN, EACH PARTY DISCLAIMS ALL OTHER WARRANTIES, EITHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING WITHOUT
LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY AND OF FITNESS FOR A PARTICULAR PURPOSE, REGARDING THE JOINT DEVELOPMENT UNDER THIS
AGREEMENT OR ANY RESULTING PRODUCTS OR PROCESSES ARISING THEREFROM OR ANY OTHER MATTER RELATING TO THIS AGREEMENT.
ARTICLE
VIII -LIABILITY AND INDEMNIFICATION
8.1
Indemnification. Each Party shall defend, indemnify and hold harmless the other Party and its directors, officers, employees and
agents (“Indemnitees”) from and against any claim, suit, or action brought by a third party against any such
Indemnitees, and shall pay all losses, damages, liabilities, judgments, fines, penalties, costs and expenses (including reasonable attorneys’
fees and litigation costs) payable to such third party, to the extent arising out of: (a) the gross negligence or willful misconduct
of such Party; (b) the material breach of this Agreement by such Party; (c) the violation of applicable law by such Party; (d) personal
injury, death or damage to tangible property caused by such Party’s gross negligence; or (e) any claim that materials, technology
or Products supplied by such Party under this Agreement infringe or violate any third-party intellectual property rights, except to the
extent such claim arises from (i) modifications by the other Party or (ii) use outside the scope of this Agreement.
Page 15 of 22
8.2
Process. The Party seeking indemnification from a Claim shall notify the other Party promptly upon becoming aware of the Claim
(provided that failure to promptly notify shall not relieve the indemnifying Party of its obligation to defend the Claim unless such
failure materially prejudices its ability to defend the Claim) and permit the other Party to control the defense and settlement of the
Claim, and shall reasonably cooperate with the indemnifying Party in such efforts (at the indemnifying Party’s request and expense).
The indemnified Party may not consent to the settlement or entry of judgment in such Claim without the indemnifying Party’s prior
written consent. The indemnified Party may participate in the defense of the Claim with its own counsel at its own expense.
8.3
Insurance. During the term of this Agreement, each Party shall maintain insurance coverage of the kind and in the amounts customary
for similarly situated companies operating in its industry and performing obligations of a similar nature.
8.4
No Special Damages. NOTWITHSTANDING ANYTHING TO THE CONTRARY IN THIS AGREEMENT, AND EXCEPT WITH RESPECT TO LOSSES PAYABLE BY A
PARTY TO A THIRD PARTY PURSUANT TO ITS INDEMNIFICATION OBLIGATIONS IN SECTION 8.1 AND EXCEPT FOR DAMAGES CAUSED BY A PARTY’S BREACH
OF ARTICLE V (CONFIDENTIALITY), NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY OR ANY OF ITS AFFILIATES FOR ANY SPECIAL, PUNITIVE,
INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES, OR FOR LOST PROFITS OR LOST REVENUES, WHETHER UNDER ANY CONTRACT, WARRANTY, NEGLIGENCE,
STRICT LIABILITY OR OTHER LEGAL OR EQUITABLE THEORY, AND WHETHER OR NOT SUCH DAMAGES WERE FORESEEABLE.
8.5
Limitation of Liability. Except with respect to (i) a Party’s breach of Article V (Confidentiality), (ii) a Party’s indemnification
obligations under Section 8.1, and (iii) a Party’s fraud or willful misconduct, in no event shall a Party’s total aggregate
liability under this Agreement exceed the greater of: (a) the total amounts paid or payable by StableX under this Agreement; and (b)
$15,000,000.
ARTICLE
IX -TERM AND TERMINATION
9.1
Term. This Agreement shall commence on the Effective Date and shall remain in full force and effect until terminated by either
Party in accordance with this Article IX.
9.2
Termination for Material Breach. In the event that a Party materially breaches any provision of this Agreement, the non-breaching
Party shall have the right to terminate this Agreement by serving on such breaching Party sixty (60) days written notice specifying such
breach; provided, however, that the breaching Party shall have the right to cure such breach during such notice period if such breach
is capable of cure.
Page 16 of 22
9.3
Termination for Bankruptcy Event. Either Party may terminate this Agreement immediately upon written notice to the other Party
if a Bankruptcy Event occurs with respect to such other Party. All rights and licenses granted under or pursuant to this Agreement are,
and shall otherwise be deemed to be, for purposes of Section 365(n) of Title 11 of the United States Code and other similar laws in any
jurisdiction outside the U.S. (collectively, the “Bankruptcy Laws”), licenses of rights to “intellectual
property” as defined under the Bankruptcy Laws. If a case is commenced during the Term by or against a Party under Bankruptcy Laws
then, unless and until this Agreement is rejected as provided in such Bankruptcy Laws, such Party (in any capacity, including debtor-in-possession)
and its successors and assigns (including a trustee) shall perform all obligations provided in this Agreement to be performed by such
Party. If this Agreement is rejected as provided in the Bankruptcy Laws and a Party in its capacity as a licensee elects to retain its
rights granted hereunder as provided in the Bankruptcy Laws, then the other Party (in any capacity, including debtor-in-possession) and
its successors and assigns shall promptly provide to the Party exercising its license rights all materials and embodiments of such intellectual
property reasonably required to enable such Party to exercise its rights under this Agreement. Without limiting the foregoing and subject
to applicable Bankruptcy Laws, the Parties acknowledge and agree that all licenses and rights granted under this Agreement are intended
to be, and shall be deemed to be, licenses of rights to “intellectual property” for purposes of Section 365(n) of the United
States Bankruptcy Code (and any analogous provisions of applicable law). In the event that this Agreement is rejected by a Party in a
case under Bankruptcy Laws, the other Party, as a licensee, shall be entitled to elect to retain its rights under this Agreement as provided
in Section 365(n), and the rejecting Party (and any trustee, receiver or debtor-in-possession) shall, upon written request, promptly
provide to the other Party all embodiments of such intellectual property and other materials reasonably necessary to enable the other
Party to exercise its rights, including source code (if applicable), technical documentation, specifications, know-how and other information.
Each Party further agrees that it shall not interfere with the other Party’s exercise of its rights under this Agreement, including
any rights retained pursuant to Section 365(n), following any such rejection.
9.4
Performance Related Termination. Either Party may terminate this Agreement upon written notice if the other Party has materially
failed to perform its obligations under the applicable Development Plan; provided that: (a) such failure is measured against the objective
criteria set out in the applicable Development Plan; (b) the non-performing Party has been given written notice specifying such failure
in reasonable detail; and (c) the non-performing Party has failed to cure such failure, or to propose and implement a reasonable remediation
plan, within thirty (30) days following such notice. For the avoidance of doubt, a Party may not terminate this Agreement solely on the
basis that the Project Technology may not result in a commercially viable product. For the avoidance of doubt, a material failure by
StableX to operate in the Ordinary Course of Business to the extent that it materially impacts the Project shall constitute a failure
to perform for the purposes of this Section 9.4.
9.5
Effect of Termination and Expiration.
(a)
Termination for Breach or Bankruptcy (by non-breaching Party). In the event of termination of this Agreement pursuant to Section 9.2
or Section 9.3: (i) the non-breaching Party shall retain its rights in the Project Technology in accordance with this Agreement; and
(ii) to the extent the terminating Party is Kopin and such termination arises from StableX’s breach, failure to fund amounts due
under this Agreement, or Bankruptcy Event, Kopin shall have the right to continue to develop, use and commercialize the Project Technology
without restriction, and StableX shall assign (and hereby assigns) to Kopin all of its right, title and interest in and to the Project
Technology.
Page 17 of 22
(b)
Termination following Performance Issues. In the event of termination pursuant to Section 9.4: (i) where termination arises from Kopin’s
uncured material breach, StableX shall retain a non-exclusive, non-transferable license to use the Project Technology within its permitted
Field, subject to the terms of this Agreement; and (ii) where termination arises from StableX’s failure to perform its obligations
(including failure to fund), the consequences set out in Section 9.5(a) shall apply.
(c)
Post-Demo Position. If StableX is deemed not to proceed with the Project pursuant to Section 2.3(e) then: (i) Kopin shall have the right
to continue the development, commercialization and exploitation of the Project Technology in any commercial field, irrespective of any
field or market restrictions otherwise applicable to StableX under this Agreement; and (ii) the Parties shall discuss in good faith whether
StableX should retain a limited license or economic participation (such as a royalty) in respect of the Project Technology, taking into
account the level of funding actually provided by StableX and the circumstances in which the Project did not proceed.
(d)
Background Technology. Under no circumstances shall ownership of Kopin Background Technology transfer to StableX. Any license granted
under Section 4.2 shall terminate upon termination of this Agreement, except to the extent necessary to give effect to any surviving
rights in Project Technology under this Section 9.5.
(e)
Accrued Rights. Termination shall not affect any rights or obligations accrued prior to the effective date of termination, including
any payment obligations.
(f)
Failure to Proceed. For the purposes of this Section 9.5, after the Negotiation Period of 1 year pursuant to Section 2.3(e), the following
shall be deemed a failure by StableX to proceed with the Project: (i) failure to fund amounts when due under Section 2.3; (ii) election
not to proceed following a Successful Demo; (iii) failure to engage in good faith discussions under Section 2.3(e); (iv) failure to operate
in the Ordinary Course of Business in a manner that materially impacts the Project; or (v) a Bankruptcy Event or cessation of active
operations. In each such case, Kopin shall have the rights set out in Section 9.5(a).
9.6
Survival. The provisions of Articles I, IV, V, VIII, X and Section 9.5 shall survive termination of this Agreement.
ARTICLE
X -MISCELLANEOUS
10.1
Rights Amendment Plan. StableX covenants and agrees that, concurrently with the execution and delivery of this Agreement, StableX
shall execute and deliver an amendment to that certain Rights Agreement (the “Rights Plan”), dated as of July
31, 2025, by and between StableX and Equiniti Trust Company, LLC, as rights agent (“Rights Agent”), whereby
the board shall have the authority to designate any Person (as defined in the Rights Plan) as an “Exempt Person” (or similar
designation) under the Rights Plan by adopting resolutions waiving the applicability of the Rights Plan to such Person. The board has
adopted such resolutions in connection with the transactions contemplated by this Agreement and, accordingly, that the Rights Plan shall
not apply to Kopin or any of its Affiliates or any future acquiror of Kopin in connection with the transactions contemplated by this
Agreement or the other Transaction Agreements, and such waiver remains in full force and effect as of the date hereof.
10.2
Applicable Law. This Agreement shall be governed by and interpreted in accordance with the laws of the State of Delaware, without
reference to its choice of law provisions. The Parties agree that, except as otherwise provided in this Agreement, should there be a
dispute arising from or related to this Agreement, it shall be brought before the courts in New York. The Parties hereby consent to the
New York courts’ personal jurisdiction and waive any objection on the basis of inconvenient forum or venue.
Page 18 of 22
10.3
Notices. All notices shall be in writing and delivered personally, by overnight express courier, or by registered or certified
mail, postage prepaid, to the following addresses of the respective Parties (or to any other address given by any Party to the other
Party by proper notice):
Kopin:
Kopin
Corporation
125 North Drive
Westborough, MA 01581
Attn:
Michael Murray
With
a copy (which will not constitute notice) to:
Morgan
Lewis & Bockius LLP
One
Federal Street
Boston,
MA 02110
Attn:
John J. Concannon
StableX:
StableX
Technologies, Inc.
1185 Avenue of the
Americas
New York, New York
10036
Attention:
Josh Silverman
With
a copy (which will not constitute notice) to:
Haynes
and Boone, LLP
30 Rockefeller Plaza
Floor 22
New
York, New York 10112
Attn:
Greg Kramer
Notices
shall be effective upon receipt if personally delivered, on the date of receipt if by express courier, or on the third (3rd)
business day following the date of mailing if actually received. Any change of address or contact name of a Party shall be promptly communicated
in writing to the other Party.
Page 19 of 22
10.4
Assignment. Neither Party may assign, transfer or otherwise dispose of any of its rights or obligations under this Agreement without
the prior written consent of the other Party, such consent not to be unreasonably withheld, conditioned or delayed, and any attempted
assignment in breach of this Section shall be void ab initio; provided, however, that: (a) Kopin may assign this Agreement in its entirety,
without consent, in connection with a bona fide sale of all or substantially all of its business, assets or equity to which this Agreement
relates, or to an Affiliate, upon written notice to StableX; (b) StableX may assign this Agreement in its entirety only with Kopin’s
prior written consent in connection with a bona fide sale of all or substantially all of its business, assets or equity to which this
Agreement relates, or to an Affiliate, such consent not to be unreasonably withheld, conditioned or delayed; and (c) no assignment (including
by way of merger, acquisition or sale of equity) shall be permitted to a direct competitor of the other Party without that Party’s
prior written consent. Any permitted assignee shall assume all obligations of the assigning Party under this Agreement. No assignment
shall relieve the assigning Party of responsibility for the performance of any accrued obligations hereunder prior to the effective date
of such assignment. For the avoidance of doubt, a change of control of a Party shall be deemed to be an assignment for the purposes of
this Section. In the event of a change of control of StableX, Kopin shall have the right to terminate this Agreement upon written notice.
In the event of a change of control of Kopin, this Agreement shall continue in full force and effect and shall be binding on the successor
entity in accordance with this Section.
10.5
Force Majeure. Except for the making of required payments, if the performance of, or any obligation under, this Agreement is prevented,
restricted, or interfered with by reason of fire, flood, explosion, or other casualty, accident, or act of God; general strikes or labor
disturbances; war, whether declared or not, or other violence; sabotage; or any law, order, proclamation, regulation, ordinance, demand,
or requirement of any government agency or court, or other cause beyond a Party’s reasonable control, the affected Party, upon
giving prompt notice to the other Party, shall be excused from such performance to the extent and for the duration of such prevention,
restriction, or interference. The affected Party shall use its commercially reasonable efforts to avoid or remove such cause of non-performance
or to limit the impact of the event on such Party’s performance and shall continue performance with commercially reasonable efforts
whenever such cause(s) are sufficiently diminished or removed.
10.6
Publicity. Each Party agrees not to directly or indirectly issue any press release or make any public announcement relating to
the subject matter or terms of this Agreement without the prior written consent of the other Party, such consent not to be unreasonably
withheld, conditioned or delayed, except as a Party believes in good faith is required by applicable law, rule, or regulation, including
any listing or trading requirement concerning its publicly-traded securities (in which case, the Party seeking to disclose the information
shall give reasonable notice to the other Party of its intent to make such a disclosure and afford the other Party an opportunity to
review and comment on such notice, if feasible).
10.7
Entire Agreement; Independent Counsel. This Agreement along with the Transaction Agreements sets forth the entire agreement between
the Parties and supersedes all previous agreements and understandings, whether oral or written, between the Parties with respect to the
subject matter of this Agreement. The Agreement may be executed in counterparts or electronically, each of which is deemed an original
and the same instrument. Each Party has had an opportunity to consult with counsel in negotiating this Agreement and the Parties have
jointly drafted and negotiated this Agreement. As such, the interpretation or construction of any provisions in this Agreement will not
be strictly construed against either Party.
Page 20 of 22
10.8
Amendment. This Agreement may not be modified or amended except by a written agreement signed by an authorized representative
of each Party.
10.9
Severability. The provisions of this Agreement are severable. If any provision in this Agreement is found or held to be invalid
or unenforceable in any tribunal, then the meaning of that provision shall be construed, to the extent feasible, to render the provision
enforceable, and the other provisions shall be unaffected, and the Parties shall negotiate in good faith a valid and enforceable provision
that most closely reflects the original intent.
10.10
Non-Waiver. No waiver of any term, provision or condition of this Agreement, whether by conduct or otherwise in any one or more
instances, shall be deemed to be or construed as a further or continuing waiver of any such term, provision or condition or of any other
term, provision or condition of this Agreement. Waivers must be in writing signed by the waiving Party to be enforceable.
10.11
Relationship of Parties. Each of the Parties hereto is an independent contractor and nothing herein shall be deemed to constitute
the relationship of partners, joint venturers, nor of principal and agent between the Parties hereto, and nothing in this Agreement shall
be deemed to create any partnership, joint venture or fiduciary relationship between the Parties.
10.12
Succession. This Agreement shall be binding upon and inure to the benefit of the Parties and their respective permitted successors
and assigns.
10.13
Authority. Each Party has the full right, power, and authority to execute and deliver this Agreement and to perform its terms.
The execution and delivery of this Agreement and the consummation of the transactions required by this Agreement will not violate or
conflict with: (i) any charter provision or bylaw of either Party or any of its Affiliates, or (ii) any agreement with any third party.
Each Party has taken all required corporate actions to approve and adopt this Agreement. Each Party represents and warrants that the
person or persons executing this Agreement on its behalf are duly authorized and empowered to do so.
10.14
Construction. The Parties have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity
or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties.
10.15
Standstill. During the Term of this Agreement and for a period of three (3) years thereafter, StableX and its Affiliates shall
not, directly or indirectly: (a) acquire beneficial ownership of more than 9.9% of the outstanding voting securities of Kopin; (b) make
or participate in any tender offer, exchange offer, merger or other business combination involving Kopin; (c) solicit proxies or consents
with respect to securities of Kopin; or (d) otherwise seek to obtain control of Kopin other than through a transaction approved by Kopin’s
board of directors. Any proposed transaction involving a change of control of Kopin shall be initiated and conducted solely through Kopin’s
board of directors or its authorised representatives.
Page 21 of 22
IN
WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed as of the Effective Date.
KOPIN CORPORATION
STABLEX TECHNOLOGIES, INC.
By: /s/
Michael Murray
By:
/s/ Joshua Silverman
Name: Michael
Murray
Name:
Josh Silverman
Title: President
and CEO
Title:
Executive Chairman
Page 22 of 22
EX-10.2
EX-10.2
Filename: ex10-2.htm · Sequence: 12
Exhibit 10.2
EXECUTION
VERSION
COMMERCIAL
SUPPLY Agreement
This
Commercial Supply Agreement (the “Agreement”), dated as of April 27, 2026 (“Effective Date”), is
entered into by and between StableX Technologies, Inc., a Delaware corporation, located at 1185 Avenue of the Americas, New York, New
York 10036 (“StableX”), and Kopin Corporation, a Delaware corporation, with offices at 125 North Drive, Westborough,
MA 01581 (“Kopin,” and together with StableX, the “Parties”, and each, a “Party”).
Recitals
WHEREAS,
Kopin is an electronics manufacturer specializing in high-resolution microdisplays and optical components;
WHEREAS,
the Parties have executed and delivered that certain Joint Development & License Agreement of even date herewith (the “Development
Agreement”) pursuant to which the Parties will develop and commercialize one or more, and own or control rights to the Products
(as defined below) and intend for this agreement to be the commercial supply agreement referred to therein.
WHEREAS,
Kopin will use its procurement, engineering and manufacturing expertise to produce the Products and StableX wishes to purchase the Products
from Kopin and resell these Products to End Users, in accordance with the terms and conditions of this Agreement; and
NOW,
THEREFORE, in consideration of the mutual covenants, terms, and conditions set out in this Agreement, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:
ARTICLE
I
Definitions
“Affiliate”
of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or
is under common control with, such Person. The term “control” (including the terms “controlled by” and “under
common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management
and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.
“Business
Day” means any day except Saturday, Sunday, or a federal holiday.
“Defective”
means, with respect to a Product, a failure to conform in any material respect to the warranties in Section 15.02 (Limited Product Warranty).
“Defective
Product(s)” means Products that are Defective. For the avoidance of doubt, where a Product is accepted under Section 9.04 (Inspection),
any failure that would have been reasonably apparent on visual inspection at the time of delivery shall not be treated as a Defect unless
it constitutes a breach of the warranties in Section 15.02.
“End
User” means the final purchaser that has acquired a Product, directly or indirectly, for its own or its Affiliate’s internal
use and not for resale, remarketing, or distribution. For the avoidance of doubt, End Users shall not include any purchaser that is a
Governmental Authority or that is acquiring Products for use in connection with military, defense or automotive applications.
“Governmental
Authority” means any federal, state, local, or foreign government or political subdivision thereof, or any agency or instrumentality
of such government or political subdivision, or any self-regulated organization or other non-governmental regulatory authority or quasi-governmental
authority (to the extent that the rules, regulations or orders of such organization or authority have the force of Law), or any arbitrator,
arbitration panel, court, or tribunal of competent jurisdiction.
“Inability
to Supply Event” means the occurrence of any of the following: (a) Kopin’s failure
to deliver at least 90% of the quantity of Products ordered by StableX in an accepted Purchase Order within the applicable Lead Times
(plus a grace period of 30 days), in each case other than where such failure is due to (x) supply constraints, component shortages or
manufacturing limitations, or (y) compliance with Kopin’s other contractual, legal or regulatory obligations; (b) Kopin’s
written notice to StableX that Kopin will be unable to fulfill a material portion of any Purchase Order; (c) Kopin’s failure, over
two (2) consecutive quarters, to use commercially reasonable efforts to maintain manufacturing capacity sufficient to support StableX’s
forecasted requirements, as agreed between the Parties; or (d) Kopin’s discontinuation of manufacturing operations for the Products
for a period of sixty (60) or more consecutive days (other
than for scheduled maintenance disclosed to StableX in advance); provided, however, that none of the foregoing shall constitute an Inability
to Supply Event to the extent directly caused by: (i) a Force Majeure Event (as defined below); (ii) StableX’s failure to perform
any of its obligations under this Agreement; (iii) Kopin’s compliance with any contractual, legal or regulatory obligation to prioritize
supply to governmental, military or defense customers; (iv) any increase in Purchase Orders or forecasted requirements by StableX that
is not consistent with the most recent forecast provided to Kopin or that exceeds agreed ramp-up parameters between the Parties; or (v)
any Purchase Order or requested delivery date that does not comply with the applicable Lead Times.
“Law”
means any statute, law, ordinance, regulation, rule, code, constitution, treaty, common law, any order, writ, judgment, injunction, decree,
stipulation, award, or determination entered by or with any Governmental Authority, or other requirement or rule of law of any Governmental
Authority.
“Person”
means any individual, partnership, corporation, trust, limited liability entity, unincorporated organization, association, Governmental
Authority or any other entity.
“Personnel”
means agents, employees, or subcontractors engaged or appointed by Kopin or StableX.
“Products”
means one or more products incorporating the Project Technology developed under the Development Agreement.
“Project
Technology” has the meaning set forth in the Development Agreement.
“Purchase
Order” means a purchase order issued by StableX for Products in accordance with this Agreement.
“Representatives”
means, with respect to a Party, its Affiliates and its and their respective employees, officers, directors, partners, agents, attorneys,
and professional advisors.
“Product
Specifications” means the acceptance criteria agreed in writing by the Parties, including any applicable numerical limits,
ranges or other objective criteria for the Products, as set forth in the Development Agreement or otherwise expressly agreed in writing
by the Parties.
“Territory”
means the entire world, excluding any country or territory that is subject to comprehensive trade or economic sanctions, embargoes or
similar restrictions administered or enforced by the United States (including by the U.S. Department of the Treasury’s Office of
Foreign Assets Control, the U.S. Department of State or the U.S. Department of Commerce).
“Warranty
Period” means a period of 12 months from delivery of the relevant Product to the End User.
2
ARTICLE
II
Appointment OF StableX
Section
2.01 Exclusive Appointment and Exclusive Supply. Kopin hereby appoints StableX,
and StableX accepts the appointment, to act as an exclusive seller of Products to End Users located in the Territory during the Term
solely in accordance with the terms and conditions of this Agreement. Kopin may, directly or indirectly, in its sole discretion: (i)
sell the Products to any Person (including resellers, retailers and End Users) outside the scope of StableX’s exclusivity under
this Agreement; (ii) sell Products directly to Government Authorities; and (iii) manufacture Products in any location (including within
the Territory) for sale or resale to such Persons. StableX will purchase its entire requirements from Kopin under this Agreement except
following an Inability to Supply Event, provided that an Inability to Supply Event shall not occur in the event a Force Majeure Event
is in effect. Notwithstanding the foregoing, Kopin shall retain exclusive supply and distribution rights with respect to the sale of
Products to the automotive, military and defence markets, and such markets shall be excluded from the scope of StableX’s appointment
hereunder. For the avoidance of doubt, Kopin shall have the right, in its sole discretion, to prioritise supply to such markets.
Section
2.02 Limited Contingent StableX Right to Manufacture.
In the event of an Inability to Supply Event as defined in this Agreement, and subject to the Parties
agreeing in writing the scope and duration of such event, StableX may, solely to the extent necessary to address such Inability to Supply
Event, manufacture Products in the Territory for sale or resale in the Territory. Any such right shall be limited to the duration and
quantities reasonably required to address the applicable Inability to Supply Event and shall terminate immediately upon Kopin’s
ability to resume supply. StableX shall use commercially reasonable efforts to ensure that no Affiliate, distributor, sub-contractor,
End User, or other agent sells, leases, or otherwise transfers, or assists any third party to do the foregoing, outside the Territory.
Kopin shall use commercially reasonable efforts to remedy the applicable Inability to Supply Event as soon as reasonably practicable.
If such Inability to Supply Event continues for a period of six (6) months (taking into account the applicable Lead Times), the Parties
shall discuss in good faith appropriate modifications to this Agreement, including with respect to exclusivity and supply arrangements.
ARTICLE
III
No Franchise or Business Opportunity Agreement
Section
3.01 No Franchise or Business Opportunity Agreement. The
Parties to this Agreement are independent contractors and nothing in this Agreement shall be deemed or constructed as creating a joint
venture, partnership, agency relationship, franchise, or business opportunity between Kopin and StableX. Neither Party, by virtue of
this Agreement, will have any right, power, or authority to act or create an obligation, express or implied, on behalf of the other Party.
Each Party assumes responsibility for the actions of their personnel under this Agreement and will be solely responsible for their supervision,
daily direction and control, wage rates, withholding income taxes, disability benefits, or the manner and means through which the work
under this Agreement will be accomplished. Except as provided otherwise in this Agreement, StableX has the sole discretion to determine
its methods of operation, accounting practices, the types and amounts of insurance StableX carries, personnel practices, advertising
and promotion, customers, and service areas and methods. If any provision of this Agreement is deemed to create a franchise relationship
between the Parties, then the Parties shall negotiate in good faith to modify this Agreement so as to effect the Parties’ original
intent as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as a
product seller agreement and not a franchise agreement.
ARTICLE
IV
Terms of Agreement Prevail Over StableX’s Purchase Order
Section
4.01 Terms of Agreement Prevail Over StableX’s Purchase Order. This
Agreement is expressly limited to the terms set out herein. The terms of this Agreement shall prevail over any terms or conditions contained
in any other documentation related to the subject matter of this Agreement and expressly exclude any additional or conflicting terms
and conditions contained in any Purchase Order or other document issued by StableX, whether or not such document is acknowledged or accepted
by Kopin.
3
ARTICLE
V
General
StableX Performance Obligations
Section
5.01 Marketing and Reselling Products. StableX shall, at its own expense:
(a) exert
commercially reasonable efforts to market, advertise, promote, and resell the Products to End Users located in the Territory consistent
with good business practice, in each case using its best efforts to maximize the sales volume of the Products;
(b) have
sufficient knowledge of the industry and products competitive with each Product (including specifications, features and benefits) so
as to be able to explain in detail to the End Users information on standard protocols and features of each Product;
(c) observe
all reasonable directions and instructions given to it by Kopin in relation to the marketing, advertisement, promotion and proper use
of the Products to the extent that these marketing materials, advertisements, or promotions refer to the Products;
(d) divulge,
in any and all contact between StableX and any End User, StableX’s full legal name, trade name, or both;
(e) market,
advertise, promote and resell Products and conduct business in a manner that reflects favorably at all times on Products and the good
name, goodwill, and reputation of Kopin; and
(f) promptly
notify Kopin of any complaint about any Product or its use of which StableX becomes aware.
Section
5.02 Authority to Perform Under this Agreement. StableX
shall, at its own expense, obtain and maintain required certifications, credentials, licenses, and any other permits necessary to conduct
business in accordance with this Agreement and applicable Law.
Section
5.03 Limited End User Support. During the Term
of this Agreement StableX shall, at its own expense:
(a) ensure
that an adequate number of trained, capable, and qualified technical Personnel with sufficient knowledge of the Product are available
during normal business hours to assist End Users; and
(b) respond
to the End Users regarding the general operation and use of the Product, including, without limitation:
(i) acting
as a liaison between the End User and Kopin in matters requiring Kopin’s participation;
(ii) providing
general Product information and configuration support on standard protocols and features; and
(iii) collecting
relevant technical problem identification information and relaying the same to Kopin or its designees.
Except
as expressly authorized by Kopin in writing or as otherwise set out in this Agreement or in a separate written agreement with Kopin,
StableX may not service, repair, modify, alter, replace, reverse engineer, or otherwise change the Products it sells to End Users.
4
Section
5.04 Prohibited Acts. Notwithstanding anything to the contrary in this Agreement,
neither StableX nor StableX’s Personnel shall directly or indirectly: (a) make any representations, warranties, guarantees, claims
or commitments on behalf of Kopin or with respect to the Products, except those expressly authorized by Kopin or as are set forth in
Kopin’s literature or other promotional materials that have been authorized by Kopin in writing for distribution to third parties;
(b) engage in any unfair, anti-competitive, misleading, or deceptive practices with respect to the Products, Kopin, or any third party,
including, without limitation, product disparagement and any trade libel of Kopin or any third party; or (c) during the Term, market,
advertise, promote, sell, or distribute other substantially similar products or products that materially compete with the Products to
any End Users in the Territory, except to the extent this restriction is prohibited by applicable Law, in which case StableX must promptly
notify Kopin of such restriction. Whether a product or product line is deemed to compete with the Products shall be determined acting
reasonably by Kopin.
ARTICLE
VI
Kopin
Obligations
Section
6.01 Kopin Obligations. During the Term, Kopin
shall:
(a) provide
such information and support as Kopin reasonably determines is appropriate, upon reasonable request by StableX, regarding the marketing,
advertising, promotion, and sale of Products sold to StableX under this Agreement; and
(b) make
available to StableX, at Kopin’s discretion, materials, such as samples, prototypes, documentation, brochures, and other items
that Kopin, in its sole discretion, deems necessary or appropriate for the promotion and sale of the Products in the Territory (“Materials”),
which may include, for example, samples, prototypes, documentation, brochures, and other promotional materials. Kopin shall retain all
rights, title, and interest in and to all Materials. StableX shall promptly return all Materials to Kopin upon Kopin’s request
or on the expiration or earlier termination of this Agreement as provided for in Article XIV (Term; Termination).
ARTICLE
VII
MANUFACTURING RAMP-UP and COOPERATION
The
Parties acknowledge that, as of the Effective Date, the Products remain under development and that the final specifications, costs, required
components, and tooling necessary for commercial-scale manufacturing have not yet been determined. The Parties agree to cooperate in
good faith to develop and implement a mutually acceptable manufacturing ramp-up plan (the “Ramp-Up Plan”), which shall
include: (a) identification and procurement of tooling, equipment, and other capital assets required for factory production of the Products;
(b) qualification and sourcing of components and raw materials necessary for manufacture of the Products; (c) establishment of a timeline
for the commencement and scaling of commercial manufacturing operations; (d) a detailed budget setting forth the estimated costs associated
with each element of the Ramp-Up Plan (the “Ramp-Up Budget”); (e) the pricing to be charged by Kopin to StableX for
the Products (the “Supply Price”), which pricing shall be determined based on Kopin’s actual costs of production
plus a reasonable profit margin; and (f) suggested retail pricing or pricing guidelines for the sale of Products by StableX to End Users
(the “End User Price”), which pricing shall take into account the Supply Price and StableX’s costs of distribution,
marketing, and sales, and shall be designed to enable StableX to achieve a reasonable profit margin on such sales. The Parties shall
use commercially reasonable efforts to seek to finalize the Ramp-Up Plan and Ramp-Up Budget within one (1) year following the completion
of the product development phase under the Development Agreement. Each Party shall designate a representative to serve as the primary
point of contact for matters relating to the Ramp-Up Plan, and such representatives shall meet on a regular basis (and no less frequently
than monthly) to review progress, address issues, and coordinate activities. In addition, the Parties shall cooperate in good faith with
respect to financing the manufacturing ramp-up, including by sharing information reasonably requested by the other Party or by potential
financing sources and participating in discussions with lenders or investors, and taking such other actions as the Parties may agree
in writing are appropriate to support efforts to obtain financing for the implementation of the Ramp-Up Plan. The Parties agree that
as part of the manufacturing ramp-up, the Parties will negotiate creating manufacturing capacity dedicated to StableX designed to reduce
the likelihood of an Inability to Supply Event arising out of Kopin’s need to comply with any other contractual, legal or regulatory
obligations, including the need to prioritize supply to governmental, military or defense customers. The Parties further agree to negotiate
the Supply Price and End User Price in good faith, with the mutual objective of ensuring that both Kopin and StableX are able to realize
a reasonable return on their respective investments in the development, manufacture, and distribution of the Products. The Parties shall
review the Supply Price and End User Price on a periodic basis (and no less frequently than annually), taking into account changes in
production costs, market conditions, and other relevant factors.
5
ARTICLE
VIII
Orders Procedure
Section
8.01 Purchase Order. StableX shall issue all Purchase
Orders to Kopin in written form via email or using the notice procedures identified herein under Section 20.02, or such other address
Kopin may specify from time to time. By placing a Purchase Order, StableX makes an offer to purchase Products under the terms and conditions
of this Agreement, and on no other terms. Any purported variations made to the terms and conditions of this Agreement by StableX in any
Purchase Order are void and have no effect.
Section
8.02 Purchase Order Transaction Terms. StableX
shall specify the following information in each Purchase Order:
(a) a
list of Products to be purchased, including make/model number;
(b) quantities
of each Product ordered; and
(c) (c)
requested delivery date, provided that such requested delivery date complies with the applicable lead times agreed between the Parties
from time to time (the “Lead Times”).
Section
8.03 Binding Effect. A Purchase Order shall become binding on Kopin only upon written
acceptance by Kopin, which acceptance shall not be unreasonably withheld and shall be subject to availability, capacity, compliance with
this Agreement and consistency with the Lead Times. Kopin shall accept or reject each Purchase Order within ten (10) Business Days of
receipt; failure to respond within such period shall be deemed acceptance, provided that any such deemed acceptance shall be subject
to the Lead Times.
Section
8.04 Forecasts. Beginning on the first day of the calendar quarter immediately following the
achievement of a successful demonstration prototype under the Development Agreement, StableX shall provide Kopin with a forecast of its
anticipated demand for the Products on a semi-annual basis. All such forecasts are provided for planning purposes only and shall be non-binding.
ARTICLE
IX
Shipment and Delivery
Section
9.01 Shipment. Unless expressly agreed to by the
Parties in writing, StableX shall select the method of shipment of and the carrier for the Products. Kopin may, in its sole discretion,
without liability or penalty, provide partial shipments of Products to StableX. Each shipment constitutes a separate sale, and StableX
shall pay for the units provided to the carrier for shipping, whether the shipment is in whole or partial fulfillment of a Purchase Order.
StableX shall be responsible for any loss or damage to Products occurring in transit following delivery to the carrier.
Section
9.02 Delivery. Unless expressly agreed to by the
Parties, Kopin shall deliver the Products to StableX’s carrier, using Kopin’s standard methods for packaging and providing
the Products. All Prices are FCA (Incoterms 2020) where StableX shall be fully responsible for arranging and payment for the carrier.
6
Section
9.03 Late Delivery. Any time quoted for delivery
is an estimate only; provided, however, that Kopin will use commercially reasonable efforts to deliver all Products on or before
the requested delivery date. Subject to StableX’s rights under this Section, no delay in the shipment or delivery of any Product
relieves StableX of its obligations under this Agreement, including accepting delivery of any remaining installment or other orders of
Products.
Section
9.04 Inspection. StableX shall inspect Products received under this Agreement within
ten (10) Business Days of receipt (the “Inspection Period”) of the Products and either accept or, if any Products
are Defective Products, reject these Products. StableX will be deemed to have accepted the Products unless it notifies Kopin in writing
of any Defective Products during the Inspection Period and furnishes written evidence or other documentation as reasonably required by
Kopin. If StableX timely notifies Kopin of any Defective Products, Kopin shall determine, in its reasonable discretion, whether the Products
are Defective Products. If Kopin, acting reasonably, determines that the Products are Defective Products, it shall either, in its sole
discretion, (i) replace such Defective Products with conforming Products, or (ii) refund the Price invoiced or paid, as applicable. StableX
shall ship, at its expense, all Defective Products to Kopin’s facility. If Kopin exercises its option to replace Defective Products,
Kopin shall provide the replacement(s) to StableX at Kopin’s expense.
StableX
acknowledges and agrees that the remedies set out in this Section are StableX’s exclusive remedy for the delivery of Defective
Products, subject to StableX’s rights under Section 15.02 and Section 15.04 regarding any Defective Products for which StableX
accepted delivery under this Section.
Section
9.05 Limited Right of Return. Except as provided
under Section 9.04 (Inspection), Section 15.02 (Limited Product Warranty) and Section 15.04 (Extent of Liability), all sales of Products
to StableX under this Agreement are made on a one-way basis and StableX has no right to return Products purchased under this Agreement.
Section
9.06 Title and Risk of Loss. Title to Products shipped under any Purchase
Order passes to StableX on Kopin’s providing such Products to the carrier at Kopin’s facility, provided that Kopin reserves
all rights to recover unpaid Products to the extent permitted by applicable law. Risk of loss to Products shipped under any Purchase
Order passes to StableX upon Kopin’s delivery of such Products to the carrier.
ARTICLE
X
Price and Payment
Section
10.01 Shipping Charges, Insurance and Taxes. StableX
shall pay for shipping charges and insurance costs in accordance with the commercial terms set forth in ARTICLE IX (Shipment and Delivery).
All Prices are exclusive of all sales, use, and excise taxes, and any other similar taxes, duties, and charges of any kind imposed by
any Governmental Authority on any amounts payable by StableX under this Agreement. StableX is responsible for all charges, costs, and
taxes.
Section
10.02 Payment Terms. Kopin will issue monthly invoices to StableX for all Products
ordered in the previous month. StableX shall pay all invoiced amounts due to Kopin within thirty (30) calendar days from the invoice
date, except for any amounts disputed by StableX in good faith and in accordance with Section 10.03. StableX shall make all payments
in US dollars by wire transfer or via any other method Kopin designates in writing to StableX. Any undisputed amounts not paid when due
shall accrue interest at a rate of 1% per month and 12% per annum (or the maximum rate permitted by applicable law, if lower), from the
due date until payment. All amounts payable by StableX under this Agreement
shall be paid in full without any set-off, counterclaim, deduction or withholding (other than as required by applicable law).
7
Section
10.03 Invoice Disputes. StableX shall notify Kopin
in writing of any dispute with any invoice (along with substantiating documentation) within thirty (30) calendar days after the date
of the invoice. StableX will be deemed to have accepted all invoices for which Kopin does not receive timely notice of disputes, and
shall pay all undisputed amounts due under these invoices within the period set out in Section 10.02 (Payment Terms). The Parties shall
seek to resolve all disputes expeditiously and in good faith. Notwithstanding the foregoing, StableX shall continue to pay all undisputed
amounts in accordance with this Agreement.
ARTICLE
XI
Resale of the Products
Section
11.01 Credit Risk on Resale to End Users. StableX
is responsible for all credit risks regarding, and for collecting payment for, all Products sold to third parties (including End Users),
whether or not StableX has made full payment to Kopin for the Products. The inability of StableX to collect the purchase price for any
product does not affect StableX’s obligation to pay Kopin for any Product.
Section
11.02 Resale Prices. StableX shall establish its
own resale prices and terms regarding Products it sells, subject to and in accordance with the provisions of the first paragraph of Article
VII.
ARTICLE
XII
Compliance with Laws
Section
12.01 General Compliance With Laws Representation and Warranty; Covenant. Each
Party represents and warrants to the other Party that it is in material compliance with all Laws applicable to this Agreement, the Products
and the operation of its business. Each Party shall at all times comply with all applicable Laws.
ARTICLE
XIII
Term; Termination
Section
13.01 Term. The term of this Agreement shall commence
on the Effective Date and, unless earlier terminated in accordance with this Agreement, shall continue for an initial period of four
(4) years, after which it shall automatically renew for successive periods of one (1) year unless either Party gives written notice of
non-renewal not less than ninety (90) days prior to the end of the then-current term (the “Term”).
Section
13.02 Effect of Expiration or Termination.
(a) The
Term’s expiration or earlier termination does not affect any rights or obligations that:
(i) are
to survive the expiration or earlier termination of this Agreement; and
(ii) were
incurred by the Parties before the expiration or earlier termination; provided that all indebtedness of StableX to Kopin of any kind
is immediately due and payable on the effective date of the Term’s expiration or earlier termination without further notice to
StableX.
(b) Any
Notice of termination will automatically operate as a cancellation of any pending Purchase Orders that have not been accepted by Kopin
and any deliveries of Products to StableX that are scheduled to be made after the effective date of termination. Regarding any Products
that are still in transit on termination of this Agreement, Kopin may require, in its sole and absolute discretion, that all sales and
deliveries of the Products be made on a cash in advance or certified funds basis.
(c) On
the expiration or earlier termination of this Agreement, StableX shall promptly cease to represent itself as Kopin’s authorized
representative regarding the Products in the Territory, and shall otherwise desist from all conduct or representations that might lead
the public to believe that StableX is authorized by Kopin to sell the Products or in any way associated with Kopin;
8
(i) return
to Kopin all documents and tangible materials (and any copies) containing, reflecting, incorporating or based on Kopin’s Confidential
Information; and
(ii) permanently
erase all of Kopin’s Confidential Information from its computer systems; and
(d) Subject
to Section 13.02(a), the Party terminating this Agreement, or in the case of the expiration of this Agreement, each Party, shall not
be liable to the other Party for any damage of any kind (whether direct or indirect) incurred by the other Party by reason of the expiration
or earlier termination of this Agreement, except for (i) accrued payment obligations, (ii) breaches of this Agreement, or (iii) any liability
that cannot be excluded under applicable Law.
ARTICLE
XIV
Confidentiality
Section
14.01 Confidentiality. All non-public, confidential or proprietary information (“Confidential
Information”) that a Party (the “Disclosing Party”) may disclose or make available to the other Party (the
“Receiving Party”) relating to the Disclosing Party, including but not limited to names or addresses of customers,
sales techniques, distribution strategies, sales terms or conditions, delivery or scheduling terms or conditions, costs, pricing, manufacturing
or processing methods, and any new product development plans the Disclosing Party may establish or issue from time to time, whether disclosed
orally or disclosed or accessed in written, electronic, or other form or media, and whether or not marked, designated, or otherwise identified
as “confidential,” in connection with this Agreement, shall be kept confidential and used solely for the Receiving Party’s
performance of its obligations under this Agreement and may not be disclosed to any third party without the Disclosing Party’s
prior written consent. The Receiving Party agrees to use commercially reasonable efforts to protect such Confidential Information, and
not to use or disclose such Confidential Information other than as permitted under this Agreement. The Receiving Party may disclose Confidential
Information to its Affiliates, employees, agents and contractors who have a need to know such information for the purposes of this Agreement,
provided that such persons are subject to confidentiality obligations no less protective than those set out in this Agreement. The Receiving
Party shall be responsible for any breach of this Section by such persons. If any unauthorized disclosure of Confidential Information
occurs or is suspected, the Receiving Party shall promptly notify the Disclosing Party and provide reasonable details of such disclosure.
To the extent the Receiving Party receives confidential information of a third party in connection with this Agreement, it shall comply
with any applicable restrictions notified to it by the Disclosing Party in relation to such information. Confidential Information excludes
information that: (a) is or becomes generally available to the public other than as a result of a breach of this Agreement; (b) is obtained
by the Receiving Party on a non-confidential basis from a third party that is not under any obligation of confidentiality; or (c) was
lawfully in the Receiving Party’s possession prior to disclosure by the Disclosing Party. The Receiving Party may disclose Confidential
Information to the extent required by applicable Law or by a governmental authority, provided that (to the extent legally permitted)
it gives the Disclosing Party reasonable prior notice and reasonably cooperates, at the Disclosing Party’s expense, with any request
to limit or protect such disclosure..
Section
14.02 Upon the earlier of the Disclosing Party’s request or the expiration or termination of this Agreement, the Receiving
Party shall return or destroy all documents and materials (and any copies) containing the Disclosing Party’s Confidential Information,
save that the Receiving Party may retain copies to the extent required by applicable Law or for internal compliance purposes, subject
to the confidentiality obligations in this Agreement. The Parties acknowledge that a breach of this Section may result in irreparable
harm, and that the Disclosing Party shall be entitled to seek injunctive or other equitable relief in respect of any such breach. Nothing
in this Agreement shall prevent disclosure of Confidential Information to the extent permitted under applicable law, including pursuant
to the Defend Trade Secrets Act of 2016.
9
Section
14.03 The obligations set out in this Article XIV shall survive the expiration or termination of this Agreement for a period of
five (5) years, or, in the case of trade secrets, for so long as such information remains a trade secret under applicable Law.
ARTICLE
XV
Representations and Warranties
Section
15.01 StableX’s Representations and Warranties. StableX
represents and warrants to Kopin that:
(a) it
is a duly organized, validly existing and in good standing in the jurisdiction of its formation;
(b) it
is duly qualified to do business and is in good standing in every jurisdiction in which such qualification is required for purposes of
this Agreement, except where the failure to be so qualified, in the aggregate, would not reasonably be expected to adversely affect its
ability to perform its obligations under this Agreement;
(c) it
has the full right, power and authority to enter into this Agreement and to perform its obligations under this Agreement;
(d) the
execution of this Agreement by its Representative whose signature is set out at the end hereof has been duly authorized by all necessary
action of StableX;
(e) when
executed and delivered by each of Kopin and StableX, this Agreement will constitute the legal, valid and binding obligation of StableX,
enforceable against StableX in accordance with its terms.
Section
15.02 Limited Product Warranty. Subject to the
provisions of Section 15.03, Section 15.04 and Section 15.05, Kopin shall make certain limited warranties regarding the Products (“Limited
Warranties”) solely to and for the End User’s benefit, which shall be, in Kopin’s sole discretion, either:
(a) a
written warranty statement included with the Product;
(b) that
the Products have been manufactured according to the agreed Product specifications and in accordance with applicable Law; or
(c) Kopin’s
standard limited warranty in force when the Product is delivered by StableX to End User.
No
warranty is extended to StableX under this Agreement. StableX shall not provide any warranty regarding any Product other than the Kopin
warranty described in this Section.
Section
15.03 Warranty Limitations. Limited Warranties
do not apply where the Product:
(a) has
been subjected to abuse, misuse, neglect, negligence, accident, improper testing, improper installation, improper storage, improper handling,
abnormal physical stress, abnormal environmental conditions, or use contrary to any instructions issued by Kopin;
(b) has
been reconstructed, repaired, or altered by Persons other than Kopin or its authorized Representative; or
(c) has
been used with any third-party product, hardware or product that has not been previously approved in writing by Kopin.
10
Section
15.04 Extent of Liability. During the Warranty
Period, regarding any Defective Products:
(a) notwithstanding
anything in this Agreement to the contrary, Kopin’s liability under the Limited Warranty is discharged, in Kopin’s sole discretion
and at its expense, by:
(i) repairing
or replacing any Defective Product(s); or
(ii) crediting
or refunding the Price of the Defective Product(s) invoiced or paid, as applicable (i.e., less any applicable discounts, rebates, or
credits).
(b) StableX
is responsible for all costs and risk of loss associated with the delivery of Defective Product(s) to Kopin (subject to change on receipt
of notice from Kopin) for warranty repair or replacement;
(c) Kopin
is responsible for all costs and risk of loss associated with the delivery of repaired or replaced products to the Delivery Point; and
(d) StableX
is responsible for all costs and risk of loss associated with the delivery and return of the repaired or replaced Products to End User.
All
claims for breach of the Limited Warranty must be received by Kopin no later than thirty (30) Business Days after the expiration of the
limited warranty period of the Product.
StableX
has no right to return for repair, replacement, credit, or refund any Product except as set out in this Section (or if otherwise applicable,
Section 9.04 (Inspection) and Section 15.02). StableX shall not reconstruct, repair, alter, or replace any Product, in whole or in part,
either itself or by or through any third party.
THIS
SECTION SETS FORTH StableX’S SOLE REMEDY AND StableX’S ENTIRE LIABILITY FOR ANY BREACH OF ANY WARRANTY RELATING TO THE PRODUCTS.
Except
as explicitly authorized in this Agreement or in a separate written agreement with Kopin, StableX shall not service, repair, modify,
alter, replace, reverse engineer, or otherwise change the Products it sells to End Users.
Section
15.05 Warranties Disclaimer; Non-reliance. EXCEPT
FOR THE LIMITED EXPRESS WARRANTIES DESCRIBED IN Section 15.01 AND Section 15.02, (A) NEITHER KOPIN NOR ANY PERSON ON KOPIN’S BEHALF
HAS MADE OR MAKES ANY EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY WHATSOEVER, INCLUDING ANY WARRANTIES OF: (i) MERCHANTABILITY; OR
(ii) FITNESS FOR A PARTICULAR PURPOSE; OR (iii) TITLE; OR (iv) NON-INFRINGEMENT; OR (v) PERFORMANCE OF PRODUCTS TO STANDARDS SPECIFIC
TO THE COUNTRY OF IMPORT, WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE, ALL OF WHICH
ARE EXPRESSLY DISCLAIMED; AND (B) STABLEX ACKNOWLEDGES THAT IT HAS NOT RELIED ON ANY REPRESENTATION OR WARRANTY MADE BY KOPIN, OR ANY
OTHER PERSON ON KOPIN’S BEHALF, EXCEPT AS SPECIFICALLY DESCRIBED IN SECTION 15.02 (Limited Product Warranty) OF THIS AGREEMENT.
ARTICLE
XVI
Indemnification
Section
16.01 StableX General Indemnification. In accordance
with the terms and conditions of this Agreement, StableX shall indemnify, hold harmless, and defend (at Kopin’s election) Kopin
and its Affiliates, and each of the foregoing’s officers, directors, partners, members, shareholders, employees, agents, successors
and assigns (collectively, “Kopin Indemnified Party”) against any and all losses, damages, liabilities, deficiencies,
claims, actions, judgments, settlements, interest, awards, penalties, fines, costs, or expenses of whatever kind, including reasonable
attorneys’ fees, fees, and the costs of enforcing any right to indemnification under this Agreement and the cost of pursuing any
insurance providers (collectively, “Losses”), incurred by the Kopin Indemnified Party, arising out of or relating
to any Claim of a third party:
11
(a) relating
to a breach or non-fulfillment of any representation, warranty, or covenant under this Agreement by the StableX or its Personnel;
(b) alleging
or relating to any act or omission of StableX or its Personnel (including any gross negligence, recklessness, or willful misconduct)
in connection with the performance of its obligations under this Agreement; or
(c) alleging
or relating to any bodily injury, death of any Person or damage to real or tangible personal property caused by the willful or grossly
negligent acts or omissions of StableX or its Personnel.
Section
16.02 Kopin General Indemnification. In accordance
with the terms and conditions of this Agreement, Kopin shall indemnify, hold harmless, and defend (at StableX’s election) StableX
and its Affiliates, and each of the foregoing’s officers, directors, partners, members, shareholders, employees, agents, successors
and assigns (collectively, “StableX Indemnified Party”) against any and all Losses incurred by the StableX Indemnified
Party, arising out of or relating to any Claim of a third party:
(a) relating
to a breach or non-fulfillment of any representation, warranty, or covenant under this Agreement by the Kopin or its Personnel;
(b) alleging
or relating to any act or omission of Kopin or its Personnel (including any gross negligence, recklessness, or willful misconduct) in
connection with the performance of its obligations under this Agreement;
(c) alleging
or relating to any bodily injury, death of any Person or damage to real or tangible personal property caused by the willful or grossly
negligent acts or omissions of Kopin or its Personnel; or
(d) any
claim that a Product supplied by Kopin is a Defective Product.
ARTICLE
XVII
Limitation of Liability
Section
17.01 No Liability for Consequential or Indirect Damages. IN NO EVENT IS EITHER
PARTY OR ITS REPRESENTATIVES LIABLE FOR CONSEQUENTIAL, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, PUNITIVE OR ENHANCED DAMAGES, LOST PROFITS
OR REVENUES OR DIMINUTION IN VALUE, ARISING OUT OF OR RELATING TO ANY BREACH OF THIS AGREEMENT, REGARDLESS OF: (A) WHETHER THE DAMAGES
WERE FORESEEABLE; (B) WHETHER OR NOT SUCH PARTY WAS ADVISED OF THE POSSIBILITY OF THE DAMAGES; OR (C) THE LEGAL OR EQUITABLE THEORY (CONTRACT,
TORT OR OTHERWISE) ON WHICH THE CLAIM IS BASED, AND NOTWITHSTANDING THE FAILURE OF ANY AGREED OR OTHER REMEDY OF ITS ESSENTIAL PURPOSE.
Section
17.02 Limitation of Liability. Except for liability arising from (i) a Party’s breach
of its confidentiality obligations under this Agreement, (ii) a Party’s indemnification obligations under Article XVI, and (iii)
a Party’s fraud or willful misconduct, each Party’s total aggregate liability arising out of or relating to this Agreement,
whether in contract, tort (including negligence), or otherwise, shall not exceed the total amounts paid or payable by StableX to Kopin
under this Agreement in the twelve (12) months preceding the event giving rise to the claim.
12
ARTICLE
XVIII
Insurance
Section
18.01 StableX Insurance Obligations. During the
Term each Party shall, at its own expense, maintain and carry in full force and effect, all types and amounts of insurance required by
applicable Law and all such insurance as is necessary to satisfy such Party’s obligations under this Agreement, including general
commercial liability insurance and product liability limits, in reasonable and customary amounts, with financially sound and reputable
insurers.
ARTICLE
XIX
Miscellaneous
Section
19.01 Entire Agreement. In accordance with the language in ARTICLE IV (Terms
of Agreement Prevail Over StableX’s Purchase Order), this Agreement, including and together with related exhibits, schedules, attachments,
and appendices, along with the Development Agreement between the Parties, constitutes the sole and entire agreement between the Parties
with respect to the subject matter of this Agreement, and supersedes all prior and contemporaneous understandings, agreements, representations,
and warranties, both written and oral, regarding such subject matter.
Section
19.02 Notices. All notices under this Agreement
shall be made in writing and shall be deemed duly given if delivered either in person, by certified or registered mail, return receipt
requested and postage prepaid, or by recognized overnight courier service. All notices shall be addressed to the Parties at their respective
addresses first set forth above (or to such other address that the receiving Party may designate from time to time in accordance with
this Section). Notices shall be effective on receipt.
Section
19.03 Severability. If any term or provision
of this Agreement is found by a court of competent jurisdiction to be invalid, illegal, or unenforceable, such invalidity, illegality,
or unenforceability shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or
provision in any other jurisdiction.
Section
19.04 Amendment and Modification. The Parties
may not amend this Agreement except by written instrument signed by the Parties.
Section
19.05 Waiver. No waiver by any Party of any of the provisions of this Agreement
shall be effective unless explicitly set forth in writing and signed by the Party so waiving. Except as otherwise set forth in this Agreement,
no failure to exercise, or delay in exercising, any right, remedy, power, or privilege arising from this Agreement shall operate or be
construed as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power, or privilege hereunder preclude
any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege.
Section
19.06 Cumulative Remedies. All rights and remedies
provided in this Agreement are cumulative and not exclusive, and the exercise by either Party of any right or remedy does not preclude
the exercise of any other rights or remedies that may now or later be available at law, in equity, by statute, in any other agreement
between the Parties or otherwise.
Section
19.07 Equitable Remedies. Each Party, as Receiving
Party, acknowledges and agrees that (a) a breach or threatened breach by such Party of any of its obligations under ARTICLE XIV (Confidentiality)
would give rise to irreparable harm to Disclosing Party for which monetary damages would not be an adequate remedy and (b) in the event
of a breach or a threatened breach by Receiving Party of any of these obligations, Disclosing Party shall, in addition to any and all
other rights and remedies that may be available to Disclosing Party at law, at equity, or otherwise in respect of this breach, be entitled
to equitable relief, including a temporary restraining order, an injunction, specific performance and any other relief that may be available
from a court of competent jurisdiction, without any requirement to post a bond or other security, and without any requirement to prove
actual damages or that monetary damages do not afford an adequate remedy. Each Party, as Receiving Party, agrees that it will not oppose
or otherwise challenge the appropriateness of equitable relief or the entry by a court of competent jurisdiction of an order granting
equitable relief, in either case, consistent with the terms of this Section.
13
Section
19.08 Assignment; Successors and Assigns. Neither
Party may assign any of its rights or delegate any of its obligations under this Agreement without the prior written consent of the other
Party, except for a sale of all or substantially all of the business assets of such Party to which this Agreement relates. In such a
sale, the purported Assignee must agree to be bound in writing by the obligations of this Agreement and a copy of such writing and such
assignment must be provided to the other Party at least ten (10) Business Days before such a transaction is executed. Any purported assignment
or delegation in violation of this Section is null and void. No assignment or delegation relieves the assigning or delegating Party of
any of the Party’s obligations under this Agreement.
Section
19.09 Choice of Law; Choice of Forum. Section
10.1 of the Development Agreement is incorporated herein by reference and made a part hereof.
Section
19.10 Counterparts. This Agreement may be executed
in counterparts, each of which is deemed an original, but all of which together are deemed to be one and the same agreement. A signed
copy of this Agreement delivered by facsimile, e-mail, or other means of electronic transmission is deemed to have the same legal effect
as delivery of an original signed copy of this Agreement.
Section
19.11 Force Majeure. No Party shall be liable or responsible to the other Party,
nor be deemed to have defaulted under or breached this Agreement, for any failure or delay in fulfilling or performing any term of this
Agreement (except as to the payment of consideration), when and to the extent such failure or delay is caused by or results from acts
beyond the affected Party’s reasonable control, including, without limitation: (a) acts of God; (b) flood, fire, earthquake, or
explosion; (c) war, invasion, hostilities (whether war is declared or not), terrorist threats or acts, riot, or other civil unrest; (d)
Law; (e) actions, embargoes, or blockades in effect on or after the date of this Agreement; (f) action by any Governmental Authority;
(g) national or regional emergency; (h) general strikes, labor stoppages or slowdowns, or other industrial disturbances; (i) shortage
of adequate power or transportation facilities; (j) epidemic or pandemic, excluding however, circumstances directly related to COVID-19
conditions as they exist at the Effective Date, and (k) U.S. military customer requiring the majority of Kopin’s manufacturing
capacity such that Kopin is unable to supply StableX with Product for so long as such requirement persists (each a “Force Majeure
Event”).
14
IN
WITNESS WHEREOF, the Parties hereto have executed this Agreement by their proper and duly authorized representatives as of the Effective
Date.
STABLEX
TECHONOLOGIES, INC.
KOPIN
CORPORATION
By:
/s/Joshua
Silverman
By:
/s/
Michael Murray
Name:
Josh
Silverman
Name:
Michael
Murray
Title:
Executive
Chairman
Title:
President
and CEO
15
EX-10.3
EX-10.3
Filename: ex10-3.htm · Sequence: 13
Exhibit
10.3
SECURITIES
PURCHASE AGREEMENT
This
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 27, 2026, is by and among StableX Technologies,
Inc., a Delaware corporation (the “Company”), and each of the investors listed on the Schedule of Buyers attached
hereto (individually, a “Buyer” and collectively, the “Buyers”).
RECITALS
A.
The Company has authorized a new series of convertible preferred stock of the Company, designated as Series K Convertible Preferred Stock,
par value $0.0001 per share, the terms of which are set forth in the certificate of designations for such series of preferred stock (the
“Certificate of Designations”) in the form attached hereto as Exhibit A (together with any convertible
preferred shares issued in replacement thereof in accordance with the terms thereof, the “Series K Preferred Stock”),
which Series K Preferred Stock shall be convertible into shares of the Company’s common stock, par value $0.0001 per share (the
“Common Stock”), in accordance with the terms of the Certificate of Designations.
B.
Each Buyer wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement, pursuant to the
exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”)
and Rule 506(b) of Regulation D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission
(the “SEC”) under the 1933 Act, (1) such aggregate number of shares of Series K Preferred Stock set forth opposite
such Buyer’s name in column (3) on the Schedule of Buyers (which aggregate amount for all Buyers shall be 21,500 Preferred Shares
and shall be referred to herein as the “Preferred Shares”) and (2) a warrant to initially acquire up to that aggregate
number of additional shares of Common Stock set forth opposite such Buyer’s name in column (4) on the Schedule of Buyers, substantially
in the form attached hereto as Exhibit B (the “Warrants”). The shares of Common Stock issuable pursuant
to the Preferred Shares, including, without limitation, upon conversion or otherwise, are herein referred to as the “Conversion
Shares.” The shares of Common Stock issuable upon exercise of the Warrants are herein referred to as the “Warrant
Shares.” The Conversion Shares and Warrant Shares are collectively herein referred to as the “Shares.”
C.
On the Closing Date, the parties hereto shall execute and deliver a Registration Rights Agreement, in the form attached hereto as Exhibit
C (the “Registration Rights Agreement”), pursuant to which the Company has agreed to provide certain registration
rights with respect to the Registrable Securities (as defined in the Registration Rights Agreement), under the 1933 Act and the rules
and regulations promulgated thereunder, and applicable state securities laws.
D.
The Preferred Shares, the Conversion Shares, the Warrants and the Warrant Shares are collectively referred to herein as the “Securities.”
AGREEMENT
NOW,
THEREFORE, in consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company and each Buyer hereby agree as follows:
1.
PURCHASE AND SALE OF PREFERRED SHARES AND WARRANTS.
(a)
Purchase of Preferred Shares and Warrants. Subject to the satisfaction (or waiver) of the conditions set forth in Sections
6 and 7 below, the Company shall issue and sell to each Buyer, and each Buyer severally, but not jointly, agrees to purchase
from the Company on the Closing Date (as defined below), such aggregate number of Preferred Shares as is set forth opposite such Buyer’s
name in column (3) on the Schedule of Buyers along with Warrants to initially acquire up to that aggregate number of Warrant Shares as
is set forth opposite such Buyer’s name in column (4) on the Schedule of Buyers.
1
(b)
Closing. The closing (the “Closing”) of the purchase of the Preferred Shares and the Warrants by the Buyers
shall occur remotely by the electronic transfer of Closing documentation. The date and time of the Closing (the “Closing Date”)
shall be 10:00 a.m., New York time, on the first (1st) Business Day on which the conditions to the Closing set forth in Sections 6
and 7 below are satisfied or waived (or such other date as is mutually agreed to by the Company and each Buyer). As used herein
“Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New
York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not
be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential
employee” or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental
authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York
generally are open for use by customers on such day.
(c)
Purchase Price. The aggregate purchase price for the Preferred Shares and the Warrants to be purchased by each Buyer (the “Purchase
Price”) shall be the amount set forth opposite such Buyer’s name in column (5) on the Schedule of Buyers.
(d)
Form of Payment. On the Closing Date, (i) each Buyer shall pay its respective Purchase Price (less, in the case of the lead Buyer,
the amounts withheld pursuant to Section 4(g)) to the Company for the Preferred Shares and the Warrants to be issued and sold to such
Buyer at the Closing, by wire transfer of immediately available funds in accordance with the Company’s written wire instructions)
and (ii) the Company shall deliver to each Buyer (A) such aggregate number of Preferred Shares as is set forth opposite such Buyer’s
name in column (3) of the Schedule of Buyers, and (B) a Warrant pursuant to which such Buyer shall have the right to initially acquire
up to such aggregate number of Warrant Shares as is set forth opposite such Buyer’s name in column (4) of the Schedule of Buyers,
in each case, duly executed on behalf of the Company and registered in the name of such Buyer or its designee.
2.
BUYER’S REPRESENTATIONS AND WARRANTIES.
Each
Buyer, severally and not jointly, represents and warrants to the Company with respect to only itself that, as of the date hereof and
as of the Closing Date:
(a)
Organization; Authority. Such Buyer is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction
of its organization with the requisite power and authority to enter into and to consummate the transactions contemplated by the Transaction
Documents (as defined below) to which it is a party and otherwise to carry out its obligations hereunder and thereunder.
(b)
No Public Sale or Distribution. Such Buyer (i) is acquiring its Preferred Shares and Warrants, (ii) upon conversion of its Preferred
Shares will acquire the Conversion Shares issuable upon conversion thereof, and (iii) upon exercise of its Warrants (other than pursuant
to a Cashless Exercise (as defined in the Warrants)) will acquire the Warrant Shares issuable upon exercise thereof, in each case, for
its own account and not with a view towards, or for resale in connection with, the public sale or distribution thereof in violation of
applicable securities laws, except pursuant to sales registered or exempted under the 1933 Act; provided, however, by making
the representations herein, such Buyer does not agree, or make any representation or warranty, to hold any of the Securities for any
minimum or other specific term and reserves the right to dispose of the Securities at any time in accordance with or pursuant to a registration
statement or an exemption from registration under the 1933 Act. Such Buyer does not presently have any agreement or understanding, directly
or indirectly, with any Person to distribute any of the Securities in violation of applicable securities laws. For purposes of this Agreement,
“Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust,
an unincorporated organization, any other entity and any Governmental Entity (as defined below) or any department or agency thereof.
(c)
Accredited Investor Status; Experience. Such Buyer is an “accredited investor” as that term is defined in Rule 501(a)
of Regulation D. Such Buyer, either alone or together with its representatives, has such knowledge, sophistication and experience in
business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Buyer is able to bear the economic risk of an investment in the Securities
and, at the present time, is able to afford a complete loss of such investment.
2
(d)
Reliance on Exemptions. Such Buyer understands that the Securities are being offered and sold to it in reliance on specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the
truth and accuracy of, and such Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and understandings
of such Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of such Buyer to acquire
the Securities.
(e)
Information. Such Buyer acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Documents (as defined below). Such Buyer and its advisors, if any, have been furnished with all materials
relating to the business, finances and operations of the Company and materials relating to the offer and sale of the Securities that
have been requested by such Buyer. Such Buyer and its advisors, if any, have been afforded the opportunity to ask questions of the Company.
Neither such inquiries nor any other due diligence investigations conducted by such Buyer or its advisors, if any, or its representatives
shall modify, amend or affect such Buyer’s right to rely on the Company’s representations and warranties contained herein.
Such Buyer understands that its investment in the Securities involves a high degree of risk. Such Buyer has sought such accounting, legal
and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Securities.
(f)
No Governmental Review. Such Buyer understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in
the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.
(g)
Transfer or Resale. Such Buyer understands that except as provided in the Registration Rights Agreement and Section 4(h)
hereof: (i) the Securities have not been and are not being registered under the 1933 Act or any state securities laws, and may not be
offered for sale, sold, assigned or transferred unless (A) subsequently registered thereunder, (B) such Buyer shall have delivered to
the Company (if requested by the Company) an opinion of counsel, in a form reasonably acceptable to the Company, to the effect that such
Securities to be sold, assigned or transferred may be sold, assigned or transferred pursuant to an exemption from such registration,
or (C) such Buyer provides the Company with reasonable assurance that such Securities can be sold, assigned or transferred pursuant to
Rule 144 or Rule 144A promulgated under the 1933 Act (or a successor rule thereto) (collectively, “Rule 144”); (ii)
any sale of the Securities made in reliance on Rule 144 may be made only in accordance with the terms of Rule 144, and further, if Rule
144 is not applicable, any resale of the Securities under circumstances in which the seller (or the Person through whom the sale is made)
may be deemed to be an underwriter (as that term is defined in the 1933 Act) may require compliance with some other exemption under the
1933 Act or the rules and regulations of the SEC promulgated thereunder; and (iii) neither the Company nor any other Person is under
any obligation to register the Securities under the 1933 Act or any state securities laws or to comply with the terms and conditions
of any exemption thereunder. Notwithstanding the foregoing, the Securities may be pledged in connection with a bona fide margin account
or other loan or financing arrangement secured by the Securities and such pledge of Securities shall not be deemed to be a transfer,
sale or assignment of the Securities hereunder, and no Buyer effecting a pledge of Securities shall be required to provide the Company
with any notice thereof or otherwise make any delivery to the Company pursuant to this Agreement or any other Transaction Document (as
defined in Section 3(b)), including, without limitation, this Section 2(g).
(h)
Validity; Enforcement. This Agreement and the Registration Rights Agreement, as applicable, have been duly and validly authorized,
executed and delivered on behalf of such Buyer and shall constitute the legal, valid and binding obligations of such Buyer enforceable
against such Buyer in accordance with their respective terms, except as such enforceability may be limited by general principles of equity
or to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally,
the enforcement of applicable creditors’ rights and remedies.
(i)
No Conflicts. The execution, delivery and performance by such Buyer of this Agreement and the Registration Rights Agreement and
the consummation by such Buyer of the transactions contemplated hereby and thereby will not (i) result in a violation of the organizational
documents of such Buyer, or (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would
become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture
or instrument to which such Buyer is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree
(including federal and state securities laws) applicable to such Buyer, except in the case of clauses (ii) and (iii) above, for such
conflicts, defaults, rights or violations which could not, individually or in the aggregate, reasonably be expected to have a material
adverse effect on the ability of such Buyer to perform its obligations hereunder.
3
(j)
No Reliance on Placement Agent. Such Buyer acknowledges and agrees that neither the Placement Agent (as defined below) nor any
affiliate of the Placement Agent has provided such Buyer with any information or advice with respect to the Securities nor is such information
or advice necessary or desired. Neither the Placement Agent nor any affiliate has made or makes any representation as to the Company
or the quality of the Securities and the Placement Agent and any affiliate may have acquired non-public information with respect to the
Company which such Buyer agrees need not be provided to it. In connection with the issuance of the Securities to such Buyer, neither
the Placement Agent nor any of its affiliates has acted as a financial advisor or fiduciary to such Buyer.
(k)
Residency. Such Buyer is a resident of that jurisdiction specified below its address on the Schedule of Buyers.
(l)
General Solicitation. Buyer represents that (i) Buyer was contacted regarding the sale of the Securities by the Placement Agent
or the Company (or authorized representative thereof) and the Buyer had a prior pre-existing relationship with the Company under the
U.S. securities laws and interpretations, (ii) to the knowledge of such Buyer, no Securities were offered or sold to it by means of any
form of general solicitation, and Buyer is not, to such Buyer’s knowledge, purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over
television or radio or presented at any seminar or, to the knowledge of such Buyer, any other general solicitation or general advertisement.
Buyer has not become interested in the offering of the Securities as a result of any registration statement of the Company filed with
the SEC or any other securities agency or regulator.
(m)
Certain Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, such Buyer has not,
nor has any Person acting on behalf of or pursuant to any understanding with such Buyer, directly or indirectly executed any purchases
or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Buyer first received
a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the
transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case
of a Buyer that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Buyer’s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other
portions of such Buyer’s assets, the representation set forth above shall only apply with respect to the portion of assets managed
by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other
Persons party to this Agreement or to such Buyer’s representatives, including, without limitation, its officers, directors, partners,
legal and other advisors, employees, agents and affiliates, such Buyer has maintained the confidentiality of all disclosures made to
it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the
avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to
locating or borrowing shares in order to effect Short Sales or similar transactions in the future. “Short Sales” means
all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include locating
and/or borrowing shares of Common Stock).
4
3.
REPRESENTATIONS AND WARRANTIES OF THE COMPANY.
The
Company represents and warrants to each of the Buyers that, as of the date hereof and as of the Closing Date:
(a)
Organization and Qualification. Each of the Company and each of its Subsidiaries are entities duly organized and validly existing
and in good standing under the laws of the jurisdiction in which they are formed, and have the requisite power and authority to own their
properties and to carry on their business as described in the SEC Documents. Each of the Company and each of its Subsidiaries is duly
qualified as a foreign entity to do business and is in good standing in every jurisdiction in which its ownership of property or the
nature of the business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified or
be in good standing would not reasonably be expected to have a Material Adverse Effect (as defined below). As used in this Agreement,
“Material Adverse Effect” means any material adverse effect on (i) the business, properties, assets, liabilities,
operations (including results thereof), condition (financial or otherwise) or prospects of the Company and its Subsidiaries (as defined
below), taken as a whole, (ii) the transactions contemplated hereby or in any of the other Transaction Documents or any other agreements
or instruments to be entered into in connection herewith or therewith or (iii) the authority or ability of the Company or any of its
Subsidiaries to perform any of their respective obligations under any of the Transaction Documents (as defined below). “Subsidiaries”
means any Person in which the Company, directly or indirectly, (I) owns any of the outstanding capital stock or holds any equity or similar
interest of such Person or (II) controls or operates all or any part of the business, operations or administration of such Person, and
each of the foregoing, is individually referred to herein as a “Subsidiary.”
(b)
Authorization; Enforcement; Validity. The Company has the requisite power and authority to enter into and perform its obligations
under this Agreement and the other Transaction Documents and to issue the Securities in accordance with the terms hereof and thereof.
Each Subsidiary has the requisite power and authority to enter into and perform its obligations under the Transaction Documents to which
it is a party. The execution and delivery of this Agreement and the other Transaction Documents by the Company and its Subsidiaries,
and the consummation by the Company and its Subsidiaries of the transactions contemplated hereby and thereby (including, without limitation,
the issuance by the Company of the Preferred Shares and the reservation for issuance and issuance of the Conversion Shares issuable upon
conversion of the Preferred Shares and the issuance of the Warrants and the reservation for issuance and issuance of the Warrant Shares
issuable upon exercise of the Warrants) have been duly authorized by the Company’s board of directors and, to the extent applicable,
each of its Subsidiaries’ board of directors or other governing body, as applicable, and (other than the filing with the SEC of
a Form D or of one or more Registration Statements (as defined in the Registration Rights Agreement) in accordance with the requirements
of the Registration Rights Agreement, the filing of the Certificate of Designations and any other filings as may be required by any state
securities agencies) no further filing, consent or authorization is required by the Company, its Subsidiaries, their respective boards
of directors or their stockholders or other governing body. This Agreement has been, and the other Transaction Documents to which it
is a party will be prior to the Closing, duly executed and delivered by the Company, and each constitutes the legal, valid and binding
obligations of the Company, enforceable against the Company in accordance with its respective terms, except as such enforceability may
be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws
relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies and except as rights to indemnification
and to contribution may be limited by federal or state securities law. Prior to the Closing, the Transaction Documents to which each
Subsidiary is a party will be duly executed and delivered by each such Subsidiary, and shall constitute the legal, valid and binding
obligations of each such Subsidiary, enforceable against each such Subsidiary in accordance with their respective terms, except as such
enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation
or similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies and except as
rights to indemnification and to contribution may be limited by federal or state securities law. “Transaction Documents”
means, collectively, this Agreement, the Certificate of Designations, the Warrants, the Registration Rights Agreement, the Irrevocable
Transfer Agent Instructions (as defined below) and each of the other agreements and instruments entered into or delivered by the Company
or any of its Subsidiaries in connection with the transactions contemplated hereby and thereby, as may be amended from time to time.
5
(c)
Issuance of Securities. The issuance of the Preferred Shares and the Warrants are duly authorized and upon issuance in accordance
with the terms of the Transaction Documents shall be validly issued, fully paid and non-assessable and free from all preemptive or similar
rights, mortgages, defects, claims, liens, pledges, charges, taxes, rights of first refusal, encumbrances, security interests and other
encumbrances (collectively “Liens”) with respect to the issuance thereof. As of the Closing, the Company shall have
reserved from its duly authorized share capital not less than the sum of (i) 200% of the maximum number of Conversion Shares issuable
upon conversion of the Preferred Shares (assuming for purposes hereof that the Preferred Shares are convertible at the Floor Price (as
defined in the Certificate of Designations) then in effect and without taking into account any limitations on the conversion of the Preferred
Shares set forth in the Certificate of Designations), and (ii) the maximum number of Warrant Shares initially issuable upon exercise
of the Warrants (without taking into account any limitations on the exercise of the Warrants set forth therein). Upon issuance or conversion
in accordance with the Preferred Shares or exercise in accordance with the Warrants (as the case may be), the Conversion Shares and the
Warrant Shares, respectively, when issued, will be validly issued, fully paid and nonassessable and free from all preemptive or similar
rights or Liens with respect to the issue thereof, with the holders being entitled to all rights accorded to a holder of shares of Common
Stock (other than restrictions on transfer as described in Section 2(g)). The Company is eligible to use Form S-3 under the 1933
Act and it meets the transaction requirements as set forth in General Instruction I.B.6 of Form S-3. Subject to the accuracy of the representations
and warranties of the Buyers in this Agreement, the offer and issuance by the Company of the Securities is exempt from registration under
the 1933 Act.
(d)
No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and its Subsidiaries and the
consummation by the Company and its Subsidiaries of the transactions contemplated hereby and thereby (including, without limitation,
the issuance of the Preferred Shares, the Warrants, the Conversion Shares and the Warrant Shares and the reservation for issuance of
the Conversion Shares and the Warrant Shares) will not (i) result in a violation of the Certificate of Incorporation (as defined below),
Bylaws (as defined below) or other organizational documents of the Company or any of its Subsidiaries, or any capital stock or other
securities of the Company or any of its Subsidiaries, (ii) conflict with, or constitute a default (or an event which with notice or lapse
of time or both would become a default) in any respect under, or give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries is a party, or (iii) result in
a violation of any law, rule, regulation, order, judgment or decree and including all applicable foreign, federal and state securities
laws, rules and regulations, and the rules and regulations of The Nasdaq Capital Market (the “Principal Market”) applicable
to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected;
except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse
Effect.
(e)
Consents. Neither the Company nor any Subsidiary is required to obtain any consent from, authorization or order of, or make any
filing or registration with (other than the filing with the SEC of one or more registration statements in accordance with the requirements
of the Registration Rights Agreement, a Form D with the SEC and any other filings as may be required by any state securities agencies,
the notice and/or application(s) to the Principal Market for the issuance and sale of the Securities and the listing of the Conversion
Shares and Warrant Shares for trading thereon in the time and manner required thereby), any Governmental Entity (as defined below) or
any regulatory or self-regulatory agency or any other Person in order for it to execute, deliver or perform any of its respective obligations
under or contemplated by the Transaction Documents, in each case, in accordance with the terms hereof or thereof. All consents, authorizations,
orders, filings and registrations which the Company or any Subsidiary is required to obtain prior to the Closing Date pursuant to the
preceding sentence have been or will be obtained or effected on or prior to the Closing Date, and neither the Company nor any of its
Subsidiaries are aware of any facts or circumstances which might prevent the Company or any of its Subsidiaries from obtaining or effecting
any of the registration, application or filings contemplated by the Transaction Documents. The Company is not in violation of the requirements
of the Principal Market and has no knowledge of any facts or circumstances which could reasonably lead to delisting or suspension of
the Common Stock in the foreseeable future. “Governmental Entity” means any nation, state, county, city, town, village,
district, or other political jurisdiction of any nature, federal, state, local, municipal, foreign, or other government, governmental
or quasi-governmental authority of any nature (including any governmental agency, branch, department, official, or entity and any court
or other tribunal), multi-national organization or body; or body exercising, or entitled to exercise, any administrative, executive,
judicial, legislative, police, regulatory, or taxing authority or power of any nature or instrumentality of any of the foregoing, including
any entity or enterprise owned or controlled by a government or a public international organization or any of the foregoing.
6
(f)
Acknowledgment Regarding Buyer’s Purchase of Securities. The Company acknowledges and agrees that each Buyer is acting solely
in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby
and thereby and that no Buyer is (i) an officer or director of the Company or any of its Subsidiaries, (ii) an “affiliate”
(as defined in Rule 144) of the Company or any of its Subsidiaries or (iii) to its knowledge, a “beneficial owner” of more
than 10% of the shares of Common Stock (as defined for purposes of Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the
“1934 Act”)). The Company further acknowledges that no Buyer is acting as a financial advisor or fiduciary of the
Company or any of its Subsidiaries (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated
hereby and thereby, and any advice given by a Buyer or any of its representatives or agents in connection with the Transaction Documents
and the transactions contemplated hereby and thereby is merely incidental to such Buyer’s purchase of the Securities. The Company
further represents to each Buyer that the Company’s and each Subsidiary’s decision to enter into the Transaction Documents
to which it is a party has been based solely on the independent evaluation by the Company, each Subsidiary and their respective representatives.
(g)
No General Solicitation; Placement Agent’s Fees. Neither the Company, nor any of its Subsidiaries or affiliates, nor any
Person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation
D) in connection with the offer or sale of the Securities. The Company shall be responsible for the payment of any placement agent’s
fees, financial advisory fees, or brokers’ commissions (other than for Persons engaged by any Buyer or its investment advisor)
relating to or arising out of the transactions contemplated hereby, including, without limitation, the advisory fees payable to GP Nurmenkari
Inc. (the “Placement Agent”) in connection with the sale of the Securities. The Company shall pay, and hold each Buyer
harmless against, any liability, loss or expense (including, without limitation, attorney’s fees and out-of-pocket expenses) arising
in connection with any such claim. The Company acknowledges that it has engaged the Placement Agent in connection with the sale of the
Securities. Other than the Placement Agent, neither the Company nor any of its Subsidiaries has engaged any placement agent or other
agent in connection with the offer or sale of the Securities.
(h)
No Integrated Offering. None of the Company, its Subsidiaries or any of their affiliates, nor any Person acting on their behalf
has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances
that would require registration of the issuance of any of the Securities under the 1933 Act, whether through integration with prior offerings
or otherwise, or caused this offering of the Securities to require approval of stockholders of the Company for purposes of the 1933 Act
or under any applicable stockholder approval provisions, including, without limitation, under the rules and regulations of any exchange
or automated quotation system on which any of the securities of the Company are listed or designated for quotation. None of the Company,
its Subsidiaries, their affiliates nor any Person acting on their behalf will take any action or steps that would require registration
of the issuance of any of the Securities under the 1933 Act (other than pursuant to the Registration Rights Agreement) or cause the offering
of any of the Securities to be integrated with other offerings of securities of the Company.
(i)
Dilutive Effect. The Company understands and acknowledges that the number of Conversion Shares and Warrant Shares will increase
in certain circumstances. The Company further acknowledges that its obligation to issue the Conversion Shares pursuant to the terms of
the Certificate of Designations in accordance with this Agreement and Warrant Shares upon exercise of the Warrants in accordance with
this Agreement, the Preferred Shares and the Warrants is, in each case, absolute and unconditional regardless of the dilutive effect
that such issuance may have on the ownership interests of other stockholders of the Company.
(j)
Application of Takeover Protections; Rights Agreement. The Company and its board of directors have taken all necessary action,
if any, in order to render inapplicable any control share acquisition, interested stockholder, business combination, poison pill (including,
without limitation, any distribution under a rights agreement), stockholder rights plan or other similar anti-takeover provision under
the Certificate of Incorporation, Bylaws or other organizational documents or the laws of the jurisdiction of its incorporation or otherwise
which is or could become applicable to any Buyer as a result of the transactions contemplated by this Agreement, including, without limitation,
the Company’s issuance of the Securities and any Buyer’s ownership of the Securities. The Company and its board of directors
have taken all necessary action, if any, in order to render inapplicable any stockholder rights plan or similar arrangement relating
to accumulations of beneficial ownership of shares of Common Stock or a change in control of the Company or any of its Subsidiaries.
7
(k)
SEC Documents; Financial Statements. During the two (2) years prior to the date hereof, the Company has timely filed all reports,
schedules, forms, proxy statements, statements and other documents required to be filed by it with the SEC pursuant to the reporting
requirements of the 1934 Act (all of the foregoing filed prior to the date hereof and all exhibits and appendices included therein and
financial statements, notes and schedules thereto and documents incorporated by reference therein being hereinafter referred to as the
“SEC Documents”). The Company has delivered or has made available to the Buyers or their respective representatives
true, correct and complete copies of each of the SEC Documents not available on the EDGAR system. As of their respective dates, the SEC
Documents complied in all material respects with the requirements of the 1934 Act and the rules and regulations of the SEC promulgated
thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue
statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. As of their respective dates, the financial statements
of the Company included in the SEC Documents complied in all material respects with applicable accounting requirements and the published
rules and regulations of the SEC with respect thereto as in effect as of the time of filing. Such financial statements have been prepared
in accordance with U.S. generally accepted accounting principles (“GAAP”), consistently applied, during the periods
involved (except (i) as may be otherwise indicated in such financial statements or the notes thereto, or (ii) in the case of unaudited
interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present in all material
respects the financial position of the Company as of the dates thereof and the results of its operations and cash flows for the periods
then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments which will not be material, either individually
or in the aggregate). No other information provided by or on behalf of the Company to any of the Buyers which is not included in the
SEC Documents (including, without limitation, information referred to in Section 2(e) of this Agreement or in the disclosure schedules
to this Agreement) contains any untrue statement of a material fact or omits to state any material fact necessary in order to make the
statements therein not misleading, in the light of the circumstances under which they are or were made. The Company is not currently
contemplating to amend or restate any of the financial statements (including, without limitation, any notes or any letter of the independent
accountants of the Company with respect thereto) included in the SEC Documents (the “Financial Statements”), nor is
the Company currently aware of facts or circumstances which would require the Company to amend or restate any of the Financial Statements,
in each case, in order for any of the Financial Statements to be in compliance with GAAP and the rules and regulations of the SEC. The
Company has not been informed by its independent accountants that they recommend that the Company amend or restate any of the Financial
Statements or that there is any need for the Company to amend or restate any of the Financial Statements.
(l)
Absence of Certain Changes. Except as disclosed in the SEC Documents, since the date of the Company’s most recent audited
financial statements contained in a Form 10-K, there has been no material adverse change and no material adverse development in the business,
assets, liabilities, properties, operations (including results thereof), condition (financial or otherwise) or prospects of the Company
or any of its Subsidiaries. Since the date of the Company’s most recent audited financial statements contained in a Form 10-K,
neither the Company nor any of its Subsidiaries has (i) declared or paid any dividends, (ii) sold any assets, individually or in the
aggregate, outside of the ordinary course of business or (iii) made any capital expenditures, individually or in the aggregate, outside
of the ordinary course of business. Neither the Company nor any of its Subsidiaries has taken any steps to seek protection pursuant to
any law or statute relating to bankruptcy, insolvency, reorganization, receivership, liquidation or winding up, nor does the Company
or any Subsidiary have any knowledge or reason to believe that any of their respective creditors intend to initiate involuntary bankruptcy
proceedings or any actual knowledge of any fact which would reasonably lead a creditor to do so. The Company and its Subsidiaries, individually
and on a consolidated basis, are not as of the date hereof, and after giving effect to the transactions contemplated hereby to occur
at the Closing, will not be Company Insolvent (as defined below). For purposes of this Section 3(l), “Company Insolvent”
means, with respect to the Company and its Subsidiaries, on a consolidated basis, (A) the present fair saleable value of the Company’s
and its Subsidiaries’ assets is less than the amount required to pay the Company’s and its Subsidiaries’ total Indebtedness
(as defined below), (B) the Company and its Subsidiaries are unable to pay their debts and liabilities, subordinated, contingent or otherwise,
as such debts and liabilities become absolute and matured or (C) the Company and its Subsidiaries intend to incur or believe that they
will incur debts that would be beyond their ability to pay as such debts mature. Neither the Company nor any of its Subsidiaries has
engaged in any business or in any transaction, and is not about to engage in any business or in any transaction, for which the Company’s
or such Subsidiary’s remaining assets constitute unreasonably small capital with which to conduct the business in which it is engaged
as such business is now conducted and is proposed to be conducted.
8
(m)
No Undisclosed Events, Liabilities, Developments or Circumstances. To the Company’s knowledge, no event, liability, development
or circumstance has occurred or exists that is reasonably likely to have a Material Adverse Effect.
(n)
Conduct of Business; Regulatory Permits. Neither the Company nor any of its Subsidiaries is in violation of any term of or in
default under its Certificate of Incorporation, organizational documents, any certificate of designations, preferences or rights of any
other outstanding series of preferred stock of the Company or any of its Subsidiaries or Bylaws, their organizational charter, certificate
of formation, memorandum of association, articles of association or certificate of incorporation or bylaws or other organizational documents,
respectively. Neither the Company nor any of its Subsidiaries is in violation of any judgment, decree or order or any statute, ordinance,
rule or regulation applicable to the Company or any of its Subsidiaries, and neither the Company nor any of its Subsidiaries will conduct
its business in violation of any of the foregoing, except in all cases for possible violations which could not, individually or in the
aggregate, have a Material Adverse Effect. Without limiting the generality of the foregoing, the Company is not in violation of any of
the rules, regulations or requirements of the Principal Market and has no knowledge of any facts or circumstances that could reasonably
lead to delisting or suspension of the Common Stock by the Principal Market in the foreseeable future. Since May 29, 2020, (i) the Common
Stock has been listed or designated for quotation on the Principal Market, (ii) trading in the Common Stock has not been suspended by
the SEC or the Principal Market and (iii) except as disclosed in the SEC Documents, the Company has received no communication, written
or oral, from the SEC or the Principal Market regarding the suspension or delisting of the Common Stock from the Principal Market. The
Company and each of its Subsidiaries possess all certificates, authorizations and permits issued by the appropriate regulatory authorities
necessary to conduct their respective businesses, except where the failure to possess such certificates, authorizations or permits would
not have, individually or in the aggregate, a Material Adverse Effect, and neither the Company nor any such Subsidiary has received any
notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit. There is no agreement,
commitment, judgment, injunction, order or decree binding upon the Company or any of its Subsidiaries or to which the Company or any
of its Subsidiaries is a party which has or would reasonably be expected to have the effect of prohibiting or materially impairing any
business practice of the Company or any of its Subsidiaries, any acquisition of property by the Company or any of its Subsidiaries or
the conduct of business by the Company or any of its Subsidiaries as currently conducted other than such effects, individually or in
the aggregate, which have not had and would not reasonably be expected to have a Material Adverse Effect on the Company or any of its
Subsidiaries.
(o)
Foreign Corrupt Practices. Neither the Company, the Company’s subsidiary or any director, officer, agent, employee, nor
any other person acting for or on behalf of the foregoing (individually and collectively, a “Company Affiliate”) have
violated the U.S. Foreign Corrupt Practices Act (the “FCPA”) or any other applicable anti-bribery or anti-corruption
laws, nor has any Company Affiliate offered, paid, promised to pay, or authorized the payment of any money, or offered, given, promised
to give, or authorized the giving of anything of value, to any officer, employee or any other person acting in an official capacity for
any Governmental Entity to any political party or official thereof or to any candidate for political office (individually and collectively,
a “Government Official”) or to any person under circumstances where such Company Affiliate knew or was aware of a
high probability that all or a portion of such money or thing of value would be offered, given or promised, directly or indirectly, to
any Government Official, for the purpose of:
(i)
influencing any act or decision of such Government Official in his/her official capacity, (A) inducing such Government Official to do
or omit to do any act in violation of his/her lawful duty, (B) securing any improper advantage, or (C) inducing such Government Official
to influence or affect any act or decision of any Governmental Entity, or
(ii)
assisting the Company or its Subsidiaries in obtaining or retaining business for or with, or directing business to, the Company or its
Subsidiaries.
(p)
Sarbanes-Oxley Act. The Company and each Subsidiary is in compliance with any and all applicable requirements of the Sarbanes-Oxley
Act of 2002, as amended, and any and all applicable rules and regulations promulgated by the SEC thereunder.
9
(q)
Transactions With Affiliates. Except as disclosed in the SEC Documents or for which no disclosure is required in the SEC Documents,
no current or former employee, partner, director, officer or stockholder (direct or indirect) of the Company or its Subsidiaries, or
any associate, or, to the knowledge of the Company, any affiliate of any thereof, or any relative with a relationship no more remote
than first cousin of any of the foregoing, is presently, or has ever been, (i) a party to any transaction with the Company or its Subsidiaries
(including any contract, agreement or other arrangement providing for the furnishing of services by, or rental of real or personal property
from, or otherwise requiring payments to, any such director, officer or stockholder or such associate or affiliate or relative Subsidiaries
(other than for ordinary course services as employees, officers or directors of the Company or any of its Subsidiaries)) or (ii) the
direct or indirect owner of an interest in any corporation, firm, association or business organization which is a competitor, supplier
or customer of the Company or its Subsidiaries (except for a passive investment (direct or indirect) in less than 5% of the common equity
of a company whose securities are traded on or quoted through an Eligible Market (as defined in the Certificate of Designations)), nor
does any such Person receive income from any source other than the Company or its Subsidiaries which relates to the business of the Company
or its Subsidiaries or should properly accrue to the Company or its Subsidiaries. No employee, officer, stockholder or director of the
Company or any of its Subsidiaries or member of his or her immediate family is indebted to the Company or its Subsidiaries, as the case
may be, nor is the Company or any of its Subsidiaries indebted (or committed to make loans or extend or guarantee credit) to any of them,
other than (i) for payment of salary for services rendered, (ii) reimbursement for reasonable expenses incurred on behalf of the Company,
and (iii) for other standard employee benefits made generally available to all employees or executives (including stock option agreements
outstanding under any stock option plan approved by the Board of Directors of the Company).
(r)
Equity Capitalization. As of the date hereof, the authorized capital stock of the Company consists solely of (i) 1,200,000,000
shares of Common Stock, of which, 1,455,975 shares of Common Stock are issued and outstanding and 34,263,605 shares are reserved for
issuance pursuant to outstanding Convertible Securities (as defined below) (other than the Preferred Shares and the Warrants); and (ii)
20,000,000 shares of Preferred Stock, of which 8 shares of Series H Convertible Preferred Stock are issued and outstanding, 1,234 shares
of Series H-3 Convertible Preferred Stock are issued and outstanding, 50 shares of Series H-6 Convertible Preferred Stock are issued
and outstanding, 829.4 shares of Series H-7 Convertible Preferred Stock are issued and outstanding, no shares of Series A Junior Participating
Preferred Stock are issued and outstanding, 7,000 shares of Series I Convertible Preferred Stock are issued and outstanding, and 51,575
shares of Series J Convertible Preferred Stock are issued and outstanding. “Convertible Securities” means any capital
stock or other security of the Company or any of its Subsidiaries that is at any time and under any circumstances directly or indirectly
convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any capital stock or other
security of the Company (including, without limitation, Common Stock) or any of its Subsidiaries. All of such outstanding shares are
duly authorized and have been, or upon issuance will be, validly issued and are fully paid and non-assessable. Except as disclosed in
the SEC Documents, (i) none of the Company’s or any Subsidiary’s capital stock is subject to preemptive rights or any other
similar rights or any liens or encumbrances suffered or permitted by the Company or any Subsidiary; (ii) there are no outstanding options,
warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible
into, or exercisable or exchangeable for, any capital stock of the Company or any of its Subsidiaries, or contracts, commitments, understandings
or arrangements by which the Company or any of its Subsidiaries is or may become bound to issue additional capital stock of the Company
or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating
to, or securities or rights convertible into, or exercisable or exchangeable for, any capital stock of the Company or any of its Subsidiaries;
(iii) there are no outstanding debt securities, notes, credit agreements, credit facilities or other agreements, documents or instruments
evidencing Indebtedness of the Company or any of its Subsidiaries or by which the Company or any of its Subsidiaries is or may become
bound; (iv) there are no financing statements securing obligations in any amounts filed in connection with the Company or any of its
Subsidiaries; (v) there are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register
the sale of any of their securities under the 1933 Act (except pursuant to the Registration Rights Agreement); (vi) there are no outstanding
securities or instruments of the Company or any of its Subsidiaries which contain any redemption or similar provisions, and there are
no contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to redeem
a security of the Company or any of its Subsidiaries; (vii) there are no securities or instruments containing anti-dilution or similar
provisions that will be triggered by the issuance of the Securities; (viii) neither the Company nor any Subsidiary has any stock appreciation
rights or “phantom stock” plans or agreements or any similar plan or agreement; and (ix) neither the Company nor any of its
Subsidiaries have any liabilities or obligations required to be disclosed in the SEC Documents which are not so disclosed in the SEC
Documents, other than those incurred in the ordinary course of the Company’s or its Subsidiaries’ respective businesses and
which, individually or in the aggregate, do not or could not have a Material Adverse Effect. The Company has furnished to the Buyers
true, correct and complete copies of the Company’s Certificate of Incorporation, as amended and as in effect on the date hereof
(the “Certificate of Incorporation”), and the Company’s bylaws, as amended and as in effect on the date hereof
(the “Bylaws”), and the terms of all Convertible Securities convertible into, or exercisable or exchangeable for,
shares of Common Stock and the material rights of the holders thereof in respect thereto.
10
(s)
Indebtedness and Other Contracts. Neither the Company nor any of its Subsidiaries, (i) has any outstanding debt securities, notes,
credit agreements, credit facilities or other agreements, documents or instruments evidencing Indebtedness of the Company or any of its
Subsidiaries or by which the Company or any of its Subsidiaries is or may become bound, (ii) is a party to any contract, agreement or
instrument, the violation of which, or default under which, by the other party(ies) to such contract, agreement or instrument could reasonably
be expected to result in a Material Adverse Effect, (iii) has any financing statements securing obligations in any amounts filed in connection
with the Company or any of its Subsidiaries; (iv) is in violation of any term of, or in default under, any contract, agreement or instrument
relating to any Indebtedness, except where such violations and defaults would not result, individually or in the aggregate, in a Material
Adverse Effect, or (v) is a party to any contract, agreement or instrument relating to any Indebtedness, the performance of which, in
the judgment of the Company’s officers, has or is expected to have a Material Adverse Effect. For purposes of this Agreement: (x)
“Indebtedness” of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all obligations
issued, undertaken or assumed as the deferred purchase price of property or services (including, without limitation, “finance leases”
in accordance with GAAP) (other than trade payables entered into in the ordinary course of business consistent with past practice), (C)
all reimbursement or payment obligations, currently due and payable, with respect to letters of credit, surety bonds and other similar
instruments, (D) all obligations evidenced by notes, bonds, debentures or similar instruments, including obligations so evidenced incurred
in connection with the acquisition of property, assets or businesses, (E) all indebtedness created or arising under any conditional sale
or other title retention agreement, or incurred as financing, in either case with respect to any property or assets acquired with the
proceeds of such indebtedness (even though the rights and remedies of the seller or bank under such agreement in the event of default
are limited to repossession or sale of such property), (F) all monetary obligations under any leasing or similar arrangement which, in
connection with GAAP, consistently applied for the periods covered thereby, is classified as a finance lease, (G) all indebtedness referred
to in clauses (A) through (F) above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise,
to be secured by) any Lien upon or in any property or assets (including accounts and contract rights) owned by any Person, even though
the Person which owns such assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all Contingent
Obligations in respect of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G) above; and (y) “Contingent
Obligation” means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect
to any Indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such
liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability will be paid or
discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability will be protected (in
whole or in part) against loss with respect thereto.
(t)
Litigation. There is no material action, suit, arbitration, proceeding, inquiry or investigation before or by the Principal Market,
any court, public board, other Governmental Entity, self-regulatory organization or body pending or, to the knowledge of the Company,
threatened against or affecting the Company or any of its Subsidiaries, the Common Stock or any of the Company’s or its Subsidiaries’
officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as such, except as disclosed in the SEC
Documents. To its knowledge, no director, officer or employee of the Company or any of its subsidiaries has willfully violated 18 U.S.C.
§1519 or engaged in spoliation in reasonable anticipation of litigation. Without limitation of the foregoing, there has not been,
and to the knowledge of the Company, there is not pending or contemplated, any investigation by the SEC involving the Company, any of
its Subsidiaries or any current or former director or officer of the Company or any of its Subsidiaries relating to the Company. Neither
the Company nor any of its Subsidiaries is subject to any order, writ, judgment, injunction, decree, determination or award of any Governmental
Entity.
11
(u)
Insurance. The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the
Company and its Subsidiaries are engaged. Neither the Company nor any such Subsidiary has been refused any insurance coverage sought
or applied for, and neither the Company nor any such Subsidiary has any reason to believe that it will be unable to renew its existing
insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue
its business at a cost that would not have a Material Adverse Effect.
(v)
Employee Matters; Benefit Plans.
(i)
The Company and its Subsidiaries have complied in all material respects with all applicable laws relating to wages, hours, equal opportunity,
collective bargaining, workers’ compensation insurance and the payment of social security and other taxes. The Company is not aware
that any officer, key employee or group of employees intends to terminate his, her or their employment with the Company or its Subsidiaries,
as the case may be, nor does the Company have a present intention, or know of a present intention of its Subsidiaries, to terminate the
employment of any officer or key employee. There are no pending or, to the knowledge of the Company, threatened employment discrimination
charges or complaints against or involving the Company or its Subsidiaries before any federal, state, or local board, department, commission
or agency, or unfair labor practice charges or complaints, disputes or grievances affecting the Company or its Subsidiaries.
(ii)
No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could
reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a
member of a union that relates to such employee’s relationship with the Company or such Subsidiary, and neither the Company nor
any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good.
(iii)
The Company and its Subsidiaries are in compliance in all material respects with the applicable provisions of the Employee Retirement
Income Security Act of 1974, as amended (“ERISA”). No benefit plan of the Company or any Subsidiary (a) is subject
to the provisions of Section 412 of the Code or Part 3 of Subtitle B of Title I of ERISA, (b) is subject to Title IV of ERISA, (c) is
a “multiemployer plan” (within the meaning of Section 3(37) of ERISA). Since inception, neither the Company, its Subsidiaries,
nor any business or entity treated as a single employer with the Company or its Subsidiaries for purposes of Title IV of ERISA contributed
to or was obliged to contribute to a pension plan that was at any time subject to Title IV of ERISA.
(w)
Assets; Title. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which
is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in material compliance.
(x)
Intellectual Property. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Documents and
which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”).
None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property
Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the
date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements
included within the SEC Documents, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate
or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect.
To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another
Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect
the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect.
12
(y)
Environmental Laws. The Company and its Subsidiaries (A) are in compliance with any and all Environmental Laws (as defined below),
(B) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
businesses and (C) are in compliance with all terms and conditions of any such permit, license or approval where, in each of the foregoing
clauses (A), (B) and (C), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material
Adverse Effect. The term “Environmental Laws” means all federal, state, local or foreign laws relating to pollution
or protection of human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface
or subsurface strata), including, without limitation, laws relating to emissions, discharges, releases or threatened releases of chemicals,
pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the
environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling
of Hazardous Materials, as well as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices
or notice letters, orders, permits, plans or regulations issued, entered, promulgated or approved thereunder.
(z)
Subsidiary Rights. The Company or one of its Subsidiaries has the unrestricted right to vote, and (subject to limitations imposed
by applicable law) to receive dividends and distributions on, all capital securities of its Subsidiaries as owned by the Company or such
Subsidiary.
(aa)
Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income
and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)
has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material
taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no
basis for any such claim.
(bb)
Internal Accounting and Disclosure Controls. Other than as disclosed in the SEC Documents, the Company and each of its Subsidiaries
maintains internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the 1934 Act) that is effective
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with GAAP, including that (i) transactions are executed in accordance with management’s general or specific
authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and
to maintain asset and liability accountability, (iii) access to assets or incurrence of liabilities is permitted only in accordance with
management’s general or specific authorization and (iv) the recorded accountability for assets and liabilities is compared with
the existing assets and liabilities at reasonable intervals and appropriate action is taken with respect to any difference. Other than
as disclosed in the SEC Documents, the Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e)
under the 1934 Act) that are effective in ensuring that information required to be disclosed by the Company in the reports that it files
or submits under the 1934 Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms
of the SEC, including, without limitation, controls and procedures designed to ensure that information required to be disclosed by the
Company in the reports that it files or submits under the 1934 Act is accumulated and communicated to the Company’s management,
including its principal executive officer or officers and its principal financial officer or officers, as appropriate, to allow timely
decisions regarding required disclosure. Since January 1, 2025, other than as disclosed in the SEC Documents, neither the Company nor
any of its Subsidiaries has received any notice or correspondence from any accountant, Governmental Entity or other Person relating to
any material weakness or significant deficiency in any part of the internal controls over financial reporting of the Company or any of
its Subsidiaries.
13
(cc)
Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its
Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act
filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
(dd)
Investment Company Status. The Company is not, and upon consummation of the sale of the Securities will not be, an “investment
company,” an affiliate of an “investment company,” a company controlled by an “investment company” or an
“affiliated person” of, or “promoter” or “principal underwriter” for, an “investment company”
as such terms are defined in the Investment Company Act of 1940, as amended.
(ee)
Acknowledgement Regarding Buyers’ Trading Activity. It is understood and acknowledged by the Company that (i) following
the public disclosure of the transactions contemplated by the Transaction Documents, in accordance with the terms thereof, none of the
Buyers have been asked by the Company or any of its Subsidiaries to agree, nor has any Buyer agreed with the Company or any of its Subsidiaries,
to desist from effecting any transactions in or with respect to (including, without limitation, purchasing or selling, long and/or short)
any securities of the Company, or “derivative” securities based on securities issued by the Company or to hold any of the
Securities for any specified term; (ii) any Buyer, and counterparties in “derivative” transactions to which any such Buyer
is a party, directly or indirectly, presently may have a “short” position in the Common Stock which was established prior
to such Buyer’s knowledge of the transactions contemplated by the Transaction Documents; (iii) each Buyer shall not be deemed to
have any affiliation with or control over any arm’s length counterparty in any “derivative” transaction; and (iv) each
Buyer may rely on the Company’s obligation to timely deliver shares of Common Stock upon conversion, exercise or exchange, as applicable,
of the Securities as and when required pursuant to the Transaction Documents for purposes of effecting trading in the Common Stock of
the Company. The Company further understands and acknowledges that following the public disclosure of the transactions contemplated by
the Transaction Documents pursuant to the 8-K Filing (as defined below) one or more Buyers may engage in hedging and/or trading activities
(including, without limitation, the location and/or reservation of borrowable shares of Common Stock) at various times during the period
that the Securities are outstanding, including, without limitation, during the periods that the value and/or number of the Warrant Shares
or Conversion Shares, as applicable, deliverable with respect to the Securities are being determined and such hedging and/or trading
activities (including, without limitation, the location and/or reservation of borrowable shares of Common Stock), if any, can reduce
the value of the existing stockholders’ equity interest in the Company both at and after the time the hedging and/or trading activities
are being conducted. The Company acknowledges that such aforementioned hedging and/or trading activities do not constitute a breach of
this Agreement, the Certificate of Designations, the Warrants or any other Transaction Document or any of the documents executed in connection
herewith or therewith.
(ff)
Manipulation of Price. Neither the Company nor any of its Subsidiaries has, and, to the knowledge of the Company, no Person acting
on their behalf has, directly or indirectly, (i) taken any action designed to cause or to result in the stabilization or manipulation
of the price of any security of the Company or any of its Subsidiaries to facilitate the sale or resale of any of the Securities, (ii)
sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities (other than the Placement Agent),
(iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company or
any of its Subsidiaries or (iv) paid or agreed to pay any Person for research services with respect to any securities of the Company
or any of its Subsidiaries.
(gg)
U.S. Real Property Holding Corporation. Neither the Company nor any of its Subsidiaries is, or has ever been a U.S. real property
holding corporation within the meaning of Section 897 of the Code, and the Company and each Subsidiary shall so certify upon any Buyer’s
request.
(hh)
Registration Eligibility. Except for rights pursuant to the Registration Rights Agreement, no Person has any right to cause the
Company or any Subsidiary to effect the registration under the 1933 Act of any securities of the Company or any Subsidiary. The Company
is eligible to register the Registrable Securities (as defined in the Registration Rights Agreement) for resale by the Buyers using Form
S-3 promulgated under the 1933 Act.
14
(ii)
Transfer Taxes. On the Closing Date, all stock transfer or other taxes (other than income or similar taxes) which are required
to be paid in connection with the issuance, sale and transfer of the Securities to be sold to each Buyer hereunder will be, or will have
been, fully paid or provided for by the Company, and all laws imposing such taxes will be or will have been complied with.
(jj)
Bank Holding Company Act. Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company Act of 1956,
as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the “Federal
Reserve”). Neither the Company nor any of its Subsidiaries or affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of
a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.
(kk)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i).
(ll)
Illegal or Unauthorized Payments; Political Contributions. Neither the Company nor any of its Subsidiaries nor, to the best of
the Company’s knowledge (after reasonable inquiry of its officers and directors), any of the officers, directors, employees, agents
or other representatives of the Company or any of its Subsidiaries or any other business entity or enterprise with which the Company
or any Subsidiary is or has been affiliated or associated, has, directly or indirectly, made or authorized any payment, contribution
or gift of money, property, or services, whether or not in contravention of applicable law, (i) as a kickback or bribe to any Person
or (ii) to any political organization, or the holder of or any aspirant to any elective or appointive public office except for personal
political contributions not involving the direct or indirect use of funds of the Company or any of its Subsidiaries.
(mm)
Money Laundering. The Company and its Subsidiaries are in compliance with, and have not previously violated, the USA Patriot Act
of 2001 and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations, including, without limitation, the laws,
regulations and Executive Orders and sanctions programs administered by the U.S. Office of Foreign Assets Control, including, but not
limited, to (i) Executive Order 13224 of September 23, 2001 entitled, “Blocking Property and Prohibiting Transactions With Persons
Who Commit, Threaten to Commit, or Support Terrorism” (66 Fed. Reg. 49079 (2001)) and (ii) any regulations contained in 31 CFR,
Subtitle B, Chapter V.
(nn)
Stock Option Plans. Each stock option granted by the Company was granted (i) in accordance with the terms of the applicable stock
option plan of the Company and (ii) with an exercise price at least equal to the fair market value of the shares of Common Stock on the
date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company’s stock
option plan has been backdated. The Company has not knowingly granted, and there is no and has been no policy or practice of the Company
to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public
announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.
(oo)
No Disagreements with Accountants and Lawyers. There are no material disagreements of any kind presently existing, or reasonably
anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company
and the Company is current with respect to any fees owed to its accountants and lawyers which could affect the Company’s ability
to perform any of its obligations under any of the Transaction Documents. In addition, on or prior to the date hereof, the Company had
discussions with its accountants about its financial statements previously filed with the SEC. Based on those discussions, the Company
has no reason to believe that it will need to restate any such financial statements or any part thereof.
15
(pp)
No Disqualification Events. With respect to Securities to be offered and sold hereunder in reliance on Rule 506(b) under the 1933
Act (“Regulation D Securities”), none of the Company, any of its predecessors, any affiliated issuer, any director,
executive officer, other officer of the Company participating in the offering contemplated hereby, any beneficial owner of 20% or more
of the Company’s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term
is defined in Rule 405 under the 1933 Act) connected with the Company in any capacity at the time of sale (each, an “Issuer
Covered Person” and, together, “Issuer Covered Persons”) is subject to any of the “Bad Actor”
disqualifications described in Rule 506(d)(1)(i) to (viii) under the 1933 Act (a “Disqualification Event”), except
for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any
Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure
obligations under Rule 506(e), and has furnished to the Buyers a copy of any disclosures provided thereunder.
(qq)
Other Covered Persons. The Company is not aware of any Person (other than the Placement Agent) that has been or will be paid (directly
or indirectly) remuneration for solicitation of Buyers or potential purchasers in connection with the sale of any Regulation D Securities.
(rr)
No Additional Agreements. The Company does not have any agreement or understanding with any Buyer with respect to the transactions
contemplated by the Transaction Documents other than as specified in the Transaction Documents.
(ss)
Public Utility Holding Act. None of the Company nor any of its Subsidiaries is a “holding company,” or an “affiliate”
of a “holding company,” as such terms are defined in the Public Utility Holding Act of 2005.
(tt)
Federal Power Act. None of the Company nor any of its Subsidiaries is subject to regulation as a “public utility”
under the Federal Power Act, as amended.
(uu)
Cybersecurity. The Company and its Subsidiaries’ information technology assets and equipment, computers, systems, networks,
hardware, software, websites, applications, and databases (collectively, “IT Systems”) are adequate for, and operate
and perform in all material respects as required in connection with the operation of the business of the Company and its subsidiaries
as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants
that would reasonably be expected to have a Material Adverse Effect on the Company’s business. The Company and its Subsidiaries
have implemented and maintained commercially reasonable physical, technical and administrative controls, policies, procedures, and safeguards
to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all
IT Systems and data, including “Personal Data,” used in connection with their businesses. “Personal Data” means
(i) a natural person’s name, street address, telephone number, e-mail address, photograph, social security number or tax identification
number, driver’s license number, passport number, credit card number, bank information, or customer or account number; (ii) any
information which would qualify as “personally identifying information” under the Federal Trade Commission Act, as amended;
(iii) “personal data” as defined by the European Union General Data Protection Regulation (“GDPR”) (EU
2016/679); (iv) any information which would qualify as “protected health information” under the Health Insurance Portability
and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act (collectively, “HIPAA”);
and (v) any other piece of information that allows the identification of such natural person, or his or her family, or permits the collection
or analysis of any data related to an identified person’s health or sexual orientation. Since January 1, 2025, there have been
no breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied without material
cost or liability or the duty to notify any other person or such, nor any incidents under internal review or investigations relating
to the same except in each case, where such would not, either individually or in the aggregate, reasonably be expected to result in a
Material Adverse Effect. The Company and its Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments,
orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations
relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from
unauthorized use, access, misappropriation or modification except in each case, where such would not, either individually or in the aggregate,
reasonably be expected to result in a Material Adverse Effect.
16
(vv)
Compliance with Data Privacy Laws. The Company and its Subsidiaries are in compliance with all applicable state and federal data
privacy and security laws and regulations, including without limitation HIPAA, and the Company and its Subsidiaries have taken commercially
reasonable actions to prepare to comply with, and since May 25, 2018, have been and currently are in compliance with, the GDPR (EU 2016/679)
(collectively, the “Privacy Laws”) except in each case, where such would not, either individually or in the aggregate,
reasonably be expected to result in a Material Adverse Effect. To ensure compliance with the Privacy Laws, the Company and its Subsidiaries
have in place, comply with, and take appropriate steps reasonably designed to ensure compliance in all material respects with their policies
and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal
Data (the “Policies”). The Company and its Subsidiaries have made all disclosures to users or customers required by
applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy have, to the knowledge
of the Company, been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect.
The Company further certifies that neither it nor any Subsidiary: (i) has received notice of any actual or potential liability under
or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would
reasonably be expected to result in any such notice; (ii) is currently conducting or paying for, in whole or in part, any investigation,
remediation, or other corrective action pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement that imposes
any obligation or liability under any Privacy Law.
(ww)
Disclosure. The Company confirms that neither it nor any other Person acting on its behalf has provided any of the Buyers
or their agents or counsel with any information that constitutes or could reasonably be expected to constitute material, non-public information
concerning the Company or any of its Subsidiaries, other than the existence of the transactions contemplated by this Agreement and the
other Transaction Documents. The Company understands and confirms that each of the Buyers will rely on the foregoing representations
in effecting transactions in securities of the Company. All disclosure provided to the Buyers regarding the Company and its Subsidiaries,
their businesses and the transactions contemplated hereby, including the schedules to this Agreement, furnished by or on behalf of the
Company or any of its Subsidiaries is true and correct and does not contain any untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made,
not misleading. Each press release issued by the Company or any of its Subsidiaries during the twelve (12) months preceding the date
of this Agreement did not at the time of release contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they are made,
not misleading. Other than with respect to the transactions contemplated by this Agreement and the other Transaction Documents, no event
or circumstance has occurred or information exists with respect to the Company or any of its Subsidiaries or its or their business, properties,
liabilities, prospects, operations (including results thereof) or conditions (financial or otherwise), which, under applicable law, rule
or regulation, requires public disclosure at or before the date hereof or announcement by the Company but which has not been so publicly
disclosed. The Company acknowledges and agrees that no Buyer makes or has made any representations or warranties with respect to the
transactions contemplated hereby other than those specifically set forth in Section 2.
4.
COVENANTS.
(a)
Best Efforts. Each Buyer shall use its best efforts to timely satisfy each of the covenants hereunder and conditions to be satisfied
by it as provided in Section 6 of this Agreement. The Company shall use its best efforts to timely satisfy each of the covenants
hereunder and conditions to be satisfied by it as provided in Section 7 of this Agreement.
(b)
Form D and Blue Sky. The Company shall file a Form D with respect to the Securities as required under Regulation D and to provide
a copy thereof to each Buyer promptly after such filing. The Company shall, on or before the Closing Date, take such action as the Company
shall reasonably determine is necessary in order to obtain an exemption for, or to, qualify the Securities for sale to the Buyers at
the Closing pursuant to this Agreement under applicable securities or “Blue Sky” laws of the states of the United States
(or to obtain an exemption from such qualification), and shall provide evidence of any such action so taken to the Buyers on or prior
to the Closing Date. Without limiting any other obligation of the Company under this Agreement, the Company shall timely make all filings
and reports relating to the offer and sale of the Securities required under all applicable securities laws (including, without limitation,
all applicable federal securities laws and all applicable “Blue Sky” laws), and the Company shall comply with all applicable
federal, foreign, state and local laws, statutes, rules, regulations and the like relating to the offering and sale of the Securities
to the Buyers.
17
(c)
Reporting Status. From the date hereof until the date on which the Buyers shall have sold all of the Registrable Securities (the
“Reporting Period”), the Company shall timely file all reports required to be filed with the SEC pursuant to the 1934
Act, and the Company shall not terminate its status as an issuer required to file reports under the 1934 Act even if the 1934 Act or
the rules and regulations thereunder would no longer require or otherwise permit such termination. The Company shall take all actions
necessary to maintain its eligibility to register the Registrable Securities for resale by the Buyers on Form S-3.
(d)
Use of Proceeds. The Company shall use the proceeds from the sale of the Securities for general corporate purposes, but not, directly
or indirectly, for (i) the satisfaction of any indebtedness of the Company or any of its Subsidiaries outstanding on the date hereof
or (ii) the settlement of any litigation outstanding on the date hereof.
(e)
Financial Information. The Company agrees to send the following to each Investor (as defined in the Registration Rights Agreement)
during the Reporting Period (i) unless the following are filed with the SEC through EDGAR and are available to the public through the
EDGAR system, within one (1) Business Day after the filing thereof with the SEC, a copy of its Annual Report on Form 10-K, Quarterly
Reports on Form 10-Q, any other interim reports or any consolidated balance sheets, income statements, stockholders’ equity statements
and/or cash flow statements for any period other than any annual report, any Current Reports on Form 8-K and any registration statements
(other than on Form S-8) or amendments filed pursuant to the 1933 Act, (ii) unless the following are either filed with the SEC through
EDGAR or are otherwise widely disseminated via a recognized news release service (such as PR Newswire), on the same day as the release
thereof, e-mail copies of all press releases issued by the Company or any of its Subsidiaries and (iii) unless the following are filed
with the SEC through EDGAR, copies of any notices and other information made available or given to the stockholders of the Company, as
applicable, generally, contemporaneously with the making available or giving thereof to the stockholders.
(f)
Listing. The Company shall promptly secure the listing or designation for quotation (as the case may be) of all of the Registrable
Securities upon each national securities exchange and automated quotation system, if any, upon which the Common Stock is then listed
or designated for quotation (as the case may be) (subject to official notice of issuance) and shall maintain such listing or designation
for quotation (as the case may be) of all Registrable Securities from time to time issuable under the terms of the Transaction Documents
on such national securities exchange or automated quotation system. The Company shall maintain the Common Stock’s listing or authorization
for quotation (as the case may be) on the Principal Market, The New York Stock Exchange, the NYSE American, the Nasdaq Global Market
or the Nasdaq Global Select Market (each, an “Eligible Market”). Neither the Company nor any of its Subsidiaries shall
take any action which could be reasonably expected to result in the delisting or suspension of the Common Stock on the Principal Market.
The Company shall pay all fees and expenses in connection with satisfying its obligations under this Section 4(f).
(g)
Fees. The Company shall reimburse the lead Buyer a non-accountable amount of $50,000 for all costs and expenses incurred by it
or its affiliates in connection with the structuring, documentation, negotiation and closing of the transactions contemplated by the
Transaction Documents (including, without limitation, as applicable, all reasonable legal fees of outside counsel and disbursements of
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (“Buyer Counsel”), counsel to the lead Buyer, any other reasonable
fees and expenses in connection with the structuring, documentation, negotiation and closing of the transactions contemplated by the
Transaction Documents and due diligence and regulatory filings in connection therewith) (the “Transaction Expenses”)
and shall be withheld by the lead Buyer from its Purchase Price at the Closing. The Company shall be responsible for the payment of any
placement agent’s fees, financial advisory fees, transfer agent fees, DTC (as defined below) fees or broker’s commissions
(other than for Persons engaged by any Buyer) relating to or arising out of the transactions contemplated hereby (including, without
limitation, any fees or commissions payable to the Placement Agent). The Company shall pay, and the Company shall hold each Buyer harmless
against, any liability, loss or expense (including, without limitation, reasonable attorneys’ fees and out-of-pocket expenses)
arising in connection with any claim relating to any such payment. Except as otherwise set forth in the Transaction Documents, each party
to this Agreement shall bear its own expenses in connection with the sale of the Securities to the Buyers.
18
(h)
Pledge of Securities. Notwithstanding anything to the contrary contained in this Agreement, the Company acknowledges and agrees
that the Securities may be pledged by a Buyer in connection with a bona fide margin agreement or other loan or financing arrangement
that is secured by the Securities. The pledge of Securities shall not be deemed to be a transfer, sale or assignment of the Securities
hereunder, and no Buyer effecting a pledge of Securities shall be required to provide the Company with any notice thereof or otherwise
make any delivery to the Company pursuant to this Agreement or any other Transaction Document, including, without limitation, Section
2(g) hereof; provided that a Buyer and its pledgee shall be required to comply with the provisions of Section 2(g)
hereof in order to effect a sale, transfer or assignment of Securities to such pledgee. The Company hereby agrees to execute and deliver
such documentation as a pledgee of the Securities may reasonably request in connection with a pledge of the Securities to such pledgee
by a Buyer.
(i)
Disclosure of Transactions and Other Material Information.
(i)
Disclosure of Transaction. The Company shall no later than 9:30 a.m., New York time, on the Business Day following the date of
this Agreement, file a Current Report on Form 8-K describing all the material terms of the transactions contemplated by the Transaction
Documents in the form required by the 1934 Act and attaching all the material Transaction Documents (including, without limitation, this
Agreement (and all schedules to this Agreement, to the extent material), the form of Certificate of Designations, the form of the Warrant
and the form of the Registration Rights Agreement) (including the attachments thereto, the “8-K Filing”). From and
after the filing of the 8-K Filing, the Company shall have disclosed all material, non-public information (if any) provided to any of
the Buyers by the Company or any of its Subsidiaries or any of their respective officers, directors, employees or agents in connection
with the transactions contemplated by the Transaction Documents. In addition, effective upon the filing of the 8-K Filing, the Company
acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between
the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one hand,
and any of the Buyers or any of their affiliates, on the other hand, shall terminate.
(ii)
Limitations on Disclosure. The Company shall not, and the Company shall cause each of its Subsidiaries and each of its and their
respective officers, directors, employees and agents not to, provide any Buyer with any material, non-public information regarding the
Company or any of its Subsidiaries from and after the date hereof without the express prior written consent of such Buyer (which may
be granted or withheld in such Buyer’s sole discretion). In the event of a breach of any of the foregoing covenants, including,
without limitation, Section 4(o) of this Agreement, or any of the covenants or agreements contained in any other Transaction Document,
by the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees and agents (as determined in
the reasonable good faith judgment of such Buyer), in addition to any other remedy provided herein or in the Transaction Documents, such
Buyer shall have the right to make a public disclosure, in the form of a press release, public advertisement or otherwise, of such breach
or such material, non-public information, as applicable, without the prior approval by the Company, any of its Subsidiaries, or any of
its or their respective officers, directors, employees or agents. No Buyer shall have any liability to the Company, any of its Subsidiaries,
or any of its or their respective officers, directors, employees, affiliates, stockholders or agents, for any such disclosure. To the
extent that the Company, directly or indirectly, delivers any material, non-public information to a Buyer without such Buyer’s
consent, the Company hereby covenants and agrees that such Buyer shall not have any duty of confidentiality with respect to, or a duty
not to trade on the basis of, such material, non-public information. Subject to the foregoing, neither the Company, its Subsidiaries
nor any Buyer shall issue any press releases or any other public statements with respect to the transactions contemplated hereby; provided,
however, the Company shall be entitled, without the prior approval of any Buyer, to make any press release or other public disclosure
with respect to such transactions (i) in substantial conformity with the 8-K Filing and contemporaneously therewith and (ii) as is required
by applicable law and regulations (provided that in the case of clause (i) each Buyer shall be consulted by the Company in connection
with any such press release or other public disclosure prior to its release). Without the prior written consent of the applicable Buyer
(which may be granted or withheld in such Buyer’s sole discretion), the Company shall not (and shall cause each of its Subsidiaries
and affiliates to not) disclose the name of such Buyer in any filing, announcement, release or otherwise. Notwithstanding anything contained
in this Agreement to the contrary and without implication that the contrary would otherwise be true, the Company expressly acknowledges
and agrees that no Buyer shall have (unless expressly agreed to by a particular Buyer after the date hereof in a written definitive and
binding agreement executed by the Company and such particular Buyer (it being understood and agreed that no Buyer may bind any other
Buyer with respect thereto)), any duty of confidentiality with respect to, or a duty not to trade on the basis of, any material, non-public
information regarding the Company and/or any of its Subsidiaries.
19
(j)
Additional Registration Statements. From the date hereof until the Applicable Date (as defined below) and at any time thereafter
while any Registration Statement (as defined in the Registration Rights Agreement) is not effective or the prospectus contained therein
is not available for use or any Current Public Information Failure (as defined in the Registration Rights Agreement) exists, the Company
shall not file a registration statement or an offering statement under the 1933 Act relating to securities that are not the Registrable
Securities (other than a registration statement on Form S-8 or such supplements or amendments to registration statements that are outstanding
and have been declared effective by the SEC as of the date hereof (solely to the extent necessary to keep such registration statements
effective and available and not with respect to any Subsequent Placement)). “Applicable Date” means the earlier of
(x) the first date on which the resale by the Buyers of all the Registrable Securities required to be filed on the initial Registration
Statement pursuant to the Registration Rights Agreement is declared effective by the SEC (and each prospectus contained therein is available
for use on such date) or (y) the first date on which all of the Registrable Securities are eligible to be resold by the Buyers pursuant
to Rule 144 (or, if a Current Public Information Failure has occurred and is continuing, such later date after which the Company has
cured such Current Public Information Failure).
(k)
Additional Issuance of Securities. So long as any Buyer beneficially owns any Preferred Shares or Warrants, the Company will not,
without the prior written consent of the Required Holders, directly or indirectly, issue any other securities that would cause a breach
or default under the Certificate of Designations or the Warrants. The Company agrees that unless Stockholder Approval (as defined herein)
is obtained, the Company shall not affect any Dilutive Issuance (as defined in the Certificate of Designations). The Company further
agrees that for the period commencing on the date hereof and ending on the date that is ninety (90) days following the Applicable Date
(provided that such period shall be extended by the number of calendar days during such period and any extension thereof contemplated
by this Section 4(k) on which any Registration Statement is not effective or any prospectus contained therein is not available
for use or any Current Public Information Failure exists) (the “Restricted Period”), neither the Company nor any of
its Subsidiaries shall directly or indirectly issue, offer, sell, grant any option or right to purchase, or otherwise dispose of (or
announce any issuance, offer, sale, grant of any option or right to purchase or other disposition of) any equity security or any equity-linked
or related security (including, without limitation, any “equity security” (as that term is defined under Rule 405 promulgated
under the 1933 Act), any Convertible Securities (as defined below), any preferred stock or any purchase rights) (any such issuance, offer,
sale, grant, disposition or announcement (whether occurring during the Restricted Period or at any time thereafter), is referred to as
a “Subsequent Placement”). Notwithstanding the foregoing, this Section 4(k) shall not apply in respect of the
issuance of (i) shares of Common Stock or other awards convertible, exercisable for or exchangeable for shares of Common Stock issued
or issuable to directors, officers, employees or other service providers of the Company in their capacity as such pursuant to an Approved
Stock Plan (as defined below), provided that (1) all such issuances (taking into account the shares of Common Stock issuable upon exercise
of such awards) do not, in the aggregate, exceed more than 10.0% of the shares of Common Stock issued and outstanding immediately prior
to such issuance and (2) the exercise price of any such options is not lowered and none of such options are amended to increase the number
of shares issuable thereunder or extend the term of such options; (ii) shares of Common Stock issued or issuable upon the conversion
or exercise of Convertible Securities (other than shares of Common Stock issued or issuable pursuant to an Approved Stock Plan that are
covered by clause (i) above) issued prior to the date hereof, provided that the conversion, exercise or other method of issuance (as
the case may be) of any such Convertible Security is made solely pursuant to the conversion, exercise or other method of issuance (as
the case may be) provisions of such Convertible Security that were in effect on the date immediately prior to the date of this Agreement,
the conversion, exercise or issuance price of any such Convertible Securities (other than standard options to purchase shares of Common
Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) is not lowered, none of such Convertible Securities
are amended to increase the number of shares issuable thereunder and none of the terms or conditions of any such Convertible Securities
(other than those issued pursuant to an Approved Stock Plan that are covered by clause (i) above) are otherwise materially changed in
any manner that materially adversely affects any of the Buyers; (iii) securities issued as consideration for the acquisition of another
entity by the Company by merger, purchase of substantially all of the assets or other reorganization or bona fide joint venture agreement,
provided that such issuance is approved by the majority of the disinterested directors of the Company and provided that such securities
are issued as “restricted securities” (as defined in Rule 144) and carry no registration rights that require or permit the
filing of any registration statement in connection therewith during the Restricted Period and such issuance does not, in the aggregate,
exceed more than 5% of the shares of Common Stock issued and outstanding immediately prior to the date hereof; (iv) the issuance of the
payment of dividends of preferred share purchase rights (the “Rights”), with each such Right entitling the holder
to purchase from the Company one one-thousandth of a share of Series A Junior Participating Preferred Stock, par value $0.0001 per share
(the “Series A Preferred Stock”), of the Company, declared by the board of directors of the Company on July 31, 2025,
to stockholders of record at the close of business on August 11, 2025; (v) the Series A Preferred Stock, pursuant to that certain Certificate
of Designations establishing the rights, preferences, restrictions and other matters relating to the Series A Preferred Stock (the “Series
A Certificate of Designations”); (vi) shares of Common Stock as payment of dividends on the Series A Preferred Stock in accordance
with the Series A Certificate of Designations; (vii) shares of Series J Convertible Preferred Stock, par value $0.0001 per share (the
“Series J Preferred Stock”), pursuant to that certain Certificate of Designations establishing the rights, preferences,
restrictions and other matters relating to the Series J Preferred Stock (the “Series J Certificate of Designations”)
(each of the foregoing in clauses (i) through (vii), collectively the “Excluded Securities”); (viii) shares of Common
Stock issuable upon conversion of the Company’s Series I Convertible Preferred Stock, par value $0.0001 per share (the “Series
I Preferred Stock”) or as payment of dividends thereon, pursuant to that certain Certificate of Designations establishing the
rights, preferences, restrictions and other matters relating to the Series I Preferred Stock (the “Series I Certificate of Designations”);
(ix) shares of Common Stock issuable upon conversion of the Company’s Series H-7 Convertible Preferred Stock, par value $0.0001
per share (the “Series H-7 Preferred Stock”) or as payment of dividends thereon, pursuant to that certain Certificate
of Designations establishing the rights, preferences, restrictions and other matters relating to the Series H-7 Preferred Stock (the
“Series H-7 Certificate of Designations”); (x) shares of Common Stock issuable upon conversion of the Company’s
Series J Preferred Stock pursuant to the Series J Certificate of Designations or as payment of dividends thereon; (xi) the Preferred
Shares; (xii) the Conversion Shares; (xiii) the Warrant Shares and any other securities issued or issuable pursuant to this Agreement
or any of the Transaction Documents, including, without limitation, any shares of Common Stock issued or issuable pursuant to Section
9 of the Certificate of Designations (each of the foregoing in clauses (viii) through (xiii), collectively the “Additional Excluded
Securities” and, the Additional Excluded Securities together with the Excluded Securities, the “Exempted Securities”);
and (xiv) provided the closing price of the Common Stock on the Trading Market equals or exceeds 200% of the initial Conversion Price
(as defined in the Certificate of Designations) for three consecutive Trading Days, sales of shares of Common Stock or Convertible Securities
at a per share purchase price in excess of 160% of the initial Conversion Price (as defined in the Certificate of Designations) (as adjusted
for stock splits, stock dividends, stock combinations, recapitalizations and similar events; provided that if 90% of the aggregate
Stated Value (as defined in the Certificate of Designations) of the Preferred Shares has been paid in full to the Buyers or otherwise
converted to Common Stock, then the Company may sell shares of Common Stock at a per share purchase price in excess of 130% of the exercise
price of the Warrants). “Approved Stock Plan” means any employee benefit plan which has been approved by the board
of directors of the Company prior to or subsequent to the date hereof pursuant to which shares of Common Stock or other awards convertible,
exercisable for or exchangeable for shares of Common Stock may be issued to any employee, officer, director or other service provider
for services provided to the Company and/or a Subsidiary in their capacity as such.
20
(l)
Reservation of Shares. So long as any of the Preferred Shares or Warrants remain outstanding, the Company shall take all action
necessary to at all times have authorized, and reserved for the purpose of issuance, no less than the sum of (i) 200% of the maximum
number of shares of Common Stock issuable upon conversion of all the Preferred Shares then outstanding (assuming for purposes hereof
that (x) the Preferred Shares are convertible at the Floor Price (as defined in the Certificate of Designations) then in effect and (y)
any such conversion shall not take into account any limitations on the conversion of the Preferred Shares set forth in the Certificate
of Designations), and (ii) the maximum number of Warrant Shares issuable upon exercise of all the Warrants then outstanding (without
regard to any limitations on the exercise of the Warrants set forth therein) (collectively, the “Required Reserve Amount”);
provided that at no time shall the number of shares of Common Stock reserved pursuant to this Section 4(l) be reduced other
than proportionally in connection with any conversion, exercise and/or redemption, as applicable of Preferred Shares and Warrants. If
at any time the number of shares of Common Stock authorized and reserved for issuance is not sufficient to meet the Required Reserve
Amount, the Company will promptly take all corporate action necessary to authorize and reserve a sufficient number of shares, including,
without limitation, calling a special meeting of stockholders to authorize additional shares to meet the Company’s obligations
pursuant to the Transaction Documents, in the case of an insufficient number of authorized shares, obtain stockholder approval of an
increase in such authorized number of shares, and voting the management shares of the Company in favor of an increase in the authorized
shares of the Company to ensure that the number of authorized shares is sufficient to meet the Required Reserve Amount.
(m)
Conduct of Business. The business of the Company and its Subsidiaries shall not be conducted in violation of any law, ordinance
or regulation of any Governmental Entity, except where such violations would not reasonably be expected to result, either individually
or in the aggregate, in a Material Adverse Effect.
(n)
Restriction on Variable Securities. Commencing on the date hereof until no Warrants remain outstanding, the Company and each Subsidiary
shall be prohibited from effecting or entering into an agreement to effect any Subsequent Placement involving a Variable Rate Transaction.
“Variable Rate Transaction” means a transaction in which the Company or any Subsidiary (i) issues or sells any Convertible
Securities either (A) at a conversion, exercise or exchange rate or other price that is based upon and/or varies with the trading prices
of or quotations for the shares of Common Stock at any time after the initial issuance of such Convertible Securities, or (B) with a
conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such Convertible
Securities or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or
the market for the Common Stock, other than pursuant to a customary “weighted average” anti-dilution provision or (ii) enters
into any agreement (including, without limitation, an equity line of credit or an “at-the-market” offering) whereby the Company
or any Subsidiary may sell securities at a future determined price (other than standard and customary “preemptive” or “participation”
rights). Each Buyer shall be entitled to obtain injunctive relief against the Company and its Subsidiaries to preclude any such issuance,
which remedy shall be in addition to any right to collect damages.
(o)
Participation Right. At any time after the Closing Date and until Preferred Shares are no longer outstanding, neither the Company
nor any of its Subsidiaries shall, directly or indirectly, effect any Subsequent Placement unless the Company shall have first complied
with this Section 4(o). The Company acknowledges and agrees that the right set forth in this Section 4(o) is a right granted
by the Company, separately, to each Buyer.
(i)
At least five (5) Trading Days prior to any proposed or intended Subsequent Placement, the Company shall deliver to each Buyer a written
notice (each such notice, a “Pre-Notice”), which Pre-Notice shall not contain any information (including, without
limitation, material, non-public information) other than: (A) if the proposed Offer Notice (as defined below) constitutes or contains
material, non-public information, a statement asking whether the Buyer is willing to accept material non-public information or (B) if
the proposed Offer Notice does not constitute or contain material, non-public information, (x) a statement that the Company proposes
or intends to effect a Subsequent Placement, (y) a statement that the statement in clause (x) above does not constitute material, non-public
information and (z) a statement informing such Buyer that it is entitled to receive an Offer Notice (as defined below) with respect to
such Subsequent Placement upon its written request. Upon the written request of a Buyer within three (3) Trading Days after the Company’s
delivery to such Buyer of such Pre-Notice, and only upon a written request by such Buyer, the Company shall promptly, but no later than
one (1) Trading Day after such request, deliver to such Buyer an irrevocable written notice (the “Offer Notice”) of
any proposed or intended issuance or sale or exchange (the “Offer”) of the securities being offered (the “Offered
Securities”) in a Subsequent Placement, which Offer Notice shall (A) identify and describe the Offered Securities, (B) describe
the price and other terms upon which they are to be issued, sold or exchanged, and the number or amount of the Offered Securities to
be issued, sold or exchanged, (C) identify the Persons (if known) to which or with which the Offered Securities are to be offered, issued,
sold or exchanged and (D) offer to issue and sell to or exchange with such Buyer in accordance with the terms of the Offer such Buyer’s
pro rata portion of 50% of the Offered Securities, provided that the number of Offered Securities which such Buyer shall have the right
to subscribe for under this Section 4(o) shall be (x) based on such Buyer’s pro rata portion of the aggregate stated value
of the Preferred Shares purchased hereunder by all Buyers (the “Basic Amount”), and (y) with respect to each Buyer
that elects to purchase its Basic Amount, any additional portion of the Offered Securities attributable to the Basic Amounts of other
Buyers as such Buyer shall indicate it will purchase or acquire should the other Buyers subscribe for less than their Basic Amounts (the
“Undersubscription Amount”), which process shall be repeated until each Buyer shall have an opportunity to subscribe
for any remaining Undersubscription Amount.
21
(ii)
To accept an Offer, in whole or in part, such Buyer must deliver a written notice to the Company prior to the end of the fifth (5th)
Business Day after such Buyer’s receipt of the Offer Notice (the “Offer Period”), setting forth the portion
of such Buyer’s Basic Amount that such Buyer elects to purchase and, if such Buyer shall elect to purchase all of its Basic Amount,
the Undersubscription Amount, if any, that such Buyer elects to purchase (in either case, the “Notice of Acceptance”).
If the Basic Amounts subscribed for by all Buyers are less than the total of all of the Basic Amounts, then each Buyer who has set forth
an Undersubscription Amount in its Notice of Acceptance shall be entitled to purchase, in addition to the Basic Amounts subscribed for,
the Undersubscription Amount it has subscribed for; provided, however, if the Undersubscription Amounts subscribed for
exceed the difference between the total of all the Basic Amounts and the Basic Amounts subscribed for (the “Available Undersubscription
Amount”), each Buyer who has subscribed for any Undersubscription Amount shall be entitled to purchase only that portion of
the Available Undersubscription Amount as the Basic Amount of such Buyer bears to the total Basic Amounts of all Buyers that have subscribed
for Undersubscription Amounts, subject to rounding by the Company to the extent it deems reasonably necessary. Notwithstanding the foregoing,
if the Company desires to modify or amend the terms and conditions of the Offer prior to the expiration of the Offer Period, the Company
may deliver to each Buyer a new Offer Notice and the Offer Period shall expire on the fifth (5th) Business Day after such Buyer’s
receipt of such new Offer Notice.
(iii)
The Company shall have five (5) Business Days from the expiration of the Offer Period above (A) to offer, issue, sell or exchange all
or any part of such Offered Securities as to which a Notice of Acceptance has not been given by a Buyer (the “Refused Securities”)
pursuant to a definitive agreement(s) (the “Subsequent Placement Agreement”), but only to the offerees described in
the Offer Notice (if so described therein) and only upon terms and conditions (including, without limitation, unit prices and interest
rates) that are not more favorable to the acquiring Person or Persons or less favorable to the Company than those set forth in the Offer
Notice and (B) to publicly announce (x) the execution of such Subsequent Placement Agreement, and (y) either (I) the consummation of
the transactions contemplated by such Subsequent Placement Agreement or (II) the termination of such Subsequent Placement Agreement,
which shall be filed with the SEC on a Current Report on Form 8-K with such Subsequent Placement Agreement and any documents contemplated
therein filed as exhibits thereto.
(iv)
In the event the Company shall propose to sell less than all the Refused Securities (any such sale to be in the manner and on the terms
specified in Section 4(o)(iii) above), then each Buyer may, at its sole option and in its sole discretion, withdraw its Notice
of Acceptance or reduce the number or amount of the Offered Securities specified in its Notice of Acceptance to an amount that shall
be not less than the number or amount of the Offered Securities that such Buyer elected to purchase pursuant to Section 4(o)(ii)
above multiplied by a fraction, (i) the numerator of which shall be the number or amount of Offered Securities the Company actually proposes
to issue, sell or exchange (including Offered Securities to be issued or sold to Buyers pursuant to this Section 4(o) prior to
such reduction) and (ii) the denominator of which shall be the original amount of the Offered Securities. In the event that any Buyer
so elects to reduce the number or amount of Offered Securities specified in its Notice of Acceptance, the Company may not issue, sell
or exchange more than the reduced number or amount of the Offered Securities unless and until such securities have again been offered
to the Buyers in accordance with Section 4(o)(i) above.
(v)
Upon the closing of the issuance, sale or exchange of all or less than all of the Refused Securities, such Buyer shall acquire from the
Company, and the Company shall issue to such Buyer, the number or amount of Offered Securities specified in its Notice of Acceptance,
as reduced pursuant to Section 4(o)(iv) above if such Buyer has so elected, upon the terms and conditions specified in the Offer.
The purchase by such Buyer of any Offered Securities is subject in all cases to the preparation, execution and delivery by the Company
and such Buyer of a separate purchase agreement relating to such Offered Securities reasonably satisfactory in form and substance to
such Buyer and its counsel.
22
(vi)
Any Offered Securities not acquired by a Buyer or other Persons in accordance with this Section 4(o) may not be issued, sold or
exchanged until they are again offered to such Buyer under the procedures specified in this Agreement.
(vii)
The Company and each Buyer agree that if any Buyer elects to participate in the Offer, (x) neither the Subsequent Placement Agreement
with respect to such Offer nor any other transaction documents related thereto (collectively, the “Subsequent Placement Documents”)
shall include any term or provision whereby such Buyer shall be required to agree to any restrictions on trading as to any securities
of the Company or be required to consent to any amendment to or termination of, or grant any waiver, release or the like under or in
connection with, any agreement previously entered into with the Company or any instrument received from the Company, and (y) any registration
rights set forth in such Subsequent Placement Documents shall be similar in all material respects to the registration rights contained
in the Registration Rights Agreement.
(viii)
Notwithstanding anything to the contrary in this Section 4(o) and unless otherwise agreed to by such Buyer, the Company shall
either confirm in writing to such Buyer that the transaction with respect to the Subsequent Placement has been abandoned or shall publicly
disclose its intention to issue the Offered Securities, in either case, in such a manner such that such Buyer will not be in possession
of any material, non-public information, by the fifth (5th) Business Day following delivery of the Offer Notice. If by such fifth (5th)
Business Day, no public disclosure regarding a transaction with respect to the Offered Securities has been made, and no notice regarding
the abandonment of such transaction has been received by such Buyer, such transaction shall be deemed to have been abandoned and such
Buyer shall not be in possession of any material, non-public information with respect to the Company or any of its Subsidiaries. Should
the Company decide to pursue such transaction with respect to the Offered Securities, the Company shall provide such Buyer with another
Offer Notice and such Buyer will again have the right of participation set forth in this Section 4(o). The Company shall not be
permitted to deliver more than one such Offer Notice to such Buyer in any sixty (60) day period, except as expressly contemplated by
the last sentence of Section 4(o)(ii).
(ix)
The restrictions contained in this Section 4(o) shall not apply in connection with the issuance of any Exempted Securities.
(p)
Dilutive Issuances. For so long as any Preferred Shares or Warrants remain outstanding, the Company shall not, in any manner,
enter into or affect any Dilutive Issuance (as defined in the Certificate of Designations) if the effect of such Dilutive Issuance is
to cause the Company to be required to issue upon conversion of any Preferred Shares or exercise of any Warrant any shares of Common
Stock in excess of that number of shares of Common Stock which the Company may issue upon conversion of the Preferred Shares and exercise
of the Warrants without breaching the Company’s obligations under the rules or regulations of the Principal Market.
(q)
Restriction of Redemption and Cash Dividends. So long as any Preferred Shares are outstanding, except as provided in the Certificate
of Designations, the Company shall not, directly or indirectly, redeem, or declare or pay any cash dividend or distribution on, any securities
of the Company without the prior express written consent of the Buyers.
(r)
Corporate Existence. So long as any Buyer beneficially owns any Preferred Shares or Warrants, the Company shall not be party to
any Fundamental Transaction (as defined in the Certificate of Designations) unless the Company is in compliance with the applicable provisions
governing Fundamental Transactions set forth in the Certificate of Designations and the Warrants.
(s)
Stock Splits. Until the Preferred Shares are no longer outstanding, the Company shall not effect any stock combination, reverse
stock split or other similar transaction (or make any public announcement or disclosure with respect to any of the foregoing) without
the prior written consent of the Required Holders (as defined below); provided, however, that the Company may effect a
stock combination, reverse stock split or other similar transaction if necessary to comply with the requirements of the Principal Market
without the prior written consent of the Required Holders.
23
(t)
Conversion and Exercise Procedures. Each of the form of Exercise Notice (as defined in the Warrants) included in the Warrants
and the form of Conversion Notice (as defined in the Certificate of Designations) included in the Certificate of Designations set forth
the totality of the procedures required of the Buyers in order to exercise the Warrants or convert the Preferred Shares. Except as provided
in Section 5(d), no additional legal opinion, other information or instructions shall be required of the Buyers to exercise their
Warrants or convert their Preferred Shares. The Company shall honor exercises of the Warrants and conversions of the Preferred Shares
and shall deliver the Conversion Shares and Warrant Shares in accordance with the terms, conditions and time periods set forth in the
Certificate of Designations and Warrants.
(u)
Regulation M. The Company will not take any action prohibited by Regulation M under the 1934 Act, in connection with the distribution
of the Securities contemplated hereby.
(v)
General Solicitation. None of the Company, any of its affiliates (as defined in Rule 501(b) under the 1933 Act) or any person
acting on behalf of the Company or such affiliate will solicit any offer to buy or offer or sell the Securities by means of any form
of general solicitation or general advertising within the meaning of Regulation D, including: (i) any advertisement, article, notice
or other communication published in any newspaper, magazine or similar medium or broadcast over television or radio; and (ii) any seminar
or meeting whose attendees have been invited by any general solicitation or general advertising.
(w)
Stockholder Approval. The Company shall provide each stockholder entitled to vote at a special meeting of stockholders of the
Company (the “Stockholder Meeting”), which shall be held no later than June 26, 2026 (the “Stockholder Meeting
Deadline”), a proxy statement, in a form reasonably acceptable to the Buyers, at the expense of the Company, soliciting each
such stockholder’s affirmative vote at the Stockholder Meeting for approval of resolutions (“Stockholder Resolutions”)
providing for the issuance of the Securities in compliance with the rules and regulations of the Principal Market (the “Stockholder
Approval”, and the date the Stockholder Approval is obtained, the “Stockholder Approval Date”), and the
Company shall use its reasonable best efforts to solicit its stockholders’ approval of such Stockholder Resolutions and to cause
the board of directors of the Company to recommend to the stockholders that they approve such Stockholder Resolutions. The Company shall
be obligated to seek to obtain the Stockholder Approval by the Stockholder Meeting Deadline. If, despite the Company’s reasonable
best efforts the Stockholder Approval is not obtained on or prior to the Stockholder Meeting Deadline, the Company shall cause an additional
Stockholder Meeting to be held within 90 days later. If, despite the Company’s reasonable best efforts the Stockholder Approval
is not obtained after such subsequent stockholder meetings, the Company shall cause an additional Stockholder Meeting to be held semi-annually
thereafter until such Stockholder Approval is obtained. Notwithstanding the above, the Company shall not be required to hold a Stockholder
Meeting or seek Stockholder Approval any time following the time when the Preferred Shares are no longer outstanding if upon full exercise
of the Warrants, the shares of Common Stock issued pursuant to the Preferred Shares and Warrants would not exceed the Exchange Cap (as
defined in the Certificate of Designations).
(x)
Integration. None of the Company, any of its affiliates (as defined in Rule 501(b) under the 1933 Act), or any person acting on
behalf of the Company or such affiliate will sell, offer for sale, or solicit offers to buy or otherwise negotiate in respect of any
security (as defined in the 1933 Act) which will be integrated with the sale of the Securities in a manner which would require the registration
of the Securities under the 1933 Act, and the Company will take all action that is appropriate or necessary to assure that its offerings
of other securities will not be integrated for purposes of the 1933 Act or the rules and regulations of the Principal Market, with the
issuance of Securities contemplated hereby.
(y)
Notice of Disqualification Events. The Company will notify the Buyers in writing, prior to the Closing Date of (i) any Disqualification
Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event
relating to any Issuer Covered Person.
(z)
Books and Records. The Company will keep proper books of record and account, in which full and correct entries shall be made of
all financial transactions and the asset and business of the Company and its Subsidiaries in accordance with GAAP.
(aa)
Closing Documents. On or prior to twenty (20) calendar days after the Closing Date, the Company agrees to deliver, or cause to
be delivered, to each Buyer and Buyer Counsel a complete closing set of the executed Transaction Documents (which may be delivered in
electronic format), Securities and any other document required to be delivered to any party pursuant to Section 7 hereof or otherwise.
24
5.
REGISTER; TRANSFER AGENT INSTRUCTIONS; LEGEND.
(a)
Register. The Company shall maintain at its principal executive offices (or such other office or agency of the Company as it may
designate by notice to each holder of Securities), a register for the Preferred Shares and the Warrants in which the Company shall record
the name and address of the Person in whose name the Preferred Shares and the Warrants have been issued (including the name and address
of each transferee), the principal amount of the Preferred Shares held by such Person, the number of Conversion Shares issuable pursuant
to the terms of the Preferred Shares and the number of Warrant Shares issuable upon exercise of the Warrants held by such Person. The
Company shall keep the register open and available at all times during business hours for inspection of any Buyer or its legal representatives.
(b)
Transfer Agent Instructions. On or prior to the Closing Date, the Company shall issue irrevocable instructions to its transfer
agent and any subsequent transfer agent (as applicable, the “Transfer Agent”) in a form acceptable to each of the
Buyers (the “Irrevocable Transfer Agent Instructions”) to issue certificates or credit shares (to the extent unrestricted
shares are issued) to the applicable balance accounts at The Depository Trust Company (“DTC”), registered in the name
of each Buyer or its respective nominee(s), for the Conversion Shares and the Warrant Shares in such amounts as specified from time to
time by each Buyer to the Company upon conversion of the Preferred Shares or the exercise of the Warrants (as the case may be). The Company
represents and warrants that no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 5(b),
and stop transfer instructions to give effect to Section 2(g) hereof, will be given by the Company to its transfer agent with
respect to the Securities, and that the Securities shall otherwise be freely transferable on the books and records of the Company, as
applicable, to the extent provided in this Agreement and the other Transaction Documents. If a Buyer effects a sale, assignment or transfer
of the Securities in accordance with Section 2(g), the Company shall permit the transfer and shall promptly instruct its transfer
agent to issue one or more certificates or credit shares to the applicable balance accounts at DTC in such name and in such denominations
as specified by such Buyer to effect such sale, transfer or assignment. In the event that such sale, assignment or transfer involves
Conversion Shares or Warrant Shares sold, assigned or transferred pursuant to an effective registration statement or in compliance with
Rule 144, the transfer agent shall issue such shares to such Buyer, assignee or transferee (as the case may be) without any restrictive
legend in accordance with Section 5(d) below. The Company acknowledges that a breach by it of its obligations hereunder will cause
irreparable harm to a Buyer. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations under this
Section 5(b) will be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of
this Section 5(b), that a Buyer shall be entitled, in addition to all other available remedies, to an order and/or injunction
restraining any breach and requiring immediate issuance and transfer, without the necessity of showing economic loss and without any
bond or other security being required. The Company shall cause its counsel to issue the legal opinion referred to in the Irrevocable
Transfer Agent Instructions to the Company’s transfer agent on each Effective Date (as defined in the Registration Rights Agreement).
Any fees (with respect to the transfer agent, counsel to the Company or otherwise) associated with the issuance of such opinion or the
removal of any legends on any of the Securities shall be borne by the Company.
(c)
Legends. Each Buyer understands that the Securities have been issued (or will be issued in the case of the Shares) pursuant to
an exemption from registration or qualification under the 1933 Act and applicable state securities laws, and except as set forth below,
the Securities shall bear any legend as required by the “blue sky” laws of any state and a restrictive legend in substantially
the following form (and a stop-transfer order may be placed against transfer of such stock certificates):
[NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE [CONVERTIBLE][EXERCISABLE]
HAVE BEEN][THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN] REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A)
AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO
THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID
ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES
MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.
25
(d)
Removal of Legends. Certificates evidencing the Shares shall not be required to contain the legend set forth in Section 5(c)
above or any other legend (i) while a registration statement (including a Registration Statement) covering the resale of such Shares
is effective under the 1933 Act, (ii) following any sale of such Shares pursuant to Rule 144 (assuming the transferor is not an affiliate
of the Company), (iii) if such Shares are eligible to be sold, assigned or transferred under Rule 144 (provided that a Buyer provides
the Company with reasonable assurances that such Shares are eligible for sale, assignment or transfer under Rule 144 which shall not
include an opinion of Buyer’s counsel), (iv) in connection with a sale, assignment or other transfer (other than under Rule 144),
provided that such Buyer provides the Company with an opinion of counsel to such Buyer, in a generally acceptable form, to the effect
that such sale, assignment or transfer of the Shares may be made without registration under the applicable requirements of the 1933 Act
or (v) if such legend is not required under applicable requirements of the 1933 Act (including, without limitation, controlling judicial
interpretations and pronouncements issued by the SEC). If a legend is not required pursuant to the foregoing, the Company shall no later
than one (1) Trading Day (or such earlier date as required pursuant to the 1934 Act or other applicable law, rule or regulation for the
settlement of a trade initiated on the date such Buyer delivers such legended certificate representing such Shares to the Company) following
the delivery by a Buyer to the Company or the transfer agent (with notice to the Company) of a legended certificate representing such
Securities (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form necessary to affect the reissuance and/or
transfer, if applicable), together with any other deliveries from such Buyer as may be required above in this Section 5(d) or
as reasonably required by the Company’s transfer agent, as directed by such Buyer, either: (A) provided that the Company’s
transfer agent is participating in the DTC Fast Automated Securities Transfer Program (“FAST”), credit the aggregate
number of shares of Common Stock to which such Buyer shall be entitled to such Buyer’s or its designee’s balance account
with DTC through its Deposit/Withdrawal at Custodian system or (B) if the Company’s transfer agent is not participating in FAST,
issue and deliver (via reputable overnight courier) to such Buyer, a certificate representing such Shares that is free from all restrictive
and other legends, registered in the name of such Buyer or its designee (the date by which such credit is so required to be made to the
balance account of such Buyer’s or such Buyer’s designee with DTC or such certificate is required to be delivered to such
Buyer pursuant to the foregoing is referred to herein as the “Required Delivery Date”, and the date such shares of
Common Stock are actually delivered without restrictive legend to such Buyer or such Buyer’s designee with DTC, as applicable,
the “Share Delivery Date”). The Company shall be responsible for any transfer agent fees or DTC fees with respect
to any issuance of Securities or the removal of any legends with respect to any Securities in accordance herewith.
(e)
[Reserved.]
(f)
FAST Compliance. While any Warrants remain outstanding, the Company shall maintain a transfer agent that participates in FAST.
6.
CONDITIONS TO THE COMPANY’S OBLIGATION TO SELL.
The
obligation of the Company hereunder to issue and sell the Preferred Shares and the related Warrants to each Buyer at the Closing is subject
to the satisfaction, at or before the Closing Date, of each of the following conditions, provided that these conditions are for the Company’s
sole benefit and may be waived by the Company at any time in its sole discretion by providing each Buyer with prior written notice thereof:
(a)
Such Buyer shall have executed each of the other Transaction Documents to which it is a party and delivered the same to the Company.
26
(b)
Such Buyer and each other Buyer shall have delivered to the Company the Purchase Price (less, in the case of any Buyer, the amounts withheld
pursuant to Section 4(g)) for the Preferred Shares and the related Warrants being purchased by such Buyer at the Closing by wire
transfer of immediately available funds in accordance with the wire instructions provided by the Company.
(c)
The representations and warranties of such Buyer shall be true and correct in all material respects as of the date when made and as of
the Closing Date as though originally made at that time (except for representations and warranties that speak as of a specific date,
which shall be true and correct as of such specific date), and such Buyer shall have performed, satisfied and complied in all material
respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by such
Buyer at or prior to the Closing Date.
(d)
No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or Governmental Entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated
by the Transaction Documents.
7.
CONDITIONS TO EACH BUYER’S OBLIGATION TO PURCHASE.
The
obligation of each Buyer hereunder to purchase its Preferred Shares and its related Warrants at the Closing is subject to the satisfaction,
at or before the Closing Date, of each of the following conditions, provided that these conditions are for each Buyer’s sole benefit
and may be waived by such Buyer at any time in its sole discretion by providing the Company with prior written notice thereof:
(a)
The Company and each Subsidiary (as the case may be) shall have duly executed and delivered to such Buyer each of the Transaction Documents
to which it is a party and the Company shall have duly delivered to such Buyer (A) such aggregate number of Preferred Shares as is set
forth across from such Buyer’s name in column (3) of the Schedule of Buyers, and (B) a Warrant initially exercisable for such aggregate
number of Warrant Shares as is set forth across from such Buyer’s name in column (4) of the Schedule of Buyers, in each case, as
being purchased by such Buyer at the Closing pursuant to this Agreement.
(b)
Such Buyer shall have received the opinion of Haynes and Boone, LLP, the Company’s counsel, dated as of the Closing Date, addressed
to each Buyer, in the form acceptable to such Buyer.
(c)
The Company shall have delivered to such Buyer a copy of the Irrevocable Transfer Agent Instructions, which instructions shall have been
delivered to and acknowledged in writing by the Company’s transfer agent.
(d)
The Company shall have delivered to such Buyer a certificate evidencing the formation and good standing of the Company in its jurisdiction
of formation issued by the Secretary of State (or comparable office) of such jurisdiction of formation as of a date within ten (10) days
of the Closing Date.
(e)
The Company shall have delivered to such Buyer a certified copy of the Certificate of Incorporation as certified by the Delaware Secretary
of State within ten (10) days of the Closing Date.
(f)
The Company shall have delivered to such Buyer a certificate, in the form acceptable to such Buyer, executed by the Secretary of the
Company and dated as of the Closing Date, as to (i) the resolutions consistent with Section 3(b) as adopted by the Company’s
board of directors in a form reasonably acceptable to such Buyer, (ii) the Certificate of Incorporation of the Company and (iii) the
Bylaws of the Company as in effect at the Closing.
(g)
Each and every representation and warranty of the Company shall be true and correct as of the date when made and as of the Closing Date
as though originally made at that time (except for representations and warranties that speak as of a specific date, which shall be true
and correct as of such specific date) and the Company shall have performed, satisfied and complied in all respects with the covenants,
agreements and conditions required to be performed, satisfied or complied with by the Company at or prior to the Closing Date. Such Buyer
shall have received a certificate, duly executed by the Chief Executive Officer or Chief Financial Officer of the Company, dated as of
the Closing Date, to the foregoing effect.
27
(h)
The Company shall have delivered to such Buyer a letter from the Company’s transfer agent certifying the number of shares of Common
Stock outstanding on the Closing Date immediately prior to the Closing.
(i)
The Common Stock (A) shall be designated for quotation or listed (as applicable) on the Principal Market and (B) shall not have been
suspended, as of the Closing Date, by the SEC or the Principal Market from trading on the Principal Market nor shall suspension by the
SEC or the Principal Market have been threatened, as of the Closing Date, either (I) in writing by the SEC or the Principal Market or
(II) by falling below the minimum maintenance requirements of the Principal Market.
(j)
The Company shall have obtained all governmental, regulatory or third party consents and approvals, if any, necessary for the sale of
the Securities, including without limitation, those required by the Principal Market, if any.
(k)
No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or Governmental Entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated
by the Transaction Documents.
(l)
Since the date of execution of this Agreement, no event or series of events shall have occurred that reasonably would have or result
in a Material Adverse Effect, provided, however, that the definition of “Material Adverse Effect” for the purpose
of this clause (l), will not include any change or effect that results from (A) changes in law or interpretations thereof, or regulatory
policy or interpretation, by any Governmental Entity so long as such change does not have a disproportionate effect on the Company, (B)
changes in applicable accounting rules or principles, including changes in GAAP, so long as such change does not have a disproportionate
effect on the Company, (C) changes in general economic conditions, and events or conditions generally affecting the industries in which
the Company operates, so long as such change does not have a disproportionate effect on the Company, or (D) national or international
hostilities, acts of terror or acts of war.
(m)
The Company shall have filed a Notification: Listing of Additional Shares with the Principal Market and shall not have received any objection
thereto to list the Shares.
(n)
Such Buyer shall have received the wire transfer instructions of the Company.
(o)
The Company and its Subsidiaries shall have delivered to such Buyer such other documents, instruments or certificates relating to the
transactions contemplated by this Agreement as such Buyer or its counsel may reasonably request.
8.
TERMINATION.
This
Agreement may be terminated (i) by the mutual consent of each of the Company and the Buyers, (ii) if the Closing shall not have occurred
by May 11, 2026 (provided that no party shall have the right to terminate if they were the proximate cause of the failure to close by
such date), or (iii) with respect to a Buyer, if the Company has breached the terms of this Agreement in a manner that would cause the
failure of the conditions to closing hereunder to be met (and such breach remains uncured after 30 days’ notice). Upon any termination
in accordance with this Section 8 by a Buyer, such party shall have the right to terminate its obligations under this Agreement
with respect to itself at any time on or after the close of business on such date (without liability of such Buyer to any other party);
provided, however, the abandonment of the sale and purchase of the Preferred Shares and Warrants by such Buyer shall be
applicable only to such Buyer providing such written notice, provided further that no such termination by any party shall affect any
obligation of the Company under this Agreement to reimburse such Buyer for the expenses described in Section 4(g) above. Nothing
contained in this Section 8 shall be deemed to release any party from any liability for any breach by such party of the terms
and provisions of this Agreement or the other Transaction Documents or to impair the right of any party to compel specific performance
by any other party of its obligations under this Agreement or the other Transaction Documents.
28
9.
MISCELLANEOUS.
(a)
Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of
this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict
of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of
any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state
and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection
herewith or under any of the other Transaction Documents or with any transaction contemplated hereby or thereby, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding
is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that
such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to
limit in any way any right to serve process in any manner permitted by law. Nothing contained herein shall be deemed or operate to preclude
any Buyer from bringing suit or taking other legal action against the Company in any other jurisdiction to collect on the Company’s
obligations to such Buyer or to enforce a judgment or other court ruling in favor of such Buyer. EACH PARTY HEREBY IRREVOCABLY WAIVES
ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR UNDER ANY OTHER TRANSACTION
DOCUMENT OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT, ANY OTHER TRANSACTION DOCUMENT OR ANY TRANSACTION CONTEMPLATED HEREBY
OR THEREBY.
(b)
Counterparts. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the
same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. In the event
that any signature is delivered by facsimile or electronic transmission (including DocuSign and similar) or by an e-mail which contains
a portable document format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation
of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were
an original thereof.
(c)
Headings; Gender. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation
of, this Agreement. Unless the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine,
neuter, singular and plural forms thereof. The terms “including,” “includes,” “include”
and words of like import shall be construed broadly as if followed by the words “without limitation.” The terms “herein,”
“hereunder,” “hereof” and words of like import refer to this entire Agreement instead of just the
provision in which they are found.
(d)
Severability; Maximum Payment Amounts. If any provision of this Agreement is prohibited by law or otherwise determined to be invalid
or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall
be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such
provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified continues
to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature,
invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal
obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties
will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s),
the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s). Notwithstanding anything
to the contrary contained in this Agreement or any other Transaction Document (and without implication that the following is required
or applicable), it is the intention of the parties that in no event shall amounts and value paid by the Company and/or any of its Subsidiaries
(as the case may be), or payable to or received by any of the Buyers, under the Transaction Documents (including without limitation,
any amounts that would be characterized as “interest” under applicable law) exceed amounts permitted under any applicable
law. Accordingly, if any obligation to pay, payment made to any Buyer, or collection by any Buyer pursuant the Transaction Documents
is finally judicially determined to be contrary to any such applicable law, such obligation to pay, payment or collection shall be deemed
to have been made by mutual mistake of such Buyer, the Company and its Subsidiaries and such amount shall be deemed to have been adjusted
with retroactive effect to the maximum amount or rate of interest, as the case may be, as would not be so prohibited by the applicable
law. Such adjustment shall be effected, to the extent necessary, by reducing or refunding, at the option of such Buyer, the amount of
interest or any other amounts which would constitute unlawful amounts required to be paid or actually paid to such Buyer under the Transaction
Documents. For greater certainty, to the extent that any interest, charges, fees, expenses or other amounts required to be paid to or
received by such Buyer under any of the Transaction Documents or related thereto are held to be within the meaning of “interest”
or another applicable term to otherwise be violative of applicable law, such amounts shall be pro-rated over the period of time to which
they relate.
29
(e)
Entire Agreement; Amendments. This Agreement, the other Transaction Documents and the schedules and exhibits attached hereto and
thereto and the instruments referenced herein and therein supersede all other prior oral or written agreements between the Buyers, the
Company, its Subsidiaries, their affiliates and Persons acting on their behalf, including, without limitation, any transactions by any
Buyer with respect to shares of Common Stock or the Securities, and the other matters contained herein and therein, and this Agreement,
the other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced herein and therein
contain the entire understanding of the parties solely with respect to the matters covered herein and therein; provided, however,
nothing contained in this Agreement or any other Transaction Document shall (or shall be deemed to) (i) have any effect on any agreements
any Buyer has entered into with, or any instruments any Buyer has received from, the Company or any of its Subsidiaries prior to the
date hereof with respect to any prior investment made by such Buyer in the Company or (ii) waive, alter, modify or amend in any respect
any obligations of the Company or any of its Subsidiaries, or any rights of or benefits to any Buyer or any other Person, in any agreement
entered into prior to the date hereof between or among the Company and/or any of its Subsidiaries and any Buyer, or any instruments any
Buyer received from the Company and/or any of its Subsidiaries prior to the date hereof, and all such agreements and instruments shall
continue in full force and effect. Except as specifically set forth herein or therein, neither the Company nor any Buyer makes any representation,
warranty, covenant or undertaking with respect to such matters. For clarification purposes, the Recitals are part of this Agreement.
No provision of this Agreement may be amended other than by an instrument in writing signed by the Company and the Required Holders (as
defined below), and any amendment to any provision of this Agreement made in conformity with the provisions of this Section 9(e)
shall be binding on all Buyers and holders of Securities, as applicable; provided that no such amendment shall be effective to
the extent that it (A) applies to less than all of the holders of the Securities then outstanding or (B) imposes any obligation or liability
on any Buyer without such Buyer’s prior written consent (which may be granted or withheld in such Buyer’s sole discretion).
No waiver shall be effective unless it is in writing and signed by an authorized representative of the waiving party, provided that the
Required Holders may waive any provision of this Agreement, and any waiver of any provision of this Agreement made in conformity with
the provisions of this Section 9(e) shall be binding on all Buyers and holders of Securities, as applicable, provided that no
such waiver shall be effective to the extent that it (1) applies to less than all of the holders of the Securities then outstanding (unless
a party gives a waiver as to itself only) or (2) imposes any obligation or liability on any Buyer without such Buyer’s prior written
consent (which may be granted or withheld in such Buyer’s sole discretion). No consideration (other than reimbursement of legal
fees) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless
the same consideration also is offered to all of the parties to the Agreement. The Company has not directly or indirectly, made any agreements
with any Buyers relating to the terms or conditions of the transactions contemplated by the Transaction Documents except as set forth
in the Transaction Documents. Without limiting the foregoing, the Company confirms that, except as set forth in this Agreement, no Buyer
has made any commitment or promise or has any other obligation to provide any financing to the Company, any Subsidiary or otherwise.
As a material inducement for each Buyer to enter into this Agreement, the Company expressly acknowledges and agrees that (x) no due diligence
or other investigation or inquiry conducted by a Buyer, any of its advisors or any of its representatives shall affect such Buyer’s
right to rely on, or shall modify or qualify in any manner or be an exception to any of, the Company’s representations and warranties
contained in this Agreement or any other Transaction Document and (y) unless a provision of this Agreement or any other Transaction Document
is expressly preceded by the phrase “except as disclosed in the SEC Documents,” nothing contained in any of the SEC Documents
shall affect such Buyer’s right to rely on, or shall modify or qualify in any manner or be an exception to any of, Company’s
representations and warranties contained in this Agreement or any other Transaction Document. “Required Holders” means
(I) prior to the Closing Date, each Buyer entitled to purchase, in the aggregate, at least a majority of the number of Preferred Shares
at the Closing and (II) on or after the Closing Date, holders of a majority of the Registrable Securities as of such time (excluding
any Registrable Securities held by the Company or any of its Subsidiaries as of such time) issued or issuable hereunder or pursuant to
the Certificate of Designations and/or the Warrants (or the Buyers, with respect to any waiver or amendment of Section 4(o));
provided, however, that in each case, each of Iroquois Master Fund Ltd. and Iroquois Capital Investment Group, LLC (each, an “Iroquois
Fund”) shall be among the Required Holders voting for such amendment or waiver, provided further that if an Iroquois Fund no
longer beneficially owns (directly or indirectly) Series K Preferred Stock, its vote shall not be required for any such amendment or
waiver.
30
(f)
Notices. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement
must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent
by electronic mail (provided that such sent email is kept on file (whether electronically or otherwise) by the sending party and the
sending party does not receive an automatically generated message from the recipient’s email server that such e-mail could not
be delivered to such recipient); or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery
specified, in each case, properly addressed to the party to receive the same. The mailing addresses and e-mail addresses for such communications
shall be:
If
to the Company:
StableX
Technologies, Inc.
1185
Avenue of the Americas
New
York, New York 10036
Telephone:
(512) 994-4917
Attention:
Chief Executive Officer
E-Mail:
jsilverman@parkfieldfund.com
With
a copy (for informational purposes only) to:
Haynes
and Boone, LLP
30
Rockefeller Plaza, 26th Floor
New
York, New York 10112
Telephone:
(212) 659-7300
Attention:
Rick Werner
E-mail:
rick.werner@haynesboone.com
If
to the Transfer Agent:
Equiniti
Trust Company LLC
1110
Centre Point Curve, Suite 101
Telephone:
919-744-2722
Attention:
Direct Transfer Compliance
E-Mail:
transfer-ID@equiniti.com
If
to a Buyer, to its mailing address and e-mail address set forth on the Schedule of Buyers, with copies to such Buyer’s representatives
as set forth on the Schedule of Buyers
with
a copy (for informational purposes only) to:
Mintz,
Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
919
Third Avenue
New
York, New York 10022
Telephone:
(212) 935-3000
Attention:
Jeffrey P. Schultz
31
or
to such other mailing address and/or e-mail address and/or to the attention of such other Person as the recipient party has specified
by written notice given to each other party five (5) days prior to the effectiveness of such change, provided that Buyer Counsel shall
only be provided copies of notices sent to the lead Buyer. Written confirmation of receipt (A) given by the recipient of such notice,
consent, waiver or other communication, (B) mechanically or electronically generated by the sender’s e-mail containing the time,
date and recipient’s e-mail or (C) provided by an overnight courier service shall be rebuttable evidence of personal service, receipt
by e-mail or receipt from an overnight courier service in accordance with clause (i), (ii) or (iii) above, respectively.
(g)
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors
and assigns, including any purchasers of any of the Preferred Shares and Warrants. The Company shall not assign this Agreement or any
rights or obligations hereunder without the prior written consent of the Required Holders, including, without limitation, by way of a
Fundamental Transaction (as defined in the Warrants) (unless the Company is in compliance with the applicable provisions governing Fundamental
Transactions set forth in the Warrants) or a Fundamental Transaction (as defined in the Certificate of Designations) (unless the Company
is in compliance with the applicable provisions governing Fundamental Transactions set forth in the Certificate of Designations). A Buyer
may assign some or all of its rights hereunder in connection with any transfer of any of its Securities without the consent of the Company,
in which event such assignee shall be deemed to be a Buyer hereunder with respect to such assigned rights.
(h)
No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, other than the
Indemnitees referred to in Section 9(k) and the Placement Agent.
(i)
Survival. The representations, warranties, agreements and covenants shall survive the Closing. Each Buyer shall be responsible
only for its own representations, warranties, agreements and covenants hereunder.
(j)
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.
(k)
Indemnification. In consideration of each Buyer’s execution and delivery of the Transaction Documents and acquiring the
Securities thereunder and in addition to all of the Company’s other obligations under the Transaction Documents, the Company shall
defend, protect, indemnify and hold harmless each Buyer and each holder of any Securities and all of their stockholders, partners, members,
officers, directors, employees and direct or indirect investors and any of the foregoing Persons’ agents or other representatives
(including, without limitation, those retained in connection with the transactions contemplated by this Agreement) (collectively, the
“Indemnitees”) from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees,
liabilities and damages, and expenses in connection therewith (irrespective of whether any such Indemnitee is a party to the action for
which indemnification hereunder is sought), and including reasonable attorneys’ fees and disbursements (the “Indemnified
Liabilities”), incurred by any Indemnitee as a result of, or arising out of, or relating to (i) any misrepresentation or breach
of any representation or warranty made by the Company or any Subsidiary in any of the Transaction Documents, (ii) any breach of any covenant,
agreement or obligation of the Company or any Subsidiary contained in any of the Transaction Documents or (iii) any cause of action,
suit, proceeding or claim brought or made against such Indemnitee by a third party (including for these purposes a derivative action
brought on behalf of the Company or any Subsidiary) or which otherwise involves such Indemnitee that arises out of or results from (A)
the execution, delivery, performance or enforcement of any of the Transaction Documents, (B) any transaction financed or to be financed
in whole or in part, directly or indirectly, with the proceeds of the issuance of the Securities, (C) any disclosure properly made by
such Buyer pursuant to Section 4(i), or (D) the status of such Buyer or holder of the Securities either as an investor in the
Company pursuant to the transactions contemplated by the Transaction Documents or as a party to this Agreement (including, without limitation,
as a party in interest or otherwise in any action or proceeding for injunctive or other equitable relief). To the extent that the foregoing
undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum contribution to the payment and satisfaction
of each of the Indemnified Liabilities which is permissible under applicable law. Except as otherwise set forth herein, the mechanics
and procedures with respect to the rights and obligations under this Section 9(k) shall be the same as those set forth in Section
6 of the Registration Rights Agreement.
32
(l)
Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual
intent, and no rules of strict construction will be applied against any party. No specific representation or warranty shall limit the
generality or applicability of a more general representation or warranty. Each and every reference to share prices, shares of Common
Stock and any other numbers in this Agreement that relate to the shares of Common Stock shall be automatically adjusted for any stock
splits, stock dividends, stock combinations, recapitalizations or other similar transactions that occur with respect to the Common Stock
after the date of this Agreement. Notwithstanding anything in this Agreement to the contrary, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty against, or a prohibition of, any actions with respect to the borrowing of, arrangement
to borrow, identification of the availability of, and/or securing of, securities of the Company in order for such Buyer (or its broker
or other financial representative) to effect short sales or similar transactions in the future.
(m)
Remedies. Each Buyer and in the event of assignment by Buyer of its rights and obligations hereunder, each holder of Securities,
shall have all rights and remedies set forth in the Transaction Documents and all rights and remedies which such holders have been granted
at any time under any other agreement or contract and all of the rights which such holders have under any law. Any Person having any
rights under any provision of this Agreement shall be entitled to enforce such rights specifically (without posting a bond or other security),
to recover damages by reason of any breach of any provision of this Agreement and to exercise all other rights granted by law. Furthermore,
the Company recognizes that in the event that it or any Subsidiary fails to perform, observe, or discharge any or all of its or such
Subsidiary’s (as the case may be) obligations under the Transaction Documents, any remedy at law would inadequate relief to the
Buyers. The Company therefore agrees that the Buyers shall be entitled to specific performance and/or temporary, preliminary and permanent
injunctive or other equitable relief from any court of competent jurisdiction in any such case without the necessity of proving actual
damages and without posting a bond or other security. The remedies provided in this Agreement and the other Transaction Documents shall
be cumulative and in addition to all other remedies available under this Agreement and the other Transaction Documents, at law or in
equity (including a decree of specific performance and/or other injunctive relief).
(n)
Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) the Transaction
Documents, whenever any Buyer exercises a right, election, demand or option under a Transaction Document and the Company or any Subsidiary
does not timely perform its related obligations within the periods therein provided, then such Buyer may rescind or withdraw, in its
sole discretion from time to time upon written notice to the Company or such Subsidiary (as the case may be), any relevant notice, demand
or election in whole or in part without prejudice to its future actions and rights.
(o)
Payment Set Aside; Currency. To the extent that the Company makes a payment or payments to any Buyer hereunder or pursuant to
any of the other Transaction Documents or any of the Buyers enforce or exercise their rights hereunder or thereunder, and such payment
or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent
or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company,
a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, foreign, state or federal law,
common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended
to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff
had not occurred. Unless otherwise expressly indicated, all dollar amounts referred to in this Agreement and the other Transaction Documents
are in United States Dollars (“U.S. Dollars”), and all amounts owing under this Agreement and all other Transaction
Documents shall be paid in U.S. Dollars. All amounts denominated in other currencies (if any) shall be converted into the U.S. Dollar
equivalent amount in accordance with the Exchange Rate on the date of calculation. “Exchange Rate” means, in relation
to any amount of currency to be converted into U.S. Dollars pursuant to this Agreement, the U.S. Dollar exchange rate as published in
the Wall Street Journal on the relevant date of calculation.
33
(p)
Judgment Currency.
(i)
If for the purpose of obtaining or enforcing judgment against the Company in connection with this Agreement or any other Transaction
Document in any court in any jurisdiction it becomes necessary to convert into any other currency (such other currency being hereinafter
in this Section 9(p) referred to as the “Judgment Currency”) an amount due in US Dollars under this Agreement,
the conversion shall be made at the Exchange Rate prevailing on the Trading Day immediately preceding:
(1)
the date actual payment of the amount due, in the case of any proceeding in the courts of New York or in the courts of any other jurisdiction
that will give effect to such conversion being made on such date: or
(2)
the date on which the foreign court determines, in the case of any proceeding in the courts of any other jurisdiction (the date as of
which such conversion is made pursuant to this Section 9(p)(i)(2) being hereinafter referred to as the “Judgment Conversion
Date”).
(ii)
If in the case of any proceeding in the court of any jurisdiction referred to in Section 9(p)(i)(2) above, there is a change in
the Exchange Rate prevailing between the Judgment Conversion Date and the date of actual payment of the amount due, the applicable party
shall pay such adjusted amount as may be necessary to ensure that the amount paid in the Judgment Currency, when converted at the Exchange
Rate prevailing on the date of payment, will produce the amount of US Dollars which could have been purchased with the amount of Judgment
Currency stipulated in the judgment or judicial order at the Exchange Rate prevailing on the Judgment Conversion Date.
(iii)
Any amount due from the Company under this provision shall be due as a separate debt and shall not be affected by judgment being obtained
for any other amounts due under or in respect of this Agreement or any other Transaction Document.
(q)
Independent Nature of Buyers’ Obligations and Rights. The obligations of each Buyer under the Transaction
Documents are several and not joint with the obligations of any other Buyer, and no Buyer shall be responsible in any way for the performance
of the obligations of any other Buyer under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Buyer pursuant hereto or thereto, shall be deemed to constitute the Buyers as, and the Company each acknowledge
that the Buyers do not so constitute, a partnership, an association, a joint venture or any other kind of group or entity, or create
a presumption that the Buyers are in any way acting in concert or as a group or entity, and the Company shall not assert any such claim
with respect to such obligations or the transactions contemplated by the Transaction Documents or any matters, and the Company acknowledges
that the Buyers are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations
or the transactions contemplated by the Transaction Documents. The decision of each Buyer to purchase Securities pursuant to the Transaction
Documents has been made by such Buyer independently of any other Buyer. Each Buyer acknowledges that no other Buyer has acted as agent
for such Buyer in connection with such Buyer making its investment hereunder and that no other Buyer will be acting as agent of such
Buyer in connection with monitoring such Buyer’s investment in the Securities or enforcing its rights under the Transaction Documents.
The Company and each Buyer confirms that each Buyer has independently participated with the Company and its Subsidiaries in the negotiation
of the transaction contemplated hereby with the advice of its own counsel and advisors. Each Buyer shall be entitled to independently
protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of any other Transaction
Documents, and it shall not be necessary for any other Buyer to be joined as an additional party in any proceeding for such purpose.
The use of a single agreement to effectuate the purchase and sale of the Securities contemplated hereby was solely in the control of
the Company, not the action or decision of any Buyer, and was done solely for the convenience of the Company and its Subsidiaries and
not because it was required or requested to do so by any Buyer. It is expressly understood and agreed that each provision contained in
this Agreement and in each other Transaction Document is between the Company, each Subsidiary and a Buyer, solely, and not between the
Company, its Subsidiaries and the Buyers collectively and not between and among the Buyers.
[signature
pages follow]
34
IN
WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this Agreement to be duly executed as
of the date first written above.
STABLEX TECHNOLOGIES, INC.
By:
Name:
Joshua Silverman
Title:
Chief Executive Officer
35
[PURCHASER
SIGNATURE PAGES TO SBLX SECURITIES PURCHASE AGREEMENT]
IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.
Name
of Purchaser: _______________________________________________________________________________
Signature
of Authorized Signatory of Purchaser: _________________________________________________________
Name
of Authorized Signatory: ______________________________________________________________________
Title
of Authorized Signatory: _______________________________________________________________________
Address of Authorized Signatory: _______________________________________________________________
Address
for Notice to Purchaser: ____________________________________________________________________
Address
for Delivery of Shares to Purchaser (if not same as address for notice): _________________________________
Subscription
Amount: $ ________________________
Preferred
Shares: _____________________________
Warrant
Shares: ______________________________
EIN
Number: ________________________________
36
SCHEDULE
OF BUYERS
(1)
(2)
(3)
(4)
(5)
(6)
Buyer
Address
and Facsimile Number
Aggregate
Number of Preferred Shares
Aggregate
Number of Warrant Shares
Purchase
Price
Legal
Representative’s Address and Facsimile Number
[LEAD
INVESTOR]
[OTHER
BUYERS]
TOTAL
37
EX-10.4
EX-10.4
Filename: ex10-4.htm · Sequence: 14
Exhibit
10.4
REGISTRATION
RIGHTS AGREEMENT
This
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 27, 2026, is by and among StableX Technologies,
Inc., a Delaware corporation (the “Company”), and the undersigned buyers (each, a “Buyer,” and
collectively, the “Buyers”).
RECITALS
A. In
connection with the Securities Purchase Agreement by and among the parties hereto, dated as of April 27, 2026 (the “Securities
Purchase Agreement”), the Company has agreed, upon the terms and subject to the conditions of the Securities Purchase Agreement,
to issue and sell to each Buyer (i) the Preferred Shares (as defined in the Securities Purchase Agreement) which will be convertible
into Conversion Shares (as defined in the Securities Purchase Agreement) in accordance with the terms of the Certificate of Designations
(as defined in the Securities Purchase Agreement) and (ii) the Warrants (as defined in the Securities Purchase Agreement) which will
be exercisable to purchase Warrant Shares (as defined in the Securities Purchase Agreement) in accordance with the terms of the Warrants.
B. To
induce the Buyers to consummate the transactions contemplated by the Securities Purchase Agreement, the Company has agreed to provide
certain registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor
statute (collectively, the “1933 Act”), and applicable state securities laws.
AGREEMENT
NOW,
THEREFORE, in consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company and each of the Buyers hereby agree as follows:
1.
Definitions.
Capitalized
terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement.
As used in this Agreement, the following terms shall have the following meanings:
(a) “Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial
banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”,
“non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day.
(b) “Closing
Date” shall have the meaning set forth in the Securities Purchase Agreement.
(c) “Effective
Date” means the date that the applicable Registration Statement has been declared effective by the SEC.
(d) “Effectiveness
Deadline” means (i) with respect to the initial Registration Statement required to be filed pursuant to Section 2(a), the earlier
of the (A) 60th calendar day after the Closing Date (or, in the event of a “full review” by the SEC, the 90h
calendar day after the Closing Date) and (B) 2nd Business Day after the date the Company is notified (orally or in writing, whichever
is earlier) by the SEC that such Registration Statement will not be reviewed or will not be subject to further review; provided, that,
in case of clause (B) if Stockholder Approval is not received by such date, the 2nd Business Day following the Stockholder Approval Date
and (ii) with respect to any additional Registration Statements which may be required hereunder, the earlier of the (I) 30th calendar
day following the date on which an additional Registration Statement is required to be filed hereunder (or, in the event of a “full
review” by the SEC, the 60th calendar day following the date such additional Registration Statement is required to be filed hereunder)
and (II) 2nd Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that such Registration
Statement will not be reviewed or will not be subject to further review, provided, further, if such Effectiveness Deadline falls on a
day that is not a Trading Day, then the Effectiveness Deadline shall be the next succeeding Trading Day.
(e) “Filing
Deadline” means (i) with respect to the initial Registration Statement required to be filed pursuant to Section 2(a), the 30th
calendar day after the Closing Date and (ii) with respect to any additional Registration Statements that may be required to be filed
by the Company pursuant to this Agreement, the date on which the Company was required to file such additional Registration Statement
pursuant to the terms of this Agreement; provided, that, if such Filing Deadline falls on a day that is not a Trading Day, then the Filing
Deadline shall be the next succeeding Trading Day.
(f) “Investor”
means a Buyer or any transferee or assignee of any Registrable Securities, Preferred Shares or Warrants, as applicable, to whom a Buyer
assigns its rights under this Agreement and who agrees to become bound by the provisions of this Agreement in accordance with Section
9 and any transferee or assignee thereof to whom a transferee or assignee of any Registrable Securities, Preferred Shares or Warrants,
as applicable, assigns its rights under this Agreement and who agrees to become bound by the provisions of this Agreement in accordance
with Section 9.
(g) “Person”
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization
or a government or any department or agency thereof.
(h) “register,”
“registered,” and “registration” refer to a registration effected by preparing and filing one or
more Registration Statements in compliance with the 1933 Act and pursuant to Rule 415 and the declaration of effectiveness of such Registration
Statement(s) by the SEC.
(i) “Registrable
Securities” means (i) the Conversion Shares, (ii) the Warrant Shares and (iii) any capital stock of the Company issued or issuable
with respect to the Conversion Shares, the Warrant Shares, the Preferred Shares or the Warrants, including, without limitation, (1) as
a result of any stock split, stock dividend, recapitalization, exchange or similar event or otherwise and (2) any capital stock of the
Company into which the shares of Common Stock are converted or exchanged and capital stock of a Successor Entity (as defined in the Warrants)
into which the shares of Common Stock are converted or exchanged, in each case, without regard to any limitations on conversion of the
Preferred Shares or exercise of the Warrants; provided, however, that any such Registrable Securities shall cease to be Registrable Securities
(and the Company shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect
thereto) for so long as (a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by
the SEC under the 1933 Act and such Registrable Securities have been disposed of by the Investor in accordance with such effective Registration
Statement, (b) such Registrable Securities have been previously sold in accordance with Rule 144, or (c) such securities become eligible
for resale without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144, including paragraph
(i) of Rule 144, as set forth in a written opinion letter to such effect, addressed, delivered and acceptable to the Company’s
transfer agent and the affected Investors (assuming that such securities and any securities issuable upon exercise, conversion or exchange
of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held by any Affiliate of the Company).
(j) “Registration
Statement” means a registration statement or registration statements of the Company filed under the 1933 Act covering Registrable
Securities.
(k) “Required
Holders” shall have the meaning as set forth in the Securities Purchase Agreement.
(l) “Required
Registration Amount” means, as of any time of determination, the sum of (i) 200% of the maximum number of Conversion Shares
issuable upon conversion of the Preferred Shares (assuming for purposes hereof that (x) the Preferred Shares are convertible at the Floor
Price (as defined in the Certificate of Designations), and (y) any such conversion shall not take into account any limitations on the
conversion of the Preferred Shares set forth in the Certificate of Designations) and (ii) 200% of the maximum number of Warrant Shares
issuable upon exercise of the Warrants (without taking into account any limitations on the exercise of the Warrants set forth therein),
all subject to adjustment as provided in Section 2(d) and/or Section 2(f); provided, that if the SEC informs the Company either orally
or in writing (including, but not limited to, pursuant to any receipt of comments by the SEC or the staff of the SEC (the “Staff”))
that it is not permitted to register the total amount required pursuant to clause (i) and (ii) of this Section 1(l), then the Required
Registration Amount shall be such lesser amount as the SEC permits to be registered.
2
(m) “Rule
144” means Rule 144 promulgated by the SEC under the 1933 Act, as such rule may be amended from time to time, or any other
similar or successor rule or regulation of the SEC that may at any time permit the Investors to sell securities of the Company to the
public without registration.
(n) “Rule
415” means Rule 415 promulgated by the SEC under the 1933 Act, as such rule may be amended from time to time, or any other
similar or successor rule or regulation of the SEC providing for offering securities on a continuous or delayed basis.
(o) “SEC”
means the United States Securities and Exchange Commission or any successor thereto.
2.
Registration.
(a)
Mandatory Registration. The Company shall prepare and, as soon as practicable, but in no event later than the Filing Deadline,
file with the SEC an initial Registration Statement on Form S-3 covering the resale of all of the Registrable Securities, provided that
such initial Registration Statement shall register for resale at least the number of shares of Common Stock equal to the Required Registration
Amount as of the date such Registration Statement is initially filed with the SEC; provided further that if Form S-3 is unavailable for
such a registration, the Company shall use such other form as is required by Section 2(c). Such initial Registration Statement, and each
other Registration Statement required to be filed pursuant to the terms of this Agreement, shall contain (except if otherwise directed
by the Required Holders) the “Selling Stockholders” and “Plan of Distribution” sections in substantially
the form attached hereto as Exhibit A and Exhibit B, respectively. The Company shall use its best efforts to have such
initial Registration Statement, and each other Registration Statement required to be filed pursuant to the terms of this Agreement, declared
effective by the SEC as soon as practicable, but in no event later than the applicable Effectiveness Deadline for such Registration Statement.
(b)
Legal Counsel. Subject to Section 5 hereof, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel solely to the lead Buyer
(“Legal Counsel”), shall be provided a copy of any registration, solely on behalf of the lead Buyer, pursuant to this
Section 2.
(c)
Ineligibility to Use Form S-3. In the event that Form S-3 is not available for the registration of the resale of Registrable Securities
hereunder, the Company shall (i) register the resale of the Registrable Securities on Form S-1 or another appropriate form reasonably
acceptable to the Required Holders and (ii) undertake to register the resale of the Registrable Securities on Form S-3 as soon as such
form is available, provided that the Company shall maintain the effectiveness of all Registration Statements then in effect until such
time as a Registration Statement on Form S-3 covering the resale of all the Registrable Securities has been declared effective by the
SEC and the prospectus contained therein is available for use.
(d)
Sufficient Number of Shares Registered. In the event the number of shares available under any Registration Statement is insufficient
to cover all of the Registrable Securities required to be covered by such Registration Statement or an Investor’s allocated portion
of the Registrable Securities pursuant to Section 2(h), the Company shall amend such Registration Statement (if permissible), or file
with the SEC a new Registration Statement (on the short form available therefor, if applicable), or both, so as to cover at least the
Required Registration Amount less any securities that are no longer Registrable Securities as of the Trading Day immediately preceding
the date of the filing of such amendment or new Registration Statement, in each case, as soon as practicable, but in any event not later
than fifteen (15) days after the necessity therefor arises. The Company shall use its best efforts to cause such amendment to such Registration
Statement and/or such new Registration Statement (as the case may be) to become effective as soon as practicable following the filing
thereof with the SEC, but in no event later than the applicable Effectiveness Deadline for such Registration Statement. For purposes
of the foregoing provision, the number of shares available under a Registration Statement shall be deemed “insufficient to cover
all of the Registrable Securities” if at any time the number of shares of Common Stock available for resale under the applicable
Registration Statement is less than the product determined by multiplying (i) the Required Registration Amount as of such time by (ii)
0.90. The calculation set forth in the foregoing sentence shall be made without regard to any limitations on conversion of the Preferred
Shares or exercise of the Warrants (and such calculation shall assume (A) that the Preferred Shares are then convertible in full into
shares of Common Stock at the Floor Price (as defined in the Certificate of Designations) and (B) the Warrants are then exercisable in
full into shares of Common Stock at the then prevailing Exercise Price (as defined in the Warrants)).
3
(e)
Effect of Failure to File and Obtain and Maintain Effectiveness of any Registration Statement. If (i) a Registration Statement
covering the resale of all of the Registrable Securities required to be covered thereby (disregarding any reduction pursuant to Section
2(f)) and required to be filed by the Company pursuant to this Agreement is (A) not filed with the SEC on or before the Filing Deadline
for such Registration Statement (a “Filing Failure”) (it being understood that if the Company files a Registration
Statement without affording each Investor the opportunity to review and comment on the same as required by Section 3(c) hereof, the Company
shall be deemed to not have satisfied this clause (i)(A) and such event shall be deemed to be a Filing Failure) or (B) not declared effective
by the SEC on or before the Effectiveness Deadline for such Registration Statement (an “Effectiveness Failure”) (it
being understood that if on the Business Day immediately following the Effective Date for such Registration Statement the Company shall
not have filed a “final” prospectus for such Registration Statement with the SEC under Rule 424(b) in accordance with Section
3(b) (whether or not such a prospectus is technically required by such rule), the Company shall be deemed to not have satisfied this
clause (i)(B) and such event shall be deemed to be an Effectiveness Failure), (ii) other than during an Allowable Grace Period (as defined
below), on any day after the Effective Date of a Registration Statement sales of all of the Registrable Securities required to be included
on such Registration Statement (disregarding any reduction pursuant to Section 2(f)) cannot be made pursuant to such Registration Statement
(including, without limitation, because of a failure to keep such Registration Statement effective, a failure to disclose such information
as is necessary for sales to be made pursuant to such Registration Statement, a suspension or delisting of (or a failure to timely list)
the Common Stock on the Principal Market or any other limitations imposed by the Principal Market, or a failure to register a sufficient
number of shares of Common Stock or by reason of a stop order) or the prospectus contained therein is not available for use for any reason
(a “Maintenance Failure”), or (iii) if a Registration Statement is not effective for any reason or the prospectus
contained therein is not available for use for any reason, and either (x) the Company fails for any reason to satisfy the requirements
of Rule 144(c)(1), including, without limitation, the failure to satisfy the current public information requirement under Rule 144(c)
or (y) the Company has ever been an issuer described in Rule 144(i)(1)(i) or becomes such an issuer in the future, and the Company shall
fail to satisfy any condition set forth in Rule 144(i)(2) (a “Current Public Information Failure”) as a result of
which any of the Investors are unable to sell Registrable Securities without restriction under Rule 144 (including, without limitation,
volume restrictions), then, as partial relief for the damages to any holder by reason of any such delay in, or reduction of, its ability
to sell the underlying shares of Common Stock (which remedy shall not be exclusive of any other remedies available at law or in equity,
including, without limitation, specific performance), the Company shall pay to each holder of Registrable Securities relating to such
Registration Statement an amount in cash equal to two percent (2%) of such Investor’s respective Purchase Price on the Closing
Date (1) on the date of such Filing Failure, Effectiveness Failure, Maintenance Failure or Current Public Information Failure, as applicable,
and (2) on every thirty (30) day anniversary of (I) a Filing Failure until such Filing Failure is cured; (II) an Effectiveness Failure
until such Effectiveness Failure is cured; (III) a Maintenance Failure until such Maintenance Failure is cured; and (IV) a Current Public
Information Failure until the earlier of (i) the date such Current Public Information Failure is cured and (ii) such time that such public
information is no longer required pursuant to Rule 144 (in each case, prorated for periods totaling less than thirty (30) days). The
payments to which a holder of Registrable Securities shall be entitled pursuant to this Section 2(e) are referred to herein as “Registration
Delay Payments.” Following the initial Registration Delay Payment for any particular event or failure (which shall be paid
on the date of such event or failure, as set forth above), without limiting the foregoing, if an event or failure giving rise to the
Registration Delay Payments is cured prior to any thirty (30) day anniversary of such event or failure, then such Registration Delay
Payment shall be made on the third (3rd) Business Day after such cure. In the event the Company fails to make Registration Delay Payments
in a timely manner in accordance with the foregoing, such Registration Delay Payments shall bear interest at the rate of one and one
half percent (1.5%) per month (prorated for partial months) until paid in full. Notwithstanding the foregoing, no Registration Delay
Payments shall be owed to an Investor (other than with respect to a Maintenance Failure resulting from a suspension or delisting of (or
a failure to timely list) the Common Stock on the Principal Market) with respect to any period during which all of such Investor’s
Registrable Securities may be sold by such Investor without restriction under Rule 144 (including, without limitation, volume restrictions)
and without the need for current public information required by Rule 144(c)(1) (or Rule 144(i)(2), if applicable).
4
(f)
Offering. Notwithstanding anything to the contrary contained in this Agreement, but subject to the payment of the Registration
Delay Payments pursuant to Section 2(e), in the event the Staff or the SEC seeks to characterize any offering pursuant to a Registration
Statement filed pursuant to this Agreement as constituting an offering of securities by, or on behalf of, the Company, or in any other
manner, such that the Staff or the SEC do not permit such Registration Statement to become effective and used for resales in a manner
that does not constitute such an offering and that permits the continuous resale at the market by the Investors participating therein
(or as otherwise may be acceptable to each Investor) without being named therein as an “underwriter,” then the Company shall
reduce the number of shares to be included in such Registration Statement by all Investors until such time as the Staff and the SEC shall
so permit such Registration Statement to become effective as aforesaid. In making such reduction, the Company shall reduce the number
of shares to be included by all Investors on a pro rata basis (based upon the number of Registrable Securities otherwise required to
be included for each Investor) unless the inclusion of shares by a particular Investor or a particular set of Investors are resulting
in the Staff or the SEC’s “by or on behalf of the Company” offering position, in which event the shares held by such
Investor or set of Investors shall be the only shares subject to reduction (and if by a set of Investors on a pro rata basis by such
Investors or on such other basis as would result in the exclusion of the least number of shares by all such Investors); provided, that,
with respect to such pro rata portion allocated to any Investor, such Investor may elect the allocation of such pro rata portion among
the Registrable Securities of such Investor. In addition, in the event that the Staff or the SEC requires any Investor seeking to sell
securities under a Registration Statement filed pursuant to this Agreement to be specifically identified as an “underwriter”
in order to permit such Registration Statement to become effective, and such Investor does not consent to being so named as an underwriter
in such Registration Statement, then, in each such case, the Company shall reduce the total number of Registrable Securities to be registered
on behalf of such Investor, until such time as the Staff or the SEC does not require such identification or until such Investor accepts
such identification and the manner thereof. Any reduction pursuant to this paragraph will first reduce all Registrable Securities other
than those issued pursuant to the Securities Purchase Agreement. In the event of any reduction in Registrable Securities pursuant to
this paragraph, an affected Investor shall have the right to require, upon delivery of a written request to the Company signed by such
Investor, the Company to file a registration statement within twenty (20) days of such request (subject to any restrictions imposed by
Rule 415 or required by the Staff or the SEC) for resale by such Investor in a manner acceptable to such Investor, and the Company shall
following such request cause to be and keep effective such registration statement in the same manner as otherwise contemplated in this
Agreement for registration statements hereunder, in each case until such time as: (i) all Registrable Securities held by such Investor
have been registered and sold pursuant to an effective Registration Statement in a manner acceptable to such Investor or (ii) all Registrable
Securities may be resold by such Investor without restriction (including, without limitation, volume limitations) pursuant to Rule 144
(taking account of any Staff position with respect to “affiliate” status) and without the need for current public information
required by Rule 144(c)(1) (or Rule 144(i)(2), if applicable) or (iii) such Investor agrees to be named as an underwriter in any such
Registration Statement in a manner acceptable to such Investor as to all Registrable Securities held by such Investor and that have not
theretofore been included in a Registration Statement under this Agreement (it being understood that the special demand right under this
sentence may be exercised by an Investor multiple times and with respect to limited amounts of Registrable Securities in order to permit
the resale thereof by such Investor as contemplated above).
(g)
Piggyback Registrations. Without limiting any obligation of the Company hereunder or under the Securities Purchase Agreement,
if there is not an effective Registration Statement covering all of the Registrable Securities or the prospectus contained therein is
not available for use and the Company shall determine to prepare and file with the SEC a registration statement or offering statement
relating to an offering for its own account or the account of others under the 1933 Act of any of its equity securities (other than on
Form S-4 or Form S-8 (each as promulgated under the 1933 Act) or their then equivalents relating to equity securities to be issued solely
in connection with any acquisition of any entity or business or equity securities issuable in connection with the Company’s share
option or other employee benefit plans), then the Company shall deliver to each Investor a written notice of such determination and,
if within fifteen (15) days after the date of the delivery of such notice, any such Investor shall so request in writing, the Company
shall include in such registration statement or offering statement all or any part of such Registrable Securities such Investor requests
to be registered; provided, however, the Company shall not be required to register any Registrable Securities pursuant to this Section
2(g) that are eligible for resale pursuant to Rule 144 without restriction (including, without limitation, volume restrictions) and without
the need for current public information required by Rule 144(c)(1) (or Rule 144(i)(2), if applicable) or that are the subject of a then-effective
Registration Statement.
5
(h)
Allocation of Registrable Securities. The initial number of Registrable Securities included in any Registration Statement and
any increase in the number of Registrable Securities included therein shall be allocated pro rata among the Investors based on the number
of Registrable Securities held by each Investor at the time such Registration Statement covering such initial number of Registrable Securities
or increase thereof is declared effective by the SEC. In the event that an Investor sells or otherwise transfers any of such Investor’s
Registrable Securities, each transferee or assignee (as the case may be) that becomes an Investor shall be allocated a pro rata portion
of the then-remaining number of Registrable Securities included in such Registration Statement for such transferor or assignee (as the
case may be). Any shares of Common Stock included in a Registration Statement and which remain allocated to any Person which ceases to
hold any Registrable Securities covered by such Registration Statement shall be allocated to the remaining Investors, pro rata based
on the number of Registrable Securities then held by such Investors which are covered by such Registration Statement.
(i)
No Inclusion of Other Securities. Other than with respect to (i) the shares of Common Stock issuable upon exercise of the Placement
Agent Warrants, and (ii) the shares of Common Stock issuable upon conversion of the Company’s Series J Preferred Stock, the Company
shall in no event include any securities other than Registrable Securities on any Registration Statement filed in accordance herewith
without the prior written consent of the Required Holders. Until the Applicable Date, the Company shall not enter into any agreement
providing any registration rights to any of its security holders, except as otherwise permitted under the Securities Purchase Agreement.
3.
Related Obligations.
The
Company shall use its best efforts to effect the registration of the Registrable Securities in accordance with the intended method of
disposition thereof, and, pursuant thereto, the Company shall have the following obligations:
(a)
The Company shall promptly prepare and file with the SEC a Registration Statement with respect to all the Registrable Securities (but
in no event later than the applicable Filing Deadline) and use its best efforts to cause such Registration Statement to become effective
as soon as practicable after such filing (but in no event later than the Effectiveness Deadline). Subject to Allowable Grace Periods,
the Company shall keep each Registration Statement effective (and the prospectus contained therein available for use) pursuant to Rule
415 for resales by the Investors on a delayed or continuous basis at then-prevailing market prices (and not fixed prices) at all times
until the earlier of (i) the date as of which all of the Investors may sell all of the Registrable Securities required to be covered
by such Registration Statement (disregarding any reduction pursuant to Section 2(f)) without restriction pursuant to Rule 144 (including,
without limitation, volume restrictions) and without the need for current public information required by Rule 144(c)(1) (or Rule 144(i)(2),
if applicable) or (ii) the date on which the Investors shall have sold all of the Registrable Securities covered by such Registration
Statement (the “Registration Period”). Notwithstanding anything to the contrary contained in this Agreement, the Company
shall ensure that, when filed and at all times while effective, each Registration Statement (including, without limitation, all amendments
and supplements thereto) and the prospectus (including, without limitation, all amendments and supplements thereto) used in connection
with such Registration Statement (1) shall not contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein, or necessary to make the statements therein (in the case of prospectuses, in the light of the circumstances in
which they were made) not misleading and (2) will disclose (whether directly or through incorporation by reference to other SEC filings
to the extent permitted) all material information regarding the Company and its securities. The Company shall submit to the SEC, within
one (1) Business Day after the date that the Company learns that no review of a particular Registration Statement will be made by the
Staff or that the Staff has no further comments on a particular Registration Statement (as the case may be), a request for acceleration
of effectiveness of such Registration Statement to a time and date not later than two (2) Business Days after the submission of such
request (but taking account of any Staff position with respect to the date on which the Staff will permit such request for acceleration
to be filed with the SEC). The Company shall respond in writing to comments made by the SEC in respect of a Registration Statement as
soon as practicable, but in no event later than fifteen (15) days after the receipt of comments by or notice from the SEC that an amendment
is required in order for a Registration Statement to be declared effective.
6
(b)
Subject to Section 3(r) of this Agreement, the Company shall prepare and file with the SEC such amendments (including, without limitation,
post-effective amendments) and supplements to each Registration Statement and the prospectus used in connection with each such Registration
Statement, which prospectus is to be filed pursuant to Rule 424 promulgated under the 1933 Act, as may be necessary to keep each such
Registration Statement effective at all times during the Registration Period for such Registration Statement, and, during such period,
comply with the provisions of the 1933 Act with respect to the disposition of all Registrable Securities of the Company required to be
covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance
with the intended methods of disposition by the seller or sellers thereof as set forth in such Registration Statement; provided, however,
by 8:30 a.m. (New York time) on the Business Day immediately following each Effective Date, the Company shall file with the SEC in accordance
with Rule 424(b) under the 1933 Act the final prospectus to be used in connection with sales pursuant to the applicable Registration
Statement (whether or not such a prospectus is technically required by such rule). In the case of amendments and supplements to any Registration
Statement which are required to be filed pursuant to this Agreement (including, without limitation, pursuant to this Section 3(b)) by
reason of the Company filing a Current Report on Form 8-K, an Annual Report on Form 10-K, a Quarterly Report on Form 10-Q or any analogous
report under the Securities Exchange Act of 1934, as amended (the “1934 Act”), the Company shall, if permitted under
the applicable rules and regulations of the SEC, have incorporated such report by reference into such Registration Statement, if applicable,
or shall file such amendments or supplements with the SEC on the same day on which the 1934 Act report is filed which created the requirement
for the Company to amend or supplement such Registration Statement.
(c)
The Company shall (A) permit each Investor to review and comment upon (i) each Registration Statement at least five (5) days prior to
its filing with the SEC and (ii) all amendments and supplements to each Registration Statement (including, without limitation, the prospectus
contained therein) (except for Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and any similar
or successor reports) within a reasonable number of days prior to their filing with the SEC, and (B) not file any Registration Statement
or amendment or supplement thereto in a form to which such Investor reasonably objects; provided, that the Company shall not have
any obligation to modify any information if the Company reasonably expects that so doing would cause (i) the Registration Statement to
contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make
the statements therein not misleading or (ii) any prospectus contained therein to contain an untrue statement of a material fact or to
omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which they were made,
not misleading. The Company shall promptly furnish to each Investor, without charge, (i) copies of any correspondence from the SEC or
the Staff to the Company or its representatives relating to each Registration Statement, provided that such correspondence shall not
contain any material, non-public information regarding the Company or any of its Subsidiaries, (ii) after the same is prepared and filed
with the SEC, one (1) copy of each Registration Statement and any amendment(s) and supplement(s) thereto, including, without limitation,
financial statements and schedules, all documents incorporated therein by reference, if requested by an Investor, and all exhibits and
(iii) upon the effectiveness of each Registration Statement, one (1) copy of the prospectus included in such Registration Statement and
all amendments and supplements thereto, provided, that any such item which is available on the EDGAR system (or successor thereto) need
not be furnished. The Company shall reasonably cooperate with each Investor in performing the Company’s obligations pursuant to
this Section 3.
(d) The
Company shall promptly furnish to each Investor whose Registrable Securities are included in any Registration Statement, without charge,
(i) after the same is prepared and filed with the SEC, at least one (1) copy of each Registration Statement and any amendment(s) and
supplement(s) thereto, including, without limitation, financial statements and schedules, all documents incorporated therein by reference,
if requested by an Investor, all exhibits and each preliminary prospectus, provided, that any such item which is available on the EDGAR
system (or successor thereto) need not be furnished.
(e) The
Company shall use its best efforts to (i) register and qualify, unless an exemption from registration and qualification applies, the
resale by Investors of the Registrable Securities covered by a Registration Statement under such other securities or “blue sky”
laws of all applicable jurisdictions in the United States, (ii) prepare and file in those jurisdictions, such amendments (including,
without limitation, post-effective amendments) and supplements to such registrations and qualifications as may be necessary to maintain
the effectiveness thereof during the Registration Period, (iii) take such other actions as may be necessary to maintain such registrations
and qualifications in effect at all times during the Registration Period, and (iv) take all other actions reasonably necessary or advisable
to qualify the Registrable Securities for sale in such jurisdictions; provided, however, the Company shall not be required in connection
therewith or as a condition thereto to (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify
but for this Section 3(e), (y) subject itself to general taxation in any such jurisdiction, or (z) file a general consent to service
of process in any such jurisdiction. The Company shall promptly notify Legal Counsel, legal counsel for each other Investor and each
Investor who holds Registrable Securities of the receipt by the Company of any notification with respect to the suspension of the registration
or qualification of any of the Registrable Securities for sale under the securities or “blue sky” laws of any jurisdiction
in the United States or its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.
7
(f)
The Company shall notify each Investor in writing of the happening of any event, as promptly as practicable after becoming aware of such
event, as a result of which the prospectus included in a Registration Statement, as then in effect, may include an untrue statement of
a material fact or omission to state a material fact required to be stated therein or necessary to make the statements therein, in the
light of the circumstances under which they were made, not misleading (provided that in no event shall such notice contain any material,
non-public information regarding the Company or any of its Subsidiaries), and, subject to Section 3(r), promptly prepare a supplement
or amendment to such Registration Statement and such prospectus contained therein to correct such untrue statement or omission and deliver
one (1) copy of such supplement or amendment to each Investor; provided, that any such item which is available on the EDGAR system (or
successor thereto) need not be furnished. The Company shall also promptly notify each Investor in writing (i) when a prospectus or any
prospectus supplement or post-effective amendment has been filed, when a Registration Statement or any post-effective amendment has become
effective (notification of such effectiveness shall be delivered to each Investor by e-mail on the same day of such effectiveness and
by overnight mail), and when the Company receives written notice from the SEC that a Registration Statement or any post-effective amendment
will be reviewed by the SEC, (ii) of any request by the SEC for amendments or supplements to a Registration Statement or related prospectus
or related information, (iii) of the Company’s reasonable determination that a post-effective amendment to a Registration Statement
would be appropriate; and (iv) of the receipt of any request by the SEC or any other federal or state governmental authority for any
additional information relating to the Registration Statement or any amendment or supplement thereto or any related prospectus. The Company
shall respond as promptly as practicable to any comments received from the SEC with respect to each Registration Statement or any amendment
thereto (it being understood and agreed that the Company’s response to any such comments shall be delivered to the SEC no later
than fifteen (15) Business Days after the receipt thereof).
(g)
The Company shall (i) use its best efforts to prevent the issuance of any stop order or other suspension of effectiveness of each Registration
Statement or the use of any prospectus contained therein, or the suspension of the qualification, or the loss of an exemption from qualification,
of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is issued, to obtain the withdrawal
of such order or suspension at the earliest possible moment and (ii) notify each Investor who holds Registrable Securities of the issuance
of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding for such purpose.
(h) If
any Investor may be required under applicable securities law to be described in any Registration Statement as an underwriter and such
Investor consents to so being named an underwriter, at the request of any Investor, the Company shall furnish to such Investor, on the
date of the effectiveness of such Registration Statement and thereafter from time to time on such dates as an Investor may reasonably
request (i) a letter, dated such date, from the Company’s independent certified public accountants in form and substance as is
customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the Investors,
and (ii) an opinion, dated as of such date, of counsel representing the Company for purposes of such Registration Statement, in form,
scope and substance as is customarily given in an underwritten public offering, addressed to the Investors.
(i) If
any Investor may be required under applicable securities law to be described in any Registration Statement as an underwriter and such
Investor consents to so being named an underwriter, upon the written request of such Investor, the Company shall make available for inspection
by (i) such Investor, (ii) legal counsel for such Investor and (iii) one (1) firm of accountants or other agents retained by such Investor
(collectively, the “Inspectors”), all pertinent financial and other records, and pertinent corporate documents and
properties of the Company (collectively, the “Records”), as shall be reasonably deemed necessary by each Inspector,
and cause the Company’s officers, directors and employees to supply all information which any Inspector may reasonably request;
provided, however, each Inspector shall agree in writing to hold in strict confidence and not to make any disclosure (except to such
Investor) or use of any Record or other information which the Company’s board of directors determines in good faith to be confidential,
and of which determination the Inspectors are so notified, unless (1) the disclosure of such Records is necessary to avoid or correct
a misstatement or omission in any Registration Statement or is otherwise required under the 1933 Act, (2) the release of such Records
is ordered pursuant to a final, non-appealable subpoena or order from a court or government body of competent jurisdiction, or (3) the
information in such Records has been made generally available to the public other than by disclosure in violation of this Agreement or
any other Transaction Document. Such Investor agrees that it shall, upon learning that disclosure of such Records is sought in or by
a court or governmental body of competent jurisdiction or through other means, give prompt notice to the Company and allow the Company,
at its expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, the Records deemed confidential.
Nothing herein (or in any other confidentiality agreement between the Company and such Investor, if any) shall be deemed to limit any
Investor’s ability to sell Registrable Securities in a manner which is otherwise consistent with applicable laws and regulations.
8
(j) The
Company shall hold in confidence and not make any disclosure of information concerning an Investor provided to the Company unless (i)
disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information
is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required to be disclosed in
such Registration Statement pursuant to the 1933 Act, (iii) the release of such information is ordered pursuant to a subpoena or other
final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such information has been made generally
available to the public other than by disclosure in violation of this Agreement or any other Transaction Document. The Company agrees
that it shall, upon learning that disclosure of such information concerning an Investor is sought in or by a court or governmental body
of competent jurisdiction or through other means, give prompt written notice to such Investor and allow such Investor, at such Investor’s
expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.
(k) Without
limiting any obligation of the Company under the Securities Purchase Agreement, the Company shall use its best efforts either to (i)
cause all of the Registrable Securities covered by each Registration Statement to be listed on each securities exchange on which securities
of the same class or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted
under the rules of such exchange, (ii) secure designation and quotation of all of the Registrable Securities covered by each Registration
Statement on an Eligible Market, or (iii) if, despite the Company’s best efforts to satisfy the preceding clauses (i) or (ii) the
Company is unsuccessful in satisfying the preceding clauses (i) or (ii), without limiting the generality of the foregoing, to use its
best efforts to arrange for at least two market makers to register with the Financial Industry Regulatory Authority (“FINRA”)
as such with respect to such Registrable Securities. In addition, the Company shall cooperate with each Investor and any broker or dealer
through which any such Investor proposes to sell its Registrable Securities in effecting a filing with FINRA pursuant to FINRA Rule 5110
as requested by such Investor. The Company shall pay all fees and expenses in connection with satisfying its obligations under this Section
3(k).
(l) The
Company shall cooperate with the Investors who hold Registrable Securities being offered and, to the extent applicable, facilitate the
timely preparation and delivery of certificates (not bearing any restrictive legend) representing the Registrable Securities to be offered
pursuant to a Registration Statement and enable such certificates to be in such denominations or amounts (as the case may be) as the
Investors may reasonably request from time to time and registered in such names as the Investors may request.
(m) If
requested by an Investor, the Company shall as soon as practicable after receipt of notice from such Investor and subject to Section
3(r) hereof, (i) incorporate in a prospectus supplement or post-effective amendment such information as an Investor reasonably requests
to be included therein relating to the sale and distribution of Registrable Securities, including, without limitation, information with
respect to the number of Registrable Securities being offered or sold, the purchase price being paid therefor and any other terms of
the offering of the Registrable Securities to be sold in such offering; (ii) make all required filings of such prospectus supplement
or post-effective amendment after being notified of the matters to be incorporated in such prospectus supplement or post-effective amendment;
and (iii) supplement or make amendments to any Registration Statement or prospectus contained therein if reasonably requested by an Investor
holding any Registrable Securities.
(n) The
Company shall use its best efforts to cause the Registrable Securities covered by a Registration Statement to be registered with or approved
by such other United States governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable
Securities.
9
(o) The
Company shall make generally available to its security holders as soon as practical, but not later than ninety (90) days after the close
of the period covered thereby, an earnings statement (in form complying with, and in the manner provided by, the provisions of Rule 158
under the 1933 Act) covering a twelve-month period beginning not later than the first day of the Company’s fiscal quarter next
following the applicable Effective Date of each Registration Statement.
(p) The
Company shall otherwise use its best efforts to comply with all applicable rules and regulations of the SEC in connection with any registration
hereunder.
(q) Within
one (1) Business Day after a Registration Statement which covers Registrable Securities is declared effective by the SEC, the Company
shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities (with
copies to the Investors whose Registrable Securities are included in such Registration Statement) confirmation that such Registration
Statement has been declared effective by the SEC in the form acceptable to the Transfer Agent.
(r) Notwithstanding
anything to the contrary herein (but subject to the last sentence of this Section 3(r)), at any time after the Effective Date of a particular
Registration Statement, the Company may delay the disclosure of material, non-public information concerning the Company or any of its
Subsidiaries the disclosure of which at the time is not, in the good faith opinion of the board of directors of the Company, in the best
interest of the Company and, in the opinion of counsel to the Company, otherwise required (a “Grace Period”), provided
that the Company shall promptly notify the Investors in writing of the (i) existence of material, non-public information giving rise
to a Grace Period (provided that in each such notice the Company shall not disclose the content of such material, non-public information
to any of the Investors) and the date on which such Grace Period will begin and (ii) date on which such Grace Period ends, provided further
that (I) no Grace Period shall exceed ten (10) consecutive days and during any three hundred sixty five (365) day period all such Grace
Periods shall not exceed an aggregate of thirty (30) days, (II) the first day of any Grace Period must be at least five (5) Trading Days
after the last day of any prior Grace Period and (III) no Grace Period may exist during the sixty (60) Trading Day period immediately
following the Effective Date of such Registration Statement (provided that such sixty (60) Trading Day period shall be extended by the
number of Trading Days during such period and any extension thereof contemplated by this proviso during which such Registration Statement
is not effective or the prospectus contained therein is not available for use) (each, an “Allowable Grace Period”).
For purposes of determining the length of a Grace Period above, such Grace Period shall begin on and include the date the Investors receive
the notice referred to in clause (i) above and shall end on and include the later of the date the Investors receive the notice referred
to in clause (ii) above and the date referred to in such notice. The provisions of Section 3(g) hereof shall not be applicable during
the period of any Allowable Grace Period. Upon expiration of each Grace Period, the Company shall again be bound by the first sentence
of Section 3(f) with respect to the information giving rise thereto unless such material, non-public information is no longer applicable.
Notwithstanding anything to the contrary contained in this Section 3(r), the Company shall cause its transfer agent to deliver unlegended
shares of Common Stock to a transferee of an Investor in accordance with the terms of the Securities Purchase Agreement in connection
with any sale of Registrable Securities with respect to which such Investor has entered into a contract for sale, and delivered a copy
of the prospectus included as part of the particular Registration Statement to the extent applicable, prior to such Investor’s
receipt of the notice of a Grace Period and for which the Investor has not yet settled.
(s) The
Company shall take all other reasonable actions necessary to expedite and facilitate disposition by each Investors of its Registrable
Securities pursuant to each Registration Statement.
(t) Neither
the Company nor any Subsidiary or affiliate thereof shall identify any Investor as an underwriter in any public disclosure or filing
with the SEC, the Principal Market or any Eligible Market and any Buyer being deemed an underwriter by the SEC shall not relieve the
Company of any obligations it has under this Agreement or any other Transaction Document; provided, however, that the foregoing shall
not prohibit the Company from including the disclosure found in the “Plan of Distribution” section attached hereto as Exhibit
A in the Registration Statement.
(u) Neither
the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries, on or after
the date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing the rights
granted to the Buyers in this Agreement or otherwise conflicts with the provisions hereof.
10
4.
Obligations of the Investors.
(a) At
least five (5) Business Days prior to the first anticipated filing date of each Registration Statement, the Company shall notify each
Investor in writing of the information the Company requires from each such Investor with respect to such Registration Statement. It shall
be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect to the
Registrable Securities of a particular Investor that such Investor shall furnish to the Company such information regarding itself, the
Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it, as shall be reasonably
required to effect and maintain the effectiveness of the registration of such Registrable Securities and shall execute such documents
in connection with such registration as the Company may reasonably request.
(b) Each
Investor, by such Investor’s acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested
by the Company in connection with the preparation and filing of each Registration Statement hereunder, unless such Investor has notified
the Company in writing of such Investor’s election to exclude all of such Investor’s Registrable Securities from such Registration
Statement.
(c) Each
Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 3(g)
or the first sentence of Section 3(f), such Investor will immediately discontinue disposition of Registrable Securities pursuant to any
Registration Statement(s) covering such Registrable Securities until such Investor’s receipt of the copies of the supplemented
or amended prospectus contemplated by Section 3(g) or the first sentence of Section 3(f) or receipt of notice that no supplement or amendment
is required. Notwithstanding anything to the contrary in this Section 4(c) and subject to applicable law, the Company shall cause its
transfer agent to deliver unlegended shares of Common Stock to a transferee of an Investor in accordance with the terms of the Securities
Purchase Agreement in connection with any sale of Registrable Securities with respect to which such Investor has entered into a contract
for sale prior to the Investor’s receipt of a notice from the Company of the happening of any event of the kind described in Section
3(g) or the first sentence of Section 3(f) and for which such Investor has not yet settled.
5.
Expenses of Registration.
All
reasonable expenses, other than underwriting discounts and commissions, incurred in connection with registrations, filings or qualifications
pursuant to Sections 2 and 3, including, without limitation, all registration, listing and qualifications fees, printers and accounting
fees, FINRA filing fees (if any) and fees and disbursements of counsel for the Company shall be paid by the Company. In no event shall
the Company be responsible for any broker or similar commissions of any Investor or, except to the extent expressly provided for in the
Transaction Documents, any legal fees or other costs of the Investors.
11
6.
Indemnification.
(a)
To the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend each Investor and each
of its directors, officers, stockholders, members, partners, employees, agents, advisors, representatives (and any other Persons with
a functionally equivalent role of a Person holding such titles notwithstanding the lack of such title or any other title) and each Person,
if any, who controls such Investor within the meaning of the 1933 Act or the 1934 Act and each of the directors, officers, stockholders,
members, partners, employees, agents, advisors, representatives (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding the lack of such title or any other title) of such controlling Persons (each, an “Indemnified
Person”), against any losses, obligations, claims, damages, liabilities, contingencies, judgments, fines, penalties, charges,
costs (including, without limitation, court costs, reasonable attorneys’ fees and costs of defense and investigation), amounts
paid in settlement or expenses, joint or several, (collectively, “Claims”) incurred in investigating, preparing or
defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or governmental,
administrative or other regulatory agency, body or the SEC, whether pending or threatened, whether or not an Indemnified Person is or
may be a party thereto (“Indemnified Damages”), to which any of them may become subject insofar as such Claims (or
actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon: (i) any untrue statement
or alleged untrue statement of a material fact in a Registration Statement or any post-effective amendment thereto or in any filing made
in connection with the qualification of the offering under the securities or other “blue sky” laws of any jurisdiction in
which Registrable Securities are offered (“Blue Sky Filing”), or the omission or alleged omission to state a material
fact required to be stated therein or necessary to make the statements therein not misleading, (ii) any untrue statement or alleged untrue
statement of a material fact contained in any preliminary prospectus if used prior to the effective date of such Registration Statement,
or contained in the final prospectus (as amended or supplemented, if the Company files any amendment thereof or supplement thereto with
the SEC) or the omission or alleged omission to state therein any material fact necessary to make the statements made therein, in light
of the circumstances under which the statements therein were made, not misleading or (iii) any violation or alleged violation by the
Company of the 1933 Act, the 1934 Act, any other law, including, without limitation, any state securities law, or any rule or regulation
thereunder relating to the offer or sale of the Registrable Securities pursuant to a Registration Statement or (iv) any violation of
this Agreement (the matters in the foregoing clauses (i) through (iv) being, collectively, “Violations”); provided,
however, that the Company shall not be liable in any such case to the extent that any such claim, loss, damage, liability, or expense
arises out of or is based upon such Indemnified Person’s gross negligence, willful misconduct or fraud or any untrue statement
or omission contained in such prospectus or other document based upon written information furnished to the Company by such Indemnified
Person expressly for use in connection with such Registration Statement. Subject to Section 6(c), the Company shall reimburse the Indemnified
Persons, promptly as such expenses are incurred and are due and payable, for reasonable legal fees or other reasonable expenses incurred
by them in connection with investigating or defending any such Claim. Notwithstanding anything to the contrary contained herein, the
indemnification agreement contained in this Section 6(a): (i) shall not apply to a Claim by an Indemnified Person arising out of or based
upon a Violation which occurs in reliance upon and in conformity with information furnished in writing to the Company by such Indemnified
Person for such Indemnified Person expressly for use in connection with the preparation of such Registration Statement or any such amendment
thereof or supplement thereto, if such prospectus was timely made available by the Company pursuant to Section 3(d); and (ii) shall not
apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Company, which
consent shall not be unreasonably withheld or delayed. Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of the Indemnified Person and shall survive the transfer of any of the Registrable Securities by any of the Investors
pursuant to Section 9.
(b)
In connection with any Registration Statement in which an Investor is participating, such Investor agrees to severally and not jointly
indemnify, hold harmless and defend, to the same extent and in the same manner as is set forth in Section 6(a), the Company, each of
its directors, each of its officers who signs the Registration Statement and each Person, if any, who controls the Company within the
meaning of the 1933 Act or the 1934 Act (each, an “Indemnified Party”), against any Claim or Indemnified Damages to
which any of them may become subject, under the 1933 Act, the 1934 Act or otherwise, insofar as such Claim or Indemnified Damages arise
out of or are based upon any Violation, in each case, to the extent, and only to the extent, that such Violation occurs in reliance upon
and in conformity with written information furnished to the Company by such Investor expressly for use in connection with such Registration
Statement; and, subject to Section 6(c) and the below provisos in this Section 6(b), such Investor will reimburse an Indemnified Party
any legal or other expenses reasonably incurred by such Indemnified Party in connection with investigating or defending any such Claim;
provided, however, the indemnity agreement contained in this Section 6(b) and the agreement with respect to contribution contained in
Section 7 shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent
of such Investor, which consent shall not be unreasonably withheld or delayed, provided further that such Investor shall be liable under
this Section 6(b) for only that amount of a Claim or Indemnified Damages as does not exceed the net proceeds to such Investor as a result
of the applicable sale of Registrable Securities pursuant to such Registration Statement. Such indemnity shall remain in full force and
effect regardless of any investigation made by or on behalf of such Indemnified Party and shall survive the transfer of any of the Registrable
Securities by any of the Investors pursuant to Section 9.
12
(c)
Promptly after receipt by an Indemnified Person or Indemnified Party (as the case may be) under this Section 6 of notice of the commencement
of any action or proceeding (including, without limitation, any governmental action or proceeding) involving a Claim, such Indemnified
Person or Indemnified Party (as the case may be) shall, if a Claim in respect thereof is to be made against any indemnifying party under
this Section 6, deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have
the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly
noticed, to assume control of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Indemnified Person
or the Indemnified Party (as the case may be); provided, however, an Indemnified Person or Indemnified Party (as the case may be) shall
have the right to retain its own counsel with the fees and expenses of such counsel to be paid by the indemnifying party if: (i) the
indemnifying party has agreed in writing to pay such fees and expenses; (ii) the indemnifying party shall have failed promptly to assume
the defense of such Claim and to employ counsel reasonably satisfactory to such Indemnified Person or Indemnified Party (as the case
may be) in any such Claim; or (iii) the named parties to any such Claim (including, without limitation, any impleaded parties) include
both such Indemnified Person or Indemnified Party (as the case may be) and the indemnifying party, and such Indemnified Person or such
Indemnified Party (as the case may be) shall have been advised by counsel that a conflict of interest is likely to exist if the same
counsel were to represent such Indemnified Person or such Indemnified Party and the indemnifying party (in which case, if such Indemnified
Person or such Indemnified Party (as the case may be) notifies the indemnifying party in writing that it elects to employ separate counsel
at the expense of the indemnifying party, then the indemnifying party shall not have the right to assume the defense thereof and such
counsel shall be at the expense of the indemnifying party, provided further that in the case of clause (iii) above the indemnifying party
shall not be responsible for the reasonable fees and expenses of more than one (1) separate legal counsel for such Indemnified Person
or Indemnified Party (as the case may be). The Indemnified Party or Indemnified Person (as the case may be) shall reasonably cooperate
with the indemnifying party in connection with any negotiation or defense of any such action or Claim by the indemnifying party and shall
furnish to the indemnifying party all information reasonably available to the Indemnified Party or Indemnified Person (as the case may
be) which relates to such action or Claim. The indemnifying party shall keep the Indemnified Party or Indemnified Person (as the case
may be) reasonably apprised at all times as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying
party shall be liable for any settlement of any action, claim or proceeding effected without its prior written consent; provided, however,
the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior
written consent of the Indemnified Party or Indemnified Person (as the case may be), consent to entry of any judgment or enter into any
settlement or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such
Indemnified Party or Indemnified Person (as the case may be) of a release from all liability in respect to such Claim or litigation,
and such settlement shall not include any admission as to fault on the part of the Indemnified Party. Following indemnification as provided
for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person (as the case may
be) with respect to all third parties, firms or corporations relating to the matter for which indemnification has been made. The failure
to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve
such indemnifying party of any liability to the Indemnified Person or Indemnified Party (as the case may be) under this Section 6, except
to the extent that the indemnifying party is materially and adversely prejudiced in its ability to defend such action.
(d)
The indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, as and when bills are received or Indemnified Damages are incurred.
(e)
The indemnity and contribution agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified
Party or Indemnified Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject
to pursuant to the law.
7.
Contribution.
To
the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum
contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law;
provided, however: (i) no contribution shall be made under circumstances where the maker would not have been liable for indemnification
under the fault standards set forth in Section 6 of this Agreement, (ii) no Person involved in the sale of Registrable Securities which
Person is guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) in connection with such sale shall
be entitled to contribution from any Person involved in such sale of Registrable Securities who was not guilty of fraudulent misrepresentation;
and (iii) contribution by any seller of Registrable Securities shall be limited in amount to the amount of net proceeds received by such
seller from the applicable sale of such Registrable Securities pursuant to such Registration Statement. Notwithstanding the provisions
of this Section 7, no Investor shall be required to contribute, in the aggregate, any amount in excess of the amount by which the net
proceeds actually received by such Investor from the applicable sale of the Registrable Securities subject to the Claim exceeds the amount
of any damages that such Investor has otherwise been required to pay, or would otherwise be required to pay under Section 6(b), by reason
of such untrue or alleged untrue statement or omission or alleged omission.
13
8.
Reports Under the 1934 Act.
With
a view to making available to the Investors the benefits of Rule 144, the Company agrees to:
(a)
make and keep public information available, as those terms are understood and defined in Rule 144;
(b)
file with the SEC in a timely manner all reports and other documents required of the Company under the 1933 Act and the 1934 Act so long
as the Company remains subject to such requirements (it being understood and agreed that nothing herein shall limit any obligations of
the Company under the Securities Purchase Agreement) and the filing of such reports and other documents is required for the applicable
provisions of Rule 144; and
(c) furnish
to each Investor so long as such Investor owns Registrable Securities, promptly upon request, (i) a written statement by the Company,
if true, that it has complied with the reporting, submission and posting requirements of Rule 144, the 1933 Act and the 1934 Act, (ii)
a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company with
the SEC if such reports are not publicly available via EDGAR, and (iii) such other information as may be reasonably requested to permit
the Investors to sell such securities pursuant to Rule 144 without registration.
9.
Assignment of Registration Rights.
All
or any portion of the rights under this Agreement shall be automatically assignable by each Investor to any transferee or assignee (as
the case may be) of all or any portion of such Investor’s Registrable Securities, Preferred Shares or Warrants if: (i) such Investor
agrees in writing with such transferee or assignee (as the case may be) to assign all or any portion of such rights, and a copy of such
agreement is furnished to the Company within a reasonable time after such transfer or assignment (as the case may be); (ii) the Company
is, within a reasonable time after such transfer or assignment (as the case may be), furnished with written notice of (a) the name and
address of such transferee or assignee (as the case may be), and (b) the securities with respect to which such registration rights are
being transferred or assigned (as the case may be); (iii) immediately following such transfer or assignment (as the case may be) the
further disposition of such securities by such transferee or assignee (as the case may be) is restricted under the 1933 Act or applicable
state securities laws if so required; (iv) at or before the time the Company receives the written notice contemplated by clause (ii)
of this sentence such transferee or assignee (as the case may be) agrees in writing with the Company to be bound by all of the provisions
contained herein; (v) such transfer or assignment (as the case may be) shall have been made in accordance with the applicable requirements
of the Securities Purchase Agreement, the Certificate of Designations and the Warrants (as the case may be); and (vi) such transfer or
assignment (as the case may be) shall have been conducted in accordance with all applicable federal and state securities laws.
10.
Amendment of Registration Rights.
Provisions
of this Agreement may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively
or prospectively), only with the written consent of the Company and the Required Holders; provided that any such amendment or waiver
that complies with the foregoing, but that disproportionately, materially and adversely affects the rights and obligations of any Investor
relative to the comparable rights and obligations of the other Investors shall require the prior written consent of such adversely affected
Investor. Any amendment or waiver effected in accordance with this Section 10 shall be binding upon each Investor and the Company, provided
that no such amendment shall be effective to the extent that it (1) applies to less than all of the holders of Registrable Securities
or (2) imposes any obligation or liability on any Investor without such Investor’s prior written consent (which may be granted
or withheld in such Investor’s sole discretion). No waiver shall be effective unless it is in writing and signed by an authorized
representative of the waiving party. No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification
of any provision of this Agreement unless the same consideration (other than the reimbursement of legal fees) also is offered to all
of the parties to this Agreement.
14
11.
Miscellaneous.
(a)
Solely for purposes of this Agreement, a Person is deemed to be a holder of Registrable Securities whenever such Person owns, or is deemed
to own, of record such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more
Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received
from such record owner of such Registrable Securities.
(b)
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in
writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by electronic
mail (provided that such sent email is kept on file (whether electronically or otherwise) by the sending party and the sending party
does not receive an automatically generated message from the recipient’s email server that such e-mail could not be delivered to
such recipient); or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified, in each
case, properly addressed to the party to receive the same. The mailing addresses and e-mail addresses for such communications shall be:
If
to the Company:
StableX
Technologies, Inc.
1185
Avenue of the Americas, 3rd Floor
New
York, New York 10036
Telephone:
(973) 242-0005
Attention: Chief Executive Officer
E-Mail: jsilverman@parkfieldfund.com
With
a copy (for informational purposes only) to:
Haynes
and Boone, LLP
30
Rockefeller Plaza, 26th Floor
New
York, New York 10112
Telephone:
(212) 659-7300
Attention:
Rick Werner
E-mail:
rick.werner@haynesboone.com
If
to the Transfer Agent:
Equiniti
Trust Company LLC
1110
Centre Point Curve, Suite 101
Mendota
Heights MN 55120
Telephone:
919-744-2722
Attention:
Direct Transfer Compliance
E-Mail:
transfer-ID@equiniti.com
If
to Legal Counsel:
Mintz,
Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
919
Third Avenue
New
York, New York 10022
Telephone:
(212) 935-3000
Attention:
Jeffrey P. Schultz
E-Mail:
jpschultz@mintz.com
If to a Buyer, to its mailing address and/or email address set forth on the Schedule of Buyers attached to the Securities
Purchase Agreement, with copies to such Buyer’s representatives as set forth on the Schedule of Buyers, or to such other mailing
address and/or email address and/or to the attention of such other Person as the recipient party has specified by written notice given
to each other party five (5) days prior to the effectiveness of such change, provided that Legal Counsel shall only be provided notices
sent to the lead investor. Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver or other communication,
(B) mechanically or electronically generated by the sender’s e-mail containing the time, date and recipient’s e-mail or (C)
provided by a courier or overnight courier service shall be rebuttable evidence of personal service, receipt by e-mail or receipt from
a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively.
15
(c)
Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right
or remedy, shall not operate as a waiver thereof. The Company and each Investor acknowledge and agree that irreparable damage would occur
in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that each party hereto shall be entitled to an injunction or injunctions to prevent or cure breaches
of the provisions of this Agreement by any other party hereto and to enforce specifically the terms and provisions hereof (without the
necessity of showing economic loss and without any bond or other security being required), this being in addition to any other remedy
to which any party may be entitled by law or equity.
(d)
All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal
laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State
of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New
York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New
York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient
forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process
and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for
such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH
PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE
HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.
(e)
If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent
jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest
extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity
of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express, without material change,
the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the
provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical
realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations
to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible
to that of the prohibited, invalid or unenforceable provision(s).
16
(f)
This Agreement, the other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced
herein and therein constitute the entire agreement among the parties hereto and thereto solely with respect to the subject matter hereof
and thereof. There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein and therein.
This Agreement, the other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced
herein and therein supersede all prior agreements and understandings among the parties hereto solely with respect to the subject matter
hereof and thereof; provided, however, nothing contained in this Agreement or any other Transaction Document shall (or shall be deemed
to) (i) have any effect on any agreements any Investor has entered into with the Company or any of its Subsidiaries prior to the date
hereof with respect to any prior investment made by such Investor in the Company, (ii) waive, alter, modify or amend in any respect any
obligations of the Company or any of its Subsidiaries or any rights of or benefits to any Investor or any other Person in any agreement
entered into prior to the date hereof between or among the Company and/or any of its Subsidiaries and any Investor and all such agreements
shall continue in full force and effect or (iii) limit any obligations of the Company under any of the other Transaction Documents.
(g)
Subject to compliance with Section 9 (if applicable), this Agreement shall inure to the benefit of and be binding upon the permitted
successors and assigns of each of the parties hereto. This Agreement is not for the benefit of, nor may any provision hereof be enforced
by, any Person, other than the parties hereto, their respective permitted successors and assigns and the Persons referred to in Sections
6 and 7 hereof.
(h)
The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Unless
the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and
plural forms thereof. The terms “including,” “includes,” “include” and words of like import shall
be construed broadly as if followed by the words “without limitation.” The terms “herein,” “hereunder,”
“hereof” and words of like import refer to this entire Agreement instead of just the provision in which they are found.
(i)
This Agreement may be executed in two or more identical counterparts, each of which shall be deemed an original, but all of which shall
be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to
the other party. In the event that any signature is delivered by facsimile or electronic transmission (including DocuSign and similar)
or by an email which contains a portable document format (.pdf) file of an executed signature page, such signature page shall create
a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect
as if such signature page were an original thereof.
(j)
Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all
such other agreements, certificates, instruments and documents as any other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.
(k)
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules
of strict construction will be applied against any party. Notwithstanding anything to the contrary set forth in Section 10, terms used
in this Agreement but defined in the other Transaction Documents shall have the meanings ascribed to such terms on the Closing Date in
such other Transaction Documents unless otherwise consented to in writing by each Investor.
(l)
All consents and other determinations required to be made by the Investors pursuant to this Agreement shall be made, unless otherwise
specified in this Agreement, by the Required Holders, determined as if all of the outstanding Preferred Shares then held by the Investors
have been converted for Registrable Securities without regard to any limitations on conversion of the Preferred Shares and the outstanding
Warrants then held by Investors have been exercised for Registrable Securities without regard to any limitations on exercise of the Warrants.
(m)
This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for
the benefit of, nor may any provision hereof be enforced by, any other Person.
(n)
The obligations of each Investor under this Agreement and the other Transaction Documents are several and not joint with the obligations
of any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under
this Agreement or any other Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken
by any Investor pursuant hereto or thereto, shall be deemed to constitute the Investors as, and the Company acknowledges that the Investors
do not so constitute, a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that
the Investors are in any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated
by the Transaction Documents or any matters, and the Company acknowledges that the Investors are not acting in concert or as a group,
and the Company shall not assert any such claim, with respect to such obligations or the transactions contemplated by this Agreement
or any of the other the Transaction Documents. Each Investor shall be entitled to independently protect and enforce its rights, including,
without limitation, the rights arising out of this Agreement or out of any other Transaction Documents, and it shall not be necessary
for any other Investor to be joined as an additional party in any proceeding for such purpose. The use of a single agreement with respect
to the obligations of the Company contained herein was solely in the control of the Company, not the action or decision of any Investor,
and was done solely for the convenience of the Company and not because it was required or requested to do so by any Investor. It is expressly
understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and
an Investor, solely, and not between the Company and the Investors collectively and not between and among Investors.
[signature
page follows]
17
IN
WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this Registration Rights Agreement to
be duly executed as of the date first written above.
STABLEX
TECHNOLOGIES, INC.
By:
Name: Joshua
Silverman
Title: Chief
Executive Officer
18
IN
WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this Registration Rights Agreement to
be duly executed as of the date first written above.
BUYER:
[●]
By:
Name: [●]
Title: [●]
19
EXHIBIT
A
SELLING
STOCKHOLDERS
The
shares of common stock being offered by the selling stockholders are those issuable to the selling stockholders upon conversion of the
preferred shares and exercise of the warrants. For additional information regarding the issuance of the preferred shares and the warrants,
see “Private Placement of Preferred Shares and Warrants” above. We are registering the shares of common stock in order to
permit the selling stockholders to offer the shares for resale from time to time. Except for the ownership of the preferred shares and
the warrants issued pursuant to the Securities Purchase Agreement, the selling stockholders have not had any material relationship with
us within the past three years.
The
table below lists the selling stockholders and other information regarding the beneficial ownership (as determined under Section 13(d)
of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder) of the shares of common stock held by each
of the selling stockholders. The second column lists the number of shares of common stock beneficially owned by the selling stockholders,
based on their respective ownership of shares of common stock, preferred shares and warrants, as of ________, [●], assuming conversion
of the preferred shares and exercise of the warrants held by each such selling stockholder on that date but taking account of any limitations
on conversion and exercise set forth therein.
The
third column lists the shares of common stock being offered by this prospectus by the selling stockholders and does not take in account
any limitations on (i) conversion of the preferred shares set forth therein or (ii) exercise of the warrants set forth therein.
In
accordance with the terms of a registration rights agreement with the holders of the preferred shares and the warrants, this prospectus
generally covers the resale of the sum of (i) the maximum number of shares of common stock issued or issuable pursuant to the preferred
shares and (ii) the maximum number of shares of common stock issued or issuable upon exercise of the warrants, in each case, determined
as if the outstanding preferred shares and warrants were converted or exercised (as the case may be) in full (without regard to any limitations
on conversion or exercise contained therein solely for the purpose of such calculation) at the floor price or exercise price (as the
case may be) calculated as of the trading day immediately preceding the date this registration statement was initially filed with the
SEC. Because the conversion price of the preferred shares and the exercise price of the warrants may be adjusted, the number of shares
that will actually be issued may be more or less than the number of shares being offered by this prospectus. The fourth column assumes
the sale of all of the shares offered by the selling stockholders pursuant to this prospectus.
Under
the terms of the Certificate of Designations and the warrants, a selling stockholder may not convert the preferred shares or exercise
the warrants to the extent (but only to the extent) such selling stockholder or any of its affiliates would beneficially own a number
of shares of our shares of common stock which would exceed [4.99][9.99]% of the outstanding shares of the Company. The number of shares
in the second column reflects these limitations. The selling stockholders may sell all, some or none of their shares in this offering.
See “Plan of Distribution.”
20
Name
of Selling Stockholder
Number
of shares of
Common Stock Owned
Prior to Offering
Maximum
Number of shares of
Common Stock to be Sold Pursuant to
this Prospectus
Number
of shares of
Common Stock of Owned
After Offering
[LEAD INVESTOR] (1)
[OTHER
BUYERS]
(1) [ ]
21
EXHIBIT
B
PLAN
OF DISTRIBUTION
We
are registering the shares of common stock issuable upon conversion of the preferred shares and exercise of the warrants to permit the
resale of these shares of common stock by the holders of the preferred shares and warrants from time to time after the date of this prospectus.
We will not receive any of the proceeds from the sale by the selling stockholders of the shares of common stock, although we will receive
the exercise price of any warrants not exercised by the selling stockholders on a cashless exercise basis. We will bear all fees and
expenses incident to our obligation to register the shares of common stock.
The
selling stockholders may sell all or a portion of the shares of common stock held by them and offered hereby from time to time directly
or through one or more underwriters, broker-dealers or agents. If the shares of common stock are sold through underwriters or broker-dealers,
the selling stockholders will be responsible for underwriting discounts or commissions or agent’s commissions. The shares of common
stock may be sold in one or more transactions at fixed prices, at prevailing market prices at the time of the sale, at varying prices
determined at the time of sale or at negotiated prices. These sales may be effected in transactions, which may involve crosses or block
transactions, pursuant to one or more of the following methods:
●
on
any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale;
●
in
the over-the-counter market;
●
in
transactions otherwise than on these exchanges or systems or in the over-the-counter market;
●
through
the writing or settlement of options, whether such options are listed on an options exchange or otherwise;
●
ordinary
brokerage transactions and transactions in which the broker-dealer solicits purchasers;
●
block
trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as
principal to facilitate the transaction;
●
purchases
by a broker-dealer as principal and resale by the broker-dealer for its account;
●
an
exchange distribution in accordance with the rules of the applicable exchange;
●
privately
negotiated transactions;
●
short
sales made after the date the Registration Statement is declared effective by the SEC;
●
broker-dealers
may agree with a selling security holder to sell a specified number of such shares at a stipulated price per share;
●
a
combination of any such methods of sale; and
●
any
other method permitted pursuant to applicable law.
The
selling stockholders may also sell shares of common stock under Rule 144 promulgated under the Securities Act of 1933, as amended, if
available, rather than under this prospectus. In addition, the selling stockholders may transfer the shares of common stock by other
means not described in this prospectus. If the selling stockholders effect such transactions by selling shares of common stock to or
through underwriters, broker-dealers or agents, such underwriters, broker-dealers or agents may receive commissions in the form of discounts,
concessions or commissions from the selling stockholders or commissions from purchasers of the shares of common stock for whom they may
act as agent or to whom they may sell as principal (which discounts, concessions or commissions as to particular underwriters, broker-dealers
or agents may be in excess of those customary in the types of transactions involved). In connection with sales of the shares of common
stock or otherwise, the selling stockholders may enter into hedging transactions with broker-dealers, which may in turn engage in short
sales of the shares of common stock in the course of hedging in positions they assume. The selling stockholders may also sell shares
of common stock short and deliver shares of common stock covered by this prospectus to close out short positions and to return borrowed
shares in connection with such short sales. The selling stockholders may also loan or pledge shares of common stock to broker-dealers
that in turn may sell such shares.
22
The
selling stockholders may pledge or grant a security interest in some or all of the preferred shares, warrants or shares of common stock
owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell
the shares of common stock from time to time pursuant to this prospectus or any amendment to this prospectus under Rule 424(b)(3) or
other applicable provision of the Securities Act amending, if necessary, the list of selling stockholders to include the pledgee, transferee
or other successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer and donate
the shares of common stock in other circumstances in which case the transferees, donees, pledgees or other successors in interest will
be the selling beneficial owners for purposes of this prospectus.
To
the extent required by the Securities Act and the rules and regulations thereunder, the selling stockholders and any broker-dealer participating
in the distribution of the shares of common stock may be deemed to be “underwriters” within the meaning of the Securities
Act, and any commission paid, or any discounts or concessions allowed to, any such broker-dealer may be deemed to be underwriting commissions
or discounts under the Securities Act. At the time a particular offering of the shares of common stock is made, a prospectus supplement,
if required, will be distributed, which will set forth the aggregate amount of shares of common stock being offered and the terms of
the offering, including the name or names of any broker-dealers or agents, any discounts, commissions and other terms constituting compensation
from the selling stockholders and any discounts, commissions or concessions allowed or re-allowed or paid to broker-dealers.
Under
the securities laws of some states, the shares of common stock may be sold in such states only through registered or licensed brokers
or dealers. In addition, in some states the shares of common stock may not be sold unless such shares have been registered or qualified
for sale in such state or an exemption from registration or qualification is available and is complied with.
There
can be no assurance that any selling stockholder will sell any or all of the shares of common stock registered pursuant to the registration
statement, of which this prospectus forms a part.
The
selling stockholders and any other person participating in such distribution will be subject to applicable provisions of the Securities
Exchange Act of 1934, as amended, and the rules and regulations thereunder, including, without limitation, to the extent applicable,
Regulation M of the Exchange Act, which may limit the timing of purchases and sales of any of the shares of common stock by the selling
stockholders and any other participating person. To the extent applicable, Regulation M may also restrict the ability of any person engaged
in the distribution of the shares of common stock to engage in market-making activities with respect to the common stock. All of the
foregoing may affect the marketability of the common stock and the ability of any person or entity to engage in market-making activities
with respect to the common stock.
We
will pay all expenses of the registration of the shares of common stock pursuant to the registration rights agreement, estimated to be
$[●] in total, including, without limitation, Securities and Exchange Commission filing fees and expenses of compliance with state
securities or “blue sky” laws; provided, however, a selling stockholder will pay all underwriting discounts and selling commissions,
if any. We will indemnify the selling stockholders against liabilities, including some liabilities under the Securities Act in accordance
with the registration rights agreements or the selling stockholders will be entitled to contribution. We may be indemnified by the selling
stockholders against civil liabilities, including liabilities under the Securities Act that may arise from any written information furnished
to us by the selling stockholder specifically for use in this prospectus, in accordance with the related registration rights agreements
or we may be entitled to contribution.
Once
sold under the registration statement, of which this prospectus forms a part, the shares of common stock will be freely tradable in the
hands of persons other than our affiliates.
23
EX-10.5
EX-10.5
Filename: ex10-5.htm · Sequence: 15
Exhibit
10.5
OMNIBUS
Waiver, Consent, notice and AMENDMENT AGREEMENT
This
Omnibus Waiver, Consent, Notice and Amendment Agreement (this “Agreement”), dated as of April 27, 2026 is by and among
StableX Technologies, Inc., a Delaware corporation (the “Company”), and the investor listed on the signature page
attached hereto (the “Investor”).
WITNESSETH
Whereas,
the Company and the Investor are party to that certain Securities Purchase Agreement, dated as of August 7, 2023 (the “Purchase
Agreement”), pursuant to which the Company issued to the Investor shares of the Company’s H-7 Convertible Preferred Stock,
par value $0.0001 per share (the “Preferred Stock”), the terms of which are set forth in the Certificate of Designations
for the Series H-7 Convertible Preferred Stock (as amended, the “Certificate of Designations”), and warrants (the
“Warrants,” and, together with the Purchase Agreement and the Certificate of Designations, the “Transaction
Documents”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”);
WHEREAS,
the Company desires to enter into a securities purchase agreement, by and among the Company and certain investors party thereto (the
“Series K Purchase Agreement”), pursuant to which the Company will sell to such investors in a private placement,
(i) newly-designated shares of the Company’s Series K Convertible Preferred Stock, par value $0.0001 per share (the “Series
K Preferred Stock”), the terms of which are set forth in the Certificate of Designations for the Series K Preferred Stock attached
as Exhibit B hereto, and (ii) warrants (the “Series K Warrants”) to purchase shares of the Company’s
Common Stock (the “Private Placement”);
WHEREAS,
the Company intends to enter into a Joint Development and License Agreement, dated on or about the date hereof (the “JD&L
Agreement”), by and between Kopin Corporation, a Delaware corporation (“Kopin”), and the Company, pursuant
to which the parties will collaborate on the development and commercialization of certain proprietary technology, in connection therewith,
the Company will issue shares of its Series J Convertible Preferred Stock, par value $0.0001 per share (“Series J Preferred
Stock” and, together with the Series K Preferred Stock, the “Concurrent Preferred Stock”) to Kopin as additional
consideration for Kopin’s contributions to the development of the Project Technology (as defined in the JD&L Agreement)(collectively,
the “Collaboration”);
WHEREAS,
the Investor, together with certain other investors entering into similar Omnibus Waiver, Consent, Notice and Amendment Agreements of
even date hereof, constitute the Required Holders pursuant to each of the Transaction Documents; and
WHEREAS,
the Company and the Investor desire to waive the applicability of certain provisions of the Transaction Documents, consent to certain
actions of the Company in connection with the Private Placement, and to amend certain other provisions of the Transaction Documents.
1
Now,
therefore, in consideration of the premises and mutual
covenants and obligations hereinafter set forth, the parties hereto, intending legally to be bound, hereby agree as follows:
1. Definitions.
Capitalized terms used herein but not otherwise defined herein shall have the respective
meanings given such terms in the Purchase Agreement.
2. Amended
and Restated Certificate of Designations. The parties hereto hereby agree to amend and
restate the rights of the Preferred Stock as set forth in the Amended and Restated Certificate
of Designations attached as Exhibit A hereto (the “Amendment”).
Upon the effectiveness of this Agreement, the Company shall promptly file the Amendment and
provide a copy thereof to each Investor promptly after such filing.
3. Waivers.
(a) Waiver
of Variable Rate Transaction. Solely for the purposes of enabling the consummation of
the Private Placement and the Collaboration, the Investor hereby waives any right the Investor
is entitled to pursuant to Section 4(n) of the Purchase Agreement, relating to the Company’s
prohibition of effecting or entering into an agreement to effect any Subsequent Placement
involving a Variable Rate Transaction.
(b) Waiver
of Fundamental Transaction. The Investor hereby agrees that the issuance and sale by
the Company of the (i) newly designated shares of the Company’s Series K Preferred
Stock, and (ii) the Series K Warrants, pursuant to the Series K Purchase Agreement, shall
not constitute a Fundamental Transaction (as defined in the Certificate of Designations and
Warrants).
(c) Waiver
Related to Dividend Payments and Installment Payments. The Investor hereby waives any
default, breach or violation of the Certificate of Designations and any associated penalties
accrued and outstanding as of the date hereof, in each case, resulting from the Company’s
prior failure to timely make any payments of Dividends and/or any Installment Amount (as
each term is defined in the Certificate of Designations), whether by means of conversion
or redemption as set forth in the Certificate of Designations, on any applicable Dividend
Date and/or Installment Date, as applicable, and the Investor further agrees that such failure
to pay shall not otherwise trigger any right or remedy of the Investor.
(d) Waiver
of Change in Nature of Business. The Investor hereby waives, any breach or default arising,
or which may arise, under the covenant set forth in Section 15(g) of the Certificate of Designations,
regarding the Company’s obligation not to engage, directly or indirectly, in any material
line of business substantially different from those lines of business conducted by or publicly
contemplated to be conducted by the Company on the date of the Purchase Agreement, solely
to the extent necessary to permit the Company to engage in the development, commercialization,
and sale of microLED-based optical interconnect technology and related fabless semiconductor
technologies.
2
(e) Waiver
of Participation Rights. The Investor hereby waives any rights of first refusal or participation
rights with respect to the Private Placement and Collaboration, including, but not limited
to, the Investor’s participation rights under Section 4(o) of the Purchase Agreement
and the Investor’s Purchase Rights (as defined in the Certificate of Designations)
under Section 7 of the Certificate of Designations, and waives any applicable notices related
thereto.
4. Issuance
of Warrants. In consideration of the foregoing, the Company agrees to issue to the Investor warrants to purchase up to [ ] shares
of Common Stock, substantially in the form attached hereto as Exhibit C (the “Consideration Warrants”)1.
5. Representation
and Warranties of the Investor. In connection with the issuance of the Consideration
Warrants, the Investor hereby represents and warrants as of the date hereof to the Company
as follows:
(a)
The Investor is an “accredited investor” as defined in Rule 501(a) under Regulation D promulgated under the Securities Act
of 1933, as amended (the “Securities Act”).
(b)
The Investor is acquiring the Consideration Warrants (and the shares of Common Stock issuable upon exercise thereof (the “Warrant
Shares”)) for its own account, for investment purposes only, and not with a view toward, or for sale in connection with, any distribution
thereof, nor with any present intention of distributing or selling the same, and the Investor has no present or contemplated agreement,
undertaking, arrangement, obligation, indebtedness or commitment providing for the disposition thereof.
(c)
The Investor acknowledges that the Consideration Warrants (and the Warrant Shares) have not been registered under the Securities Act
or the securities laws of any state or other jurisdiction, and that the Consideration Warrants (and such Warrant Shares) may not be sold,
transferred, offered for sale, pledged, hypothecated or otherwise disposed of unless such sale, transfer, offer, pledge, hypothecation
or other disposition is pursuant to the terms of an effective registration statement under the Securities Act, or pursuant to an exemption
from registration under the Securities Act and applicable state securities laws.
(d)
The Investor has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the
merits and risks of the prospective investment in the Consideration Warrants (and the Warrant Shares), and has so evaluated the merits
and risks of such investment. The Investor is able to bear the economic risk of an investment in the Consideration Warrants (and Warrant
Shares) and, at the present time, is able to afford a complete loss of such investment.
(e)
The Investor has been furnished with or has had full access to all the information that it considers necessary or appropriate to make
an informed investment decision with respect to the Consideration Warrants (and the Warrant Shares). The Investor has had an opportunity
to ask questions of, and receive answers from, the Company regarding the terms and conditions of the offering of the Consideration Warrants
and the business, properties, prospects and financial condition of the Company.
1
NTD: The Company shall issue an aggregate number of warrants to purchase up to 1,000,000 shares of Common Stock to the Series H-7 Preferred
Stock holders and Series I Preferred Stock holders. Each investor is entitled to their pro rata portion of such warrants based on their
respective outstanding shares of preferred stock as of the date of this Agreement.
3
6. Consent.
Each Investor hereby consents, pursuant to Section 2 and Section 18 of the Certificate of
Designations relating to the Company’s creation, authorization (by reclassification
or otherwise), issuance, purchase, repurchase, redemption or repayment of any class or series
of Junior Stock (as defined in the Certificate of Designations), to the creation, authorization,
issuance, purchase, repurchase, redemption and/or repayment by the Company of the Concurrent
Preferred Stock. In addition, for the avoidance of doubt and notwithstanding anything to
the contrary contained in Section 15 of the Certificate of Designations, each Investor hereby
provides consent to the issuance of the Concurrent Preferred Stock and such issuance shall
not be deemed a violation of any covenant or limitation contained therein.
7. Notice.
The Investor hereby acknowledges that this Agreement constitutes notice, as required by Section
8(c) of the Certificate of Designations, to the Investor, to the extent the Concurrent Preferred
Stock constitutes Variable Price Securities (as defined in the Certificate of Designations),
of the Company’s intention to issue such Concurrent Preferred Stock pursuant to the
Private Placement or JD&L Agreement, as applicable.
8. Counterparts;
Facsimile Execution. This Agreement may be executed in one or more counterparts (including
by electronic mail, in PDF or by DocuSign or similar electronic signature), all of which
shall be considered one and the same agreement and shall become effective when one or more
counterparts have been signed by each of the parties and delivered to the other parties.
Counterparts may be delivered via facsimile, electronic mail (including any electronic signature
covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic
Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission
method and any counterpart so delivered shall be deemed to have been duly and validly delivered
and be valid and effective for all purposes.
9. Governing
Law. THIS AGREEMENT SHALL BE SUBJECT TO THE PROVISIONS
REGARDING GOVERNING LAW SET FORTH IN SECTION 9(a) OF THE Purchase AGREEMENT, AND SUCH PROVISIONS
ARE INCORPORATED HEREIN BY THIS REFERENCE, MUTATIS MUTANDIS.
10. Terms
and Conditions of the Transaction Documents. Except as modified and amended herein, all
of the terms and conditions of the Transaction Documents shall remain in full force and effect.
[Signature
pages follow immediately.]
4
IN
WITNESS WHEREOF, the undersigned has executed and delivered this Agreement as of the date first above written.
Company:
StableX
Technologies, Inc.
By:
Name: Joshua
Silverman
Title: Chief
Executive Officer
5
In
witness whereof, the undersigned has executed and delivered
this Agreement as of the date first above written.
Name
of Investor:
By:
Name
of signatory:
Title:
[Investor
Signature Page to Waiver and Amendment Agreement]
6
EXHIBIT
A
Form
of the Amended and Restated Certificate of Designations
of
Series H-7 Convertible Preferred Stock
7
EXHIBIT
B
Certificate
of Designations of Series K Convertible Preferred Stock
8
EXHIBIT
C
Form
of Warrant
9
EX-10.6
EX-10.6
Filename: ex10-6.htm · Sequence: 16
Exhibit 10.6
OMNIBUS
Waiver, Consent, notice and AMENDMENT AGREEMENT
This
Omnibus Waiver, Consent, Notice and Amendment Agreement (this “Agreement”), dated as of April 27, 2026 is by and among
StableX Technologies, Inc., a Delaware corporation (the “Company”), and the investor listed on the signature page
attached hereto (the “Investor”).
WITNESSETH
Whereas,
the Company and the Investor are party to that certain Securities Purchase Agreement, dated as of August 4, 2025 (the “Purchase
Agreement”), pursuant to which the Company issued to the Investor shares of the Company’s I Convertible Preferred Stock,
par value $0.0001 per share (the “Preferred Stock”), the terms of which are set forth in the Certificate of Designations
for the Series I Convertible Preferred Stock (the “Certificate of Designations”), and warrants (the “Warrants,”
and, together with the Purchase Agreement and the Certificate of Designations, the “Transaction Documents”) to purchase
shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”);
WHEREAS,
the Company desires to enter into a securities purchase agreement, by and among the Company and certain investors party thereto (the
“Series K Purchase Agreement”), pursuant to which the Company will sell to such investors in a private placement,
(i) newly-designated shares of the Company’s Series K Convertible Preferred Stock, par value $0.0001 per share (the “Series
K Preferred Stock”), the terms of which are set forth in the Certificate of Designations for the Series K Preferred Stock attached
as Exhibit B hereto, and (ii) warrants (the “Series K Warrants”) to purchase shares of the Company’s
Common Stock (the “Private Placement”);
WHEREAS,
the Company intends to enter into a Joint Development and License Agreement, dated on or about the date hereof (the “JD&L
Agreement”), by and between Kopin Corporation, a Delaware corporation (“Kopin”), and the Company, pursuant
to which the parties will collaborate on the development and commercialization of certain proprietary technology, in connection therewith,
the Company will issue shares of its Series J Convertible Preferred Stock, par value $0.0001 per share (“Series J Preferred
Stock” and, together with the Series K Preferred Stock, the “Concurrent Preferred Stock”) to Kopin as additional
consideration for Kopin’s contributions to the development of the Project Technology (as defined in the JD&L Agreement) (collectively,
the “Collaboration”);
WHEREAS,
the Investor, together with certain other investors entering into similar Omnibus Waiver, Consent, Notice and Amendment Agreements of
even date hereof, constitute the Required Holders pursuant to each of the Transaction Documents; and
WHEREAS,
the Company and the Investor desire to waive the applicability of certain provisions of the Transaction Documents, consent to certain
actions of the Company in connection with the Private Placement, and to amend certain other provisions of the Transaction Documents.
1
Now,
therefore, in consideration of the premises and mutual
covenants and obligations hereinafter set forth, the parties hereto, intending legally to be bound, hereby agree as follows:
1. Definitions.
Capitalized terms used herein but not otherwise defined herein shall have the respective
meanings given such terms in the Purchase Agreement.
2. Amended
and Restated Certificate of Designations. The parties hereto hereby agree to amend and
restate the rights of the Preferred Stock as set forth in the Amended and Restated Certificate
of Designations attached as Exhibit A hereto (the “Amendment”).
Upon the effectiveness of this Agreement, the Company shall promptly file the Amendment and
provide a copy thereof to the Investor promptly after such filing.
3. Waivers.
(a) Waiver
of Variable Rate Transaction. Solely for the purposes of enabling the consummation of
the Private Placement and the Collaboration, the Investor hereby waives any right the Investor
is entitled to pursuant to Section 4(n) of the Purchase Agreement, relating to the Company’s
prohibition of effecting or entering into an agreement to effect any Subsequent Placement
involving a Variable Rate Transaction.
(b) Waiver
of Fundamental Transaction. The Investor hereby agrees that the issuance and sale by
the Company of the (i) newly designated shares of the Company’s Series K Preferred
Stock, and (ii) the Series K Warrants, pursuant to the Series K Purchase Agreement, shall
not constitute a Fundamental Transaction (as defined in the Certificate of Designations and
Warrants).
(c) Waiver
of Participation Rights. The Investor hereby waives any rights of first refusal or participation
rights with respect to the Private Placement and Collaboration, including, but not limited
to, the Investor’s participation rights under Section 4(o) of the Purchase Agreement
and the Investor’s Purchase Rights (as defined in the Certificate of Designations)
under Section 7 of the Certificate of Designations, and waives any applicable notices related
thereto.
(d) Waiver
of Change in Nature of Business. The Investor hereby waives, any breach or default arising,
or which may arise, under the covenant set forth in Section 15(g) of the Certificate of Designations,
regarding the Company’s obligation not to engage, directly or indirectly, in any material
line of business substantially different from those lines of business conducted by or publicly
contemplated to be conducted by the Company on the date of the Purchase Agreement, solely
to the extent necessary to permit the Company to engage in the development, commercialization,
and sale of microLED-based optical interconnect technology and related fabless semiconductor
technologies.
(e) Waiver
Related to Dividend Payments and Installment Payments. The Investor hereby waives any
default, breach or violation of the Certificate of Designations and any associated penalties
accrued and outstanding as of the date hereof, in each case, resulting from the Company’s
prior failure to timely make any payments of Dividends and/or any Installment Amount (as
each term is defined in the Certificate of Designations), whether by means of conversion
or redemption as set forth in the Certificate of Designations, on any applicable Dividend
Date and/or Installment Date, as applicable, and the Investor further agrees that such failure
to pay shall not otherwise trigger any right or remedy of the Investor.
2
4. Issuance
of Warrant. In consideration of the foregoing, the Company agrees to issue to the Investor
warrants to purchase up to [ ] shares of Common Stock, substantially in the form attached
hereto as Exhibit C (the “Consideration Warrants”).1
5. Representation
and Warranties of the Investors. In connection with the issuance of the Consideration
Warrants, the Investor hereby represents and warrants as of the date hereof to the Company
as follows:
(a) The
Investor is an “accredited investor” as defined in Rule 501(a) under Regulation D promulgated under the Securities Act of
1933, as amended (the “Securities Act”).
(b) The
Investor is acquiring the Consideration Warrants (and the shares of Common Stock issuable upon exercise thereof (the “Warrant Shares”))
for its own account, for investment purposes only, and not with a view toward, or for sale in connection with, any distribution thereof,
nor with any present intention of distributing or selling the same, and the Investor has no present or contemplated agreement, undertaking,
arrangement, obligation, indebtedness or commitment providing for the disposition thereof.
(c) The Investor acknowledges that the Consideration Warrants (and the Warrant Shares) have not been registered under the Securities Act
or the securities laws of any state or other jurisdiction, and that the Consideration Warrants (and such Warrant Shares) may not be
sold, transferred, offered for sale, pledged, hypothecated or otherwise disposed of unless such sale, transfer, offer, pledge,
hypothecation or other disposition is pursuant to the terms of an effective registration statement under the Securities Act, or
pursuant to an exemption from registration under the Securities Act and applicable state securities laws.
(d)
The Investor has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating
the merits and risks of the prospective investment in the Consideration Warrants (and the Warrant Shares), and has so evaluated the
merits and risks of such investment. The Investor is able to bear the economic risk of an investment in the Consideration Warrants
(and Warrant Shares) and, at the present time, is able to afford a complete loss of such investment.
(e) The
Investor has been furnished with or has had full access to all the information that it considers necessary or appropriate to make an
informed investment decision with respect to the Consideration Warrants (and the Warrant Shares). The Investor has had an opportunity
to ask questions of, and receive answers from, the Company regarding the terms and conditions of the offering of the Consideration Warrants
and the business, properties, prospects and financial condition of the Company.
1
NTD: The Company shall issue an aggregate number of warrants to purchase up to 1,000,000 shares of Common Stock to the Series H-7 Preferred
Stock holders and Series I Preferred Stock holders. Each investor is entitled to their pro rata portion of such warrants based on their
respective outstanding shares of preferred stock as of the date of this Agreement.
3
6. Consent.
Each Investor hereby consents, pursuant to Section 2 and Section 18 of the Certificate of
Designations relating to the Company’s creation, authorization (by reclassification
or otherwise), issuance, purchase, repurchase, redemption or repayment of any class or series
of Junior Stock (as defined in the Certificate of Designations), to the creation, authorization,
issuance, purchase, repurchase, redemption and/or repayment by the Company of the Concurrent
Preferred Stock. In addition, for the avoidance of doubt and notwithstanding anything to
the contrary contained in Section 15 of the Certificate of Designations, each Investor hereby
provides consent to the issuance of the Concurrent Preferred Stock and such issuance shall
not be deemed a violation of any covenant or limitation contained therein.
7. Notice.
The Investor hereby acknowledges that this Agreement constitutes notice, as required by Section
8(c) of the Certificate of Designations, to the Investor, to the extent the Concurrent Preferred
Stock constitutes Variable Price Securities (as defined in the Certificate of Designations),
of the Company’s intention to issue such Concurrent Preferred Stock pursuant to the
Private Placement or JD&L Agreement, as applicable.
8. Counterparts;
Facsimile Execution. This Agreement may be executed in one or more counterparts (including
by electronic mail, in PDF or by DocuSign or similar electronic signature), all of which
shall be considered one and the same agreement and shall become effective when one or more
counterparts have been signed by each of the parties and delivered to the other parties.
Counterparts may be delivered via facsimile, electronic mail (including any electronic signature
covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic
Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission
method and any counterpart so delivered shall be deemed to have been duly and validly delivered
and be valid and effective for all purposes.
9. Governing
Law. THIS AGREEMENT SHALL BE SUBJECT TO THE PROVISIONS
REGARDING GOVERNING LAW SET FORTH IN SECTION 9(a) OF THE Purchase AGREEMENT, AND SUCH PROVISIONS
ARE INCORPORATED HEREIN BY THIS REFERENCE, MUTATIS MUTANDIS.
10. Terms
and Conditions of the Transaction Documents. Except as modified and amended herein, all
of the terms and conditions of the Transaction Documents shall remain in full force and effect.
[Signature
pages follow immediately.]
4
IN
WITNESS WHEREOF, the undersigned has executed and delivered this Agreement as of the date first above written.
Company:
StableX Technologies, Inc.
By:
Name:
Joshua Silverman
Title:
Chief Executive Officer
5
In
witness whereof, the undersigned has executed and delivered
this Agreement as of the date first above written.
Name of
Investor:
By:
Name of signatory:
Title:
[Investor
Signature Page to Waiver and Amendment Agreement]
6
EXHIBIT
A
Form
of the Amended and Restated Certificate of Designations of Series I Convertible Preferred Stock
7
EXHIBIT
B
Certificate
of Designations of Series K Convertible Preferred Stock
8
EXHIBT
C
Form
of Warrant
9
EX-10.7
EX-10.7
Filename: ex10-7.htm · Sequence: 17
Exhibit 10.7
AMENDED
AND RESTATED CONSULTING SERVICES AGREEMENT
This
Amended and Restated Consulting Services Agreement (the “Agreement”) is made effective as of April 27, 2026
(the “Effective Date”), by and between StableX Technologies, Inc., a Delaware corporation (f/k/a AYRO, Inc.)
(the “Company”) and JD Advisors, LLC, an Ohio limited liability company (the “Consultant”)
(collectively, the Company and the Consultant shall be referred to as, the “Parties” or individually as a “Party”).
WHEREAS,
the Consultant currently provides consulting services to the Company and the Consultant desires to continue to provide such consulting
services to the Company;
Whereas,
the Company and the Consultant desire to set forth in writing the terms and conditions of their agreement and understandings with respect
to the services of the Consultant, which shall amend, restate, and supersede in its entirety that certain Consulting Services Agreement,
dated as of August 4, 2025, by and between Z-List Media, Inc., Mr. James Altucher, and the Company (the “Prior Consulting
Agreement”); and
WHEREAS,
the Parties desire to enter into this Agreement, pursuant to which the Consultant will continue to provide consulting services to the
Company, subject to the terms and conditions set forth below.
NOW,
THEREFORE, in consideration of the mutual covenants and obligations contained herein, the Parties, intending to be legally bound,
hereby agree as follows:
A. Engagement
The
Consultant shall provide the Services defined below in Section C herein for the Company (the “Engagement”).
In this capacity, the Consultant agrees to devote its best efforts, energy and skill to the full discharge of the Consultant’s
duties and responsibilities.
B. Term
1. Term.
Services under this Agreement shall commence on the Effective Date and shall continue through the two (2) year anniversary of the Effective
Date, unless earlier terminated pursuant to Section B(2) hereof or upon the mutual written consent of the Parties (the “Term”).
The term of this Agreement shall be extended for additional terms upon mutual written consent.
2. Termination.
The Consultant or the Company may terminate this Agreement, effective immediately upon written notice to the other party to this Agreement,
if the other party materially breaches this Agreement, and such breach is incapable of cure, or with respect to a material breach capable
of cure, the other party does not cure such breach within 10 calendar days after receipt of written notice of such breach. For purposes
of clarity, a material breach shall include, without limitation, the Consultant’s failure to provide the Services contemplated
hereunder on a timely and reasonably satisfactory basis.
C. Services
to be Performed
1. Services.
The Services rendered pursuant to this Agreement shall be rendered to the Executive Chairman of the Board of Directors of the Company.
During the Term of this Agreement, the Consultant shall assist the Company in general corporate activities including, but not limited
to, the following (collectively, the “Services”):
● comprehensive
strategic and operational consulting services to the Company, including but not limited to:
contributing to product development and roadmap decisions; leading and advising on marketing
strategy, branding, and go-to-market execution; assisting with recruiting, hiring, and team-building
efforts; managing and guiding social media presence and communications; and supporting general
management initiatives across the business; and
1
● any
other consulting or advisory services which the Company reasonably requests that Consultant
provide to the Company.
2.
Exclusivity of Services. The Parties acknowledge and agree that this Agreement is a non- exclusive engagement for
Consultant’s services and that the Consultant shall have the right to engage in any other gainful activities and business; provided,
however, that, during the Term, the Consultant shall not, directly or indirectly, engage in any activities or business, or
engage or participate in or provide services to any business, with respect to or otherwise related to the development,
commercialization, or deployment of optical or photonic interconnect technologies for computing infrastructure. The Consultant
understands and acknowledges that this obligation is necessary and reasonable to protect legitimate business interests and is
provided as further inducement for Company to enter into this Agreement.
D. Compensation
for Services
1. Warrants.
In consideration for the Services rendered by the Consultant and the Consultant’s other obligations under this Agreement and
subject to the Consultant entering into the Warrant Cancellation Agreement in the form attached hereto as Exhibit A
for the purpose of cancelling previously issued warrants, the Company shall issue to the Consultant on the Effective Date warrants
to purchase shares of common stock of the Company (“Common Stock”), in the amounts as set forth on Exhibit
B attached hereto and in the form attached hereto as Exhibit C (the “Warrants”). The
Warrants shall be subject to the terms and conditions, including vesting and forfeiture conditions, as set forth therein. The
Company shall provide a PDF copy of the executed Warrants upon execution of this Agreement. The Consultant represents that it is not
and will not work with any persons and/or entities that have been convicted of or otherwise committed an act or omission
constituting any of the “bad actor” events listed in Rule 506(d) (as provided in Rule 506 of Regulation D of the
Securities Act of 1933, as amended (the “Act”)) (a “Bad Actor”). The Consultant
further represents, warranties and covenants to the Company that (i) the Consultant is an Accredited Investor (as defined under the
Act), and is acquiring the Warrants for investment purposes and not with a view towards distribution, (ii) understands and agrees
that the Warrants and the shares of Common Stock issuable upon exercise of the Warrants (the “Warrant
Shares”) are “restricted securities” as defined under Rule 144 of the Act and will contain a standard
restrictive legend and may only be sold and/or transferred pursuant to an effective registration statement covering the resale of
such Warrants and/or Warrant Shares or pursuant to an exemption from the registration requirements of the Act, and (iii) it will not
transfer any of the Warrants and/or Warrant Shares to any person and/or entity and no person and/or entity has any direct and/or
indirect interest in the Warrants and/or Warrant Shares or in the profits therefrom who is a Bad Actor. Assuming the Consultant has
complied with the provisions and requirements of Rule 144 promulgated under the Act, the Company agrees to assist the Consultant to
remove the restrictive legend from the Warrant Shares, including, without limitation, (i) authorizing the Company’s transfer
agent to remove the restrictive legend, (ii) obtaining a legal opinion from the Company’s authorized counsel at the
Company’s expense, and (iii) cooperating and communicating with Consultant, its broker and the transfer agent in order to
clear the Warrant Shares of restriction as soon as possible, in each case as further set forth in the Warrants.
2. Entire
Compensation. The Consultant acknowledges that the Warrants constitute the sole and entire compensation and reimbursements payable
for the Engagement and the provision of the Services of the Consultant, and the Parties specifically agree that no other compensation,
benefits or reimbursements of any other nature shall be paid or payable to the Consultant as a result of the provision of Services hereunder.
2
E. Nondisclosure
of Confidential and Proprietary Information.
1. Obligation
to Maintain Confidentiality. The Consultant acknowledges that it will have access to and possession of trade secrets, confidential
information, and proprietary information (collectively, as defined more extensively below, “Confidential Information”)
of the Company, its parents, subsidiaries, and affiliates and their respective business relations. The Consultant recognizes and acknowledges
that this Confidential Information is valuable, special, and unique to the Company’s business, and that access thereto and knowledge
thereof are essential to the Consultant’s performance of Services. During the Term and thereafter, the Consultant will keep secret
and will not use or disclose to any person or entity other than the Company, in any fashion or for any purpose whatsoever, any Confidential
Information, except at the request of the Company. The Consultant will use no less than a reasonable standard of care to prevent disclosing
to third parties any Confidential Information. This Section shall not preclude the Consultant from the use or disclosure of any and all
information known generally to the public or from disclosure of information required by law or court order, provided that the Company
is reasonably notified of any such disclosure required by law or court order in order for the Company to seek a protective order and
after all reasonable remedies for maintaining the Confidential Information in confidence have been examined, is afforded the opportunity,
to the extent practicable, to dictate the manner and timing of any such disclosure.
2. Third
Party Information. The Consultant further recognizes that the Company has received and in the future will receive from third parties
confidential or proprietary information (“Third Party Information”) subject to a duty on the Company’s
part to maintain the confidentiality of such information and to use it only for certain limited purposes. During the Term and thereafter,
the Consultant will hold Third Party Information in the strictest confidence and will not disclose Third Party Information to anyone
(other than Company personnel who need to know such information in connection with the Consultant’s work for the Company) or use
Third Party Information, except in connection with the services required under this Agreement for the Company, unless expressly authorized
by the Company in writing.
3. Treatment
and Ownership of Confidential Information. The Consultant shall store and maintain all Confidential Information in a secure place.
Such material at all times will remain the exclusive property of the Company, unless otherwise agreed to in writing by the Company. Upon
termination or expiration of the Term, the Consultant shall not make further use of any Confidential Information.
4. Use
of Information of Prior Employers. At no time will the Consultant improperly use or disclose any confidential information or trade
secrets, if any, of any former employer or any other person to whom the Consultant has an obligation of confidentiality, or bring onto
the premises of the Company any unpublished documents or any property belonging to any former employer or any other person to whom the
Consultant has an obligation of confidentiality unless consented to in writing by that former employer or person and agreed to by the
Company.
5. Defend
Trade Secrets Act. Pursuant to the Defend Trade Secrets Act of 2016, the Company hereby provides notice and the Consultant hereby
acknowledges that the Consultant may be held criminally or civilly liable under any federal or state trade secret law for the disclosure
of a trade secret that (i) is made (A) in confidence to a federal, state, or local government official, either directly or indirectly,
or to an attorney; and (B) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint
or other document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, if the Consultant files a lawsuit
or other court proceeding against the Company for retaliating against the Consultant, for reporting a suspected violation of law, the
Consultant, may disclose the trade secret to the attorney representing the Consultant and use the trade secret in the court proceeding,
so long as the Consultant files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant
to court order.
3
6. Return
of Company Property. Upon any termination of this Agreement, the Consultant will deliver to the Company (and will not keep in his
possession, recreate or deliver to anyone else) any and all Confidential Information, devices, records, recordings, data, notes, reports,
proposals, lists, correspondence, specifications, drawings, blueprints, sketches, materials, computer materials, equipment, other documents
or property, together with all copies thereof (in whatever medium recorded), belonging to the Company, its successors or assigns. The
Consultant expressly acknowledges and agrees that any property situated on the Company’s premises and owned by the Company (including
computer disks and other digital, analog or hard copy storage media, filing cabinets or other work areas) is subject to inspection by
Company personnel at any time with or without notice.
F. Intellectual
Property. Any
know-how, inventions, discoveries, data, information, specifications, sketches, records, reports, proposals, software, charts, designs,
or other documents, whether or not of a technical, operational, or economic nature, and any United States and foreign patent applications
related thereto, which are or were conceived or developed by the Consultant, whether individually, or jointly with any Company employee,
and arising out of the services provided to the Company or out of exposure to Confidential Information, are hereby assigned, and shall
be assigned, to the Company, and shall be the sole property of the Company. The Consultant agrees to promptly notify the Company of any
patentable inventions which are conceived or reduced to practice by or for the Consultant, in connection with the services to the Company
provided by the Consultant. The Consultant shall perform such acts and execute such assignments, papers, agreements and instruments as
are necessary to vest, ensure and perfect the Company’s rights and title therein. Except as otherwise provided herein, the Consultant
further agrees that all reports, information, data and documents developed or generated during the Consultant’s services (including
any Confidential Information) shall be deemed works made for hire for the Company and shall be owned solely, exclusively and entirely
by the Company and shall be usable by the Company for any purpose. As to any such materials subject to the protection of the Copyright
Act of 1976 (including any of same which are not deemed works made for hire for any reason), the Consultant agrees that all rights to
copyright and reproduction shall be the property of the Company, and the Consultant shall execute any and all such assignments, papers,
agreements and instruments as are necessary to vest, ensure and perfect the Company’s title and copyright therein. Notwithstanding
the foregoing, this Section does not apply to any invention for which no equipment, supplies, facilities, or trade secret information
of the Company was used and which was developed entirely on the Consultant’s own time, unless (i) the invention relates to the
business of the Company or the Company’s actual or demonstrably anticipated research or development, or (ii) the invention results
from any work performed by the Consultant for the Company. The Consultant has attached hereto, as an exhibit, a list describing all inventions,
original works of authorship, developments, improvements, and trade secrets which were made by the Consultant, prior to Consultant’s
service (collectively referred to as “Prior Inventions”), which belong to the Consultant, which relate to the
Company’s business, products or research and development, and which are not assigned to the Company hereunder; or, if no such list
is attached, the Consultant represents that there are no such Prior Inventions.
G. Legal
and Equitable Remedies.
Because the Consultant’s services are personal and unique and because the Consultant has and will continue to have access to, and
become acquainted with, Confidential Information, the Consultant expressly acknowledges and agrees that (1) a breach or threatened breach
of any of Sections E or F by the Consultant would result in irreparable harm for which money damages would be an inadequate remedy, and
(2) the Company will have the right to enforce Sections E and F and any of their provisions by injunction, restraining order, specific
performance or other injunction relief, without posting a bond or other security, and without prejudice to any other rights and remedies
that the Company may have for a breach of this Agreement. The Company’s remedies under this Section G are not exclusive and shall
not prejudice or prohibit any other rights or remedies under this Agreement or otherwise.
4
H. Indemnification
1.
The Consultant shall not be liable to the Company or their subsidiaries or affiliates for any loss, liability, damage or expense
(collectively, a “Loss”) arising out of or in connection with the performance of services contemplated by
this Agreement, unless such Loss shall be proven to result directly from gross negligence, willful misconduct or bad faith on the
part of the Consultant. In no event will any of the parties hereto be liable to any other party hereto for any indirect, special,
incidental or consequential damages, including lost profits or savings, whether or not such damages are foreseeable, or in respect
of any liabilities relating to any third party claims (whether based in contract, tort or otherwise) other than for the Claims (as
defined below) relating to the Services which may be provided by the Consultant hereunder. The Company and its subsidiaries shall
defend, indemnify and hold harmless the Consultant from and against any and all Losses arising from any claim by any person with
respect to, or in any way related to, this Agreement (including attorneys’ fees) (collectively,
“Claims”) resulting from any act or omission of either of the Company other than for Claims which are a
result of gross negligence, bad faith or willful misconduct by the Consultant. The Company and its subsidiaries shall defend at its
own cost and expense any and all suits or actions (just or unjust) which may be brought against the Company or its subsidiaries and
the Consultant in which the Consultant may be included with others upon any Claims, or upon any matter, directly or indirectly,
related to or arising out of this Agreement or the performance hereof by the Consultant, except that if such damage is the result of
gross negligence, bad faith or willful misconduct by the Consultant then the Consultant shall reimburse the Company and their
subsidiaries for the reasonable costs of defense and other costs incurred by the Company and its subsidiaries (including any losses
as a result of such actions).
2.
The Parties further agree that they shall not, without the prior written consent of the other Party, settle, compromise or consent
to the entry of any judgment in any pending or threatened claim, action, suit or proceeding in respect of which defense and/or
indemnification may be sought hereunder unless such settlement, compromise or consent includes an unconditional release of the Party
seeking defense and/or indemnity from all liability arising out of such claim, action, suit or proceeding.
3.
The Party seeking defense or indemnification hereunder shall: (i) promptly notify the other Party of the matter for which defense or
indemnification is sought; (ii) subject to the immediately preceding sentence of this paragraph, provide the other Party with sole
control over the defense and/or settlement thereof, including but not limited to the selection of counsel; and (iii) at the request
of the Party providing defense and/or indemnification, fully cooperate in the provision of full and complete information and
reasonable assistance with respect to the defense of such matter.
I. Survival
The
obligations of the Parties pursuant to Sections E, F, and H shall survive the Termination of this Agreement, regardless of the reason
for such Termination, along with any and all other provisions that expressly provide for survival of Termination.
J. Relationship
of the Parties; Independent Contractor Status
The
Parties agree that the relationship created by this Engagement is one of an independent contractor. The Parties further agree that the
Consultant is not and shall not be considered an employee of the Company and is not and shall not be entitled to any of the rights and/or
benefits that the Company provides for the Company’s employees (including any employee pension, health, vacation pay, sick pay
or other fringe benefits offered by the Company under plan or practice) by virtue of the Services being rendered by the Consultant or
otherwise. The Consultant is responsible for all taxes, if any, imposed on it in connection with its performance of Services under this
Agreement, including any federal, state and local income, sales, use, excise and other taxes or assessments thereon.
5
K. Binding
Nature; Assignments
This
Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective successors, representatives, administrators,
heirs, executors and permitted assigns, except that the duties the Consultant are personal and shall not be assigned or subcontracted
without the Company’s prior written consent and any purported assignment without such written consent shall be deemed void and
unenforceable.
L. Entire
Agreement; Amendments
This
Agreement contains the entire understanding between the Parties with respect to its subject matter and supersedes all previous negotiations,
agreements or understandings between the Parties, whether written or verbal, including, without limitation, the Prior Consulting Agreement.
This Agreement may not be amended or modified, except in writing, executed by duly authorized representatives of the Parties hereto.
M. Counterparts
This
Agreement may be signed simultaneously in any number of counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same document.
N. Governing
Law; Consent to Jurisdiction and Venue
This
Agreement shall be governed by the internal laws of the State of Delaware without regard to choice of law principles. Any dispute regarding
this Agreement shall be subject to the exclusive jurisdiction of the state and federal courts of the State of New York located in the
New York County, and of the United States District Court of the Southern District of New York and the parties agree to submit to the
personal jurisdiction and venue in these courts. Each Party waives the right to a trial by jury in any such dispute. The prevailing
or non-dismissing party in any such dispute shall be entitled to reimbursement of all reasonable expenses, including court costs and
attorney fees incurred in good faith.
O. Notices
All
notices, requests, demands and other communications hereunder must be in writing and shall be deemed to have been duly given (i) when
delivered personally to the party to receive the same, (ii) when mailed first class postage prepaid, by certified mail, return receipt
requested, or (iii) when transmitted by electronic mail, in each case addressed to the party to receive the same at his or its address
set forth below, or such other address as the party to receive the same shall have specified by written notice given in the manner provided
for in this Section O:
If
to the Company:
StableX
Technologies, Inc.
1185 Avenue
of the Americas
New York,
NY 10036
Attn: Joshua
Silverman, Chief Executive Officer
If to the
Consultant:
To the most
recent address of the Consultant in the Company’s records
P. Severability
If
any provision of this Agreement is found to be invalid or unenforceable for any reason by a court of competent jurisdiction, that provision
shall be stricken from this Agreement and that finding shall not invalidate any other terms of this Agreement, which terms shall remain
in full force and effect according to the surviving terms of this Agreement. In such an event, the Parties shall negotiate with one another
to agree on a provision which the Parties would have agreed if they had known of the defect when they signed this Agreement, in order
to achieve the same commercial outcome and objectives of this Agreement that were intended upon its execution.
[Signature
Page Follows]
6
IN
WITNESS WHEREOF, this Agreement has been duly executed by or on behalf of the Parties as of its Effective Date.
COMPANY:
StableX
Technologies, Inc.
By:
/s/Joshua
Silverman
Name:
Joshua Silverman
Title:
Chief
Executive Officer
CONSULTANT:
JD
Advisors, LLC
By:
/s/
James Altucher
Name:
James Altucher
Title:
Co-Manger
[Signature
Page to Consulting Services Agreement]
Exhibit
A
Warrant
Cancellation Agreement
Exhibit
B
Consulting Fee
1. Warrants
to purchase 300,000 shares of Common Stock, at an exercise price of $3.00 per share.
2. Warrants
to purchase 200,000 shares of Common Stock, at an exercise price of $6.00 per share.
3. Warrants
to purchase 200,000 shares of Common Stock, at an exercise price of $9.00 per share.
4. Warrants
to purchase 200,000 shares of Common Stock, at an exercise price of $12.00 per share.
Each
Warrant shall be subject to vesting, forfeiture and such other terms as set forth in the form of warrant agreement.
Exhibit
C
Forms
of Warrant
[provided
separately]
EX-99.1
EX-99.1
Filename: ex99-1.htm · Sequence: 18
Exhibit
99.1
Fabric.AI
(Nasdaq: SBLX) Launches Breakthrough MicroLED Interconnect Technology as First Step in Building Next-Generation “AI Factory”
Infrastructure. Partners with Leading MicroLED Developer Kopin Corporation (Nasdaq: KOPN)
Introducing
a new suite of fabless semiconductor technologies designed to power AI factories—smart data centers optimized for producing intelligence
at scale; Initial focus on MicroLED optical interconnects to take leadership in $100 Billion+ industry in partnership with Kopin Corporation,
the only company to produce programmable MicroLEDs. As part of the development deal, Kopin Corporation will own 19.9% of Fabric.AI
Company
raises $21.5 million led by existing investors
NEW
YORK, NY (April 28, 2026) – Fabric.AI, (Nasdaq: SBLX) formerly StableX Technologies Inc., (the “Company”
or, “Fabric.AI”), today announces its official launch, unveiling a breakthrough MicroLED-based optical interconnect technology
(an “interconnect”) designed to address one of the most critical bottlenecks in modern AI computing: the movement of data
between increasingly powerful compute systems.
Fabric.AI’s
initial technology, the Neural I/o™ chip, being developed in collaboration with Kopin Corporation, the only company to produce
programmable MicroLEDs, replaces traditional electrical interconnects with MicroLED-based optical links. This enables ultra-high-bandwidth,
low-latency communication between compute nodes while significantly improving energy efficiency. This represents the first in a broader
suite of fabless semiconductor technologies that Fabric.AI is developing to power AI factories (a term coined by Jensen Huang
at the Nvidia GTC Conference),smart data centers optimized for continuously producing intelligence at scale.
The
Neural I/o™ chip leverages Kopin’s proprietary MicroLED and patented bi-directional NeuralDisplay™ architecture, repurposing
programmable MicroLED pixels as ultra-high speed optical transceivers capable of moving data at ultra-high speeds while consuming considerably
less power per bit than existing copper or laser-based solutions.
“MicroLED
technology represents a powerful new frontier beyond displays,” said Michael Murray, CEO of Kopin Corporation. “Our collaboration
with Fabric.AI extends the reach of our technology into AI infrastructure, enabling a new class of interconnect solutions designed for
scale, efficiency, and performance. Performance that aims to far exceed that of laser- based or traditional copper-based interconnects.”
The
interconnect market is estimated at approximately $138B according to 360iResearch and is dominated by copper and electricity solutions
as opposed to faster, lower latency optical MicroLED solutions. Unlike traditional copper-based interconnects, which suffer from signal
degradation, heat generation, and power inefficiencies at scale, Fabric.AI’s optical approach enables more efficient data transmission—unlocking
higher system-level performance.
Building
on this foundation, Fabric.AI is developing a broader suite of fabless semiconductor technologies designed specifically for AI workloads.
“AI
is no longer just software—it’s an industrial process,” said Josh Silverman, Fabric.AI’s Chief Executive Officer.
“The defining challenge is no longer just compute performance, but how efficiently that compute can communicate and operate as
a unified system. We’re starting with interconnects because that’s where the bottleneck is most acute, but our vision is
much broader. Fabric.AI is building the semiconductor technologies that aim to power the next generation of smart data centers.”
Fabric.AI
also announced that it changed its corporate name from StableX Technologies, Inc. to Fabric.AI, Inc., effective today, to better reflect
its strategic transformation. In addition to its new name, Fabric.AI will also be changing its ticker to “FABC,” which will
commence trading under the new symbol on Nasdaq beginning with the market open on April 29, 2026.
Strategic
Collaboration with Kopin Corporation
Fabric.AI’s
interconnect technology, designed specifically for AI workloads, is being developed in close collaboration with Kopin Corporation,
leveraging Kopin’s proprietary MicroLED innovations as the foundation for next-generation optical communication systems.
This
collaboration combines Fabric.AI’s system-level design with Kopin’s deep expertise in MicroLED materials, process development,
and fabrication. Both companies will jointly develop and share in the intellectual property created through the partnership, accelerating
innovation while working to establish a defensible technology position in AI infrastructure.
Positioned
for the AI Infrastructure Era
Fabric.AI
is currently engaged in preliminary discussions with leading AI and hyperscale technology companies regarding the integration of its
MicroLED-based interconnect technology into next-generation systems. The Company believes this growing interest reflects a broader shift
toward smarter, more tightly integrated data centers optimized specifically for AI.
By
developing a suite of tightly integrated semiconductor technologies—beginning with interconnect and expanding into additional system-critical
components—Fabric.AI aims to become a foundational technology provider for the infrastructure powering the next era of artificial
intelligence.
Financing
Fabric.AI
also announces that it will be raising $21.5 million, mostly from existing shareholders with the sale in a private placement of 21,500
shares of its newly designated Series K convertible preferred stock ("preferred stock"), with a stated value of $1,000 per
share, convertible into shares of the Company’s common stock and accompanying warrants. The shares of preferred stock have
an initial conversion price of $2.51 per share. The warrants are exercisable immediately upon issuance, have an initial exercise price
of $2.51 per share and expire five years from the date of issuance. The transaction is expected to close on or about April 29, 2026,
subject to the satisfaction of customary closing conditions. The full conversion of the preferred stock and the full exercise of the
accompanying warrants are subject to stockholder approval.
The
financing will be more fully disclosed in the Company’s Current Report on Form 8-K to be filed with the SEC on or about April
28, 2026.
The
securities in the private placement were offered and sold in transactions exempt from the registration requirements of the Securities
Act of 1933, as amended (the “Securities Act”), pursuant to the exemption for transactions by an issuer not involving any
public offering under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D of the Securities Act and in reliance on similar
exemptions under applicable state laws.
This
press release is not an offer to sell, or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state
or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities
laws of any such state or jurisdiction.
About
Fabric.AI
Fabric.AI
is an infrastructure company building a suite of fabless semiconductor technologies to power AI factories—smart data centers optimized
for producing intelligence at scale. The Company has exited its prior digital asset treasury strategy and is now singularly focused on
capturing the significantly larger opportunity in AI infrastructure.
The
Company is reallocating capital to accelerate development of its core technologies. Fabric.AI is building MicroLED-based optical interconnects
and other system-critical semiconductor solutions designed to unlock faster, more efficient, and more scalable AI workloads.
In
connection with this transformation, the Company is changing its name to Fabric.AI and intends to change its stock symbol to FABC.
Fabric.AI’s
mission is to solve the bottlenecks of AI data centers using breakthrough technologies in AI infrastructure.
About
Kopin Corporation
Kopin
Corporation (Nasdaq: KOPN) is a leading developer and provider of innovative display and application-specific optical solutions sold
as critical components and subassemblies for defense, enterprise, professional and consumer products. Kopin’s portfolio includes
microdisplays, display modules, eyepiece assemblies, image projection modules and vehicle mounted and head-mounted display systems that
incorporate ultra-small high-resolution Active Matrix Liquid Crystal displays (AMLCD), Ferroelectric Liquid Crystal on Silicon (FLCoS)
displays, MicroLED displays (µLED) and Organic Light Emitting Diode (OLED) displays, a variety of optics and low-power ASICs. For
more information, please visit Kopin’s website at www.kopin.com. Kopin is a trademark of Kopin Corporation.
Forward-Looking
Statements
This
press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve known and unknown risks, uncertainties
and other factors which may cause actual results, performance or achievements to be materially different from any expected future results,
performance or achievements. Words such as “anticipate,” “believe,” “could,” “estimate,”
“intend,” “expect,” “may,” “plan,” “will,” “would” and their
opposites and similar expressions are intended to identify forward-looking statements. Forward-looking statements in this press release
include, but are not limited to, statements regarding: the expected capabilities and performance of the Company’s MicroLED-based
optical interconnect technology; the Company’s plans to develop a broader suite of fabless semiconductor technologies for AI workloads;
the anticipated benefits of the Company’s collaboration with Kopin Corporation; the expected completion of the private placement
and satisfaction of customary closing conditions; and the Company’s strategic vision to become a foundational technology provider
for AI infrastructure. Such forward-looking statements are based on the beliefs of management as well as assumptions made by and information
currently available to management.
Important
factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, without
limitation: the Company’s MicroLED-based interconnect technology is at an early stage of development and may not achieve the anticipated
performance; the Company’s dependence on its collaboration with Kopin Corporation for critical MicroLED technology components and
intellectual property, and the risk that such collaboration may not produce commercially viable products or may be terminated; the Company
may be unable to successfully develop or commercialize additional semiconductor technologies; the markets for AI infrastructure and optical
interconnect technologies are rapidly evolving and highly competitive; the Company has limited operating history in the AI semiconductor
industry, which makes evaluating its business and future prospects difficult; the Company may require substantial additional capital
to fund the development and commercialization of its technologies, and such capital may not be available on acceptable terms or at all;
the Company’s transition from its prior digital asset treasury strategy involves risks; and the Company may face intellectual property
risks, including the ability to protect its proprietary technology and avoid infringement of third-party rights.
A
discussion of these and other factors with respect to the Company is set forth in the Company’s most recent Annual Report on Form
10-K and subsequent reports on Form 10-Q filed with the Securities and Exchange Commission. Forward-looking statements speak only as
of the date they are made, and the Company disclaims any intention or obligation to revise any forward-looking statements, whether as
a result of new information, future events or otherwise.
IR
Contact:
CORE IR
212-644-0924
ir@fabric-ai.co
Media
Contact:
Fabric.AI
press@fabric-ai.co
www.fabricai.com
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 23
v3.26.1
Cover
Apr. 27, 2026
Cover [Abstract]
Document Type
8-K
Amendment Flag
false
Document Period End Date
Apr. 27, 2026
Current Fiscal Year End Date
--12-31
Entity File Number
001-34643
Entity Registrant Name
StableX
Technologies, Inc.
Entity Central Index Key
0001086745
Entity Tax Identification Number
98-0204758
Entity Incorporation, State or Country Code
DE
Entity Address, Address Line One
1185
Avenue of the Americas
Entity Address, City or Town
New
York
Entity Address, State or Province
NY
Entity Address, Postal Zip Code
10036
City Area Code
512
Local Phone Number
994-4917
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Common
stock, par value $0.0001 per share
Trading Symbol
SBLX
Security Exchange Name
NASDAQ
Entity Emerging Growth Company
false
Entity Information, Former Legal or Registered Name
StableX
Technologies, Inc.
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details
Name:
dei_CurrentFiscalYearEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:gMonthDayItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Former Legal or Registered Name of an entity
+ References
No definition available.
+ Details
Name:
dei_EntityInformationFormerLegalOrRegisteredName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration